0000102816falseN-CSREATON VANCE GROWTH TRUSTN-1A2026-08-310000102816eatonvance:C000104752Member2025-09-012026-08-3100001028162025-09-012026-08-310000102816eatonvance:EATONVANCEIndexMSCIWorld19148BroadBasedIndexMember2025-09-012026-08-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19148AdditionalIndexMember2025-09-012026-08-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19148AdditionalIndexMember2025-09-012026-08-310000102816eatonvance:C000104752Member2016-08-312016-08-310000102816eatonvance:EATONVANCEIndexMSCIWorld19148BroadBasedIndexMember2016-08-312016-08-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19148AdditionalIndexMember2016-08-312016-08-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19148AdditionalIndexMember2016-08-312016-08-310000102816eatonvance:C000104752Member2016-09-012016-09-300000102816eatonvance:EATONVANCEIndexMSCIWorld19148BroadBasedIndexMember2016-09-012016-09-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19148AdditionalIndexMember2016-09-012016-09-300000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19148AdditionalIndexMember2016-09-012016-09-300000102816eatonvance:C000104752Member2016-09-012016-10-310000102816eatonvance:EATONVANCEIndexMSCIWorld19148BroadBasedIndexMember2016-09-012016-10-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19148AdditionalIndexMember2016-09-012016-10-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19148AdditionalIndexMember2016-09-012016-10-310000102816eatonvance:C000104752Member2016-09-012016-11-300000102816eatonvance:EATONVANCEIndexMSCIWorld19148BroadBasedIndexMember2016-09-012016-11-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19148AdditionalIndexMember2016-09-012016-11-300000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19148AdditionalIndexMember2016-09-012016-11-300000102816eatonvance:C000104752Member2016-09-012016-12-310000102816eatonvance:EATONVANCEIndexMSCIWorld19148BroadBasedIndexMember2016-09-012016-12-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19148AdditionalIndexMember2016-09-012016-12-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19148AdditionalIndexMember2016-09-012016-12-310000102816eatonvance:C000104752Member2016-09-012017-01-310000102816eatonvance:EATONVANCEIndexMSCIWorld19148BroadBasedIndexMember2016-09-012017-01-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19148AdditionalIndexMember2016-09-012017-01-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19148AdditionalIndexMember2016-09-012017-01-310000102816eatonvance:C000104752Member2016-09-012017-02-280000102816eatonvance:EATONVANCEIndexMSCIWorld19148BroadBasedIndexMember2016-09-012017-02-280000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19148AdditionalIndexMember2016-09-012017-02-280000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19148AdditionalIndexMember2016-09-012017-02-280000102816eatonvance:C000104752Member2016-09-012017-03-310000102816eatonvance:EATONVANCEIndexMSCIWorld19148BroadBasedIndexMember2016-09-012017-03-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19148AdditionalIndexMember2016-09-012017-03-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19148AdditionalIndexMember2016-09-012017-03-310000102816eatonvance:C000104752Member2016-09-012017-04-300000102816eatonvance:EATONVANCEIndexMSCIWorld19148BroadBasedIndexMember2016-09-012017-04-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19148AdditionalIndexMember2016-09-012017-04-300000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19148AdditionalIndexMember2016-09-012017-04-300000102816eatonvance:C000104752Member2016-09-012017-05-310000102816eatonvance:EATONVANCEIndexMSCIWorld19148BroadBasedIndexMember2016-09-012017-05-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19148AdditionalIndexMember2016-09-012017-05-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19148AdditionalIndexMember2016-09-012017-05-310000102816eatonvance:C000104752Member2016-09-012017-06-300000102816eatonvance:EATONVANCEIndexMSCIWorld19148BroadBasedIndexMember2016-09-012017-06-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19148AdditionalIndexMember2016-09-012017-06-300000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19148AdditionalIndexMember2016-09-012017-06-300000102816eatonvance:C000104752Member2016-09-012017-07-310000102816eatonvance:EATONVANCEIndexMSCIWorld19148BroadBasedIndexMember2016-09-012017-07-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19148AdditionalIndexMember2016-09-012017-07-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19148AdditionalIndexMember2016-09-012017-07-310000102816eatonvance:C000104752Member2016-09-012017-08-310000102816eatonvance:EATONVANCEIndexMSCIWorld19148BroadBasedIndexMember2016-09-012017-08-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19148AdditionalIndexMember2016-09-012017-08-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19148AdditionalIndexMember2016-09-012017-08-310000102816eatonvance:C000104752Member2016-09-012017-09-300000102816eatonvance:EATONVANCEIndexMSCIWorld19148BroadBasedIndexMember2016-09-012017-09-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19148AdditionalIndexMember2016-09-012017-09-300000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19148AdditionalIndexMember2016-09-012017-09-300000102816eatonvance:C000104752Member2016-09-012017-10-310000102816eatonvance:EATONVANCEIndexMSCIWorld19148BroadBasedIndexMember2016-09-012017-10-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19148AdditionalIndexMember2016-09-012017-10-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19148AdditionalIndexMember2016-09-012017-10-310000102816eatonvance:C000104752Member2016-09-012017-11-300000102816eatonvance:EATONVANCEIndexMSCIWorld19148BroadBasedIndexMember2016-09-012017-11-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19148AdditionalIndexMember2016-09-012017-11-300000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19148AdditionalIndexMember2016-09-012017-11-300000102816eatonvance:C000104752Member2016-09-012017-12-310000102816eatonvance:EATONVANCEIndexMSCIWorld19148BroadBasedIndexMember2016-09-012017-12-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19148AdditionalIndexMember2016-09-012017-12-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19148AdditionalIndexMember2016-09-012017-12-310000102816eatonvance:C000104752Member2016-09-012018-01-310000102816eatonvance:EATONVANCEIndexMSCIWorld19148BroadBasedIndexMember2016-09-012018-01-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19148AdditionalIndexMember2016-09-012018-01-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19148AdditionalIndexMember2016-09-012018-01-310000102816eatonvance:C000104752Member2016-09-012018-02-280000102816eatonvance:EATONVANCEIndexMSCIWorld19148BroadBasedIndexMember2016-09-012018-02-280000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19148AdditionalIndexMember2016-09-012018-02-280000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19148AdditionalIndexMember2016-09-012018-02-280000102816eatonvance:C000104752Member2016-09-012018-03-310000102816eatonvance:EATONVANCEIndexMSCIWorld19148BroadBasedIndexMember2016-09-012018-03-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19148AdditionalIndexMember2016-09-012018-03-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19148AdditionalIndexMember2016-09-012018-03-310000102816eatonvance:C000104752Member2016-09-012018-04-300000102816eatonvance:EATONVANCEIndexMSCIWorld19148BroadBasedIndexMember2016-09-012018-04-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19148AdditionalIndexMember2016-09-012018-04-300000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19148AdditionalIndexMember2016-09-012018-04-300000102816eatonvance:C000104752Member2016-09-012018-05-310000102816eatonvance:EATONVANCEIndexMSCIWorld19148BroadBasedIndexMember2016-09-012018-05-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19148AdditionalIndexMember2016-09-012018-05-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19148AdditionalIndexMember2016-09-012018-05-310000102816eatonvance:C000104752Member2016-09-012018-06-300000102816eatonvance:EATONVANCEIndexMSCIWorld19148BroadBasedIndexMember2016-09-012018-06-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19148AdditionalIndexMember2016-09-012018-06-300000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19148AdditionalIndexMember2016-09-012018-06-300000102816eatonvance:C000104752Member2016-09-012018-07-310000102816eatonvance:EATONVANCEIndexMSCIWorld19148BroadBasedIndexMember2016-09-012018-07-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19148AdditionalIndexMember2016-09-012018-07-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19148AdditionalIndexMember2016-09-012018-07-310000102816eatonvance:C000104752Member2016-09-012018-08-310000102816eatonvance:EATONVANCEIndexMSCIWorld19148BroadBasedIndexMember2016-09-012018-08-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19148AdditionalIndexMember2016-09-012018-08-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19148AdditionalIndexMember2016-09-012018-08-310000102816eatonvance:C000104752Member2016-09-012018-09-300000102816eatonvance:EATONVANCEIndexMSCIWorld19148BroadBasedIndexMember2016-09-012018-09-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19148AdditionalIndexMember2016-09-012018-09-300000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19148AdditionalIndexMember2016-09-012018-09-300000102816eatonvance:C000104752Member2016-09-012018-10-310000102816eatonvance:EATONVANCEIndexMSCIWorld19148BroadBasedIndexMember2016-09-012018-10-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19148AdditionalIndexMember2016-09-012018-10-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19148AdditionalIndexMember2016-09-012018-10-310000102816eatonvance:C000104752Member2016-09-012018-11-300000102816eatonvance:EATONVANCEIndexMSCIWorld19148BroadBasedIndexMember2016-09-012018-11-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19148AdditionalIndexMember2016-09-012018-11-300000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19148AdditionalIndexMember2016-09-012018-11-300000102816eatonvance:C000104752Member2016-09-012018-12-310000102816eatonvance:EATONVANCEIndexMSCIWorld19148BroadBasedIndexMember2016-09-012018-12-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19148AdditionalIndexMember2016-09-012018-12-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19148AdditionalIndexMember2016-09-012018-12-310000102816eatonvance:C000104752Member2016-09-012019-01-310000102816eatonvance:EATONVANCEIndexMSCIWorld19148BroadBasedIndexMember2016-09-012019-01-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19148AdditionalIndexMember2016-09-012019-01-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19148AdditionalIndexMember2016-09-012019-01-310000102816eatonvance:C000104752Member2016-09-012019-02-280000102816eatonvance:EATONVANCEIndexMSCIWorld19148BroadBasedIndexMember2016-09-012019-02-280000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19148AdditionalIndexMember2016-09-012019-02-280000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19148AdditionalIndexMember2016-09-012019-02-280000102816eatonvance:C000104752Member2016-09-012019-03-310000102816eatonvance:EATONVANCEIndexMSCIWorld19148BroadBasedIndexMember2016-09-012019-03-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19148AdditionalIndexMember2016-09-012019-03-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19148AdditionalIndexMember2016-09-012019-03-310000102816eatonvance:C000104752Member2016-09-012019-04-300000102816eatonvance:EATONVANCEIndexMSCIWorld19148BroadBasedIndexMember2016-09-012019-04-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19148AdditionalIndexMember2016-09-012019-04-300000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19148AdditionalIndexMember2016-09-012019-04-300000102816eatonvance:C000104752Member2016-09-012019-05-310000102816eatonvance:EATONVANCEIndexMSCIWorld19148BroadBasedIndexMember2016-09-012019-05-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19148AdditionalIndexMember2016-09-012019-05-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19148AdditionalIndexMember2016-09-012019-05-310000102816eatonvance:C000104752Member2016-09-012019-06-300000102816eatonvance:EATONVANCEIndexMSCIWorld19148BroadBasedIndexMember2016-09-012019-06-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19148AdditionalIndexMember2016-09-012019-06-300000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19148AdditionalIndexMember2016-09-012019-06-300000102816eatonvance:C000104752Member2016-09-012019-07-310000102816eatonvance:EATONVANCEIndexMSCIWorld19148BroadBasedIndexMember2016-09-012019-07-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19148AdditionalIndexMember2016-09-012019-07-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19148AdditionalIndexMember2016-09-012019-07-310000102816eatonvance:C000104752Member2016-09-012019-08-310000102816eatonvance:EATONVANCEIndexMSCIWorld19148BroadBasedIndexMember2016-09-012019-08-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19148AdditionalIndexMember2016-09-012019-08-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19148AdditionalIndexMember2016-09-012019-08-310000102816eatonvance:C000104752Member2016-09-012019-09-300000102816eatonvance:EATONVANCEIndexMSCIWorld19148BroadBasedIndexMember2016-09-012019-09-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19148AdditionalIndexMember2016-09-012019-09-300000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19148AdditionalIndexMember2016-09-012019-09-300000102816eatonvance:C000104752Member2016-09-012019-10-310000102816eatonvance:EATONVANCEIndexMSCIWorld19148BroadBasedIndexMember2016-09-012019-10-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19148AdditionalIndexMember2016-09-012019-10-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19148AdditionalIndexMember2016-09-012019-10-310000102816eatonvance:C000104752Member2016-09-012019-11-300000102816eatonvance:EATONVANCEIndexMSCIWorld19148BroadBasedIndexMember2016-09-012019-11-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19148AdditionalIndexMember2016-09-012019-11-300000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19148AdditionalIndexMember2016-09-012019-11-300000102816eatonvance:C000104752Member2016-09-012019-12-310000102816eatonvance:EATONVANCEIndexMSCIWorld19148BroadBasedIndexMember2016-09-012019-12-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19148AdditionalIndexMember2016-09-012019-12-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19148AdditionalIndexMember2016-09-012019-12-310000102816eatonvance:C000104752Member2016-09-012020-01-310000102816eatonvance:EATONVANCEIndexMSCIWorld19148BroadBasedIndexMember2016-09-012020-01-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19148AdditionalIndexMember2016-09-012020-01-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19148AdditionalIndexMember2016-09-012020-01-310000102816eatonvance:C000104752Member2016-09-012020-02-290000102816eatonvance:EATONVANCEIndexMSCIWorld19148BroadBasedIndexMember2016-09-012020-02-290000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19148AdditionalIndexMember2016-09-012020-02-290000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19148AdditionalIndexMember2016-09-012020-02-290000102816eatonvance:C000104752Member2016-09-012020-03-310000102816eatonvance:EATONVANCEIndexMSCIWorld19148BroadBasedIndexMember2016-09-012020-03-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19148AdditionalIndexMember2016-09-012020-03-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19148AdditionalIndexMember2016-09-012020-03-310000102816eatonvance:C000104752Member2016-09-012020-04-300000102816eatonvance:EATONVANCEIndexMSCIWorld19148BroadBasedIndexMember2016-09-012020-04-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19148AdditionalIndexMember2016-09-012020-04-300000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19148AdditionalIndexMember2016-09-012020-04-300000102816eatonvance:C000104752Member2016-09-012020-05-310000102816eatonvance:EATONVANCEIndexMSCIWorld19148BroadBasedIndexMember2016-09-012020-05-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19148AdditionalIndexMember2016-09-012020-05-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19148AdditionalIndexMember2016-09-012020-05-310000102816eatonvance:C000104752Member2016-09-012020-06-300000102816eatonvance:EATONVANCEIndexMSCIWorld19148BroadBasedIndexMember2016-09-012020-06-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19148AdditionalIndexMember2016-09-012020-06-300000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19148AdditionalIndexMember2016-09-012020-06-300000102816eatonvance:C000104752Member2016-09-012020-07-310000102816eatonvance:EATONVANCEIndexMSCIWorld19148BroadBasedIndexMember2016-09-012020-07-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19148AdditionalIndexMember2016-09-012020-07-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19148AdditionalIndexMember2016-09-012020-07-310000102816eatonvance:C000104752Member2016-09-012020-08-310000102816eatonvance:EATONVANCEIndexMSCIWorld19148BroadBasedIndexMember2016-09-012020-08-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19148AdditionalIndexMember2016-09-012020-08-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19148AdditionalIndexMember2016-09-012020-08-310000102816eatonvance:C000104752Member2016-09-012020-09-300000102816eatonvance:EATONVANCEIndexMSCIWorld19148BroadBasedIndexMember2016-09-012020-09-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19148AdditionalIndexMember2016-09-012020-09-300000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19148AdditionalIndexMember2016-09-012020-09-300000102816eatonvance:C000104752Member2016-09-012020-10-310000102816eatonvance:EATONVANCEIndexMSCIWorld19148BroadBasedIndexMember2016-09-012020-10-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19148AdditionalIndexMember2016-09-012020-10-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19148AdditionalIndexMember2016-09-012020-10-310000102816eatonvance:C000104752Member2016-09-012020-11-300000102816eatonvance:EATONVANCEIndexMSCIWorld19148BroadBasedIndexMember2016-09-012020-11-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19148AdditionalIndexMember2016-09-012020-11-300000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19148AdditionalIndexMember2016-09-012020-11-300000102816eatonvance:C000104752Member2016-09-012020-12-310000102816eatonvance:EATONVANCEIndexMSCIWorld19148BroadBasedIndexMember2016-09-012020-12-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19148AdditionalIndexMember2016-09-012020-12-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19148AdditionalIndexMember2016-09-012020-12-310000102816eatonvance:C000104752Member2016-09-012021-01-310000102816eatonvance:EATONVANCEIndexMSCIWorld19148BroadBasedIndexMember2016-09-012021-01-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19148AdditionalIndexMember2016-09-012021-01-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19148AdditionalIndexMember2016-09-012021-01-310000102816eatonvance:C000104752Member2016-09-012021-02-280000102816eatonvance:EATONVANCEIndexMSCIWorld19148BroadBasedIndexMember2016-09-012021-02-280000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19148AdditionalIndexMember2016-09-012021-02-280000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19148AdditionalIndexMember2016-09-012021-02-280000102816eatonvance:C000104752Member2016-09-012021-03-310000102816eatonvance:EATONVANCEIndexMSCIWorld19148BroadBasedIndexMember2016-09-012021-03-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19148AdditionalIndexMember2016-09-012021-03-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19148AdditionalIndexMember2016-09-012021-03-310000102816eatonvance:C000104752Member2016-09-012021-04-300000102816eatonvance:EATONVANCEIndexMSCIWorld19148BroadBasedIndexMember2016-09-012021-04-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19148AdditionalIndexMember2016-09-012021-04-300000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19148AdditionalIndexMember2016-09-012021-04-300000102816eatonvance:C000104752Member2016-09-012021-05-310000102816eatonvance:EATONVANCEIndexMSCIWorld19148BroadBasedIndexMember2016-09-012021-05-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19148AdditionalIndexMember2016-09-012021-05-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19148AdditionalIndexMember2016-09-012021-05-310000102816eatonvance:C000104752Member2016-09-012021-06-300000102816eatonvance:EATONVANCEIndexMSCIWorld19148BroadBasedIndexMember2016-09-012021-06-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19148AdditionalIndexMember2016-09-012021-06-300000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19148AdditionalIndexMember2016-09-012021-06-300000102816eatonvance:C000104752Member2016-09-012021-07-310000102816eatonvance:EATONVANCEIndexMSCIWorld19148BroadBasedIndexMember2016-09-012021-07-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19148AdditionalIndexMember2016-09-012021-07-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19148AdditionalIndexMember2016-09-012021-07-310000102816eatonvance:C000104752Member2016-09-012021-08-310000102816eatonvance:EATONVANCEIndexMSCIWorld19148BroadBasedIndexMember2016-09-012021-08-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19148AdditionalIndexMember2016-09-012021-08-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19148AdditionalIndexMember2016-09-012021-08-310000102816eatonvance:C000104752Member2016-09-012021-09-300000102816eatonvance:EATONVANCEIndexMSCIWorld19148BroadBasedIndexMember2016-09-012021-09-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19148AdditionalIndexMember2016-09-012021-09-300000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19148AdditionalIndexMember2016-09-012021-09-300000102816eatonvance:C000104752Member2016-09-012021-10-310000102816eatonvance:EATONVANCEIndexMSCIWorld19148BroadBasedIndexMember2016-09-012021-10-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19148AdditionalIndexMember2016-09-012021-10-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19148AdditionalIndexMember2016-09-012021-10-310000102816eatonvance:C000104752Member2016-09-012021-11-300000102816eatonvance:EATONVANCEIndexMSCIWorld19148BroadBasedIndexMember2016-09-012021-11-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19148AdditionalIndexMember2016-09-012021-11-300000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19148AdditionalIndexMember2016-09-012021-11-300000102816eatonvance:C000104752Member2016-09-012021-12-310000102816eatonvance:EATONVANCEIndexMSCIWorld19148BroadBasedIndexMember2016-09-012021-12-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19148AdditionalIndexMember2016-09-012021-12-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19148AdditionalIndexMember2016-09-012021-12-310000102816eatonvance:C000104752Member2016-09-012022-01-310000102816eatonvance:EATONVANCEIndexMSCIWorld19148BroadBasedIndexMember2016-09-012022-01-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19148AdditionalIndexMember2016-09-012022-01-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19148AdditionalIndexMember2016-09-012022-01-310000102816eatonvance:C000104752Member2016-09-012022-02-280000102816eatonvance:EATONVANCEIndexMSCIWorld19148BroadBasedIndexMember2016-09-012022-02-280000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19148AdditionalIndexMember2016-09-012022-02-280000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19148AdditionalIndexMember2016-09-012022-02-280000102816eatonvance:C000104752Member2016-09-012022-03-310000102816eatonvance:EATONVANCEIndexMSCIWorld19148BroadBasedIndexMember2016-09-012022-03-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19148AdditionalIndexMember2016-09-012022-03-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19148AdditionalIndexMember2016-09-012022-03-310000102816eatonvance:C000104752Member2016-09-012022-04-300000102816eatonvance:EATONVANCEIndexMSCIWorld19148BroadBasedIndexMember2016-09-012022-04-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19148AdditionalIndexMember2016-09-012022-04-300000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19148AdditionalIndexMember2016-09-012022-04-300000102816eatonvance:C000104752Member2016-09-012022-05-310000102816eatonvance:EATONVANCEIndexMSCIWorld19148BroadBasedIndexMember2016-09-012022-05-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19148AdditionalIndexMember2016-09-012022-05-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19148AdditionalIndexMember2016-09-012022-05-310000102816eatonvance:C000104752Member2016-09-012022-06-300000102816eatonvance:EATONVANCEIndexMSCIWorld19148BroadBasedIndexMember2016-09-012022-06-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19148AdditionalIndexMember2016-09-012022-06-300000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19148AdditionalIndexMember2016-09-012022-06-300000102816eatonvance:C000104752Member2016-09-012022-07-310000102816eatonvance:EATONVANCEIndexMSCIWorld19148BroadBasedIndexMember2016-09-012022-07-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19148AdditionalIndexMember2016-09-012022-07-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19148AdditionalIndexMember2016-09-012022-07-310000102816eatonvance:C000104752Member2016-09-012022-08-310000102816eatonvance:EATONVANCEIndexMSCIWorld19148BroadBasedIndexMember2016-09-012022-08-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19148AdditionalIndexMember2016-09-012022-08-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19148AdditionalIndexMember2016-09-012022-08-310000102816eatonvance:C000104752Member2016-09-012022-09-300000102816eatonvance:EATONVANCEIndexMSCIWorld19148BroadBasedIndexMember2016-09-012022-09-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19148AdditionalIndexMember2016-09-012022-09-300000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19148AdditionalIndexMember2016-09-012022-09-300000102816eatonvance:C000104752Member2016-09-012022-10-310000102816eatonvance:EATONVANCEIndexMSCIWorld19148BroadBasedIndexMember2016-09-012022-10-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19148AdditionalIndexMember2016-09-012022-10-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19148AdditionalIndexMember2016-09-012022-10-310000102816eatonvance:C000104752Member2016-09-012022-11-300000102816eatonvance:EATONVANCEIndexMSCIWorld19148BroadBasedIndexMember2016-09-012022-11-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19148AdditionalIndexMember2016-09-012022-11-300000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19148AdditionalIndexMember2016-09-012022-11-300000102816eatonvance:C000104752Member2016-09-012022-12-310000102816eatonvance:EATONVANCEIndexMSCIWorld19148BroadBasedIndexMember2016-09-012022-12-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19148AdditionalIndexMember2016-09-012022-12-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19148AdditionalIndexMember2016-09-012022-12-310000102816eatonvance:C000104752Member2016-09-012023-01-310000102816eatonvance:EATONVANCEIndexMSCIWorld19148BroadBasedIndexMember2016-09-012023-01-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19148AdditionalIndexMember2016-09-012023-01-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19148AdditionalIndexMember2016-09-012023-01-310000102816eatonvance:C000104752Member2016-09-012023-02-280000102816eatonvance:EATONVANCEIndexMSCIWorld19148BroadBasedIndexMember2016-09-012023-02-280000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19148AdditionalIndexMember2016-09-012023-02-280000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19148AdditionalIndexMember2016-09-012023-02-280000102816eatonvance:C000104752Member2016-09-012023-03-310000102816eatonvance:EATONVANCEIndexMSCIWorld19148BroadBasedIndexMember2016-09-012023-03-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19148AdditionalIndexMember2016-09-012023-03-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19148AdditionalIndexMember2016-09-012023-03-310000102816eatonvance:C000104752Member2016-09-012023-04-300000102816eatonvance:EATONVANCEIndexMSCIWorld19148BroadBasedIndexMember2016-09-012023-04-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19148AdditionalIndexMember2016-09-012023-04-300000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19148AdditionalIndexMember2016-09-012023-04-300000102816eatonvance:C000104752Member2016-09-012023-05-310000102816eatonvance:EATONVANCEIndexMSCIWorld19148BroadBasedIndexMember2016-09-012023-05-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19148AdditionalIndexMember2016-09-012023-05-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19148AdditionalIndexMember2016-09-012023-05-310000102816eatonvance:C000104752Member2016-09-012023-06-300000102816eatonvance:EATONVANCEIndexMSCIWorld19148BroadBasedIndexMember2016-09-012023-06-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19148AdditionalIndexMember2016-09-012023-06-300000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19148AdditionalIndexMember2016-09-012023-06-300000102816eatonvance:C000104752Member2016-09-012023-07-310000102816eatonvance:EATONVANCEIndexMSCIWorld19148BroadBasedIndexMember2016-09-012023-07-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19148AdditionalIndexMember2016-09-012023-07-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19148AdditionalIndexMember2016-09-012023-07-310000102816eatonvance:C000104752Member2016-09-012023-08-310000102816eatonvance:EATONVANCEIndexMSCIWorld19148BroadBasedIndexMember2016-09-012023-08-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19148AdditionalIndexMember2016-09-012023-08-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19148AdditionalIndexMember2016-09-012023-08-310000102816eatonvance:C000104752Member2016-09-012023-09-300000102816eatonvance:EATONVANCEIndexMSCIWorld19148BroadBasedIndexMember2016-09-012023-09-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19148AdditionalIndexMember2016-09-012023-09-300000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19148AdditionalIndexMember2016-09-012023-09-300000102816eatonvance:C000104752Member2016-09-012023-10-310000102816eatonvance:EATONVANCEIndexMSCIWorld19148BroadBasedIndexMember2016-09-012023-10-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19148AdditionalIndexMember2016-09-012023-10-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19148AdditionalIndexMember2016-09-012023-10-310000102816eatonvance:C000104752Member2016-09-012023-11-300000102816eatonvance:EATONVANCEIndexMSCIWorld19148BroadBasedIndexMember2016-09-012023-11-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19148AdditionalIndexMember2016-09-012023-11-300000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19148AdditionalIndexMember2016-09-012023-11-300000102816eatonvance:C000104752Member2016-09-012023-12-310000102816eatonvance:EATONVANCEIndexMSCIWorld19148BroadBasedIndexMember2016-09-012023-12-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19148AdditionalIndexMember2016-09-012023-12-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19148AdditionalIndexMember2016-09-012023-12-310000102816eatonvance:C000104752Member2016-09-012024-01-310000102816eatonvance:EATONVANCEIndexMSCIWorld19148BroadBasedIndexMember2016-09-012024-01-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19148AdditionalIndexMember2016-09-012024-01-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19148AdditionalIndexMember2016-09-012024-01-310000102816eatonvance:C000104752Member2016-09-012024-02-290000102816eatonvance:EATONVANCEIndexMSCIWorld19148BroadBasedIndexMember2016-09-012024-02-290000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19148AdditionalIndexMember2016-09-012024-02-290000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19148AdditionalIndexMember2016-09-012024-02-290000102816eatonvance:C000104752Member2016-09-012024-03-310000102816eatonvance:EATONVANCEIndexMSCIWorld19148BroadBasedIndexMember2016-09-012024-03-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19148AdditionalIndexMember2016-09-012024-03-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19148AdditionalIndexMember2016-09-012024-03-310000102816eatonvance:C000104752Member2016-09-012024-04-300000102816eatonvance:EATONVANCEIndexMSCIWorld19148BroadBasedIndexMember2016-09-012024-04-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19148AdditionalIndexMember2016-09-012024-04-300000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19148AdditionalIndexMember2016-09-012024-04-300000102816eatonvance:C000104752Member2016-09-012024-05-310000102816eatonvance:EATONVANCEIndexMSCIWorld19148BroadBasedIndexMember2016-09-012024-05-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19148AdditionalIndexMember2016-09-012024-05-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19148AdditionalIndexMember2016-09-012024-05-310000102816eatonvance:C000104752Member2016-09-012024-06-300000102816eatonvance:EATONVANCEIndexMSCIWorld19148BroadBasedIndexMember2016-09-012024-06-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19148AdditionalIndexMember2016-09-012024-06-300000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19148AdditionalIndexMember2016-09-012024-06-300000102816eatonvance:C000104752Member2016-09-012024-07-310000102816eatonvance:EATONVANCEIndexMSCIWorld19148BroadBasedIndexMember2016-09-012024-07-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19148AdditionalIndexMember2016-09-012024-07-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19148AdditionalIndexMember2016-09-012024-07-310000102816eatonvance:C000104752Member2016-09-012024-08-310000102816eatonvance:EATONVANCEIndexMSCIWorld19148BroadBasedIndexMember2016-09-012024-08-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19148AdditionalIndexMember2016-09-012024-08-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19148AdditionalIndexMember2016-09-012024-08-310000102816eatonvance:C000104752Member2016-09-012024-09-300000102816eatonvance:EATONVANCEIndexMSCIWorld19148BroadBasedIndexMember2016-09-012024-09-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19148AdditionalIndexMember2016-09-012024-09-300000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19148AdditionalIndexMember2016-09-012024-09-300000102816eatonvance:C000104752Member2016-09-012024-10-310000102816eatonvance:EATONVANCEIndexMSCIWorld19148BroadBasedIndexMember2016-09-012024-10-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19148AdditionalIndexMember2016-09-012024-10-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19148AdditionalIndexMember2016-09-012024-10-310000102816eatonvance:C000104752Member2016-09-012024-11-300000102816eatonvance:EATONVANCEIndexMSCIWorld19148BroadBasedIndexMember2016-09-012024-11-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19148AdditionalIndexMember2016-09-012024-11-300000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19148AdditionalIndexMember2016-09-012024-11-300000102816eatonvance:C000104752Member2016-09-012024-12-310000102816eatonvance:EATONVANCEIndexMSCIWorld19148BroadBasedIndexMember2016-09-012024-12-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19148AdditionalIndexMember2016-09-012024-12-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19148AdditionalIndexMember2016-09-012024-12-310000102816eatonvance:C000104752Member2016-09-012025-01-310000102816eatonvance:EATONVANCEIndexMSCIWorld19148BroadBasedIndexMember2016-09-012025-01-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19148AdditionalIndexMember2016-09-012025-01-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19148AdditionalIndexMember2016-09-012025-01-310000102816eatonvance:C000104752Member2016-09-012025-02-280000102816eatonvance:EATONVANCEIndexMSCIWorld19148BroadBasedIndexMember2016-09-012025-02-280000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19148AdditionalIndexMember2016-09-012025-02-280000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19148AdditionalIndexMember2016-09-012025-02-280000102816eatonvance:C000104752Member2016-09-012025-03-310000102816eatonvance:EATONVANCEIndexMSCIWorld19148BroadBasedIndexMember2016-09-012025-03-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19148AdditionalIndexMember2016-09-012025-03-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19148AdditionalIndexMember2016-09-012025-03-310000102816eatonvance:C000104752Member2016-09-012025-04-300000102816eatonvance:EATONVANCEIndexMSCIWorld19148BroadBasedIndexMember2016-09-012025-04-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19148AdditionalIndexMember2016-09-012025-04-300000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19148AdditionalIndexMember2016-09-012025-04-300000102816eatonvance:C000104752Member2016-09-012025-05-310000102816eatonvance:EATONVANCEIndexMSCIWorld19148BroadBasedIndexMember2016-09-012025-05-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19148AdditionalIndexMember2016-09-012025-05-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19148AdditionalIndexMember2016-09-012025-05-310000102816eatonvance:C000104752Member2016-09-012025-06-300000102816eatonvance:EATONVANCEIndexMSCIWorld19148BroadBasedIndexMember2016-09-012025-06-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19148AdditionalIndexMember2016-09-012025-06-300000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19148AdditionalIndexMember2016-09-012025-06-300000102816eatonvance:C000104752Member2016-09-012025-07-310000102816eatonvance:EATONVANCEIndexMSCIWorld19148BroadBasedIndexMember2016-09-012025-07-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19148AdditionalIndexMember2016-09-012025-07-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19148AdditionalIndexMember2016-09-012025-07-310000102816eatonvance:C000104752Member2016-09-012025-08-310000102816eatonvance:EATONVANCEIndexMSCIWorld19148BroadBasedIndexMember2016-09-012025-08-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19148AdditionalIndexMember2016-09-012025-08-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19148AdditionalIndexMember2016-09-012025-08-310000102816eatonvance:C000104752Member2016-09-012025-09-300000102816eatonvance:EATONVANCEIndexMSCIWorld19148BroadBasedIndexMember2016-09-012025-09-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19148AdditionalIndexMember2016-09-012025-09-300000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19148AdditionalIndexMember2016-09-012025-09-300000102816eatonvance:C000104752Member2016-09-012025-10-310000102816eatonvance:EATONVANCEIndexMSCIWorld19148BroadBasedIndexMember2016-09-012025-10-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19148AdditionalIndexMember2016-09-012025-10-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19148AdditionalIndexMember2016-09-012025-10-310000102816eatonvance:C000104752Member2016-09-012025-11-300000102816eatonvance:EATONVANCEIndexMSCIWorld19148BroadBasedIndexMember2016-09-012025-11-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19148AdditionalIndexMember2016-09-012025-11-300000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19148AdditionalIndexMember2016-09-012025-11-300000102816eatonvance:C000104752Member2016-09-012025-12-310000102816eatonvance:EATONVANCEIndexMSCIWorld19148BroadBasedIndexMember2016-09-012025-12-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19148AdditionalIndexMember2016-09-012025-12-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19148AdditionalIndexMember2016-09-012025-12-310000102816eatonvance:C000104752Member2016-09-012026-01-310000102816eatonvance:EATONVANCEIndexMSCIWorld19148BroadBasedIndexMember2016-09-012026-01-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19148AdditionalIndexMember2016-09-012026-01-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19148AdditionalIndexMember2016-09-012026-01-310000102816eatonvance:C000104752Member2016-09-012026-02-280000102816eatonvance:EATONVANCEIndexMSCIWorld19148BroadBasedIndexMember2016-09-012026-02-280000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19148AdditionalIndexMember2016-09-012026-02-280000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19148AdditionalIndexMember2016-09-012026-02-280000102816eatonvance:C000104752Member2016-09-012026-03-310000102816eatonvance:EATONVANCEIndexMSCIWorld19148BroadBasedIndexMember2016-09-012026-03-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19148AdditionalIndexMember2016-09-012026-03-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19148AdditionalIndexMember2016-09-012026-03-310000102816eatonvance:C000104752Member2016-09-012026-04-300000102816eatonvance:EATONVANCEIndexMSCIWorld19148BroadBasedIndexMember2016-09-012026-04-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19148AdditionalIndexMember2016-09-012026-04-300000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19148AdditionalIndexMember2016-09-012026-04-300000102816eatonvance:C000104752Member2016-09-012026-05-310000102816eatonvance:EATONVANCEIndexMSCIWorld19148BroadBasedIndexMember2016-09-012026-05-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19148AdditionalIndexMember2016-09-012026-05-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19148AdditionalIndexMember2016-09-012026-05-310000102816eatonvance:C000104752Member2016-09-012026-06-300000102816eatonvance:EATONVANCEIndexMSCIWorld19148BroadBasedIndexMember2016-09-012026-06-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19148AdditionalIndexMember2016-09-012026-06-300000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19148AdditionalIndexMember2016-09-012026-06-300000102816eatonvance:C000104752Member2016-09-012026-07-310000102816eatonvance:EATONVANCEIndexMSCIWorld19148BroadBasedIndexMember2016-09-012026-07-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19148AdditionalIndexMember2016-09-012026-07-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19148AdditionalIndexMember2016-09-012026-07-310000102816eatonvance:C000104752Member2016-09-012026-08-310000102816eatonvance:EATONVANCEIndexMSCIWorld19148BroadBasedIndexMember2016-09-012026-08-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19148AdditionalIndexMember2016-09-012026-08-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19148AdditionalIndexMember2016-09-012026-08-310000102816eatonvance:C000104752Memberoef:WithoutSalesLoadMember2025-09-012026-08-310000102816eatonvance:C000104752Memberoef:WithoutSalesLoadMember2021-09-012026-08-310000102816eatonvance:C000104752Memberoef:WithoutSalesLoadMember2016-09-012026-08-310000102816eatonvance:C000104752Member2021-09-012026-08-310000102816eatonvance:EATONVANCEIndexMSCIWorld19148BroadBasedIndexMember2021-09-012026-08-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19148AdditionalIndexMember2021-09-012026-08-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19148AdditionalIndexMember2021-09-012026-08-310000102816eatonvance:EatonVanceIndexBlendedIndex60MSCIACWIIndexand40BloombergUSAggregateBondIndex19148AdditionalIndexMember2025-09-012026-08-310000102816eatonvance:EatonVanceIndexBlendedIndex60MSCIACWIIndexand40BloombergUSAggregateBondIndex19148AdditionalIndexMember2021-09-012026-08-310000102816eatonvance:EatonVanceIndexBlendedIndex60MSCIACWIIndexand40BloombergUSAggregateBondIndex19148AdditionalIndexMember2016-09-012026-08-310000102816eatonvance:C000104752Member2026-08-310000102816eatonvance:C000104752Membereatonvance:AssetSovereignGovernmentBondsCTIMember2026-08-310000102816eatonvance:C000104752Membereatonvance:AssetShortMinusTermInvestmentsCTIMember2026-08-310000102816eatonvance:C000104752Membereatonvance:AssetExchangeMinusTradedFundsCTIMember2026-08-310000102816eatonvance:C000104752Membereatonvance:AssetCommonStocksCTIMember2026-08-310000102816eatonvance:C000104752Membereatonvance:FR61774R841CTIMember2026-08-310000102816eatonvance:C000104752Membereatonvance:FR61774R767CTIMember2026-08-310000102816eatonvance:C000104752Membereatonvance:FR921946885CTIMember2026-08-310000102816eatonvance:C000104752Membereatonvance:FR46434G103CTIMember2026-08-310000102816eatonvance:C000104752Membereatonvance:FR464287176CTIMember2026-08-310000102816eatonvance:C000104752Membereatonvance:FR67066G104CTIMember2026-08-310000102816eatonvance:C000104752Membereatonvance:FRACI2T4QH6CTIMember2026-08-310000102816eatonvance:C000104752Membereatonvance:FR594918104CTIMember2026-08-310000102816eatonvance:C000104752Membereatonvance:FR037833100CTIMember2026-08-310000102816eatonvance:C000104752Membereatonvance:FR023135106CTIMember2026-08-310000102816eatonvance:C000104752Membereatonvance:AmazoncomIncCTIMember2026-08-310000102816eatonvance:C000104752Member2024-09-012025-08-310000102816eatonvance:C000104753Member2025-09-012026-08-310000102816eatonvance:EATONVANCEIndexMSCIWorld19220BroadBasedIndexMember2025-09-012026-08-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19220AdditionalIndexMember2025-09-012026-08-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19220AdditionalIndexMember2025-09-012026-08-310000102816eatonvance:C000104753Member2016-08-312016-08-310000102816eatonvance:EATONVANCEIndexMSCIWorld19220BroadBasedIndexMember2016-08-312016-08-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19220AdditionalIndexMember2016-08-312016-08-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19220AdditionalIndexMember2016-08-312016-08-310000102816eatonvance:C000104753Member2016-09-012016-09-300000102816eatonvance:EATONVANCEIndexMSCIWorld19220BroadBasedIndexMember2016-09-012016-09-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19220AdditionalIndexMember2016-09-012016-09-300000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19220AdditionalIndexMember2016-09-012016-09-300000102816eatonvance:C000104753Member2016-09-012016-10-310000102816eatonvance:EATONVANCEIndexMSCIWorld19220BroadBasedIndexMember2016-09-012016-10-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19220AdditionalIndexMember2016-09-012016-10-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19220AdditionalIndexMember2016-09-012016-10-310000102816eatonvance:C000104753Member2016-09-012016-11-300000102816eatonvance:EATONVANCEIndexMSCIWorld19220BroadBasedIndexMember2016-09-012016-11-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19220AdditionalIndexMember2016-09-012016-11-300000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19220AdditionalIndexMember2016-09-012016-11-300000102816eatonvance:C000104753Member2016-09-012016-12-310000102816eatonvance:EATONVANCEIndexMSCIWorld19220BroadBasedIndexMember2016-09-012016-12-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19220AdditionalIndexMember2016-09-012016-12-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19220AdditionalIndexMember2016-09-012016-12-310000102816eatonvance:C000104753Member2016-09-012017-01-310000102816eatonvance:EATONVANCEIndexMSCIWorld19220BroadBasedIndexMember2016-09-012017-01-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19220AdditionalIndexMember2016-09-012017-01-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19220AdditionalIndexMember2016-09-012017-01-310000102816eatonvance:C000104753Member2016-09-012017-02-280000102816eatonvance:EATONVANCEIndexMSCIWorld19220BroadBasedIndexMember2016-09-012017-02-280000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19220AdditionalIndexMember2016-09-012017-02-280000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19220AdditionalIndexMember2016-09-012017-02-280000102816eatonvance:C000104753Member2016-09-012017-03-310000102816eatonvance:EATONVANCEIndexMSCIWorld19220BroadBasedIndexMember2016-09-012017-03-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19220AdditionalIndexMember2016-09-012017-03-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19220AdditionalIndexMember2016-09-012017-03-310000102816eatonvance:C000104753Member2016-09-012017-04-300000102816eatonvance:EATONVANCEIndexMSCIWorld19220BroadBasedIndexMember2016-09-012017-04-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19220AdditionalIndexMember2016-09-012017-04-300000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19220AdditionalIndexMember2016-09-012017-04-300000102816eatonvance:C000104753Member2016-09-012017-05-310000102816eatonvance:EATONVANCEIndexMSCIWorld19220BroadBasedIndexMember2016-09-012017-05-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19220AdditionalIndexMember2016-09-012017-05-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19220AdditionalIndexMember2016-09-012017-05-310000102816eatonvance:C000104753Member2016-09-012017-06-300000102816eatonvance:EATONVANCEIndexMSCIWorld19220BroadBasedIndexMember2016-09-012017-06-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19220AdditionalIndexMember2016-09-012017-06-300000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19220AdditionalIndexMember2016-09-012017-06-300000102816eatonvance:C000104753Member2016-09-012017-07-310000102816eatonvance:EATONVANCEIndexMSCIWorld19220BroadBasedIndexMember2016-09-012017-07-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19220AdditionalIndexMember2016-09-012017-07-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19220AdditionalIndexMember2016-09-012017-07-310000102816eatonvance:C000104753Member2016-09-012017-08-310000102816eatonvance:EATONVANCEIndexMSCIWorld19220BroadBasedIndexMember2016-09-012017-08-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19220AdditionalIndexMember2016-09-012017-08-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19220AdditionalIndexMember2016-09-012017-08-310000102816eatonvance:C000104753Member2016-09-012017-09-300000102816eatonvance:EATONVANCEIndexMSCIWorld19220BroadBasedIndexMember2016-09-012017-09-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19220AdditionalIndexMember2016-09-012017-09-300000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19220AdditionalIndexMember2016-09-012017-09-300000102816eatonvance:C000104753Member2016-09-012017-10-310000102816eatonvance:EATONVANCEIndexMSCIWorld19220BroadBasedIndexMember2016-09-012017-10-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19220AdditionalIndexMember2016-09-012017-10-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19220AdditionalIndexMember2016-09-012017-10-310000102816eatonvance:C000104753Member2016-09-012017-11-300000102816eatonvance:EATONVANCEIndexMSCIWorld19220BroadBasedIndexMember2016-09-012017-11-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19220AdditionalIndexMember2016-09-012017-11-300000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19220AdditionalIndexMember2016-09-012017-11-300000102816eatonvance:C000104753Member2016-09-012017-12-310000102816eatonvance:EATONVANCEIndexMSCIWorld19220BroadBasedIndexMember2016-09-012017-12-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19220AdditionalIndexMember2016-09-012017-12-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19220AdditionalIndexMember2016-09-012017-12-310000102816eatonvance:C000104753Member2016-09-012018-01-310000102816eatonvance:EATONVANCEIndexMSCIWorld19220BroadBasedIndexMember2016-09-012018-01-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19220AdditionalIndexMember2016-09-012018-01-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19220AdditionalIndexMember2016-09-012018-01-310000102816eatonvance:C000104753Member2016-09-012018-02-280000102816eatonvance:EATONVANCEIndexMSCIWorld19220BroadBasedIndexMember2016-09-012018-02-280000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19220AdditionalIndexMember2016-09-012018-02-280000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19220AdditionalIndexMember2016-09-012018-02-280000102816eatonvance:C000104753Member2016-09-012018-03-310000102816eatonvance:EATONVANCEIndexMSCIWorld19220BroadBasedIndexMember2016-09-012018-03-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19220AdditionalIndexMember2016-09-012018-03-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19220AdditionalIndexMember2016-09-012018-03-310000102816eatonvance:C000104753Member2016-09-012018-04-300000102816eatonvance:EATONVANCEIndexMSCIWorld19220BroadBasedIndexMember2016-09-012018-04-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19220AdditionalIndexMember2016-09-012018-04-300000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19220AdditionalIndexMember2016-09-012018-04-300000102816eatonvance:C000104753Member2016-09-012018-05-310000102816eatonvance:EATONVANCEIndexMSCIWorld19220BroadBasedIndexMember2016-09-012018-05-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19220AdditionalIndexMember2016-09-012018-05-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19220AdditionalIndexMember2016-09-012018-05-310000102816eatonvance:C000104753Member2016-09-012018-06-300000102816eatonvance:EATONVANCEIndexMSCIWorld19220BroadBasedIndexMember2016-09-012018-06-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19220AdditionalIndexMember2016-09-012018-06-300000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19220AdditionalIndexMember2016-09-012018-06-300000102816eatonvance:C000104753Member2016-09-012018-07-310000102816eatonvance:EATONVANCEIndexMSCIWorld19220BroadBasedIndexMember2016-09-012018-07-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19220AdditionalIndexMember2016-09-012018-07-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19220AdditionalIndexMember2016-09-012018-07-310000102816eatonvance:C000104753Member2016-09-012018-08-310000102816eatonvance:EATONVANCEIndexMSCIWorld19220BroadBasedIndexMember2016-09-012018-08-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19220AdditionalIndexMember2016-09-012018-08-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19220AdditionalIndexMember2016-09-012018-08-310000102816eatonvance:C000104753Member2016-09-012018-09-300000102816eatonvance:EATONVANCEIndexMSCIWorld19220BroadBasedIndexMember2016-09-012018-09-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19220AdditionalIndexMember2016-09-012018-09-300000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19220AdditionalIndexMember2016-09-012018-09-300000102816eatonvance:C000104753Member2016-09-012018-10-310000102816eatonvance:EATONVANCEIndexMSCIWorld19220BroadBasedIndexMember2016-09-012018-10-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19220AdditionalIndexMember2016-09-012018-10-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19220AdditionalIndexMember2016-09-012018-10-310000102816eatonvance:C000104753Member2016-09-012018-11-300000102816eatonvance:EATONVANCEIndexMSCIWorld19220BroadBasedIndexMember2016-09-012018-11-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19220AdditionalIndexMember2016-09-012018-11-300000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19220AdditionalIndexMember2016-09-012018-11-300000102816eatonvance:C000104753Member2016-09-012018-12-310000102816eatonvance:EATONVANCEIndexMSCIWorld19220BroadBasedIndexMember2016-09-012018-12-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19220AdditionalIndexMember2016-09-012018-12-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19220AdditionalIndexMember2016-09-012018-12-310000102816eatonvance:C000104753Member2016-09-012019-01-310000102816eatonvance:EATONVANCEIndexMSCIWorld19220BroadBasedIndexMember2016-09-012019-01-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19220AdditionalIndexMember2016-09-012019-01-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19220AdditionalIndexMember2016-09-012019-01-310000102816eatonvance:C000104753Member2016-09-012019-02-280000102816eatonvance:EATONVANCEIndexMSCIWorld19220BroadBasedIndexMember2016-09-012019-02-280000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19220AdditionalIndexMember2016-09-012019-02-280000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19220AdditionalIndexMember2016-09-012019-02-280000102816eatonvance:C000104753Member2016-09-012019-03-310000102816eatonvance:EATONVANCEIndexMSCIWorld19220BroadBasedIndexMember2016-09-012019-03-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19220AdditionalIndexMember2016-09-012019-03-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19220AdditionalIndexMember2016-09-012019-03-310000102816eatonvance:C000104753Member2016-09-012019-04-300000102816eatonvance:EATONVANCEIndexMSCIWorld19220BroadBasedIndexMember2016-09-012019-04-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19220AdditionalIndexMember2016-09-012019-04-300000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19220AdditionalIndexMember2016-09-012019-04-300000102816eatonvance:C000104753Member2016-09-012019-05-310000102816eatonvance:EATONVANCEIndexMSCIWorld19220BroadBasedIndexMember2016-09-012019-05-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19220AdditionalIndexMember2016-09-012019-05-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19220AdditionalIndexMember2016-09-012019-05-310000102816eatonvance:C000104753Member2016-09-012019-06-300000102816eatonvance:EATONVANCEIndexMSCIWorld19220BroadBasedIndexMember2016-09-012019-06-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19220AdditionalIndexMember2016-09-012019-06-300000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19220AdditionalIndexMember2016-09-012019-06-300000102816eatonvance:C000104753Member2016-09-012019-07-310000102816eatonvance:EATONVANCEIndexMSCIWorld19220BroadBasedIndexMember2016-09-012019-07-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19220AdditionalIndexMember2016-09-012019-07-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19220AdditionalIndexMember2016-09-012019-07-310000102816eatonvance:C000104753Member2016-09-012019-08-310000102816eatonvance:EATONVANCEIndexMSCIWorld19220BroadBasedIndexMember2016-09-012019-08-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19220AdditionalIndexMember2016-09-012019-08-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19220AdditionalIndexMember2016-09-012019-08-310000102816eatonvance:C000104753Member2016-09-012019-09-300000102816eatonvance:EATONVANCEIndexMSCIWorld19220BroadBasedIndexMember2016-09-012019-09-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19220AdditionalIndexMember2016-09-012019-09-300000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19220AdditionalIndexMember2016-09-012019-09-300000102816eatonvance:C000104753Member2016-09-012019-10-310000102816eatonvance:EATONVANCEIndexMSCIWorld19220BroadBasedIndexMember2016-09-012019-10-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19220AdditionalIndexMember2016-09-012019-10-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19220AdditionalIndexMember2016-09-012019-10-310000102816eatonvance:C000104753Member2016-09-012019-11-300000102816eatonvance:EATONVANCEIndexMSCIWorld19220BroadBasedIndexMember2016-09-012019-11-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19220AdditionalIndexMember2016-09-012019-11-300000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19220AdditionalIndexMember2016-09-012019-11-300000102816eatonvance:C000104753Member2016-09-012019-12-310000102816eatonvance:EATONVANCEIndexMSCIWorld19220BroadBasedIndexMember2016-09-012019-12-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19220AdditionalIndexMember2016-09-012019-12-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19220AdditionalIndexMember2016-09-012019-12-310000102816eatonvance:C000104753Member2016-09-012020-01-310000102816eatonvance:EATONVANCEIndexMSCIWorld19220BroadBasedIndexMember2016-09-012020-01-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19220AdditionalIndexMember2016-09-012020-01-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19220AdditionalIndexMember2016-09-012020-01-310000102816eatonvance:C000104753Member2016-09-012020-02-290000102816eatonvance:EATONVANCEIndexMSCIWorld19220BroadBasedIndexMember2016-09-012020-02-290000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19220AdditionalIndexMember2016-09-012020-02-290000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19220AdditionalIndexMember2016-09-012020-02-290000102816eatonvance:C000104753Member2016-09-012020-03-310000102816eatonvance:EATONVANCEIndexMSCIWorld19220BroadBasedIndexMember2016-09-012020-03-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19220AdditionalIndexMember2016-09-012020-03-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19220AdditionalIndexMember2016-09-012020-03-310000102816eatonvance:C000104753Member2016-09-012020-04-300000102816eatonvance:EATONVANCEIndexMSCIWorld19220BroadBasedIndexMember2016-09-012020-04-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19220AdditionalIndexMember2016-09-012020-04-300000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19220AdditionalIndexMember2016-09-012020-04-300000102816eatonvance:C000104753Member2016-09-012020-05-310000102816eatonvance:EATONVANCEIndexMSCIWorld19220BroadBasedIndexMember2016-09-012020-05-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19220AdditionalIndexMember2016-09-012020-05-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19220AdditionalIndexMember2016-09-012020-05-310000102816eatonvance:C000104753Member2016-09-012020-06-300000102816eatonvance:EATONVANCEIndexMSCIWorld19220BroadBasedIndexMember2016-09-012020-06-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19220AdditionalIndexMember2016-09-012020-06-300000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19220AdditionalIndexMember2016-09-012020-06-300000102816eatonvance:C000104753Member2016-09-012020-07-310000102816eatonvance:EATONVANCEIndexMSCIWorld19220BroadBasedIndexMember2016-09-012020-07-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19220AdditionalIndexMember2016-09-012020-07-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19220AdditionalIndexMember2016-09-012020-07-310000102816eatonvance:C000104753Member2016-09-012020-08-310000102816eatonvance:EATONVANCEIndexMSCIWorld19220BroadBasedIndexMember2016-09-012020-08-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19220AdditionalIndexMember2016-09-012020-08-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19220AdditionalIndexMember2016-09-012020-08-310000102816eatonvance:C000104753Member2016-09-012020-09-300000102816eatonvance:EATONVANCEIndexMSCIWorld19220BroadBasedIndexMember2016-09-012020-09-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19220AdditionalIndexMember2016-09-012020-09-300000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19220AdditionalIndexMember2016-09-012020-09-300000102816eatonvance:C000104753Member2016-09-012020-10-310000102816eatonvance:EATONVANCEIndexMSCIWorld19220BroadBasedIndexMember2016-09-012020-10-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19220AdditionalIndexMember2016-09-012020-10-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19220AdditionalIndexMember2016-09-012020-10-310000102816eatonvance:C000104753Member2016-09-012020-11-300000102816eatonvance:EATONVANCEIndexMSCIWorld19220BroadBasedIndexMember2016-09-012020-11-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19220AdditionalIndexMember2016-09-012020-11-300000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19220AdditionalIndexMember2016-09-012020-11-300000102816eatonvance:C000104753Member2016-09-012020-12-310000102816eatonvance:EATONVANCEIndexMSCIWorld19220BroadBasedIndexMember2016-09-012020-12-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19220AdditionalIndexMember2016-09-012020-12-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19220AdditionalIndexMember2016-09-012020-12-310000102816eatonvance:C000104753Member2016-09-012021-01-310000102816eatonvance:EATONVANCEIndexMSCIWorld19220BroadBasedIndexMember2016-09-012021-01-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19220AdditionalIndexMember2016-09-012021-01-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19220AdditionalIndexMember2016-09-012021-01-310000102816eatonvance:C000104753Member2016-09-012021-02-280000102816eatonvance:EATONVANCEIndexMSCIWorld19220BroadBasedIndexMember2016-09-012021-02-280000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19220AdditionalIndexMember2016-09-012021-02-280000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19220AdditionalIndexMember2016-09-012021-02-280000102816eatonvance:C000104753Member2016-09-012021-03-310000102816eatonvance:EATONVANCEIndexMSCIWorld19220BroadBasedIndexMember2016-09-012021-03-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19220AdditionalIndexMember2016-09-012021-03-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19220AdditionalIndexMember2016-09-012021-03-310000102816eatonvance:C000104753Member2016-09-012021-04-300000102816eatonvance:EATONVANCEIndexMSCIWorld19220BroadBasedIndexMember2016-09-012021-04-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19220AdditionalIndexMember2016-09-012021-04-300000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19220AdditionalIndexMember2016-09-012021-04-300000102816eatonvance:C000104753Member2016-09-012021-05-310000102816eatonvance:EATONVANCEIndexMSCIWorld19220BroadBasedIndexMember2016-09-012021-05-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19220AdditionalIndexMember2016-09-012021-05-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19220AdditionalIndexMember2016-09-012021-05-310000102816eatonvance:C000104753Member2016-09-012021-06-300000102816eatonvance:EATONVANCEIndexMSCIWorld19220BroadBasedIndexMember2016-09-012021-06-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19220AdditionalIndexMember2016-09-012021-06-300000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19220AdditionalIndexMember2016-09-012021-06-300000102816eatonvance:C000104753Member2016-09-012021-07-310000102816eatonvance:EATONVANCEIndexMSCIWorld19220BroadBasedIndexMember2016-09-012021-07-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19220AdditionalIndexMember2016-09-012021-07-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19220AdditionalIndexMember2016-09-012021-07-310000102816eatonvance:C000104753Member2016-09-012021-08-310000102816eatonvance:EATONVANCEIndexMSCIWorld19220BroadBasedIndexMember2016-09-012021-08-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19220AdditionalIndexMember2016-09-012021-08-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19220AdditionalIndexMember2016-09-012021-08-310000102816eatonvance:C000104753Member2016-09-012021-09-300000102816eatonvance:EATONVANCEIndexMSCIWorld19220BroadBasedIndexMember2016-09-012021-09-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19220AdditionalIndexMember2016-09-012021-09-300000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19220AdditionalIndexMember2016-09-012021-09-300000102816eatonvance:C000104753Member2016-09-012021-10-310000102816eatonvance:EATONVANCEIndexMSCIWorld19220BroadBasedIndexMember2016-09-012021-10-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19220AdditionalIndexMember2016-09-012021-10-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19220AdditionalIndexMember2016-09-012021-10-310000102816eatonvance:C000104753Member2016-09-012021-11-300000102816eatonvance:EATONVANCEIndexMSCIWorld19220BroadBasedIndexMember2016-09-012021-11-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19220AdditionalIndexMember2016-09-012021-11-300000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19220AdditionalIndexMember2016-09-012021-11-300000102816eatonvance:C000104753Member2016-09-012021-12-310000102816eatonvance:EATONVANCEIndexMSCIWorld19220BroadBasedIndexMember2016-09-012021-12-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19220AdditionalIndexMember2016-09-012021-12-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19220AdditionalIndexMember2016-09-012021-12-310000102816eatonvance:C000104753Member2016-09-012022-01-310000102816eatonvance:EATONVANCEIndexMSCIWorld19220BroadBasedIndexMember2016-09-012022-01-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19220AdditionalIndexMember2016-09-012022-01-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19220AdditionalIndexMember2016-09-012022-01-310000102816eatonvance:C000104753Member2016-09-012022-02-280000102816eatonvance:EATONVANCEIndexMSCIWorld19220BroadBasedIndexMember2016-09-012022-02-280000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19220AdditionalIndexMember2016-09-012022-02-280000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19220AdditionalIndexMember2016-09-012022-02-280000102816eatonvance:C000104753Member2016-09-012022-03-310000102816eatonvance:EATONVANCEIndexMSCIWorld19220BroadBasedIndexMember2016-09-012022-03-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19220AdditionalIndexMember2016-09-012022-03-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19220AdditionalIndexMember2016-09-012022-03-310000102816eatonvance:C000104753Member2016-09-012022-04-300000102816eatonvance:EATONVANCEIndexMSCIWorld19220BroadBasedIndexMember2016-09-012022-04-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19220AdditionalIndexMember2016-09-012022-04-300000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19220AdditionalIndexMember2016-09-012022-04-300000102816eatonvance:C000104753Member2016-09-012022-05-310000102816eatonvance:EATONVANCEIndexMSCIWorld19220BroadBasedIndexMember2016-09-012022-05-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19220AdditionalIndexMember2016-09-012022-05-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19220AdditionalIndexMember2016-09-012022-05-310000102816eatonvance:C000104753Member2016-09-012022-06-300000102816eatonvance:EATONVANCEIndexMSCIWorld19220BroadBasedIndexMember2016-09-012022-06-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19220AdditionalIndexMember2016-09-012022-06-300000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19220AdditionalIndexMember2016-09-012022-06-300000102816eatonvance:C000104753Member2016-09-012022-07-310000102816eatonvance:EATONVANCEIndexMSCIWorld19220BroadBasedIndexMember2016-09-012022-07-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19220AdditionalIndexMember2016-09-012022-07-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19220AdditionalIndexMember2016-09-012022-07-310000102816eatonvance:C000104753Member2016-09-012022-08-310000102816eatonvance:EATONVANCEIndexMSCIWorld19220BroadBasedIndexMember2016-09-012022-08-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19220AdditionalIndexMember2016-09-012022-08-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19220AdditionalIndexMember2016-09-012022-08-310000102816eatonvance:C000104753Member2016-09-012022-09-300000102816eatonvance:EATONVANCEIndexMSCIWorld19220BroadBasedIndexMember2016-09-012022-09-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19220AdditionalIndexMember2016-09-012022-09-300000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19220AdditionalIndexMember2016-09-012022-09-300000102816eatonvance:C000104753Member2016-09-012022-10-310000102816eatonvance:EATONVANCEIndexMSCIWorld19220BroadBasedIndexMember2016-09-012022-10-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19220AdditionalIndexMember2016-09-012022-10-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19220AdditionalIndexMember2016-09-012022-10-310000102816eatonvance:C000104753Member2016-09-012022-11-300000102816eatonvance:EATONVANCEIndexMSCIWorld19220BroadBasedIndexMember2016-09-012022-11-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19220AdditionalIndexMember2016-09-012022-11-300000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19220AdditionalIndexMember2016-09-012022-11-300000102816eatonvance:C000104753Member2016-09-012022-12-310000102816eatonvance:EATONVANCEIndexMSCIWorld19220BroadBasedIndexMember2016-09-012022-12-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19220AdditionalIndexMember2016-09-012022-12-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19220AdditionalIndexMember2016-09-012022-12-310000102816eatonvance:C000104753Member2016-09-012023-01-310000102816eatonvance:EATONVANCEIndexMSCIWorld19220BroadBasedIndexMember2016-09-012023-01-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19220AdditionalIndexMember2016-09-012023-01-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19220AdditionalIndexMember2016-09-012023-01-310000102816eatonvance:C000104753Member2016-09-012023-02-280000102816eatonvance:EATONVANCEIndexMSCIWorld19220BroadBasedIndexMember2016-09-012023-02-280000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19220AdditionalIndexMember2016-09-012023-02-280000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19220AdditionalIndexMember2016-09-012023-02-280000102816eatonvance:C000104753Member2016-09-012023-03-310000102816eatonvance:EATONVANCEIndexMSCIWorld19220BroadBasedIndexMember2016-09-012023-03-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19220AdditionalIndexMember2016-09-012023-03-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19220AdditionalIndexMember2016-09-012023-03-310000102816eatonvance:C000104753Member2016-09-012023-04-300000102816eatonvance:EATONVANCEIndexMSCIWorld19220BroadBasedIndexMember2016-09-012023-04-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19220AdditionalIndexMember2016-09-012023-04-300000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19220AdditionalIndexMember2016-09-012023-04-300000102816eatonvance:C000104753Member2016-09-012023-05-310000102816eatonvance:EATONVANCEIndexMSCIWorld19220BroadBasedIndexMember2016-09-012023-05-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19220AdditionalIndexMember2016-09-012023-05-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19220AdditionalIndexMember2016-09-012023-05-310000102816eatonvance:C000104753Member2016-09-012023-06-300000102816eatonvance:EATONVANCEIndexMSCIWorld19220BroadBasedIndexMember2016-09-012023-06-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19220AdditionalIndexMember2016-09-012023-06-300000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19220AdditionalIndexMember2016-09-012023-06-300000102816eatonvance:C000104753Member2016-09-012023-07-310000102816eatonvance:EATONVANCEIndexMSCIWorld19220BroadBasedIndexMember2016-09-012023-07-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19220AdditionalIndexMember2016-09-012023-07-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19220AdditionalIndexMember2016-09-012023-07-310000102816eatonvance:C000104753Member2016-09-012023-08-310000102816eatonvance:EATONVANCEIndexMSCIWorld19220BroadBasedIndexMember2016-09-012023-08-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19220AdditionalIndexMember2016-09-012023-08-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19220AdditionalIndexMember2016-09-012023-08-310000102816eatonvance:C000104753Member2016-09-012023-09-300000102816eatonvance:EATONVANCEIndexMSCIWorld19220BroadBasedIndexMember2016-09-012023-09-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19220AdditionalIndexMember2016-09-012023-09-300000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19220AdditionalIndexMember2016-09-012023-09-300000102816eatonvance:C000104753Member2016-09-012023-10-310000102816eatonvance:EATONVANCEIndexMSCIWorld19220BroadBasedIndexMember2016-09-012023-10-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19220AdditionalIndexMember2016-09-012023-10-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19220AdditionalIndexMember2016-09-012023-10-310000102816eatonvance:C000104753Member2016-09-012023-11-300000102816eatonvance:EATONVANCEIndexMSCIWorld19220BroadBasedIndexMember2016-09-012023-11-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19220AdditionalIndexMember2016-09-012023-11-300000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19220AdditionalIndexMember2016-09-012023-11-300000102816eatonvance:C000104753Member2016-09-012023-12-310000102816eatonvance:EATONVANCEIndexMSCIWorld19220BroadBasedIndexMember2016-09-012023-12-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19220AdditionalIndexMember2016-09-012023-12-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19220AdditionalIndexMember2016-09-012023-12-310000102816eatonvance:C000104753Member2016-09-012024-01-310000102816eatonvance:EATONVANCEIndexMSCIWorld19220BroadBasedIndexMember2016-09-012024-01-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19220AdditionalIndexMember2016-09-012024-01-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19220AdditionalIndexMember2016-09-012024-01-310000102816eatonvance:C000104753Member2016-09-012024-02-290000102816eatonvance:EATONVANCEIndexMSCIWorld19220BroadBasedIndexMember2016-09-012024-02-290000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19220AdditionalIndexMember2016-09-012024-02-290000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19220AdditionalIndexMember2016-09-012024-02-290000102816eatonvance:C000104753Member2016-09-012024-03-310000102816eatonvance:EATONVANCEIndexMSCIWorld19220BroadBasedIndexMember2016-09-012024-03-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19220AdditionalIndexMember2016-09-012024-03-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19220AdditionalIndexMember2016-09-012024-03-310000102816eatonvance:C000104753Member2016-09-012024-04-300000102816eatonvance:EATONVANCEIndexMSCIWorld19220BroadBasedIndexMember2016-09-012024-04-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19220AdditionalIndexMember2016-09-012024-04-300000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19220AdditionalIndexMember2016-09-012024-04-300000102816eatonvance:C000104753Member2016-09-012024-05-310000102816eatonvance:EATONVANCEIndexMSCIWorld19220BroadBasedIndexMember2016-09-012024-05-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19220AdditionalIndexMember2016-09-012024-05-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19220AdditionalIndexMember2016-09-012024-05-310000102816eatonvance:C000104753Member2016-09-012024-06-300000102816eatonvance:EATONVANCEIndexMSCIWorld19220BroadBasedIndexMember2016-09-012024-06-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19220AdditionalIndexMember2016-09-012024-06-300000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19220AdditionalIndexMember2016-09-012024-06-300000102816eatonvance:C000104753Member2016-09-012024-07-310000102816eatonvance:EATONVANCEIndexMSCIWorld19220BroadBasedIndexMember2016-09-012024-07-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19220AdditionalIndexMember2016-09-012024-07-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19220AdditionalIndexMember2016-09-012024-07-310000102816eatonvance:C000104753Member2016-09-012024-08-310000102816eatonvance:EATONVANCEIndexMSCIWorld19220BroadBasedIndexMember2016-09-012024-08-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19220AdditionalIndexMember2016-09-012024-08-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19220AdditionalIndexMember2016-09-012024-08-310000102816eatonvance:C000104753Member2016-09-012024-09-300000102816eatonvance:EATONVANCEIndexMSCIWorld19220BroadBasedIndexMember2016-09-012024-09-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19220AdditionalIndexMember2016-09-012024-09-300000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19220AdditionalIndexMember2016-09-012024-09-300000102816eatonvance:C000104753Member2016-09-012024-10-310000102816eatonvance:EATONVANCEIndexMSCIWorld19220BroadBasedIndexMember2016-09-012024-10-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19220AdditionalIndexMember2016-09-012024-10-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19220AdditionalIndexMember2016-09-012024-10-310000102816eatonvance:C000104753Member2016-09-012024-11-300000102816eatonvance:EATONVANCEIndexMSCIWorld19220BroadBasedIndexMember2016-09-012024-11-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19220AdditionalIndexMember2016-09-012024-11-300000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19220AdditionalIndexMember2016-09-012024-11-300000102816eatonvance:C000104753Member2016-09-012024-12-310000102816eatonvance:EATONVANCEIndexMSCIWorld19220BroadBasedIndexMember2016-09-012024-12-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19220AdditionalIndexMember2016-09-012024-12-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19220AdditionalIndexMember2016-09-012024-12-310000102816eatonvance:C000104753Member2016-09-012025-01-310000102816eatonvance:EATONVANCEIndexMSCIWorld19220BroadBasedIndexMember2016-09-012025-01-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19220AdditionalIndexMember2016-09-012025-01-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19220AdditionalIndexMember2016-09-012025-01-310000102816eatonvance:C000104753Member2016-09-012025-02-280000102816eatonvance:EATONVANCEIndexMSCIWorld19220BroadBasedIndexMember2016-09-012025-02-280000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19220AdditionalIndexMember2016-09-012025-02-280000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19220AdditionalIndexMember2016-09-012025-02-280000102816eatonvance:C000104753Member2016-09-012025-03-310000102816eatonvance:EATONVANCEIndexMSCIWorld19220BroadBasedIndexMember2016-09-012025-03-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19220AdditionalIndexMember2016-09-012025-03-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19220AdditionalIndexMember2016-09-012025-03-310000102816eatonvance:C000104753Member2016-09-012025-04-300000102816eatonvance:EATONVANCEIndexMSCIWorld19220BroadBasedIndexMember2016-09-012025-04-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19220AdditionalIndexMember2016-09-012025-04-300000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19220AdditionalIndexMember2016-09-012025-04-300000102816eatonvance:C000104753Member2016-09-012025-05-310000102816eatonvance:EATONVANCEIndexMSCIWorld19220BroadBasedIndexMember2016-09-012025-05-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19220AdditionalIndexMember2016-09-012025-05-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19220AdditionalIndexMember2016-09-012025-05-310000102816eatonvance:C000104753Member2016-09-012025-06-300000102816eatonvance:EATONVANCEIndexMSCIWorld19220BroadBasedIndexMember2016-09-012025-06-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19220AdditionalIndexMember2016-09-012025-06-300000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19220AdditionalIndexMember2016-09-012025-06-300000102816eatonvance:C000104753Member2016-09-012025-07-310000102816eatonvance:EATONVANCEIndexMSCIWorld19220BroadBasedIndexMember2016-09-012025-07-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19220AdditionalIndexMember2016-09-012025-07-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19220AdditionalIndexMember2016-09-012025-07-310000102816eatonvance:C000104753Member2016-09-012025-08-310000102816eatonvance:EATONVANCEIndexMSCIWorld19220BroadBasedIndexMember2016-09-012025-08-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19220AdditionalIndexMember2016-09-012025-08-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19220AdditionalIndexMember2016-09-012025-08-310000102816eatonvance:C000104753Member2016-09-012025-09-300000102816eatonvance:EATONVANCEIndexMSCIWorld19220BroadBasedIndexMember2016-09-012025-09-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19220AdditionalIndexMember2016-09-012025-09-300000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19220AdditionalIndexMember2016-09-012025-09-300000102816eatonvance:C000104753Member2016-09-012025-10-310000102816eatonvance:EATONVANCEIndexMSCIWorld19220BroadBasedIndexMember2016-09-012025-10-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19220AdditionalIndexMember2016-09-012025-10-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19220AdditionalIndexMember2016-09-012025-10-310000102816eatonvance:C000104753Member2016-09-012025-11-300000102816eatonvance:EATONVANCEIndexMSCIWorld19220BroadBasedIndexMember2016-09-012025-11-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19220AdditionalIndexMember2016-09-012025-11-300000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19220AdditionalIndexMember2016-09-012025-11-300000102816eatonvance:C000104753Member2016-09-012025-12-310000102816eatonvance:EATONVANCEIndexMSCIWorld19220BroadBasedIndexMember2016-09-012025-12-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19220AdditionalIndexMember2016-09-012025-12-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19220AdditionalIndexMember2016-09-012025-12-310000102816eatonvance:C000104753Member2016-09-012026-01-310000102816eatonvance:EATONVANCEIndexMSCIWorld19220BroadBasedIndexMember2016-09-012026-01-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19220AdditionalIndexMember2016-09-012026-01-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19220AdditionalIndexMember2016-09-012026-01-310000102816eatonvance:C000104753Member2016-09-012026-02-280000102816eatonvance:EATONVANCEIndexMSCIWorld19220BroadBasedIndexMember2016-09-012026-02-280000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19220AdditionalIndexMember2016-09-012026-02-280000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19220AdditionalIndexMember2016-09-012026-02-280000102816eatonvance:C000104753Member2016-09-012026-03-310000102816eatonvance:EATONVANCEIndexMSCIWorld19220BroadBasedIndexMember2016-09-012026-03-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19220AdditionalIndexMember2016-09-012026-03-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19220AdditionalIndexMember2016-09-012026-03-310000102816eatonvance:C000104753Member2016-09-012026-04-300000102816eatonvance:EATONVANCEIndexMSCIWorld19220BroadBasedIndexMember2016-09-012026-04-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19220AdditionalIndexMember2016-09-012026-04-300000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19220AdditionalIndexMember2016-09-012026-04-300000102816eatonvance:C000104753Member2016-09-012026-05-310000102816eatonvance:EATONVANCEIndexMSCIWorld19220BroadBasedIndexMember2016-09-012026-05-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19220AdditionalIndexMember2016-09-012026-05-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19220AdditionalIndexMember2016-09-012026-05-310000102816eatonvance:C000104753Member2016-09-012026-06-300000102816eatonvance:EATONVANCEIndexMSCIWorld19220BroadBasedIndexMember2016-09-012026-06-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19220AdditionalIndexMember2016-09-012026-06-300000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19220AdditionalIndexMember2016-09-012026-06-300000102816eatonvance:C000104753Member2016-09-012026-07-310000102816eatonvance:EATONVANCEIndexMSCIWorld19220BroadBasedIndexMember2016-09-012026-07-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19220AdditionalIndexMember2016-09-012026-07-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19220AdditionalIndexMember2016-09-012026-07-310000102816eatonvance:C000104753Member2016-09-012026-08-310000102816eatonvance:EATONVANCEIndexMSCIWorld19220BroadBasedIndexMember2016-09-012026-08-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19220AdditionalIndexMember2016-09-012026-08-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19220AdditionalIndexMember2016-09-012026-08-310000102816eatonvance:C000104753Memberoef:WithoutSalesLoadMember2025-09-012026-08-310000102816eatonvance:C000104753Memberoef:WithoutSalesLoadMember2021-09-012026-08-310000102816eatonvance:C000104753Memberoef:WithoutSalesLoadMember2016-09-012026-08-310000102816eatonvance:C000104753Member2021-09-012026-08-310000102816eatonvance:EATONVANCEIndexMSCIWorld19220BroadBasedIndexMember2021-09-012026-08-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19220AdditionalIndexMember2021-09-012026-08-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19220AdditionalIndexMember2021-09-012026-08-310000102816eatonvance:EatonVanceIndexBlendedIndex60MSCIACWIIndexand40BloombergUSAggregateBondIndex19220AdditionalIndexMember2025-09-012026-08-310000102816eatonvance:EatonVanceIndexBlendedIndex60MSCIACWIIndexand40BloombergUSAggregateBondIndex19220AdditionalIndexMember2021-09-012026-08-310000102816eatonvance:EatonVanceIndexBlendedIndex60MSCIACWIIndexand40BloombergUSAggregateBondIndex19220AdditionalIndexMember2016-09-012026-08-310000102816eatonvance:C000104753Member2026-08-310000102816eatonvance:C000104753Membereatonvance:AssetSovereignGovernmentBondsCTIMember2026-08-310000102816eatonvance:C000104753Membereatonvance:AssetShortMinusTermInvestmentsCTIMember2026-08-310000102816eatonvance:C000104753Membereatonvance:AssetExchangeMinusTradedFundsCTIMember2026-08-310000102816eatonvance:C000104753Membereatonvance:AssetCommonStocksCTIMember2026-08-310000102816eatonvance:C000104753Membereatonvance:FR61774R841CTIMember2026-08-310000102816eatonvance:C000104753Membereatonvance:FR61774R767CTIMember2026-08-310000102816eatonvance:C000104753Membereatonvance:FR921946885CTIMember2026-08-310000102816eatonvance:C000104753Membereatonvance:FR46434G103CTIMember2026-08-310000102816eatonvance:C000104753Membereatonvance:FR464287176CTIMember2026-08-310000102816eatonvance:C000104753Membereatonvance:FR67066G104CTIMember2026-08-310000102816eatonvance:C000104753Membereatonvance:FRACI2T4QH6CTIMember2026-08-310000102816eatonvance:C000104753Membereatonvance:FR594918104CTIMember2026-08-310000102816eatonvance:C000104753Membereatonvance:FR037833100CTIMember2026-08-310000102816eatonvance:C000104753Membereatonvance:FR023135106CTIMember2026-08-310000102816eatonvance:C000104753Membereatonvance:AmazoncomIncCTIMember2026-08-310000102816eatonvance:C000104753Member2024-09-012025-08-310000102816eatonvance:C000104754Member2025-09-012026-08-310000102816eatonvance:EATONVANCEIndexMSCIWorld19325BroadBasedIndexMember2025-09-012026-08-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19325AdditionalIndexMember2025-09-012026-08-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19325AdditionalIndexMember2025-09-012026-08-310000102816eatonvance:C000104754Member2016-08-312016-08-310000102816eatonvance:EATONVANCEIndexMSCIWorld19325BroadBasedIndexMember2016-08-312016-08-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19325AdditionalIndexMember2016-08-312016-08-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19325AdditionalIndexMember2016-08-312016-08-310000102816eatonvance:C000104754Member2016-09-012016-09-300000102816eatonvance:EATONVANCEIndexMSCIWorld19325BroadBasedIndexMember2016-09-012016-09-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19325AdditionalIndexMember2016-09-012016-09-300000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19325AdditionalIndexMember2016-09-012016-09-300000102816eatonvance:C000104754Member2016-09-012016-10-310000102816eatonvance:EATONVANCEIndexMSCIWorld19325BroadBasedIndexMember2016-09-012016-10-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19325AdditionalIndexMember2016-09-012016-10-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19325AdditionalIndexMember2016-09-012016-10-310000102816eatonvance:C000104754Member2016-09-012016-11-300000102816eatonvance:EATONVANCEIndexMSCIWorld19325BroadBasedIndexMember2016-09-012016-11-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19325AdditionalIndexMember2016-09-012016-11-300000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19325AdditionalIndexMember2016-09-012016-11-300000102816eatonvance:C000104754Member2016-09-012016-12-310000102816eatonvance:EATONVANCEIndexMSCIWorld19325BroadBasedIndexMember2016-09-012016-12-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19325AdditionalIndexMember2016-09-012016-12-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19325AdditionalIndexMember2016-09-012016-12-310000102816eatonvance:C000104754Member2016-09-012017-01-310000102816eatonvance:EATONVANCEIndexMSCIWorld19325BroadBasedIndexMember2016-09-012017-01-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19325AdditionalIndexMember2016-09-012017-01-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19325AdditionalIndexMember2016-09-012017-01-310000102816eatonvance:C000104754Member2016-09-012017-02-280000102816eatonvance:EATONVANCEIndexMSCIWorld19325BroadBasedIndexMember2016-09-012017-02-280000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19325AdditionalIndexMember2016-09-012017-02-280000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19325AdditionalIndexMember2016-09-012017-02-280000102816eatonvance:C000104754Member2016-09-012017-03-310000102816eatonvance:EATONVANCEIndexMSCIWorld19325BroadBasedIndexMember2016-09-012017-03-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19325AdditionalIndexMember2016-09-012017-03-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19325AdditionalIndexMember2016-09-012017-03-310000102816eatonvance:C000104754Member2016-09-012017-04-300000102816eatonvance:EATONVANCEIndexMSCIWorld19325BroadBasedIndexMember2016-09-012017-04-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19325AdditionalIndexMember2016-09-012017-04-300000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19325AdditionalIndexMember2016-09-012017-04-300000102816eatonvance:C000104754Member2016-09-012017-05-310000102816eatonvance:EATONVANCEIndexMSCIWorld19325BroadBasedIndexMember2016-09-012017-05-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19325AdditionalIndexMember2016-09-012017-05-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19325AdditionalIndexMember2016-09-012017-05-310000102816eatonvance:C000104754Member2016-09-012017-06-300000102816eatonvance:EATONVANCEIndexMSCIWorld19325BroadBasedIndexMember2016-09-012017-06-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19325AdditionalIndexMember2016-09-012017-06-300000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19325AdditionalIndexMember2016-09-012017-06-300000102816eatonvance:C000104754Member2016-09-012017-07-310000102816eatonvance:EATONVANCEIndexMSCIWorld19325BroadBasedIndexMember2016-09-012017-07-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19325AdditionalIndexMember2016-09-012017-07-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19325AdditionalIndexMember2016-09-012017-07-310000102816eatonvance:C000104754Member2016-09-012017-08-310000102816eatonvance:EATONVANCEIndexMSCIWorld19325BroadBasedIndexMember2016-09-012017-08-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19325AdditionalIndexMember2016-09-012017-08-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19325AdditionalIndexMember2016-09-012017-08-310000102816eatonvance:C000104754Member2016-09-012017-09-300000102816eatonvance:EATONVANCEIndexMSCIWorld19325BroadBasedIndexMember2016-09-012017-09-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19325AdditionalIndexMember2016-09-012017-09-300000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19325AdditionalIndexMember2016-09-012017-09-300000102816eatonvance:C000104754Member2016-09-012017-10-310000102816eatonvance:EATONVANCEIndexMSCIWorld19325BroadBasedIndexMember2016-09-012017-10-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19325AdditionalIndexMember2016-09-012017-10-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19325AdditionalIndexMember2016-09-012017-10-310000102816eatonvance:C000104754Member2016-09-012017-11-300000102816eatonvance:EATONVANCEIndexMSCIWorld19325BroadBasedIndexMember2016-09-012017-11-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19325AdditionalIndexMember2016-09-012017-11-300000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19325AdditionalIndexMember2016-09-012017-11-300000102816eatonvance:C000104754Member2016-09-012017-12-310000102816eatonvance:EATONVANCEIndexMSCIWorld19325BroadBasedIndexMember2016-09-012017-12-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19325AdditionalIndexMember2016-09-012017-12-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19325AdditionalIndexMember2016-09-012017-12-310000102816eatonvance:C000104754Member2016-09-012018-01-310000102816eatonvance:EATONVANCEIndexMSCIWorld19325BroadBasedIndexMember2016-09-012018-01-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19325AdditionalIndexMember2016-09-012018-01-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19325AdditionalIndexMember2016-09-012018-01-310000102816eatonvance:C000104754Member2016-09-012018-02-280000102816eatonvance:EATONVANCEIndexMSCIWorld19325BroadBasedIndexMember2016-09-012018-02-280000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19325AdditionalIndexMember2016-09-012018-02-280000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19325AdditionalIndexMember2016-09-012018-02-280000102816eatonvance:C000104754Member2016-09-012018-03-310000102816eatonvance:EATONVANCEIndexMSCIWorld19325BroadBasedIndexMember2016-09-012018-03-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19325AdditionalIndexMember2016-09-012018-03-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19325AdditionalIndexMember2016-09-012018-03-310000102816eatonvance:C000104754Member2016-09-012018-04-300000102816eatonvance:EATONVANCEIndexMSCIWorld19325BroadBasedIndexMember2016-09-012018-04-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19325AdditionalIndexMember2016-09-012018-04-300000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19325AdditionalIndexMember2016-09-012018-04-300000102816eatonvance:C000104754Member2016-09-012018-05-310000102816eatonvance:EATONVANCEIndexMSCIWorld19325BroadBasedIndexMember2016-09-012018-05-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19325AdditionalIndexMember2016-09-012018-05-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19325AdditionalIndexMember2016-09-012018-05-310000102816eatonvance:C000104754Member2016-09-012018-06-300000102816eatonvance:EATONVANCEIndexMSCIWorld19325BroadBasedIndexMember2016-09-012018-06-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19325AdditionalIndexMember2016-09-012018-06-300000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19325AdditionalIndexMember2016-09-012018-06-300000102816eatonvance:C000104754Member2016-09-012018-07-310000102816eatonvance:EATONVANCEIndexMSCIWorld19325BroadBasedIndexMember2016-09-012018-07-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19325AdditionalIndexMember2016-09-012018-07-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19325AdditionalIndexMember2016-09-012018-07-310000102816eatonvance:C000104754Member2016-09-012018-08-310000102816eatonvance:EATONVANCEIndexMSCIWorld19325BroadBasedIndexMember2016-09-012018-08-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19325AdditionalIndexMember2016-09-012018-08-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19325AdditionalIndexMember2016-09-012018-08-310000102816eatonvance:C000104754Member2016-09-012018-09-300000102816eatonvance:EATONVANCEIndexMSCIWorld19325BroadBasedIndexMember2016-09-012018-09-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19325AdditionalIndexMember2016-09-012018-09-300000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19325AdditionalIndexMember2016-09-012018-09-300000102816eatonvance:C000104754Member2016-09-012018-10-310000102816eatonvance:EATONVANCEIndexMSCIWorld19325BroadBasedIndexMember2016-09-012018-10-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19325AdditionalIndexMember2016-09-012018-10-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19325AdditionalIndexMember2016-09-012018-10-310000102816eatonvance:C000104754Member2016-09-012018-11-300000102816eatonvance:EATONVANCEIndexMSCIWorld19325BroadBasedIndexMember2016-09-012018-11-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19325AdditionalIndexMember2016-09-012018-11-300000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19325AdditionalIndexMember2016-09-012018-11-300000102816eatonvance:C000104754Member2016-09-012018-12-310000102816eatonvance:EATONVANCEIndexMSCIWorld19325BroadBasedIndexMember2016-09-012018-12-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19325AdditionalIndexMember2016-09-012018-12-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19325AdditionalIndexMember2016-09-012018-12-310000102816eatonvance:C000104754Member2016-09-012019-01-310000102816eatonvance:EATONVANCEIndexMSCIWorld19325BroadBasedIndexMember2016-09-012019-01-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19325AdditionalIndexMember2016-09-012019-01-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19325AdditionalIndexMember2016-09-012019-01-310000102816eatonvance:C000104754Member2016-09-012019-02-280000102816eatonvance:EATONVANCEIndexMSCIWorld19325BroadBasedIndexMember2016-09-012019-02-280000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19325AdditionalIndexMember2016-09-012019-02-280000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19325AdditionalIndexMember2016-09-012019-02-280000102816eatonvance:C000104754Member2016-09-012019-03-310000102816eatonvance:EATONVANCEIndexMSCIWorld19325BroadBasedIndexMember2016-09-012019-03-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19325AdditionalIndexMember2016-09-012019-03-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19325AdditionalIndexMember2016-09-012019-03-310000102816eatonvance:C000104754Member2016-09-012019-04-300000102816eatonvance:EATONVANCEIndexMSCIWorld19325BroadBasedIndexMember2016-09-012019-04-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19325AdditionalIndexMember2016-09-012019-04-300000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19325AdditionalIndexMember2016-09-012019-04-300000102816eatonvance:C000104754Member2016-09-012019-05-310000102816eatonvance:EATONVANCEIndexMSCIWorld19325BroadBasedIndexMember2016-09-012019-05-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19325AdditionalIndexMember2016-09-012019-05-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19325AdditionalIndexMember2016-09-012019-05-310000102816eatonvance:C000104754Member2016-09-012019-06-300000102816eatonvance:EATONVANCEIndexMSCIWorld19325BroadBasedIndexMember2016-09-012019-06-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19325AdditionalIndexMember2016-09-012019-06-300000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19325AdditionalIndexMember2016-09-012019-06-300000102816eatonvance:C000104754Member2016-09-012019-07-310000102816eatonvance:EATONVANCEIndexMSCIWorld19325BroadBasedIndexMember2016-09-012019-07-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19325AdditionalIndexMember2016-09-012019-07-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19325AdditionalIndexMember2016-09-012019-07-310000102816eatonvance:C000104754Member2016-09-012019-08-310000102816eatonvance:EATONVANCEIndexMSCIWorld19325BroadBasedIndexMember2016-09-012019-08-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19325AdditionalIndexMember2016-09-012019-08-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19325AdditionalIndexMember2016-09-012019-08-310000102816eatonvance:C000104754Member2016-09-012019-09-300000102816eatonvance:EATONVANCEIndexMSCIWorld19325BroadBasedIndexMember2016-09-012019-09-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19325AdditionalIndexMember2016-09-012019-09-300000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19325AdditionalIndexMember2016-09-012019-09-300000102816eatonvance:C000104754Member2016-09-012019-10-310000102816eatonvance:EATONVANCEIndexMSCIWorld19325BroadBasedIndexMember2016-09-012019-10-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19325AdditionalIndexMember2016-09-012019-10-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19325AdditionalIndexMember2016-09-012019-10-310000102816eatonvance:C000104754Member2016-09-012019-11-300000102816eatonvance:EATONVANCEIndexMSCIWorld19325BroadBasedIndexMember2016-09-012019-11-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19325AdditionalIndexMember2016-09-012019-11-300000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19325AdditionalIndexMember2016-09-012019-11-300000102816eatonvance:C000104754Member2016-09-012019-12-310000102816eatonvance:EATONVANCEIndexMSCIWorld19325BroadBasedIndexMember2016-09-012019-12-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19325AdditionalIndexMember2016-09-012019-12-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19325AdditionalIndexMember2016-09-012019-12-310000102816eatonvance:C000104754Member2016-09-012020-01-310000102816eatonvance:EATONVANCEIndexMSCIWorld19325BroadBasedIndexMember2016-09-012020-01-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19325AdditionalIndexMember2016-09-012020-01-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19325AdditionalIndexMember2016-09-012020-01-310000102816eatonvance:C000104754Member2016-09-012020-02-290000102816eatonvance:EATONVANCEIndexMSCIWorld19325BroadBasedIndexMember2016-09-012020-02-290000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19325AdditionalIndexMember2016-09-012020-02-290000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19325AdditionalIndexMember2016-09-012020-02-290000102816eatonvance:C000104754Member2016-09-012020-03-310000102816eatonvance:EATONVANCEIndexMSCIWorld19325BroadBasedIndexMember2016-09-012020-03-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19325AdditionalIndexMember2016-09-012020-03-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19325AdditionalIndexMember2016-09-012020-03-310000102816eatonvance:C000104754Member2016-09-012020-04-300000102816eatonvance:EATONVANCEIndexMSCIWorld19325BroadBasedIndexMember2016-09-012020-04-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19325AdditionalIndexMember2016-09-012020-04-300000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19325AdditionalIndexMember2016-09-012020-04-300000102816eatonvance:C000104754Member2016-09-012020-05-310000102816eatonvance:EATONVANCEIndexMSCIWorld19325BroadBasedIndexMember2016-09-012020-05-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19325AdditionalIndexMember2016-09-012020-05-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19325AdditionalIndexMember2016-09-012020-05-310000102816eatonvance:C000104754Member2016-09-012020-06-300000102816eatonvance:EATONVANCEIndexMSCIWorld19325BroadBasedIndexMember2016-09-012020-06-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19325AdditionalIndexMember2016-09-012020-06-300000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19325AdditionalIndexMember2016-09-012020-06-300000102816eatonvance:C000104754Member2016-09-012020-07-310000102816eatonvance:EATONVANCEIndexMSCIWorld19325BroadBasedIndexMember2016-09-012020-07-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19325AdditionalIndexMember2016-09-012020-07-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19325AdditionalIndexMember2016-09-012020-07-310000102816eatonvance:C000104754Member2016-09-012020-08-310000102816eatonvance:EATONVANCEIndexMSCIWorld19325BroadBasedIndexMember2016-09-012020-08-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19325AdditionalIndexMember2016-09-012020-08-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19325AdditionalIndexMember2016-09-012020-08-310000102816eatonvance:C000104754Member2016-09-012020-09-300000102816eatonvance:EATONVANCEIndexMSCIWorld19325BroadBasedIndexMember2016-09-012020-09-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19325AdditionalIndexMember2016-09-012020-09-300000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19325AdditionalIndexMember2016-09-012020-09-300000102816eatonvance:C000104754Member2016-09-012020-10-310000102816eatonvance:EATONVANCEIndexMSCIWorld19325BroadBasedIndexMember2016-09-012020-10-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19325AdditionalIndexMember2016-09-012020-10-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19325AdditionalIndexMember2016-09-012020-10-310000102816eatonvance:C000104754Member2016-09-012020-11-300000102816eatonvance:EATONVANCEIndexMSCIWorld19325BroadBasedIndexMember2016-09-012020-11-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19325AdditionalIndexMember2016-09-012020-11-300000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19325AdditionalIndexMember2016-09-012020-11-300000102816eatonvance:C000104754Member2016-09-012020-12-310000102816eatonvance:EATONVANCEIndexMSCIWorld19325BroadBasedIndexMember2016-09-012020-12-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19325AdditionalIndexMember2016-09-012020-12-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19325AdditionalIndexMember2016-09-012020-12-310000102816eatonvance:C000104754Member2016-09-012021-01-310000102816eatonvance:EATONVANCEIndexMSCIWorld19325BroadBasedIndexMember2016-09-012021-01-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19325AdditionalIndexMember2016-09-012021-01-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19325AdditionalIndexMember2016-09-012021-01-310000102816eatonvance:C000104754Member2016-09-012021-02-280000102816eatonvance:EATONVANCEIndexMSCIWorld19325BroadBasedIndexMember2016-09-012021-02-280000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19325AdditionalIndexMember2016-09-012021-02-280000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19325AdditionalIndexMember2016-09-012021-02-280000102816eatonvance:C000104754Member2016-09-012021-03-310000102816eatonvance:EATONVANCEIndexMSCIWorld19325BroadBasedIndexMember2016-09-012021-03-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19325AdditionalIndexMember2016-09-012021-03-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19325AdditionalIndexMember2016-09-012021-03-310000102816eatonvance:C000104754Member2016-09-012021-04-300000102816eatonvance:EATONVANCEIndexMSCIWorld19325BroadBasedIndexMember2016-09-012021-04-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19325AdditionalIndexMember2016-09-012021-04-300000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19325AdditionalIndexMember2016-09-012021-04-300000102816eatonvance:C000104754Member2016-09-012021-05-310000102816eatonvance:EATONVANCEIndexMSCIWorld19325BroadBasedIndexMember2016-09-012021-05-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19325AdditionalIndexMember2016-09-012021-05-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19325AdditionalIndexMember2016-09-012021-05-310000102816eatonvance:C000104754Member2016-09-012021-06-300000102816eatonvance:EATONVANCEIndexMSCIWorld19325BroadBasedIndexMember2016-09-012021-06-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19325AdditionalIndexMember2016-09-012021-06-300000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19325AdditionalIndexMember2016-09-012021-06-300000102816eatonvance:C000104754Member2016-09-012021-07-310000102816eatonvance:EATONVANCEIndexMSCIWorld19325BroadBasedIndexMember2016-09-012021-07-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19325AdditionalIndexMember2016-09-012021-07-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19325AdditionalIndexMember2016-09-012021-07-310000102816eatonvance:C000104754Member2016-09-012021-08-310000102816eatonvance:EATONVANCEIndexMSCIWorld19325BroadBasedIndexMember2016-09-012021-08-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19325AdditionalIndexMember2016-09-012021-08-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19325AdditionalIndexMember2016-09-012021-08-310000102816eatonvance:C000104754Member2016-09-012021-09-300000102816eatonvance:EATONVANCEIndexMSCIWorld19325BroadBasedIndexMember2016-09-012021-09-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19325AdditionalIndexMember2016-09-012021-09-300000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19325AdditionalIndexMember2016-09-012021-09-300000102816eatonvance:C000104754Member2016-09-012021-10-310000102816eatonvance:EATONVANCEIndexMSCIWorld19325BroadBasedIndexMember2016-09-012021-10-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19325AdditionalIndexMember2016-09-012021-10-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19325AdditionalIndexMember2016-09-012021-10-310000102816eatonvance:C000104754Member2016-09-012021-11-300000102816eatonvance:EATONVANCEIndexMSCIWorld19325BroadBasedIndexMember2016-09-012021-11-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19325AdditionalIndexMember2016-09-012021-11-300000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19325AdditionalIndexMember2016-09-012021-11-300000102816eatonvance:C000104754Member2016-09-012021-12-310000102816eatonvance:EATONVANCEIndexMSCIWorld19325BroadBasedIndexMember2016-09-012021-12-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19325AdditionalIndexMember2016-09-012021-12-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19325AdditionalIndexMember2016-09-012021-12-310000102816eatonvance:C000104754Member2016-09-012022-01-310000102816eatonvance:EATONVANCEIndexMSCIWorld19325BroadBasedIndexMember2016-09-012022-01-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19325AdditionalIndexMember2016-09-012022-01-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19325AdditionalIndexMember2016-09-012022-01-310000102816eatonvance:C000104754Member2016-09-012022-02-280000102816eatonvance:EATONVANCEIndexMSCIWorld19325BroadBasedIndexMember2016-09-012022-02-280000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19325AdditionalIndexMember2016-09-012022-02-280000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19325AdditionalIndexMember2016-09-012022-02-280000102816eatonvance:C000104754Member2016-09-012022-03-310000102816eatonvance:EATONVANCEIndexMSCIWorld19325BroadBasedIndexMember2016-09-012022-03-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19325AdditionalIndexMember2016-09-012022-03-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19325AdditionalIndexMember2016-09-012022-03-310000102816eatonvance:C000104754Member2016-09-012022-04-300000102816eatonvance:EATONVANCEIndexMSCIWorld19325BroadBasedIndexMember2016-09-012022-04-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19325AdditionalIndexMember2016-09-012022-04-300000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19325AdditionalIndexMember2016-09-012022-04-300000102816eatonvance:C000104754Member2016-09-012022-05-310000102816eatonvance:EATONVANCEIndexMSCIWorld19325BroadBasedIndexMember2016-09-012022-05-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19325AdditionalIndexMember2016-09-012022-05-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19325AdditionalIndexMember2016-09-012022-05-310000102816eatonvance:C000104754Member2016-09-012022-06-300000102816eatonvance:EATONVANCEIndexMSCIWorld19325BroadBasedIndexMember2016-09-012022-06-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19325AdditionalIndexMember2016-09-012022-06-300000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19325AdditionalIndexMember2016-09-012022-06-300000102816eatonvance:C000104754Member2016-09-012022-07-310000102816eatonvance:EATONVANCEIndexMSCIWorld19325BroadBasedIndexMember2016-09-012022-07-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19325AdditionalIndexMember2016-09-012022-07-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19325AdditionalIndexMember2016-09-012022-07-310000102816eatonvance:C000104754Member2016-09-012022-08-310000102816eatonvance:EATONVANCEIndexMSCIWorld19325BroadBasedIndexMember2016-09-012022-08-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19325AdditionalIndexMember2016-09-012022-08-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19325AdditionalIndexMember2016-09-012022-08-310000102816eatonvance:C000104754Member2016-09-012022-09-300000102816eatonvance:EATONVANCEIndexMSCIWorld19325BroadBasedIndexMember2016-09-012022-09-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19325AdditionalIndexMember2016-09-012022-09-300000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19325AdditionalIndexMember2016-09-012022-09-300000102816eatonvance:C000104754Member2016-09-012022-10-310000102816eatonvance:EATONVANCEIndexMSCIWorld19325BroadBasedIndexMember2016-09-012022-10-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19325AdditionalIndexMember2016-09-012022-10-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19325AdditionalIndexMember2016-09-012022-10-310000102816eatonvance:C000104754Member2016-09-012022-11-300000102816eatonvance:EATONVANCEIndexMSCIWorld19325BroadBasedIndexMember2016-09-012022-11-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19325AdditionalIndexMember2016-09-012022-11-300000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19325AdditionalIndexMember2016-09-012022-11-300000102816eatonvance:C000104754Member2016-09-012022-12-310000102816eatonvance:EATONVANCEIndexMSCIWorld19325BroadBasedIndexMember2016-09-012022-12-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19325AdditionalIndexMember2016-09-012022-12-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19325AdditionalIndexMember2016-09-012022-12-310000102816eatonvance:C000104754Member2016-09-012023-01-310000102816eatonvance:EATONVANCEIndexMSCIWorld19325BroadBasedIndexMember2016-09-012023-01-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19325AdditionalIndexMember2016-09-012023-01-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19325AdditionalIndexMember2016-09-012023-01-310000102816eatonvance:C000104754Member2016-09-012023-02-280000102816eatonvance:EATONVANCEIndexMSCIWorld19325BroadBasedIndexMember2016-09-012023-02-280000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19325AdditionalIndexMember2016-09-012023-02-280000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19325AdditionalIndexMember2016-09-012023-02-280000102816eatonvance:C000104754Member2016-09-012023-03-310000102816eatonvance:EATONVANCEIndexMSCIWorld19325BroadBasedIndexMember2016-09-012023-03-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19325AdditionalIndexMember2016-09-012023-03-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19325AdditionalIndexMember2016-09-012023-03-310000102816eatonvance:C000104754Member2016-09-012023-04-300000102816eatonvance:EATONVANCEIndexMSCIWorld19325BroadBasedIndexMember2016-09-012023-04-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19325AdditionalIndexMember2016-09-012023-04-300000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19325AdditionalIndexMember2016-09-012023-04-300000102816eatonvance:C000104754Member2016-09-012023-05-310000102816eatonvance:EATONVANCEIndexMSCIWorld19325BroadBasedIndexMember2016-09-012023-05-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19325AdditionalIndexMember2016-09-012023-05-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19325AdditionalIndexMember2016-09-012023-05-310000102816eatonvance:C000104754Member2016-09-012023-06-300000102816eatonvance:EATONVANCEIndexMSCIWorld19325BroadBasedIndexMember2016-09-012023-06-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19325AdditionalIndexMember2016-09-012023-06-300000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19325AdditionalIndexMember2016-09-012023-06-300000102816eatonvance:C000104754Member2016-09-012023-07-310000102816eatonvance:EATONVANCEIndexMSCIWorld19325BroadBasedIndexMember2016-09-012023-07-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19325AdditionalIndexMember2016-09-012023-07-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19325AdditionalIndexMember2016-09-012023-07-310000102816eatonvance:C000104754Member2016-09-012023-08-310000102816eatonvance:EATONVANCEIndexMSCIWorld19325BroadBasedIndexMember2016-09-012023-08-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19325AdditionalIndexMember2016-09-012023-08-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19325AdditionalIndexMember2016-09-012023-08-310000102816eatonvance:C000104754Member2016-09-012023-09-300000102816eatonvance:EATONVANCEIndexMSCIWorld19325BroadBasedIndexMember2016-09-012023-09-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19325AdditionalIndexMember2016-09-012023-09-300000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19325AdditionalIndexMember2016-09-012023-09-300000102816eatonvance:C000104754Member2016-09-012023-10-310000102816eatonvance:EATONVANCEIndexMSCIWorld19325BroadBasedIndexMember2016-09-012023-10-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19325AdditionalIndexMember2016-09-012023-10-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19325AdditionalIndexMember2016-09-012023-10-310000102816eatonvance:C000104754Member2016-09-012023-11-300000102816eatonvance:EATONVANCEIndexMSCIWorld19325BroadBasedIndexMember2016-09-012023-11-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19325AdditionalIndexMember2016-09-012023-11-300000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19325AdditionalIndexMember2016-09-012023-11-300000102816eatonvance:C000104754Member2016-09-012023-12-310000102816eatonvance:EATONVANCEIndexMSCIWorld19325BroadBasedIndexMember2016-09-012023-12-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19325AdditionalIndexMember2016-09-012023-12-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19325AdditionalIndexMember2016-09-012023-12-310000102816eatonvance:C000104754Member2016-09-012024-01-310000102816eatonvance:EATONVANCEIndexMSCIWorld19325BroadBasedIndexMember2016-09-012024-01-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19325AdditionalIndexMember2016-09-012024-01-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19325AdditionalIndexMember2016-09-012024-01-310000102816eatonvance:C000104754Member2016-09-012024-02-290000102816eatonvance:EATONVANCEIndexMSCIWorld19325BroadBasedIndexMember2016-09-012024-02-290000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19325AdditionalIndexMember2016-09-012024-02-290000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19325AdditionalIndexMember2016-09-012024-02-290000102816eatonvance:C000104754Member2016-09-012024-03-310000102816eatonvance:EATONVANCEIndexMSCIWorld19325BroadBasedIndexMember2016-09-012024-03-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19325AdditionalIndexMember2016-09-012024-03-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19325AdditionalIndexMember2016-09-012024-03-310000102816eatonvance:C000104754Member2016-09-012024-04-300000102816eatonvance:EATONVANCEIndexMSCIWorld19325BroadBasedIndexMember2016-09-012024-04-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19325AdditionalIndexMember2016-09-012024-04-300000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19325AdditionalIndexMember2016-09-012024-04-300000102816eatonvance:C000104754Member2016-09-012024-05-310000102816eatonvance:EATONVANCEIndexMSCIWorld19325BroadBasedIndexMember2016-09-012024-05-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19325AdditionalIndexMember2016-09-012024-05-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19325AdditionalIndexMember2016-09-012024-05-310000102816eatonvance:C000104754Member2016-09-012024-06-300000102816eatonvance:EATONVANCEIndexMSCIWorld19325BroadBasedIndexMember2016-09-012024-06-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19325AdditionalIndexMember2016-09-012024-06-300000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19325AdditionalIndexMember2016-09-012024-06-300000102816eatonvance:C000104754Member2016-09-012024-07-310000102816eatonvance:EATONVANCEIndexMSCIWorld19325BroadBasedIndexMember2016-09-012024-07-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19325AdditionalIndexMember2016-09-012024-07-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19325AdditionalIndexMember2016-09-012024-07-310000102816eatonvance:C000104754Member2016-09-012024-08-310000102816eatonvance:EATONVANCEIndexMSCIWorld19325BroadBasedIndexMember2016-09-012024-08-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19325AdditionalIndexMember2016-09-012024-08-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19325AdditionalIndexMember2016-09-012024-08-310000102816eatonvance:C000104754Member2016-09-012024-09-300000102816eatonvance:EATONVANCEIndexMSCIWorld19325BroadBasedIndexMember2016-09-012024-09-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19325AdditionalIndexMember2016-09-012024-09-300000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19325AdditionalIndexMember2016-09-012024-09-300000102816eatonvance:C000104754Member2016-09-012024-10-310000102816eatonvance:EATONVANCEIndexMSCIWorld19325BroadBasedIndexMember2016-09-012024-10-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19325AdditionalIndexMember2016-09-012024-10-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19325AdditionalIndexMember2016-09-012024-10-310000102816eatonvance:C000104754Member2016-09-012024-11-300000102816eatonvance:EATONVANCEIndexMSCIWorld19325BroadBasedIndexMember2016-09-012024-11-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19325AdditionalIndexMember2016-09-012024-11-300000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19325AdditionalIndexMember2016-09-012024-11-300000102816eatonvance:C000104754Member2016-09-012024-12-310000102816eatonvance:EATONVANCEIndexMSCIWorld19325BroadBasedIndexMember2016-09-012024-12-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19325AdditionalIndexMember2016-09-012024-12-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19325AdditionalIndexMember2016-09-012024-12-310000102816eatonvance:C000104754Member2016-09-012025-01-310000102816eatonvance:EATONVANCEIndexMSCIWorld19325BroadBasedIndexMember2016-09-012025-01-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19325AdditionalIndexMember2016-09-012025-01-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19325AdditionalIndexMember2016-09-012025-01-310000102816eatonvance:C000104754Member2016-09-012025-02-280000102816eatonvance:EATONVANCEIndexMSCIWorld19325BroadBasedIndexMember2016-09-012025-02-280000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19325AdditionalIndexMember2016-09-012025-02-280000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19325AdditionalIndexMember2016-09-012025-02-280000102816eatonvance:C000104754Member2016-09-012025-03-310000102816eatonvance:EATONVANCEIndexMSCIWorld19325BroadBasedIndexMember2016-09-012025-03-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19325AdditionalIndexMember2016-09-012025-03-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19325AdditionalIndexMember2016-09-012025-03-310000102816eatonvance:C000104754Member2016-09-012025-04-300000102816eatonvance:EATONVANCEIndexMSCIWorld19325BroadBasedIndexMember2016-09-012025-04-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19325AdditionalIndexMember2016-09-012025-04-300000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19325AdditionalIndexMember2016-09-012025-04-300000102816eatonvance:C000104754Member2016-09-012025-05-310000102816eatonvance:EATONVANCEIndexMSCIWorld19325BroadBasedIndexMember2016-09-012025-05-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19325AdditionalIndexMember2016-09-012025-05-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19325AdditionalIndexMember2016-09-012025-05-310000102816eatonvance:C000104754Member2016-09-012025-06-300000102816eatonvance:EATONVANCEIndexMSCIWorld19325BroadBasedIndexMember2016-09-012025-06-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19325AdditionalIndexMember2016-09-012025-06-300000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19325AdditionalIndexMember2016-09-012025-06-300000102816eatonvance:C000104754Member2016-09-012025-07-310000102816eatonvance:EATONVANCEIndexMSCIWorld19325BroadBasedIndexMember2016-09-012025-07-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19325AdditionalIndexMember2016-09-012025-07-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19325AdditionalIndexMember2016-09-012025-07-310000102816eatonvance:C000104754Member2016-09-012025-08-310000102816eatonvance:EATONVANCEIndexMSCIWorld19325BroadBasedIndexMember2016-09-012025-08-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19325AdditionalIndexMember2016-09-012025-08-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19325AdditionalIndexMember2016-09-012025-08-310000102816eatonvance:C000104754Member2016-09-012025-09-300000102816eatonvance:EATONVANCEIndexMSCIWorld19325BroadBasedIndexMember2016-09-012025-09-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19325AdditionalIndexMember2016-09-012025-09-300000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19325AdditionalIndexMember2016-09-012025-09-300000102816eatonvance:C000104754Member2016-09-012025-10-310000102816eatonvance:EATONVANCEIndexMSCIWorld19325BroadBasedIndexMember2016-09-012025-10-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19325AdditionalIndexMember2016-09-012025-10-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19325AdditionalIndexMember2016-09-012025-10-310000102816eatonvance:C000104754Member2016-09-012025-11-300000102816eatonvance:EATONVANCEIndexMSCIWorld19325BroadBasedIndexMember2016-09-012025-11-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19325AdditionalIndexMember2016-09-012025-11-300000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19325AdditionalIndexMember2016-09-012025-11-300000102816eatonvance:C000104754Member2016-09-012025-12-310000102816eatonvance:EATONVANCEIndexMSCIWorld19325BroadBasedIndexMember2016-09-012025-12-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19325AdditionalIndexMember2016-09-012025-12-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19325AdditionalIndexMember2016-09-012025-12-310000102816eatonvance:C000104754Member2016-09-012026-01-310000102816eatonvance:EATONVANCEIndexMSCIWorld19325BroadBasedIndexMember2016-09-012026-01-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19325AdditionalIndexMember2016-09-012026-01-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19325AdditionalIndexMember2016-09-012026-01-310000102816eatonvance:C000104754Member2016-09-012026-02-280000102816eatonvance:EATONVANCEIndexMSCIWorld19325BroadBasedIndexMember2016-09-012026-02-280000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19325AdditionalIndexMember2016-09-012026-02-280000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19325AdditionalIndexMember2016-09-012026-02-280000102816eatonvance:C000104754Member2016-09-012026-03-310000102816eatonvance:EATONVANCEIndexMSCIWorld19325BroadBasedIndexMember2016-09-012026-03-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19325AdditionalIndexMember2016-09-012026-03-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19325AdditionalIndexMember2016-09-012026-03-310000102816eatonvance:C000104754Member2016-09-012026-04-300000102816eatonvance:EATONVANCEIndexMSCIWorld19325BroadBasedIndexMember2016-09-012026-04-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19325AdditionalIndexMember2016-09-012026-04-300000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19325AdditionalIndexMember2016-09-012026-04-300000102816eatonvance:C000104754Member2016-09-012026-05-310000102816eatonvance:EATONVANCEIndexMSCIWorld19325BroadBasedIndexMember2016-09-012026-05-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19325AdditionalIndexMember2016-09-012026-05-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19325AdditionalIndexMember2016-09-012026-05-310000102816eatonvance:C000104754Member2016-09-012026-06-300000102816eatonvance:EATONVANCEIndexMSCIWorld19325BroadBasedIndexMember2016-09-012026-06-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19325AdditionalIndexMember2016-09-012026-06-300000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19325AdditionalIndexMember2016-09-012026-06-300000102816eatonvance:C000104754Member2016-09-012026-07-310000102816eatonvance:EATONVANCEIndexMSCIWorld19325BroadBasedIndexMember2016-09-012026-07-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19325AdditionalIndexMember2016-09-012026-07-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19325AdditionalIndexMember2016-09-012026-07-310000102816eatonvance:C000104754Member2016-09-012026-08-310000102816eatonvance:EATONVANCEIndexMSCIWorld19325BroadBasedIndexMember2016-09-012026-08-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19325AdditionalIndexMember2016-09-012026-08-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19325AdditionalIndexMember2016-09-012026-08-310000102816eatonvance:C000104754Memberoef:WithoutSalesLoadMember2025-09-012026-08-310000102816eatonvance:C000104754Memberoef:WithoutSalesLoadMember2021-09-012026-08-310000102816eatonvance:C000104754Memberoef:WithoutSalesLoadMember2016-09-012026-08-310000102816eatonvance:EATONVANCEIndexMSCIWorld19325BroadBasedIndexMember2021-09-012026-08-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19325AdditionalIndexMember2021-09-012026-08-310000102816eatonvance:EATONVANCEIndexBloombergUSAggregateBondIndex19325AdditionalIndexMember2021-09-012026-08-310000102816eatonvance:EatonVanceIndexBlendedIndex60MSCIACWIIndexand40BloombergUSAggregateBondIndex19325AdditionalIndexMember2025-09-012026-08-310000102816eatonvance:EatonVanceIndexBlendedIndex60MSCIACWIIndexand40BloombergUSAggregateBondIndex19325AdditionalIndexMember2021-09-012026-08-310000102816eatonvance:EatonVanceIndexBlendedIndex60MSCIACWIIndexand40BloombergUSAggregateBondIndex19325AdditionalIndexMember2016-09-012026-08-310000102816eatonvance:C000104754Member2026-08-310000102816eatonvance:C000104754Membereatonvance:AssetSovereignGovernmentBondsCTIMember2026-08-310000102816eatonvance:C000104754Membereatonvance:AssetShortMinusTermInvestmentsCTIMember2026-08-310000102816eatonvance:C000104754Membereatonvance:AssetExchangeMinusTradedFundsCTIMember2026-08-310000102816eatonvance:C000104754Membereatonvance:AssetCommonStocksCTIMember2026-08-310000102816eatonvance:C000104754Membereatonvance:FR61774R841CTIMember2026-08-310000102816eatonvance:C000104754Membereatonvance:FR61774R767CTIMember2026-08-310000102816eatonvance:C000104754Membereatonvance:FR921946885CTIMember2026-08-310000102816eatonvance:C000104754Membereatonvance:FR46434G103CTIMember2026-08-310000102816eatonvance:C000104754Membereatonvance:FR464287176CTIMember2026-08-310000102816eatonvance:C000104754Membereatonvance:FR67066G104CTIMember2026-08-310000102816eatonvance:C000104754Membereatonvance:FRACI2T4QH6CTIMember2026-08-310000102816eatonvance:C000104754Membereatonvance:FR594918104CTIMember2026-08-310000102816eatonvance:C000104754Membereatonvance:FR037833100CTIMember2026-08-310000102816eatonvance:C000104754Membereatonvance:FR023135106CTIMember2026-08-310000102816eatonvance:C000104754Membereatonvance:AmazoncomIncCTIMember2026-08-310000102816eatonvance:C000104754Member2024-09-012025-08-310000102816eatonvance:C000092730Member2025-09-012026-08-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19113BroadBasedIndexMember2025-09-012026-08-310000102816eatonvance:C000092730Member2016-08-312016-08-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19113BroadBasedIndexMember2016-08-312016-08-310000102816eatonvance:C000092730Member2016-09-012016-09-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19113BroadBasedIndexMember2016-09-012016-09-300000102816eatonvance:C000092730Member2016-09-012016-10-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19113BroadBasedIndexMember2016-09-012016-10-310000102816eatonvance:C000092730Member2016-09-012016-11-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19113BroadBasedIndexMember2016-09-012016-11-300000102816eatonvance:C000092730Member2016-09-012016-12-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19113BroadBasedIndexMember2016-09-012016-12-310000102816eatonvance:C000092730Member2016-09-012017-01-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19113BroadBasedIndexMember2016-09-012017-01-310000102816eatonvance:C000092730Member2016-09-012017-02-280000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19113BroadBasedIndexMember2016-09-012017-02-280000102816eatonvance:C000092730Member2016-09-012017-03-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19113BroadBasedIndexMember2016-09-012017-03-310000102816eatonvance:C000092730Member2016-09-012017-04-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19113BroadBasedIndexMember2016-09-012017-04-300000102816eatonvance:C000092730Member2016-09-012017-05-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19113BroadBasedIndexMember2016-09-012017-05-310000102816eatonvance:C000092730Member2016-09-012017-06-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19113BroadBasedIndexMember2016-09-012017-06-300000102816eatonvance:C000092730Member2016-09-012017-07-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19113BroadBasedIndexMember2016-09-012017-07-310000102816eatonvance:C000092730Member2016-09-012017-08-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19113BroadBasedIndexMember2016-09-012017-08-310000102816eatonvance:C000092730Member2016-09-012017-09-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19113BroadBasedIndexMember2016-09-012017-09-300000102816eatonvance:C000092730Member2016-09-012017-10-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19113BroadBasedIndexMember2016-09-012017-10-310000102816eatonvance:C000092730Member2016-09-012017-11-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19113BroadBasedIndexMember2016-09-012017-11-300000102816eatonvance:C000092730Member2016-09-012017-12-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19113BroadBasedIndexMember2016-09-012017-12-310000102816eatonvance:C000092730Member2016-09-012018-01-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19113BroadBasedIndexMember2016-09-012018-01-310000102816eatonvance:C000092730Member2016-09-012018-02-280000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19113BroadBasedIndexMember2016-09-012018-02-280000102816eatonvance:C000092730Member2016-09-012018-03-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19113BroadBasedIndexMember2016-09-012018-03-310000102816eatonvance:C000092730Member2016-09-012018-04-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19113BroadBasedIndexMember2016-09-012018-04-300000102816eatonvance:C000092730Member2016-09-012018-05-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19113BroadBasedIndexMember2016-09-012018-05-310000102816eatonvance:C000092730Member2016-09-012018-06-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19113BroadBasedIndexMember2016-09-012018-06-300000102816eatonvance:C000092730Member2016-09-012018-07-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19113BroadBasedIndexMember2016-09-012018-07-310000102816eatonvance:C000092730Member2016-09-012018-08-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19113BroadBasedIndexMember2016-09-012018-08-310000102816eatonvance:C000092730Member2016-09-012018-09-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19113BroadBasedIndexMember2016-09-012018-09-300000102816eatonvance:C000092730Member2016-09-012018-10-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19113BroadBasedIndexMember2016-09-012018-10-310000102816eatonvance:C000092730Member2016-09-012018-11-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19113BroadBasedIndexMember2016-09-012018-11-300000102816eatonvance:C000092730Member2016-09-012018-12-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19113BroadBasedIndexMember2016-09-012018-12-310000102816eatonvance:C000092730Member2016-09-012019-01-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19113BroadBasedIndexMember2016-09-012019-01-310000102816eatonvance:C000092730Member2016-09-012019-02-280000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19113BroadBasedIndexMember2016-09-012019-02-280000102816eatonvance:C000092730Member2016-09-012019-03-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19113BroadBasedIndexMember2016-09-012019-03-310000102816eatonvance:C000092730Member2016-09-012019-04-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19113BroadBasedIndexMember2016-09-012019-04-300000102816eatonvance:C000092730Member2016-09-012019-05-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19113BroadBasedIndexMember2016-09-012019-05-310000102816eatonvance:C000092730Member2016-09-012019-06-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19113BroadBasedIndexMember2016-09-012019-06-300000102816eatonvance:C000092730Member2016-09-012019-07-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19113BroadBasedIndexMember2016-09-012019-07-310000102816eatonvance:C000092730Member2016-09-012019-08-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19113BroadBasedIndexMember2016-09-012019-08-310000102816eatonvance:C000092730Member2016-09-012019-09-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19113BroadBasedIndexMember2016-09-012019-09-300000102816eatonvance:C000092730Member2016-09-012019-10-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19113BroadBasedIndexMember2016-09-012019-10-310000102816eatonvance:C000092730Member2016-09-012019-11-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19113BroadBasedIndexMember2016-09-012019-11-300000102816eatonvance:C000092730Member2016-09-012019-12-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19113BroadBasedIndexMember2016-09-012019-12-310000102816eatonvance:C000092730Member2016-09-012020-01-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19113BroadBasedIndexMember2016-09-012020-01-310000102816eatonvance:C000092730Member2016-09-012020-02-290000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19113BroadBasedIndexMember2016-09-012020-02-290000102816eatonvance:C000092730Member2016-09-012020-03-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19113BroadBasedIndexMember2016-09-012020-03-310000102816eatonvance:C000092730Member2016-09-012020-04-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19113BroadBasedIndexMember2016-09-012020-04-300000102816eatonvance:C000092730Member2016-09-012020-05-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19113BroadBasedIndexMember2016-09-012020-05-310000102816eatonvance:C000092730Member2016-09-012020-06-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19113BroadBasedIndexMember2016-09-012020-06-300000102816eatonvance:C000092730Member2016-09-012020-07-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19113BroadBasedIndexMember2016-09-012020-07-310000102816eatonvance:C000092730Member2016-09-012020-08-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19113BroadBasedIndexMember2016-09-012020-08-310000102816eatonvance:C000092730Member2016-09-012020-09-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19113BroadBasedIndexMember2016-09-012020-09-300000102816eatonvance:C000092730Member2016-09-012020-10-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19113BroadBasedIndexMember2016-09-012020-10-310000102816eatonvance:C000092730Member2016-09-012020-11-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19113BroadBasedIndexMember2016-09-012020-11-300000102816eatonvance:C000092730Member2016-09-012020-12-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19113BroadBasedIndexMember2016-09-012020-12-310000102816eatonvance:C000092730Member2016-09-012021-01-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19113BroadBasedIndexMember2016-09-012021-01-310000102816eatonvance:C000092730Member2016-09-012021-02-280000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19113BroadBasedIndexMember2016-09-012021-02-280000102816eatonvance:C000092730Member2016-09-012021-03-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19113BroadBasedIndexMember2016-09-012021-03-310000102816eatonvance:C000092730Member2016-09-012021-04-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19113BroadBasedIndexMember2016-09-012021-04-300000102816eatonvance:C000092730Member2016-09-012021-05-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19113BroadBasedIndexMember2016-09-012021-05-310000102816eatonvance:C000092730Member2016-09-012021-06-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19113BroadBasedIndexMember2016-09-012021-06-300000102816eatonvance:C000092730Member2016-09-012021-07-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19113BroadBasedIndexMember2016-09-012021-07-310000102816eatonvance:C000092730Member2016-09-012021-08-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19113BroadBasedIndexMember2016-09-012021-08-310000102816eatonvance:C000092730Member2016-09-012021-09-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19113BroadBasedIndexMember2016-09-012021-09-300000102816eatonvance:C000092730Member2016-09-012021-10-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19113BroadBasedIndexMember2016-09-012021-10-310000102816eatonvance:C000092730Member2016-09-012021-11-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19113BroadBasedIndexMember2016-09-012021-11-300000102816eatonvance:C000092730Member2016-09-012021-12-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19113BroadBasedIndexMember2016-09-012021-12-310000102816eatonvance:C000092730Member2016-09-012022-01-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19113BroadBasedIndexMember2016-09-012022-01-310000102816eatonvance:C000092730Member2016-09-012022-02-280000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19113BroadBasedIndexMember2016-09-012022-02-280000102816eatonvance:C000092730Member2016-09-012022-03-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19113BroadBasedIndexMember2016-09-012022-03-310000102816eatonvance:C000092730Member2016-09-012022-04-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19113BroadBasedIndexMember2016-09-012022-04-300000102816eatonvance:C000092730Member2016-09-012022-05-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19113BroadBasedIndexMember2016-09-012022-05-310000102816eatonvance:C000092730Member2016-09-012022-06-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19113BroadBasedIndexMember2016-09-012022-06-300000102816eatonvance:C000092730Member2016-09-012022-07-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19113BroadBasedIndexMember2016-09-012022-07-310000102816eatonvance:C000092730Member2016-09-012022-08-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19113BroadBasedIndexMember2016-09-012022-08-310000102816eatonvance:C000092730Member2016-09-012022-09-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19113BroadBasedIndexMember2016-09-012022-09-300000102816eatonvance:C000092730Member2016-09-012022-10-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19113BroadBasedIndexMember2016-09-012022-10-310000102816eatonvance:C000092730Member2016-09-012022-11-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19113BroadBasedIndexMember2016-09-012022-11-300000102816eatonvance:C000092730Member2016-09-012022-12-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19113BroadBasedIndexMember2016-09-012022-12-310000102816eatonvance:C000092730Member2016-09-012023-01-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19113BroadBasedIndexMember2016-09-012023-01-310000102816eatonvance:C000092730Member2016-09-012023-02-280000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19113BroadBasedIndexMember2016-09-012023-02-280000102816eatonvance:C000092730Member2016-09-012023-03-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19113BroadBasedIndexMember2016-09-012023-03-310000102816eatonvance:C000092730Member2016-09-012023-04-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19113BroadBasedIndexMember2016-09-012023-04-300000102816eatonvance:C000092730Member2016-09-012023-05-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19113BroadBasedIndexMember2016-09-012023-05-310000102816eatonvance:C000092730Member2016-09-012023-06-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19113BroadBasedIndexMember2016-09-012023-06-300000102816eatonvance:C000092730Member2016-09-012023-07-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19113BroadBasedIndexMember2016-09-012023-07-310000102816eatonvance:C000092730Member2016-09-012023-08-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19113BroadBasedIndexMember2016-09-012023-08-310000102816eatonvance:C000092730Member2016-09-012023-09-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19113BroadBasedIndexMember2016-09-012023-09-300000102816eatonvance:C000092730Member2016-09-012023-10-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19113BroadBasedIndexMember2016-09-012023-10-310000102816eatonvance:C000092730Member2016-09-012023-11-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19113BroadBasedIndexMember2016-09-012023-11-300000102816eatonvance:C000092730Member2016-09-012023-12-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19113BroadBasedIndexMember2016-09-012023-12-310000102816eatonvance:C000092730Member2016-09-012024-01-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19113BroadBasedIndexMember2016-09-012024-01-310000102816eatonvance:C000092730Member2016-09-012024-02-290000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19113BroadBasedIndexMember2016-09-012024-02-290000102816eatonvance:C000092730Member2016-09-012024-03-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19113BroadBasedIndexMember2016-09-012024-03-310000102816eatonvance:C000092730Member2016-09-012024-04-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19113BroadBasedIndexMember2016-09-012024-04-300000102816eatonvance:C000092730Member2016-09-012024-05-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19113BroadBasedIndexMember2016-09-012024-05-310000102816eatonvance:C000092730Member2016-09-012024-06-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19113BroadBasedIndexMember2016-09-012024-06-300000102816eatonvance:C000092730Member2016-09-012024-07-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19113BroadBasedIndexMember2016-09-012024-07-310000102816eatonvance:C000092730Member2016-09-012024-08-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19113BroadBasedIndexMember2016-09-012024-08-310000102816eatonvance:C000092730Member2016-09-012024-09-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19113BroadBasedIndexMember2016-09-012024-09-300000102816eatonvance:C000092730Member2016-09-012024-10-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19113BroadBasedIndexMember2016-09-012024-10-310000102816eatonvance:C000092730Member2016-09-012024-11-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19113BroadBasedIndexMember2016-09-012024-11-300000102816eatonvance:C000092730Member2016-09-012024-12-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19113BroadBasedIndexMember2016-09-012024-12-310000102816eatonvance:C000092730Member2016-09-012025-01-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19113BroadBasedIndexMember2016-09-012025-01-310000102816eatonvance:C000092730Member2016-09-012025-02-280000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19113BroadBasedIndexMember2016-09-012025-02-280000102816eatonvance:C000092730Member2016-09-012025-03-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19113BroadBasedIndexMember2016-09-012025-03-310000102816eatonvance:C000092730Member2016-09-012025-04-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19113BroadBasedIndexMember2016-09-012025-04-300000102816eatonvance:C000092730Member2016-09-012025-05-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19113BroadBasedIndexMember2016-09-012025-05-310000102816eatonvance:C000092730Member2016-09-012025-06-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19113BroadBasedIndexMember2016-09-012025-06-300000102816eatonvance:C000092730Member2016-09-012025-07-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19113BroadBasedIndexMember2016-09-012025-07-310000102816eatonvance:C000092730Member2016-09-012025-08-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19113BroadBasedIndexMember2016-09-012025-08-310000102816eatonvance:C000092730Member2016-09-012025-09-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19113BroadBasedIndexMember2016-09-012025-09-300000102816eatonvance:C000092730Member2016-09-012025-10-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19113BroadBasedIndexMember2016-09-012025-10-310000102816eatonvance:C000092730Member2016-09-012025-11-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19113BroadBasedIndexMember2016-09-012025-11-300000102816eatonvance:C000092730Member2016-09-012025-12-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19113BroadBasedIndexMember2016-09-012025-12-310000102816eatonvance:C000092730Member2016-09-012026-01-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19113BroadBasedIndexMember2016-09-012026-01-310000102816eatonvance:C000092730Member2016-09-012026-02-280000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19113BroadBasedIndexMember2016-09-012026-02-280000102816eatonvance:C000092730Member2016-09-012026-03-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19113BroadBasedIndexMember2016-09-012026-03-310000102816eatonvance:C000092730Member2016-09-012026-04-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19113BroadBasedIndexMember2016-09-012026-04-300000102816eatonvance:C000092730Member2016-09-012026-05-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19113BroadBasedIndexMember2016-09-012026-05-310000102816eatonvance:C000092730Member2016-09-012026-06-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19113BroadBasedIndexMember2016-09-012026-06-300000102816eatonvance:C000092730Member2016-09-012026-07-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19113BroadBasedIndexMember2016-09-012026-07-310000102816eatonvance:C000092730Member2016-09-012026-08-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19113BroadBasedIndexMember2016-09-012026-08-310000102816eatonvance:C000092730Memberoef:WithoutSalesLoadMember2025-09-012026-08-310000102816eatonvance:C000092730Memberoef:WithoutSalesLoadMember2021-09-012026-08-310000102816eatonvance:C000092730Memberoef:WithoutSalesLoadMember2016-09-012026-08-310000102816eatonvance:C000092730Member2021-09-012026-08-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19113BroadBasedIndexMember2021-09-012026-08-310000102816eatonvance:C000092730Member2026-08-310000102816eatonvance:C000092730Membereatonvance:SectorRealEstateSectorMember2026-08-310000102816eatonvance:C000092730Membereatonvance:SectorMaterialsSectorMember2026-08-310000102816eatonvance:C000092730Membereatonvance:SectorConsumerStaplesSectorMember2026-08-310000102816eatonvance:C000092730Membereatonvance:SectorEnergySectorMember2026-08-310000102816eatonvance:C000092730Membereatonvance:SectorShortMinusTermInvestmentsSectorMember2026-08-310000102816eatonvance:C000092730Membereatonvance:SectorCommunicationServicesSectorMember2026-08-310000102816eatonvance:C000092730Membereatonvance:SectorUtilitiesSectorMember2026-08-310000102816eatonvance:C000092730Membereatonvance:SectorConsumerDiscretionarySectorMember2026-08-310000102816eatonvance:C000092730Membereatonvance:SectorHealthCareSectorMember2026-08-310000102816eatonvance:C000092730Membereatonvance:SectorExchangeMinusTradedFundsSectorMember2026-08-310000102816eatonvance:C000092730Membereatonvance:SectorIndustrialsSectorMember2026-08-310000102816eatonvance:C000092730Membereatonvance:SectorFinancialsSectorMember2026-08-310000102816eatonvance:C000092730Membereatonvance:SectorInformationTechnologySectorMember2026-08-310000102816eatonvance:C000092730Membereatonvance:FR46434G103CTIMember2026-08-310000102816eatonvance:C000092730Membereatonvance:FR67066G104CTIMember2026-08-310000102816eatonvance:C000092730Membereatonvance:FR594918104CTIMember2026-08-310000102816eatonvance:C000092730Membereatonvance:FR037833100CTIMember2026-08-310000102816eatonvance:C000092730Membereatonvance:FR023135106CTIMember2026-08-310000102816eatonvance:C000092730Membereatonvance:FR02079K305CTIMember2026-08-310000102816eatonvance:C000092730Membereatonvance:FR11135F101CTIMember2026-08-310000102816eatonvance:C000092730Membereatonvance:FR464286400CTIMember2026-08-310000102816eatonvance:C000092730Membereatonvance:FR46434G772CTIMember2026-08-310000102816eatonvance:C000092730Membereatonvance:FR595112103CTIMember2026-08-310000102816eatonvance:C000092730Membereatonvance:MicronTechnologyIncCTIMember2026-08-310000102816eatonvance:C000092730Member2024-09-012025-08-310000102816eatonvance:C000092731Member2025-09-012026-08-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19236BroadBasedIndexMember2025-09-012026-08-310000102816eatonvance:C000092731Member2016-08-312016-08-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19236BroadBasedIndexMember2016-08-312016-08-310000102816eatonvance:C000092731Member2016-09-012016-09-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19236BroadBasedIndexMember2016-09-012016-09-300000102816eatonvance:C000092731Member2016-09-012016-10-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19236BroadBasedIndexMember2016-09-012016-10-310000102816eatonvance:C000092731Member2016-09-012016-11-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19236BroadBasedIndexMember2016-09-012016-11-300000102816eatonvance:C000092731Member2016-09-012016-12-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19236BroadBasedIndexMember2016-09-012016-12-310000102816eatonvance:C000092731Member2016-09-012017-01-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19236BroadBasedIndexMember2016-09-012017-01-310000102816eatonvance:C000092731Member2016-09-012017-02-280000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19236BroadBasedIndexMember2016-09-012017-02-280000102816eatonvance:C000092731Member2016-09-012017-03-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19236BroadBasedIndexMember2016-09-012017-03-310000102816eatonvance:C000092731Member2016-09-012017-04-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19236BroadBasedIndexMember2016-09-012017-04-300000102816eatonvance:C000092731Member2016-09-012017-05-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19236BroadBasedIndexMember2016-09-012017-05-310000102816eatonvance:C000092731Member2016-09-012017-06-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19236BroadBasedIndexMember2016-09-012017-06-300000102816eatonvance:C000092731Member2016-09-012017-07-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19236BroadBasedIndexMember2016-09-012017-07-310000102816eatonvance:C000092731Member2016-09-012017-08-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19236BroadBasedIndexMember2016-09-012017-08-310000102816eatonvance:C000092731Member2016-09-012017-09-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19236BroadBasedIndexMember2016-09-012017-09-300000102816eatonvance:C000092731Member2016-09-012017-10-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19236BroadBasedIndexMember2016-09-012017-10-310000102816eatonvance:C000092731Member2016-09-012017-11-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19236BroadBasedIndexMember2016-09-012017-11-300000102816eatonvance:C000092731Member2016-09-012017-12-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19236BroadBasedIndexMember2016-09-012017-12-310000102816eatonvance:C000092731Member2016-09-012018-01-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19236BroadBasedIndexMember2016-09-012018-01-310000102816eatonvance:C000092731Member2016-09-012018-02-280000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19236BroadBasedIndexMember2016-09-012018-02-280000102816eatonvance:C000092731Member2016-09-012018-03-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19236BroadBasedIndexMember2016-09-012018-03-310000102816eatonvance:C000092731Member2016-09-012018-04-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19236BroadBasedIndexMember2016-09-012018-04-300000102816eatonvance:C000092731Member2016-09-012018-05-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19236BroadBasedIndexMember2016-09-012018-05-310000102816eatonvance:C000092731Member2016-09-012018-06-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19236BroadBasedIndexMember2016-09-012018-06-300000102816eatonvance:C000092731Member2016-09-012018-07-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19236BroadBasedIndexMember2016-09-012018-07-310000102816eatonvance:C000092731Member2016-09-012018-08-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19236BroadBasedIndexMember2016-09-012018-08-310000102816eatonvance:C000092731Member2016-09-012018-09-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19236BroadBasedIndexMember2016-09-012018-09-300000102816eatonvance:C000092731Member2016-09-012018-10-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19236BroadBasedIndexMember2016-09-012018-10-310000102816eatonvance:C000092731Member2016-09-012018-11-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19236BroadBasedIndexMember2016-09-012018-11-300000102816eatonvance:C000092731Member2016-09-012018-12-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19236BroadBasedIndexMember2016-09-012018-12-310000102816eatonvance:C000092731Member2016-09-012019-01-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19236BroadBasedIndexMember2016-09-012019-01-310000102816eatonvance:C000092731Member2016-09-012019-02-280000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19236BroadBasedIndexMember2016-09-012019-02-280000102816eatonvance:C000092731Member2016-09-012019-03-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19236BroadBasedIndexMember2016-09-012019-03-310000102816eatonvance:C000092731Member2016-09-012019-04-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19236BroadBasedIndexMember2016-09-012019-04-300000102816eatonvance:C000092731Member2016-09-012019-05-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19236BroadBasedIndexMember2016-09-012019-05-310000102816eatonvance:C000092731Member2016-09-012019-06-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19236BroadBasedIndexMember2016-09-012019-06-300000102816eatonvance:C000092731Member2016-09-012019-07-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19236BroadBasedIndexMember2016-09-012019-07-310000102816eatonvance:C000092731Member2016-09-012019-08-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19236BroadBasedIndexMember2016-09-012019-08-310000102816eatonvance:C000092731Member2016-09-012019-09-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19236BroadBasedIndexMember2016-09-012019-09-300000102816eatonvance:C000092731Member2016-09-012019-10-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19236BroadBasedIndexMember2016-09-012019-10-310000102816eatonvance:C000092731Member2016-09-012019-11-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19236BroadBasedIndexMember2016-09-012019-11-300000102816eatonvance:C000092731Member2016-09-012019-12-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19236BroadBasedIndexMember2016-09-012019-12-310000102816eatonvance:C000092731Member2016-09-012020-01-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19236BroadBasedIndexMember2016-09-012020-01-310000102816eatonvance:C000092731Member2016-09-012020-02-290000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19236BroadBasedIndexMember2016-09-012020-02-290000102816eatonvance:C000092731Member2016-09-012020-03-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19236BroadBasedIndexMember2016-09-012020-03-310000102816eatonvance:C000092731Member2016-09-012020-04-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19236BroadBasedIndexMember2016-09-012020-04-300000102816eatonvance:C000092731Member2016-09-012020-05-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19236BroadBasedIndexMember2016-09-012020-05-310000102816eatonvance:C000092731Member2016-09-012020-06-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19236BroadBasedIndexMember2016-09-012020-06-300000102816eatonvance:C000092731Member2016-09-012020-07-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19236BroadBasedIndexMember2016-09-012020-07-310000102816eatonvance:C000092731Member2016-09-012020-08-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19236BroadBasedIndexMember2016-09-012020-08-310000102816eatonvance:C000092731Member2016-09-012020-09-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19236BroadBasedIndexMember2016-09-012020-09-300000102816eatonvance:C000092731Member2016-09-012020-10-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19236BroadBasedIndexMember2016-09-012020-10-310000102816eatonvance:C000092731Member2016-09-012020-11-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19236BroadBasedIndexMember2016-09-012020-11-300000102816eatonvance:C000092731Member2016-09-012020-12-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19236BroadBasedIndexMember2016-09-012020-12-310000102816eatonvance:C000092731Member2016-09-012021-01-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19236BroadBasedIndexMember2016-09-012021-01-310000102816eatonvance:C000092731Member2016-09-012021-02-280000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19236BroadBasedIndexMember2016-09-012021-02-280000102816eatonvance:C000092731Member2016-09-012021-03-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19236BroadBasedIndexMember2016-09-012021-03-310000102816eatonvance:C000092731Member2016-09-012021-04-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19236BroadBasedIndexMember2016-09-012021-04-300000102816eatonvance:C000092731Member2016-09-012021-05-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19236BroadBasedIndexMember2016-09-012021-05-310000102816eatonvance:C000092731Member2016-09-012021-06-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19236BroadBasedIndexMember2016-09-012021-06-300000102816eatonvance:C000092731Member2016-09-012021-07-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19236BroadBasedIndexMember2016-09-012021-07-310000102816eatonvance:C000092731Member2016-09-012021-08-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19236BroadBasedIndexMember2016-09-012021-08-310000102816eatonvance:C000092731Member2016-09-012021-09-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19236BroadBasedIndexMember2016-09-012021-09-300000102816eatonvance:C000092731Member2016-09-012021-10-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19236BroadBasedIndexMember2016-09-012021-10-310000102816eatonvance:C000092731Member2016-09-012021-11-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19236BroadBasedIndexMember2016-09-012021-11-300000102816eatonvance:C000092731Member2016-09-012021-12-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19236BroadBasedIndexMember2016-09-012021-12-310000102816eatonvance:C000092731Member2016-09-012022-01-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19236BroadBasedIndexMember2016-09-012022-01-310000102816eatonvance:C000092731Member2016-09-012022-02-280000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19236BroadBasedIndexMember2016-09-012022-02-280000102816eatonvance:C000092731Member2016-09-012022-03-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19236BroadBasedIndexMember2016-09-012022-03-310000102816eatonvance:C000092731Member2016-09-012022-04-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19236BroadBasedIndexMember2016-09-012022-04-300000102816eatonvance:C000092731Member2016-09-012022-05-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19236BroadBasedIndexMember2016-09-012022-05-310000102816eatonvance:C000092731Member2016-09-012022-06-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19236BroadBasedIndexMember2016-09-012022-06-300000102816eatonvance:C000092731Member2016-09-012022-07-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19236BroadBasedIndexMember2016-09-012022-07-310000102816eatonvance:C000092731Member2016-09-012022-08-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19236BroadBasedIndexMember2016-09-012022-08-310000102816eatonvance:C000092731Member2016-09-012022-09-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19236BroadBasedIndexMember2016-09-012022-09-300000102816eatonvance:C000092731Member2016-09-012022-10-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19236BroadBasedIndexMember2016-09-012022-10-310000102816eatonvance:C000092731Member2016-09-012022-11-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19236BroadBasedIndexMember2016-09-012022-11-300000102816eatonvance:C000092731Member2016-09-012022-12-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19236BroadBasedIndexMember2016-09-012022-12-310000102816eatonvance:C000092731Member2016-09-012023-01-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19236BroadBasedIndexMember2016-09-012023-01-310000102816eatonvance:C000092731Member2016-09-012023-02-280000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19236BroadBasedIndexMember2016-09-012023-02-280000102816eatonvance:C000092731Member2016-09-012023-03-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19236BroadBasedIndexMember2016-09-012023-03-310000102816eatonvance:C000092731Member2016-09-012023-04-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19236BroadBasedIndexMember2016-09-012023-04-300000102816eatonvance:C000092731Member2016-09-012023-05-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19236BroadBasedIndexMember2016-09-012023-05-310000102816eatonvance:C000092731Member2016-09-012023-06-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19236BroadBasedIndexMember2016-09-012023-06-300000102816eatonvance:C000092731Member2016-09-012023-07-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19236BroadBasedIndexMember2016-09-012023-07-310000102816eatonvance:C000092731Member2016-09-012023-08-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19236BroadBasedIndexMember2016-09-012023-08-310000102816eatonvance:C000092731Member2016-09-012023-09-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19236BroadBasedIndexMember2016-09-012023-09-300000102816eatonvance:C000092731Member2016-09-012023-10-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19236BroadBasedIndexMember2016-09-012023-10-310000102816eatonvance:C000092731Member2016-09-012023-11-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19236BroadBasedIndexMember2016-09-012023-11-300000102816eatonvance:C000092731Member2016-09-012023-12-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19236BroadBasedIndexMember2016-09-012023-12-310000102816eatonvance:C000092731Member2016-09-012024-01-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19236BroadBasedIndexMember2016-09-012024-01-310000102816eatonvance:C000092731Member2016-09-012024-02-290000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19236BroadBasedIndexMember2016-09-012024-02-290000102816eatonvance:C000092731Member2016-09-012024-03-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19236BroadBasedIndexMember2016-09-012024-03-310000102816eatonvance:C000092731Member2016-09-012024-04-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19236BroadBasedIndexMember2016-09-012024-04-300000102816eatonvance:C000092731Member2016-09-012024-05-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19236BroadBasedIndexMember2016-09-012024-05-310000102816eatonvance:C000092731Member2016-09-012024-06-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19236BroadBasedIndexMember2016-09-012024-06-300000102816eatonvance:C000092731Member2016-09-012024-07-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19236BroadBasedIndexMember2016-09-012024-07-310000102816eatonvance:C000092731Member2016-09-012024-08-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19236BroadBasedIndexMember2016-09-012024-08-310000102816eatonvance:C000092731Member2016-09-012024-09-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19236BroadBasedIndexMember2016-09-012024-09-300000102816eatonvance:C000092731Member2016-09-012024-10-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19236BroadBasedIndexMember2016-09-012024-10-310000102816eatonvance:C000092731Member2016-09-012024-11-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19236BroadBasedIndexMember2016-09-012024-11-300000102816eatonvance:C000092731Member2016-09-012024-12-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19236BroadBasedIndexMember2016-09-012024-12-310000102816eatonvance:C000092731Member2016-09-012025-01-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19236BroadBasedIndexMember2016-09-012025-01-310000102816eatonvance:C000092731Member2016-09-012025-02-280000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19236BroadBasedIndexMember2016-09-012025-02-280000102816eatonvance:C000092731Member2016-09-012025-03-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19236BroadBasedIndexMember2016-09-012025-03-310000102816eatonvance:C000092731Member2016-09-012025-04-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19236BroadBasedIndexMember2016-09-012025-04-300000102816eatonvance:C000092731Member2016-09-012025-05-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19236BroadBasedIndexMember2016-09-012025-05-310000102816eatonvance:C000092731Member2016-09-012025-06-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19236BroadBasedIndexMember2016-09-012025-06-300000102816eatonvance:C000092731Member2016-09-012025-07-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19236BroadBasedIndexMember2016-09-012025-07-310000102816eatonvance:C000092731Member2016-09-012025-08-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19236BroadBasedIndexMember2016-09-012025-08-310000102816eatonvance:C000092731Member2016-09-012025-09-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19236BroadBasedIndexMember2016-09-012025-09-300000102816eatonvance:C000092731Member2016-09-012025-10-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19236BroadBasedIndexMember2016-09-012025-10-310000102816eatonvance:C000092731Member2016-09-012025-11-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19236BroadBasedIndexMember2016-09-012025-11-300000102816eatonvance:C000092731Member2016-09-012025-12-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19236BroadBasedIndexMember2016-09-012025-12-310000102816eatonvance:C000092731Member2016-09-012026-01-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19236BroadBasedIndexMember2016-09-012026-01-310000102816eatonvance:C000092731Member2016-09-012026-02-280000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19236BroadBasedIndexMember2016-09-012026-02-280000102816eatonvance:C000092731Member2016-09-012026-03-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19236BroadBasedIndexMember2016-09-012026-03-310000102816eatonvance:C000092731Member2016-09-012026-04-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19236BroadBasedIndexMember2016-09-012026-04-300000102816eatonvance:C000092731Member2016-09-012026-05-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19236BroadBasedIndexMember2016-09-012026-05-310000102816eatonvance:C000092731Member2016-09-012026-06-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19236BroadBasedIndexMember2016-09-012026-06-300000102816eatonvance:C000092731Member2016-09-012026-07-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19236BroadBasedIndexMember2016-09-012026-07-310000102816eatonvance:C000092731Member2016-09-012026-08-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19236BroadBasedIndexMember2016-09-012026-08-310000102816eatonvance:C000092731Memberoef:WithoutSalesLoadMember2025-09-012026-08-310000102816eatonvance:C000092731Memberoef:WithoutSalesLoadMember2021-09-012026-08-310000102816eatonvance:C000092731Memberoef:WithoutSalesLoadMember2016-09-012026-08-310000102816eatonvance:C000092731Member2021-09-012026-08-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19236BroadBasedIndexMember2021-09-012026-08-310000102816eatonvance:C000092731Member2026-08-310000102816eatonvance:C000092731Membereatonvance:SectorRealEstateSectorMember2026-08-310000102816eatonvance:C000092731Membereatonvance:SectorMaterialsSectorMember2026-08-310000102816eatonvance:C000092731Membereatonvance:SectorConsumerStaplesSectorMember2026-08-310000102816eatonvance:C000092731Membereatonvance:SectorEnergySectorMember2026-08-310000102816eatonvance:C000092731Membereatonvance:SectorShortMinusTermInvestmentsSectorMember2026-08-310000102816eatonvance:C000092731Membereatonvance:SectorCommunicationServicesSectorMember2026-08-310000102816eatonvance:C000092731Membereatonvance:SectorUtilitiesSectorMember2026-08-310000102816eatonvance:C000092731Membereatonvance:SectorConsumerDiscretionarySectorMember2026-08-310000102816eatonvance:C000092731Membereatonvance:SectorHealthCareSectorMember2026-08-310000102816eatonvance:C000092731Membereatonvance:SectorExchangeMinusTradedFundsSectorMember2026-08-310000102816eatonvance:C000092731Membereatonvance:SectorIndustrialsSectorMember2026-08-310000102816eatonvance:C000092731Membereatonvance:SectorFinancialsSectorMember2026-08-310000102816eatonvance:C000092731Membereatonvance:SectorInformationTechnologySectorMember2026-08-310000102816eatonvance:C000092731Membereatonvance:FR46434G103CTIMember2026-08-310000102816eatonvance:C000092731Membereatonvance:FR67066G104CTIMember2026-08-310000102816eatonvance:C000092731Membereatonvance:FR594918104CTIMember2026-08-310000102816eatonvance:C000092731Membereatonvance:FR037833100CTIMember2026-08-310000102816eatonvance:C000092731Membereatonvance:FR023135106CTIMember2026-08-310000102816eatonvance:C000092731Membereatonvance:FR02079K305CTIMember2026-08-310000102816eatonvance:C000092731Membereatonvance:FR11135F101CTIMember2026-08-310000102816eatonvance:C000092731Membereatonvance:FR464286400CTIMember2026-08-310000102816eatonvance:C000092731Membereatonvance:FR46434G772CTIMember2026-08-310000102816eatonvance:C000092731Membereatonvance:FR595112103CTIMember2026-08-310000102816eatonvance:C000092731Membereatonvance:MicronTechnologyIncCTIMember2026-08-310000102816eatonvance:C000092731Member2024-09-012025-08-310000102816eatonvance:C000092732Member2025-09-012026-08-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19351BroadBasedIndexMember2025-09-012026-08-310000102816eatonvance:C000092732Member2016-08-312016-08-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19351BroadBasedIndexMember2016-08-312016-08-310000102816eatonvance:C000092732Member2016-09-012016-09-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19351BroadBasedIndexMember2016-09-012016-09-300000102816eatonvance:C000092732Member2016-09-012016-10-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19351BroadBasedIndexMember2016-09-012016-10-310000102816eatonvance:C000092732Member2016-09-012016-11-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19351BroadBasedIndexMember2016-09-012016-11-300000102816eatonvance:C000092732Member2016-09-012016-12-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19351BroadBasedIndexMember2016-09-012016-12-310000102816eatonvance:C000092732Member2016-09-012017-01-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19351BroadBasedIndexMember2016-09-012017-01-310000102816eatonvance:C000092732Member2016-09-012017-02-280000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19351BroadBasedIndexMember2016-09-012017-02-280000102816eatonvance:C000092732Member2016-09-012017-03-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19351BroadBasedIndexMember2016-09-012017-03-310000102816eatonvance:C000092732Member2016-09-012017-04-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19351BroadBasedIndexMember2016-09-012017-04-300000102816eatonvance:C000092732Member2016-09-012017-05-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19351BroadBasedIndexMember2016-09-012017-05-310000102816eatonvance:C000092732Member2016-09-012017-06-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19351BroadBasedIndexMember2016-09-012017-06-300000102816eatonvance:C000092732Member2016-09-012017-07-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19351BroadBasedIndexMember2016-09-012017-07-310000102816eatonvance:C000092732Member2016-09-012017-08-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19351BroadBasedIndexMember2016-09-012017-08-310000102816eatonvance:C000092732Member2016-09-012017-09-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19351BroadBasedIndexMember2016-09-012017-09-300000102816eatonvance:C000092732Member2016-09-012017-10-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19351BroadBasedIndexMember2016-09-012017-10-310000102816eatonvance:C000092732Member2016-09-012017-11-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19351BroadBasedIndexMember2016-09-012017-11-300000102816eatonvance:C000092732Member2016-09-012017-12-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19351BroadBasedIndexMember2016-09-012017-12-310000102816eatonvance:C000092732Member2016-09-012018-01-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19351BroadBasedIndexMember2016-09-012018-01-310000102816eatonvance:C000092732Member2016-09-012018-02-280000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19351BroadBasedIndexMember2016-09-012018-02-280000102816eatonvance:C000092732Member2016-09-012018-03-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19351BroadBasedIndexMember2016-09-012018-03-310000102816eatonvance:C000092732Member2016-09-012018-04-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19351BroadBasedIndexMember2016-09-012018-04-300000102816eatonvance:C000092732Member2016-09-012018-05-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19351BroadBasedIndexMember2016-09-012018-05-310000102816eatonvance:C000092732Member2016-09-012018-06-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19351BroadBasedIndexMember2016-09-012018-06-300000102816eatonvance:C000092732Member2016-09-012018-07-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19351BroadBasedIndexMember2016-09-012018-07-310000102816eatonvance:C000092732Member2016-09-012018-08-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19351BroadBasedIndexMember2016-09-012018-08-310000102816eatonvance:C000092732Member2016-09-012018-09-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19351BroadBasedIndexMember2016-09-012018-09-300000102816eatonvance:C000092732Member2016-09-012018-10-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19351BroadBasedIndexMember2016-09-012018-10-310000102816eatonvance:C000092732Member2016-09-012018-11-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19351BroadBasedIndexMember2016-09-012018-11-300000102816eatonvance:C000092732Member2016-09-012018-12-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19351BroadBasedIndexMember2016-09-012018-12-310000102816eatonvance:C000092732Member2016-09-012019-01-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19351BroadBasedIndexMember2016-09-012019-01-310000102816eatonvance:C000092732Member2016-09-012019-02-280000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19351BroadBasedIndexMember2016-09-012019-02-280000102816eatonvance:C000092732Member2016-09-012019-03-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19351BroadBasedIndexMember2016-09-012019-03-310000102816eatonvance:C000092732Member2016-09-012019-04-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19351BroadBasedIndexMember2016-09-012019-04-300000102816eatonvance:C000092732Member2016-09-012019-05-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19351BroadBasedIndexMember2016-09-012019-05-310000102816eatonvance:C000092732Member2016-09-012019-06-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19351BroadBasedIndexMember2016-09-012019-06-300000102816eatonvance:C000092732Member2016-09-012019-07-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19351BroadBasedIndexMember2016-09-012019-07-310000102816eatonvance:C000092732Member2016-09-012019-08-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19351BroadBasedIndexMember2016-09-012019-08-310000102816eatonvance:C000092732Member2016-09-012019-09-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19351BroadBasedIndexMember2016-09-012019-09-300000102816eatonvance:C000092732Member2016-09-012019-10-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19351BroadBasedIndexMember2016-09-012019-10-310000102816eatonvance:C000092732Member2016-09-012019-11-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19351BroadBasedIndexMember2016-09-012019-11-300000102816eatonvance:C000092732Member2016-09-012019-12-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19351BroadBasedIndexMember2016-09-012019-12-310000102816eatonvance:C000092732Member2016-09-012020-01-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19351BroadBasedIndexMember2016-09-012020-01-310000102816eatonvance:C000092732Member2016-09-012020-02-290000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19351BroadBasedIndexMember2016-09-012020-02-290000102816eatonvance:C000092732Member2016-09-012020-03-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19351BroadBasedIndexMember2016-09-012020-03-310000102816eatonvance:C000092732Member2016-09-012020-04-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19351BroadBasedIndexMember2016-09-012020-04-300000102816eatonvance:C000092732Member2016-09-012020-05-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19351BroadBasedIndexMember2016-09-012020-05-310000102816eatonvance:C000092732Member2016-09-012020-06-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19351BroadBasedIndexMember2016-09-012020-06-300000102816eatonvance:C000092732Member2016-09-012020-07-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19351BroadBasedIndexMember2016-09-012020-07-310000102816eatonvance:C000092732Member2016-09-012020-08-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19351BroadBasedIndexMember2016-09-012020-08-310000102816eatonvance:C000092732Member2016-09-012020-09-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19351BroadBasedIndexMember2016-09-012020-09-300000102816eatonvance:C000092732Member2016-09-012020-10-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19351BroadBasedIndexMember2016-09-012020-10-310000102816eatonvance:C000092732Member2016-09-012020-11-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19351BroadBasedIndexMember2016-09-012020-11-300000102816eatonvance:C000092732Member2016-09-012020-12-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19351BroadBasedIndexMember2016-09-012020-12-310000102816eatonvance:C000092732Member2016-09-012021-01-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19351BroadBasedIndexMember2016-09-012021-01-310000102816eatonvance:C000092732Member2016-09-012021-02-280000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19351BroadBasedIndexMember2016-09-012021-02-280000102816eatonvance:C000092732Member2016-09-012021-03-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19351BroadBasedIndexMember2016-09-012021-03-310000102816eatonvance:C000092732Member2016-09-012021-04-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19351BroadBasedIndexMember2016-09-012021-04-300000102816eatonvance:C000092732Member2016-09-012021-05-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19351BroadBasedIndexMember2016-09-012021-05-310000102816eatonvance:C000092732Member2016-09-012021-06-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19351BroadBasedIndexMember2016-09-012021-06-300000102816eatonvance:C000092732Member2016-09-012021-07-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19351BroadBasedIndexMember2016-09-012021-07-310000102816eatonvance:C000092732Member2016-09-012021-08-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19351BroadBasedIndexMember2016-09-012021-08-310000102816eatonvance:C000092732Member2016-09-012021-09-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19351BroadBasedIndexMember2016-09-012021-09-300000102816eatonvance:C000092732Member2016-09-012021-10-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19351BroadBasedIndexMember2016-09-012021-10-310000102816eatonvance:C000092732Member2016-09-012021-11-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19351BroadBasedIndexMember2016-09-012021-11-300000102816eatonvance:C000092732Member2016-09-012021-12-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19351BroadBasedIndexMember2016-09-012021-12-310000102816eatonvance:C000092732Member2016-09-012022-01-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19351BroadBasedIndexMember2016-09-012022-01-310000102816eatonvance:C000092732Member2016-09-012022-02-280000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19351BroadBasedIndexMember2016-09-012022-02-280000102816eatonvance:C000092732Member2016-09-012022-03-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19351BroadBasedIndexMember2016-09-012022-03-310000102816eatonvance:C000092732Member2016-09-012022-04-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19351BroadBasedIndexMember2016-09-012022-04-300000102816eatonvance:C000092732Member2016-09-012022-05-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19351BroadBasedIndexMember2016-09-012022-05-310000102816eatonvance:C000092732Member2016-09-012022-06-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19351BroadBasedIndexMember2016-09-012022-06-300000102816eatonvance:C000092732Member2016-09-012022-07-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19351BroadBasedIndexMember2016-09-012022-07-310000102816eatonvance:C000092732Member2016-09-012022-08-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19351BroadBasedIndexMember2016-09-012022-08-310000102816eatonvance:C000092732Member2016-09-012022-09-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19351BroadBasedIndexMember2016-09-012022-09-300000102816eatonvance:C000092732Member2016-09-012022-10-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19351BroadBasedIndexMember2016-09-012022-10-310000102816eatonvance:C000092732Member2016-09-012022-11-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19351BroadBasedIndexMember2016-09-012022-11-300000102816eatonvance:C000092732Member2016-09-012022-12-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19351BroadBasedIndexMember2016-09-012022-12-310000102816eatonvance:C000092732Member2016-09-012023-01-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19351BroadBasedIndexMember2016-09-012023-01-310000102816eatonvance:C000092732Member2016-09-012023-02-280000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19351BroadBasedIndexMember2016-09-012023-02-280000102816eatonvance:C000092732Member2016-09-012023-03-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19351BroadBasedIndexMember2016-09-012023-03-310000102816eatonvance:C000092732Member2016-09-012023-04-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19351BroadBasedIndexMember2016-09-012023-04-300000102816eatonvance:C000092732Member2016-09-012023-05-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19351BroadBasedIndexMember2016-09-012023-05-310000102816eatonvance:C000092732Member2016-09-012023-06-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19351BroadBasedIndexMember2016-09-012023-06-300000102816eatonvance:C000092732Member2016-09-012023-07-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19351BroadBasedIndexMember2016-09-012023-07-310000102816eatonvance:C000092732Member2016-09-012023-08-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19351BroadBasedIndexMember2016-09-012023-08-310000102816eatonvance:C000092732Member2016-09-012023-09-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19351BroadBasedIndexMember2016-09-012023-09-300000102816eatonvance:C000092732Member2016-09-012023-10-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19351BroadBasedIndexMember2016-09-012023-10-310000102816eatonvance:C000092732Member2016-09-012023-11-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19351BroadBasedIndexMember2016-09-012023-11-300000102816eatonvance:C000092732Member2016-09-012023-12-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19351BroadBasedIndexMember2016-09-012023-12-310000102816eatonvance:C000092732Member2016-09-012024-01-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19351BroadBasedIndexMember2016-09-012024-01-310000102816eatonvance:C000092732Member2016-09-012024-02-290000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19351BroadBasedIndexMember2016-09-012024-02-290000102816eatonvance:C000092732Member2016-09-012024-03-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19351BroadBasedIndexMember2016-09-012024-03-310000102816eatonvance:C000092732Member2016-09-012024-04-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19351BroadBasedIndexMember2016-09-012024-04-300000102816eatonvance:C000092732Member2016-09-012024-05-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19351BroadBasedIndexMember2016-09-012024-05-310000102816eatonvance:C000092732Member2016-09-012024-06-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19351BroadBasedIndexMember2016-09-012024-06-300000102816eatonvance:C000092732Member2016-09-012024-07-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19351BroadBasedIndexMember2016-09-012024-07-310000102816eatonvance:C000092732Member2016-09-012024-08-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19351BroadBasedIndexMember2016-09-012024-08-310000102816eatonvance:C000092732Member2016-09-012024-09-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19351BroadBasedIndexMember2016-09-012024-09-300000102816eatonvance:C000092732Member2016-09-012024-10-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19351BroadBasedIndexMember2016-09-012024-10-310000102816eatonvance:C000092732Member2016-09-012024-11-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19351BroadBasedIndexMember2016-09-012024-11-300000102816eatonvance:C000092732Member2016-09-012024-12-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19351BroadBasedIndexMember2016-09-012024-12-310000102816eatonvance:C000092732Member2016-09-012025-01-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19351BroadBasedIndexMember2016-09-012025-01-310000102816eatonvance:C000092732Member2016-09-012025-02-280000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19351BroadBasedIndexMember2016-09-012025-02-280000102816eatonvance:C000092732Member2016-09-012025-03-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19351BroadBasedIndexMember2016-09-012025-03-310000102816eatonvance:C000092732Member2016-09-012025-04-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19351BroadBasedIndexMember2016-09-012025-04-300000102816eatonvance:C000092732Member2016-09-012025-05-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19351BroadBasedIndexMember2016-09-012025-05-310000102816eatonvance:C000092732Member2016-09-012025-06-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19351BroadBasedIndexMember2016-09-012025-06-300000102816eatonvance:C000092732Member2016-09-012025-07-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19351BroadBasedIndexMember2016-09-012025-07-310000102816eatonvance:C000092732Member2016-09-012025-08-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19351BroadBasedIndexMember2016-09-012025-08-310000102816eatonvance:C000092732Member2016-09-012025-09-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19351BroadBasedIndexMember2016-09-012025-09-300000102816eatonvance:C000092732Member2016-09-012025-10-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19351BroadBasedIndexMember2016-09-012025-10-310000102816eatonvance:C000092732Member2016-09-012025-11-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19351BroadBasedIndexMember2016-09-012025-11-300000102816eatonvance:C000092732Member2016-09-012025-12-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19351BroadBasedIndexMember2016-09-012025-12-310000102816eatonvance:C000092732Member2016-09-012026-01-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19351BroadBasedIndexMember2016-09-012026-01-310000102816eatonvance:C000092732Member2016-09-012026-02-280000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19351BroadBasedIndexMember2016-09-012026-02-280000102816eatonvance:C000092732Member2016-09-012026-03-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19351BroadBasedIndexMember2016-09-012026-03-310000102816eatonvance:C000092732Member2016-09-012026-04-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19351BroadBasedIndexMember2016-09-012026-04-300000102816eatonvance:C000092732Member2016-09-012026-05-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19351BroadBasedIndexMember2016-09-012026-05-310000102816eatonvance:C000092732Member2016-09-012026-06-300000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19351BroadBasedIndexMember2016-09-012026-06-300000102816eatonvance:C000092732Member2016-09-012026-07-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19351BroadBasedIndexMember2016-09-012026-07-310000102816eatonvance:C000092732Member2016-09-012026-08-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19351BroadBasedIndexMember2016-09-012026-08-310000102816eatonvance:C000092732Memberoef:WithoutSalesLoadMember2025-09-012026-08-310000102816eatonvance:C000092732Memberoef:WithoutSalesLoadMember2021-09-012026-08-310000102816eatonvance:C000092732Memberoef:WithoutSalesLoadMember2016-09-012026-08-310000102816eatonvance:EATONVANCEIndexMSCIACWIIndex19351BroadBasedIndexMember2021-09-012026-08-310000102816eatonvance:C000092732Member2026-08-310000102816eatonvance:C000092732Membereatonvance:SectorRealEstateSectorMember2026-08-310000102816eatonvance:C000092732Membereatonvance:SectorMaterialsSectorMember2026-08-310000102816eatonvance:C000092732Membereatonvance:SectorConsumerStaplesSectorMember2026-08-310000102816eatonvance:C000092732Membereatonvance:SectorEnergySectorMember2026-08-310000102816eatonvance:C000092732Membereatonvance:SectorShortMinusTermInvestmentsSectorMember2026-08-310000102816eatonvance:C000092732Membereatonvance:SectorCommunicationServicesSectorMember2026-08-310000102816eatonvance:C000092732Membereatonvance:SectorUtilitiesSectorMember2026-08-310000102816eatonvance:C000092732Membereatonvance:SectorConsumerDiscretionarySectorMember2026-08-310000102816eatonvance:C000092732Membereatonvance:SectorHealthCareSectorMember2026-08-310000102816eatonvance:C000092732Membereatonvance:SectorExchangeMinusTradedFundsSectorMember2026-08-310000102816eatonvance:C000092732Membereatonvance:SectorIndustrialsSectorMember2026-08-310000102816eatonvance:C000092732Membereatonvance:SectorFinancialsSectorMember2026-08-310000102816eatonvance:C000092732Membereatonvance:SectorInformationTechnologySectorMember2026-08-310000102816eatonvance:C000092732Membereatonvance:FR46434G103CTIMember2026-08-310000102816eatonvance:C000092732Membereatonvance:FR67066G104CTIMember2026-08-310000102816eatonvance:C000092732Membereatonvance:FR594918104CTIMember2026-08-310000102816eatonvance:C000092732Membereatonvance:FR037833100CTIMember2026-08-310000102816eatonvance:C000092732Membereatonvance:FR023135106CTIMember2026-08-310000102816eatonvance:C000092732Membereatonvance:FR02079K305CTIMember2026-08-310000102816eatonvance:C000092732Membereatonvance:FR11135F101CTIMember2026-08-310000102816eatonvance:C000092732Membereatonvance:FR464286400CTIMember2026-08-310000102816eatonvance:C000092732Membereatonvance:FR46434G772CTIMember2026-08-310000102816eatonvance:C000092732Membereatonvance:FR595112103CTIMember2026-08-310000102816eatonvance:C000092732Membereatonvance:MicronTechnologyIncCTIMember2026-08-310000102816eatonvance:C000092732Member2024-09-012025-08-310000102816eatonvance:C000014185Member2025-09-012026-08-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19139BroadBasedIndexMember2025-09-012026-08-310000102816eatonvance:C000014185Member2016-08-312016-08-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19139BroadBasedIndexMember2016-08-312016-08-310000102816eatonvance:C000014185Member2016-09-012016-09-300000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19139BroadBasedIndexMember2016-09-012016-09-300000102816eatonvance:C000014185Member2016-09-012016-10-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19139BroadBasedIndexMember2016-09-012016-10-310000102816eatonvance:C000014185Member2016-09-012016-11-300000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19139BroadBasedIndexMember2016-09-012016-11-300000102816eatonvance:C000014185Member2016-09-012016-12-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19139BroadBasedIndexMember2016-09-012016-12-310000102816eatonvance:C000014185Member2016-09-012017-01-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19139BroadBasedIndexMember2016-09-012017-01-310000102816eatonvance:C000014185Member2016-09-012017-02-280000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19139BroadBasedIndexMember2016-09-012017-02-280000102816eatonvance:C000014185Member2016-09-012017-03-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19139BroadBasedIndexMember2016-09-012017-03-310000102816eatonvance:C000014185Member2016-09-012017-04-300000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19139BroadBasedIndexMember2016-09-012017-04-300000102816eatonvance:C000014185Member2016-09-012017-05-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19139BroadBasedIndexMember2016-09-012017-05-310000102816eatonvance:C000014185Member2016-09-012017-06-300000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19139BroadBasedIndexMember2016-09-012017-06-300000102816eatonvance:C000014185Member2016-09-012017-07-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19139BroadBasedIndexMember2016-09-012017-07-310000102816eatonvance:C000014185Member2016-09-012017-08-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19139BroadBasedIndexMember2016-09-012017-08-310000102816eatonvance:C000014185Member2016-09-012017-09-300000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19139BroadBasedIndexMember2016-09-012017-09-300000102816eatonvance:C000014185Member2016-09-012017-10-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19139BroadBasedIndexMember2016-09-012017-10-310000102816eatonvance:C000014185Member2016-09-012017-11-300000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19139BroadBasedIndexMember2016-09-012017-11-300000102816eatonvance:C000014185Member2016-09-012017-12-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19139BroadBasedIndexMember2016-09-012017-12-310000102816eatonvance:C000014185Member2016-09-012018-01-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19139BroadBasedIndexMember2016-09-012018-01-310000102816eatonvance:C000014185Member2016-09-012018-02-280000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19139BroadBasedIndexMember2016-09-012018-02-280000102816eatonvance:C000014185Member2016-09-012018-03-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19139BroadBasedIndexMember2016-09-012018-03-310000102816eatonvance:C000014185Member2016-09-012018-04-300000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19139BroadBasedIndexMember2016-09-012018-04-300000102816eatonvance:C000014185Member2016-09-012018-05-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19139BroadBasedIndexMember2016-09-012018-05-310000102816eatonvance:C000014185Member2016-09-012018-06-300000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19139BroadBasedIndexMember2016-09-012018-06-300000102816eatonvance:C000014185Member2016-09-012018-07-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19139BroadBasedIndexMember2016-09-012018-07-310000102816eatonvance:C000014185Member2016-09-012018-08-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19139BroadBasedIndexMember2016-09-012018-08-310000102816eatonvance:C000014185Member2016-09-012018-09-300000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19139BroadBasedIndexMember2016-09-012018-09-300000102816eatonvance:C000014185Member2016-09-012018-10-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19139BroadBasedIndexMember2016-09-012018-10-310000102816eatonvance:C000014185Member2016-09-012018-11-300000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19139BroadBasedIndexMember2016-09-012018-11-300000102816eatonvance:C000014185Member2016-09-012018-12-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19139BroadBasedIndexMember2016-09-012018-12-310000102816eatonvance:C000014185Member2016-09-012019-01-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19139BroadBasedIndexMember2016-09-012019-01-310000102816eatonvance:C000014185Member2016-09-012019-02-280000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19139BroadBasedIndexMember2016-09-012019-02-280000102816eatonvance:C000014185Member2016-09-012019-03-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19139BroadBasedIndexMember2016-09-012019-03-310000102816eatonvance:C000014185Member2016-09-012019-04-300000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19139BroadBasedIndexMember2016-09-012019-04-300000102816eatonvance:C000014185Member2016-09-012019-05-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19139BroadBasedIndexMember2016-09-012019-05-310000102816eatonvance:C000014185Member2016-09-012019-06-300000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19139BroadBasedIndexMember2016-09-012019-06-300000102816eatonvance:C000014185Member2016-09-012019-07-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19139BroadBasedIndexMember2016-09-012019-07-310000102816eatonvance:C000014185Member2016-09-012019-08-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19139BroadBasedIndexMember2016-09-012019-08-310000102816eatonvance:C000014185Member2016-09-012019-09-300000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19139BroadBasedIndexMember2016-09-012019-09-300000102816eatonvance:C000014185Member2016-09-012019-10-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19139BroadBasedIndexMember2016-09-012019-10-310000102816eatonvance:C000014185Member2016-09-012019-11-300000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19139BroadBasedIndexMember2016-09-012019-11-300000102816eatonvance:C000014185Member2016-09-012019-12-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19139BroadBasedIndexMember2016-09-012019-12-310000102816eatonvance:C000014185Member2016-09-012020-01-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19139BroadBasedIndexMember2016-09-012020-01-310000102816eatonvance:C000014185Member2016-09-012020-02-290000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19139BroadBasedIndexMember2016-09-012020-02-290000102816eatonvance:C000014185Member2016-09-012020-03-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19139BroadBasedIndexMember2016-09-012020-03-310000102816eatonvance:C000014185Member2016-09-012020-04-300000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19139BroadBasedIndexMember2016-09-012020-04-300000102816eatonvance:C000014185Member2016-09-012020-05-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19139BroadBasedIndexMember2016-09-012020-05-310000102816eatonvance:C000014185Member2016-09-012020-06-300000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19139BroadBasedIndexMember2016-09-012020-06-300000102816eatonvance:C000014185Member2016-09-012020-07-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19139BroadBasedIndexMember2016-09-012020-07-310000102816eatonvance:C000014185Member2016-09-012020-08-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19139BroadBasedIndexMember2016-09-012020-08-310000102816eatonvance:C000014185Member2016-09-012020-09-300000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19139BroadBasedIndexMember2016-09-012020-09-300000102816eatonvance:C000014185Member2016-09-012020-10-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19139BroadBasedIndexMember2016-09-012020-10-310000102816eatonvance:C000014185Member2016-09-012020-11-300000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19139BroadBasedIndexMember2016-09-012020-11-300000102816eatonvance:C000014185Member2016-09-012020-12-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19139BroadBasedIndexMember2016-09-012020-12-310000102816eatonvance:C000014185Member2016-09-012021-01-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19139BroadBasedIndexMember2016-09-012021-01-310000102816eatonvance:C000014185Member2016-09-012021-02-280000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19139BroadBasedIndexMember2016-09-012021-02-280000102816eatonvance:C000014185Member2016-09-012021-03-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19139BroadBasedIndexMember2016-09-012021-03-310000102816eatonvance:C000014185Member2016-09-012021-04-300000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19139BroadBasedIndexMember2016-09-012021-04-300000102816eatonvance:C000014185Member2016-09-012021-05-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19139BroadBasedIndexMember2016-09-012021-05-310000102816eatonvance:C000014185Member2016-09-012021-06-300000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19139BroadBasedIndexMember2016-09-012021-06-300000102816eatonvance:C000014185Member2016-09-012021-07-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19139BroadBasedIndexMember2016-09-012021-07-310000102816eatonvance:C000014185Member2016-09-012021-08-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19139BroadBasedIndexMember2016-09-012021-08-310000102816eatonvance:C000014185Member2016-09-012021-09-300000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19139BroadBasedIndexMember2016-09-012021-09-300000102816eatonvance:C000014185Member2016-09-012021-10-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19139BroadBasedIndexMember2016-09-012021-10-310000102816eatonvance:C000014185Member2016-09-012021-11-300000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19139BroadBasedIndexMember2016-09-012021-11-300000102816eatonvance:C000014185Member2016-09-012021-12-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19139BroadBasedIndexMember2016-09-012021-12-310000102816eatonvance:C000014185Member2016-09-012022-01-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19139BroadBasedIndexMember2016-09-012022-01-310000102816eatonvance:C000014185Member2016-09-012022-02-280000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19139BroadBasedIndexMember2016-09-012022-02-280000102816eatonvance:C000014185Member2016-09-012022-03-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19139BroadBasedIndexMember2016-09-012022-03-310000102816eatonvance:C000014185Member2016-09-012022-04-300000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19139BroadBasedIndexMember2016-09-012022-04-300000102816eatonvance:C000014185Member2016-09-012022-05-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19139BroadBasedIndexMember2016-09-012022-05-310000102816eatonvance:C000014185Member2016-09-012022-06-300000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19139BroadBasedIndexMember2016-09-012022-06-300000102816eatonvance:C000014185Member2016-09-012022-07-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19139BroadBasedIndexMember2016-09-012022-07-310000102816eatonvance:C000014185Member2016-09-012022-08-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19139BroadBasedIndexMember2016-09-012022-08-310000102816eatonvance:C000014185Member2016-09-012022-09-300000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19139BroadBasedIndexMember2016-09-012022-09-300000102816eatonvance:C000014185Member2016-09-012022-10-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19139BroadBasedIndexMember2016-09-012022-10-310000102816eatonvance:C000014185Member2016-09-012022-11-300000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19139BroadBasedIndexMember2016-09-012022-11-300000102816eatonvance:C000014185Member2016-09-012022-12-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19139BroadBasedIndexMember2016-09-012022-12-310000102816eatonvance:C000014185Member2016-09-012023-01-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19139BroadBasedIndexMember2016-09-012023-01-310000102816eatonvance:C000014185Member2016-09-012023-02-280000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19139BroadBasedIndexMember2016-09-012023-02-280000102816eatonvance:C000014185Member2016-09-012023-03-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19139BroadBasedIndexMember2016-09-012023-03-310000102816eatonvance:C000014185Member2016-09-012023-04-300000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19139BroadBasedIndexMember2016-09-012023-04-300000102816eatonvance:C000014185Member2016-09-012023-05-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19139BroadBasedIndexMember2016-09-012023-05-310000102816eatonvance:C000014185Member2016-09-012023-06-300000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19139BroadBasedIndexMember2016-09-012023-06-300000102816eatonvance:C000014185Member2016-09-012023-07-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19139BroadBasedIndexMember2016-09-012023-07-310000102816eatonvance:C000014185Member2016-09-012023-08-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19139BroadBasedIndexMember2016-09-012023-08-310000102816eatonvance:C000014185Member2016-09-012023-09-300000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19139BroadBasedIndexMember2016-09-012023-09-300000102816eatonvance:C000014185Member2016-09-012023-10-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19139BroadBasedIndexMember2016-09-012023-10-310000102816eatonvance:C000014185Member2016-09-012023-11-300000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19139BroadBasedIndexMember2016-09-012023-11-300000102816eatonvance:C000014185Member2016-09-012023-12-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19139BroadBasedIndexMember2016-09-012023-12-310000102816eatonvance:C000014185Member2016-09-012024-01-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19139BroadBasedIndexMember2016-09-012024-01-310000102816eatonvance:C000014185Member2016-09-012024-02-290000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19139BroadBasedIndexMember2016-09-012024-02-290000102816eatonvance:C000014185Member2016-09-012024-03-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19139BroadBasedIndexMember2016-09-012024-03-310000102816eatonvance:C000014185Member2016-09-012024-04-300000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19139BroadBasedIndexMember2016-09-012024-04-300000102816eatonvance:C000014185Member2016-09-012024-05-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19139BroadBasedIndexMember2016-09-012024-05-310000102816eatonvance:C000014185Member2016-09-012024-06-300000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19139BroadBasedIndexMember2016-09-012024-06-300000102816eatonvance:C000014185Member2016-09-012024-07-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19139BroadBasedIndexMember2016-09-012024-07-310000102816eatonvance:C000014185Member2016-09-012024-08-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19139BroadBasedIndexMember2016-09-012024-08-310000102816eatonvance:C000014185Member2016-09-012024-09-300000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19139BroadBasedIndexMember2016-09-012024-09-300000102816eatonvance:C000014185Member2016-09-012024-10-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19139BroadBasedIndexMember2016-09-012024-10-310000102816eatonvance:C000014185Member2016-09-012024-11-300000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19139BroadBasedIndexMember2016-09-012024-11-300000102816eatonvance:C000014185Member2016-09-012024-12-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19139BroadBasedIndexMember2016-09-012024-12-310000102816eatonvance:C000014185Member2016-09-012025-01-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19139BroadBasedIndexMember2016-09-012025-01-310000102816eatonvance:C000014185Member2016-09-012025-02-280000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19139BroadBasedIndexMember2016-09-012025-02-280000102816eatonvance:C000014185Member2016-09-012025-03-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19139BroadBasedIndexMember2016-09-012025-03-310000102816eatonvance:C000014185Member2016-09-012025-04-300000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19139BroadBasedIndexMember2016-09-012025-04-300000102816eatonvance:C000014185Member2016-09-012025-05-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19139BroadBasedIndexMember2016-09-012025-05-310000102816eatonvance:C000014185Member2016-09-012025-06-300000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19139BroadBasedIndexMember2016-09-012025-06-300000102816eatonvance:C000014185Member2016-09-012025-07-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19139BroadBasedIndexMember2016-09-012025-07-310000102816eatonvance:C000014185Member2016-09-012025-08-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19139BroadBasedIndexMember2016-09-012025-08-310000102816eatonvance:C000014185Member2016-09-012025-09-300000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19139BroadBasedIndexMember2016-09-012025-09-300000102816eatonvance:C000014185Member2016-09-012025-10-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19139BroadBasedIndexMember2016-09-012025-10-310000102816eatonvance:C000014185Member2016-09-012025-11-300000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19139BroadBasedIndexMember2016-09-012025-11-300000102816eatonvance:C000014185Member2016-09-012025-12-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19139BroadBasedIndexMember2016-09-012025-12-310000102816eatonvance:C000014185Member2016-09-012026-01-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19139BroadBasedIndexMember2016-09-012026-01-310000102816eatonvance:C000014185Member2016-09-012026-02-280000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19139BroadBasedIndexMember2016-09-012026-02-280000102816eatonvance:C000014185Member2016-09-012026-03-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19139BroadBasedIndexMember2016-09-012026-03-310000102816eatonvance:C000014185Member2016-09-012026-04-300000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19139BroadBasedIndexMember2016-09-012026-04-300000102816eatonvance:C000014185Member2016-09-012026-05-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19139BroadBasedIndexMember2016-09-012026-05-310000102816eatonvance:C000014185Member2016-09-012026-06-300000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19139BroadBasedIndexMember2016-09-012026-06-300000102816eatonvance:C000014185Member2016-09-012026-07-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19139BroadBasedIndexMember2016-09-012026-07-310000102816eatonvance:C000014185Member2016-09-012026-08-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19139BroadBasedIndexMember2016-09-012026-08-310000102816eatonvance:C000014185Memberoef:WithoutSalesLoadMember2025-09-012026-08-310000102816eatonvance:C000014185Memberoef:WithoutSalesLoadMember2021-09-012026-08-310000102816eatonvance:C000014185Memberoef:WithoutSalesLoadMember2016-09-012026-08-310000102816eatonvance:C000014185Member2021-09-012026-08-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19139BroadBasedIndexMember2021-09-012026-08-310000102816eatonvance:C000014185Member2026-08-310000102816eatonvance:C000014185Membereatonvance:SectorShortMinusTermInvestmentsSectorMember2026-08-310000102816eatonvance:C000014185Membereatonvance:SectorUtilitiesSectorMember2026-08-310000102816eatonvance:C000014185Membereatonvance:SectorRealEstateSectorMember2026-08-310000102816eatonvance:C000014185Membereatonvance:SectorConsumerStaplesSectorMember2026-08-310000102816eatonvance:C000014185Membereatonvance:SectorEnergySectorMember2026-08-310000102816eatonvance:C000014185Membereatonvance:SectorHealthCareSectorMember2026-08-310000102816eatonvance:C000014185Membereatonvance:SectorMaterialsSectorMember2026-08-310000102816eatonvance:C000014185Membereatonvance:SectorIndustrialsSectorMember2026-08-310000102816eatonvance:C000014185Membereatonvance:SectorInformationTechnologySectorMember2026-08-310000102816eatonvance:C000014185Membereatonvance:SectorCommunicationServicesSectorMember2026-08-310000102816eatonvance:C000014185Membereatonvance:SectorConsumerDiscretionarySectorMember2026-08-310000102816eatonvance:C000014185Membereatonvance:SectorFinancialsSectorMember2026-08-310000102816eatonvance:C000014185Membereatonvance:FRBMMV2K903CTIMember2026-08-310000102816eatonvance:C000014185Membereatonvance:FRBK6YZP902CTIMember2026-08-310000102816eatonvance:C000014185Membereatonvance:FRB0LMTQ900CTIMember2026-08-310000102816eatonvance:C000014185Membereatonvance:FRBD5LYF900CTIMember2026-08-310000102816eatonvance:C000014185Membereatonvance:FRB1G1QD902CTIMember2026-08-310000102816eatonvance:C000014185Membereatonvance:FR672529906CTIMember2026-08-310000102816eatonvance:C000014185Membereatonvance:FR967JXD907CTIMember2026-08-310000102816eatonvance:C000014185Membereatonvance:FRB01FLR903CTIMember2026-08-310000102816eatonvance:C000014185Membereatonvance:FRBHQPSY905CTIMember2026-08-310000102816eatonvance:C000014185Membereatonvance:FRB09N7M905CTIMember2026-08-310000102816eatonvance:C000014185Membereatonvance:ChinaShenhuaEnergyCoLtdHCTIMember2026-08-310000102816eatonvance:C000014187Member2025-09-012026-08-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19182BroadBasedIndexMember2025-09-012026-08-310000102816eatonvance:C000014187Member2016-08-312016-08-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19182BroadBasedIndexMember2016-08-312016-08-310000102816eatonvance:C000014187Member2016-09-012016-09-300000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19182BroadBasedIndexMember2016-09-012016-09-300000102816eatonvance:C000014187Member2016-09-012016-10-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19182BroadBasedIndexMember2016-09-012016-10-310000102816eatonvance:C000014187Member2016-09-012016-11-300000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19182BroadBasedIndexMember2016-09-012016-11-300000102816eatonvance:C000014187Member2016-09-012016-12-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19182BroadBasedIndexMember2016-09-012016-12-310000102816eatonvance:C000014187Member2016-09-012017-01-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19182BroadBasedIndexMember2016-09-012017-01-310000102816eatonvance:C000014187Member2016-09-012017-02-280000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19182BroadBasedIndexMember2016-09-012017-02-280000102816eatonvance:C000014187Member2016-09-012017-03-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19182BroadBasedIndexMember2016-09-012017-03-310000102816eatonvance:C000014187Member2016-09-012017-04-300000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19182BroadBasedIndexMember2016-09-012017-04-300000102816eatonvance:C000014187Member2016-09-012017-05-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19182BroadBasedIndexMember2016-09-012017-05-310000102816eatonvance:C000014187Member2016-09-012017-06-300000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19182BroadBasedIndexMember2016-09-012017-06-300000102816eatonvance:C000014187Member2016-09-012017-07-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19182BroadBasedIndexMember2016-09-012017-07-310000102816eatonvance:C000014187Member2016-09-012017-08-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19182BroadBasedIndexMember2016-09-012017-08-310000102816eatonvance:C000014187Member2016-09-012017-09-300000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19182BroadBasedIndexMember2016-09-012017-09-300000102816eatonvance:C000014187Member2016-09-012017-10-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19182BroadBasedIndexMember2016-09-012017-10-310000102816eatonvance:C000014187Member2016-09-012017-11-300000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19182BroadBasedIndexMember2016-09-012017-11-300000102816eatonvance:C000014187Member2016-09-012017-12-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19182BroadBasedIndexMember2016-09-012017-12-310000102816eatonvance:C000014187Member2016-09-012018-01-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19182BroadBasedIndexMember2016-09-012018-01-310000102816eatonvance:C000014187Member2016-09-012018-02-280000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19182BroadBasedIndexMember2016-09-012018-02-280000102816eatonvance:C000014187Member2016-09-012018-03-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19182BroadBasedIndexMember2016-09-012018-03-310000102816eatonvance:C000014187Member2016-09-012018-04-300000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19182BroadBasedIndexMember2016-09-012018-04-300000102816eatonvance:C000014187Member2016-09-012018-05-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19182BroadBasedIndexMember2016-09-012018-05-310000102816eatonvance:C000014187Member2016-09-012018-06-300000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19182BroadBasedIndexMember2016-09-012018-06-300000102816eatonvance:C000014187Member2016-09-012018-07-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19182BroadBasedIndexMember2016-09-012018-07-310000102816eatonvance:C000014187Member2016-09-012018-08-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19182BroadBasedIndexMember2016-09-012018-08-310000102816eatonvance:C000014187Member2016-09-012018-09-300000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19182BroadBasedIndexMember2016-09-012018-09-300000102816eatonvance:C000014187Member2016-09-012018-10-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19182BroadBasedIndexMember2016-09-012018-10-310000102816eatonvance:C000014187Member2016-09-012018-11-300000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19182BroadBasedIndexMember2016-09-012018-11-300000102816eatonvance:C000014187Member2016-09-012018-12-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19182BroadBasedIndexMember2016-09-012018-12-310000102816eatonvance:C000014187Member2016-09-012019-01-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19182BroadBasedIndexMember2016-09-012019-01-310000102816eatonvance:C000014187Member2016-09-012019-02-280000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19182BroadBasedIndexMember2016-09-012019-02-280000102816eatonvance:C000014187Member2016-09-012019-03-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19182BroadBasedIndexMember2016-09-012019-03-310000102816eatonvance:C000014187Member2016-09-012019-04-300000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19182BroadBasedIndexMember2016-09-012019-04-300000102816eatonvance:C000014187Member2016-09-012019-05-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19182BroadBasedIndexMember2016-09-012019-05-310000102816eatonvance:C000014187Member2016-09-012019-06-300000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19182BroadBasedIndexMember2016-09-012019-06-300000102816eatonvance:C000014187Member2016-09-012019-07-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19182BroadBasedIndexMember2016-09-012019-07-310000102816eatonvance:C000014187Member2016-09-012019-08-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19182BroadBasedIndexMember2016-09-012019-08-310000102816eatonvance:C000014187Member2016-09-012019-09-300000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19182BroadBasedIndexMember2016-09-012019-09-300000102816eatonvance:C000014187Member2016-09-012019-10-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19182BroadBasedIndexMember2016-09-012019-10-310000102816eatonvance:C000014187Member2016-09-012019-11-300000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19182BroadBasedIndexMember2016-09-012019-11-300000102816eatonvance:C000014187Member2016-09-012019-12-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19182BroadBasedIndexMember2016-09-012019-12-310000102816eatonvance:C000014187Member2016-09-012020-01-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19182BroadBasedIndexMember2016-09-012020-01-310000102816eatonvance:C000014187Member2016-09-012020-02-290000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19182BroadBasedIndexMember2016-09-012020-02-290000102816eatonvance:C000014187Member2016-09-012020-03-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19182BroadBasedIndexMember2016-09-012020-03-310000102816eatonvance:C000014187Member2016-09-012020-04-300000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19182BroadBasedIndexMember2016-09-012020-04-300000102816eatonvance:C000014187Member2016-09-012020-05-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19182BroadBasedIndexMember2016-09-012020-05-310000102816eatonvance:C000014187Member2016-09-012020-06-300000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19182BroadBasedIndexMember2016-09-012020-06-300000102816eatonvance:C000014187Member2016-09-012020-07-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19182BroadBasedIndexMember2016-09-012020-07-310000102816eatonvance:C000014187Member2016-09-012020-08-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19182BroadBasedIndexMember2016-09-012020-08-310000102816eatonvance:C000014187Member2016-09-012020-09-300000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19182BroadBasedIndexMember2016-09-012020-09-300000102816eatonvance:C000014187Member2016-09-012020-10-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19182BroadBasedIndexMember2016-09-012020-10-310000102816eatonvance:C000014187Member2016-09-012020-11-300000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19182BroadBasedIndexMember2016-09-012020-11-300000102816eatonvance:C000014187Member2016-09-012020-12-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19182BroadBasedIndexMember2016-09-012020-12-310000102816eatonvance:C000014187Member2016-09-012021-01-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19182BroadBasedIndexMember2016-09-012021-01-310000102816eatonvance:C000014187Member2016-09-012021-02-280000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19182BroadBasedIndexMember2016-09-012021-02-280000102816eatonvance:C000014187Member2016-09-012021-03-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19182BroadBasedIndexMember2016-09-012021-03-310000102816eatonvance:C000014187Member2016-09-012021-04-300000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19182BroadBasedIndexMember2016-09-012021-04-300000102816eatonvance:C000014187Member2016-09-012021-05-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19182BroadBasedIndexMember2016-09-012021-05-310000102816eatonvance:C000014187Member2016-09-012021-06-300000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19182BroadBasedIndexMember2016-09-012021-06-300000102816eatonvance:C000014187Member2016-09-012021-07-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19182BroadBasedIndexMember2016-09-012021-07-310000102816eatonvance:C000014187Member2016-09-012021-08-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19182BroadBasedIndexMember2016-09-012021-08-310000102816eatonvance:C000014187Member2016-09-012021-09-300000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19182BroadBasedIndexMember2016-09-012021-09-300000102816eatonvance:C000014187Member2016-09-012021-10-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19182BroadBasedIndexMember2016-09-012021-10-310000102816eatonvance:C000014187Member2016-09-012021-11-300000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19182BroadBasedIndexMember2016-09-012021-11-300000102816eatonvance:C000014187Member2016-09-012021-12-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19182BroadBasedIndexMember2016-09-012021-12-310000102816eatonvance:C000014187Member2016-09-012022-01-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19182BroadBasedIndexMember2016-09-012022-01-310000102816eatonvance:C000014187Member2016-09-012022-02-280000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19182BroadBasedIndexMember2016-09-012022-02-280000102816eatonvance:C000014187Member2016-09-012022-03-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19182BroadBasedIndexMember2016-09-012022-03-310000102816eatonvance:C000014187Member2016-09-012022-04-300000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19182BroadBasedIndexMember2016-09-012022-04-300000102816eatonvance:C000014187Member2016-09-012022-05-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19182BroadBasedIndexMember2016-09-012022-05-310000102816eatonvance:C000014187Member2016-09-012022-06-300000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19182BroadBasedIndexMember2016-09-012022-06-300000102816eatonvance:C000014187Member2016-09-012022-07-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19182BroadBasedIndexMember2016-09-012022-07-310000102816eatonvance:C000014187Member2016-09-012022-08-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19182BroadBasedIndexMember2016-09-012022-08-310000102816eatonvance:C000014187Member2016-09-012022-09-300000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19182BroadBasedIndexMember2016-09-012022-09-300000102816eatonvance:C000014187Member2016-09-012022-10-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19182BroadBasedIndexMember2016-09-012022-10-310000102816eatonvance:C000014187Member2016-09-012022-11-300000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19182BroadBasedIndexMember2016-09-012022-11-300000102816eatonvance:C000014187Member2016-09-012022-12-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19182BroadBasedIndexMember2016-09-012022-12-310000102816eatonvance:C000014187Member2016-09-012023-01-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19182BroadBasedIndexMember2016-09-012023-01-310000102816eatonvance:C000014187Member2016-09-012023-02-280000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19182BroadBasedIndexMember2016-09-012023-02-280000102816eatonvance:C000014187Member2016-09-012023-03-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19182BroadBasedIndexMember2016-09-012023-03-310000102816eatonvance:C000014187Member2016-09-012023-04-300000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19182BroadBasedIndexMember2016-09-012023-04-300000102816eatonvance:C000014187Member2016-09-012023-05-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19182BroadBasedIndexMember2016-09-012023-05-310000102816eatonvance:C000014187Member2016-09-012023-06-300000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19182BroadBasedIndexMember2016-09-012023-06-300000102816eatonvance:C000014187Member2016-09-012023-07-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19182BroadBasedIndexMember2016-09-012023-07-310000102816eatonvance:C000014187Member2016-09-012023-08-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19182BroadBasedIndexMember2016-09-012023-08-310000102816eatonvance:C000014187Member2016-09-012023-09-300000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19182BroadBasedIndexMember2016-09-012023-09-300000102816eatonvance:C000014187Member2016-09-012023-10-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19182BroadBasedIndexMember2016-09-012023-10-310000102816eatonvance:C000014187Member2016-09-012023-11-300000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19182BroadBasedIndexMember2016-09-012023-11-300000102816eatonvance:C000014187Member2016-09-012023-12-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19182BroadBasedIndexMember2016-09-012023-12-310000102816eatonvance:C000014187Member2016-09-012024-01-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19182BroadBasedIndexMember2016-09-012024-01-310000102816eatonvance:C000014187Member2016-09-012024-02-290000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19182BroadBasedIndexMember2016-09-012024-02-290000102816eatonvance:C000014187Member2016-09-012024-03-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19182BroadBasedIndexMember2016-09-012024-03-310000102816eatonvance:C000014187Member2016-09-012024-04-300000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19182BroadBasedIndexMember2016-09-012024-04-300000102816eatonvance:C000014187Member2016-09-012024-05-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19182BroadBasedIndexMember2016-09-012024-05-310000102816eatonvance:C000014187Member2016-09-012024-06-300000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19182BroadBasedIndexMember2016-09-012024-06-300000102816eatonvance:C000014187Member2016-09-012024-07-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19182BroadBasedIndexMember2016-09-012024-07-310000102816eatonvance:C000014187Member2016-09-012024-08-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19182BroadBasedIndexMember2016-09-012024-08-310000102816eatonvance:C000014187Member2016-09-012024-09-300000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19182BroadBasedIndexMember2016-09-012024-09-300000102816eatonvance:C000014187Member2016-09-012024-10-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19182BroadBasedIndexMember2016-09-012024-10-310000102816eatonvance:C000014187Member2016-09-012024-11-300000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19182BroadBasedIndexMember2016-09-012024-11-300000102816eatonvance:C000014187Member2016-09-012024-12-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19182BroadBasedIndexMember2016-09-012024-12-310000102816eatonvance:C000014187Member2016-09-012025-01-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19182BroadBasedIndexMember2016-09-012025-01-310000102816eatonvance:C000014187Member2016-09-012025-02-280000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19182BroadBasedIndexMember2016-09-012025-02-280000102816eatonvance:C000014187Member2016-09-012025-03-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19182BroadBasedIndexMember2016-09-012025-03-310000102816eatonvance:C000014187Member2016-09-012025-04-300000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19182BroadBasedIndexMember2016-09-012025-04-300000102816eatonvance:C000014187Member2016-09-012025-05-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19182BroadBasedIndexMember2016-09-012025-05-310000102816eatonvance:C000014187Member2016-09-012025-06-300000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19182BroadBasedIndexMember2016-09-012025-06-300000102816eatonvance:C000014187Member2016-09-012025-07-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19182BroadBasedIndexMember2016-09-012025-07-310000102816eatonvance:C000014187Member2016-09-012025-08-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19182BroadBasedIndexMember2016-09-012025-08-310000102816eatonvance:C000014187Member2016-09-012025-09-300000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19182BroadBasedIndexMember2016-09-012025-09-300000102816eatonvance:C000014187Member2016-09-012025-10-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19182BroadBasedIndexMember2016-09-012025-10-310000102816eatonvance:C000014187Member2016-09-012025-11-300000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19182BroadBasedIndexMember2016-09-012025-11-300000102816eatonvance:C000014187Member2016-09-012025-12-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19182BroadBasedIndexMember2016-09-012025-12-310000102816eatonvance:C000014187Member2016-09-012026-01-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19182BroadBasedIndexMember2016-09-012026-01-310000102816eatonvance:C000014187Member2016-09-012026-02-280000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19182BroadBasedIndexMember2016-09-012026-02-280000102816eatonvance:C000014187Member2016-09-012026-03-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19182BroadBasedIndexMember2016-09-012026-03-310000102816eatonvance:C000014187Member2016-09-012026-04-300000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19182BroadBasedIndexMember2016-09-012026-04-300000102816eatonvance:C000014187Member2016-09-012026-05-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19182BroadBasedIndexMember2016-09-012026-05-310000102816eatonvance:C000014187Member2016-09-012026-06-300000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19182BroadBasedIndexMember2016-09-012026-06-300000102816eatonvance:C000014187Member2016-09-012026-07-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19182BroadBasedIndexMember2016-09-012026-07-310000102816eatonvance:C000014187Member2016-09-012026-08-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19182BroadBasedIndexMember2016-09-012026-08-310000102816eatonvance:C000014187Memberoef:WithoutSalesLoadMember2025-09-012026-08-310000102816eatonvance:C000014187Memberoef:WithoutSalesLoadMember2021-09-012026-08-310000102816eatonvance:C000014187Memberoef:WithoutSalesLoadMember2016-09-012026-08-310000102816eatonvance:C000014187Member2021-09-012026-08-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19182BroadBasedIndexMember2021-09-012026-08-310000102816eatonvance:C000014187Member2026-08-310000102816eatonvance:C000014187Membereatonvance:SectorShortMinusTermInvestmentsSectorMember2026-08-310000102816eatonvance:C000014187Membereatonvance:SectorUtilitiesSectorMember2026-08-310000102816eatonvance:C000014187Membereatonvance:SectorRealEstateSectorMember2026-08-310000102816eatonvance:C000014187Membereatonvance:SectorConsumerStaplesSectorMember2026-08-310000102816eatonvance:C000014187Membereatonvance:SectorEnergySectorMember2026-08-310000102816eatonvance:C000014187Membereatonvance:SectorHealthCareSectorMember2026-08-310000102816eatonvance:C000014187Membereatonvance:SectorMaterialsSectorMember2026-08-310000102816eatonvance:C000014187Membereatonvance:SectorIndustrialsSectorMember2026-08-310000102816eatonvance:C000014187Membereatonvance:SectorInformationTechnologySectorMember2026-08-310000102816eatonvance:C000014187Membereatonvance:SectorCommunicationServicesSectorMember2026-08-310000102816eatonvance:C000014187Membereatonvance:SectorConsumerDiscretionarySectorMember2026-08-310000102816eatonvance:C000014187Membereatonvance:SectorFinancialsSectorMember2026-08-310000102816eatonvance:C000014187Membereatonvance:FRBMMV2K903CTIMember2026-08-310000102816eatonvance:C000014187Membereatonvance:FRBK6YZP902CTIMember2026-08-310000102816eatonvance:C000014187Membereatonvance:FRB0LMTQ900CTIMember2026-08-310000102816eatonvance:C000014187Membereatonvance:FRBD5LYF900CTIMember2026-08-310000102816eatonvance:C000014187Membereatonvance:FRB1G1QD902CTIMember2026-08-310000102816eatonvance:C000014187Membereatonvance:FR672529906CTIMember2026-08-310000102816eatonvance:C000014187Membereatonvance:FR967JXD907CTIMember2026-08-310000102816eatonvance:C000014187Membereatonvance:FRB01FLR903CTIMember2026-08-310000102816eatonvance:C000014187Membereatonvance:FRBHQPSY905CTIMember2026-08-310000102816eatonvance:C000014187Membereatonvance:FRB09N7M905CTIMember2026-08-310000102816eatonvance:C000014187Membereatonvance:ChinaShenhuaEnergyCoLtdHCTIMember2026-08-310000102816eatonvance:C000014184Member2025-09-012026-08-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19296BroadBasedIndexMember2025-09-012026-08-310000102816eatonvance:C000014184Member2016-08-312016-08-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19296BroadBasedIndexMember2016-08-312016-08-310000102816eatonvance:C000014184Member2016-09-012016-09-300000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19296BroadBasedIndexMember2016-09-012016-09-300000102816eatonvance:C000014184Member2016-09-012016-10-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19296BroadBasedIndexMember2016-09-012016-10-310000102816eatonvance:C000014184Member2016-09-012016-11-300000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19296BroadBasedIndexMember2016-09-012016-11-300000102816eatonvance:C000014184Member2016-09-012016-12-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19296BroadBasedIndexMember2016-09-012016-12-310000102816eatonvance:C000014184Member2016-09-012017-01-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19296BroadBasedIndexMember2016-09-012017-01-310000102816eatonvance:C000014184Member2016-09-012017-02-280000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19296BroadBasedIndexMember2016-09-012017-02-280000102816eatonvance:C000014184Member2016-09-012017-03-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19296BroadBasedIndexMember2016-09-012017-03-310000102816eatonvance:C000014184Member2016-09-012017-04-300000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19296BroadBasedIndexMember2016-09-012017-04-300000102816eatonvance:C000014184Member2016-09-012017-05-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19296BroadBasedIndexMember2016-09-012017-05-310000102816eatonvance:C000014184Member2016-09-012017-06-300000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19296BroadBasedIndexMember2016-09-012017-06-300000102816eatonvance:C000014184Member2016-09-012017-07-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19296BroadBasedIndexMember2016-09-012017-07-310000102816eatonvance:C000014184Member2016-09-012017-08-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19296BroadBasedIndexMember2016-09-012017-08-310000102816eatonvance:C000014184Member2016-09-012017-09-300000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19296BroadBasedIndexMember2016-09-012017-09-300000102816eatonvance:C000014184Member2016-09-012017-10-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19296BroadBasedIndexMember2016-09-012017-10-310000102816eatonvance:C000014184Member2016-09-012017-11-300000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19296BroadBasedIndexMember2016-09-012017-11-300000102816eatonvance:C000014184Member2016-09-012017-12-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19296BroadBasedIndexMember2016-09-012017-12-310000102816eatonvance:C000014184Member2016-09-012018-01-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19296BroadBasedIndexMember2016-09-012018-01-310000102816eatonvance:C000014184Member2016-09-012018-02-280000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19296BroadBasedIndexMember2016-09-012018-02-280000102816eatonvance:C000014184Member2016-09-012018-03-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19296BroadBasedIndexMember2016-09-012018-03-310000102816eatonvance:C000014184Member2016-09-012018-04-300000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19296BroadBasedIndexMember2016-09-012018-04-300000102816eatonvance:C000014184Member2016-09-012018-05-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19296BroadBasedIndexMember2016-09-012018-05-310000102816eatonvance:C000014184Member2016-09-012018-06-300000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19296BroadBasedIndexMember2016-09-012018-06-300000102816eatonvance:C000014184Member2016-09-012018-07-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19296BroadBasedIndexMember2016-09-012018-07-310000102816eatonvance:C000014184Member2016-09-012018-08-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19296BroadBasedIndexMember2016-09-012018-08-310000102816eatonvance:C000014184Member2016-09-012018-09-300000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19296BroadBasedIndexMember2016-09-012018-09-300000102816eatonvance:C000014184Member2016-09-012018-10-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19296BroadBasedIndexMember2016-09-012018-10-310000102816eatonvance:C000014184Member2016-09-012018-11-300000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19296BroadBasedIndexMember2016-09-012018-11-300000102816eatonvance:C000014184Member2016-09-012018-12-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19296BroadBasedIndexMember2016-09-012018-12-310000102816eatonvance:C000014184Member2016-09-012019-01-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19296BroadBasedIndexMember2016-09-012019-01-310000102816eatonvance:C000014184Member2016-09-012019-02-280000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19296BroadBasedIndexMember2016-09-012019-02-280000102816eatonvance:C000014184Member2016-09-012019-03-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19296BroadBasedIndexMember2016-09-012019-03-310000102816eatonvance:C000014184Member2016-09-012019-04-300000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19296BroadBasedIndexMember2016-09-012019-04-300000102816eatonvance:C000014184Member2016-09-012019-05-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19296BroadBasedIndexMember2016-09-012019-05-310000102816eatonvance:C000014184Member2016-09-012019-06-300000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19296BroadBasedIndexMember2016-09-012019-06-300000102816eatonvance:C000014184Member2016-09-012019-07-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19296BroadBasedIndexMember2016-09-012019-07-310000102816eatonvance:C000014184Member2016-09-012019-08-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19296BroadBasedIndexMember2016-09-012019-08-310000102816eatonvance:C000014184Member2016-09-012019-09-300000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19296BroadBasedIndexMember2016-09-012019-09-300000102816eatonvance:C000014184Member2016-09-012019-10-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19296BroadBasedIndexMember2016-09-012019-10-310000102816eatonvance:C000014184Member2016-09-012019-11-300000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19296BroadBasedIndexMember2016-09-012019-11-300000102816eatonvance:C000014184Member2016-09-012019-12-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19296BroadBasedIndexMember2016-09-012019-12-310000102816eatonvance:C000014184Member2016-09-012020-01-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19296BroadBasedIndexMember2016-09-012020-01-310000102816eatonvance:C000014184Member2016-09-012020-02-290000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19296BroadBasedIndexMember2016-09-012020-02-290000102816eatonvance:C000014184Member2016-09-012020-03-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19296BroadBasedIndexMember2016-09-012020-03-310000102816eatonvance:C000014184Member2016-09-012020-04-300000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19296BroadBasedIndexMember2016-09-012020-04-300000102816eatonvance:C000014184Member2016-09-012020-05-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19296BroadBasedIndexMember2016-09-012020-05-310000102816eatonvance:C000014184Member2016-09-012020-06-300000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19296BroadBasedIndexMember2016-09-012020-06-300000102816eatonvance:C000014184Member2016-09-012020-07-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19296BroadBasedIndexMember2016-09-012020-07-310000102816eatonvance:C000014184Member2016-09-012020-08-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19296BroadBasedIndexMember2016-09-012020-08-310000102816eatonvance:C000014184Member2016-09-012020-09-300000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19296BroadBasedIndexMember2016-09-012020-09-300000102816eatonvance:C000014184Member2016-09-012020-10-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19296BroadBasedIndexMember2016-09-012020-10-310000102816eatonvance:C000014184Member2016-09-012020-11-300000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19296BroadBasedIndexMember2016-09-012020-11-300000102816eatonvance:C000014184Member2016-09-012020-12-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19296BroadBasedIndexMember2016-09-012020-12-310000102816eatonvance:C000014184Member2016-09-012021-01-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19296BroadBasedIndexMember2016-09-012021-01-310000102816eatonvance:C000014184Member2016-09-012021-02-280000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19296BroadBasedIndexMember2016-09-012021-02-280000102816eatonvance:C000014184Member2016-09-012021-03-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19296BroadBasedIndexMember2016-09-012021-03-310000102816eatonvance:C000014184Member2016-09-012021-04-300000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19296BroadBasedIndexMember2016-09-012021-04-300000102816eatonvance:C000014184Member2016-09-012021-05-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19296BroadBasedIndexMember2016-09-012021-05-310000102816eatonvance:C000014184Member2016-09-012021-06-300000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19296BroadBasedIndexMember2016-09-012021-06-300000102816eatonvance:C000014184Member2016-09-012021-07-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19296BroadBasedIndexMember2016-09-012021-07-310000102816eatonvance:C000014184Member2016-09-012021-08-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19296BroadBasedIndexMember2016-09-012021-08-310000102816eatonvance:C000014184Member2016-09-012021-09-300000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19296BroadBasedIndexMember2016-09-012021-09-300000102816eatonvance:C000014184Member2016-09-012021-10-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19296BroadBasedIndexMember2016-09-012021-10-310000102816eatonvance:C000014184Member2016-09-012021-11-300000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19296BroadBasedIndexMember2016-09-012021-11-300000102816eatonvance:C000014184Member2016-09-012021-12-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19296BroadBasedIndexMember2016-09-012021-12-310000102816eatonvance:C000014184Member2016-09-012022-01-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19296BroadBasedIndexMember2016-09-012022-01-310000102816eatonvance:C000014184Member2016-09-012022-02-280000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19296BroadBasedIndexMember2016-09-012022-02-280000102816eatonvance:C000014184Member2016-09-012022-03-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19296BroadBasedIndexMember2016-09-012022-03-310000102816eatonvance:C000014184Member2016-09-012022-04-300000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19296BroadBasedIndexMember2016-09-012022-04-300000102816eatonvance:C000014184Member2016-09-012022-05-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19296BroadBasedIndexMember2016-09-012022-05-310000102816eatonvance:C000014184Member2016-09-012022-06-300000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19296BroadBasedIndexMember2016-09-012022-06-300000102816eatonvance:C000014184Member2016-09-012022-07-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19296BroadBasedIndexMember2016-09-012022-07-310000102816eatonvance:C000014184Member2016-09-012022-08-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19296BroadBasedIndexMember2016-09-012022-08-310000102816eatonvance:C000014184Member2016-09-012022-09-300000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19296BroadBasedIndexMember2016-09-012022-09-300000102816eatonvance:C000014184Member2016-09-012022-10-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19296BroadBasedIndexMember2016-09-012022-10-310000102816eatonvance:C000014184Member2016-09-012022-11-300000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19296BroadBasedIndexMember2016-09-012022-11-300000102816eatonvance:C000014184Member2016-09-012022-12-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19296BroadBasedIndexMember2016-09-012022-12-310000102816eatonvance:C000014184Member2016-09-012023-01-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19296BroadBasedIndexMember2016-09-012023-01-310000102816eatonvance:C000014184Member2016-09-012023-02-280000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19296BroadBasedIndexMember2016-09-012023-02-280000102816eatonvance:C000014184Member2016-09-012023-03-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19296BroadBasedIndexMember2016-09-012023-03-310000102816eatonvance:C000014184Member2016-09-012023-04-300000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19296BroadBasedIndexMember2016-09-012023-04-300000102816eatonvance:C000014184Member2016-09-012023-05-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19296BroadBasedIndexMember2016-09-012023-05-310000102816eatonvance:C000014184Member2016-09-012023-06-300000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19296BroadBasedIndexMember2016-09-012023-06-300000102816eatonvance:C000014184Member2016-09-012023-07-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19296BroadBasedIndexMember2016-09-012023-07-310000102816eatonvance:C000014184Member2016-09-012023-08-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19296BroadBasedIndexMember2016-09-012023-08-310000102816eatonvance:C000014184Member2016-09-012023-09-300000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19296BroadBasedIndexMember2016-09-012023-09-300000102816eatonvance:C000014184Member2016-09-012023-10-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19296BroadBasedIndexMember2016-09-012023-10-310000102816eatonvance:C000014184Member2016-09-012023-11-300000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19296BroadBasedIndexMember2016-09-012023-11-300000102816eatonvance:C000014184Member2016-09-012023-12-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19296BroadBasedIndexMember2016-09-012023-12-310000102816eatonvance:C000014184Member2016-09-012024-01-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19296BroadBasedIndexMember2016-09-012024-01-310000102816eatonvance:C000014184Member2016-09-012024-02-290000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19296BroadBasedIndexMember2016-09-012024-02-290000102816eatonvance:C000014184Member2016-09-012024-03-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19296BroadBasedIndexMember2016-09-012024-03-310000102816eatonvance:C000014184Member2016-09-012024-04-300000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19296BroadBasedIndexMember2016-09-012024-04-300000102816eatonvance:C000014184Member2016-09-012024-05-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19296BroadBasedIndexMember2016-09-012024-05-310000102816eatonvance:C000014184Member2016-09-012024-06-300000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19296BroadBasedIndexMember2016-09-012024-06-300000102816eatonvance:C000014184Member2016-09-012024-07-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19296BroadBasedIndexMember2016-09-012024-07-310000102816eatonvance:C000014184Member2016-09-012024-08-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19296BroadBasedIndexMember2016-09-012024-08-310000102816eatonvance:C000014184Member2016-09-012024-09-300000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19296BroadBasedIndexMember2016-09-012024-09-300000102816eatonvance:C000014184Member2016-09-012024-10-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19296BroadBasedIndexMember2016-09-012024-10-310000102816eatonvance:C000014184Member2016-09-012024-11-300000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19296BroadBasedIndexMember2016-09-012024-11-300000102816eatonvance:C000014184Member2016-09-012024-12-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19296BroadBasedIndexMember2016-09-012024-12-310000102816eatonvance:C000014184Member2016-09-012025-01-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19296BroadBasedIndexMember2016-09-012025-01-310000102816eatonvance:C000014184Member2016-09-012025-02-280000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19296BroadBasedIndexMember2016-09-012025-02-280000102816eatonvance:C000014184Member2016-09-012025-03-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19296BroadBasedIndexMember2016-09-012025-03-310000102816eatonvance:C000014184Member2016-09-012025-04-300000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19296BroadBasedIndexMember2016-09-012025-04-300000102816eatonvance:C000014184Member2016-09-012025-05-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19296BroadBasedIndexMember2016-09-012025-05-310000102816eatonvance:C000014184Member2016-09-012025-06-300000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19296BroadBasedIndexMember2016-09-012025-06-300000102816eatonvance:C000014184Member2016-09-012025-07-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19296BroadBasedIndexMember2016-09-012025-07-310000102816eatonvance:C000014184Member2016-09-012025-08-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19296BroadBasedIndexMember2016-09-012025-08-310000102816eatonvance:C000014184Member2016-09-012025-09-300000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19296BroadBasedIndexMember2016-09-012025-09-300000102816eatonvance:C000014184Member2016-09-012025-10-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19296BroadBasedIndexMember2016-09-012025-10-310000102816eatonvance:C000014184Member2016-09-012025-11-300000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19296BroadBasedIndexMember2016-09-012025-11-300000102816eatonvance:C000014184Member2016-09-012025-12-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19296BroadBasedIndexMember2016-09-012025-12-310000102816eatonvance:C000014184Member2016-09-012026-01-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19296BroadBasedIndexMember2016-09-012026-01-310000102816eatonvance:C000014184Member2016-09-012026-02-280000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19296BroadBasedIndexMember2016-09-012026-02-280000102816eatonvance:C000014184Member2016-09-012026-03-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19296BroadBasedIndexMember2016-09-012026-03-310000102816eatonvance:C000014184Member2016-09-012026-04-300000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19296BroadBasedIndexMember2016-09-012026-04-300000102816eatonvance:C000014184Member2016-09-012026-05-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19296BroadBasedIndexMember2016-09-012026-05-310000102816eatonvance:C000014184Member2016-09-012026-06-300000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19296BroadBasedIndexMember2016-09-012026-06-300000102816eatonvance:C000014184Member2016-09-012026-07-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19296BroadBasedIndexMember2016-09-012026-07-310000102816eatonvance:C000014184Member2016-09-012026-08-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19296BroadBasedIndexMember2016-09-012026-08-310000102816eatonvance:C000014184Memberoef:WithoutSalesLoadMember2025-09-012026-08-310000102816eatonvance:C000014184Memberoef:WithoutSalesLoadMember2021-09-012026-08-310000102816eatonvance:C000014184Memberoef:WithoutSalesLoadMember2016-09-012026-08-310000102816eatonvance:EATONVANCEIndexMSCIChinaIndex19296BroadBasedIndexMember2021-09-012026-08-310000102816eatonvance:C000014184Member2026-08-310000102816eatonvance:C000014184Membereatonvance:SectorShortMinusTermInvestmentsSectorMember2026-08-310000102816eatonvance:C000014184Membereatonvance:SectorUtilitiesSectorMember2026-08-310000102816eatonvance:C000014184Membereatonvance:SectorRealEstateSectorMember2026-08-310000102816eatonvance:C000014184Membereatonvance:SectorConsumerStaplesSectorMember2026-08-310000102816eatonvance:C000014184Membereatonvance:SectorEnergySectorMember2026-08-310000102816eatonvance:C000014184Membereatonvance:SectorHealthCareSectorMember2026-08-310000102816eatonvance:C000014184Membereatonvance:SectorMaterialsSectorMember2026-08-310000102816eatonvance:C000014184Membereatonvance:SectorIndustrialsSectorMember2026-08-310000102816eatonvance:C000014184Membereatonvance:SectorInformationTechnologySectorMember2026-08-310000102816eatonvance:C000014184Membereatonvance:SectorCommunicationServicesSectorMember2026-08-310000102816eatonvance:C000014184Membereatonvance:SectorConsumerDiscretionarySectorMember2026-08-310000102816eatonvance:C000014184Membereatonvance:SectorFinancialsSectorMember2026-08-310000102816eatonvance:C000014184Membereatonvance:FRBMMV2K903CTIMember2026-08-310000102816eatonvance:C000014184Membereatonvance:FRBK6YZP902CTIMember2026-08-310000102816eatonvance:C000014184Membereatonvance:FRB0LMTQ900CTIMember2026-08-310000102816eatonvance:C000014184Membereatonvance:FRBD5LYF900CTIMember2026-08-310000102816eatonvance:C000014184Membereatonvance:FRB1G1QD902CTIMember2026-08-310000102816eatonvance:C000014184Membereatonvance:FR672529906CTIMember2026-08-310000102816eatonvance:C000014184Membereatonvance:FR967JXD907CTIMember2026-08-310000102816eatonvance:C000014184Membereatonvance:FRB01FLR903CTIMember2026-08-310000102816eatonvance:C000014184Membereatonvance:FRBHQPSY905CTIMember2026-08-310000102816eatonvance:C000014184Membereatonvance:FRB09N7M905CTIMember2026-08-310000102816eatonvance:C000014184Membereatonvance:ChinaShenhuaEnergyCoLtdHCTIMember2026-08-310000102816eatonvance:C000014191Member2025-09-012026-08-310000102816eatonvance:EATONVANCEIndexMSCIWorld19122BroadBasedIndexMember2025-09-012026-08-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19122AdditionalIndexMember2025-09-012026-08-310000102816eatonvance:EATONVANCEIndexSP50019122AdditionalIndexMember2025-09-012026-08-310000102816eatonvance:C000014191Member2016-08-312016-08-310000102816eatonvance:EATONVANCEIndexMSCIWorld19122BroadBasedIndexMember2016-08-312016-08-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19122AdditionalIndexMember2016-08-312016-08-310000102816eatonvance:EATONVANCEIndexSP50019122AdditionalIndexMember2016-08-312016-08-310000102816eatonvance:C000014191Member2016-09-012016-09-300000102816eatonvance:EATONVANCEIndexMSCIWorld19122BroadBasedIndexMember2016-09-012016-09-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19122AdditionalIndexMember2016-09-012016-09-300000102816eatonvance:EATONVANCEIndexSP50019122AdditionalIndexMember2016-09-012016-09-300000102816eatonvance:C000014191Member2016-09-012016-10-310000102816eatonvance:EATONVANCEIndexMSCIWorld19122BroadBasedIndexMember2016-09-012016-10-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19122AdditionalIndexMember2016-09-012016-10-310000102816eatonvance:EATONVANCEIndexSP50019122AdditionalIndexMember2016-09-012016-10-310000102816eatonvance:C000014191Member2016-09-012016-11-300000102816eatonvance:EATONVANCEIndexMSCIWorld19122BroadBasedIndexMember2016-09-012016-11-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19122AdditionalIndexMember2016-09-012016-11-300000102816eatonvance:EATONVANCEIndexSP50019122AdditionalIndexMember2016-09-012016-11-300000102816eatonvance:C000014191Member2016-09-012016-12-310000102816eatonvance:EATONVANCEIndexMSCIWorld19122BroadBasedIndexMember2016-09-012016-12-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19122AdditionalIndexMember2016-09-012016-12-310000102816eatonvance:EATONVANCEIndexSP50019122AdditionalIndexMember2016-09-012016-12-310000102816eatonvance:C000014191Member2016-09-012017-01-310000102816eatonvance:EATONVANCEIndexMSCIWorld19122BroadBasedIndexMember2016-09-012017-01-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19122AdditionalIndexMember2016-09-012017-01-310000102816eatonvance:EATONVANCEIndexSP50019122AdditionalIndexMember2016-09-012017-01-310000102816eatonvance:C000014191Member2016-09-012017-02-280000102816eatonvance:EATONVANCEIndexMSCIWorld19122BroadBasedIndexMember2016-09-012017-02-280000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19122AdditionalIndexMember2016-09-012017-02-280000102816eatonvance:EATONVANCEIndexSP50019122AdditionalIndexMember2016-09-012017-02-280000102816eatonvance:C000014191Member2016-09-012017-03-310000102816eatonvance:EATONVANCEIndexMSCIWorld19122BroadBasedIndexMember2016-09-012017-03-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19122AdditionalIndexMember2016-09-012017-03-310000102816eatonvance:EATONVANCEIndexSP50019122AdditionalIndexMember2016-09-012017-03-310000102816eatonvance:C000014191Member2016-09-012017-04-300000102816eatonvance:EATONVANCEIndexMSCIWorld19122BroadBasedIndexMember2016-09-012017-04-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19122AdditionalIndexMember2016-09-012017-04-300000102816eatonvance:EATONVANCEIndexSP50019122AdditionalIndexMember2016-09-012017-04-300000102816eatonvance:C000014191Member2016-09-012017-05-310000102816eatonvance:EATONVANCEIndexMSCIWorld19122BroadBasedIndexMember2016-09-012017-05-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19122AdditionalIndexMember2016-09-012017-05-310000102816eatonvance:EATONVANCEIndexSP50019122AdditionalIndexMember2016-09-012017-05-310000102816eatonvance:C000014191Member2016-09-012017-06-300000102816eatonvance:EATONVANCEIndexMSCIWorld19122BroadBasedIndexMember2016-09-012017-06-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19122AdditionalIndexMember2016-09-012017-06-300000102816eatonvance:EATONVANCEIndexSP50019122AdditionalIndexMember2016-09-012017-06-300000102816eatonvance:C000014191Member2016-09-012017-07-310000102816eatonvance:EATONVANCEIndexMSCIWorld19122BroadBasedIndexMember2016-09-012017-07-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19122AdditionalIndexMember2016-09-012017-07-310000102816eatonvance:EATONVANCEIndexSP50019122AdditionalIndexMember2016-09-012017-07-310000102816eatonvance:C000014191Member2016-09-012017-08-310000102816eatonvance:EATONVANCEIndexMSCIWorld19122BroadBasedIndexMember2016-09-012017-08-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19122AdditionalIndexMember2016-09-012017-08-310000102816eatonvance:EATONVANCEIndexSP50019122AdditionalIndexMember2016-09-012017-08-310000102816eatonvance:C000014191Member2016-09-012017-09-300000102816eatonvance:EATONVANCEIndexMSCIWorld19122BroadBasedIndexMember2016-09-012017-09-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19122AdditionalIndexMember2016-09-012017-09-300000102816eatonvance:EATONVANCEIndexSP50019122AdditionalIndexMember2016-09-012017-09-300000102816eatonvance:C000014191Member2016-09-012017-10-310000102816eatonvance:EATONVANCEIndexMSCIWorld19122BroadBasedIndexMember2016-09-012017-10-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19122AdditionalIndexMember2016-09-012017-10-310000102816eatonvance:EATONVANCEIndexSP50019122AdditionalIndexMember2016-09-012017-10-310000102816eatonvance:C000014191Member2016-09-012017-11-300000102816eatonvance:EATONVANCEIndexMSCIWorld19122BroadBasedIndexMember2016-09-012017-11-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19122AdditionalIndexMember2016-09-012017-11-300000102816eatonvance:EATONVANCEIndexSP50019122AdditionalIndexMember2016-09-012017-11-300000102816eatonvance:C000014191Member2016-09-012017-12-310000102816eatonvance:EATONVANCEIndexMSCIWorld19122BroadBasedIndexMember2016-09-012017-12-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19122AdditionalIndexMember2016-09-012017-12-310000102816eatonvance:EATONVANCEIndexSP50019122AdditionalIndexMember2016-09-012017-12-310000102816eatonvance:C000014191Member2016-09-012018-01-310000102816eatonvance:EATONVANCEIndexMSCIWorld19122BroadBasedIndexMember2016-09-012018-01-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19122AdditionalIndexMember2016-09-012018-01-310000102816eatonvance:EATONVANCEIndexSP50019122AdditionalIndexMember2016-09-012018-01-310000102816eatonvance:C000014191Member2016-09-012018-02-280000102816eatonvance:EATONVANCEIndexMSCIWorld19122BroadBasedIndexMember2016-09-012018-02-280000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19122AdditionalIndexMember2016-09-012018-02-280000102816eatonvance:EATONVANCEIndexSP50019122AdditionalIndexMember2016-09-012018-02-280000102816eatonvance:C000014191Member2016-09-012018-03-310000102816eatonvance:EATONVANCEIndexMSCIWorld19122BroadBasedIndexMember2016-09-012018-03-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19122AdditionalIndexMember2016-09-012018-03-310000102816eatonvance:EATONVANCEIndexSP50019122AdditionalIndexMember2016-09-012018-03-310000102816eatonvance:C000014191Member2016-09-012018-04-300000102816eatonvance:EATONVANCEIndexMSCIWorld19122BroadBasedIndexMember2016-09-012018-04-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19122AdditionalIndexMember2016-09-012018-04-300000102816eatonvance:EATONVANCEIndexSP50019122AdditionalIndexMember2016-09-012018-04-300000102816eatonvance:C000014191Member2016-09-012018-05-310000102816eatonvance:EATONVANCEIndexMSCIWorld19122BroadBasedIndexMember2016-09-012018-05-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19122AdditionalIndexMember2016-09-012018-05-310000102816eatonvance:EATONVANCEIndexSP50019122AdditionalIndexMember2016-09-012018-05-310000102816eatonvance:C000014191Member2016-09-012018-06-300000102816eatonvance:EATONVANCEIndexMSCIWorld19122BroadBasedIndexMember2016-09-012018-06-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19122AdditionalIndexMember2016-09-012018-06-300000102816eatonvance:EATONVANCEIndexSP50019122AdditionalIndexMember2016-09-012018-06-300000102816eatonvance:C000014191Member2016-09-012018-07-310000102816eatonvance:EATONVANCEIndexMSCIWorld19122BroadBasedIndexMember2016-09-012018-07-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19122AdditionalIndexMember2016-09-012018-07-310000102816eatonvance:EATONVANCEIndexSP50019122AdditionalIndexMember2016-09-012018-07-310000102816eatonvance:C000014191Member2016-09-012018-08-310000102816eatonvance:EATONVANCEIndexMSCIWorld19122BroadBasedIndexMember2016-09-012018-08-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19122AdditionalIndexMember2016-09-012018-08-310000102816eatonvance:EATONVANCEIndexSP50019122AdditionalIndexMember2016-09-012018-08-310000102816eatonvance:C000014191Member2016-09-012018-09-300000102816eatonvance:EATONVANCEIndexMSCIWorld19122BroadBasedIndexMember2016-09-012018-09-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19122AdditionalIndexMember2016-09-012018-09-300000102816eatonvance:EATONVANCEIndexSP50019122AdditionalIndexMember2016-09-012018-09-300000102816eatonvance:C000014191Member2016-09-012018-10-310000102816eatonvance:EATONVANCEIndexMSCIWorld19122BroadBasedIndexMember2016-09-012018-10-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19122AdditionalIndexMember2016-09-012018-10-310000102816eatonvance:EATONVANCEIndexSP50019122AdditionalIndexMember2016-09-012018-10-310000102816eatonvance:C000014191Member2016-09-012018-11-300000102816eatonvance:EATONVANCEIndexMSCIWorld19122BroadBasedIndexMember2016-09-012018-11-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19122AdditionalIndexMember2016-09-012018-11-300000102816eatonvance:EATONVANCEIndexSP50019122AdditionalIndexMember2016-09-012018-11-300000102816eatonvance:C000014191Member2016-09-012018-12-310000102816eatonvance:EATONVANCEIndexMSCIWorld19122BroadBasedIndexMember2016-09-012018-12-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19122AdditionalIndexMember2016-09-012018-12-310000102816eatonvance:EATONVANCEIndexSP50019122AdditionalIndexMember2016-09-012018-12-310000102816eatonvance:C000014191Member2016-09-012019-01-310000102816eatonvance:EATONVANCEIndexMSCIWorld19122BroadBasedIndexMember2016-09-012019-01-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19122AdditionalIndexMember2016-09-012019-01-310000102816eatonvance:EATONVANCEIndexSP50019122AdditionalIndexMember2016-09-012019-01-310000102816eatonvance:C000014191Member2016-09-012019-02-280000102816eatonvance:EATONVANCEIndexMSCIWorld19122BroadBasedIndexMember2016-09-012019-02-280000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19122AdditionalIndexMember2016-09-012019-02-280000102816eatonvance:EATONVANCEIndexSP50019122AdditionalIndexMember2016-09-012019-02-280000102816eatonvance:C000014191Member2016-09-012019-03-310000102816eatonvance:EATONVANCEIndexMSCIWorld19122BroadBasedIndexMember2016-09-012019-03-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19122AdditionalIndexMember2016-09-012019-03-310000102816eatonvance:EATONVANCEIndexSP50019122AdditionalIndexMember2016-09-012019-03-310000102816eatonvance:C000014191Member2016-09-012019-04-300000102816eatonvance:EATONVANCEIndexMSCIWorld19122BroadBasedIndexMember2016-09-012019-04-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19122AdditionalIndexMember2016-09-012019-04-300000102816eatonvance:EATONVANCEIndexSP50019122AdditionalIndexMember2016-09-012019-04-300000102816eatonvance:C000014191Member2016-09-012019-05-310000102816eatonvance:EATONVANCEIndexMSCIWorld19122BroadBasedIndexMember2016-09-012019-05-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19122AdditionalIndexMember2016-09-012019-05-310000102816eatonvance:EATONVANCEIndexSP50019122AdditionalIndexMember2016-09-012019-05-310000102816eatonvance:C000014191Member2016-09-012019-06-300000102816eatonvance:EATONVANCEIndexMSCIWorld19122BroadBasedIndexMember2016-09-012019-06-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19122AdditionalIndexMember2016-09-012019-06-300000102816eatonvance:EATONVANCEIndexSP50019122AdditionalIndexMember2016-09-012019-06-300000102816eatonvance:C000014191Member2016-09-012019-07-310000102816eatonvance:EATONVANCEIndexMSCIWorld19122BroadBasedIndexMember2016-09-012019-07-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19122AdditionalIndexMember2016-09-012019-07-310000102816eatonvance:EATONVANCEIndexSP50019122AdditionalIndexMember2016-09-012019-07-310000102816eatonvance:C000014191Member2016-09-012019-08-310000102816eatonvance:EATONVANCEIndexMSCIWorld19122BroadBasedIndexMember2016-09-012019-08-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19122AdditionalIndexMember2016-09-012019-08-310000102816eatonvance:EATONVANCEIndexSP50019122AdditionalIndexMember2016-09-012019-08-310000102816eatonvance:C000014191Member2016-09-012019-09-300000102816eatonvance:EATONVANCEIndexMSCIWorld19122BroadBasedIndexMember2016-09-012019-09-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19122AdditionalIndexMember2016-09-012019-09-300000102816eatonvance:EATONVANCEIndexSP50019122AdditionalIndexMember2016-09-012019-09-300000102816eatonvance:C000014191Member2016-09-012019-10-310000102816eatonvance:EATONVANCEIndexMSCIWorld19122BroadBasedIndexMember2016-09-012019-10-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19122AdditionalIndexMember2016-09-012019-10-310000102816eatonvance:EATONVANCEIndexSP50019122AdditionalIndexMember2016-09-012019-10-310000102816eatonvance:C000014191Member2016-09-012019-11-300000102816eatonvance:EATONVANCEIndexMSCIWorld19122BroadBasedIndexMember2016-09-012019-11-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19122AdditionalIndexMember2016-09-012019-11-300000102816eatonvance:EATONVANCEIndexSP50019122AdditionalIndexMember2016-09-012019-11-300000102816eatonvance:C000014191Member2016-09-012019-12-310000102816eatonvance:EATONVANCEIndexMSCIWorld19122BroadBasedIndexMember2016-09-012019-12-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19122AdditionalIndexMember2016-09-012019-12-310000102816eatonvance:EATONVANCEIndexSP50019122AdditionalIndexMember2016-09-012019-12-310000102816eatonvance:C000014191Member2016-09-012020-01-310000102816eatonvance:EATONVANCEIndexMSCIWorld19122BroadBasedIndexMember2016-09-012020-01-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19122AdditionalIndexMember2016-09-012020-01-310000102816eatonvance:EATONVANCEIndexSP50019122AdditionalIndexMember2016-09-012020-01-310000102816eatonvance:C000014191Member2016-09-012020-02-290000102816eatonvance:EATONVANCEIndexMSCIWorld19122BroadBasedIndexMember2016-09-012020-02-290000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19122AdditionalIndexMember2016-09-012020-02-290000102816eatonvance:EATONVANCEIndexSP50019122AdditionalIndexMember2016-09-012020-02-290000102816eatonvance:C000014191Member2016-09-012020-03-310000102816eatonvance:EATONVANCEIndexMSCIWorld19122BroadBasedIndexMember2016-09-012020-03-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19122AdditionalIndexMember2016-09-012020-03-310000102816eatonvance:EATONVANCEIndexSP50019122AdditionalIndexMember2016-09-012020-03-310000102816eatonvance:C000014191Member2016-09-012020-04-300000102816eatonvance:EATONVANCEIndexMSCIWorld19122BroadBasedIndexMember2016-09-012020-04-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19122AdditionalIndexMember2016-09-012020-04-300000102816eatonvance:EATONVANCEIndexSP50019122AdditionalIndexMember2016-09-012020-04-300000102816eatonvance:C000014191Member2016-09-012020-05-310000102816eatonvance:EATONVANCEIndexMSCIWorld19122BroadBasedIndexMember2016-09-012020-05-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19122AdditionalIndexMember2016-09-012020-05-310000102816eatonvance:EATONVANCEIndexSP50019122AdditionalIndexMember2016-09-012020-05-310000102816eatonvance:C000014191Member2016-09-012020-06-300000102816eatonvance:EATONVANCEIndexMSCIWorld19122BroadBasedIndexMember2016-09-012020-06-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19122AdditionalIndexMember2016-09-012020-06-300000102816eatonvance:EATONVANCEIndexSP50019122AdditionalIndexMember2016-09-012020-06-300000102816eatonvance:C000014191Member2016-09-012020-07-310000102816eatonvance:EATONVANCEIndexMSCIWorld19122BroadBasedIndexMember2016-09-012020-07-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19122AdditionalIndexMember2016-09-012020-07-310000102816eatonvance:EATONVANCEIndexSP50019122AdditionalIndexMember2016-09-012020-07-310000102816eatonvance:C000014191Member2016-09-012020-08-310000102816eatonvance:EATONVANCEIndexMSCIWorld19122BroadBasedIndexMember2016-09-012020-08-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19122AdditionalIndexMember2016-09-012020-08-310000102816eatonvance:EATONVANCEIndexSP50019122AdditionalIndexMember2016-09-012020-08-310000102816eatonvance:C000014191Member2016-09-012020-09-300000102816eatonvance:EATONVANCEIndexMSCIWorld19122BroadBasedIndexMember2016-09-012020-09-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19122AdditionalIndexMember2016-09-012020-09-300000102816eatonvance:EATONVANCEIndexSP50019122AdditionalIndexMember2016-09-012020-09-300000102816eatonvance:C000014191Member2016-09-012020-10-310000102816eatonvance:EATONVANCEIndexMSCIWorld19122BroadBasedIndexMember2016-09-012020-10-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19122AdditionalIndexMember2016-09-012020-10-310000102816eatonvance:EATONVANCEIndexSP50019122AdditionalIndexMember2016-09-012020-10-310000102816eatonvance:C000014191Member2016-09-012020-11-300000102816eatonvance:EATONVANCEIndexMSCIWorld19122BroadBasedIndexMember2016-09-012020-11-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19122AdditionalIndexMember2016-09-012020-11-300000102816eatonvance:EATONVANCEIndexSP50019122AdditionalIndexMember2016-09-012020-11-300000102816eatonvance:C000014191Member2016-09-012020-12-310000102816eatonvance:EATONVANCEIndexMSCIWorld19122BroadBasedIndexMember2016-09-012020-12-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19122AdditionalIndexMember2016-09-012020-12-310000102816eatonvance:EATONVANCEIndexSP50019122AdditionalIndexMember2016-09-012020-12-310000102816eatonvance:C000014191Member2016-09-012021-01-310000102816eatonvance:EATONVANCEIndexMSCIWorld19122BroadBasedIndexMember2016-09-012021-01-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19122AdditionalIndexMember2016-09-012021-01-310000102816eatonvance:EATONVANCEIndexSP50019122AdditionalIndexMember2016-09-012021-01-310000102816eatonvance:C000014191Member2016-09-012021-02-280000102816eatonvance:EATONVANCEIndexMSCIWorld19122BroadBasedIndexMember2016-09-012021-02-280000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19122AdditionalIndexMember2016-09-012021-02-280000102816eatonvance:EATONVANCEIndexSP50019122AdditionalIndexMember2016-09-012021-02-280000102816eatonvance:C000014191Member2016-09-012021-03-310000102816eatonvance:EATONVANCEIndexMSCIWorld19122BroadBasedIndexMember2016-09-012021-03-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19122AdditionalIndexMember2016-09-012021-03-310000102816eatonvance:EATONVANCEIndexSP50019122AdditionalIndexMember2016-09-012021-03-310000102816eatonvance:C000014191Member2016-09-012021-04-300000102816eatonvance:EATONVANCEIndexMSCIWorld19122BroadBasedIndexMember2016-09-012021-04-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19122AdditionalIndexMember2016-09-012021-04-300000102816eatonvance:EATONVANCEIndexSP50019122AdditionalIndexMember2016-09-012021-04-300000102816eatonvance:C000014191Member2016-09-012021-05-310000102816eatonvance:EATONVANCEIndexMSCIWorld19122BroadBasedIndexMember2016-09-012021-05-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19122AdditionalIndexMember2016-09-012021-05-310000102816eatonvance:EATONVANCEIndexSP50019122AdditionalIndexMember2016-09-012021-05-310000102816eatonvance:C000014191Member2016-09-012021-06-300000102816eatonvance:EATONVANCEIndexMSCIWorld19122BroadBasedIndexMember2016-09-012021-06-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19122AdditionalIndexMember2016-09-012021-06-300000102816eatonvance:EATONVANCEIndexSP50019122AdditionalIndexMember2016-09-012021-06-300000102816eatonvance:C000014191Member2016-09-012021-07-310000102816eatonvance:EATONVANCEIndexMSCIWorld19122BroadBasedIndexMember2016-09-012021-07-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19122AdditionalIndexMember2016-09-012021-07-310000102816eatonvance:EATONVANCEIndexSP50019122AdditionalIndexMember2016-09-012021-07-310000102816eatonvance:C000014191Member2016-09-012021-08-310000102816eatonvance:EATONVANCEIndexMSCIWorld19122BroadBasedIndexMember2016-09-012021-08-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19122AdditionalIndexMember2016-09-012021-08-310000102816eatonvance:EATONVANCEIndexSP50019122AdditionalIndexMember2016-09-012021-08-310000102816eatonvance:C000014191Member2016-09-012021-09-300000102816eatonvance:EATONVANCEIndexMSCIWorld19122BroadBasedIndexMember2016-09-012021-09-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19122AdditionalIndexMember2016-09-012021-09-300000102816eatonvance:EATONVANCEIndexSP50019122AdditionalIndexMember2016-09-012021-09-300000102816eatonvance:C000014191Member2016-09-012021-10-310000102816eatonvance:EATONVANCEIndexMSCIWorld19122BroadBasedIndexMember2016-09-012021-10-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19122AdditionalIndexMember2016-09-012021-10-310000102816eatonvance:EATONVANCEIndexSP50019122AdditionalIndexMember2016-09-012021-10-310000102816eatonvance:C000014191Member2016-09-012021-11-300000102816eatonvance:EATONVANCEIndexMSCIWorld19122BroadBasedIndexMember2016-09-012021-11-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19122AdditionalIndexMember2016-09-012021-11-300000102816eatonvance:EATONVANCEIndexSP50019122AdditionalIndexMember2016-09-012021-11-300000102816eatonvance:C000014191Member2016-09-012021-12-310000102816eatonvance:EATONVANCEIndexMSCIWorld19122BroadBasedIndexMember2016-09-012021-12-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19122AdditionalIndexMember2016-09-012021-12-310000102816eatonvance:EATONVANCEIndexSP50019122AdditionalIndexMember2016-09-012021-12-310000102816eatonvance:C000014191Member2016-09-012022-01-310000102816eatonvance:EATONVANCEIndexMSCIWorld19122BroadBasedIndexMember2016-09-012022-01-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19122AdditionalIndexMember2016-09-012022-01-310000102816eatonvance:EATONVANCEIndexSP50019122AdditionalIndexMember2016-09-012022-01-310000102816eatonvance:C000014191Member2016-09-012022-02-280000102816eatonvance:EATONVANCEIndexMSCIWorld19122BroadBasedIndexMember2016-09-012022-02-280000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19122AdditionalIndexMember2016-09-012022-02-280000102816eatonvance:EATONVANCEIndexSP50019122AdditionalIndexMember2016-09-012022-02-280000102816eatonvance:C000014191Member2016-09-012022-03-310000102816eatonvance:EATONVANCEIndexMSCIWorld19122BroadBasedIndexMember2016-09-012022-03-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19122AdditionalIndexMember2016-09-012022-03-310000102816eatonvance:EATONVANCEIndexSP50019122AdditionalIndexMember2016-09-012022-03-310000102816eatonvance:C000014191Member2016-09-012022-04-300000102816eatonvance:EATONVANCEIndexMSCIWorld19122BroadBasedIndexMember2016-09-012022-04-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19122AdditionalIndexMember2016-09-012022-04-300000102816eatonvance:EATONVANCEIndexSP50019122AdditionalIndexMember2016-09-012022-04-300000102816eatonvance:C000014191Member2016-09-012022-05-310000102816eatonvance:EATONVANCEIndexMSCIWorld19122BroadBasedIndexMember2016-09-012022-05-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19122AdditionalIndexMember2016-09-012022-05-310000102816eatonvance:EATONVANCEIndexSP50019122AdditionalIndexMember2016-09-012022-05-310000102816eatonvance:C000014191Member2016-09-012022-06-300000102816eatonvance:EATONVANCEIndexMSCIWorld19122BroadBasedIndexMember2016-09-012022-06-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19122AdditionalIndexMember2016-09-012022-06-300000102816eatonvance:EATONVANCEIndexSP50019122AdditionalIndexMember2016-09-012022-06-300000102816eatonvance:C000014191Member2016-09-012022-07-310000102816eatonvance:EATONVANCEIndexMSCIWorld19122BroadBasedIndexMember2016-09-012022-07-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19122AdditionalIndexMember2016-09-012022-07-310000102816eatonvance:EATONVANCEIndexSP50019122AdditionalIndexMember2016-09-012022-07-310000102816eatonvance:C000014191Member2016-09-012022-08-310000102816eatonvance:EATONVANCEIndexMSCIWorld19122BroadBasedIndexMember2016-09-012022-08-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19122AdditionalIndexMember2016-09-012022-08-310000102816eatonvance:EATONVANCEIndexSP50019122AdditionalIndexMember2016-09-012022-08-310000102816eatonvance:C000014191Member2016-09-012022-09-300000102816eatonvance:EATONVANCEIndexMSCIWorld19122BroadBasedIndexMember2016-09-012022-09-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19122AdditionalIndexMember2016-09-012022-09-300000102816eatonvance:EATONVANCEIndexSP50019122AdditionalIndexMember2016-09-012022-09-300000102816eatonvance:C000014191Member2016-09-012022-10-310000102816eatonvance:EATONVANCEIndexMSCIWorld19122BroadBasedIndexMember2016-09-012022-10-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19122AdditionalIndexMember2016-09-012022-10-310000102816eatonvance:EATONVANCEIndexSP50019122AdditionalIndexMember2016-09-012022-10-310000102816eatonvance:C000014191Member2016-09-012022-11-300000102816eatonvance:EATONVANCEIndexMSCIWorld19122BroadBasedIndexMember2016-09-012022-11-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19122AdditionalIndexMember2016-09-012022-11-300000102816eatonvance:EATONVANCEIndexSP50019122AdditionalIndexMember2016-09-012022-11-300000102816eatonvance:C000014191Member2016-09-012022-12-310000102816eatonvance:EATONVANCEIndexMSCIWorld19122BroadBasedIndexMember2016-09-012022-12-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19122AdditionalIndexMember2016-09-012022-12-310000102816eatonvance:EATONVANCEIndexSP50019122AdditionalIndexMember2016-09-012022-12-310000102816eatonvance:C000014191Member2016-09-012023-01-310000102816eatonvance:EATONVANCEIndexMSCIWorld19122BroadBasedIndexMember2016-09-012023-01-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19122AdditionalIndexMember2016-09-012023-01-310000102816eatonvance:EATONVANCEIndexSP50019122AdditionalIndexMember2016-09-012023-01-310000102816eatonvance:C000014191Member2016-09-012023-02-280000102816eatonvance:EATONVANCEIndexMSCIWorld19122BroadBasedIndexMember2016-09-012023-02-280000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19122AdditionalIndexMember2016-09-012023-02-280000102816eatonvance:EATONVANCEIndexSP50019122AdditionalIndexMember2016-09-012023-02-280000102816eatonvance:C000014191Member2016-09-012023-03-310000102816eatonvance:EATONVANCEIndexMSCIWorld19122BroadBasedIndexMember2016-09-012023-03-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19122AdditionalIndexMember2016-09-012023-03-310000102816eatonvance:EATONVANCEIndexSP50019122AdditionalIndexMember2016-09-012023-03-310000102816eatonvance:C000014191Member2016-09-012023-04-300000102816eatonvance:EATONVANCEIndexMSCIWorld19122BroadBasedIndexMember2016-09-012023-04-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19122AdditionalIndexMember2016-09-012023-04-300000102816eatonvance:EATONVANCEIndexSP50019122AdditionalIndexMember2016-09-012023-04-300000102816eatonvance:C000014191Member2016-09-012023-05-310000102816eatonvance:EATONVANCEIndexMSCIWorld19122BroadBasedIndexMember2016-09-012023-05-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19122AdditionalIndexMember2016-09-012023-05-310000102816eatonvance:EATONVANCEIndexSP50019122AdditionalIndexMember2016-09-012023-05-310000102816eatonvance:C000014191Member2016-09-012023-06-300000102816eatonvance:EATONVANCEIndexMSCIWorld19122BroadBasedIndexMember2016-09-012023-06-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19122AdditionalIndexMember2016-09-012023-06-300000102816eatonvance:EATONVANCEIndexSP50019122AdditionalIndexMember2016-09-012023-06-300000102816eatonvance:C000014191Member2016-09-012023-07-310000102816eatonvance:EATONVANCEIndexMSCIWorld19122BroadBasedIndexMember2016-09-012023-07-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19122AdditionalIndexMember2016-09-012023-07-310000102816eatonvance:EATONVANCEIndexSP50019122AdditionalIndexMember2016-09-012023-07-310000102816eatonvance:C000014191Member2016-09-012023-08-310000102816eatonvance:EATONVANCEIndexMSCIWorld19122BroadBasedIndexMember2016-09-012023-08-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19122AdditionalIndexMember2016-09-012023-08-310000102816eatonvance:EATONVANCEIndexSP50019122AdditionalIndexMember2016-09-012023-08-310000102816eatonvance:C000014191Member2016-09-012023-09-300000102816eatonvance:EATONVANCEIndexMSCIWorld19122BroadBasedIndexMember2016-09-012023-09-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19122AdditionalIndexMember2016-09-012023-09-300000102816eatonvance:EATONVANCEIndexSP50019122AdditionalIndexMember2016-09-012023-09-300000102816eatonvance:C000014191Member2016-09-012023-10-310000102816eatonvance:EATONVANCEIndexMSCIWorld19122BroadBasedIndexMember2016-09-012023-10-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19122AdditionalIndexMember2016-09-012023-10-310000102816eatonvance:EATONVANCEIndexSP50019122AdditionalIndexMember2016-09-012023-10-310000102816eatonvance:C000014191Member2016-09-012023-11-300000102816eatonvance:EATONVANCEIndexMSCIWorld19122BroadBasedIndexMember2016-09-012023-11-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19122AdditionalIndexMember2016-09-012023-11-300000102816eatonvance:EATONVANCEIndexSP50019122AdditionalIndexMember2016-09-012023-11-300000102816eatonvance:C000014191Member2016-09-012023-12-310000102816eatonvance:EATONVANCEIndexMSCIWorld19122BroadBasedIndexMember2016-09-012023-12-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19122AdditionalIndexMember2016-09-012023-12-310000102816eatonvance:EATONVANCEIndexSP50019122AdditionalIndexMember2016-09-012023-12-310000102816eatonvance:C000014191Member2016-09-012024-01-310000102816eatonvance:EATONVANCEIndexMSCIWorld19122BroadBasedIndexMember2016-09-012024-01-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19122AdditionalIndexMember2016-09-012024-01-310000102816eatonvance:EATONVANCEIndexSP50019122AdditionalIndexMember2016-09-012024-01-310000102816eatonvance:C000014191Member2016-09-012024-02-290000102816eatonvance:EATONVANCEIndexMSCIWorld19122BroadBasedIndexMember2016-09-012024-02-290000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19122AdditionalIndexMember2016-09-012024-02-290000102816eatonvance:EATONVANCEIndexSP50019122AdditionalIndexMember2016-09-012024-02-290000102816eatonvance:C000014191Member2016-09-012024-03-310000102816eatonvance:EATONVANCEIndexMSCIWorld19122BroadBasedIndexMember2016-09-012024-03-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19122AdditionalIndexMember2016-09-012024-03-310000102816eatonvance:EATONVANCEIndexSP50019122AdditionalIndexMember2016-09-012024-03-310000102816eatonvance:C000014191Member2016-09-012024-04-300000102816eatonvance:EATONVANCEIndexMSCIWorld19122BroadBasedIndexMember2016-09-012024-04-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19122AdditionalIndexMember2016-09-012024-04-300000102816eatonvance:EATONVANCEIndexSP50019122AdditionalIndexMember2016-09-012024-04-300000102816eatonvance:C000014191Member2016-09-012024-05-310000102816eatonvance:EATONVANCEIndexMSCIWorld19122BroadBasedIndexMember2016-09-012024-05-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19122AdditionalIndexMember2016-09-012024-05-310000102816eatonvance:EATONVANCEIndexSP50019122AdditionalIndexMember2016-09-012024-05-310000102816eatonvance:C000014191Member2016-09-012024-06-300000102816eatonvance:EATONVANCEIndexMSCIWorld19122BroadBasedIndexMember2016-09-012024-06-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19122AdditionalIndexMember2016-09-012024-06-300000102816eatonvance:EATONVANCEIndexSP50019122AdditionalIndexMember2016-09-012024-06-300000102816eatonvance:C000014191Member2016-09-012024-07-310000102816eatonvance:EATONVANCEIndexMSCIWorld19122BroadBasedIndexMember2016-09-012024-07-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19122AdditionalIndexMember2016-09-012024-07-310000102816eatonvance:EATONVANCEIndexSP50019122AdditionalIndexMember2016-09-012024-07-310000102816eatonvance:C000014191Member2016-09-012024-08-310000102816eatonvance:EATONVANCEIndexMSCIWorld19122BroadBasedIndexMember2016-09-012024-08-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19122AdditionalIndexMember2016-09-012024-08-310000102816eatonvance:EATONVANCEIndexSP50019122AdditionalIndexMember2016-09-012024-08-310000102816eatonvance:C000014191Member2016-09-012024-09-300000102816eatonvance:EATONVANCEIndexMSCIWorld19122BroadBasedIndexMember2016-09-012024-09-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19122AdditionalIndexMember2016-09-012024-09-300000102816eatonvance:EATONVANCEIndexSP50019122AdditionalIndexMember2016-09-012024-09-300000102816eatonvance:C000014191Member2016-09-012024-10-310000102816eatonvance:EATONVANCEIndexMSCIWorld19122BroadBasedIndexMember2016-09-012024-10-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19122AdditionalIndexMember2016-09-012024-10-310000102816eatonvance:EATONVANCEIndexSP50019122AdditionalIndexMember2016-09-012024-10-310000102816eatonvance:C000014191Member2016-09-012024-11-300000102816eatonvance:EATONVANCEIndexMSCIWorld19122BroadBasedIndexMember2016-09-012024-11-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19122AdditionalIndexMember2016-09-012024-11-300000102816eatonvance:EATONVANCEIndexSP50019122AdditionalIndexMember2016-09-012024-11-300000102816eatonvance:C000014191Member2016-09-012024-12-310000102816eatonvance:EATONVANCEIndexMSCIWorld19122BroadBasedIndexMember2016-09-012024-12-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19122AdditionalIndexMember2016-09-012024-12-310000102816eatonvance:EATONVANCEIndexSP50019122AdditionalIndexMember2016-09-012024-12-310000102816eatonvance:C000014191Member2016-09-012025-01-310000102816eatonvance:EATONVANCEIndexMSCIWorld19122BroadBasedIndexMember2016-09-012025-01-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19122AdditionalIndexMember2016-09-012025-01-310000102816eatonvance:EATONVANCEIndexSP50019122AdditionalIndexMember2016-09-012025-01-310000102816eatonvance:C000014191Member2016-09-012025-02-280000102816eatonvance:EATONVANCEIndexMSCIWorld19122BroadBasedIndexMember2016-09-012025-02-280000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19122AdditionalIndexMember2016-09-012025-02-280000102816eatonvance:EATONVANCEIndexSP50019122AdditionalIndexMember2016-09-012025-02-280000102816eatonvance:C000014191Member2016-09-012025-03-310000102816eatonvance:EATONVANCEIndexMSCIWorld19122BroadBasedIndexMember2016-09-012025-03-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19122AdditionalIndexMember2016-09-012025-03-310000102816eatonvance:EATONVANCEIndexSP50019122AdditionalIndexMember2016-09-012025-03-310000102816eatonvance:C000014191Member2016-09-012025-04-300000102816eatonvance:EATONVANCEIndexMSCIWorld19122BroadBasedIndexMember2016-09-012025-04-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19122AdditionalIndexMember2016-09-012025-04-300000102816eatonvance:EATONVANCEIndexSP50019122AdditionalIndexMember2016-09-012025-04-300000102816eatonvance:C000014191Member2016-09-012025-05-310000102816eatonvance:EATONVANCEIndexMSCIWorld19122BroadBasedIndexMember2016-09-012025-05-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19122AdditionalIndexMember2016-09-012025-05-310000102816eatonvance:EATONVANCEIndexSP50019122AdditionalIndexMember2016-09-012025-05-310000102816eatonvance:C000014191Member2016-09-012025-06-300000102816eatonvance:EATONVANCEIndexMSCIWorld19122BroadBasedIndexMember2016-09-012025-06-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19122AdditionalIndexMember2016-09-012025-06-300000102816eatonvance:EATONVANCEIndexSP50019122AdditionalIndexMember2016-09-012025-06-300000102816eatonvance:C000014191Member2016-09-012025-07-310000102816eatonvance:EATONVANCEIndexMSCIWorld19122BroadBasedIndexMember2016-09-012025-07-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19122AdditionalIndexMember2016-09-012025-07-310000102816eatonvance:EATONVANCEIndexSP50019122AdditionalIndexMember2016-09-012025-07-310000102816eatonvance:C000014191Member2016-09-012025-08-310000102816eatonvance:EATONVANCEIndexMSCIWorld19122BroadBasedIndexMember2016-09-012025-08-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19122AdditionalIndexMember2016-09-012025-08-310000102816eatonvance:EATONVANCEIndexSP50019122AdditionalIndexMember2016-09-012025-08-310000102816eatonvance:C000014191Member2016-09-012025-09-300000102816eatonvance:EATONVANCEIndexMSCIWorld19122BroadBasedIndexMember2016-09-012025-09-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19122AdditionalIndexMember2016-09-012025-09-300000102816eatonvance:EATONVANCEIndexSP50019122AdditionalIndexMember2016-09-012025-09-300000102816eatonvance:C000014191Member2016-09-012025-10-310000102816eatonvance:EATONVANCEIndexMSCIWorld19122BroadBasedIndexMember2016-09-012025-10-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19122AdditionalIndexMember2016-09-012025-10-310000102816eatonvance:EATONVANCEIndexSP50019122AdditionalIndexMember2016-09-012025-10-310000102816eatonvance:C000014191Member2016-09-012025-11-300000102816eatonvance:EATONVANCEIndexMSCIWorld19122BroadBasedIndexMember2016-09-012025-11-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19122AdditionalIndexMember2016-09-012025-11-300000102816eatonvance:EATONVANCEIndexSP50019122AdditionalIndexMember2016-09-012025-11-300000102816eatonvance:C000014191Member2016-09-012025-12-310000102816eatonvance:EATONVANCEIndexMSCIWorld19122BroadBasedIndexMember2016-09-012025-12-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19122AdditionalIndexMember2016-09-012025-12-310000102816eatonvance:EATONVANCEIndexSP50019122AdditionalIndexMember2016-09-012025-12-310000102816eatonvance:C000014191Member2016-09-012026-01-310000102816eatonvance:EATONVANCEIndexMSCIWorld19122BroadBasedIndexMember2016-09-012026-01-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19122AdditionalIndexMember2016-09-012026-01-310000102816eatonvance:EATONVANCEIndexSP50019122AdditionalIndexMember2016-09-012026-01-310000102816eatonvance:C000014191Member2016-09-012026-02-280000102816eatonvance:EATONVANCEIndexMSCIWorld19122BroadBasedIndexMember2016-09-012026-02-280000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19122AdditionalIndexMember2016-09-012026-02-280000102816eatonvance:EATONVANCEIndexSP50019122AdditionalIndexMember2016-09-012026-02-280000102816eatonvance:C000014191Member2016-09-012026-03-310000102816eatonvance:EATONVANCEIndexMSCIWorld19122BroadBasedIndexMember2016-09-012026-03-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19122AdditionalIndexMember2016-09-012026-03-310000102816eatonvance:EATONVANCEIndexSP50019122AdditionalIndexMember2016-09-012026-03-310000102816eatonvance:C000014191Member2016-09-012026-04-300000102816eatonvance:EATONVANCEIndexMSCIWorld19122BroadBasedIndexMember2016-09-012026-04-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19122AdditionalIndexMember2016-09-012026-04-300000102816eatonvance:EATONVANCEIndexSP50019122AdditionalIndexMember2016-09-012026-04-300000102816eatonvance:C000014191Member2016-09-012026-05-310000102816eatonvance:EATONVANCEIndexMSCIWorld19122BroadBasedIndexMember2016-09-012026-05-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19122AdditionalIndexMember2016-09-012026-05-310000102816eatonvance:EATONVANCEIndexSP50019122AdditionalIndexMember2016-09-012026-05-310000102816eatonvance:C000014191Member2016-09-012026-06-300000102816eatonvance:EATONVANCEIndexMSCIWorld19122BroadBasedIndexMember2016-09-012026-06-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19122AdditionalIndexMember2016-09-012026-06-300000102816eatonvance:EATONVANCEIndexSP50019122AdditionalIndexMember2016-09-012026-06-300000102816eatonvance:C000014191Member2016-09-012026-07-310000102816eatonvance:EATONVANCEIndexMSCIWorld19122BroadBasedIndexMember2016-09-012026-07-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19122AdditionalIndexMember2016-09-012026-07-310000102816eatonvance:EATONVANCEIndexSP50019122AdditionalIndexMember2016-09-012026-07-310000102816eatonvance:C000014191Member2016-09-012026-08-310000102816eatonvance:EATONVANCEIndexMSCIWorld19122BroadBasedIndexMember2016-09-012026-08-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19122AdditionalIndexMember2016-09-012026-08-310000102816eatonvance:EATONVANCEIndexSP50019122AdditionalIndexMember2016-09-012026-08-310000102816eatonvance:C000014191Memberoef:WithoutSalesLoadMember2025-09-012026-08-310000102816eatonvance:C000014191Memberoef:WithoutSalesLoadMember2021-09-012026-08-310000102816eatonvance:C000014191Memberoef:WithoutSalesLoadMember2016-09-012026-08-310000102816eatonvance:C000014191Member2021-09-012026-08-310000102816eatonvance:EATONVANCEIndexMSCIWorld19122BroadBasedIndexMember2021-09-012026-08-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19122AdditionalIndexMember2021-09-012026-08-310000102816eatonvance:EATONVANCEIndexSP50019122AdditionalIndexMember2021-09-012026-08-310000102816eatonvance:C000014191Member2026-08-310000102816eatonvance:C000014191Membereatonvance:ShortMinusTermInvestmentsSectorMember2026-08-310000102816eatonvance:C000014191Membereatonvance:HealthCareTechnologySectorMember2026-08-310000102816eatonvance:C000014191Membereatonvance:HealthCareSuppliesSectorMember2026-08-310000102816eatonvance:C000014191Membereatonvance:HealthCareServicesSectorMember2026-08-310000102816eatonvance:C000014191Membereatonvance:ManagedHealthCareSectorMember2026-08-310000102816eatonvance:C000014191Membereatonvance:LifeSciencesToolsServicesSectorMember2026-08-310000102816eatonvance:C000014191Membereatonvance:HealthCareEquipmentSectorMember2026-08-310000102816eatonvance:C000014191Membereatonvance:BiotechnologySectorMember2026-08-310000102816eatonvance:C000014191Membereatonvance:PharmaceuticalsSectorMember2026-08-310000102816eatonvance:C000014191Membereatonvance:FR532457108CTIMember2026-08-310000102816eatonvance:C000014191Membereatonvance:FR478160104CTIMember2026-08-310000102816eatonvance:C000014191Membereatonvance:FR00287Y109CTIMember2026-08-310000102816eatonvance:C000014191Membereatonvance:FR58933Y105CTIMember2026-08-310000102816eatonvance:C000014191Membereatonvance:FRACI38LVK6CTIMember2026-08-310000102816eatonvance:C000014191Membereatonvance:FR91324P102CTIMember2026-08-310000102816eatonvance:C000014191Membereatonvance:FR098952906CTIMember2026-08-310000102816eatonvance:C000014191Membereatonvance:FR110122108CTIMember2026-08-310000102816eatonvance:C000014191Membereatonvance:FR92532F100CTIMember2026-08-310000102816eatonvance:C000014191Membereatonvance:FR002824100CTIMember2026-08-310000102816eatonvance:C000014191Membereatonvance:AbbottLaboratoriesCTIMember2026-08-310000102816eatonvance:C000014193Member2025-09-012026-08-310000102816eatonvance:EATONVANCEIndexMSCIWorld19197BroadBasedIndexMember2025-09-012026-08-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19197AdditionalIndexMember2025-09-012026-08-310000102816eatonvance:EATONVANCEIndexSP50019197AdditionalIndexMember2025-09-012026-08-310000102816eatonvance:C000014193Member2016-08-312016-08-310000102816eatonvance:EATONVANCEIndexMSCIWorld19197BroadBasedIndexMember2016-08-312016-08-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19197AdditionalIndexMember2016-08-312016-08-310000102816eatonvance:EATONVANCEIndexSP50019197AdditionalIndexMember2016-08-312016-08-310000102816eatonvance:C000014193Member2016-09-012016-09-300000102816eatonvance:EATONVANCEIndexMSCIWorld19197BroadBasedIndexMember2016-09-012016-09-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19197AdditionalIndexMember2016-09-012016-09-300000102816eatonvance:EATONVANCEIndexSP50019197AdditionalIndexMember2016-09-012016-09-300000102816eatonvance:C000014193Member2016-09-012016-10-310000102816eatonvance:EATONVANCEIndexMSCIWorld19197BroadBasedIndexMember2016-09-012016-10-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19197AdditionalIndexMember2016-09-012016-10-310000102816eatonvance:EATONVANCEIndexSP50019197AdditionalIndexMember2016-09-012016-10-310000102816eatonvance:C000014193Member2016-09-012016-11-300000102816eatonvance:EATONVANCEIndexMSCIWorld19197BroadBasedIndexMember2016-09-012016-11-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19197AdditionalIndexMember2016-09-012016-11-300000102816eatonvance:EATONVANCEIndexSP50019197AdditionalIndexMember2016-09-012016-11-300000102816eatonvance:C000014193Member2016-09-012016-12-310000102816eatonvance:EATONVANCEIndexMSCIWorld19197BroadBasedIndexMember2016-09-012016-12-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19197AdditionalIndexMember2016-09-012016-12-310000102816eatonvance:EATONVANCEIndexSP50019197AdditionalIndexMember2016-09-012016-12-310000102816eatonvance:C000014193Member2016-09-012017-01-310000102816eatonvance:EATONVANCEIndexMSCIWorld19197BroadBasedIndexMember2016-09-012017-01-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19197AdditionalIndexMember2016-09-012017-01-310000102816eatonvance:EATONVANCEIndexSP50019197AdditionalIndexMember2016-09-012017-01-310000102816eatonvance:C000014193Member2016-09-012017-02-280000102816eatonvance:EATONVANCEIndexMSCIWorld19197BroadBasedIndexMember2016-09-012017-02-280000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19197AdditionalIndexMember2016-09-012017-02-280000102816eatonvance:EATONVANCEIndexSP50019197AdditionalIndexMember2016-09-012017-02-280000102816eatonvance:C000014193Member2016-09-012017-03-310000102816eatonvance:EATONVANCEIndexMSCIWorld19197BroadBasedIndexMember2016-09-012017-03-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19197AdditionalIndexMember2016-09-012017-03-310000102816eatonvance:EATONVANCEIndexSP50019197AdditionalIndexMember2016-09-012017-03-310000102816eatonvance:C000014193Member2016-09-012017-04-300000102816eatonvance:EATONVANCEIndexMSCIWorld19197BroadBasedIndexMember2016-09-012017-04-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19197AdditionalIndexMember2016-09-012017-04-300000102816eatonvance:EATONVANCEIndexSP50019197AdditionalIndexMember2016-09-012017-04-300000102816eatonvance:C000014193Member2016-09-012017-05-310000102816eatonvance:EATONVANCEIndexMSCIWorld19197BroadBasedIndexMember2016-09-012017-05-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19197AdditionalIndexMember2016-09-012017-05-310000102816eatonvance:EATONVANCEIndexSP50019197AdditionalIndexMember2016-09-012017-05-310000102816eatonvance:C000014193Member2016-09-012017-06-300000102816eatonvance:EATONVANCEIndexMSCIWorld19197BroadBasedIndexMember2016-09-012017-06-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19197AdditionalIndexMember2016-09-012017-06-300000102816eatonvance:EATONVANCEIndexSP50019197AdditionalIndexMember2016-09-012017-06-300000102816eatonvance:C000014193Member2016-09-012017-07-310000102816eatonvance:EATONVANCEIndexMSCIWorld19197BroadBasedIndexMember2016-09-012017-07-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19197AdditionalIndexMember2016-09-012017-07-310000102816eatonvance:EATONVANCEIndexSP50019197AdditionalIndexMember2016-09-012017-07-310000102816eatonvance:C000014193Member2016-09-012017-08-310000102816eatonvance:EATONVANCEIndexMSCIWorld19197BroadBasedIndexMember2016-09-012017-08-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19197AdditionalIndexMember2016-09-012017-08-310000102816eatonvance:EATONVANCEIndexSP50019197AdditionalIndexMember2016-09-012017-08-310000102816eatonvance:C000014193Member2016-09-012017-09-300000102816eatonvance:EATONVANCEIndexMSCIWorld19197BroadBasedIndexMember2016-09-012017-09-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19197AdditionalIndexMember2016-09-012017-09-300000102816eatonvance:EATONVANCEIndexSP50019197AdditionalIndexMember2016-09-012017-09-300000102816eatonvance:C000014193Member2016-09-012017-10-310000102816eatonvance:EATONVANCEIndexMSCIWorld19197BroadBasedIndexMember2016-09-012017-10-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19197AdditionalIndexMember2016-09-012017-10-310000102816eatonvance:EATONVANCEIndexSP50019197AdditionalIndexMember2016-09-012017-10-310000102816eatonvance:C000014193Member2016-09-012017-11-300000102816eatonvance:EATONVANCEIndexMSCIWorld19197BroadBasedIndexMember2016-09-012017-11-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19197AdditionalIndexMember2016-09-012017-11-300000102816eatonvance:EATONVANCEIndexSP50019197AdditionalIndexMember2016-09-012017-11-300000102816eatonvance:C000014193Member2016-09-012017-12-310000102816eatonvance:EATONVANCEIndexMSCIWorld19197BroadBasedIndexMember2016-09-012017-12-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19197AdditionalIndexMember2016-09-012017-12-310000102816eatonvance:EATONVANCEIndexSP50019197AdditionalIndexMember2016-09-012017-12-310000102816eatonvance:C000014193Member2016-09-012018-01-310000102816eatonvance:EATONVANCEIndexMSCIWorld19197BroadBasedIndexMember2016-09-012018-01-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19197AdditionalIndexMember2016-09-012018-01-310000102816eatonvance:EATONVANCEIndexSP50019197AdditionalIndexMember2016-09-012018-01-310000102816eatonvance:C000014193Member2016-09-012018-02-280000102816eatonvance:EATONVANCEIndexMSCIWorld19197BroadBasedIndexMember2016-09-012018-02-280000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19197AdditionalIndexMember2016-09-012018-02-280000102816eatonvance:EATONVANCEIndexSP50019197AdditionalIndexMember2016-09-012018-02-280000102816eatonvance:C000014193Member2016-09-012018-03-310000102816eatonvance:EATONVANCEIndexMSCIWorld19197BroadBasedIndexMember2016-09-012018-03-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19197AdditionalIndexMember2016-09-012018-03-310000102816eatonvance:EATONVANCEIndexSP50019197AdditionalIndexMember2016-09-012018-03-310000102816eatonvance:C000014193Member2016-09-012018-04-300000102816eatonvance:EATONVANCEIndexMSCIWorld19197BroadBasedIndexMember2016-09-012018-04-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19197AdditionalIndexMember2016-09-012018-04-300000102816eatonvance:EATONVANCEIndexSP50019197AdditionalIndexMember2016-09-012018-04-300000102816eatonvance:C000014193Member2016-09-012018-05-310000102816eatonvance:EATONVANCEIndexMSCIWorld19197BroadBasedIndexMember2016-09-012018-05-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19197AdditionalIndexMember2016-09-012018-05-310000102816eatonvance:EATONVANCEIndexSP50019197AdditionalIndexMember2016-09-012018-05-310000102816eatonvance:C000014193Member2016-09-012018-06-300000102816eatonvance:EATONVANCEIndexMSCIWorld19197BroadBasedIndexMember2016-09-012018-06-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19197AdditionalIndexMember2016-09-012018-06-300000102816eatonvance:EATONVANCEIndexSP50019197AdditionalIndexMember2016-09-012018-06-300000102816eatonvance:C000014193Member2016-09-012018-07-310000102816eatonvance:EATONVANCEIndexMSCIWorld19197BroadBasedIndexMember2016-09-012018-07-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19197AdditionalIndexMember2016-09-012018-07-310000102816eatonvance:EATONVANCEIndexSP50019197AdditionalIndexMember2016-09-012018-07-310000102816eatonvance:C000014193Member2016-09-012018-08-310000102816eatonvance:EATONVANCEIndexMSCIWorld19197BroadBasedIndexMember2016-09-012018-08-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19197AdditionalIndexMember2016-09-012018-08-310000102816eatonvance:EATONVANCEIndexSP50019197AdditionalIndexMember2016-09-012018-08-310000102816eatonvance:C000014193Member2016-09-012018-09-300000102816eatonvance:EATONVANCEIndexMSCIWorld19197BroadBasedIndexMember2016-09-012018-09-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19197AdditionalIndexMember2016-09-012018-09-300000102816eatonvance:EATONVANCEIndexSP50019197AdditionalIndexMember2016-09-012018-09-300000102816eatonvance:C000014193Member2016-09-012018-10-310000102816eatonvance:EATONVANCEIndexMSCIWorld19197BroadBasedIndexMember2016-09-012018-10-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19197AdditionalIndexMember2016-09-012018-10-310000102816eatonvance:EATONVANCEIndexSP50019197AdditionalIndexMember2016-09-012018-10-310000102816eatonvance:C000014193Member2016-09-012018-11-300000102816eatonvance:EATONVANCEIndexMSCIWorld19197BroadBasedIndexMember2016-09-012018-11-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19197AdditionalIndexMember2016-09-012018-11-300000102816eatonvance:EATONVANCEIndexSP50019197AdditionalIndexMember2016-09-012018-11-300000102816eatonvance:C000014193Member2016-09-012018-12-310000102816eatonvance:EATONVANCEIndexMSCIWorld19197BroadBasedIndexMember2016-09-012018-12-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19197AdditionalIndexMember2016-09-012018-12-310000102816eatonvance:EATONVANCEIndexSP50019197AdditionalIndexMember2016-09-012018-12-310000102816eatonvance:C000014193Member2016-09-012019-01-310000102816eatonvance:EATONVANCEIndexMSCIWorld19197BroadBasedIndexMember2016-09-012019-01-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19197AdditionalIndexMember2016-09-012019-01-310000102816eatonvance:EATONVANCEIndexSP50019197AdditionalIndexMember2016-09-012019-01-310000102816eatonvance:C000014193Member2016-09-012019-02-280000102816eatonvance:EATONVANCEIndexMSCIWorld19197BroadBasedIndexMember2016-09-012019-02-280000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19197AdditionalIndexMember2016-09-012019-02-280000102816eatonvance:EATONVANCEIndexSP50019197AdditionalIndexMember2016-09-012019-02-280000102816eatonvance:C000014193Member2016-09-012019-03-310000102816eatonvance:EATONVANCEIndexMSCIWorld19197BroadBasedIndexMember2016-09-012019-03-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19197AdditionalIndexMember2016-09-012019-03-310000102816eatonvance:EATONVANCEIndexSP50019197AdditionalIndexMember2016-09-012019-03-310000102816eatonvance:C000014193Member2016-09-012019-04-300000102816eatonvance:EATONVANCEIndexMSCIWorld19197BroadBasedIndexMember2016-09-012019-04-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19197AdditionalIndexMember2016-09-012019-04-300000102816eatonvance:EATONVANCEIndexSP50019197AdditionalIndexMember2016-09-012019-04-300000102816eatonvance:C000014193Member2016-09-012019-05-310000102816eatonvance:EATONVANCEIndexMSCIWorld19197BroadBasedIndexMember2016-09-012019-05-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19197AdditionalIndexMember2016-09-012019-05-310000102816eatonvance:EATONVANCEIndexSP50019197AdditionalIndexMember2016-09-012019-05-310000102816eatonvance:C000014193Member2016-09-012019-06-300000102816eatonvance:EATONVANCEIndexMSCIWorld19197BroadBasedIndexMember2016-09-012019-06-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19197AdditionalIndexMember2016-09-012019-06-300000102816eatonvance:EATONVANCEIndexSP50019197AdditionalIndexMember2016-09-012019-06-300000102816eatonvance:C000014193Member2016-09-012019-07-310000102816eatonvance:EATONVANCEIndexMSCIWorld19197BroadBasedIndexMember2016-09-012019-07-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19197AdditionalIndexMember2016-09-012019-07-310000102816eatonvance:EATONVANCEIndexSP50019197AdditionalIndexMember2016-09-012019-07-310000102816eatonvance:C000014193Member2016-09-012019-08-310000102816eatonvance:EATONVANCEIndexMSCIWorld19197BroadBasedIndexMember2016-09-012019-08-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19197AdditionalIndexMember2016-09-012019-08-310000102816eatonvance:EATONVANCEIndexSP50019197AdditionalIndexMember2016-09-012019-08-310000102816eatonvance:C000014193Member2016-09-012019-09-300000102816eatonvance:EATONVANCEIndexMSCIWorld19197BroadBasedIndexMember2016-09-012019-09-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19197AdditionalIndexMember2016-09-012019-09-300000102816eatonvance:EATONVANCEIndexSP50019197AdditionalIndexMember2016-09-012019-09-300000102816eatonvance:C000014193Member2016-09-012019-10-310000102816eatonvance:EATONVANCEIndexMSCIWorld19197BroadBasedIndexMember2016-09-012019-10-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19197AdditionalIndexMember2016-09-012019-10-310000102816eatonvance:EATONVANCEIndexSP50019197AdditionalIndexMember2016-09-012019-10-310000102816eatonvance:C000014193Member2016-09-012019-11-300000102816eatonvance:EATONVANCEIndexMSCIWorld19197BroadBasedIndexMember2016-09-012019-11-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19197AdditionalIndexMember2016-09-012019-11-300000102816eatonvance:EATONVANCEIndexSP50019197AdditionalIndexMember2016-09-012019-11-300000102816eatonvance:C000014193Member2016-09-012019-12-310000102816eatonvance:EATONVANCEIndexMSCIWorld19197BroadBasedIndexMember2016-09-012019-12-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19197AdditionalIndexMember2016-09-012019-12-310000102816eatonvance:EATONVANCEIndexSP50019197AdditionalIndexMember2016-09-012019-12-310000102816eatonvance:C000014193Member2016-09-012020-01-310000102816eatonvance:EATONVANCEIndexMSCIWorld19197BroadBasedIndexMember2016-09-012020-01-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19197AdditionalIndexMember2016-09-012020-01-310000102816eatonvance:EATONVANCEIndexSP50019197AdditionalIndexMember2016-09-012020-01-310000102816eatonvance:C000014193Member2016-09-012020-02-290000102816eatonvance:EATONVANCEIndexMSCIWorld19197BroadBasedIndexMember2016-09-012020-02-290000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19197AdditionalIndexMember2016-09-012020-02-290000102816eatonvance:EATONVANCEIndexSP50019197AdditionalIndexMember2016-09-012020-02-290000102816eatonvance:C000014193Member2016-09-012020-03-310000102816eatonvance:EATONVANCEIndexMSCIWorld19197BroadBasedIndexMember2016-09-012020-03-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19197AdditionalIndexMember2016-09-012020-03-310000102816eatonvance:EATONVANCEIndexSP50019197AdditionalIndexMember2016-09-012020-03-310000102816eatonvance:C000014193Member2016-09-012020-04-300000102816eatonvance:EATONVANCEIndexMSCIWorld19197BroadBasedIndexMember2016-09-012020-04-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19197AdditionalIndexMember2016-09-012020-04-300000102816eatonvance:EATONVANCEIndexSP50019197AdditionalIndexMember2016-09-012020-04-300000102816eatonvance:C000014193Member2016-09-012020-05-310000102816eatonvance:EATONVANCEIndexMSCIWorld19197BroadBasedIndexMember2016-09-012020-05-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19197AdditionalIndexMember2016-09-012020-05-310000102816eatonvance:EATONVANCEIndexSP50019197AdditionalIndexMember2016-09-012020-05-310000102816eatonvance:C000014193Member2016-09-012020-06-300000102816eatonvance:EATONVANCEIndexMSCIWorld19197BroadBasedIndexMember2016-09-012020-06-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19197AdditionalIndexMember2016-09-012020-06-300000102816eatonvance:EATONVANCEIndexSP50019197AdditionalIndexMember2016-09-012020-06-300000102816eatonvance:C000014193Member2016-09-012020-07-310000102816eatonvance:EATONVANCEIndexMSCIWorld19197BroadBasedIndexMember2016-09-012020-07-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19197AdditionalIndexMember2016-09-012020-07-310000102816eatonvance:EATONVANCEIndexSP50019197AdditionalIndexMember2016-09-012020-07-310000102816eatonvance:C000014193Member2016-09-012020-08-310000102816eatonvance:EATONVANCEIndexMSCIWorld19197BroadBasedIndexMember2016-09-012020-08-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19197AdditionalIndexMember2016-09-012020-08-310000102816eatonvance:EATONVANCEIndexSP50019197AdditionalIndexMember2016-09-012020-08-310000102816eatonvance:C000014193Member2016-09-012020-09-300000102816eatonvance:EATONVANCEIndexMSCIWorld19197BroadBasedIndexMember2016-09-012020-09-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19197AdditionalIndexMember2016-09-012020-09-300000102816eatonvance:EATONVANCEIndexSP50019197AdditionalIndexMember2016-09-012020-09-300000102816eatonvance:C000014193Member2016-09-012020-10-310000102816eatonvance:EATONVANCEIndexMSCIWorld19197BroadBasedIndexMember2016-09-012020-10-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19197AdditionalIndexMember2016-09-012020-10-310000102816eatonvance:EATONVANCEIndexSP50019197AdditionalIndexMember2016-09-012020-10-310000102816eatonvance:C000014193Member2016-09-012020-11-300000102816eatonvance:EATONVANCEIndexMSCIWorld19197BroadBasedIndexMember2016-09-012020-11-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19197AdditionalIndexMember2016-09-012020-11-300000102816eatonvance:EATONVANCEIndexSP50019197AdditionalIndexMember2016-09-012020-11-300000102816eatonvance:C000014193Member2016-09-012020-12-310000102816eatonvance:EATONVANCEIndexMSCIWorld19197BroadBasedIndexMember2016-09-012020-12-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19197AdditionalIndexMember2016-09-012020-12-310000102816eatonvance:EATONVANCEIndexSP50019197AdditionalIndexMember2016-09-012020-12-310000102816eatonvance:C000014193Member2016-09-012021-01-310000102816eatonvance:EATONVANCEIndexMSCIWorld19197BroadBasedIndexMember2016-09-012021-01-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19197AdditionalIndexMember2016-09-012021-01-310000102816eatonvance:EATONVANCEIndexSP50019197AdditionalIndexMember2016-09-012021-01-310000102816eatonvance:C000014193Member2016-09-012021-02-280000102816eatonvance:EATONVANCEIndexMSCIWorld19197BroadBasedIndexMember2016-09-012021-02-280000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19197AdditionalIndexMember2016-09-012021-02-280000102816eatonvance:EATONVANCEIndexSP50019197AdditionalIndexMember2016-09-012021-02-280000102816eatonvance:C000014193Member2016-09-012021-03-310000102816eatonvance:EATONVANCEIndexMSCIWorld19197BroadBasedIndexMember2016-09-012021-03-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19197AdditionalIndexMember2016-09-012021-03-310000102816eatonvance:EATONVANCEIndexSP50019197AdditionalIndexMember2016-09-012021-03-310000102816eatonvance:C000014193Member2016-09-012021-04-300000102816eatonvance:EATONVANCEIndexMSCIWorld19197BroadBasedIndexMember2016-09-012021-04-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19197AdditionalIndexMember2016-09-012021-04-300000102816eatonvance:EATONVANCEIndexSP50019197AdditionalIndexMember2016-09-012021-04-300000102816eatonvance:C000014193Member2016-09-012021-05-310000102816eatonvance:EATONVANCEIndexMSCIWorld19197BroadBasedIndexMember2016-09-012021-05-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19197AdditionalIndexMember2016-09-012021-05-310000102816eatonvance:EATONVANCEIndexSP50019197AdditionalIndexMember2016-09-012021-05-310000102816eatonvance:C000014193Member2016-09-012021-06-300000102816eatonvance:EATONVANCEIndexMSCIWorld19197BroadBasedIndexMember2016-09-012021-06-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19197AdditionalIndexMember2016-09-012021-06-300000102816eatonvance:EATONVANCEIndexSP50019197AdditionalIndexMember2016-09-012021-06-300000102816eatonvance:C000014193Member2016-09-012021-07-310000102816eatonvance:EATONVANCEIndexMSCIWorld19197BroadBasedIndexMember2016-09-012021-07-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19197AdditionalIndexMember2016-09-012021-07-310000102816eatonvance:EATONVANCEIndexSP50019197AdditionalIndexMember2016-09-012021-07-310000102816eatonvance:C000014193Member2016-09-012021-08-310000102816eatonvance:EATONVANCEIndexMSCIWorld19197BroadBasedIndexMember2016-09-012021-08-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19197AdditionalIndexMember2016-09-012021-08-310000102816eatonvance:EATONVANCEIndexSP50019197AdditionalIndexMember2016-09-012021-08-310000102816eatonvance:C000014193Member2016-09-012021-09-300000102816eatonvance:EATONVANCEIndexMSCIWorld19197BroadBasedIndexMember2016-09-012021-09-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19197AdditionalIndexMember2016-09-012021-09-300000102816eatonvance:EATONVANCEIndexSP50019197AdditionalIndexMember2016-09-012021-09-300000102816eatonvance:C000014193Member2016-09-012021-10-310000102816eatonvance:EATONVANCEIndexMSCIWorld19197BroadBasedIndexMember2016-09-012021-10-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19197AdditionalIndexMember2016-09-012021-10-310000102816eatonvance:EATONVANCEIndexSP50019197AdditionalIndexMember2016-09-012021-10-310000102816eatonvance:C000014193Member2016-09-012021-11-300000102816eatonvance:EATONVANCEIndexMSCIWorld19197BroadBasedIndexMember2016-09-012021-11-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19197AdditionalIndexMember2016-09-012021-11-300000102816eatonvance:EATONVANCEIndexSP50019197AdditionalIndexMember2016-09-012021-11-300000102816eatonvance:C000014193Member2016-09-012021-12-310000102816eatonvance:EATONVANCEIndexMSCIWorld19197BroadBasedIndexMember2016-09-012021-12-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19197AdditionalIndexMember2016-09-012021-12-310000102816eatonvance:EATONVANCEIndexSP50019197AdditionalIndexMember2016-09-012021-12-310000102816eatonvance:C000014193Member2016-09-012022-01-310000102816eatonvance:EATONVANCEIndexMSCIWorld19197BroadBasedIndexMember2016-09-012022-01-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19197AdditionalIndexMember2016-09-012022-01-310000102816eatonvance:EATONVANCEIndexSP50019197AdditionalIndexMember2016-09-012022-01-310000102816eatonvance:C000014193Member2016-09-012022-02-280000102816eatonvance:EATONVANCEIndexMSCIWorld19197BroadBasedIndexMember2016-09-012022-02-280000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19197AdditionalIndexMember2016-09-012022-02-280000102816eatonvance:EATONVANCEIndexSP50019197AdditionalIndexMember2016-09-012022-02-280000102816eatonvance:C000014193Member2016-09-012022-03-310000102816eatonvance:EATONVANCEIndexMSCIWorld19197BroadBasedIndexMember2016-09-012022-03-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19197AdditionalIndexMember2016-09-012022-03-310000102816eatonvance:EATONVANCEIndexSP50019197AdditionalIndexMember2016-09-012022-03-310000102816eatonvance:C000014193Member2016-09-012022-04-300000102816eatonvance:EATONVANCEIndexMSCIWorld19197BroadBasedIndexMember2016-09-012022-04-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19197AdditionalIndexMember2016-09-012022-04-300000102816eatonvance:EATONVANCEIndexSP50019197AdditionalIndexMember2016-09-012022-04-300000102816eatonvance:C000014193Member2016-09-012022-05-310000102816eatonvance:EATONVANCEIndexMSCIWorld19197BroadBasedIndexMember2016-09-012022-05-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19197AdditionalIndexMember2016-09-012022-05-310000102816eatonvance:EATONVANCEIndexSP50019197AdditionalIndexMember2016-09-012022-05-310000102816eatonvance:C000014193Member2016-09-012022-06-300000102816eatonvance:EATONVANCEIndexMSCIWorld19197BroadBasedIndexMember2016-09-012022-06-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19197AdditionalIndexMember2016-09-012022-06-300000102816eatonvance:EATONVANCEIndexSP50019197AdditionalIndexMember2016-09-012022-06-300000102816eatonvance:C000014193Member2016-09-012022-07-310000102816eatonvance:EATONVANCEIndexMSCIWorld19197BroadBasedIndexMember2016-09-012022-07-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19197AdditionalIndexMember2016-09-012022-07-310000102816eatonvance:EATONVANCEIndexSP50019197AdditionalIndexMember2016-09-012022-07-310000102816eatonvance:C000014193Member2016-09-012022-08-310000102816eatonvance:EATONVANCEIndexMSCIWorld19197BroadBasedIndexMember2016-09-012022-08-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19197AdditionalIndexMember2016-09-012022-08-310000102816eatonvance:EATONVANCEIndexSP50019197AdditionalIndexMember2016-09-012022-08-310000102816eatonvance:C000014193Member2016-09-012022-09-300000102816eatonvance:EATONVANCEIndexMSCIWorld19197BroadBasedIndexMember2016-09-012022-09-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19197AdditionalIndexMember2016-09-012022-09-300000102816eatonvance:EATONVANCEIndexSP50019197AdditionalIndexMember2016-09-012022-09-300000102816eatonvance:C000014193Member2016-09-012022-10-310000102816eatonvance:EATONVANCEIndexMSCIWorld19197BroadBasedIndexMember2016-09-012022-10-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19197AdditionalIndexMember2016-09-012022-10-310000102816eatonvance:EATONVANCEIndexSP50019197AdditionalIndexMember2016-09-012022-10-310000102816eatonvance:C000014193Member2016-09-012022-11-300000102816eatonvance:EATONVANCEIndexMSCIWorld19197BroadBasedIndexMember2016-09-012022-11-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19197AdditionalIndexMember2016-09-012022-11-300000102816eatonvance:EATONVANCEIndexSP50019197AdditionalIndexMember2016-09-012022-11-300000102816eatonvance:C000014193Member2016-09-012022-12-310000102816eatonvance:EATONVANCEIndexMSCIWorld19197BroadBasedIndexMember2016-09-012022-12-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19197AdditionalIndexMember2016-09-012022-12-310000102816eatonvance:EATONVANCEIndexSP50019197AdditionalIndexMember2016-09-012022-12-310000102816eatonvance:C000014193Member2016-09-012023-01-310000102816eatonvance:EATONVANCEIndexMSCIWorld19197BroadBasedIndexMember2016-09-012023-01-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19197AdditionalIndexMember2016-09-012023-01-310000102816eatonvance:EATONVANCEIndexSP50019197AdditionalIndexMember2016-09-012023-01-310000102816eatonvance:C000014193Member2016-09-012023-02-280000102816eatonvance:EATONVANCEIndexMSCIWorld19197BroadBasedIndexMember2016-09-012023-02-280000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19197AdditionalIndexMember2016-09-012023-02-280000102816eatonvance:EATONVANCEIndexSP50019197AdditionalIndexMember2016-09-012023-02-280000102816eatonvance:C000014193Member2016-09-012023-03-310000102816eatonvance:EATONVANCEIndexMSCIWorld19197BroadBasedIndexMember2016-09-012023-03-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19197AdditionalIndexMember2016-09-012023-03-310000102816eatonvance:EATONVANCEIndexSP50019197AdditionalIndexMember2016-09-012023-03-310000102816eatonvance:C000014193Member2016-09-012023-04-300000102816eatonvance:EATONVANCEIndexMSCIWorld19197BroadBasedIndexMember2016-09-012023-04-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19197AdditionalIndexMember2016-09-012023-04-300000102816eatonvance:EATONVANCEIndexSP50019197AdditionalIndexMember2016-09-012023-04-300000102816eatonvance:C000014193Member2016-09-012023-05-310000102816eatonvance:EATONVANCEIndexMSCIWorld19197BroadBasedIndexMember2016-09-012023-05-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19197AdditionalIndexMember2016-09-012023-05-310000102816eatonvance:EATONVANCEIndexSP50019197AdditionalIndexMember2016-09-012023-05-310000102816eatonvance:C000014193Member2016-09-012023-06-300000102816eatonvance:EATONVANCEIndexMSCIWorld19197BroadBasedIndexMember2016-09-012023-06-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19197AdditionalIndexMember2016-09-012023-06-300000102816eatonvance:EATONVANCEIndexSP50019197AdditionalIndexMember2016-09-012023-06-300000102816eatonvance:C000014193Member2016-09-012023-07-310000102816eatonvance:EATONVANCEIndexMSCIWorld19197BroadBasedIndexMember2016-09-012023-07-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19197AdditionalIndexMember2016-09-012023-07-310000102816eatonvance:EATONVANCEIndexSP50019197AdditionalIndexMember2016-09-012023-07-310000102816eatonvance:C000014193Member2016-09-012023-08-310000102816eatonvance:EATONVANCEIndexMSCIWorld19197BroadBasedIndexMember2016-09-012023-08-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19197AdditionalIndexMember2016-09-012023-08-310000102816eatonvance:EATONVANCEIndexSP50019197AdditionalIndexMember2016-09-012023-08-310000102816eatonvance:C000014193Member2016-09-012023-09-300000102816eatonvance:EATONVANCEIndexMSCIWorld19197BroadBasedIndexMember2016-09-012023-09-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19197AdditionalIndexMember2016-09-012023-09-300000102816eatonvance:EATONVANCEIndexSP50019197AdditionalIndexMember2016-09-012023-09-300000102816eatonvance:C000014193Member2016-09-012023-10-310000102816eatonvance:EATONVANCEIndexMSCIWorld19197BroadBasedIndexMember2016-09-012023-10-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19197AdditionalIndexMember2016-09-012023-10-310000102816eatonvance:EATONVANCEIndexSP50019197AdditionalIndexMember2016-09-012023-10-310000102816eatonvance:C000014193Member2016-09-012023-11-300000102816eatonvance:EATONVANCEIndexMSCIWorld19197BroadBasedIndexMember2016-09-012023-11-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19197AdditionalIndexMember2016-09-012023-11-300000102816eatonvance:EATONVANCEIndexSP50019197AdditionalIndexMember2016-09-012023-11-300000102816eatonvance:C000014193Member2016-09-012023-12-310000102816eatonvance:EATONVANCEIndexMSCIWorld19197BroadBasedIndexMember2016-09-012023-12-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19197AdditionalIndexMember2016-09-012023-12-310000102816eatonvance:EATONVANCEIndexSP50019197AdditionalIndexMember2016-09-012023-12-310000102816eatonvance:C000014193Member2016-09-012024-01-310000102816eatonvance:EATONVANCEIndexMSCIWorld19197BroadBasedIndexMember2016-09-012024-01-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19197AdditionalIndexMember2016-09-012024-01-310000102816eatonvance:EATONVANCEIndexSP50019197AdditionalIndexMember2016-09-012024-01-310000102816eatonvance:C000014193Member2016-09-012024-02-290000102816eatonvance:EATONVANCEIndexMSCIWorld19197BroadBasedIndexMember2016-09-012024-02-290000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19197AdditionalIndexMember2016-09-012024-02-290000102816eatonvance:EATONVANCEIndexSP50019197AdditionalIndexMember2016-09-012024-02-290000102816eatonvance:C000014193Member2016-09-012024-03-310000102816eatonvance:EATONVANCEIndexMSCIWorld19197BroadBasedIndexMember2016-09-012024-03-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19197AdditionalIndexMember2016-09-012024-03-310000102816eatonvance:EATONVANCEIndexSP50019197AdditionalIndexMember2016-09-012024-03-310000102816eatonvance:C000014193Member2016-09-012024-04-300000102816eatonvance:EATONVANCEIndexMSCIWorld19197BroadBasedIndexMember2016-09-012024-04-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19197AdditionalIndexMember2016-09-012024-04-300000102816eatonvance:EATONVANCEIndexSP50019197AdditionalIndexMember2016-09-012024-04-300000102816eatonvance:C000014193Member2016-09-012024-05-310000102816eatonvance:EATONVANCEIndexMSCIWorld19197BroadBasedIndexMember2016-09-012024-05-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19197AdditionalIndexMember2016-09-012024-05-310000102816eatonvance:EATONVANCEIndexSP50019197AdditionalIndexMember2016-09-012024-05-310000102816eatonvance:C000014193Member2016-09-012024-06-300000102816eatonvance:EATONVANCEIndexMSCIWorld19197BroadBasedIndexMember2016-09-012024-06-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19197AdditionalIndexMember2016-09-012024-06-300000102816eatonvance:EATONVANCEIndexSP50019197AdditionalIndexMember2016-09-012024-06-300000102816eatonvance:C000014193Member2016-09-012024-07-310000102816eatonvance:EATONVANCEIndexMSCIWorld19197BroadBasedIndexMember2016-09-012024-07-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19197AdditionalIndexMember2016-09-012024-07-310000102816eatonvance:EATONVANCEIndexSP50019197AdditionalIndexMember2016-09-012024-07-310000102816eatonvance:C000014193Member2016-09-012024-08-310000102816eatonvance:EATONVANCEIndexMSCIWorld19197BroadBasedIndexMember2016-09-012024-08-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19197AdditionalIndexMember2016-09-012024-08-310000102816eatonvance:EATONVANCEIndexSP50019197AdditionalIndexMember2016-09-012024-08-310000102816eatonvance:C000014193Member2016-09-012024-09-300000102816eatonvance:EATONVANCEIndexMSCIWorld19197BroadBasedIndexMember2016-09-012024-09-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19197AdditionalIndexMember2016-09-012024-09-300000102816eatonvance:EATONVANCEIndexSP50019197AdditionalIndexMember2016-09-012024-09-300000102816eatonvance:C000014193Member2016-09-012024-10-310000102816eatonvance:EATONVANCEIndexMSCIWorld19197BroadBasedIndexMember2016-09-012024-10-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19197AdditionalIndexMember2016-09-012024-10-310000102816eatonvance:EATONVANCEIndexSP50019197AdditionalIndexMember2016-09-012024-10-310000102816eatonvance:C000014193Member2016-09-012024-11-300000102816eatonvance:EATONVANCEIndexMSCIWorld19197BroadBasedIndexMember2016-09-012024-11-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19197AdditionalIndexMember2016-09-012024-11-300000102816eatonvance:EATONVANCEIndexSP50019197AdditionalIndexMember2016-09-012024-11-300000102816eatonvance:C000014193Member2016-09-012024-12-310000102816eatonvance:EATONVANCEIndexMSCIWorld19197BroadBasedIndexMember2016-09-012024-12-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19197AdditionalIndexMember2016-09-012024-12-310000102816eatonvance:EATONVANCEIndexSP50019197AdditionalIndexMember2016-09-012024-12-310000102816eatonvance:C000014193Member2016-09-012025-01-310000102816eatonvance:EATONVANCEIndexMSCIWorld19197BroadBasedIndexMember2016-09-012025-01-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19197AdditionalIndexMember2016-09-012025-01-310000102816eatonvance:EATONVANCEIndexSP50019197AdditionalIndexMember2016-09-012025-01-310000102816eatonvance:C000014193Member2016-09-012025-02-280000102816eatonvance:EATONVANCEIndexMSCIWorld19197BroadBasedIndexMember2016-09-012025-02-280000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19197AdditionalIndexMember2016-09-012025-02-280000102816eatonvance:EATONVANCEIndexSP50019197AdditionalIndexMember2016-09-012025-02-280000102816eatonvance:C000014193Member2016-09-012025-03-310000102816eatonvance:EATONVANCEIndexMSCIWorld19197BroadBasedIndexMember2016-09-012025-03-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19197AdditionalIndexMember2016-09-012025-03-310000102816eatonvance:EATONVANCEIndexSP50019197AdditionalIndexMember2016-09-012025-03-310000102816eatonvance:C000014193Member2016-09-012025-04-300000102816eatonvance:EATONVANCEIndexMSCIWorld19197BroadBasedIndexMember2016-09-012025-04-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19197AdditionalIndexMember2016-09-012025-04-300000102816eatonvance:EATONVANCEIndexSP50019197AdditionalIndexMember2016-09-012025-04-300000102816eatonvance:C000014193Member2016-09-012025-05-310000102816eatonvance:EATONVANCEIndexMSCIWorld19197BroadBasedIndexMember2016-09-012025-05-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19197AdditionalIndexMember2016-09-012025-05-310000102816eatonvance:EATONVANCEIndexSP50019197AdditionalIndexMember2016-09-012025-05-310000102816eatonvance:C000014193Member2016-09-012025-06-300000102816eatonvance:EATONVANCEIndexMSCIWorld19197BroadBasedIndexMember2016-09-012025-06-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19197AdditionalIndexMember2016-09-012025-06-300000102816eatonvance:EATONVANCEIndexSP50019197AdditionalIndexMember2016-09-012025-06-300000102816eatonvance:C000014193Member2016-09-012025-07-310000102816eatonvance:EATONVANCEIndexMSCIWorld19197BroadBasedIndexMember2016-09-012025-07-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19197AdditionalIndexMember2016-09-012025-07-310000102816eatonvance:EATONVANCEIndexSP50019197AdditionalIndexMember2016-09-012025-07-310000102816eatonvance:C000014193Member2016-09-012025-08-310000102816eatonvance:EATONVANCEIndexMSCIWorld19197BroadBasedIndexMember2016-09-012025-08-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19197AdditionalIndexMember2016-09-012025-08-310000102816eatonvance:EATONVANCEIndexSP50019197AdditionalIndexMember2016-09-012025-08-310000102816eatonvance:C000014193Member2016-09-012025-09-300000102816eatonvance:EATONVANCEIndexMSCIWorld19197BroadBasedIndexMember2016-09-012025-09-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19197AdditionalIndexMember2016-09-012025-09-300000102816eatonvance:EATONVANCEIndexSP50019197AdditionalIndexMember2016-09-012025-09-300000102816eatonvance:C000014193Member2016-09-012025-10-310000102816eatonvance:EATONVANCEIndexMSCIWorld19197BroadBasedIndexMember2016-09-012025-10-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19197AdditionalIndexMember2016-09-012025-10-310000102816eatonvance:EATONVANCEIndexSP50019197AdditionalIndexMember2016-09-012025-10-310000102816eatonvance:C000014193Member2016-09-012025-11-300000102816eatonvance:EATONVANCEIndexMSCIWorld19197BroadBasedIndexMember2016-09-012025-11-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19197AdditionalIndexMember2016-09-012025-11-300000102816eatonvance:EATONVANCEIndexSP50019197AdditionalIndexMember2016-09-012025-11-300000102816eatonvance:C000014193Member2016-09-012025-12-310000102816eatonvance:EATONVANCEIndexMSCIWorld19197BroadBasedIndexMember2016-09-012025-12-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19197AdditionalIndexMember2016-09-012025-12-310000102816eatonvance:EATONVANCEIndexSP50019197AdditionalIndexMember2016-09-012025-12-310000102816eatonvance:C000014193Member2016-09-012026-01-310000102816eatonvance:EATONVANCEIndexMSCIWorld19197BroadBasedIndexMember2016-09-012026-01-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19197AdditionalIndexMember2016-09-012026-01-310000102816eatonvance:EATONVANCEIndexSP50019197AdditionalIndexMember2016-09-012026-01-310000102816eatonvance:C000014193Member2016-09-012026-02-280000102816eatonvance:EATONVANCEIndexMSCIWorld19197BroadBasedIndexMember2016-09-012026-02-280000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19197AdditionalIndexMember2016-09-012026-02-280000102816eatonvance:EATONVANCEIndexSP50019197AdditionalIndexMember2016-09-012026-02-280000102816eatonvance:C000014193Member2016-09-012026-03-310000102816eatonvance:EATONVANCEIndexMSCIWorld19197BroadBasedIndexMember2016-09-012026-03-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19197AdditionalIndexMember2016-09-012026-03-310000102816eatonvance:EATONVANCEIndexSP50019197AdditionalIndexMember2016-09-012026-03-310000102816eatonvance:C000014193Member2016-09-012026-04-300000102816eatonvance:EATONVANCEIndexMSCIWorld19197BroadBasedIndexMember2016-09-012026-04-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19197AdditionalIndexMember2016-09-012026-04-300000102816eatonvance:EATONVANCEIndexSP50019197AdditionalIndexMember2016-09-012026-04-300000102816eatonvance:C000014193Member2016-09-012026-05-310000102816eatonvance:EATONVANCEIndexMSCIWorld19197BroadBasedIndexMember2016-09-012026-05-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19197AdditionalIndexMember2016-09-012026-05-310000102816eatonvance:EATONVANCEIndexSP50019197AdditionalIndexMember2016-09-012026-05-310000102816eatonvance:C000014193Member2016-09-012026-06-300000102816eatonvance:EATONVANCEIndexMSCIWorld19197BroadBasedIndexMember2016-09-012026-06-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19197AdditionalIndexMember2016-09-012026-06-300000102816eatonvance:EATONVANCEIndexSP50019197AdditionalIndexMember2016-09-012026-06-300000102816eatonvance:C000014193Member2016-09-012026-07-310000102816eatonvance:EATONVANCEIndexMSCIWorld19197BroadBasedIndexMember2016-09-012026-07-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19197AdditionalIndexMember2016-09-012026-07-310000102816eatonvance:EATONVANCEIndexSP50019197AdditionalIndexMember2016-09-012026-07-310000102816eatonvance:C000014193Member2016-09-012026-08-310000102816eatonvance:EATONVANCEIndexMSCIWorld19197BroadBasedIndexMember2016-09-012026-08-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19197AdditionalIndexMember2016-09-012026-08-310000102816eatonvance:EATONVANCEIndexSP50019197AdditionalIndexMember2016-09-012026-08-310000102816eatonvance:C000014193Memberoef:WithoutSalesLoadMember2025-09-012026-08-310000102816eatonvance:C000014193Memberoef:WithoutSalesLoadMember2021-09-012026-08-310000102816eatonvance:C000014193Memberoef:WithoutSalesLoadMember2016-09-012026-08-310000102816eatonvance:C000014193Member2021-09-012026-08-310000102816eatonvance:EATONVANCEIndexMSCIWorld19197BroadBasedIndexMember2021-09-012026-08-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19197AdditionalIndexMember2021-09-012026-08-310000102816eatonvance:EATONVANCEIndexSP50019197AdditionalIndexMember2021-09-012026-08-310000102816eatonvance:C000014193Member2026-08-310000102816eatonvance:C000014193Membereatonvance:ShortMinusTermInvestmentsSectorMember2026-08-310000102816eatonvance:C000014193Membereatonvance:HealthCareTechnologySectorMember2026-08-310000102816eatonvance:C000014193Membereatonvance:HealthCareSuppliesSectorMember2026-08-310000102816eatonvance:C000014193Membereatonvance:HealthCareServicesSectorMember2026-08-310000102816eatonvance:C000014193Membereatonvance:ManagedHealthCareSectorMember2026-08-310000102816eatonvance:C000014193Membereatonvance:LifeSciencesToolsServicesSectorMember2026-08-310000102816eatonvance:C000014193Membereatonvance:HealthCareEquipmentSectorMember2026-08-310000102816eatonvance:C000014193Membereatonvance:BiotechnologySectorMember2026-08-310000102816eatonvance:C000014193Membereatonvance:PharmaceuticalsSectorMember2026-08-310000102816eatonvance:C000014193Membereatonvance:FR532457108CTIMember2026-08-310000102816eatonvance:C000014193Membereatonvance:FR478160104CTIMember2026-08-310000102816eatonvance:C000014193Membereatonvance:FR00287Y109CTIMember2026-08-310000102816eatonvance:C000014193Membereatonvance:FR58933Y105CTIMember2026-08-310000102816eatonvance:C000014193Membereatonvance:FRACI38LVK6CTIMember2026-08-310000102816eatonvance:C000014193Membereatonvance:FR91324P102CTIMember2026-08-310000102816eatonvance:C000014193Membereatonvance:FR098952906CTIMember2026-08-310000102816eatonvance:C000014193Membereatonvance:FR110122108CTIMember2026-08-310000102816eatonvance:C000014193Membereatonvance:FR92532F100CTIMember2026-08-310000102816eatonvance:C000014193Membereatonvance:FR002824100CTIMember2026-08-310000102816eatonvance:C000014193Membereatonvance:AbbottLaboratoriesCTIMember2026-08-310000102816eatonvance:C000081646Member2025-09-012026-08-310000102816eatonvance:EATONVANCEIndexMSCIWorld19312BroadBasedIndexMember2025-09-012026-08-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19312AdditionalIndexMember2025-09-012026-08-310000102816eatonvance:EATONVANCEIndexSP50019312AdditionalIndexMember2025-09-012026-08-310000102816eatonvance:C000081646Member2016-08-312016-08-310000102816eatonvance:EATONVANCEIndexMSCIWorld19312BroadBasedIndexMember2016-08-312016-08-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19312AdditionalIndexMember2016-08-312016-08-310000102816eatonvance:EATONVANCEIndexSP50019312AdditionalIndexMember2016-08-312016-08-310000102816eatonvance:C000081646Member2016-09-012016-09-300000102816eatonvance:EATONVANCEIndexMSCIWorld19312BroadBasedIndexMember2016-09-012016-09-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19312AdditionalIndexMember2016-09-012016-09-300000102816eatonvance:EATONVANCEIndexSP50019312AdditionalIndexMember2016-09-012016-09-300000102816eatonvance:C000081646Member2016-09-012016-10-310000102816eatonvance:EATONVANCEIndexMSCIWorld19312BroadBasedIndexMember2016-09-012016-10-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19312AdditionalIndexMember2016-09-012016-10-310000102816eatonvance:EATONVANCEIndexSP50019312AdditionalIndexMember2016-09-012016-10-310000102816eatonvance:C000081646Member2016-09-012016-11-300000102816eatonvance:EATONVANCEIndexMSCIWorld19312BroadBasedIndexMember2016-09-012016-11-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19312AdditionalIndexMember2016-09-012016-11-300000102816eatonvance:EATONVANCEIndexSP50019312AdditionalIndexMember2016-09-012016-11-300000102816eatonvance:C000081646Member2016-09-012016-12-310000102816eatonvance:EATONVANCEIndexMSCIWorld19312BroadBasedIndexMember2016-09-012016-12-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19312AdditionalIndexMember2016-09-012016-12-310000102816eatonvance:EATONVANCEIndexSP50019312AdditionalIndexMember2016-09-012016-12-310000102816eatonvance:C000081646Member2016-09-012017-01-310000102816eatonvance:EATONVANCEIndexMSCIWorld19312BroadBasedIndexMember2016-09-012017-01-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19312AdditionalIndexMember2016-09-012017-01-310000102816eatonvance:EATONVANCEIndexSP50019312AdditionalIndexMember2016-09-012017-01-310000102816eatonvance:C000081646Member2016-09-012017-02-280000102816eatonvance:EATONVANCEIndexMSCIWorld19312BroadBasedIndexMember2016-09-012017-02-280000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19312AdditionalIndexMember2016-09-012017-02-280000102816eatonvance:EATONVANCEIndexSP50019312AdditionalIndexMember2016-09-012017-02-280000102816eatonvance:C000081646Member2016-09-012017-03-310000102816eatonvance:EATONVANCEIndexMSCIWorld19312BroadBasedIndexMember2016-09-012017-03-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19312AdditionalIndexMember2016-09-012017-03-310000102816eatonvance:EATONVANCEIndexSP50019312AdditionalIndexMember2016-09-012017-03-310000102816eatonvance:C000081646Member2016-09-012017-04-300000102816eatonvance:EATONVANCEIndexMSCIWorld19312BroadBasedIndexMember2016-09-012017-04-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19312AdditionalIndexMember2016-09-012017-04-300000102816eatonvance:EATONVANCEIndexSP50019312AdditionalIndexMember2016-09-012017-04-300000102816eatonvance:C000081646Member2016-09-012017-05-310000102816eatonvance:EATONVANCEIndexMSCIWorld19312BroadBasedIndexMember2016-09-012017-05-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19312AdditionalIndexMember2016-09-012017-05-310000102816eatonvance:EATONVANCEIndexSP50019312AdditionalIndexMember2016-09-012017-05-310000102816eatonvance:C000081646Member2016-09-012017-06-300000102816eatonvance:EATONVANCEIndexMSCIWorld19312BroadBasedIndexMember2016-09-012017-06-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19312AdditionalIndexMember2016-09-012017-06-300000102816eatonvance:EATONVANCEIndexSP50019312AdditionalIndexMember2016-09-012017-06-300000102816eatonvance:C000081646Member2016-09-012017-07-310000102816eatonvance:EATONVANCEIndexMSCIWorld19312BroadBasedIndexMember2016-09-012017-07-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19312AdditionalIndexMember2016-09-012017-07-310000102816eatonvance:EATONVANCEIndexSP50019312AdditionalIndexMember2016-09-012017-07-310000102816eatonvance:C000081646Member2016-09-012017-08-310000102816eatonvance:EATONVANCEIndexMSCIWorld19312BroadBasedIndexMember2016-09-012017-08-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19312AdditionalIndexMember2016-09-012017-08-310000102816eatonvance:EATONVANCEIndexSP50019312AdditionalIndexMember2016-09-012017-08-310000102816eatonvance:C000081646Member2016-09-012017-09-300000102816eatonvance:EATONVANCEIndexMSCIWorld19312BroadBasedIndexMember2016-09-012017-09-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19312AdditionalIndexMember2016-09-012017-09-300000102816eatonvance:EATONVANCEIndexSP50019312AdditionalIndexMember2016-09-012017-09-300000102816eatonvance:C000081646Member2016-09-012017-10-310000102816eatonvance:EATONVANCEIndexMSCIWorld19312BroadBasedIndexMember2016-09-012017-10-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19312AdditionalIndexMember2016-09-012017-10-310000102816eatonvance:EATONVANCEIndexSP50019312AdditionalIndexMember2016-09-012017-10-310000102816eatonvance:C000081646Member2016-09-012017-11-300000102816eatonvance:EATONVANCEIndexMSCIWorld19312BroadBasedIndexMember2016-09-012017-11-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19312AdditionalIndexMember2016-09-012017-11-300000102816eatonvance:EATONVANCEIndexSP50019312AdditionalIndexMember2016-09-012017-11-300000102816eatonvance:C000081646Member2016-09-012017-12-310000102816eatonvance:EATONVANCEIndexMSCIWorld19312BroadBasedIndexMember2016-09-012017-12-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19312AdditionalIndexMember2016-09-012017-12-310000102816eatonvance:EATONVANCEIndexSP50019312AdditionalIndexMember2016-09-012017-12-310000102816eatonvance:C000081646Member2016-09-012018-01-310000102816eatonvance:EATONVANCEIndexMSCIWorld19312BroadBasedIndexMember2016-09-012018-01-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19312AdditionalIndexMember2016-09-012018-01-310000102816eatonvance:EATONVANCEIndexSP50019312AdditionalIndexMember2016-09-012018-01-310000102816eatonvance:C000081646Member2016-09-012018-02-280000102816eatonvance:EATONVANCEIndexMSCIWorld19312BroadBasedIndexMember2016-09-012018-02-280000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19312AdditionalIndexMember2016-09-012018-02-280000102816eatonvance:EATONVANCEIndexSP50019312AdditionalIndexMember2016-09-012018-02-280000102816eatonvance:C000081646Member2016-09-012018-03-310000102816eatonvance:EATONVANCEIndexMSCIWorld19312BroadBasedIndexMember2016-09-012018-03-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19312AdditionalIndexMember2016-09-012018-03-310000102816eatonvance:EATONVANCEIndexSP50019312AdditionalIndexMember2016-09-012018-03-310000102816eatonvance:C000081646Member2016-09-012018-04-300000102816eatonvance:EATONVANCEIndexMSCIWorld19312BroadBasedIndexMember2016-09-012018-04-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19312AdditionalIndexMember2016-09-012018-04-300000102816eatonvance:EATONVANCEIndexSP50019312AdditionalIndexMember2016-09-012018-04-300000102816eatonvance:C000081646Member2016-09-012018-05-310000102816eatonvance:EATONVANCEIndexMSCIWorld19312BroadBasedIndexMember2016-09-012018-05-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19312AdditionalIndexMember2016-09-012018-05-310000102816eatonvance:EATONVANCEIndexSP50019312AdditionalIndexMember2016-09-012018-05-310000102816eatonvance:C000081646Member2016-09-012018-06-300000102816eatonvance:EATONVANCEIndexMSCIWorld19312BroadBasedIndexMember2016-09-012018-06-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19312AdditionalIndexMember2016-09-012018-06-300000102816eatonvance:EATONVANCEIndexSP50019312AdditionalIndexMember2016-09-012018-06-300000102816eatonvance:C000081646Member2016-09-012018-07-310000102816eatonvance:EATONVANCEIndexMSCIWorld19312BroadBasedIndexMember2016-09-012018-07-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19312AdditionalIndexMember2016-09-012018-07-310000102816eatonvance:EATONVANCEIndexSP50019312AdditionalIndexMember2016-09-012018-07-310000102816eatonvance:C000081646Member2016-09-012018-08-310000102816eatonvance:EATONVANCEIndexMSCIWorld19312BroadBasedIndexMember2016-09-012018-08-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19312AdditionalIndexMember2016-09-012018-08-310000102816eatonvance:EATONVANCEIndexSP50019312AdditionalIndexMember2016-09-012018-08-310000102816eatonvance:C000081646Member2016-09-012018-09-300000102816eatonvance:EATONVANCEIndexMSCIWorld19312BroadBasedIndexMember2016-09-012018-09-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19312AdditionalIndexMember2016-09-012018-09-300000102816eatonvance:EATONVANCEIndexSP50019312AdditionalIndexMember2016-09-012018-09-300000102816eatonvance:C000081646Member2016-09-012018-10-310000102816eatonvance:EATONVANCEIndexMSCIWorld19312BroadBasedIndexMember2016-09-012018-10-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19312AdditionalIndexMember2016-09-012018-10-310000102816eatonvance:EATONVANCEIndexSP50019312AdditionalIndexMember2016-09-012018-10-310000102816eatonvance:C000081646Member2016-09-012018-11-300000102816eatonvance:EATONVANCEIndexMSCIWorld19312BroadBasedIndexMember2016-09-012018-11-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19312AdditionalIndexMember2016-09-012018-11-300000102816eatonvance:EATONVANCEIndexSP50019312AdditionalIndexMember2016-09-012018-11-300000102816eatonvance:C000081646Member2016-09-012018-12-310000102816eatonvance:EATONVANCEIndexMSCIWorld19312BroadBasedIndexMember2016-09-012018-12-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19312AdditionalIndexMember2016-09-012018-12-310000102816eatonvance:EATONVANCEIndexSP50019312AdditionalIndexMember2016-09-012018-12-310000102816eatonvance:C000081646Member2016-09-012019-01-310000102816eatonvance:EATONVANCEIndexMSCIWorld19312BroadBasedIndexMember2016-09-012019-01-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19312AdditionalIndexMember2016-09-012019-01-310000102816eatonvance:EATONVANCEIndexSP50019312AdditionalIndexMember2016-09-012019-01-310000102816eatonvance:C000081646Member2016-09-012019-02-280000102816eatonvance:EATONVANCEIndexMSCIWorld19312BroadBasedIndexMember2016-09-012019-02-280000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19312AdditionalIndexMember2016-09-012019-02-280000102816eatonvance:EATONVANCEIndexSP50019312AdditionalIndexMember2016-09-012019-02-280000102816eatonvance:C000081646Member2016-09-012019-03-310000102816eatonvance:EATONVANCEIndexMSCIWorld19312BroadBasedIndexMember2016-09-012019-03-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19312AdditionalIndexMember2016-09-012019-03-310000102816eatonvance:EATONVANCEIndexSP50019312AdditionalIndexMember2016-09-012019-03-310000102816eatonvance:C000081646Member2016-09-012019-04-300000102816eatonvance:EATONVANCEIndexMSCIWorld19312BroadBasedIndexMember2016-09-012019-04-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19312AdditionalIndexMember2016-09-012019-04-300000102816eatonvance:EATONVANCEIndexSP50019312AdditionalIndexMember2016-09-012019-04-300000102816eatonvance:C000081646Member2016-09-012019-05-310000102816eatonvance:EATONVANCEIndexMSCIWorld19312BroadBasedIndexMember2016-09-012019-05-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19312AdditionalIndexMember2016-09-012019-05-310000102816eatonvance:EATONVANCEIndexSP50019312AdditionalIndexMember2016-09-012019-05-310000102816eatonvance:C000081646Member2016-09-012019-06-300000102816eatonvance:EATONVANCEIndexMSCIWorld19312BroadBasedIndexMember2016-09-012019-06-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19312AdditionalIndexMember2016-09-012019-06-300000102816eatonvance:EATONVANCEIndexSP50019312AdditionalIndexMember2016-09-012019-06-300000102816eatonvance:C000081646Member2016-09-012019-07-310000102816eatonvance:EATONVANCEIndexMSCIWorld19312BroadBasedIndexMember2016-09-012019-07-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19312AdditionalIndexMember2016-09-012019-07-310000102816eatonvance:EATONVANCEIndexSP50019312AdditionalIndexMember2016-09-012019-07-310000102816eatonvance:C000081646Member2016-09-012019-08-310000102816eatonvance:EATONVANCEIndexMSCIWorld19312BroadBasedIndexMember2016-09-012019-08-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19312AdditionalIndexMember2016-09-012019-08-310000102816eatonvance:EATONVANCEIndexSP50019312AdditionalIndexMember2016-09-012019-08-310000102816eatonvance:C000081646Member2016-09-012019-09-300000102816eatonvance:EATONVANCEIndexMSCIWorld19312BroadBasedIndexMember2016-09-012019-09-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19312AdditionalIndexMember2016-09-012019-09-300000102816eatonvance:EATONVANCEIndexSP50019312AdditionalIndexMember2016-09-012019-09-300000102816eatonvance:C000081646Member2016-09-012019-10-310000102816eatonvance:EATONVANCEIndexMSCIWorld19312BroadBasedIndexMember2016-09-012019-10-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19312AdditionalIndexMember2016-09-012019-10-310000102816eatonvance:EATONVANCEIndexSP50019312AdditionalIndexMember2016-09-012019-10-310000102816eatonvance:C000081646Member2016-09-012019-11-300000102816eatonvance:EATONVANCEIndexMSCIWorld19312BroadBasedIndexMember2016-09-012019-11-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19312AdditionalIndexMember2016-09-012019-11-300000102816eatonvance:EATONVANCEIndexSP50019312AdditionalIndexMember2016-09-012019-11-300000102816eatonvance:C000081646Member2016-09-012019-12-310000102816eatonvance:EATONVANCEIndexMSCIWorld19312BroadBasedIndexMember2016-09-012019-12-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19312AdditionalIndexMember2016-09-012019-12-310000102816eatonvance:EATONVANCEIndexSP50019312AdditionalIndexMember2016-09-012019-12-310000102816eatonvance:C000081646Member2016-09-012020-01-310000102816eatonvance:EATONVANCEIndexMSCIWorld19312BroadBasedIndexMember2016-09-012020-01-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19312AdditionalIndexMember2016-09-012020-01-310000102816eatonvance:EATONVANCEIndexSP50019312AdditionalIndexMember2016-09-012020-01-310000102816eatonvance:C000081646Member2016-09-012020-02-290000102816eatonvance:EATONVANCEIndexMSCIWorld19312BroadBasedIndexMember2016-09-012020-02-290000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19312AdditionalIndexMember2016-09-012020-02-290000102816eatonvance:EATONVANCEIndexSP50019312AdditionalIndexMember2016-09-012020-02-290000102816eatonvance:C000081646Member2016-09-012020-03-310000102816eatonvance:EATONVANCEIndexMSCIWorld19312BroadBasedIndexMember2016-09-012020-03-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19312AdditionalIndexMember2016-09-012020-03-310000102816eatonvance:EATONVANCEIndexSP50019312AdditionalIndexMember2016-09-012020-03-310000102816eatonvance:C000081646Member2016-09-012020-04-300000102816eatonvance:EATONVANCEIndexMSCIWorld19312BroadBasedIndexMember2016-09-012020-04-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19312AdditionalIndexMember2016-09-012020-04-300000102816eatonvance:EATONVANCEIndexSP50019312AdditionalIndexMember2016-09-012020-04-300000102816eatonvance:C000081646Member2016-09-012020-05-310000102816eatonvance:EATONVANCEIndexMSCIWorld19312BroadBasedIndexMember2016-09-012020-05-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19312AdditionalIndexMember2016-09-012020-05-310000102816eatonvance:EATONVANCEIndexSP50019312AdditionalIndexMember2016-09-012020-05-310000102816eatonvance:C000081646Member2016-09-012020-06-300000102816eatonvance:EATONVANCEIndexMSCIWorld19312BroadBasedIndexMember2016-09-012020-06-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19312AdditionalIndexMember2016-09-012020-06-300000102816eatonvance:EATONVANCEIndexSP50019312AdditionalIndexMember2016-09-012020-06-300000102816eatonvance:C000081646Member2016-09-012020-07-310000102816eatonvance:EATONVANCEIndexMSCIWorld19312BroadBasedIndexMember2016-09-012020-07-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19312AdditionalIndexMember2016-09-012020-07-310000102816eatonvance:EATONVANCEIndexSP50019312AdditionalIndexMember2016-09-012020-07-310000102816eatonvance:C000081646Member2016-09-012020-08-310000102816eatonvance:EATONVANCEIndexMSCIWorld19312BroadBasedIndexMember2016-09-012020-08-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19312AdditionalIndexMember2016-09-012020-08-310000102816eatonvance:EATONVANCEIndexSP50019312AdditionalIndexMember2016-09-012020-08-310000102816eatonvance:C000081646Member2016-09-012020-09-300000102816eatonvance:EATONVANCEIndexMSCIWorld19312BroadBasedIndexMember2016-09-012020-09-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19312AdditionalIndexMember2016-09-012020-09-300000102816eatonvance:EATONVANCEIndexSP50019312AdditionalIndexMember2016-09-012020-09-300000102816eatonvance:C000081646Member2016-09-012020-10-310000102816eatonvance:EATONVANCEIndexMSCIWorld19312BroadBasedIndexMember2016-09-012020-10-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19312AdditionalIndexMember2016-09-012020-10-310000102816eatonvance:EATONVANCEIndexSP50019312AdditionalIndexMember2016-09-012020-10-310000102816eatonvance:C000081646Member2016-09-012020-11-300000102816eatonvance:EATONVANCEIndexMSCIWorld19312BroadBasedIndexMember2016-09-012020-11-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19312AdditionalIndexMember2016-09-012020-11-300000102816eatonvance:EATONVANCEIndexSP50019312AdditionalIndexMember2016-09-012020-11-300000102816eatonvance:C000081646Member2016-09-012020-12-310000102816eatonvance:EATONVANCEIndexMSCIWorld19312BroadBasedIndexMember2016-09-012020-12-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19312AdditionalIndexMember2016-09-012020-12-310000102816eatonvance:EATONVANCEIndexSP50019312AdditionalIndexMember2016-09-012020-12-310000102816eatonvance:C000081646Member2016-09-012021-01-310000102816eatonvance:EATONVANCEIndexMSCIWorld19312BroadBasedIndexMember2016-09-012021-01-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19312AdditionalIndexMember2016-09-012021-01-310000102816eatonvance:EATONVANCEIndexSP50019312AdditionalIndexMember2016-09-012021-01-310000102816eatonvance:C000081646Member2016-09-012021-02-280000102816eatonvance:EATONVANCEIndexMSCIWorld19312BroadBasedIndexMember2016-09-012021-02-280000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19312AdditionalIndexMember2016-09-012021-02-280000102816eatonvance:EATONVANCEIndexSP50019312AdditionalIndexMember2016-09-012021-02-280000102816eatonvance:C000081646Member2016-09-012021-03-310000102816eatonvance:EATONVANCEIndexMSCIWorld19312BroadBasedIndexMember2016-09-012021-03-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19312AdditionalIndexMember2016-09-012021-03-310000102816eatonvance:EATONVANCEIndexSP50019312AdditionalIndexMember2016-09-012021-03-310000102816eatonvance:C000081646Member2016-09-012021-04-300000102816eatonvance:EATONVANCEIndexMSCIWorld19312BroadBasedIndexMember2016-09-012021-04-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19312AdditionalIndexMember2016-09-012021-04-300000102816eatonvance:EATONVANCEIndexSP50019312AdditionalIndexMember2016-09-012021-04-300000102816eatonvance:C000081646Member2016-09-012021-05-310000102816eatonvance:EATONVANCEIndexMSCIWorld19312BroadBasedIndexMember2016-09-012021-05-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19312AdditionalIndexMember2016-09-012021-05-310000102816eatonvance:EATONVANCEIndexSP50019312AdditionalIndexMember2016-09-012021-05-310000102816eatonvance:C000081646Member2016-09-012021-06-300000102816eatonvance:EATONVANCEIndexMSCIWorld19312BroadBasedIndexMember2016-09-012021-06-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19312AdditionalIndexMember2016-09-012021-06-300000102816eatonvance:EATONVANCEIndexSP50019312AdditionalIndexMember2016-09-012021-06-300000102816eatonvance:C000081646Member2016-09-012021-07-310000102816eatonvance:EATONVANCEIndexMSCIWorld19312BroadBasedIndexMember2016-09-012021-07-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19312AdditionalIndexMember2016-09-012021-07-310000102816eatonvance:EATONVANCEIndexSP50019312AdditionalIndexMember2016-09-012021-07-310000102816eatonvance:C000081646Member2016-09-012021-08-310000102816eatonvance:EATONVANCEIndexMSCIWorld19312BroadBasedIndexMember2016-09-012021-08-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19312AdditionalIndexMember2016-09-012021-08-310000102816eatonvance:EATONVANCEIndexSP50019312AdditionalIndexMember2016-09-012021-08-310000102816eatonvance:C000081646Member2016-09-012021-09-300000102816eatonvance:EATONVANCEIndexMSCIWorld19312BroadBasedIndexMember2016-09-012021-09-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19312AdditionalIndexMember2016-09-012021-09-300000102816eatonvance:EATONVANCEIndexSP50019312AdditionalIndexMember2016-09-012021-09-300000102816eatonvance:C000081646Member2016-09-012021-10-310000102816eatonvance:EATONVANCEIndexMSCIWorld19312BroadBasedIndexMember2016-09-012021-10-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19312AdditionalIndexMember2016-09-012021-10-310000102816eatonvance:EATONVANCEIndexSP50019312AdditionalIndexMember2016-09-012021-10-310000102816eatonvance:C000081646Member2016-09-012021-11-300000102816eatonvance:EATONVANCEIndexMSCIWorld19312BroadBasedIndexMember2016-09-012021-11-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19312AdditionalIndexMember2016-09-012021-11-300000102816eatonvance:EATONVANCEIndexSP50019312AdditionalIndexMember2016-09-012021-11-300000102816eatonvance:C000081646Member2016-09-012021-12-310000102816eatonvance:EATONVANCEIndexMSCIWorld19312BroadBasedIndexMember2016-09-012021-12-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19312AdditionalIndexMember2016-09-012021-12-310000102816eatonvance:EATONVANCEIndexSP50019312AdditionalIndexMember2016-09-012021-12-310000102816eatonvance:C000081646Member2016-09-012022-01-310000102816eatonvance:EATONVANCEIndexMSCIWorld19312BroadBasedIndexMember2016-09-012022-01-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19312AdditionalIndexMember2016-09-012022-01-310000102816eatonvance:EATONVANCEIndexSP50019312AdditionalIndexMember2016-09-012022-01-310000102816eatonvance:C000081646Member2016-09-012022-02-280000102816eatonvance:EATONVANCEIndexMSCIWorld19312BroadBasedIndexMember2016-09-012022-02-280000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19312AdditionalIndexMember2016-09-012022-02-280000102816eatonvance:EATONVANCEIndexSP50019312AdditionalIndexMember2016-09-012022-02-280000102816eatonvance:C000081646Member2016-09-012022-03-310000102816eatonvance:EATONVANCEIndexMSCIWorld19312BroadBasedIndexMember2016-09-012022-03-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19312AdditionalIndexMember2016-09-012022-03-310000102816eatonvance:EATONVANCEIndexSP50019312AdditionalIndexMember2016-09-012022-03-310000102816eatonvance:C000081646Member2016-09-012022-04-300000102816eatonvance:EATONVANCEIndexMSCIWorld19312BroadBasedIndexMember2016-09-012022-04-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19312AdditionalIndexMember2016-09-012022-04-300000102816eatonvance:EATONVANCEIndexSP50019312AdditionalIndexMember2016-09-012022-04-300000102816eatonvance:C000081646Member2016-09-012022-05-310000102816eatonvance:EATONVANCEIndexMSCIWorld19312BroadBasedIndexMember2016-09-012022-05-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19312AdditionalIndexMember2016-09-012022-05-310000102816eatonvance:EATONVANCEIndexSP50019312AdditionalIndexMember2016-09-012022-05-310000102816eatonvance:C000081646Member2016-09-012022-06-300000102816eatonvance:EATONVANCEIndexMSCIWorld19312BroadBasedIndexMember2016-09-012022-06-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19312AdditionalIndexMember2016-09-012022-06-300000102816eatonvance:EATONVANCEIndexSP50019312AdditionalIndexMember2016-09-012022-06-300000102816eatonvance:C000081646Member2016-09-012022-07-310000102816eatonvance:EATONVANCEIndexMSCIWorld19312BroadBasedIndexMember2016-09-012022-07-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19312AdditionalIndexMember2016-09-012022-07-310000102816eatonvance:EATONVANCEIndexSP50019312AdditionalIndexMember2016-09-012022-07-310000102816eatonvance:C000081646Member2016-09-012022-08-310000102816eatonvance:EATONVANCEIndexMSCIWorld19312BroadBasedIndexMember2016-09-012022-08-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19312AdditionalIndexMember2016-09-012022-08-310000102816eatonvance:EATONVANCEIndexSP50019312AdditionalIndexMember2016-09-012022-08-310000102816eatonvance:C000081646Member2016-09-012022-09-300000102816eatonvance:EATONVANCEIndexMSCIWorld19312BroadBasedIndexMember2016-09-012022-09-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19312AdditionalIndexMember2016-09-012022-09-300000102816eatonvance:EATONVANCEIndexSP50019312AdditionalIndexMember2016-09-012022-09-300000102816eatonvance:C000081646Member2016-09-012022-10-310000102816eatonvance:EATONVANCEIndexMSCIWorld19312BroadBasedIndexMember2016-09-012022-10-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19312AdditionalIndexMember2016-09-012022-10-310000102816eatonvance:EATONVANCEIndexSP50019312AdditionalIndexMember2016-09-012022-10-310000102816eatonvance:C000081646Member2016-09-012022-11-300000102816eatonvance:EATONVANCEIndexMSCIWorld19312BroadBasedIndexMember2016-09-012022-11-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19312AdditionalIndexMember2016-09-012022-11-300000102816eatonvance:EATONVANCEIndexSP50019312AdditionalIndexMember2016-09-012022-11-300000102816eatonvance:C000081646Member2016-09-012022-12-310000102816eatonvance:EATONVANCEIndexMSCIWorld19312BroadBasedIndexMember2016-09-012022-12-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19312AdditionalIndexMember2016-09-012022-12-310000102816eatonvance:EATONVANCEIndexSP50019312AdditionalIndexMember2016-09-012022-12-310000102816eatonvance:C000081646Member2016-09-012023-01-310000102816eatonvance:EATONVANCEIndexMSCIWorld19312BroadBasedIndexMember2016-09-012023-01-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19312AdditionalIndexMember2016-09-012023-01-310000102816eatonvance:EATONVANCEIndexSP50019312AdditionalIndexMember2016-09-012023-01-310000102816eatonvance:C000081646Member2016-09-012023-02-280000102816eatonvance:EATONVANCEIndexMSCIWorld19312BroadBasedIndexMember2016-09-012023-02-280000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19312AdditionalIndexMember2016-09-012023-02-280000102816eatonvance:EATONVANCEIndexSP50019312AdditionalIndexMember2016-09-012023-02-280000102816eatonvance:C000081646Member2016-09-012023-03-310000102816eatonvance:EATONVANCEIndexMSCIWorld19312BroadBasedIndexMember2016-09-012023-03-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19312AdditionalIndexMember2016-09-012023-03-310000102816eatonvance:EATONVANCEIndexSP50019312AdditionalIndexMember2016-09-012023-03-310000102816eatonvance:C000081646Member2016-09-012023-04-300000102816eatonvance:EATONVANCEIndexMSCIWorld19312BroadBasedIndexMember2016-09-012023-04-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19312AdditionalIndexMember2016-09-012023-04-300000102816eatonvance:EATONVANCEIndexSP50019312AdditionalIndexMember2016-09-012023-04-300000102816eatonvance:C000081646Member2016-09-012023-05-310000102816eatonvance:EATONVANCEIndexMSCIWorld19312BroadBasedIndexMember2016-09-012023-05-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19312AdditionalIndexMember2016-09-012023-05-310000102816eatonvance:EATONVANCEIndexSP50019312AdditionalIndexMember2016-09-012023-05-310000102816eatonvance:C000081646Member2016-09-012023-06-300000102816eatonvance:EATONVANCEIndexMSCIWorld19312BroadBasedIndexMember2016-09-012023-06-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19312AdditionalIndexMember2016-09-012023-06-300000102816eatonvance:EATONVANCEIndexSP50019312AdditionalIndexMember2016-09-012023-06-300000102816eatonvance:C000081646Member2016-09-012023-07-310000102816eatonvance:EATONVANCEIndexMSCIWorld19312BroadBasedIndexMember2016-09-012023-07-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19312AdditionalIndexMember2016-09-012023-07-310000102816eatonvance:EATONVANCEIndexSP50019312AdditionalIndexMember2016-09-012023-07-310000102816eatonvance:C000081646Member2016-09-012023-08-310000102816eatonvance:EATONVANCEIndexMSCIWorld19312BroadBasedIndexMember2016-09-012023-08-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19312AdditionalIndexMember2016-09-012023-08-310000102816eatonvance:EATONVANCEIndexSP50019312AdditionalIndexMember2016-09-012023-08-310000102816eatonvance:C000081646Member2016-09-012023-09-300000102816eatonvance:EATONVANCEIndexMSCIWorld19312BroadBasedIndexMember2016-09-012023-09-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19312AdditionalIndexMember2016-09-012023-09-300000102816eatonvance:EATONVANCEIndexSP50019312AdditionalIndexMember2016-09-012023-09-300000102816eatonvance:C000081646Member2016-09-012023-10-310000102816eatonvance:EATONVANCEIndexMSCIWorld19312BroadBasedIndexMember2016-09-012023-10-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19312AdditionalIndexMember2016-09-012023-10-310000102816eatonvance:EATONVANCEIndexSP50019312AdditionalIndexMember2016-09-012023-10-310000102816eatonvance:C000081646Member2016-09-012023-11-300000102816eatonvance:EATONVANCEIndexMSCIWorld19312BroadBasedIndexMember2016-09-012023-11-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19312AdditionalIndexMember2016-09-012023-11-300000102816eatonvance:EATONVANCEIndexSP50019312AdditionalIndexMember2016-09-012023-11-300000102816eatonvance:C000081646Member2016-09-012023-12-310000102816eatonvance:EATONVANCEIndexMSCIWorld19312BroadBasedIndexMember2016-09-012023-12-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19312AdditionalIndexMember2016-09-012023-12-310000102816eatonvance:EATONVANCEIndexSP50019312AdditionalIndexMember2016-09-012023-12-310000102816eatonvance:C000081646Member2016-09-012024-01-310000102816eatonvance:EATONVANCEIndexMSCIWorld19312BroadBasedIndexMember2016-09-012024-01-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19312AdditionalIndexMember2016-09-012024-01-310000102816eatonvance:EATONVANCEIndexSP50019312AdditionalIndexMember2016-09-012024-01-310000102816eatonvance:C000081646Member2016-09-012024-02-290000102816eatonvance:EATONVANCEIndexMSCIWorld19312BroadBasedIndexMember2016-09-012024-02-290000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19312AdditionalIndexMember2016-09-012024-02-290000102816eatonvance:EATONVANCEIndexSP50019312AdditionalIndexMember2016-09-012024-02-290000102816eatonvance:C000081646Member2016-09-012024-03-310000102816eatonvance:EATONVANCEIndexMSCIWorld19312BroadBasedIndexMember2016-09-012024-03-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19312AdditionalIndexMember2016-09-012024-03-310000102816eatonvance:EATONVANCEIndexSP50019312AdditionalIndexMember2016-09-012024-03-310000102816eatonvance:C000081646Member2016-09-012024-04-300000102816eatonvance:EATONVANCEIndexMSCIWorld19312BroadBasedIndexMember2016-09-012024-04-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19312AdditionalIndexMember2016-09-012024-04-300000102816eatonvance:EATONVANCEIndexSP50019312AdditionalIndexMember2016-09-012024-04-300000102816eatonvance:C000081646Member2016-09-012024-05-310000102816eatonvance:EATONVANCEIndexMSCIWorld19312BroadBasedIndexMember2016-09-012024-05-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19312AdditionalIndexMember2016-09-012024-05-310000102816eatonvance:EATONVANCEIndexSP50019312AdditionalIndexMember2016-09-012024-05-310000102816eatonvance:C000081646Member2016-09-012024-06-300000102816eatonvance:EATONVANCEIndexMSCIWorld19312BroadBasedIndexMember2016-09-012024-06-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19312AdditionalIndexMember2016-09-012024-06-300000102816eatonvance:EATONVANCEIndexSP50019312AdditionalIndexMember2016-09-012024-06-300000102816eatonvance:C000081646Member2016-09-012024-07-310000102816eatonvance:EATONVANCEIndexMSCIWorld19312BroadBasedIndexMember2016-09-012024-07-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19312AdditionalIndexMember2016-09-012024-07-310000102816eatonvance:EATONVANCEIndexSP50019312AdditionalIndexMember2016-09-012024-07-310000102816eatonvance:C000081646Member2016-09-012024-08-310000102816eatonvance:EATONVANCEIndexMSCIWorld19312BroadBasedIndexMember2016-09-012024-08-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19312AdditionalIndexMember2016-09-012024-08-310000102816eatonvance:EATONVANCEIndexSP50019312AdditionalIndexMember2016-09-012024-08-310000102816eatonvance:C000081646Member2016-09-012024-09-300000102816eatonvance:EATONVANCEIndexMSCIWorld19312BroadBasedIndexMember2016-09-012024-09-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19312AdditionalIndexMember2016-09-012024-09-300000102816eatonvance:EATONVANCEIndexSP50019312AdditionalIndexMember2016-09-012024-09-300000102816eatonvance:C000081646Member2016-09-012024-10-310000102816eatonvance:EATONVANCEIndexMSCIWorld19312BroadBasedIndexMember2016-09-012024-10-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19312AdditionalIndexMember2016-09-012024-10-310000102816eatonvance:EATONVANCEIndexSP50019312AdditionalIndexMember2016-09-012024-10-310000102816eatonvance:C000081646Member2016-09-012024-11-300000102816eatonvance:EATONVANCEIndexMSCIWorld19312BroadBasedIndexMember2016-09-012024-11-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19312AdditionalIndexMember2016-09-012024-11-300000102816eatonvance:EATONVANCEIndexSP50019312AdditionalIndexMember2016-09-012024-11-300000102816eatonvance:C000081646Member2016-09-012024-12-310000102816eatonvance:EATONVANCEIndexMSCIWorld19312BroadBasedIndexMember2016-09-012024-12-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19312AdditionalIndexMember2016-09-012024-12-310000102816eatonvance:EATONVANCEIndexSP50019312AdditionalIndexMember2016-09-012024-12-310000102816eatonvance:C000081646Member2016-09-012025-01-310000102816eatonvance:EATONVANCEIndexMSCIWorld19312BroadBasedIndexMember2016-09-012025-01-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19312AdditionalIndexMember2016-09-012025-01-310000102816eatonvance:EATONVANCEIndexSP50019312AdditionalIndexMember2016-09-012025-01-310000102816eatonvance:C000081646Member2016-09-012025-02-280000102816eatonvance:EATONVANCEIndexMSCIWorld19312BroadBasedIndexMember2016-09-012025-02-280000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19312AdditionalIndexMember2016-09-012025-02-280000102816eatonvance:EATONVANCEIndexSP50019312AdditionalIndexMember2016-09-012025-02-280000102816eatonvance:C000081646Member2016-09-012025-03-310000102816eatonvance:EATONVANCEIndexMSCIWorld19312BroadBasedIndexMember2016-09-012025-03-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19312AdditionalIndexMember2016-09-012025-03-310000102816eatonvance:EATONVANCEIndexSP50019312AdditionalIndexMember2016-09-012025-03-310000102816eatonvance:C000081646Member2016-09-012025-04-300000102816eatonvance:EATONVANCEIndexMSCIWorld19312BroadBasedIndexMember2016-09-012025-04-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19312AdditionalIndexMember2016-09-012025-04-300000102816eatonvance:EATONVANCEIndexSP50019312AdditionalIndexMember2016-09-012025-04-300000102816eatonvance:C000081646Member2016-09-012025-05-310000102816eatonvance:EATONVANCEIndexMSCIWorld19312BroadBasedIndexMember2016-09-012025-05-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19312AdditionalIndexMember2016-09-012025-05-310000102816eatonvance:EATONVANCEIndexSP50019312AdditionalIndexMember2016-09-012025-05-310000102816eatonvance:C000081646Member2016-09-012025-06-300000102816eatonvance:EATONVANCEIndexMSCIWorld19312BroadBasedIndexMember2016-09-012025-06-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19312AdditionalIndexMember2016-09-012025-06-300000102816eatonvance:EATONVANCEIndexSP50019312AdditionalIndexMember2016-09-012025-06-300000102816eatonvance:C000081646Member2016-09-012025-07-310000102816eatonvance:EATONVANCEIndexMSCIWorld19312BroadBasedIndexMember2016-09-012025-07-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19312AdditionalIndexMember2016-09-012025-07-310000102816eatonvance:EATONVANCEIndexSP50019312AdditionalIndexMember2016-09-012025-07-310000102816eatonvance:C000081646Member2016-09-012025-08-310000102816eatonvance:EATONVANCEIndexMSCIWorld19312BroadBasedIndexMember2016-09-012025-08-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19312AdditionalIndexMember2016-09-012025-08-310000102816eatonvance:EATONVANCEIndexSP50019312AdditionalIndexMember2016-09-012025-08-310000102816eatonvance:C000081646Member2016-09-012025-09-300000102816eatonvance:EATONVANCEIndexMSCIWorld19312BroadBasedIndexMember2016-09-012025-09-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19312AdditionalIndexMember2016-09-012025-09-300000102816eatonvance:EATONVANCEIndexSP50019312AdditionalIndexMember2016-09-012025-09-300000102816eatonvance:C000081646Member2016-09-012025-10-310000102816eatonvance:EATONVANCEIndexMSCIWorld19312BroadBasedIndexMember2016-09-012025-10-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19312AdditionalIndexMember2016-09-012025-10-310000102816eatonvance:EATONVANCEIndexSP50019312AdditionalIndexMember2016-09-012025-10-310000102816eatonvance:C000081646Member2016-09-012025-11-300000102816eatonvance:EATONVANCEIndexMSCIWorld19312BroadBasedIndexMember2016-09-012025-11-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19312AdditionalIndexMember2016-09-012025-11-300000102816eatonvance:EATONVANCEIndexSP50019312AdditionalIndexMember2016-09-012025-11-300000102816eatonvance:C000081646Member2016-09-012025-12-310000102816eatonvance:EATONVANCEIndexMSCIWorld19312BroadBasedIndexMember2016-09-012025-12-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19312AdditionalIndexMember2016-09-012025-12-310000102816eatonvance:EATONVANCEIndexSP50019312AdditionalIndexMember2016-09-012025-12-310000102816eatonvance:C000081646Member2016-09-012026-01-310000102816eatonvance:EATONVANCEIndexMSCIWorld19312BroadBasedIndexMember2016-09-012026-01-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19312AdditionalIndexMember2016-09-012026-01-310000102816eatonvance:EATONVANCEIndexSP50019312AdditionalIndexMember2016-09-012026-01-310000102816eatonvance:C000081646Member2016-09-012026-02-280000102816eatonvance:EATONVANCEIndexMSCIWorld19312BroadBasedIndexMember2016-09-012026-02-280000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19312AdditionalIndexMember2016-09-012026-02-280000102816eatonvance:EATONVANCEIndexSP50019312AdditionalIndexMember2016-09-012026-02-280000102816eatonvance:C000081646Member2016-09-012026-03-310000102816eatonvance:EATONVANCEIndexMSCIWorld19312BroadBasedIndexMember2016-09-012026-03-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19312AdditionalIndexMember2016-09-012026-03-310000102816eatonvance:EATONVANCEIndexSP50019312AdditionalIndexMember2016-09-012026-03-310000102816eatonvance:C000081646Member2016-09-012026-04-300000102816eatonvance:EATONVANCEIndexMSCIWorld19312BroadBasedIndexMember2016-09-012026-04-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19312AdditionalIndexMember2016-09-012026-04-300000102816eatonvance:EATONVANCEIndexSP50019312AdditionalIndexMember2016-09-012026-04-300000102816eatonvance:C000081646Member2016-09-012026-05-310000102816eatonvance:EATONVANCEIndexMSCIWorld19312BroadBasedIndexMember2016-09-012026-05-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19312AdditionalIndexMember2016-09-012026-05-310000102816eatonvance:EATONVANCEIndexSP50019312AdditionalIndexMember2016-09-012026-05-310000102816eatonvance:C000081646Member2016-09-012026-06-300000102816eatonvance:EATONVANCEIndexMSCIWorld19312BroadBasedIndexMember2016-09-012026-06-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19312AdditionalIndexMember2016-09-012026-06-300000102816eatonvance:EATONVANCEIndexSP50019312AdditionalIndexMember2016-09-012026-06-300000102816eatonvance:C000081646Member2016-09-012026-07-310000102816eatonvance:EATONVANCEIndexMSCIWorld19312BroadBasedIndexMember2016-09-012026-07-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19312AdditionalIndexMember2016-09-012026-07-310000102816eatonvance:EATONVANCEIndexSP50019312AdditionalIndexMember2016-09-012026-07-310000102816eatonvance:C000081646Member2016-09-012026-08-310000102816eatonvance:EATONVANCEIndexMSCIWorld19312BroadBasedIndexMember2016-09-012026-08-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19312AdditionalIndexMember2016-09-012026-08-310000102816eatonvance:EATONVANCEIndexSP50019312AdditionalIndexMember2016-09-012026-08-310000102816eatonvance:C000081646Memberoef:WithoutSalesLoadMember2025-09-012026-08-310000102816eatonvance:C000081646Memberoef:WithoutSalesLoadMember2021-09-012026-08-310000102816eatonvance:C000081646Memberoef:WithoutSalesLoadMember2016-09-012026-08-310000102816eatonvance:EATONVANCEIndexMSCIWorld19312BroadBasedIndexMember2021-09-012026-08-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19312AdditionalIndexMember2021-09-012026-08-310000102816eatonvance:EATONVANCEIndexSP50019312AdditionalIndexMember2021-09-012026-08-310000102816eatonvance:C000081646Member2026-08-310000102816eatonvance:C000081646Membereatonvance:ShortMinusTermInvestmentsSectorMember2026-08-310000102816eatonvance:C000081646Membereatonvance:HealthCareTechnologySectorMember2026-08-310000102816eatonvance:C000081646Membereatonvance:HealthCareSuppliesSectorMember2026-08-310000102816eatonvance:C000081646Membereatonvance:HealthCareServicesSectorMember2026-08-310000102816eatonvance:C000081646Membereatonvance:ManagedHealthCareSectorMember2026-08-310000102816eatonvance:C000081646Membereatonvance:LifeSciencesToolsServicesSectorMember2026-08-310000102816eatonvance:C000081646Membereatonvance:HealthCareEquipmentSectorMember2026-08-310000102816eatonvance:C000081646Membereatonvance:BiotechnologySectorMember2026-08-310000102816eatonvance:C000081646Membereatonvance:PharmaceuticalsSectorMember2026-08-310000102816eatonvance:C000081646Membereatonvance:FR532457108CTIMember2026-08-310000102816eatonvance:C000081646Membereatonvance:FR478160104CTIMember2026-08-310000102816eatonvance:C000081646Membereatonvance:FR00287Y109CTIMember2026-08-310000102816eatonvance:C000081646Membereatonvance:FR58933Y105CTIMember2026-08-310000102816eatonvance:C000081646Membereatonvance:FRACI38LVK6CTIMember2026-08-310000102816eatonvance:C000081646Membereatonvance:FR91324P102CTIMember2026-08-310000102816eatonvance:C000081646Membereatonvance:FR098952906CTIMember2026-08-310000102816eatonvance:C000081646Membereatonvance:FR110122108CTIMember2026-08-310000102816eatonvance:C000081646Membereatonvance:FR92532F100CTIMember2026-08-310000102816eatonvance:C000081646Membereatonvance:FR002824100CTIMember2026-08-310000102816eatonvance:C000081646Membereatonvance:AbbottLaboratoriesCTIMember2026-08-310000102816eatonvance:C000014194Member2025-09-012026-08-310000102816eatonvance:EATONVANCEIndexMSCIWorld19368BroadBasedIndexMember2025-09-012026-08-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19368AdditionalIndexMember2025-09-012026-08-310000102816eatonvance:EATONVANCEIndexSP50019368AdditionalIndexMember2025-09-012026-08-310000102816eatonvance:C000014194Member2016-08-312016-08-310000102816eatonvance:EATONVANCEIndexMSCIWorld19368BroadBasedIndexMember2016-08-312016-08-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19368AdditionalIndexMember2016-08-312016-08-310000102816eatonvance:EATONVANCEIndexSP50019368AdditionalIndexMember2016-08-312016-08-310000102816eatonvance:C000014194Member2016-09-012016-09-300000102816eatonvance:EATONVANCEIndexMSCIWorld19368BroadBasedIndexMember2016-09-012016-09-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19368AdditionalIndexMember2016-09-012016-09-300000102816eatonvance:EATONVANCEIndexSP50019368AdditionalIndexMember2016-09-012016-09-300000102816eatonvance:C000014194Member2016-09-012016-10-310000102816eatonvance:EATONVANCEIndexMSCIWorld19368BroadBasedIndexMember2016-09-012016-10-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19368AdditionalIndexMember2016-09-012016-10-310000102816eatonvance:EATONVANCEIndexSP50019368AdditionalIndexMember2016-09-012016-10-310000102816eatonvance:C000014194Member2016-09-012016-11-300000102816eatonvance:EATONVANCEIndexMSCIWorld19368BroadBasedIndexMember2016-09-012016-11-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19368AdditionalIndexMember2016-09-012016-11-300000102816eatonvance:EATONVANCEIndexSP50019368AdditionalIndexMember2016-09-012016-11-300000102816eatonvance:C000014194Member2016-09-012016-12-310000102816eatonvance:EATONVANCEIndexMSCIWorld19368BroadBasedIndexMember2016-09-012016-12-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19368AdditionalIndexMember2016-09-012016-12-310000102816eatonvance:EATONVANCEIndexSP50019368AdditionalIndexMember2016-09-012016-12-310000102816eatonvance:C000014194Member2016-09-012017-01-310000102816eatonvance:EATONVANCEIndexMSCIWorld19368BroadBasedIndexMember2016-09-012017-01-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19368AdditionalIndexMember2016-09-012017-01-310000102816eatonvance:EATONVANCEIndexSP50019368AdditionalIndexMember2016-09-012017-01-310000102816eatonvance:C000014194Member2016-09-012017-02-280000102816eatonvance:EATONVANCEIndexMSCIWorld19368BroadBasedIndexMember2016-09-012017-02-280000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19368AdditionalIndexMember2016-09-012017-02-280000102816eatonvance:EATONVANCEIndexSP50019368AdditionalIndexMember2016-09-012017-02-280000102816eatonvance:C000014194Member2016-09-012017-03-310000102816eatonvance:EATONVANCEIndexMSCIWorld19368BroadBasedIndexMember2016-09-012017-03-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19368AdditionalIndexMember2016-09-012017-03-310000102816eatonvance:EATONVANCEIndexSP50019368AdditionalIndexMember2016-09-012017-03-310000102816eatonvance:C000014194Member2016-09-012017-04-300000102816eatonvance:EATONVANCEIndexMSCIWorld19368BroadBasedIndexMember2016-09-012017-04-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19368AdditionalIndexMember2016-09-012017-04-300000102816eatonvance:EATONVANCEIndexSP50019368AdditionalIndexMember2016-09-012017-04-300000102816eatonvance:C000014194Member2016-09-012017-05-310000102816eatonvance:EATONVANCEIndexMSCIWorld19368BroadBasedIndexMember2016-09-012017-05-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19368AdditionalIndexMember2016-09-012017-05-310000102816eatonvance:EATONVANCEIndexSP50019368AdditionalIndexMember2016-09-012017-05-310000102816eatonvance:C000014194Member2016-09-012017-06-300000102816eatonvance:EATONVANCEIndexMSCIWorld19368BroadBasedIndexMember2016-09-012017-06-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19368AdditionalIndexMember2016-09-012017-06-300000102816eatonvance:EATONVANCEIndexSP50019368AdditionalIndexMember2016-09-012017-06-300000102816eatonvance:C000014194Member2016-09-012017-07-310000102816eatonvance:EATONVANCEIndexMSCIWorld19368BroadBasedIndexMember2016-09-012017-07-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19368AdditionalIndexMember2016-09-012017-07-310000102816eatonvance:EATONVANCEIndexSP50019368AdditionalIndexMember2016-09-012017-07-310000102816eatonvance:C000014194Member2016-09-012017-08-310000102816eatonvance:EATONVANCEIndexMSCIWorld19368BroadBasedIndexMember2016-09-012017-08-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19368AdditionalIndexMember2016-09-012017-08-310000102816eatonvance:EATONVANCEIndexSP50019368AdditionalIndexMember2016-09-012017-08-310000102816eatonvance:C000014194Member2016-09-012017-09-300000102816eatonvance:EATONVANCEIndexMSCIWorld19368BroadBasedIndexMember2016-09-012017-09-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19368AdditionalIndexMember2016-09-012017-09-300000102816eatonvance:EATONVANCEIndexSP50019368AdditionalIndexMember2016-09-012017-09-300000102816eatonvance:C000014194Member2016-09-012017-10-310000102816eatonvance:EATONVANCEIndexMSCIWorld19368BroadBasedIndexMember2016-09-012017-10-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19368AdditionalIndexMember2016-09-012017-10-310000102816eatonvance:EATONVANCEIndexSP50019368AdditionalIndexMember2016-09-012017-10-310000102816eatonvance:C000014194Member2016-09-012017-11-300000102816eatonvance:EATONVANCEIndexMSCIWorld19368BroadBasedIndexMember2016-09-012017-11-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19368AdditionalIndexMember2016-09-012017-11-300000102816eatonvance:EATONVANCEIndexSP50019368AdditionalIndexMember2016-09-012017-11-300000102816eatonvance:C000014194Member2016-09-012017-12-310000102816eatonvance:EATONVANCEIndexMSCIWorld19368BroadBasedIndexMember2016-09-012017-12-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19368AdditionalIndexMember2016-09-012017-12-310000102816eatonvance:EATONVANCEIndexSP50019368AdditionalIndexMember2016-09-012017-12-310000102816eatonvance:C000014194Member2016-09-012018-01-310000102816eatonvance:EATONVANCEIndexMSCIWorld19368BroadBasedIndexMember2016-09-012018-01-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19368AdditionalIndexMember2016-09-012018-01-310000102816eatonvance:EATONVANCEIndexSP50019368AdditionalIndexMember2016-09-012018-01-310000102816eatonvance:C000014194Member2016-09-012018-02-280000102816eatonvance:EATONVANCEIndexMSCIWorld19368BroadBasedIndexMember2016-09-012018-02-280000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19368AdditionalIndexMember2016-09-012018-02-280000102816eatonvance:EATONVANCEIndexSP50019368AdditionalIndexMember2016-09-012018-02-280000102816eatonvance:C000014194Member2016-09-012018-03-310000102816eatonvance:EATONVANCEIndexMSCIWorld19368BroadBasedIndexMember2016-09-012018-03-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19368AdditionalIndexMember2016-09-012018-03-310000102816eatonvance:EATONVANCEIndexSP50019368AdditionalIndexMember2016-09-012018-03-310000102816eatonvance:C000014194Member2016-09-012018-04-300000102816eatonvance:EATONVANCEIndexMSCIWorld19368BroadBasedIndexMember2016-09-012018-04-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19368AdditionalIndexMember2016-09-012018-04-300000102816eatonvance:EATONVANCEIndexSP50019368AdditionalIndexMember2016-09-012018-04-300000102816eatonvance:C000014194Member2016-09-012018-05-310000102816eatonvance:EATONVANCEIndexMSCIWorld19368BroadBasedIndexMember2016-09-012018-05-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19368AdditionalIndexMember2016-09-012018-05-310000102816eatonvance:EATONVANCEIndexSP50019368AdditionalIndexMember2016-09-012018-05-310000102816eatonvance:C000014194Member2016-09-012018-06-300000102816eatonvance:EATONVANCEIndexMSCIWorld19368BroadBasedIndexMember2016-09-012018-06-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19368AdditionalIndexMember2016-09-012018-06-300000102816eatonvance:EATONVANCEIndexSP50019368AdditionalIndexMember2016-09-012018-06-300000102816eatonvance:C000014194Member2016-09-012018-07-310000102816eatonvance:EATONVANCEIndexMSCIWorld19368BroadBasedIndexMember2016-09-012018-07-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19368AdditionalIndexMember2016-09-012018-07-310000102816eatonvance:EATONVANCEIndexSP50019368AdditionalIndexMember2016-09-012018-07-310000102816eatonvance:C000014194Member2016-09-012018-08-310000102816eatonvance:EATONVANCEIndexMSCIWorld19368BroadBasedIndexMember2016-09-012018-08-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19368AdditionalIndexMember2016-09-012018-08-310000102816eatonvance:EATONVANCEIndexSP50019368AdditionalIndexMember2016-09-012018-08-310000102816eatonvance:C000014194Member2016-09-012018-09-300000102816eatonvance:EATONVANCEIndexMSCIWorld19368BroadBasedIndexMember2016-09-012018-09-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19368AdditionalIndexMember2016-09-012018-09-300000102816eatonvance:EATONVANCEIndexSP50019368AdditionalIndexMember2016-09-012018-09-300000102816eatonvance:C000014194Member2016-09-012018-10-310000102816eatonvance:EATONVANCEIndexMSCIWorld19368BroadBasedIndexMember2016-09-012018-10-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19368AdditionalIndexMember2016-09-012018-10-310000102816eatonvance:EATONVANCEIndexSP50019368AdditionalIndexMember2016-09-012018-10-310000102816eatonvance:C000014194Member2016-09-012018-11-300000102816eatonvance:EATONVANCEIndexMSCIWorld19368BroadBasedIndexMember2016-09-012018-11-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19368AdditionalIndexMember2016-09-012018-11-300000102816eatonvance:EATONVANCEIndexSP50019368AdditionalIndexMember2016-09-012018-11-300000102816eatonvance:C000014194Member2016-09-012018-12-310000102816eatonvance:EATONVANCEIndexMSCIWorld19368BroadBasedIndexMember2016-09-012018-12-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19368AdditionalIndexMember2016-09-012018-12-310000102816eatonvance:EATONVANCEIndexSP50019368AdditionalIndexMember2016-09-012018-12-310000102816eatonvance:C000014194Member2016-09-012019-01-310000102816eatonvance:EATONVANCEIndexMSCIWorld19368BroadBasedIndexMember2016-09-012019-01-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19368AdditionalIndexMember2016-09-012019-01-310000102816eatonvance:EATONVANCEIndexSP50019368AdditionalIndexMember2016-09-012019-01-310000102816eatonvance:C000014194Member2016-09-012019-02-280000102816eatonvance:EATONVANCEIndexMSCIWorld19368BroadBasedIndexMember2016-09-012019-02-280000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19368AdditionalIndexMember2016-09-012019-02-280000102816eatonvance:EATONVANCEIndexSP50019368AdditionalIndexMember2016-09-012019-02-280000102816eatonvance:C000014194Member2016-09-012019-03-310000102816eatonvance:EATONVANCEIndexMSCIWorld19368BroadBasedIndexMember2016-09-012019-03-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19368AdditionalIndexMember2016-09-012019-03-310000102816eatonvance:EATONVANCEIndexSP50019368AdditionalIndexMember2016-09-012019-03-310000102816eatonvance:C000014194Member2016-09-012019-04-300000102816eatonvance:EATONVANCEIndexMSCIWorld19368BroadBasedIndexMember2016-09-012019-04-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19368AdditionalIndexMember2016-09-012019-04-300000102816eatonvance:EATONVANCEIndexSP50019368AdditionalIndexMember2016-09-012019-04-300000102816eatonvance:C000014194Member2016-09-012019-05-310000102816eatonvance:EATONVANCEIndexMSCIWorld19368BroadBasedIndexMember2016-09-012019-05-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19368AdditionalIndexMember2016-09-012019-05-310000102816eatonvance:EATONVANCEIndexSP50019368AdditionalIndexMember2016-09-012019-05-310000102816eatonvance:C000014194Member2016-09-012019-06-300000102816eatonvance:EATONVANCEIndexMSCIWorld19368BroadBasedIndexMember2016-09-012019-06-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19368AdditionalIndexMember2016-09-012019-06-300000102816eatonvance:EATONVANCEIndexSP50019368AdditionalIndexMember2016-09-012019-06-300000102816eatonvance:C000014194Member2016-09-012019-07-310000102816eatonvance:EATONVANCEIndexMSCIWorld19368BroadBasedIndexMember2016-09-012019-07-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19368AdditionalIndexMember2016-09-012019-07-310000102816eatonvance:EATONVANCEIndexSP50019368AdditionalIndexMember2016-09-012019-07-310000102816eatonvance:C000014194Member2016-09-012019-08-310000102816eatonvance:EATONVANCEIndexMSCIWorld19368BroadBasedIndexMember2016-09-012019-08-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19368AdditionalIndexMember2016-09-012019-08-310000102816eatonvance:EATONVANCEIndexSP50019368AdditionalIndexMember2016-09-012019-08-310000102816eatonvance:C000014194Member2016-09-012019-09-300000102816eatonvance:EATONVANCEIndexMSCIWorld19368BroadBasedIndexMember2016-09-012019-09-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19368AdditionalIndexMember2016-09-012019-09-300000102816eatonvance:EATONVANCEIndexSP50019368AdditionalIndexMember2016-09-012019-09-300000102816eatonvance:C000014194Member2016-09-012019-10-310000102816eatonvance:EATONVANCEIndexMSCIWorld19368BroadBasedIndexMember2016-09-012019-10-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19368AdditionalIndexMember2016-09-012019-10-310000102816eatonvance:EATONVANCEIndexSP50019368AdditionalIndexMember2016-09-012019-10-310000102816eatonvance:C000014194Member2016-09-012019-11-300000102816eatonvance:EATONVANCEIndexMSCIWorld19368BroadBasedIndexMember2016-09-012019-11-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19368AdditionalIndexMember2016-09-012019-11-300000102816eatonvance:EATONVANCEIndexSP50019368AdditionalIndexMember2016-09-012019-11-300000102816eatonvance:C000014194Member2016-09-012019-12-310000102816eatonvance:EATONVANCEIndexMSCIWorld19368BroadBasedIndexMember2016-09-012019-12-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19368AdditionalIndexMember2016-09-012019-12-310000102816eatonvance:EATONVANCEIndexSP50019368AdditionalIndexMember2016-09-012019-12-310000102816eatonvance:C000014194Member2016-09-012020-01-310000102816eatonvance:EATONVANCEIndexMSCIWorld19368BroadBasedIndexMember2016-09-012020-01-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19368AdditionalIndexMember2016-09-012020-01-310000102816eatonvance:EATONVANCEIndexSP50019368AdditionalIndexMember2016-09-012020-01-310000102816eatonvance:C000014194Member2016-09-012020-02-290000102816eatonvance:EATONVANCEIndexMSCIWorld19368BroadBasedIndexMember2016-09-012020-02-290000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19368AdditionalIndexMember2016-09-012020-02-290000102816eatonvance:EATONVANCEIndexSP50019368AdditionalIndexMember2016-09-012020-02-290000102816eatonvance:C000014194Member2016-09-012020-03-310000102816eatonvance:EATONVANCEIndexMSCIWorld19368BroadBasedIndexMember2016-09-012020-03-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19368AdditionalIndexMember2016-09-012020-03-310000102816eatonvance:EATONVANCEIndexSP50019368AdditionalIndexMember2016-09-012020-03-310000102816eatonvance:C000014194Member2016-09-012020-04-300000102816eatonvance:EATONVANCEIndexMSCIWorld19368BroadBasedIndexMember2016-09-012020-04-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19368AdditionalIndexMember2016-09-012020-04-300000102816eatonvance:EATONVANCEIndexSP50019368AdditionalIndexMember2016-09-012020-04-300000102816eatonvance:C000014194Member2016-09-012020-05-310000102816eatonvance:EATONVANCEIndexMSCIWorld19368BroadBasedIndexMember2016-09-012020-05-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19368AdditionalIndexMember2016-09-012020-05-310000102816eatonvance:EATONVANCEIndexSP50019368AdditionalIndexMember2016-09-012020-05-310000102816eatonvance:C000014194Member2016-09-012020-06-300000102816eatonvance:EATONVANCEIndexMSCIWorld19368BroadBasedIndexMember2016-09-012020-06-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19368AdditionalIndexMember2016-09-012020-06-300000102816eatonvance:EATONVANCEIndexSP50019368AdditionalIndexMember2016-09-012020-06-300000102816eatonvance:C000014194Member2016-09-012020-07-310000102816eatonvance:EATONVANCEIndexMSCIWorld19368BroadBasedIndexMember2016-09-012020-07-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19368AdditionalIndexMember2016-09-012020-07-310000102816eatonvance:EATONVANCEIndexSP50019368AdditionalIndexMember2016-09-012020-07-310000102816eatonvance:C000014194Member2016-09-012020-08-310000102816eatonvance:EATONVANCEIndexMSCIWorld19368BroadBasedIndexMember2016-09-012020-08-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19368AdditionalIndexMember2016-09-012020-08-310000102816eatonvance:EATONVANCEIndexSP50019368AdditionalIndexMember2016-09-012020-08-310000102816eatonvance:C000014194Member2016-09-012020-09-300000102816eatonvance:EATONVANCEIndexMSCIWorld19368BroadBasedIndexMember2016-09-012020-09-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19368AdditionalIndexMember2016-09-012020-09-300000102816eatonvance:EATONVANCEIndexSP50019368AdditionalIndexMember2016-09-012020-09-300000102816eatonvance:C000014194Member2016-09-012020-10-310000102816eatonvance:EATONVANCEIndexMSCIWorld19368BroadBasedIndexMember2016-09-012020-10-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19368AdditionalIndexMember2016-09-012020-10-310000102816eatonvance:EATONVANCEIndexSP50019368AdditionalIndexMember2016-09-012020-10-310000102816eatonvance:C000014194Member2016-09-012020-11-300000102816eatonvance:EATONVANCEIndexMSCIWorld19368BroadBasedIndexMember2016-09-012020-11-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19368AdditionalIndexMember2016-09-012020-11-300000102816eatonvance:EATONVANCEIndexSP50019368AdditionalIndexMember2016-09-012020-11-300000102816eatonvance:C000014194Member2016-09-012020-12-310000102816eatonvance:EATONVANCEIndexMSCIWorld19368BroadBasedIndexMember2016-09-012020-12-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19368AdditionalIndexMember2016-09-012020-12-310000102816eatonvance:EATONVANCEIndexSP50019368AdditionalIndexMember2016-09-012020-12-310000102816eatonvance:C000014194Member2016-09-012021-01-310000102816eatonvance:EATONVANCEIndexMSCIWorld19368BroadBasedIndexMember2016-09-012021-01-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19368AdditionalIndexMember2016-09-012021-01-310000102816eatonvance:EATONVANCEIndexSP50019368AdditionalIndexMember2016-09-012021-01-310000102816eatonvance:C000014194Member2016-09-012021-02-280000102816eatonvance:EATONVANCEIndexMSCIWorld19368BroadBasedIndexMember2016-09-012021-02-280000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19368AdditionalIndexMember2016-09-012021-02-280000102816eatonvance:EATONVANCEIndexSP50019368AdditionalIndexMember2016-09-012021-02-280000102816eatonvance:C000014194Member2016-09-012021-03-310000102816eatonvance:EATONVANCEIndexMSCIWorld19368BroadBasedIndexMember2016-09-012021-03-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19368AdditionalIndexMember2016-09-012021-03-310000102816eatonvance:EATONVANCEIndexSP50019368AdditionalIndexMember2016-09-012021-03-310000102816eatonvance:C000014194Member2016-09-012021-04-300000102816eatonvance:EATONVANCEIndexMSCIWorld19368BroadBasedIndexMember2016-09-012021-04-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19368AdditionalIndexMember2016-09-012021-04-300000102816eatonvance:EATONVANCEIndexSP50019368AdditionalIndexMember2016-09-012021-04-300000102816eatonvance:C000014194Member2016-09-012021-05-310000102816eatonvance:EATONVANCEIndexMSCIWorld19368BroadBasedIndexMember2016-09-012021-05-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19368AdditionalIndexMember2016-09-012021-05-310000102816eatonvance:EATONVANCEIndexSP50019368AdditionalIndexMember2016-09-012021-05-310000102816eatonvance:C000014194Member2016-09-012021-06-300000102816eatonvance:EATONVANCEIndexMSCIWorld19368BroadBasedIndexMember2016-09-012021-06-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19368AdditionalIndexMember2016-09-012021-06-300000102816eatonvance:EATONVANCEIndexSP50019368AdditionalIndexMember2016-09-012021-06-300000102816eatonvance:C000014194Member2016-09-012021-07-310000102816eatonvance:EATONVANCEIndexMSCIWorld19368BroadBasedIndexMember2016-09-012021-07-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19368AdditionalIndexMember2016-09-012021-07-310000102816eatonvance:EATONVANCEIndexSP50019368AdditionalIndexMember2016-09-012021-07-310000102816eatonvance:C000014194Member2016-09-012021-08-310000102816eatonvance:EATONVANCEIndexMSCIWorld19368BroadBasedIndexMember2016-09-012021-08-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19368AdditionalIndexMember2016-09-012021-08-310000102816eatonvance:EATONVANCEIndexSP50019368AdditionalIndexMember2016-09-012021-08-310000102816eatonvance:C000014194Member2016-09-012021-09-300000102816eatonvance:EATONVANCEIndexMSCIWorld19368BroadBasedIndexMember2016-09-012021-09-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19368AdditionalIndexMember2016-09-012021-09-300000102816eatonvance:EATONVANCEIndexSP50019368AdditionalIndexMember2016-09-012021-09-300000102816eatonvance:C000014194Member2016-09-012021-10-310000102816eatonvance:EATONVANCEIndexMSCIWorld19368BroadBasedIndexMember2016-09-012021-10-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19368AdditionalIndexMember2016-09-012021-10-310000102816eatonvance:EATONVANCEIndexSP50019368AdditionalIndexMember2016-09-012021-10-310000102816eatonvance:C000014194Member2016-09-012021-11-300000102816eatonvance:EATONVANCEIndexMSCIWorld19368BroadBasedIndexMember2016-09-012021-11-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19368AdditionalIndexMember2016-09-012021-11-300000102816eatonvance:EATONVANCEIndexSP50019368AdditionalIndexMember2016-09-012021-11-300000102816eatonvance:C000014194Member2016-09-012021-12-310000102816eatonvance:EATONVANCEIndexMSCIWorld19368BroadBasedIndexMember2016-09-012021-12-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19368AdditionalIndexMember2016-09-012021-12-310000102816eatonvance:EATONVANCEIndexSP50019368AdditionalIndexMember2016-09-012021-12-310000102816eatonvance:C000014194Member2016-09-012022-01-310000102816eatonvance:EATONVANCEIndexMSCIWorld19368BroadBasedIndexMember2016-09-012022-01-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19368AdditionalIndexMember2016-09-012022-01-310000102816eatonvance:EATONVANCEIndexSP50019368AdditionalIndexMember2016-09-012022-01-310000102816eatonvance:C000014194Member2016-09-012022-02-280000102816eatonvance:EATONVANCEIndexMSCIWorld19368BroadBasedIndexMember2016-09-012022-02-280000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19368AdditionalIndexMember2016-09-012022-02-280000102816eatonvance:EATONVANCEIndexSP50019368AdditionalIndexMember2016-09-012022-02-280000102816eatonvance:C000014194Member2016-09-012022-03-310000102816eatonvance:EATONVANCEIndexMSCIWorld19368BroadBasedIndexMember2016-09-012022-03-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19368AdditionalIndexMember2016-09-012022-03-310000102816eatonvance:EATONVANCEIndexSP50019368AdditionalIndexMember2016-09-012022-03-310000102816eatonvance:C000014194Member2016-09-012022-04-300000102816eatonvance:EATONVANCEIndexMSCIWorld19368BroadBasedIndexMember2016-09-012022-04-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19368AdditionalIndexMember2016-09-012022-04-300000102816eatonvance:EATONVANCEIndexSP50019368AdditionalIndexMember2016-09-012022-04-300000102816eatonvance:C000014194Member2016-09-012022-05-310000102816eatonvance:EATONVANCEIndexMSCIWorld19368BroadBasedIndexMember2016-09-012022-05-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19368AdditionalIndexMember2016-09-012022-05-310000102816eatonvance:EATONVANCEIndexSP50019368AdditionalIndexMember2016-09-012022-05-310000102816eatonvance:C000014194Member2016-09-012022-06-300000102816eatonvance:EATONVANCEIndexMSCIWorld19368BroadBasedIndexMember2016-09-012022-06-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19368AdditionalIndexMember2016-09-012022-06-300000102816eatonvance:EATONVANCEIndexSP50019368AdditionalIndexMember2016-09-012022-06-300000102816eatonvance:C000014194Member2016-09-012022-07-310000102816eatonvance:EATONVANCEIndexMSCIWorld19368BroadBasedIndexMember2016-09-012022-07-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19368AdditionalIndexMember2016-09-012022-07-310000102816eatonvance:EATONVANCEIndexSP50019368AdditionalIndexMember2016-09-012022-07-310000102816eatonvance:C000014194Member2016-09-012022-08-310000102816eatonvance:EATONVANCEIndexMSCIWorld19368BroadBasedIndexMember2016-09-012022-08-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19368AdditionalIndexMember2016-09-012022-08-310000102816eatonvance:EATONVANCEIndexSP50019368AdditionalIndexMember2016-09-012022-08-310000102816eatonvance:C000014194Member2016-09-012022-09-300000102816eatonvance:EATONVANCEIndexMSCIWorld19368BroadBasedIndexMember2016-09-012022-09-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19368AdditionalIndexMember2016-09-012022-09-300000102816eatonvance:EATONVANCEIndexSP50019368AdditionalIndexMember2016-09-012022-09-300000102816eatonvance:C000014194Member2016-09-012022-10-310000102816eatonvance:EATONVANCEIndexMSCIWorld19368BroadBasedIndexMember2016-09-012022-10-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19368AdditionalIndexMember2016-09-012022-10-310000102816eatonvance:EATONVANCEIndexSP50019368AdditionalIndexMember2016-09-012022-10-310000102816eatonvance:C000014194Member2016-09-012022-11-300000102816eatonvance:EATONVANCEIndexMSCIWorld19368BroadBasedIndexMember2016-09-012022-11-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19368AdditionalIndexMember2016-09-012022-11-300000102816eatonvance:EATONVANCEIndexSP50019368AdditionalIndexMember2016-09-012022-11-300000102816eatonvance:C000014194Member2016-09-012022-12-310000102816eatonvance:EATONVANCEIndexMSCIWorld19368BroadBasedIndexMember2016-09-012022-12-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19368AdditionalIndexMember2016-09-012022-12-310000102816eatonvance:EATONVANCEIndexSP50019368AdditionalIndexMember2016-09-012022-12-310000102816eatonvance:C000014194Member2016-09-012023-01-310000102816eatonvance:EATONVANCEIndexMSCIWorld19368BroadBasedIndexMember2016-09-012023-01-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19368AdditionalIndexMember2016-09-012023-01-310000102816eatonvance:EATONVANCEIndexSP50019368AdditionalIndexMember2016-09-012023-01-310000102816eatonvance:C000014194Member2016-09-012023-02-280000102816eatonvance:EATONVANCEIndexMSCIWorld19368BroadBasedIndexMember2016-09-012023-02-280000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19368AdditionalIndexMember2016-09-012023-02-280000102816eatonvance:EATONVANCEIndexSP50019368AdditionalIndexMember2016-09-012023-02-280000102816eatonvance:C000014194Member2016-09-012023-03-310000102816eatonvance:EATONVANCEIndexMSCIWorld19368BroadBasedIndexMember2016-09-012023-03-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19368AdditionalIndexMember2016-09-012023-03-310000102816eatonvance:EATONVANCEIndexSP50019368AdditionalIndexMember2016-09-012023-03-310000102816eatonvance:C000014194Member2016-09-012023-04-300000102816eatonvance:EATONVANCEIndexMSCIWorld19368BroadBasedIndexMember2016-09-012023-04-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19368AdditionalIndexMember2016-09-012023-04-300000102816eatonvance:EATONVANCEIndexSP50019368AdditionalIndexMember2016-09-012023-04-300000102816eatonvance:C000014194Member2016-09-012023-05-310000102816eatonvance:EATONVANCEIndexMSCIWorld19368BroadBasedIndexMember2016-09-012023-05-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19368AdditionalIndexMember2016-09-012023-05-310000102816eatonvance:EATONVANCEIndexSP50019368AdditionalIndexMember2016-09-012023-05-310000102816eatonvance:C000014194Member2016-09-012023-06-300000102816eatonvance:EATONVANCEIndexMSCIWorld19368BroadBasedIndexMember2016-09-012023-06-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19368AdditionalIndexMember2016-09-012023-06-300000102816eatonvance:EATONVANCEIndexSP50019368AdditionalIndexMember2016-09-012023-06-300000102816eatonvance:C000014194Member2016-09-012023-07-310000102816eatonvance:EATONVANCEIndexMSCIWorld19368BroadBasedIndexMember2016-09-012023-07-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19368AdditionalIndexMember2016-09-012023-07-310000102816eatonvance:EATONVANCEIndexSP50019368AdditionalIndexMember2016-09-012023-07-310000102816eatonvance:C000014194Member2016-09-012023-08-310000102816eatonvance:EATONVANCEIndexMSCIWorld19368BroadBasedIndexMember2016-09-012023-08-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19368AdditionalIndexMember2016-09-012023-08-310000102816eatonvance:EATONVANCEIndexSP50019368AdditionalIndexMember2016-09-012023-08-310000102816eatonvance:C000014194Member2016-09-012023-09-300000102816eatonvance:EATONVANCEIndexMSCIWorld19368BroadBasedIndexMember2016-09-012023-09-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19368AdditionalIndexMember2016-09-012023-09-300000102816eatonvance:EATONVANCEIndexSP50019368AdditionalIndexMember2016-09-012023-09-300000102816eatonvance:C000014194Member2016-09-012023-10-310000102816eatonvance:EATONVANCEIndexMSCIWorld19368BroadBasedIndexMember2016-09-012023-10-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19368AdditionalIndexMember2016-09-012023-10-310000102816eatonvance:EATONVANCEIndexSP50019368AdditionalIndexMember2016-09-012023-10-310000102816eatonvance:C000014194Member2016-09-012023-11-300000102816eatonvance:EATONVANCEIndexMSCIWorld19368BroadBasedIndexMember2016-09-012023-11-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19368AdditionalIndexMember2016-09-012023-11-300000102816eatonvance:EATONVANCEIndexSP50019368AdditionalIndexMember2016-09-012023-11-300000102816eatonvance:C000014194Member2016-09-012023-12-310000102816eatonvance:EATONVANCEIndexMSCIWorld19368BroadBasedIndexMember2016-09-012023-12-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19368AdditionalIndexMember2016-09-012023-12-310000102816eatonvance:EATONVANCEIndexSP50019368AdditionalIndexMember2016-09-012023-12-310000102816eatonvance:C000014194Member2016-09-012024-01-310000102816eatonvance:EATONVANCEIndexMSCIWorld19368BroadBasedIndexMember2016-09-012024-01-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19368AdditionalIndexMember2016-09-012024-01-310000102816eatonvance:EATONVANCEIndexSP50019368AdditionalIndexMember2016-09-012024-01-310000102816eatonvance:C000014194Member2016-09-012024-02-290000102816eatonvance:EATONVANCEIndexMSCIWorld19368BroadBasedIndexMember2016-09-012024-02-290000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19368AdditionalIndexMember2016-09-012024-02-290000102816eatonvance:EATONVANCEIndexSP50019368AdditionalIndexMember2016-09-012024-02-290000102816eatonvance:C000014194Member2016-09-012024-03-310000102816eatonvance:EATONVANCEIndexMSCIWorld19368BroadBasedIndexMember2016-09-012024-03-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19368AdditionalIndexMember2016-09-012024-03-310000102816eatonvance:EATONVANCEIndexSP50019368AdditionalIndexMember2016-09-012024-03-310000102816eatonvance:C000014194Member2016-09-012024-04-300000102816eatonvance:EATONVANCEIndexMSCIWorld19368BroadBasedIndexMember2016-09-012024-04-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19368AdditionalIndexMember2016-09-012024-04-300000102816eatonvance:EATONVANCEIndexSP50019368AdditionalIndexMember2016-09-012024-04-300000102816eatonvance:C000014194Member2016-09-012024-05-310000102816eatonvance:EATONVANCEIndexMSCIWorld19368BroadBasedIndexMember2016-09-012024-05-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19368AdditionalIndexMember2016-09-012024-05-310000102816eatonvance:EATONVANCEIndexSP50019368AdditionalIndexMember2016-09-012024-05-310000102816eatonvance:C000014194Member2016-09-012024-06-300000102816eatonvance:EATONVANCEIndexMSCIWorld19368BroadBasedIndexMember2016-09-012024-06-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19368AdditionalIndexMember2016-09-012024-06-300000102816eatonvance:EATONVANCEIndexSP50019368AdditionalIndexMember2016-09-012024-06-300000102816eatonvance:C000014194Member2016-09-012024-07-310000102816eatonvance:EATONVANCEIndexMSCIWorld19368BroadBasedIndexMember2016-09-012024-07-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19368AdditionalIndexMember2016-09-012024-07-310000102816eatonvance:EATONVANCEIndexSP50019368AdditionalIndexMember2016-09-012024-07-310000102816eatonvance:C000014194Member2016-09-012024-08-310000102816eatonvance:EATONVANCEIndexMSCIWorld19368BroadBasedIndexMember2016-09-012024-08-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19368AdditionalIndexMember2016-09-012024-08-310000102816eatonvance:EATONVANCEIndexSP50019368AdditionalIndexMember2016-09-012024-08-310000102816eatonvance:C000014194Member2016-09-012024-09-300000102816eatonvance:EATONVANCEIndexMSCIWorld19368BroadBasedIndexMember2016-09-012024-09-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19368AdditionalIndexMember2016-09-012024-09-300000102816eatonvance:EATONVANCEIndexSP50019368AdditionalIndexMember2016-09-012024-09-300000102816eatonvance:C000014194Member2016-09-012024-10-310000102816eatonvance:EATONVANCEIndexMSCIWorld19368BroadBasedIndexMember2016-09-012024-10-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19368AdditionalIndexMember2016-09-012024-10-310000102816eatonvance:EATONVANCEIndexSP50019368AdditionalIndexMember2016-09-012024-10-310000102816eatonvance:C000014194Member2016-09-012024-11-300000102816eatonvance:EATONVANCEIndexMSCIWorld19368BroadBasedIndexMember2016-09-012024-11-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19368AdditionalIndexMember2016-09-012024-11-300000102816eatonvance:EATONVANCEIndexSP50019368AdditionalIndexMember2016-09-012024-11-300000102816eatonvance:C000014194Member2016-09-012024-12-310000102816eatonvance:EATONVANCEIndexMSCIWorld19368BroadBasedIndexMember2016-09-012024-12-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19368AdditionalIndexMember2016-09-012024-12-310000102816eatonvance:EATONVANCEIndexSP50019368AdditionalIndexMember2016-09-012024-12-310000102816eatonvance:C000014194Member2016-09-012025-01-310000102816eatonvance:EATONVANCEIndexMSCIWorld19368BroadBasedIndexMember2016-09-012025-01-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19368AdditionalIndexMember2016-09-012025-01-310000102816eatonvance:EATONVANCEIndexSP50019368AdditionalIndexMember2016-09-012025-01-310000102816eatonvance:C000014194Member2016-09-012025-02-280000102816eatonvance:EATONVANCEIndexMSCIWorld19368BroadBasedIndexMember2016-09-012025-02-280000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19368AdditionalIndexMember2016-09-012025-02-280000102816eatonvance:EATONVANCEIndexSP50019368AdditionalIndexMember2016-09-012025-02-280000102816eatonvance:C000014194Member2016-09-012025-03-310000102816eatonvance:EATONVANCEIndexMSCIWorld19368BroadBasedIndexMember2016-09-012025-03-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19368AdditionalIndexMember2016-09-012025-03-310000102816eatonvance:EATONVANCEIndexSP50019368AdditionalIndexMember2016-09-012025-03-310000102816eatonvance:C000014194Member2016-09-012025-04-300000102816eatonvance:EATONVANCEIndexMSCIWorld19368BroadBasedIndexMember2016-09-012025-04-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19368AdditionalIndexMember2016-09-012025-04-300000102816eatonvance:EATONVANCEIndexSP50019368AdditionalIndexMember2016-09-012025-04-300000102816eatonvance:C000014194Member2016-09-012025-05-310000102816eatonvance:EATONVANCEIndexMSCIWorld19368BroadBasedIndexMember2016-09-012025-05-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19368AdditionalIndexMember2016-09-012025-05-310000102816eatonvance:EATONVANCEIndexSP50019368AdditionalIndexMember2016-09-012025-05-310000102816eatonvance:C000014194Member2016-09-012025-06-300000102816eatonvance:EATONVANCEIndexMSCIWorld19368BroadBasedIndexMember2016-09-012025-06-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19368AdditionalIndexMember2016-09-012025-06-300000102816eatonvance:EATONVANCEIndexSP50019368AdditionalIndexMember2016-09-012025-06-300000102816eatonvance:C000014194Member2016-09-012025-07-310000102816eatonvance:EATONVANCEIndexMSCIWorld19368BroadBasedIndexMember2016-09-012025-07-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19368AdditionalIndexMember2016-09-012025-07-310000102816eatonvance:EATONVANCEIndexSP50019368AdditionalIndexMember2016-09-012025-07-310000102816eatonvance:C000014194Member2016-09-012025-08-310000102816eatonvance:EATONVANCEIndexMSCIWorld19368BroadBasedIndexMember2016-09-012025-08-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19368AdditionalIndexMember2016-09-012025-08-310000102816eatonvance:EATONVANCEIndexSP50019368AdditionalIndexMember2016-09-012025-08-310000102816eatonvance:C000014194Member2016-09-012025-09-300000102816eatonvance:EATONVANCEIndexMSCIWorld19368BroadBasedIndexMember2016-09-012025-09-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19368AdditionalIndexMember2016-09-012025-09-300000102816eatonvance:EATONVANCEIndexSP50019368AdditionalIndexMember2016-09-012025-09-300000102816eatonvance:C000014194Member2016-09-012025-10-310000102816eatonvance:EATONVANCEIndexMSCIWorld19368BroadBasedIndexMember2016-09-012025-10-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19368AdditionalIndexMember2016-09-012025-10-310000102816eatonvance:EATONVANCEIndexSP50019368AdditionalIndexMember2016-09-012025-10-310000102816eatonvance:C000014194Member2016-09-012025-11-300000102816eatonvance:EATONVANCEIndexMSCIWorld19368BroadBasedIndexMember2016-09-012025-11-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19368AdditionalIndexMember2016-09-012025-11-300000102816eatonvance:EATONVANCEIndexSP50019368AdditionalIndexMember2016-09-012025-11-300000102816eatonvance:C000014194Member2016-09-012025-12-310000102816eatonvance:EATONVANCEIndexMSCIWorld19368BroadBasedIndexMember2016-09-012025-12-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19368AdditionalIndexMember2016-09-012025-12-310000102816eatonvance:EATONVANCEIndexSP50019368AdditionalIndexMember2016-09-012025-12-310000102816eatonvance:C000014194Member2016-09-012026-01-310000102816eatonvance:EATONVANCEIndexMSCIWorld19368BroadBasedIndexMember2016-09-012026-01-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19368AdditionalIndexMember2016-09-012026-01-310000102816eatonvance:EATONVANCEIndexSP50019368AdditionalIndexMember2016-09-012026-01-310000102816eatonvance:C000014194Member2016-09-012026-02-280000102816eatonvance:EATONVANCEIndexMSCIWorld19368BroadBasedIndexMember2016-09-012026-02-280000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19368AdditionalIndexMember2016-09-012026-02-280000102816eatonvance:EATONVANCEIndexSP50019368AdditionalIndexMember2016-09-012026-02-280000102816eatonvance:C000014194Member2016-09-012026-03-310000102816eatonvance:EATONVANCEIndexMSCIWorld19368BroadBasedIndexMember2016-09-012026-03-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19368AdditionalIndexMember2016-09-012026-03-310000102816eatonvance:EATONVANCEIndexSP50019368AdditionalIndexMember2016-09-012026-03-310000102816eatonvance:C000014194Member2016-09-012026-04-300000102816eatonvance:EATONVANCEIndexMSCIWorld19368BroadBasedIndexMember2016-09-012026-04-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19368AdditionalIndexMember2016-09-012026-04-300000102816eatonvance:EATONVANCEIndexSP50019368AdditionalIndexMember2016-09-012026-04-300000102816eatonvance:C000014194Member2016-09-012026-05-310000102816eatonvance:EATONVANCEIndexMSCIWorld19368BroadBasedIndexMember2016-09-012026-05-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19368AdditionalIndexMember2016-09-012026-05-310000102816eatonvance:EATONVANCEIndexSP50019368AdditionalIndexMember2016-09-012026-05-310000102816eatonvance:C000014194Member2016-09-012026-06-300000102816eatonvance:EATONVANCEIndexMSCIWorld19368BroadBasedIndexMember2016-09-012026-06-300000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19368AdditionalIndexMember2016-09-012026-06-300000102816eatonvance:EATONVANCEIndexSP50019368AdditionalIndexMember2016-09-012026-06-300000102816eatonvance:C000014194Member2016-09-012026-07-310000102816eatonvance:EATONVANCEIndexMSCIWorld19368BroadBasedIndexMember2016-09-012026-07-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19368AdditionalIndexMember2016-09-012026-07-310000102816eatonvance:EATONVANCEIndexSP50019368AdditionalIndexMember2016-09-012026-07-310000102816eatonvance:C000014194Member2016-09-012026-08-310000102816eatonvance:EATONVANCEIndexMSCIWorld19368BroadBasedIndexMember2016-09-012026-08-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19368AdditionalIndexMember2016-09-012026-08-310000102816eatonvance:EATONVANCEIndexSP50019368AdditionalIndexMember2016-09-012026-08-310000102816eatonvance:C000014194Memberoef:WithoutSalesLoadMember2025-09-012026-08-310000102816eatonvance:C000014194Memberoef:WithoutSalesLoadMember2021-09-012026-08-310000102816eatonvance:C000014194Memberoef:WithoutSalesLoadMember2016-09-012026-08-310000102816eatonvance:EATONVANCEIndexMSCIWorld19368BroadBasedIndexMember2021-09-012026-08-310000102816eatonvance:EATONVANCEIndexMSCIWorldHealthCareIndex19368AdditionalIndexMember2021-09-012026-08-310000102816eatonvance:EATONVANCEIndexSP50019368AdditionalIndexMember2021-09-012026-08-310000102816eatonvance:C000014194Member2026-08-310000102816eatonvance:C000014194Membereatonvance:ShortMinusTermInvestmentsSectorMember2026-08-310000102816eatonvance:C000014194Membereatonvance:HealthCareTechnologySectorMember2026-08-310000102816eatonvance:C000014194Membereatonvance:HealthCareSuppliesSectorMember2026-08-310000102816eatonvance:C000014194Membereatonvance:HealthCareServicesSectorMember2026-08-310000102816eatonvance:C000014194Membereatonvance:ManagedHealthCareSectorMember2026-08-310000102816eatonvance:C000014194Membereatonvance:LifeSciencesToolsServicesSectorMember2026-08-310000102816eatonvance:C000014194Membereatonvance:HealthCareEquipmentSectorMember2026-08-310000102816eatonvance:C000014194Membereatonvance:BiotechnologySectorMember2026-08-310000102816eatonvance:C000014194Membereatonvance:PharmaceuticalsSectorMember2026-08-310000102816eatonvance:C000014194Membereatonvance:FR532457108CTIMember2026-08-310000102816eatonvance:C000014194Membereatonvance:FR478160104CTIMember2026-08-310000102816eatonvance:C000014194Membereatonvance:FR00287Y109CTIMember2026-08-310000102816eatonvance:C000014194Membereatonvance:FR58933Y105CTIMember2026-08-310000102816eatonvance:C000014194Membereatonvance:FRACI38LVK6CTIMember2026-08-310000102816eatonvance:C000014194Membereatonvance:FR91324P102CTIMember2026-08-310000102816eatonvance:C000014194Membereatonvance:FR098952906CTIMember2026-08-310000102816eatonvance:C000014194Membereatonvance:FR110122108CTIMember2026-08-310000102816eatonvance:C000014194Membereatonvance:FR92532F100CTIMember2026-08-310000102816eatonvance:C000014194Membereatonvance:FR002824100CTIMember2026-08-310000102816eatonvance:C000014194Membereatonvance:AbbottLaboratoriesCTIMember2026-08-31iso4217:USDxbrli:sharesiso4217:USDxbrli:sharesxbrli:pureutr:Deatonvance:Holding
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form N-CSR
CERTIFIED SHAREHOLDER REPORT OF REGISTERED
MANAGEMENT INVESTMENT COMPANIES
Investment Company Act File Number: 811-01241
Eaton Vance Growth Trust
(Exact Name of Registrant as Specified in Charter)
One Post Office Square, Boston, Massachusetts 02109
(Address of Principal Executive Offices)
Deidre E. Walsh
One Post Office Square, Boston, Massachusetts 02109
(Name and Address of Agent for Services)
(617) 482-8260
(Registrant’s Telephone Number)
August 31
Date of Fiscal Year End
August 31, 2026
Date of Reporting Period
Item 1. Reports to Stockholders
(a)
Eaton Vance All Asset Strategy Fund
Annual Shareholder Report August 31, 2026
This annual shareholder report contains important information about the Eaton Vance All Asset Strategy Fund for the period of September 1, 2025 to August 31, 2026. You can find additional information about the Fund at www.eatonvance.com/open-end-mutual-fund-documents.php. You can also request this information by contacting us at 1-800-262-1122.
This report describes changes to the Fund that occurred during the reporting period.
What were the Fund costs for the last year?
(based on a hypothetical $10,000 investment)
Table Summary
Class Name |
Costs of a $10,000 investment |
Costs paid as a percentage of a $10,000 investment |
Class A |
$108 |
1.01% |
How did the Fund perform last year and what affected its performance?
Key contributors to (↑) and detractors from (↓) performance, relative to 60% MSCI ACWI Index/40% Bloomberg U.S. Aggregate Bond Index (the Blended Index):
↑ An overweight exposure to equities and an underweight exposure to fixed income assets helped relative returns
↑ An overweight exposure to emerging markets (EM), particularly South Korea and Taiwan, contributed to performance
↑ An overweight exposure to EM government bonds also added to returns
↓ Exposure to the global equities basket detracted from performance
↓ Exposure to Treasury Inflation-Protected Securities mildly detracted from performance
Comparison of the change in value of a $10,000 investment for the period indicated.

Table Summary
|
Class A with Maximum Sales Charge |
MSCI World Index |
MSCI ACWI Index |
Bloomberg U.S. Aggregate Bond Index |
8/16 |
$10,000 |
$10,000 |
$10,000 |
$10,000 |
9/16 |
$9,526 |
$10,053 |
$10,061 |
$9,994 |
10/16 |
$9,395 |
$9,859 |
$9,891 |
$9,918 |
11/16 |
$9,417 |
$10,000 |
$9,966 |
$9,683 |
12/16 |
$9,578 |
$10,240 |
$10,181 |
$9,697 |
1/17 |
$9,760 |
$10,487 |
$10,459 |
$9,716 |
2/17 |
$9,935 |
$10,778 |
$10,753 |
$9,781 |
3/17 |
$10,008 |
$10,892 |
$10,884 |
$9,776 |
4/17 |
$10,081 |
$11,054 |
$11,054 |
$9,851 |
5/17 |
$10,147 |
$11,288 |
$11,298 |
$9,927 |
6/17 |
$10,198 |
$11,331 |
$11,349 |
$9,917 |
7/17 |
$10,438 |
$11,602 |
$11,667 |
$9,960 |
8/17 |
$10,445 |
$11,619 |
$11,711 |
$10,049 |
9/17 |
$10,584 |
$11,879 |
$11,938 |
$10,001 |
10/17 |
$10,773 |
$12,104 |
$12,185 |
$10,007 |
11/17 |
$10,861 |
$12,366 |
$12,421 |
$9,994 |
12/17 |
$10,986 |
$12,533 |
$12,622 |
$10,040 |
1/18 |
$11,492 |
$13,195 |
$13,334 |
$9,925 |
2/18 |
$11,113 |
$12,648 |
$12,774 |
$9,831 |
3/18 |
$10,927 |
$12,373 |
$12,500 |
$9,894 |
4/18 |
$10,860 |
$12,515 |
$12,620 |
$9,820 |
5/18 |
$11,016 |
$12,593 |
$12,635 |
$9,890 |
6/18 |
$10,904 |
$12,587 |
$12,567 |
$9,878 |
7/18 |
$11,157 |
$12,980 |
$12,946 |
$9,880 |
8/18 |
$11,247 |
$13,141 |
$13,048 |
$9,944 |
9/18 |
$11,276 |
$13,214 |
$13,104 |
$9,880 |
10/18 |
$10,569 |
$12,244 |
$12,122 |
$9,802 |
11/18 |
$10,703 |
$12,383 |
$12,300 |
$9,860 |
12/18 |
$10,148 |
$11,441 |
$11,433 |
$10,041 |
1/19 |
$10,500 |
$12,332 |
$12,336 |
$10,148 |
2/19 |
$10,675 |
$12,703 |
$12,666 |
$10,142 |
3/19 |
$10,782 |
$12,869 |
$12,825 |
$10,337 |
4/19 |
$10,912 |
$13,326 |
$13,258 |
$10,340 |
5/19 |
$10,629 |
$12,557 |
$12,472 |
$10,523 |
6/19 |
$10,950 |
$13,384 |
$13,289 |
$10,655 |
7/19 |
$10,958 |
$13,451 |
$13,327 |
$10,679 |
8/19 |
$10,973 |
$13,175 |
$13,011 |
$10,955 |
9/19 |
$11,004 |
$13,456 |
$13,285 |
$10,897 |
10/19 |
$11,110 |
$13,798 |
$13,649 |
$10,930 |
11/19 |
$11,240 |
$14,182 |
$13,982 |
$10,924 |
12/19 |
$11,417 |
$14,607 |
$14,474 |
$10,917 |
1/20 |
$11,473 |
$14,518 |
$14,314 |
$11,127 |
2/20 |
$11,226 |
$13,291 |
$13,158 |
$11,327 |
3/20 |
$10,692 |
$11,532 |
$11,382 |
$11,260 |
4/20 |
$11,154 |
$12,792 |
$12,601 |
$11,460 |
5/20 |
$11,346 |
$13,410 |
$13,149 |
$11,514 |
6/20 |
$11,465 |
$13,765 |
$13,569 |
$11,586 |
7/20 |
$11,792 |
$14,423 |
$14,287 |
$11,759 |
8/20 |
$12,063 |
$15,387 |
$15,161 |
$11,665 |
9/20 |
$11,895 |
$14,856 |
$14,672 |
$11,658 |
10/20 |
$11,712 |
$14,400 |
$14,316 |
$11,606 |
11/20 |
$12,302 |
$16,242 |
$16,080 |
$11,720 |
12/20 |
$12,509 |
$16,930 |
$16,827 |
$11,736 |
1/21 |
$12,402 |
$16,762 |
$16,751 |
$11,652 |
2/21 |
$12,558 |
$17,192 |
$17,139 |
$11,484 |
3/21 |
$12,755 |
$17,764 |
$17,596 |
$11,340 |
4/21 |
$13,018 |
$18,590 |
$18,366 |
$11,430 |
5/21 |
$13,182 |
$18,858 |
$18,651 |
$11,467 |
6/21 |
$13,198 |
$19,139 |
$18,897 |
$11,548 |
7/21 |
$13,157 |
$19,482 |
$19,027 |
$11,677 |
8/21 |
$13,296 |
$19,967 |
$19,504 |
$11,655 |
9/21 |
$12,952 |
$19,138 |
$18,698 |
$11,554 |
10/21 |
$13,255 |
$20,222 |
$19,652 |
$11,551 |
11/21 |
$13,059 |
$19,779 |
$19,179 |
$11,585 |
12/21 |
$13,376 |
$20,624 |
$19,946 |
$11,555 |
1/22 |
$13,030 |
$19,533 |
$18,967 |
$11,306 |
2/22 |
$12,805 |
$19,039 |
$18,477 |
$11,180 |
3/22 |
$12,805 |
$19,561 |
$18,877 |
$10,869 |
4/22 |
$12,191 |
$17,936 |
$17,366 |
$10,457 |
5/22 |
$12,242 |
$17,950 |
$17,386 |
$10,524 |
6/22 |
$11,715 |
$16,395 |
$15,921 |
$10,359 |
7/22 |
$12,104 |
$17,697 |
$17,033 |
$10,612 |
8/22 |
$11,663 |
$16,957 |
$16,406 |
$10,313 |
9/22 |
$10,901 |
$15,380 |
$14,835 |
$9,867 |
10/22 |
$10,945 |
$16,485 |
$15,730 |
$9,739 |
11/22 |
$11,620 |
$17,631 |
$16,950 |
$10,097 |
12/22 |
$11,381 |
$16,882 |
$16,283 |
$10,052 |
1/23 |
$11,852 |
$18,077 |
$17,451 |
$10,361 |
2/23 |
$11,486 |
$17,642 |
$16,950 |
$10,093 |
3/23 |
$11,887 |
$18,188 |
$17,473 |
$10,350 |
4/23 |
$12,009 |
$18,506 |
$17,724 |
$10,412 |
5/23 |
$11,791 |
$18,322 |
$17,534 |
$10,299 |
6/23 |
$11,939 |
$19,430 |
$18,552 |
$10,262 |
7/23 |
$12,000 |
$20,082 |
$19,232 |
$10,255 |
8/23 |
$11,774 |
$19,603 |
$18,694 |
$10,189 |
9/23 |
$11,294 |
$18,757 |
$17,921 |
$9,931 |
10/23 |
$11,032 |
$18,213 |
$17,382 |
$9,774 |
11/23 |
$11,669 |
$19,920 |
$18,987 |
$10,216 |
12/23 |
$12,118 |
$20,898 |
$19,899 |
$10,608 |
1/24 |
$12,056 |
$21,149 |
$20,015 |
$10,578 |
2/24 |
$12,198 |
$22,046 |
$20,874 |
$10,429 |
3/24 |
$12,421 |
$22,754 |
$21,530 |
$10,525 |
4/24 |
$12,118 |
$21,909 |
$20,819 |
$10,259 |
5/24 |
$12,475 |
$22,887 |
$21,665 |
$10,433 |
6/24 |
$12,627 |
$23,353 |
$22,147 |
$10,532 |
7/24 |
$12,930 |
$23,765 |
$22,504 |
$10,778 |
8/24 |
$13,109 |
$24,393 |
$23,076 |
$10,933 |
9/24 |
$13,287 |
$24,839 |
$23,612 |
$11,079 |
10/24 |
$13,010 |
$24,347 |
$23,082 |
$10,805 |
11/24 |
$13,323 |
$25,464 |
$23,945 |
$10,919 |
12/24 |
$13,019 |
$24,800 |
$23,379 |
$10,740 |
1/25 |
$13,201 |
$25,675 |
$24,163 |
$10,797 |
2/25 |
$13,237 |
$25,491 |
$24,018 |
$11,035 |
3/25 |
$12,982 |
$24,356 |
$23,069 |
$11,039 |
4/25 |
$13,091 |
$24,572 |
$23,284 |
$11,082 |
5/25 |
$13,356 |
$26,027 |
$24,622 |
$11,003 |
6/25 |
$13,702 |
$27,150 |
$25,728 |
$11,172 |
7/25 |
$13,693 |
$27,499 |
$26,077 |
$11,143 |
8/25 |
$13,902 |
$28,217 |
$26,721 |
$11,276 |
9/25 |
$14,248 |
$29,124 |
$27,689 |
$11,399 |
10/25 |
$14,494 |
$29,707 |
$28,309 |
$11,470 |
11/25 |
$14,540 |
$29,791 |
$28,305 |
$11,541 |
12/25 |
$14,657 |
$30,032 |
$28,601 |
$11,524 |
1/26 |
$15,021 |
$30,704 |
$29,449 |
$11,537 |
2/26 |
$15,189 |
$30,929 |
$29,827 |
$11,726 |
3/26 |
$14,395 |
$28,959 |
$27,685 |
$11,519 |
4/26 |
$15,311 |
$31,736 |
$30,502 |
$11,532 |
5/26 |
$15,731 |
$33,181 |
$32,075 |
$11,568 |
6/26 |
$15,787 |
$32,943 |
$31,818 |
$11,596 |
7/26 |
$15,581 |
$33,112 |
$31,842 |
$11,445 |
8/26 |
$15,857 |
$33,965 |
$32,693 |
$11,489 |
Average Annual Total Returns (%)Footnote Reference1
Table Summary
Fund |
1 Year |
5 Years |
10 Years |
Class A |
14.03% |
3.58% |
5.28% |
Class A with 5.25% Maximum Sales Charge |
8.01% |
2.46% |
4.72% |
MSCI World Index (net of foreign withholding taxes) |
20.37% |
11.20% |
13.00% |
MSCI ACWI Index (net of foreign withholding taxes) |
22.35% |
10.88% |
12.57% |
Bloomberg U.S. Aggregate Bond Index |
1.89% |
(0.29)% |
1.40% |
Blended Index (60% MSCI ACWI Index/40% Bloomberg U.S. Aggregate Bond Index) |
13.95% |
6.45% |
8.20% |
| Footnote |
Description |
Footnote1 |
Performance prior to August 18, 2025 reflects the Fund’s performance under its former principal investment strategies and is that of the Fund’s former investment sub-adviser. |
Performance does not reflect the deduction of taxes that a shareholder would pay on Fund distributions or redemption of Fund shares. Performance assumes that all dividends and distributions, if any, were reinvested. For more recent performance information, visit www.eatonvance.com/performance.php.
THE FUND'S PAST PERFORMANCE IS NO GUARANTEE OF FUTURE RESULTS.
Table Summary
Total Net Assets |
$206,898,592 |
# of Portfolio Holdings |
232 |
Portfolio Turnover Rate |
107% |
Total Advisory Fees Paid |
$1,310,691 |
What did the Fund invest in?
The following tables reflect what the Fund invested in as of the report date.
Asset Allocation (% of total investments)
Table Summary
Value |
Value |
Sovereign Government Bonds |
3.1% |
Short-Term Investments |
4.4% |
Exchange-Traded Funds |
37.2% |
Common Stocks |
55.3% |
Top Ten Holdings (% of total investments)Footnote Referencea
Table Summary
Eaton Vance Total Return Bond ETF |
11.0% |
Eaton Vance Mortgage Opportunities ETF |
8.6% |
Vanguard Emerging Markets Government Bond ETF |
5.0% |
iShares Core MSCI Emerging Markets ETF |
5.0% |
iShares TIPS Bond ETF |
3.5% |
NVIDIA Corp. |
3.2% |
Brazil Letras do Tesouro Nacional, 0.00%, 1/1/29 |
3.1% |
Microsoft Corp. |
2.5% |
Apple, Inc. |
2.4% |
Amazon.com, Inc. |
1.7% |
Total |
46.0% |
| Footnote |
Description |
Footnotea |
Excluding cash equivalents |
This is a summary of certain changes to the Fund since August 31, 2025. For more complete information, you may review the Fund’s next prospectus, which we expect to be available by January 1, 2027 at www.eatonvance.com/open-end-mutual-fund-documents.php or upon request by contacting us at 1-800-262-1122.
The net expense ratio decreased from the prior fiscal year primarily because the reduction in the investment adviser and administration fee and the agreement to reimburse the Fund’s expenses, both effective August 18, 2025, were in effect throughout the current fiscal year. The decrease also reflected a reduction in the investment adviser and administration fee due to the Fund’s investments in affiliated funds.
If you wish to view additional information about the Fund, including the prospectus, statement of additional information, financial statements and holdings, please scan the QR code or visit www.eatonvance.com/open-end-mutual-fund-documents.php. For proxy information, please visit www.eatonvance.com/proxyvoting.
The Funds may deliver a single copy of certain required shareholder documents (including prospectuses, shareholder reports, and proxy materials) to investors with the same last name and the same address. Your participation will continue indefinitely unless you instruct otherwise by calling 1-800-262-1122 or by contacting your financial intermediary. Your instruction will typically be effective within 30 days of receipt.
Not FDIC Insured | May Lose Value | No Bank Guarantee
Annual Shareholder Report August 31, 2026
Eaton Vance All Asset Strategy Fund
Annual Shareholder Report August 31, 2026
This annual shareholder report contains important information about the Eaton Vance All Asset Strategy Fund for the period of September 1, 2025 to August 31, 2026. You can find additional information about the Fund at www.eatonvance.com/open-end-mutual-fund-documents.php. You can also request this information by contacting us at 1-800-262-1122.
This report describes changes to the Fund that occurred during the reporting period.
What were the Fund costs for the last year?
(based on a hypothetical $10,000 investment)
Table Summary
Class Name |
Costs of a $10,000 investment |
Costs paid as a percentage of a $10,000 investment |
Class C |
$188 |
1.76% |
How did the Fund perform last year and what affected its performance?
Key contributors to (↑) and detractors from (↓) performance, relative to 60% MSCI ACWI Index/40% Bloomberg U.S. Aggregate Bond Index (the Blended Index):
↓ Exposure to the global equities basket detracted from performance
↓ Exposure to Treasury Inflation-Protected Securities mildly detracted from performance
↑ An overweight exposure to equities and an underweight exposure to fixed income assets helped relative returns
↑ An overweight exposure to emerging markets (EM), particularly South Korea and Taiwan, contributed to performance
↑ An overweight exposure to EM government bonds also added to returns
Comparison of the change in value of a $10,000 investment for the period indicated.

Table Summary
|
Class C |
MSCI World Index |
MSCI ACWI Index |
Bloomberg U.S. Aggregate Bond Index |
8/16 |
$10,000 |
$10,000 |
$10,000 |
$10,000 |
9/16 |
$10,047 |
$10,053 |
$10,061 |
$9,994 |
10/16 |
$9,899 |
$9,859 |
$9,891 |
$9,918 |
11/16 |
$9,922 |
$10,000 |
$9,966 |
$9,683 |
12/16 |
$10,078 |
$10,240 |
$10,181 |
$9,697 |
1/17 |
$10,265 |
$10,487 |
$10,459 |
$9,716 |
2/17 |
$10,444 |
$10,778 |
$10,753 |
$9,781 |
3/17 |
$10,507 |
$10,892 |
$10,884 |
$9,776 |
4/17 |
$10,577 |
$11,054 |
$11,054 |
$9,851 |
5/17 |
$10,647 |
$11,288 |
$11,298 |
$9,927 |
6/17 |
$10,694 |
$11,331 |
$11,349 |
$9,917 |
7/17 |
$10,935 |
$11,602 |
$11,667 |
$9,960 |
8/17 |
$10,935 |
$11,619 |
$11,711 |
$10,049 |
9/17 |
$11,083 |
$11,879 |
$11,938 |
$10,001 |
10/17 |
$11,263 |
$12,104 |
$12,185 |
$10,007 |
11/17 |
$11,348 |
$12,366 |
$12,421 |
$9,994 |
12/17 |
$11,477 |
$12,533 |
$12,622 |
$10,040 |
1/18 |
$11,991 |
$13,195 |
$13,334 |
$9,925 |
2/18 |
$11,588 |
$12,648 |
$12,774 |
$9,831 |
3/18 |
$11,390 |
$12,373 |
$12,500 |
$9,894 |
4/18 |
$11,319 |
$12,515 |
$12,620 |
$9,820 |
5/18 |
$11,469 |
$12,593 |
$12,635 |
$9,890 |
6/18 |
$11,343 |
$12,587 |
$12,567 |
$9,878 |
7/18 |
$11,604 |
$12,980 |
$12,946 |
$9,880 |
8/18 |
$11,690 |
$13,141 |
$13,048 |
$9,944 |
9/18 |
$11,714 |
$13,214 |
$13,104 |
$9,880 |
10/18 |
$10,971 |
$12,244 |
$12,122 |
$9,802 |
11/18 |
$11,106 |
$12,383 |
$12,300 |
$9,860 |
12/18 |
$10,522 |
$11,441 |
$11,433 |
$10,041 |
1/19 |
$10,885 |
$12,332 |
$12,336 |
$10,148 |
2/19 |
$11,054 |
$12,703 |
$12,666 |
$10,142 |
3/19 |
$11,159 |
$12,869 |
$12,825 |
$10,337 |
4/19 |
$11,288 |
$13,326 |
$13,258 |
$10,340 |
5/19 |
$10,982 |
$12,557 |
$12,472 |
$10,523 |
6/19 |
$11,313 |
$13,384 |
$13,289 |
$10,655 |
7/19 |
$11,313 |
$13,451 |
$13,327 |
$10,679 |
8/19 |
$11,321 |
$13,175 |
$13,011 |
$10,955 |
9/19 |
$11,345 |
$13,456 |
$13,285 |
$10,897 |
10/19 |
$11,450 |
$13,798 |
$13,649 |
$10,930 |
11/19 |
$11,571 |
$14,182 |
$13,982 |
$10,924 |
12/19 |
$11,745 |
$14,607 |
$14,474 |
$10,917 |
1/20 |
$11,795 |
$14,518 |
$14,314 |
$11,127 |
2/20 |
$11,536 |
$13,291 |
$13,158 |
$11,327 |
3/20 |
$10,985 |
$11,532 |
$11,382 |
$11,260 |
4/20 |
$11,444 |
$12,792 |
$12,601 |
$11,460 |
5/20 |
$11,637 |
$13,410 |
$13,149 |
$11,514 |
6/20 |
$11,754 |
$13,765 |
$13,569 |
$11,586 |
7/20 |
$12,088 |
$14,423 |
$14,287 |
$11,759 |
8/20 |
$12,356 |
$15,387 |
$15,161 |
$11,665 |
9/20 |
$12,172 |
$14,856 |
$14,672 |
$11,658 |
10/20 |
$11,979 |
$14,400 |
$14,316 |
$11,606 |
11/20 |
$12,573 |
$16,242 |
$16,080 |
$11,720 |
12/20 |
$12,774 |
$16,930 |
$16,827 |
$11,736 |
1/21 |
$12,663 |
$16,762 |
$16,751 |
$11,652 |
2/21 |
$12,809 |
$17,192 |
$17,139 |
$11,484 |
3/21 |
$13,005 |
$17,764 |
$17,596 |
$11,340 |
4/21 |
$13,262 |
$18,590 |
$18,366 |
$11,430 |
5/21 |
$13,424 |
$18,858 |
$18,651 |
$11,467 |
6/21 |
$13,432 |
$19,139 |
$18,897 |
$11,548 |
7/21 |
$13,373 |
$19,482 |
$19,027 |
$11,677 |
8/21 |
$13,509 |
$19,967 |
$19,504 |
$11,655 |
9/21 |
$13,159 |
$19,138 |
$18,698 |
$11,554 |
10/21 |
$13,450 |
$20,222 |
$19,652 |
$11,551 |
11/21 |
$13,244 |
$19,779 |
$19,179 |
$11,585 |
12/21 |
$13,554 |
$20,624 |
$19,946 |
$11,555 |
1/22 |
$13,205 |
$19,533 |
$18,967 |
$11,306 |
2/22 |
$12,963 |
$19,039 |
$18,477 |
$11,180 |
3/22 |
$12,954 |
$19,561 |
$18,877 |
$10,869 |
4/22 |
$12,327 |
$17,936 |
$17,366 |
$10,457 |
5/22 |
$12,372 |
$17,950 |
$17,386 |
$10,524 |
6/22 |
$11,835 |
$16,395 |
$15,921 |
$10,359 |
7/22 |
$12,220 |
$17,697 |
$17,033 |
$10,612 |
8/22 |
$11,763 |
$16,957 |
$16,406 |
$10,313 |
9/22 |
$10,993 |
$15,380 |
$14,835 |
$9,867 |
10/22 |
$11,020 |
$16,485 |
$15,730 |
$9,739 |
11/22 |
$11,692 |
$17,631 |
$16,950 |
$10,097 |
12/22 |
$11,443 |
$16,882 |
$16,283 |
$10,052 |
1/23 |
$11,918 |
$18,077 |
$17,451 |
$10,361 |
2/23 |
$11,550 |
$17,642 |
$16,950 |
$10,093 |
3/23 |
$11,935 |
$18,188 |
$17,473 |
$10,350 |
4/23 |
$12,052 |
$18,506 |
$17,724 |
$10,412 |
5/23 |
$11,828 |
$18,322 |
$17,534 |
$10,299 |
6/23 |
$11,971 |
$19,430 |
$18,552 |
$10,262 |
7/23 |
$12,025 |
$20,082 |
$19,232 |
$10,255 |
8/23 |
$11,792 |
$19,603 |
$18,694 |
$10,189 |
9/23 |
$11,300 |
$18,757 |
$17,921 |
$9,931 |
10/23 |
$11,031 |
$18,213 |
$17,382 |
$9,774 |
11/23 |
$11,658 |
$19,920 |
$18,987 |
$10,216 |
12/23 |
$12,103 |
$20,898 |
$19,899 |
$10,608 |
1/24 |
$12,031 |
$21,149 |
$20,015 |
$10,578 |
2/24 |
$12,167 |
$22,046 |
$20,874 |
$10,429 |
3/24 |
$12,385 |
$22,754 |
$21,530 |
$10,525 |
4/24 |
$12,067 |
$21,909 |
$20,819 |
$10,259 |
5/24 |
$12,421 |
$22,887 |
$21,665 |
$10,433 |
6/24 |
$12,567 |
$23,353 |
$22,147 |
$10,532 |
7/24 |
$12,857 |
$23,765 |
$22,504 |
$10,778 |
8/24 |
$13,030 |
$24,393 |
$23,076 |
$10,933 |
9/24 |
$13,194 |
$24,839 |
$23,612 |
$11,079 |
10/24 |
$12,912 |
$24,347 |
$23,082 |
$10,805 |
11/24 |
$13,212 |
$25,464 |
$23,945 |
$10,919 |
12/24 |
$12,905 |
$24,800 |
$23,379 |
$10,740 |
1/25 |
$13,070 |
$25,675 |
$24,163 |
$10,797 |
2/25 |
$13,107 |
$25,491 |
$24,018 |
$11,035 |
3/25 |
$12,850 |
$24,356 |
$23,069 |
$11,039 |
4/25 |
$12,951 |
$24,572 |
$23,284 |
$11,082 |
5/25 |
$13,199 |
$26,027 |
$24,622 |
$11,003 |
6/25 |
$13,530 |
$27,150 |
$25,728 |
$11,172 |
7/25 |
$13,512 |
$27,499 |
$26,077 |
$11,143 |
8/25 |
$13,705 |
$28,217 |
$26,721 |
$11,276 |
9/25 |
$14,045 |
$29,124 |
$27,689 |
$11,399 |
10/25 |
$14,275 |
$29,707 |
$28,309 |
$11,470 |
11/25 |
$14,312 |
$29,791 |
$28,305 |
$11,541 |
12/25 |
$14,419 |
$30,032 |
$28,601 |
$11,524 |
1/26 |
$14,774 |
$30,704 |
$29,449 |
$11,537 |
2/26 |
$14,924 |
$30,929 |
$29,827 |
$11,726 |
3/26 |
$14,139 |
$28,959 |
$27,685 |
$11,519 |
4/26 |
$15,027 |
$31,736 |
$30,502 |
$11,532 |
5/26 |
$15,428 |
$33,181 |
$32,075 |
$11,568 |
6/26 |
$15,475 |
$32,943 |
$31,818 |
$11,596 |
7/26 |
$15,260 |
$33,112 |
$31,842 |
$11,445 |
8/26 |
$15,758 |
$33,965 |
$32,693 |
$11,489 |
Average Annual Total Returns (%)Footnote Reference1
Table Summary
Fund |
1 Year |
5 Years |
10 Years |
Class C, with conversion to Class A after 8 years |
13.26% |
2.81% |
4.65% |
Class C, with 1% Maximum Contingent Deferred Sales Charge and conversion to Class A after 8 years |
12.26% |
2.81% |
4.65% |
MSCI World Index (net of foreign withholding taxes) |
20.37% |
11.20% |
13.00% |
MSCI ACWI Index (net of foreign withholding taxes) |
22.35% |
10.88% |
12.57% |
Bloomberg U.S. Aggregate Bond Index |
1.89% |
(0.29)% |
1.40% |
Blended Index (60% MSCI ACWI Index/40% Bloomberg U.S. Aggregate Bond Index) |
13.95% |
6.45% |
8.20% |
| Footnote |
Description |
Footnote1 |
Performance prior to August 18, 2025 reflects the Fund’s performance under its former principal investment strategies and is that of the Fund’s former investment sub-adviser. |
Performance does not reflect the deduction of taxes that a shareholder would pay on Fund distributions or redemption of Fund shares. Performance assumes that all dividends and distributions, if any, were reinvested. For more recent performance information, visit www.eatonvance.com/performance.php.
THE FUND'S PAST PERFORMANCE IS NO GUARANTEE OF FUTURE RESULTS.
Table Summary
Total Net Assets |
$206,898,592 |
# of Portfolio Holdings |
232 |
Portfolio Turnover Rate |
107% |
Total Advisory Fees Paid |
$1,310,691 |
What did the Fund invest in?
The following tables reflect what the Fund invested in as of the report date.
Asset Allocation (% of total investments)
Table Summary
Value |
Value |
Sovereign Government Bonds |
3.1% |
Short-Term Investments |
4.4% |
Exchange-Traded Funds |
37.2% |
Common Stocks |
55.3% |
Top Ten Holdings (% of total investments)Footnote Referencea
Table Summary
Eaton Vance Total Return Bond ETF |
11.0% |
Eaton Vance Mortgage Opportunities ETF |
8.6% |
Vanguard Emerging Markets Government Bond ETF |
5.0% |
iShares Core MSCI Emerging Markets ETF |
5.0% |
iShares TIPS Bond ETF |
3.5% |
NVIDIA Corp. |
3.2% |
Brazil Letras do Tesouro Nacional, 0.00%, 1/1/29 |
3.1% |
Microsoft Corp. |
2.5% |
Apple, Inc. |
2.4% |
Amazon.com, Inc. |
1.7% |
Total |
46.0% |
| Footnote |
Description |
Footnotea |
Excluding cash equivalents |
This is a summary of certain changes to the Fund since August 31, 2025. For more complete information, you may review the Fund’s next prospectus, which we expect to be available by January 1, 2027 at www.eatonvance.com/open-end-mutual-fund-documents.php or upon request by contacting us at 1-800-262-1122.
The net expense ratio decreased from the prior fiscal year primarily because the reduction in the investment adviser and administration fee and the agreement to reimburse the Fund’s expenses, both effective August 18, 2025, were in effect throughout the current fiscal year. The decrease also reflected a reduction in the investment adviser and administration fee due to the Fund’s investments in affiliated funds.
If you wish to view additional information about the Fund, including the prospectus, statement of additional information, financial statements and holdings, please scan the QR code or visit www.eatonvance.com/open-end-mutual-fund-documents.php. For proxy information, please visit www.eatonvance.com/proxyvoting.
The Funds may deliver a single copy of certain required shareholder documents (including prospectuses, shareholder reports, and proxy materials) to investors with the same last name and the same address. Your participation will continue indefinitely unless you instruct otherwise by calling 1-800-262-1122 or by contacting your financial intermediary. Your instruction will typically be effective within 30 days of receipt.
Not FDIC Insured | May Lose Value | No Bank Guarantee
Annual Shareholder Report August 31, 2026
Eaton Vance All Asset Strategy Fund
Annual Shareholder Report August 31, 2026
This annual shareholder report contains important information about the Eaton Vance All Asset Strategy Fund for the period of September 1, 2025 to August 31, 2026. You can find additional information about the Fund at www.eatonvance.com/open-end-mutual-fund-documents.php. You can also request this information by contacting us at 1-800-262-1122.
This report describes changes to the Fund that occurred during the reporting period.
What were the Fund costs for the last year?
(based on a hypothetical $10,000 investment)
Table Summary
Class Name |
Costs of a $10,000 investment |
Costs paid as a percentage of a $10,000 investment |
Class I |
$81 |
0.76% |
How did the Fund perform last year and what affected its performance?
Key contributors to (↑) and detractors from (↓) performance, relative to 60% MSCI ACWI Index/40% Bloomberg U.S. Aggregate Bond Index (the Blended Index):
↑ An overweight exposure to equities and an underweight exposure to fixed income assets helped relative returns
↑ An overweight exposure to emerging markets (EM), particularly South Korea and Taiwan, contributed to performance
↑ An overweight exposure to EM government bonds also added to returns
↓ Exposure to the global equities basket detracted from performance
↓ Exposure to Treasury Inflation-Protected Securities mildly detracted from performance
Comparison of the change in value of a $1,000,000 investment for the period indicated.

Table Summary
|
Class I |
MSCI World Index |
MSCI ACWI Index |
Bloomberg U.S. Aggregate Bond Index |
8/16 |
$1,000,000 |
$1,000,000 |
$1,000,000 |
$1,000,000 |
9/16 |
$1,005,331 |
$1,005,312 |
$1,006,129 |
$999,414 |
10/16 |
$991,622 |
$985,856 |
$989,052 |
$991,770 |
11/16 |
$993,907 |
$1,000,032 |
$996,568 |
$968,311 |
12/16 |
$1,011,146 |
$1,023,961 |
$1,018,096 |
$969,676 |
1/17 |
$1,030,325 |
$1,048,674 |
$1,045,934 |
$971,579 |
2/17 |
$1,049,505 |
$1,077,768 |
$1,075,274 |
$978,109 |
3/17 |
$1,057,177 |
$1,089,249 |
$1,088,428 |
$977,596 |
4/17 |
$1,064,849 |
$1,105,377 |
$1,105,391 |
$985,140 |
5/17 |
$1,072,521 |
$1,128,761 |
$1,129,801 |
$992,723 |
6/17 |
$1,077,891 |
$1,133,104 |
$1,134,939 |
$991,724 |
7/17 |
$1,103,208 |
$1,160,221 |
$1,166,656 |
$995,991 |
8/17 |
$1,103,975 |
$1,161,855 |
$1,171,126 |
$1,004,925 |
9/17 |
$1,120,086 |
$1,187,932 |
$1,193,752 |
$1,000,139 |
10/17 |
$1,139,265 |
$1,210,382 |
$1,218,541 |
$1,000,718 |
11/17 |
$1,149,239 |
$1,236,608 |
$1,242,130 |
$999,434 |
12/17 |
$1,162,905 |
$1,253,332 |
$1,262,155 |
$1,004,021 |
1/18 |
$1,216,300 |
$1,319,508 |
$1,333,361 |
$992,458 |
2/18 |
$1,176,254 |
$1,264,844 |
$1,277,362 |
$983,050 |
3/18 |
$1,156,623 |
$1,237,275 |
$1,250,018 |
$989,354 |
4/18 |
$1,150,341 |
$1,251,493 |
$1,261,955 |
$981,996 |
5/18 |
$1,166,831 |
$1,259,335 |
$1,263,531 |
$989,004 |
6/18 |
$1,155,053 |
$1,258,734 |
$1,256,688 |
$987,788 |
7/18 |
$1,182,535 |
$1,298,049 |
$1,294,586 |
$988,022 |
8/18 |
$1,192,743 |
$1,314,109 |
$1,304,757 |
$994,380 |
9/18 |
$1,195,884 |
$1,321,427 |
$1,310,435 |
$987,977 |
10/18 |
$1,121,288 |
$1,224,397 |
$1,212,233 |
$980,169 |
11/18 |
$1,135,422 |
$1,238,306 |
$1,229,962 |
$986,020 |
12/18 |
$1,076,602 |
$1,144,148 |
$1,143,330 |
$1,004,135 |
1/19 |
$1,114,561 |
$1,233,169 |
$1,233,607 |
$1,014,798 |
2/19 |
$1,133,137 |
$1,270,250 |
$1,266,603 |
$1,014,210 |
3/19 |
$1,145,252 |
$1,286,934 |
$1,282,532 |
$1,033,685 |
4/19 |
$1,158,175 |
$1,332,568 |
$1,325,837 |
$1,033,950 |
5/19 |
$1,128,291 |
$1,255,678 |
$1,247,190 |
$1,052,304 |
6/19 |
$1,163,021 |
$1,338,421 |
$1,328,855 |
$1,065,519 |
7/19 |
$1,164,636 |
$1,345,050 |
$1,332,749 |
$1,067,862 |
8/19 |
$1,166,251 |
$1,317,538 |
$1,301,133 |
$1,095,533 |
9/19 |
$1,170,289 |
$1,345,576 |
$1,328,511 |
$1,089,698 |
10/19 |
$1,181,597 |
$1,379,818 |
$1,364,871 |
$1,092,980 |
11/19 |
$1,195,327 |
$1,418,246 |
$1,398,189 |
$1,092,424 |
12/19 |
$1,214,669 |
$1,460,734 |
$1,447,427 |
$1,091,662 |
1/20 |
$1,220,581 |
$1,451,843 |
$1,431,439 |
$1,112,671 |
2/20 |
$1,194,396 |
$1,329,126 |
$1,315,822 |
$1,132,697 |
3/20 |
$1,138,646 |
$1,153,226 |
$1,138,181 |
$1,126,032 |
4/20 |
$1,186,794 |
$1,279,209 |
$1,260,109 |
$1,146,048 |
5/20 |
$1,207,911 |
$1,341,005 |
$1,314,912 |
$1,151,384 |
6/20 |
$1,220,581 |
$1,376,476 |
$1,356,927 |
$1,158,637 |
7/20 |
$1,256,059 |
$1,442,329 |
$1,428,691 |
$1,175,943 |
8/20 |
$1,285,623 |
$1,538,697 |
$1,516,134 |
$1,166,451 |
9/20 |
$1,267,884 |
$1,485,613 |
$1,467,249 |
$1,165,812 |
10/20 |
$1,248,456 |
$1,440,042 |
$1,431,582 |
$1,160,606 |
11/20 |
$1,310,964 |
$1,624,168 |
$1,608,043 |
$1,171,994 |
12/20 |
$1,333,971 |
$1,693,027 |
$1,682,704 |
$1,173,609 |
1/21 |
$1,322,644 |
$1,676,201 |
$1,675,051 |
$1,165,195 |
2/21 |
$1,340,071 |
$1,719,152 |
$1,713,851 |
$1,148,369 |
3/21 |
$1,360,982 |
$1,776,352 |
$1,759,627 |
$1,134,029 |
4/21 |
$1,388,864 |
$1,859,024 |
$1,836,562 |
$1,142,988 |
5/21 |
$1,407,161 |
$1,885,804 |
$1,865,143 |
$1,146,722 |
6/21 |
$1,409,775 |
$1,913,915 |
$1,889,724 |
$1,154,779 |
7/21 |
$1,404,547 |
$1,948,195 |
$1,902,743 |
$1,167,691 |
8/21 |
$1,420,231 |
$1,996,683 |
$1,950,367 |
$1,165,468 |
9/21 |
$1,383,636 |
$1,913,779 |
$1,869,798 |
$1,155,377 |
10/21 |
$1,415,874 |
$2,022,177 |
$1,965,239 |
$1,155,059 |
11/21 |
$1,394,963 |
$1,977,865 |
$1,917,915 |
$1,158,476 |
12/21 |
$1,429,455 |
$2,062,399 |
$1,994,633 |
$1,155,512 |
1/22 |
$1,393,534 |
$1,953,276 |
$1,896,671 |
$1,130,617 |
2/22 |
$1,369,587 |
$1,903,875 |
$1,847,686 |
$1,118,004 |
3/22 |
$1,369,587 |
$1,956,124 |
$1,887,705 |
$1,086,944 |
4/22 |
$1,304,194 |
$1,793,622 |
$1,736,609 |
$1,045,696 |
5/22 |
$1,309,720 |
$1,794,980 |
$1,738,642 |
$1,052,438 |
6/22 |
$1,254,457 |
$1,639,496 |
$1,592,081 |
$1,035,928 |
7/22 |
$1,295,904 |
$1,769,666 |
$1,703,260 |
$1,061,240 |
8/22 |
$1,248,931 |
$1,695,680 |
$1,640,554 |
$1,031,253 |
9/22 |
$1,167,880 |
$1,538,049 |
$1,483,505 |
$986,696 |
10/22 |
$1,172,485 |
$1,648,501 |
$1,573,030 |
$973,916 |
11/22 |
$1,244,326 |
$1,763,122 |
$1,695,040 |
$1,009,733 |
12/22 |
$1,218,947 |
$1,688,247 |
$1,628,338 |
$1,005,178 |
1/23 |
$1,270,164 |
$1,807,701 |
$1,745,053 |
$1,036,102 |
2/23 |
$1,231,984 |
$1,764,247 |
$1,695,039 |
$1,009,313 |
3/23 |
$1,274,820 |
$1,818,761 |
$1,747,302 |
$1,034,952 |
4/23 |
$1,287,857 |
$1,850,643 |
$1,772,415 |
$1,041,224 |
5/23 |
$1,265,508 |
$1,832,168 |
$1,753,431 |
$1,029,887 |
6/23 |
$1,281,338 |
$1,942,973 |
$1,855,237 |
$1,026,214 |
7/23 |
$1,287,857 |
$2,008,243 |
$1,923,154 |
$1,025,498 |
8/23 |
$1,263,645 |
$1,960,275 |
$1,869,413 |
$1,018,948 |
9/23 |
$1,212,429 |
$1,875,711 |
$1,792,112 |
$993,055 |
10/23 |
$1,185,424 |
$1,821,286 |
$1,738,228 |
$977,383 |
11/23 |
$1,253,402 |
$1,992,035 |
$1,898,660 |
$1,021,645 |
12/23 |
$1,301,898 |
$2,089,833 |
$1,989,860 |
$1,060,753 |
1/24 |
$1,296,167 |
$2,114,912 |
$2,001,525 |
$1,057,840 |
2/24 |
$1,311,449 |
$2,204,579 |
$2,087,417 |
$1,042,894 |
3/24 |
$1,335,329 |
$2,275,423 |
$2,152,955 |
$1,052,524 |
4/24 |
$1,302,853 |
$2,190,903 |
$2,081,923 |
$1,025,939 |
5/24 |
$1,341,060 |
$2,288,731 |
$2,166,477 |
$1,043,332 |
6/24 |
$1,358,253 |
$2,335,302 |
$2,214,729 |
$1,053,210 |
7/24 |
$1,391,684 |
$2,376,456 |
$2,250,447 |
$1,077,810 |
8/24 |
$1,410,787 |
$2,439,267 |
$2,307,601 |
$1,093,298 |
9/24 |
$1,429,891 |
$2,483,939 |
$2,361,209 |
$1,107,936 |
10/24 |
$1,401,236 |
$2,434,666 |
$2,308,207 |
$1,080,461 |
11/24 |
$1,433,711 |
$2,546,384 |
$2,394,543 |
$1,091,884 |
12/24 |
$1,401,904 |
$2,480,024 |
$2,337,860 |
$1,074,015 |
1/25 |
$1,421,456 |
$2,567,540 |
$2,416,333 |
$1,079,713 |
2/25 |
$1,426,344 |
$2,549,061 |
$2,401,776 |
$1,103,468 |
3/25 |
$1,398,971 |
$2,435,576 |
$2,306,894 |
$1,103,883 |
4/25 |
$1,411,680 |
$2,457,221 |
$2,328,410 |
$1,108,222 |
5/25 |
$1,440,031 |
$2,602,668 |
$2,462,244 |
$1,100,287 |
6/25 |
$1,477,180 |
$2,714,981 |
$2,572,802 |
$1,117,205 |
7/25 |
$1,477,180 |
$2,749,930 |
$2,607,694 |
$1,114,258 |
8/25 |
$1,499,665 |
$2,821,663 |
$2,672,080 |
$1,127,585 |
9/25 |
$1,537,793 |
$2,912,368 |
$2,768,921 |
$1,139,886 |
10/25 |
$1,564,188 |
$2,970,689 |
$2,830,851 |
$1,147,008 |
11/25 |
$1,570,054 |
$2,979,081 |
$2,830,536 |
$1,154,135 |
12/25 |
$1,582,680 |
$3,003,162 |
$2,860,077 |
$1,152,428 |
1/26 |
$1,621,870 |
$3,070,370 |
$2,944,863 |
$1,153,658 |
2/26 |
$1,640,962 |
$3,092,861 |
$2,982,721 |
$1,172,551 |
3/26 |
$1,554,543 |
$2,895,861 |
$2,768,510 |
$1,151,886 |
4/26 |
$1,654,026 |
$3,173,627 |
$3,050,166 |
$1,153,181 |
5/26 |
$1,700,250 |
$3,318,094 |
$3,207,544 |
$1,156,768 |
6/26 |
$1,706,279 |
$3,294,285 |
$3,181,815 |
$1,159,558 |
7/26 |
$1,685,177 |
$3,311,191 |
$3,184,249 |
$1,144,450 |
8/26 |
$1,714,318 |
$3,396,519 |
$3,269,271 |
$1,148,905 |
Average Annual Total Returns (%)Footnote Reference1
Table Summary
Fund |
1 Year |
5 Years |
10 Years |
Class I |
14.31% |
3.83% |
5.53% |
MSCI World Index (net of foreign withholding taxes) |
20.37% |
11.20% |
13.00% |
MSCI ACWI Index (net of foreign withholding taxes) |
22.35% |
10.88% |
12.57% |
Bloomberg U.S. Aggregate Bond Index |
1.89% |
(0.29)% |
1.40% |
Blended Index (60% MSCI ACWI Index/40% Bloomberg U.S. Aggregate Bond Index) |
13.95% |
6.45% |
8.20% |
| Footnote |
Description |
Footnote1 |
Performance prior to August 18, 2025 reflects the Fund’s performance under its former principal investment strategies and is that of the Fund’s former investment sub-adviser. |
Performance does not reflect the deduction of taxes that a shareholder would pay on Fund distributions or redemption of Fund shares. Performance assumes that all dividends and distributions, if any, were reinvested. For more recent performance information, visit www.eatonvance.com/performance.php.
THE FUND'S PAST PERFORMANCE IS NO GUARANTEE OF FUTURE RESULTS.
Table Summary
Total Net Assets |
$206,898,592 |
# of Portfolio Holdings |
232 |
Portfolio Turnover Rate |
107% |
Total Advisory Fees Paid |
$1,310,691 |
What did the Fund invest in?
The following tables reflect what the Fund invested in as of the report date.
Asset Allocation (% of total investments)
Table Summary
Value |
Value |
Sovereign Government Bonds |
3.1% |
Short-Term Investments |
4.4% |
Exchange-Traded Funds |
37.2% |
Common Stocks |
55.3% |
Top Ten Holdings (% of total investments)Footnote Referencea
Table Summary
Eaton Vance Total Return Bond ETF |
11.0% |
Eaton Vance Mortgage Opportunities ETF |
8.6% |
Vanguard Emerging Markets Government Bond ETF |
5.0% |
iShares Core MSCI Emerging Markets ETF |
5.0% |
iShares TIPS Bond ETF |
3.5% |
NVIDIA Corp. |
3.2% |
Brazil Letras do Tesouro Nacional, 0.00%, 1/1/29 |
3.1% |
Microsoft Corp. |
2.5% |
Apple, Inc. |
2.4% |
Amazon.com, Inc. |
1.7% |
Total |
46.0% |
| Footnote |
Description |
Footnotea |
Excluding cash equivalents |
This is a summary of certain changes to the Fund since August 31, 2025. For more complete information, you may review the Fund’s next prospectus, which we expect to be available by January 1, 2027 at www.eatonvance.com/open-end-mutual-fund-documents.php or upon request by contacting us at 1-800-262-1122.
The net expense ratio decreased from the prior fiscal year primarily because the reduction in the investment adviser and administration fee and the agreement to reimburse the Fund’s expenses, both effective August 18, 2025, were in effect throughout the current fiscal year. The decrease also reflected a reduction in the investment adviser and administration fee due to the Fund’s investments in affiliated funds.
If you wish to view additional information about the Fund, including the prospectus, statement of additional information, financial statements and holdings, please scan the QR code or visit www.eatonvance.com/open-end-mutual-fund-documents.php. For proxy information, please visit www.eatonvance.com/proxyvoting.
The Funds may deliver a single copy of certain required shareholder documents (including prospectuses, shareholder reports, and proxy materials) to investors with the same last name and the same address. Your participation will continue indefinitely unless you instruct otherwise by calling 1-800-262-1122 or by contacting your financial intermediary. Your instruction will typically be effective within 30 days of receipt.
Not FDIC Insured | May Lose Value | No Bank Guarantee
Annual Shareholder Report August 31, 2026
Eaton Vance Equity Strategy Fund
Annual Shareholder Report August 31, 2026
This annual shareholder report contains important information about the Eaton Vance Equity Strategy Fund for the period of September 1, 2025 to August 31, 2026. You can find additional information about the Fund at www.eatonvance.com/open-end-mutual-fund-documents.php. You can also request this information by contacting us at 1-800-262-1122.
This report describes changes to the Fund that occurred during the reporting period.
What were the Fund costs for the last year?
(based on a hypothetical $10,000 investment)
Table Summary
Class Name |
Costs of a $10,000 investment |
Costs paid as a percentage of a $10,000 investment |
Class A |
$121 |
1.10% |
How did the Fund perform last year and what affected its performance?
Key contributors to (↑) and detractors from (↓) performance, relative to the MSCI ACWI Index (the Index):
↓ Security selection in the global equities basket detracted from returns during the period
↓ Exposure to Brazil and India equity markets also detracted from performance
↓ Exposure to China equity markets modestly detracted from performance
↑ Exposure to core emerging markets contributed to returns
↑ Exposure to Taiwan and South Korea equities also contributed to returns
↑ Exposure to S&P 500 stocks basket also added to returns during the period
Comparison of the change in value of a $10,000 investment for the period indicated.

Table Summary
|
Class A with Maximum Sales Charge |
MSCI ACWI Index |
8/16 |
$10,000 |
$10,000 |
9/16 |
$9,533 |
$10,061 |
10/16 |
$9,385 |
$9,891 |
11/16 |
$9,673 |
$9,966 |
12/16 |
$9,875 |
$10,181 |
1/17 |
$10,099 |
$10,459 |
2/17 |
$10,350 |
$10,753 |
3/17 |
$10,443 |
$10,884 |
4/17 |
$10,555 |
$11,054 |
5/17 |
$10,648 |
$11,298 |
6/17 |
$10,727 |
$11,349 |
7/17 |
$11,064 |
$11,667 |
8/17 |
$11,051 |
$11,711 |
9/17 |
$11,296 |
$11,938 |
10/17 |
$11,593 |
$12,185 |
11/17 |
$11,765 |
$12,421 |
12/17 |
$11,919 |
$12,622 |
1/18 |
$12,679 |
$13,334 |
2/18 |
$12,149 |
$12,774 |
3/18 |
$11,891 |
$12,500 |
4/18 |
$11,772 |
$12,620 |
5/18 |
$12,037 |
$12,635 |
6/18 |
$11,870 |
$12,567 |
7/18 |
$12,211 |
$12,946 |
8/18 |
$12,267 |
$13,048 |
9/18 |
$12,288 |
$13,104 |
10/18 |
$11,228 |
$12,122 |
11/18 |
$11,493 |
$12,300 |
12/18 |
$10,495 |
$11,433 |
1/19 |
$11,207 |
$12,336 |
2/19 |
$11,544 |
$12,666 |
3/19 |
$11,786 |
$12,825 |
4/19 |
$12,080 |
$13,258 |
5/19 |
$11,427 |
$12,472 |
6/19 |
$12,080 |
$13,289 |
7/19 |
$12,102 |
$13,327 |
8/19 |
$12,109 |
$13,011 |
9/19 |
$12,212 |
$13,285 |
10/19 |
$12,462 |
$13,649 |
11/19 |
$12,755 |
$13,982 |
12/19 |
$13,155 |
$14,474 |
1/20 |
$13,139 |
$14,314 |
2/20 |
$12,274 |
$13,158 |
3/20 |
$11,089 |
$11,382 |
4/20 |
$12,018 |
$12,601 |
5/20 |
$12,547 |
$13,149 |
6/20 |
$12,771 |
$13,569 |
7/20 |
$13,500 |
$14,287 |
8/20 |
$14,276 |
$15,161 |
9/20 |
$13,788 |
$14,672 |
10/20 |
$13,451 |
$14,316 |
11/20 |
$14,741 |
$16,080 |
12/20 |
$15,287 |
$16,827 |
1/21 |
$15,131 |
$16,751 |
2/21 |
$15,721 |
$17,139 |
3/21 |
$16,296 |
$17,596 |
4/21 |
$16,928 |
$18,366 |
5/21 |
$17,297 |
$18,651 |
6/21 |
$17,297 |
$18,897 |
7/21 |
$17,174 |
$19,027 |
8/21 |
$17,518 |
$19,504 |
9/21 |
$16,805 |
$18,698 |
10/21 |
$17,576 |
$19,652 |
11/21 |
$17,149 |
$19,179 |
12/21 |
$17,919 |
$19,946 |
1/22 |
$17,382 |
$18,967 |
2/22 |
$16,955 |
$18,477 |
3/22 |
$17,187 |
$18,877 |
4/22 |
$15,973 |
$17,366 |
5/22 |
$16,084 |
$17,386 |
6/22 |
$14,981 |
$15,921 |
7/22 |
$15,769 |
$17,033 |
8/22 |
$15,157 |
$16,406 |
9/22 |
$13,729 |
$14,835 |
10/22 |
$14,499 |
$15,730 |
11/22 |
$15,750 |
$16,950 |
12/22 |
$15,240 |
$16,283 |
1/23 |
$15,995 |
$17,451 |
2/23 |
$15,475 |
$16,950 |
3/23 |
$16,151 |
$17,473 |
4/23 |
$16,475 |
$17,724 |
5/23 |
$16,053 |
$17,534 |
6/23 |
$16,749 |
$18,552 |
7/23 |
$17,287 |
$19,232 |
8/23 |
$16,739 |
$18,694 |
9/23 |
$15,936 |
$17,921 |
10/23 |
$15,564 |
$17,382 |
11/23 |
$16,710 |
$18,987 |
12/23 |
$17,426 |
$19,899 |
1/24 |
$17,278 |
$20,015 |
2/24 |
$18,022 |
$20,874 |
3/24 |
$18,596 |
$21,530 |
4/24 |
$18,139 |
$20,819 |
5/24 |
$18,936 |
$21,665 |
6/24 |
$19,245 |
$22,147 |
7/24 |
$19,744 |
$22,504 |
8/24 |
$20,031 |
$23,076 |
9/24 |
$20,287 |
$23,612 |
10/24 |
$19,925 |
$23,082 |
11/24 |
$20,712 |
$23,945 |
12/24 |
$19,985 |
$23,379 |
1/25 |
$20,471 |
$24,163 |
2/25 |
$20,195 |
$24,018 |
3/25 |
$19,433 |
$23,069 |
4/25 |
$19,544 |
$23,284 |
5/25 |
$20,593 |
$24,622 |
6/25 |
$21,365 |
$25,728 |
7/25 |
$21,531 |
$26,077 |
8/25 |
$21,940 |
$26,721 |
9/25 |
$22,713 |
$27,689 |
10/25 |
$23,265 |
$28,309 |
11/25 |
$23,298 |
$28,305 |
12/25 |
$23,597 |
$28,601 |
1/26 |
$24,351 |
$29,449 |
2/26 |
$24,598 |
$29,827 |
3/26 |
$22,921 |
$27,685 |
4/26 |
$25,144 |
$30,502 |
5/26 |
$26,132 |
$32,075 |
6/26 |
$26,236 |
$31,818 |
7/26 |
$25,820 |
$31,842 |
8/26 |
$26,484 |
$32,693 |
Average Annual Total Returns (%)Footnote Reference1
Table Summary
Fund |
1 Year |
5 Years |
10 Years |
Class A |
20.71% |
8.61% |
10.82% |
Class A with 5.25% Maximum Sales Charge |
14.38% |
7.45% |
10.22% |
MSCI ACWI Index (net of foreign withholding taxes) |
22.35% |
10.88% |
12.57% |
| Footnote |
Description |
Footnote1 |
Performance prior to August 18, 2025 reflects the Fund’s performance under its former principal investment strategies and is that of the Fund’s former investment sub-adviser. |
Performance does not reflect the deduction of taxes that a shareholder would pay on Fund distributions or redemption of Fund shares. Performance assumes that all dividends and distributions, if any, were reinvested. For more recent performance information, visit www.eatonvance.com/performance.php.
THE FUND'S PAST PERFORMANCE IS NO GUARANTEE OF FUTURE RESULTS.
Table Summary
Total Net Assets |
$605,561,232 |
# of Portfolio Holdings |
250 |
Portfolio Turnover Rate |
190% |
Total Advisory Fees Paid |
$3,824,222 |
What did the Fund invest in?
The following tables reflect what the Fund invested in as of the report date.
Sector Allocation (% of total investments)
Table Summary
Value |
Value |
Real Estate |
1.0% |
Materials |
1.5% |
Consumer Staples |
1.6% |
Energy |
1.8% |
Short-Term Investments |
3.7% |
Communication Services |
5.3% |
Utilities |
5.5% |
Consumer Discretionary |
6.7% |
Health Care |
7.7% |
Exchange-Traded Funds |
11.2% |
Industrials |
11.6% |
Financials |
15.8% |
Information Technology |
26.6% |
Top Ten Holdings (% of total investments)Footnote Referencea
Table Summary
iShares Core MSCI Emerging Markets ETF |
4.8% |
NVIDIA Corp. |
4.8% |
Microsoft Corp. |
3.7% |
Apple, Inc. |
3.5% |
Amazon.com, Inc. |
2.5% |
Alphabet, Inc., Class A |
2.3% |
Broadcom, Inc. |
1.8% |
iShares MSCI Brazil ETF |
1.8% |
iShares MSCI Taiwan ETF |
1.6% |
Micron Technology, Inc. |
1.3% |
Total |
28.1% |
| Footnote |
Description |
Footnotea |
Excluding cash equivalents |
This is a summary of certain changes to the Fund since August 31, 2025. For more complete information, you may review the Fund’s next prospectus, which we expect to be available by January 1, 2027 at www.eatonvance.com/open-end-mutual-fund-documents.php or upon request by contacting us at 1-800-262-1122.
The net expense ratio decreased from the prior fiscal year primarily because the reduction in the investment adviser and administration fee and the agreement to reimburse the Fund’s expenses, both effective August 18, 2025, were in effect throughout the current fiscal year.
If you wish to view additional information about the Fund, including the prospectus, statement of additional information, financial statements and holdings, please scan the QR code or visit www.eatonvance.com/open-end-mutual-fund-documents.php. For proxy information, please visit www.eatonvance.com/proxyvoting.
The Funds may deliver a single copy of certain required shareholder documents (including prospectuses, shareholder reports, and proxy materials) to investors with the same last name and the same address. Your participation will continue indefinitely unless you instruct otherwise by calling 1-800-262-1122 or by contacting your financial intermediary. Your instruction will typically be effective within 30 days of receipt.
Not FDIC Insured | May Lose Value | No Bank Guarantee
Annual Shareholder Report August 31, 2026
Eaton Vance Equity Strategy Fund
Annual Shareholder Report August 31, 2026
This annual shareholder report contains important information about the Eaton Vance Equity Strategy Fund for the period of September 1, 2025 to August 31, 2026. You can find additional information about the Fund at www.eatonvance.com/open-end-mutual-fund-documents.php. You can also request this information by contacting us at 1-800-262-1122.
This report describes changes to the Fund that occurred during the reporting period.
What were the Fund costs for the last year?
(based on a hypothetical $10,000 investment)
Table Summary
Class Name |
Costs of a $10,000 investment |
Costs paid as a percentage of a $10,000 investment |
Class C |
$203 |
1.85% |
How did the Fund perform last year and what affected its performance?
Key contributors to (↑) and detractors from (↓) performance, relative to the MSCI ACWI Index (the Index):
↓ Security selection in the global equities basket detracted from returns during the period
↓ Exposure to Brazil and India equity markets also detracted from performance
↓ Exposure to China equity markets modestly detracted from performance
↑ Exposure to core emerging markets contributed to returns
↑ Exposure to Taiwan and South Korea equities also contributed to returns
↑ Exposure to S&P 500 stocks basket also added to returns during the period
Comparison of the change in value of a $10,000 investment for the period indicated.

Table Summary
|
Class C |
MSCI ACWI Index |
8/16 |
$10,000 |
$10,000 |
9/16 |
$10,055 |
$10,061 |
10/16 |
$9,890 |
$9,891 |
11/16 |
$10,192 |
$9,966 |
12/16 |
$10,394 |
$10,181 |
1/17 |
$10,626 |
$10,459 |
2/17 |
$10,886 |
$10,753 |
3/17 |
$10,977 |
$10,884 |
4/17 |
$11,089 |
$11,054 |
5/17 |
$11,180 |
$11,298 |
6/17 |
$11,251 |
$11,349 |
7/17 |
$11,601 |
$11,667 |
8/17 |
$11,580 |
$11,711 |
9/17 |
$11,826 |
$11,938 |
10/17 |
$12,128 |
$12,185 |
11/17 |
$12,296 |
$12,421 |
12/17 |
$12,455 |
$12,622 |
1/18 |
$13,241 |
$13,334 |
2/18 |
$12,675 |
$12,774 |
3/18 |
$12,403 |
$12,500 |
4/18 |
$12,271 |
$12,620 |
5/18 |
$12,536 |
$12,635 |
6/18 |
$12,352 |
$12,567 |
7/18 |
$12,705 |
$12,946 |
8/18 |
$12,756 |
$13,048 |
9/18 |
$12,764 |
$13,104 |
10/18 |
$11,653 |
$12,122 |
11/18 |
$11,925 |
$12,300 |
12/18 |
$10,884 |
$11,433 |
1/19 |
$11,609 |
$12,336 |
2/19 |
$11,955 |
$12,666 |
3/19 |
$12,202 |
$12,825 |
4/19 |
$12,495 |
$13,258 |
5/19 |
$11,809 |
$12,472 |
6/19 |
$12,480 |
$13,289 |
7/19 |
$12,495 |
$13,327 |
8/19 |
$12,495 |
$13,011 |
9/19 |
$12,595 |
$13,285 |
10/19 |
$12,850 |
$13,649 |
11/19 |
$13,135 |
$13,982 |
12/19 |
$13,546 |
$14,474 |
1/20 |
$13,520 |
$14,314 |
2/20 |
$12,619 |
$13,158 |
3/20 |
$11,391 |
$11,382 |
4/20 |
$12,335 |
$12,601 |
5/20 |
$12,877 |
$13,149 |
6/20 |
$13,095 |
$13,569 |
7/20 |
$13,838 |
$14,287 |
8/20 |
$14,614 |
$15,161 |
9/20 |
$14,113 |
$14,672 |
10/20 |
$13,763 |
$14,316 |
11/20 |
$15,065 |
$16,080 |
12/20 |
$15,614 |
$16,827 |
1/21 |
$15,452 |
$16,751 |
2/21 |
$16,040 |
$17,139 |
3/21 |
$16,611 |
$17,596 |
4/21 |
$17,250 |
$18,366 |
5/21 |
$17,608 |
$18,651 |
6/21 |
$17,600 |
$18,897 |
7/21 |
$17,472 |
$19,027 |
8/21 |
$17,813 |
$19,504 |
9/21 |
$17,071 |
$18,698 |
10/21 |
$17,847 |
$19,652 |
11/21 |
$17,395 |
$19,179 |
12/21 |
$18,167 |
$19,946 |
1/22 |
$17,613 |
$18,967 |
2/22 |
$17,172 |
$18,477 |
3/22 |
$17,393 |
$18,877 |
4/22 |
$16,158 |
$17,366 |
5/22 |
$16,254 |
$17,386 |
6/22 |
$15,135 |
$15,921 |
7/22 |
$15,919 |
$17,033 |
8/22 |
$15,288 |
$16,406 |
9/22 |
$13,843 |
$14,835 |
10/22 |
$14,609 |
$15,730 |
11/22 |
$15,862 |
$16,950 |
12/22 |
$15,335 |
$16,283 |
1/23 |
$16,090 |
$17,451 |
2/23 |
$15,556 |
$16,950 |
3/23 |
$16,220 |
$17,473 |
4/23 |
$16,542 |
$17,724 |
5/23 |
$16,110 |
$17,534 |
6/23 |
$16,784 |
$18,552 |
7/23 |
$17,317 |
$19,232 |
8/23 |
$16,754 |
$18,694 |
9/23 |
$15,949 |
$17,921 |
10/23 |
$15,566 |
$17,382 |
11/23 |
$16,703 |
$18,987 |
12/23 |
$17,400 |
$19,899 |
1/24 |
$17,248 |
$20,015 |
2/24 |
$17,975 |
$20,874 |
3/24 |
$18,539 |
$21,530 |
4/24 |
$18,073 |
$20,819 |
5/24 |
$18,854 |
$21,665 |
6/24 |
$19,158 |
$22,147 |
7/24 |
$19,635 |
$22,504 |
8/24 |
$19,906 |
$23,076 |
9/24 |
$20,145 |
$23,612 |
10/24 |
$19,776 |
$23,082 |
11/24 |
$20,546 |
$23,945 |
12/24 |
$19,815 |
$23,379 |
1/25 |
$20,285 |
$24,163 |
2/25 |
$19,994 |
$24,018 |
3/25 |
$19,232 |
$23,069 |
4/25 |
$19,322 |
$23,284 |
5/25 |
$20,353 |
$24,622 |
6/25 |
$21,103 |
$25,728 |
7/25 |
$21,249 |
$26,077 |
8/25 |
$21,641 |
$26,721 |
9/25 |
$22,391 |
$27,689 |
10/25 |
$22,929 |
$28,309 |
11/25 |
$22,940 |
$28,305 |
12/25 |
$23,221 |
$28,601 |
1/26 |
$23,944 |
$29,449 |
2/26 |
$24,167 |
$29,827 |
3/26 |
$22,512 |
$27,685 |
4/26 |
$24,679 |
$30,502 |
5/26 |
$25,625 |
$32,075 |
6/26 |
$25,717 |
$31,818 |
7/26 |
$25,297 |
$31,842 |
8/26 |
$26,317 |
$32,693 |
Average Annual Total Returns (%)Footnote Reference1
Table Summary
Fund |
1 Year |
5 Years |
10 Years |
Class C, with conversion to Class A after 8 years |
19.81% |
7.79% |
10.15% |
Class C, with 1% Maximum Contingent Deferred Sales Charge and conversion to Class A after 8 years |
18.81% |
7.79% |
10.15% |
MSCI ACWI Index (net of foreign withholding taxes) |
22.35% |
10.88% |
12.57% |
| Footnote |
Description |
Footnote1 |
Performance prior to August 18, 2025 reflects the Fund’s performance under its former principal investment strategies and is that of the Fund’s former investment sub-adviser. |
Performance does not reflect the deduction of taxes that a shareholder would pay on Fund distributions or redemption of Fund shares. Performance assumes that all dividends and distributions, if any, were reinvested. For more recent performance information, visit www.eatonvance.com/performance.php.
THE FUND'S PAST PERFORMANCE IS NO GUARANTEE OF FUTURE RESULTS.
Table Summary
Total Net Assets |
$605,561,232 |
# of Portfolio Holdings |
250 |
Portfolio Turnover Rate |
190% |
Total Advisory Fees Paid |
$3,824,222 |
What did the Fund invest in?
The following tables reflect what the Fund invested in as of the report date.
Sector Allocation (% of total investments)
Table Summary
Value |
Value |
Real Estate |
1.0% |
Materials |
1.5% |
Consumer Staples |
1.6% |
Energy |
1.8% |
Short-Term Investments |
3.7% |
Communication Services |
5.3% |
Utilities |
5.5% |
Consumer Discretionary |
6.7% |
Health Care |
7.7% |
Exchange-Traded Funds |
11.2% |
Industrials |
11.6% |
Financials |
15.8% |
Information Technology |
26.6% |
Top Ten Holdings (% of total investments)Footnote Referencea
Table Summary
iShares Core MSCI Emerging Markets ETF |
4.8% |
NVIDIA Corp. |
4.8% |
Microsoft Corp. |
3.7% |
Apple, Inc. |
3.5% |
Amazon.com, Inc. |
2.5% |
Alphabet, Inc., Class A |
2.3% |
Broadcom, Inc. |
1.8% |
iShares MSCI Brazil ETF |
1.8% |
iShares MSCI Taiwan ETF |
1.6% |
Micron Technology, Inc. |
1.3% |
Total |
28.1% |
| Footnote |
Description |
Footnotea |
Excluding cash equivalents |
This is a summary of certain changes to the Fund since August 31, 2025. For more complete information, you may review the Fund’s next prospectus, which we expect to be available by January 1, 2027 at www.eatonvance.com/open-end-mutual-fund-documents.php or upon request by contacting us at 1-800-262-1122.
The net expense ratio decreased from the prior fiscal year primarily because the reduction in the investment adviser and administration fee and the agreement to reimburse the Fund’s expenses, both effective August 18, 2025, were in effect throughout the current fiscal year.
If you wish to view additional information about the Fund, including the prospectus, statement of additional information, financial statements and holdings, please scan the QR code or visit www.eatonvance.com/open-end-mutual-fund-documents.php. For proxy information, please visit www.eatonvance.com/proxyvoting.
The Funds may deliver a single copy of certain required shareholder documents (including prospectuses, shareholder reports, and proxy materials) to investors with the same last name and the same address. Your participation will continue indefinitely unless you instruct otherwise by calling 1-800-262-1122 or by contacting your financial intermediary. Your instruction will typically be effective within 30 days of receipt.
Not FDIC Insured | May Lose Value | No Bank Guarantee
Annual Shareholder Report August 31, 2026
Eaton Vance Equity Strategy Fund
Annual Shareholder Report August 31, 2026
This annual shareholder report contains important information about the Eaton Vance Equity Strategy Fund for the period of September 1, 2025 to August 31, 2026. You can find additional information about the Fund at www.eatonvance.com/open-end-mutual-fund-documents.php. You can also request this information by contacting us at 1-800-262-1122.
This report describes changes to the Fund that occurred during the reporting period.
What were the Fund costs for the last year?
(based on a hypothetical $10,000 investment)
Table Summary
Class Name |
Costs of a $10,000 investment |
Costs paid as a percentage of a $10,000 investment |
Class I |
$94 |
0.85% |
How did the Fund perform last year and what affected its performance?
Key contributors to (↑) and detractors from (↓) performance, relative to the MSCI ACWI Index (the Index):
↓ Security selection in the global equities basket detracted from returns during the period
↓ Exposure to Brazil and India equity markets also detracted from performance
↓ Exposure to China equity markets modestly detracted from performance
↑ Exposure to core emerging markets contributed to returns
↑ Exposure to Taiwan and South Korea equities also contributed to returns
↑ Exposure to S&P 500 stocks basket also added to returns during the period
Comparison of the change in value of a $1,000,000 investment for the period indicated.

Table Summary
|
Class I |
MSCI ACWI Index |
8/16 |
$1,000,000 |
$1,000,000 |
9/16 |
$1,006,065 |
$1,006,129 |
10/16 |
$990,566 |
$989,052 |
11/16 |
$1,021,563 |
$996,568 |
12/16 |
$1,043,527 |
$1,018,096 |
1/17 |
$1,066,561 |
$1,045,934 |
2/17 |
$1,093,784 |
$1,075,274 |
3/17 |
$1,103,556 |
$1,088,428 |
4/17 |
$1,116,120 |
$1,105,391 |
5/17 |
$1,126,590 |
$1,129,801 |
6/17 |
$1,134,269 |
$1,134,939 |
7/17 |
$1,170,565 |
$1,166,656 |
8/17 |
$1,169,867 |
$1,171,126 |
9/17 |
$1,195,694 |
$1,193,752 |
10/17 |
$1,227,104 |
$1,218,541 |
11/17 |
$1,245,252 |
$1,242,130 |
12/17 |
$1,261,858 |
$1,262,155 |
1/18 |
$1,343,078 |
$1,333,361 |
2/18 |
$1,286,962 |
$1,277,362 |
3/18 |
$1,259,643 |
$1,250,018 |
4/18 |
$1,247,829 |
$1,261,955 |
5/18 |
$1,275,887 |
$1,263,531 |
6/18 |
$1,258,166 |
$1,256,688 |
7/18 |
$1,295,084 |
$1,294,586 |
8/18 |
$1,301,730 |
$1,304,757 |
9/18 |
$1,303,206 |
$1,310,435 |
10/18 |
$1,190,975 |
$1,212,233 |
11/18 |
$1,219,772 |
$1,229,962 |
12/18 |
$1,114,141 |
$1,143,330 |
1/19 |
$1,189,715 |
$1,233,607 |
2/19 |
$1,226,334 |
$1,266,603 |
3/19 |
$1,252,045 |
$1,282,532 |
4/19 |
$1,283,210 |
$1,325,837 |
5/19 |
$1,213,868 |
$1,247,190 |
6/19 |
$1,283,989 |
$1,328,855 |
7/19 |
$1,286,326 |
$1,332,749 |
8/19 |
$1,287,884 |
$1,301,133 |
9/19 |
$1,298,792 |
$1,328,511 |
10/19 |
$1,326,061 |
$1,364,871 |
11/19 |
$1,357,226 |
$1,398,189 |
12/19 |
$1,400,109 |
$1,447,427 |
1/20 |
$1,399,257 |
$1,431,439 |
2/20 |
$1,307,223 |
$1,315,822 |
3/20 |
$1,180,250 |
$1,138,181 |
4/20 |
$1,279,953 |
$1,260,109 |
5/20 |
$1,337,049 |
$1,314,912 |
6/20 |
$1,360,909 |
$1,356,927 |
7/20 |
$1,438,456 |
$1,428,691 |
8/20 |
$1,521,116 |
$1,516,134 |
9/20 |
$1,469,986 |
$1,467,249 |
10/20 |
$1,435,048 |
$1,431,582 |
11/20 |
$1,572,246 |
$1,608,043 |
12/20 |
$1,630,816 |
$1,682,704 |
1/21 |
$1,615,068 |
$1,675,051 |
2/21 |
$1,678,061 |
$1,713,851 |
3/21 |
$1,739,304 |
$1,759,627 |
4/21 |
$1,807,546 |
$1,836,562 |
5/21 |
$1,846,917 |
$1,865,143 |
6/21 |
$1,847,792 |
$1,889,724 |
7/21 |
$1,834,668 |
$1,902,743 |
8/21 |
$1,872,289 |
$1,950,367 |
9/21 |
$1,796,172 |
$1,869,798 |
10/21 |
$1,879,288 |
$1,965,239 |
11/21 |
$1,832,918 |
$1,917,915 |
12/21 |
$1,916,047 |
$1,994,633 |
1/22 |
$1,859,576 |
$1,896,671 |
2/22 |
$1,814,003 |
$1,847,686 |
3/22 |
$1,839,761 |
$1,887,705 |
4/22 |
$1,709,978 |
$1,736,609 |
5/22 |
$1,721,866 |
$1,738,642 |
6/22 |
$1,603,971 |
$1,592,081 |
7/22 |
$1,689,172 |
$1,703,260 |
8/22 |
$1,623,785 |
$1,640,554 |
9/22 |
$1,471,215 |
$1,483,505 |
10/22 |
$1,554,435 |
$1,573,030 |
11/22 |
$1,688,182 |
$1,695,040 |
12/22 |
$1,633,368 |
$1,628,338 |
1/23 |
$1,715,246 |
$1,745,053 |
2/23 |
$1,659,611 |
$1,695,039 |
3/23 |
$1,732,041 |
$1,747,302 |
4/23 |
$1,767,732 |
$1,772,415 |
5/23 |
$1,723,644 |
$1,753,431 |
6/23 |
$1,797,124 |
$1,855,237 |
7/23 |
$1,855,909 |
$1,923,154 |
8/23 |
$1,797,124 |
$1,869,413 |
9/23 |
$1,712,097 |
$1,792,112 |
10/23 |
$1,672,207 |
$1,738,228 |
11/23 |
$1,796,075 |
$1,898,660 |
12/23 |
$1,872,026 |
$1,989,860 |
1/24 |
$1,857,178 |
$2,001,525 |
2/24 |
$1,937,130 |
$2,087,417 |
3/24 |
$1,999,950 |
$2,152,955 |
4/24 |
$1,950,836 |
$2,081,923 |
5/24 |
$2,037,641 |
$2,166,477 |
6/24 |
$2,071,907 |
$2,214,729 |
7/24 |
$2,125,589 |
$2,250,447 |
8/24 |
$2,156,428 |
$2,307,601 |
9/24 |
$2,183,840 |
$2,361,209 |
10/24 |
$2,145,006 |
$2,308,207 |
11/24 |
$2,230,669 |
$2,394,543 |
12/24 |
$2,153,543 |
$2,337,860 |
1/25 |
$2,207,055 |
$2,416,333 |
2/25 |
$2,176,137 |
$2,401,776 |
3/25 |
$2,095,275 |
$2,306,894 |
4/25 |
$2,107,166 |
$2,328,410 |
5/25 |
$2,221,324 |
$2,462,244 |
6/25 |
$2,304,564 |
$2,572,802 |
7/25 |
$2,323,591 |
$2,607,694 |
8/25 |
$2,367,589 |
$2,672,080 |
9/25 |
$2,450,829 |
$2,768,921 |
10/25 |
$2,512,665 |
$2,830,851 |
11/25 |
$2,516,232 |
$2,830,536 |
12/25 |
$2,548,882 |
$2,860,077 |
1/26 |
$2,631,693 |
$2,944,863 |
2/26 |
$2,656,957 |
$2,982,721 |
3/26 |
$2,477,300 |
$2,768,510 |
4/26 |
$2,717,311 |
$3,050,166 |
5/26 |
$2,825,385 |
$3,207,544 |
6/26 |
$2,838,018 |
$3,181,815 |
7/26 |
$2,793,103 |
$3,184,249 |
8/26 |
$2,864,685 |
$3,269,271 |
Average Annual Total Returns (%)Footnote Reference1
Table Summary
Fund |
1 Year |
5 Years |
10 Years |
Class I |
21.00% |
8.87% |
11.09% |
MSCI ACWI Index (net of foreign withholding taxes) |
22.35% |
10.88% |
12.57% |
| Footnote |
Description |
Footnote1 |
Performance prior to August 18, 2025 reflects the Fund’s performance under its former principal investment strategies and is that of the Fund’s former investment sub-adviser. |
Performance does not reflect the deduction of taxes that a shareholder would pay on Fund distributions or redemption of Fund shares. Performance assumes that all dividends and distributions, if any, were reinvested. For more recent performance information, visit www.eatonvance.com/performance.php.
THE FUND'S PAST PERFORMANCE IS NO GUARANTEE OF FUTURE RESULTS.
Table Summary
Total Net Assets |
$605,561,232 |
# of Portfolio Holdings |
250 |
Portfolio Turnover Rate |
190% |
Total Advisory Fees Paid |
$3,824,222 |
What did the Fund invest in?
The following tables reflect what the Fund invested in as of the report date.
Sector Allocation (% of total investments)
Table Summary
Value |
Value |
Real Estate |
1.0% |
Materials |
1.5% |
Consumer Staples |
1.6% |
Energy |
1.8% |
Short-Term Investments |
3.7% |
Communication Services |
5.3% |
Utilities |
5.5% |
Consumer Discretionary |
6.7% |
Health Care |
7.7% |
Exchange-Traded Funds |
11.2% |
Industrials |
11.6% |
Financials |
15.8% |
Information Technology |
26.6% |
Top Ten Holdings (% of total investments)Footnote Referencea
Table Summary
iShares Core MSCI Emerging Markets ETF |
4.8% |
NVIDIA Corp. |
4.8% |
Microsoft Corp. |
3.7% |
Apple, Inc. |
3.5% |
Amazon.com, Inc. |
2.5% |
Alphabet, Inc., Class A |
2.3% |
Broadcom, Inc. |
1.8% |
iShares MSCI Brazil ETF |
1.8% |
iShares MSCI Taiwan ETF |
1.6% |
Micron Technology, Inc. |
1.3% |
Total |
28.1% |
| Footnote |
Description |
Footnotea |
Excluding cash equivalents |
This is a summary of certain changes to the Fund since August 31, 2025. For more complete information, you may review the Fund’s next prospectus, which we expect to be available by January 1, 2027 at www.eatonvance.com/open-end-mutual-fund-documents.php or upon request by contacting us at 1-800-262-1122.
The net expense ratio decreased from the prior fiscal year primarily because the reduction in the investment adviser and administration fee and the agreement to reimburse the Fund’s expenses, both effective August 18, 2025, were in effect throughout the current fiscal year.
If you wish to view additional information about the Fund, including the prospectus, statement of additional information, financial statements and holdings, please scan the QR code or visit www.eatonvance.com/open-end-mutual-fund-documents.php. For proxy information, please visit www.eatonvance.com/proxyvoting.
The Funds may deliver a single copy of certain required shareholder documents (including prospectuses, shareholder reports, and proxy materials) to investors with the same last name and the same address. Your participation will continue indefinitely unless you instruct otherwise by calling 1-800-262-1122 or by contacting your financial intermediary. Your instruction will typically be effective within 30 days of receipt.
Not FDIC Insured | May Lose Value | No Bank Guarantee
Annual Shareholder Report August 31, 2026
Eaton Vance China Equity Fund
Annual Shareholder Report August 31, 2026
This annual shareholder report contains important information about the Eaton Vance China Equity Fund for the period of September 1, 2025 to August 31, 2026. You can find additional information about the Fund at www.eatonvance.com/open-end-mutual-fund-documents.php. You can also request this information by contacting us at 1-800-262-1122.
What were the Fund costs for the last year?
(based on a hypothetical $10,000 investment)
Table Summary
Class Name |
Costs of a $10,000 investment |
Costs paid as a percentage of a $10,000 investment |
Class A |
$146 |
1.50% |
How did the Fund perform last year and what affected its performance?
Key contributors to (↑) and detractors from (↓) performance, relative to the MSCI China Index (the Index):
↑ An overweight position in global semiconductor equipment maker NAURA Technology helped as the stock gained from ongoing semiconductor production localization
↑ An overweight position in China Construction Bank helped as net interest margin stabilized and state-owned enterprise bank re-rating strengthened capital base
↑ An out-of-index position in Shanghai Xizhi Technology helped as shares rallied from the initial public offering price on the AI optical-interconnect theme. The position was sold by the end of the period
↑ On a sector basis, stock selection in information technology and health care helped performance
↓ Overweight positions in Alibaba and Tencent Holdings detracted as stocks fell sharply amid a broad selloff in Chinese internet and communication services names
↓ No holdings in Bank of China Ltd. detracted as the stock rose amid demand for high-dividend-yielding financials as investors sought portfolio diversification
↓ On a sector basis, stock selection in consumer discretionary, an underweight to materials and an overweight to communication services hurt returns
Comparison of the change in value of a $10,000 investment for the period indicated.

Table Summary
|
Class A with Maximum Sales Charge |
MSCI China Index |
8/16 |
$10,000 |
$10,000 |
9/16 |
$9,768 |
$10,253 |
10/16 |
$9,498 |
$10,054 |
11/16 |
$9,336 |
$9,934 |
12/16 |
$8,897 |
$9,527 |
1/17 |
$9,394 |
$10,174 |
2/17 |
$9,676 |
$10,534 |
3/17 |
$10,013 |
$10,759 |
4/17 |
$10,347 |
$11,046 |
5/17 |
$10,774 |
$11,629 |
6/17 |
$11,032 |
$11,896 |
7/17 |
$11,595 |
$12,953 |
8/17 |
$11,956 |
$13,500 |
9/17 |
$11,980 |
$13,640 |
10/17 |
$12,468 |
$14,182 |
11/17 |
$12,848 |
$14,403 |
12/17 |
$13,290 |
$14,679 |
1/18 |
$14,359 |
$16,512 |
2/18 |
$13,709 |
$15,454 |
3/18 |
$13,583 |
$14,946 |
4/18 |
$13,348 |
$14,942 |
5/18 |
$13,746 |
$15,217 |
6/18 |
$13,447 |
$14,422 |
7/18 |
$13,264 |
$14,063 |
8/18 |
$12,876 |
$13,529 |
9/18 |
$12,787 |
$13,340 |
10/18 |
$11,492 |
$11,810 |
11/18 |
$12,147 |
$12,675 |
12/18 |
$11,965 |
$11,908 |
1/19 |
$12,811 |
$13,225 |
2/19 |
$13,340 |
$13,681 |
3/19 |
$13,915 |
$14,015 |
4/19 |
$14,001 |
$14,327 |
5/19 |
$13,012 |
$12,452 |
6/19 |
$13,794 |
$13,452 |
7/19 |
$13,599 |
$13,379 |
8/19 |
$13,346 |
$12,819 |
9/19 |
$13,317 |
$12,816 |
10/19 |
$13,984 |
$13,333 |
11/19 |
$13,875 |
$13,571 |
12/19 |
$14,746 |
$14,701 |
1/20 |
$14,092 |
$13,995 |
2/20 |
$14,145 |
$14,131 |
3/20 |
$12,844 |
$13,200 |
4/20 |
$13,801 |
$14,033 |
5/20 |
$13,670 |
$13,964 |
6/20 |
$14,555 |
$15,218 |
7/20 |
$15,530 |
$16,655 |
8/20 |
$16,207 |
$17,600 |
9/20 |
$15,761 |
$17,119 |
10/20 |
$16,148 |
$18,025 |
11/20 |
$17,205 |
$18,525 |
12/20 |
$18,452 |
$19,037 |
1/21 |
$19,355 |
$20,439 |
2/21 |
$19,440 |
$20,227 |
3/21 |
$19,113 |
$18,956 |
4/21 |
$19,388 |
$19,219 |
5/21 |
$19,807 |
$19,367 |
6/21 |
$19,074 |
$19,386 |
7/21 |
$17,706 |
$16,702 |
8/21 |
$17,582 |
$16,703 |
9/21 |
$16,986 |
$15,864 |
10/21 |
$17,176 |
$16,365 |
11/21 |
$16,672 |
$15,387 |
12/21 |
$16,673 |
$14,903 |
1/22 |
$16,246 |
$14,463 |
2/22 |
$15,427 |
$13,899 |
3/22 |
$13,541 |
$12,788 |
4/22 |
$13,052 |
$12,265 |
5/22 |
$13,334 |
$12,410 |
6/22 |
$14,071 |
$13,224 |
7/22 |
$13,045 |
$11,968 |
8/22 |
$12,997 |
$11,995 |
9/22 |
$11,317 |
$10,249 |
10/22 |
$9,273 |
$8,526 |
11/22 |
$12,412 |
$11,059 |
12/22 |
$12,889 |
$11,634 |
1/23 |
$14,371 |
$13,005 |
2/23 |
$13,101 |
$11,656 |
3/23 |
$13,079 |
$12,182 |
4/23 |
$12,422 |
$11,554 |
5/23 |
$11,043 |
$10,580 |
6/23 |
$11,400 |
$10,999 |
7/23 |
$12,458 |
$12,183 |
8/23 |
$11,532 |
$11,092 |
9/23 |
$10,991 |
$10,786 |
10/23 |
$10,714 |
$10,327 |
11/23 |
$11,094 |
$10,587 |
12/23 |
$10,656 |
$10,332 |
1/24 |
$9,183 |
$9,235 |
2/24 |
$9,705 |
$10,010 |
3/24 |
$9,801 |
$10,105 |
4/24 |
$10,387 |
$10,771 |
5/24 |
$10,775 |
$11,030 |
6/24 |
$10,609 |
$10,821 |
7/24 |
$10,125 |
$10,678 |
8/24 |
$10,054 |
$10,785 |
9/24 |
$11,987 |
$13,363 |
10/24 |
$11,559 |
$12,573 |
11/24 |
$11,132 |
$12,015 |
12/24 |
$11,646 |
$12,338 |
1/25 |
$11,832 |
$12,452 |
2/25 |
$12,812 |
$13,916 |
3/25 |
$13,339 |
$14,192 |
4/25 |
$12,691 |
$13,586 |
5/25 |
$13,088 |
$13,958 |
6/25 |
$13,549 |
$14,476 |
7/25 |
$13,946 |
$15,172 |
8/25 |
$14,699 |
$15,921 |
9/25 |
$15,825 |
$17,473 |
10/25 |
$15,274 |
$16,807 |
11/25 |
$14,959 |
$16,387 |
12/25 |
$14,681 |
$16,184 |
1/26 |
$15,117 |
$16,944 |
2/26 |
$14,385 |
$15,967 |
3/26 |
$13,488 |
$14,738 |
4/26 |
$14,237 |
$15,273 |
5/26 |
$13,710 |
$14,810 |
6/26 |
$13,266 |
$13,761 |
7/26 |
$14,031 |
$14,999 |
8/26 |
$13,932 |
$14,948 |
Average Annual Total Returns (%)
Table Summary
Fund |
1 Year |
5 Years |
10 Years |
Class A |
(5.22)% |
(4.54)% |
3.93% |
Class A with 5.25% Maximum Sales Charge |
(10.21)% |
(5.57)% |
3.37% |
MSCI China Index (net of foreign withholding taxes) |
(6.11)% |
(2.19)% |
4.10% |
Performance does not reflect the deduction of taxes that a shareholder would pay on Fund distributions or redemption of Fund shares. Performance assumes that all dividends and distributions, if any, were reinvested. For more recent performance information, visit www.eatonvance.com/performance.php.
THE FUND'S PAST PERFORMANCE IS NO GUARANTEE OF FUTURE RESULTS.
Table Summary
Total Net Assets |
$33,702,059 |
# of Portfolio Holdings |
63 |
Portfolio Turnover Rate |
34% |
Total Advisory Fees Paid |
$101,348 |
What did the Fund invest in?
The following tables reflect what the Fund invested in as of the report date.
Sector Allocation (% of total investments)
Table Summary
Value |
Value |
Short-Term Investments |
0.0%Footnote Reference* |
Utilities |
1.1% |
Real Estate |
1.3% |
Consumer Staples |
2.1% |
Energy |
4.0% |
Health Care |
5.0% |
Materials |
5.3% |
Industrials |
7.9% |
Information Technology |
14.7% |
Communication Services |
17.7% |
Consumer Discretionary |
18.2% |
Financials |
22.7% |
| Footnote |
Description |
Footnote* |
Amount is less than 0.05%. |
Top Ten Holdings (% of total investments)Footnote Referencea
Table Summary
Tencent Holdings Ltd. |
17.7% |
Alibaba Group Holding Ltd. |
11.2% |
China Construction Bank Corp., Class H |
10.0% |
NAURA Technology Group Co. Ltd., Class A |
4.6% |
Industrial & Commercial Bank of China Ltd., Class H |
3.7% |
Zijin Mining Group Co. Ltd., Class H |
3.6% |
Wuxi Biologics Cayman, Inc. |
3.3% |
Ping An Insurance Group Co. of China Ltd., Class H |
3.0% |
Contemporary Amperex Technology Co. Ltd., Class A |
2.7% |
China Shenhua Energy Co. Ltd., Class H |
2.1% |
Total |
61.9% |
| Footnote |
Description |
Footnotea |
Excluding cash equivalents |
If you wish to view additional information about the Fund, including the prospectus, statement of additional information, financial statements and holdings, please scan the QR code or visit www.eatonvance.com/open-end-mutual-fund-documents.php. For proxy information, please visit www.eatonvance.com/proxyvoting.
The Funds may deliver a single copy of certain required shareholder documents (including prospectuses, shareholder reports, and proxy materials) to investors with the same last name and the same address. Your participation will continue indefinitely unless you instruct otherwise by calling 1-800-262-1122 or by contacting your financial intermediary. Your instruction will typically be effective within 30 days of receipt.
Not FDIC Insured | May Lose Value | No Bank Guarantee
Annual Shareholder Report August 31, 2026
Eaton Vance China Equity Fund
Annual Shareholder Report August 31, 2026
This annual shareholder report contains important information about the Eaton Vance China Equity Fund for the period of September 1, 2025 to August 31, 2026. You can find additional information about the Fund at www.eatonvance.com/open-end-mutual-fund-documents.php. You can also request this information by contacting us at 1-800-262-1122.
What were the Fund costs for the last year?
(based on a hypothetical $10,000 investment)
Table Summary
Class Name |
Costs of a $10,000 investment |
Costs paid as a percentage of a $10,000 investment |
Class C |
$218 |
2.25% |
How did the Fund perform last year and what affected its performance?
Key contributors to (↑) and detractors from (↓) performance, relative to the MSCI China Index (the Index):
↑ An overweight position in global semiconductor equipment maker NAURA Technology helped as the stock gained from ongoing semiconductor production localization
↑ An overweight position in China Construction Bank helped as net interest margin stabilized and state-owned enterprise bank re-rating strengthened capital base
↑ An out-of-index position in Shanghai Xizhi Technology helped as shares rallied from the initial public offering price on the AI optical-interconnect theme. The position was sold by the end of the period
↑ On a sector basis, stock selection in information technology and health care helped performance
↓ Overweight positions in Alibaba and Tencent Holdings detracted as stocks fell sharply amid a broad selloff in Chinese internet and communication services names
↓ No holdings in Bank of China Ltd. detracted as the stock rose amid demand for high-dividend-yielding financials as investors sought portfolio diversification
↓ On a sector basis, stock selection in consumer discretionary, an underweight to materials and an overweight to communication services hurt returns
Comparison of the change in value of a $10,000 investment for the period indicated.

Table Summary
|
Class C |
MSCI China Index |
8/16 |
$10,000 |
$10,000 |
9/16 |
$10,304 |
$10,253 |
10/16 |
$10,010 |
$10,054 |
11/16 |
$9,830 |
$9,934 |
12/16 |
$9,364 |
$9,527 |
1/17 |
$9,884 |
$10,174 |
2/17 |
$10,175 |
$10,534 |
3/17 |
$10,523 |
$10,759 |
4/17 |
$10,865 |
$11,046 |
5/17 |
$11,307 |
$11,629 |
6/17 |
$11,572 |
$11,896 |
7/17 |
$12,154 |
$12,953 |
8/17 |
$12,527 |
$13,500 |
9/17 |
$12,543 |
$13,640 |
10/17 |
$13,047 |
$14,182 |
11/17 |
$13,436 |
$14,403 |
12/17 |
$13,889 |
$14,679 |
1/18 |
$14,997 |
$16,512 |
2/18 |
$14,312 |
$15,454 |
3/18 |
$14,173 |
$14,946 |
4/18 |
$13,923 |
$14,942 |
5/18 |
$14,330 |
$15,217 |
6/18 |
$14,005 |
$14,422 |
7/18 |
$13,807 |
$14,063 |
8/18 |
$13,396 |
$13,529 |
9/18 |
$13,297 |
$13,340 |
10/18 |
$11,939 |
$11,810 |
11/18 |
$12,612 |
$12,675 |
12/18 |
$12,422 |
$11,908 |
1/19 |
$13,287 |
$13,225 |
2/19 |
$13,827 |
$13,681 |
3/19 |
$14,418 |
$14,015 |
4/19 |
$14,501 |
$14,327 |
5/19 |
$13,471 |
$12,452 |
6/19 |
$14,266 |
$13,452 |
7/19 |
$14,056 |
$13,379 |
8/19 |
$13,789 |
$12,819 |
9/19 |
$13,751 |
$12,816 |
10/19 |
$14,431 |
$13,333 |
11/19 |
$14,310 |
$13,571 |
12/19 |
$15,198 |
$14,701 |
1/20 |
$14,516 |
$13,995 |
2/20 |
$14,569 |
$14,131 |
3/20 |
$13,217 |
$13,200 |
4/20 |
$14,195 |
$14,033 |
5/20 |
$14,050 |
$13,964 |
6/20 |
$14,949 |
$15,218 |
7/20 |
$15,939 |
$16,655 |
8/20 |
$16,628 |
$17,600 |
9/20 |
$16,162 |
$17,119 |
10/20 |
$16,543 |
$18,025 |
11/20 |
$17,625 |
$18,525 |
12/20 |
$18,885 |
$19,037 |
1/21 |
$19,805 |
$20,439 |
2/21 |
$19,877 |
$20,227 |
3/21 |
$19,532 |
$18,956 |
4/21 |
$19,798 |
$19,219 |
5/21 |
$20,215 |
$19,367 |
6/21 |
$19,453 |
$19,386 |
7/21 |
$18,052 |
$16,702 |
8/21 |
$17,915 |
$16,703 |
9/21 |
$17,297 |
$15,864 |
10/21 |
$17,477 |
$16,365 |
11/21 |
$16,952 |
$15,387 |
12/21 |
$16,946 |
$14,903 |
1/22 |
$16,505 |
$14,463 |
2/22 |
$15,663 |
$13,899 |
3/22 |
$13,734 |
$12,788 |
4/22 |
$13,233 |
$12,265 |
5/22 |
$13,514 |
$12,410 |
6/22 |
$14,251 |
$13,224 |
7/22 |
$13,203 |
$11,968 |
8/22 |
$13,150 |
$11,995 |
9/22 |
$11,441 |
$10,249 |
10/22 |
$9,369 |
$8,526 |
11/22 |
$12,535 |
$11,059 |
12/22 |
$13,007 |
$11,634 |
1/23 |
$14,489 |
$13,005 |
2/23 |
$13,202 |
$11,656 |
3/23 |
$13,169 |
$12,182 |
4/23 |
$12,505 |
$11,554 |
5/23 |
$11,105 |
$10,580 |
6/23 |
$11,461 |
$10,999 |
7/23 |
$12,514 |
$12,183 |
8/23 |
$11,575 |
$11,092 |
9/23 |
$11,032 |
$10,786 |
10/23 |
$10,741 |
$10,327 |
11/23 |
$11,113 |
$10,587 |
12/23 |
$10,662 |
$10,332 |
1/24 |
$9,193 |
$9,235 |
2/24 |
$9,706 |
$10,010 |
3/24 |
$9,795 |
$10,105 |
4/24 |
$10,379 |
$10,771 |
5/24 |
$10,750 |
$11,030 |
6/24 |
$10,582 |
$10,821 |
7/24 |
$10,096 |
$10,678 |
8/24 |
$10,016 |
$10,785 |
9/24 |
$11,936 |
$13,363 |
10/24 |
$11,503 |
$12,573 |
11/24 |
$11,069 |
$12,015 |
12/24 |
$11,572 |
$12,338 |
1/25 |
$11,752 |
$12,452 |
2/25 |
$12,721 |
$13,916 |
3/25 |
$13,232 |
$14,192 |
4/25 |
$12,577 |
$13,586 |
5/25 |
$12,963 |
$13,958 |
6/25 |
$13,412 |
$14,476 |
7/25 |
$13,797 |
$15,172 |
8/25 |
$14,533 |
$15,921 |
9/25 |
$15,645 |
$17,473 |
10/25 |
$15,080 |
$16,807 |
11/25 |
$14,766 |
$16,387 |
12/25 |
$14,481 |
$16,184 |
1/26 |
$14,899 |
$16,944 |
2/26 |
$14,164 |
$15,967 |
3/26 |
$13,275 |
$14,738 |
4/26 |
$14,010 |
$15,273 |
5/26 |
$13,483 |
$14,810 |
6/26 |
$13,039 |
$13,761 |
7/26 |
$13,774 |
$14,999 |
8/26 |
$13,674 |
$14,948 |
Average Annual Total Returns (%)
Table Summary
Fund |
1 Year |
5 Years |
10 Years |
Class C, with conversion to Class A after 8 years |
(5.91)% |
(5.26)% |
3.18% |
Class C, with 1% Maximum Contingent Deferred Sales Charge and conversion to Class A after 8 years |
(6.84)% |
(5.26)% |
3.18% |
MSCI China Index (net of foreign withholding taxes) |
(6.11)% |
(2.19)% |
4.10% |
Performance does not reflect the deduction of taxes that a shareholder would pay on Fund distributions or redemption of Fund shares. Performance assumes that all dividends and distributions, if any, were reinvested. For more recent performance information, visit www.eatonvance.com/performance.php.
THE FUND'S PAST PERFORMANCE IS NO GUARANTEE OF FUTURE RESULTS.
Table Summary
Total Net Assets |
$33,702,059 |
# of Portfolio Holdings |
63 |
Portfolio Turnover Rate |
34% |
Total Advisory Fees Paid |
$101,348 |
What did the Fund invest in?
The following tables reflect what the Fund invested in as of the report date.
Sector Allocation (% of total investments)
Table Summary
Value |
Value |
Short-Term Investments |
0.0%Footnote Reference* |
Utilities |
1.1% |
Real Estate |
1.3% |
Consumer Staples |
2.1% |
Energy |
4.0% |
Health Care |
5.0% |
Materials |
5.3% |
Industrials |
7.9% |
Information Technology |
14.7% |
Communication Services |
17.7% |
Consumer Discretionary |
18.2% |
Financials |
22.7% |
| Footnote |
Description |
Footnote* |
Amount is less than 0.05%. |
Top Ten Holdings (% of total investments)Footnote Referencea
Table Summary
Tencent Holdings Ltd. |
17.7% |
Alibaba Group Holding Ltd. |
11.2% |
China Construction Bank Corp., Class H |
10.0% |
NAURA Technology Group Co. Ltd., Class A |
4.6% |
Industrial & Commercial Bank of China Ltd., Class H |
3.7% |
Zijin Mining Group Co. Ltd., Class H |
3.6% |
Wuxi Biologics Cayman, Inc. |
3.3% |
Ping An Insurance Group Co. of China Ltd., Class H |
3.0% |
Contemporary Amperex Technology Co. Ltd., Class A |
2.7% |
China Shenhua Energy Co. Ltd., Class H |
2.1% |
Total |
61.9% |
| Footnote |
Description |
Footnotea |
Excluding cash equivalents |
If you wish to view additional information about the Fund, including the prospectus, statement of additional information, financial statements and holdings, please scan the QR code or visit www.eatonvance.com/open-end-mutual-fund-documents.php. For proxy information, please visit www.eatonvance.com/proxyvoting.
The Funds may deliver a single copy of certain required shareholder documents (including prospectuses, shareholder reports, and proxy materials) to investors with the same last name and the same address. Your participation will continue indefinitely unless you instruct otherwise by calling 1-800-262-1122 or by contacting your financial intermediary. Your instruction will typically be effective within 30 days of receipt.
Not FDIC Insured | May Lose Value | No Bank Guarantee
Annual Shareholder Report August 31, 2026
Eaton Vance China Equity Fund
Annual Shareholder Report August 31, 2026
This annual shareholder report contains important information about the Eaton Vance China Equity Fund for the period of September 1, 2025 to August 31, 2026. You can find additional information about the Fund at www.eatonvance.com/open-end-mutual-fund-documents.php. You can also request this information by contacting us at 1-800-262-1122.
What were the Fund costs for the last year?
(based on a hypothetical $10,000 investment)
Table Summary
Class Name |
Costs of a $10,000 investment |
Costs paid as a percentage of a $10,000 investment |
Class I |
$122 |
1.25% |
How did the Fund perform last year and what affected its performance?
Key contributors to (↑) and detractors from (↓) performance, relative to the MSCI China Index (the Index):
↑ An overweight position in global semiconductor equipment maker NAURA Technology helped as the stock gained from ongoing semiconductor production localization
↑ An overweight position in China Construction Bank helped as net interest margin stabilized and state-owned enterprise bank re-rating strengthened capital base
↑ An out-of-index position in Shanghai Xizhi Technology helped as shares rallied from the initial public offering price on the AI optical-interconnect theme. The position was sold by the end of the period
↑ On a sector basis, stock selection in information technology and health care helped performance
↓ Overweight positions in Alibaba and Tencent Holdings detracted as stocks fell sharply amid a broad selloff in Chinese internet and communication services names
↓ No holdings in Bank of China Ltd. detracted as the stock rose amid demand for high-dividend-yielding financials as investors sought portfolio diversification
↓ On a sector basis, stock selection in consumer discretionary, an underweight to materials and an overweight to communication services hurt returns
Comparison of the change in value of a $1,000,000 investment for the period indicated.

Table Summary
|
Class I |
MSCI China Index |
8/16 |
$1,000,000 |
$1,000,000 |
9/16 |
$1,030,717 |
$1,025,273 |
10/16 |
$1,002,438 |
$1,005,418 |
11/16 |
$985,373 |
$993,384 |
12/16 |
$939,247 |
$952,740 |
1/17 |
$992,440 |
$1,017,407 |
2/17 |
$1,022,484 |
$1,053,408 |
3/17 |
$1,058,438 |
$1,075,898 |
4/17 |
$1,093,407 |
$1,104,590 |
5/17 |
$1,139,212 |
$1,162,868 |
6/17 |
$1,166,794 |
$1,189,635 |
7/17 |
$1,226,882 |
$1,295,339 |
8/17 |
$1,264,806 |
$1,349,963 |
9/17 |
$1,268,254 |
$1,363,990 |
10/17 |
$1,319,969 |
$1,418,200 |
11/17 |
$1,360,356 |
$1,440,307 |
12/17 |
$1,407,534 |
$1,467,879 |
1/18 |
$1,521,107 |
$1,651,189 |
2/18 |
$1,452,743 |
$1,545,446 |
3/18 |
$1,440,063 |
$1,494,579 |
4/18 |
$1,415,253 |
$1,494,225 |
5/18 |
$1,457,705 |
$1,521,668 |
6/18 |
$1,426,279 |
$1,442,237 |
7/18 |
$1,407,534 |
$1,406,264 |
8/18 |
$1,366,736 |
$1,352,880 |
9/18 |
$1,357,364 |
$1,333,953 |
10/18 |
$1,220,084 |
$1,180,958 |
11/18 |
$1,290,102 |
$1,267,519 |
12/18 |
$1,271,429 |
$1,190,805 |
1/19 |
$1,361,206 |
$1,322,495 |
2/19 |
$1,417,619 |
$1,368,147 |
3/19 |
$1,479,492 |
$1,401,473 |
4/19 |
$1,488,591 |
$1,432,692 |
5/19 |
$1,384,256 |
$1,245,195 |
6/19 |
$1,467,360 |
$1,345,194 |
7/19 |
$1,446,736 |
$1,337,904 |
8/19 |
$1,420,652 |
$1,281,904 |
9/19 |
$1,417,619 |
$1,281,578 |
10/19 |
$1,489,198 |
$1,333,312 |
11/19 |
$1,477,672 |
$1,357,086 |
12/19 |
$1,570,873 |
$1,470,134 |
1/20 |
$1,501,783 |
$1,399,521 |
2/20 |
$1,508,064 |
$1,413,130 |
3/20 |
$1,369,254 |
$1,319,951 |
4/20 |
$1,471,634 |
$1,403,296 |
5/20 |
$1,458,444 |
$1,396,369 |
6/20 |
$1,553,287 |
$1,521,788 |
7/20 |
$1,657,551 |
$1,665,506 |
8/20 |
$1,730,410 |
$1,760,031 |
9/20 |
$1,683,303 |
$1,711,938 |
10/20 |
$1,724,757 |
$1,802,486 |
11/20 |
$1,838,443 |
$1,852,470 |
12/20 |
$1,972,259 |
$1,903,735 |
1/21 |
$2,069,278 |
$2,043,908 |
2/21 |
$2,078,980 |
$2,022,744 |
3/21 |
$2,044,330 |
$1,895,620 |
4/21 |
$2,074,129 |
$1,921,928 |
5/21 |
$2,119,173 |
$1,936,712 |
6/21 |
$2,041,558 |
$1,938,608 |
7/21 |
$1,896,030 |
$1,670,242 |
8/21 |
$1,882,863 |
$1,670,309 |
9/21 |
$1,819,107 |
$1,586,413 |
10/21 |
$1,839,897 |
$1,636,472 |
11/21 |
$1,786,537 |
$1,538,745 |
12/21 |
$1,786,615 |
$1,490,256 |
1/22 |
$1,741,439 |
$1,446,293 |
2/22 |
$1,654,003 |
$1,389,890 |
3/22 |
$1,452,171 |
$1,278,753 |
4/22 |
$1,399,709 |
$1,226,532 |
5/22 |
$1,430,312 |
$1,240,988 |
6/22 |
$1,509,733 |
$1,322,394 |
7/22 |
$1,399,709 |
$1,196,805 |
8/22 |
$1,395,337 |
$1,199,478 |
9/22 |
$1,215,364 |
$1,024,901 |
10/22 |
$996,045 |
$852,618 |
11/22 |
$1,333,403 |
$1,105,916 |
12/22 |
$1,385,367 |
$1,163,435 |
1/23 |
$1,544,356 |
$1,300,495 |
2/23 |
$1,408,521 |
$1,165,571 |
3/23 |
$1,406,205 |
$1,218,208 |
4/23 |
$1,335,972 |
$1,155,384 |
5/23 |
$1,187,788 |
$1,057,964 |
6/23 |
$1,226,378 |
$1,099,940 |
7/23 |
$1,340,603 |
$1,218,279 |
8/23 |
$1,241,813 |
$1,109,177 |
9/23 |
$1,183,929 |
$1,078,634 |
10/23 |
$1,154,601 |
$1,032,657 |
11/23 |
$1,195,506 |
$1,058,683 |
12/23 |
$1,147,615 |
$1,033,160 |
1/24 |
$989,786 |
$923,522 |
2/24 |
$1,046,034 |
$1,001,044 |
3/24 |
$1,056,948 |
$1,010,485 |
4/24 |
$1,119,911 |
$1,077,137 |
5/24 |
$1,161,887 |
$1,102,973 |
6/24 |
$1,144,257 |
$1,082,132 |
7/24 |
$1,093,047 |
$1,067,756 |
8/24 |
$1,085,491 |
$1,078,484 |
9/24 |
$1,293,690 |
$1,336,293 |
10/24 |
$1,248,357 |
$1,257,259 |
11/24 |
$1,202,183 |
$1,201,479 |
12/24 |
$1,258,133 |
$1,233,793 |
1/25 |
$1,278,772 |
$1,245,152 |
2/25 |
$1,384,548 |
$1,391,616 |
3/25 |
$1,441,306 |
$1,419,162 |
4/25 |
$1,371,649 |
$1,358,564 |
5/25 |
$1,414,647 |
$1,395,796 |
6/25 |
$1,465,385 |
$1,447,649 |
7/25 |
$1,508,383 |
$1,517,194 |
8/25 |
$1,590,940 |
$1,592,095 |
9/25 |
$1,713,056 |
$1,747,347 |
10/25 |
$1,652,858 |
$1,680,662 |
11/25 |
$1,620,179 |
$1,638,654 |
12/25 |
$1,590,020 |
$1,618,400 |
1/26 |
$1,637,274 |
$1,694,413 |
2/26 |
$1,557,642 |
$1,596,683 |
3/26 |
$1,461,383 |
$1,473,795 |
4/26 |
$1,543,641 |
$1,527,345 |
5/26 |
$1,485,886 |
$1,481,044 |
6/26 |
$1,438,631 |
$1,376,106 |
7/26 |
$1,521,764 |
$1,499,929 |
8/26 |
$1,511,263 |
$1,494,793 |
Average Annual Total Returns (%)
Table Summary
Fund |
1 Year |
5 Years |
10 Years |
Class I |
(5.01)% |
(4.30)% |
4.21% |
MSCI China Index (net of foreign withholding taxes) |
(6.11)% |
(2.19)% |
4.10% |
Performance does not reflect the deduction of taxes that a shareholder would pay on Fund distributions or redemption of Fund shares. Performance assumes that all dividends and distributions, if any, were reinvested. For more recent performance information, visit www.eatonvance.com/performance.php.
THE FUND'S PAST PERFORMANCE IS NO GUARANTEE OF FUTURE RESULTS.
Table Summary
Total Net Assets |
$33,702,059 |
# of Portfolio Holdings |
63 |
Portfolio Turnover Rate |
34% |
Total Advisory Fees Paid |
$101,348 |
What did the Fund invest in?
The following tables reflect what the Fund invested in as of the report date.
Sector Allocation (% of total investments)
Table Summary
Value |
Value |
Short-Term Investments |
0.0%Footnote Reference* |
Utilities |
1.1% |
Real Estate |
1.3% |
Consumer Staples |
2.1% |
Energy |
4.0% |
Health Care |
5.0% |
Materials |
5.3% |
Industrials |
7.9% |
Information Technology |
14.7% |
Communication Services |
17.7% |
Consumer Discretionary |
18.2% |
Financials |
22.7% |
| Footnote |
Description |
Footnote* |
Amount is less than 0.05%. |
Top Ten Holdings (% of total investments)Footnote Referencea
Table Summary
Tencent Holdings Ltd. |
17.7% |
Alibaba Group Holding Ltd. |
11.2% |
China Construction Bank Corp., Class H |
10.0% |
NAURA Technology Group Co. Ltd., Class A |
4.6% |
Industrial & Commercial Bank of China Ltd., Class H |
3.7% |
Zijin Mining Group Co. Ltd., Class H |
3.6% |
Wuxi Biologics Cayman, Inc. |
3.3% |
Ping An Insurance Group Co. of China Ltd., Class H |
3.0% |
Contemporary Amperex Technology Co. Ltd., Class A |
2.7% |
China Shenhua Energy Co. Ltd., Class H |
2.1% |
Total |
61.9% |
| Footnote |
Description |
Footnotea |
Excluding cash equivalents |
If you wish to view additional information about the Fund, including the prospectus, statement of additional information, financial statements and holdings, please scan the QR code or visit www.eatonvance.com/open-end-mutual-fund-documents.php. For proxy information, please visit www.eatonvance.com/proxyvoting.
The Funds may deliver a single copy of certain required shareholder documents (including prospectuses, shareholder reports, and proxy materials) to investors with the same last name and the same address. Your participation will continue indefinitely unless you instruct otherwise by calling 1-800-262-1122 or by contacting your financial intermediary. Your instruction will typically be effective within 30 days of receipt.
Not FDIC Insured | May Lose Value | No Bank Guarantee
Annual Shareholder Report August 31, 2026
Eaton Vance Worldwide Health Sciences Fund
Annual Shareholder Report August 31, 2026
This annual shareholder report contains important information about the Eaton Vance Worldwide Health Sciences Fund for the period of September 1, 2025 to August 31, 2026. You can find additional information about the Fund at www.eatonvance.com/open-end-mutual-fund-documents.php. You can also request this information by contacting us at 1-800-262-1122.
What were the Fund costs for the last year?
(based on a hypothetical $10,000 investment)
Table Summary
Class Name |
Costs of a $10,000 investment |
Costs paid as a percentage of a $10,000 investment |
Class A |
$121 |
1.13% |
How did the Fund perform last year and what affected its performance?
Key contributors to (↑) and detractors from (↓) performance, relative to the MSCI World Health Care Index (the Index):
↓ Overweight to Zoetis, Inc. detracted due to its lowered 2026 guidance on weaker US pet demand and competition in dermatology and parasiticide products. This was sold by period end
↓ Overweight to Boston Scientific Corp. detracted as its 2026 growth outlook was cut on weaker WATCHMAN demand and electrophysiology US market share losses. This was sold by period end
↓ Overweight to CSL Ltd. hurt due to weaker US flu vaccine demand, lower immunoglobulin and China albumin sales and a chief executive officer change. This was sold by period end
↓ On an industry basis, stock selection in biotechnology detracted the most, followed by health care equipment and supplies, and life science tools and services
↑ Overweight to Eli Lilly & Co. helped as strong Mounjaro and Zepbound GLP-1 drugs sales and US approval of obesity pill Foundayo supported shares
↑ Out-of-index allocation to Structure Therapeutics, Inc. added as shares rose on strong mid-stage trial results for its oral weight-loss drug. This was sold by period end
↑ Overweight to Bristol Myers Squibb Co. helped as growth from newer drugs in cardiomyopathy and blood cancers more than offset declines in older drugs
↑ Stock selection in pharmaceuticals and health care technology helped returns
Comparison of the change in value of a $10,000 investment for the period indicated.

Table Summary
|
Class A with Maximum Sales Charge |
MSCI World Index |
MSCI World Health Care Index |
S&P 500® Index |
8/16 |
$10,000 |
$10,000 |
$10,000 |
$10,000 |
9/16 |
$9,475 |
$10,053 |
$9,987 |
$10,002 |
10/16 |
$8,624 |
$9,859 |
$9,297 |
$9,819 |
11/16 |
$8,607 |
$10,000 |
$9,306 |
$10,183 |
12/16 |
$8,745 |
$10,240 |
$9,452 |
$10,384 |
1/17 |
$8,975 |
$10,487 |
$9,659 |
$10,581 |
2/17 |
$9,493 |
$10,778 |
$10,217 |
$11,001 |
3/17 |
$9,551 |
$10,892 |
$10,250 |
$11,014 |
4/17 |
$9,781 |
$11,054 |
$10,443 |
$11,127 |
5/17 |
$9,724 |
$11,288 |
$10,671 |
$11,284 |
6/17 |
$10,069 |
$11,331 |
$10,961 |
$11,354 |
7/17 |
$10,137 |
$11,602 |
$10,969 |
$11,588 |
8/17 |
$10,281 |
$11,619 |
$11,077 |
$11,623 |
9/17 |
$10,329 |
$11,879 |
$11,226 |
$11,863 |
10/17 |
$9,983 |
$12,104 |
$11,080 |
$12,140 |
11/17 |
$10,233 |
$12,366 |
$11,331 |
$12,512 |
12/17 |
$10,165 |
$12,533 |
$11,324 |
$12,651 |
1/18 |
$10,717 |
$13,195 |
$11,958 |
$13,376 |
2/18 |
$10,204 |
$12,648 |
$11,422 |
$12,883 |
3/18 |
$10,046 |
$12,373 |
$11,184 |
$12,555 |
4/18 |
$10,175 |
$12,515 |
$11,291 |
$12,604 |
5/18 |
$10,332 |
$12,593 |
$11,345 |
$12,907 |
6/18 |
$10,530 |
$12,587 |
$11,495 |
$12,987 |
7/18 |
$11,201 |
$12,980 |
$12,202 |
$13,470 |
8/18 |
$11,546 |
$13,141 |
$12,562 |
$13,909 |
9/18 |
$11,763 |
$13,214 |
$12,817 |
$13,988 |
10/18 |
$11,023 |
$12,244 |
$11,974 |
$13,032 |
11/18 |
$11,684 |
$12,383 |
$12,627 |
$13,297 |
12/18 |
$10,772 |
$11,441 |
$11,608 |
$12,097 |
1/19 |
$11,488 |
$12,332 |
$12,206 |
$13,066 |
2/19 |
$11,748 |
$12,703 |
$12,447 |
$13,486 |
3/19 |
$11,976 |
$12,869 |
$12,553 |
$13,748 |
4/19 |
$11,613 |
$13,326 |
$12,229 |
$14,304 |
5/19 |
$11,385 |
$12,557 |
$11,936 |
$13,395 |
6/19 |
$12,205 |
$13,384 |
$12,741 |
$14,339 |
7/19 |
$12,049 |
$13,451 |
$12,600 |
$14,546 |
8/19 |
$12,049 |
$13,175 |
$12,596 |
$14,315 |
9/19 |
$11,966 |
$13,456 |
$12,583 |
$14,583 |
10/19 |
$12,485 |
$13,798 |
$13,211 |
$14,899 |
11/19 |
$13,056 |
$14,182 |
$13,835 |
$15,440 |
12/19 |
$13,572 |
$14,607 |
$14,306 |
$15,906 |
1/20 |
$13,353 |
$14,518 |
$14,103 |
$15,899 |
2/20 |
$12,487 |
$13,291 |
$13,139 |
$14,591 |
3/20 |
$12,071 |
$11,532 |
$12,664 |
$12,788 |
4/20 |
$13,419 |
$12,792 |
$14,134 |
$14,428 |
5/20 |
$13,923 |
$13,410 |
$14,705 |
$15,115 |
6/20 |
$13,781 |
$13,765 |
$14,508 |
$15,416 |
7/20 |
$14,285 |
$14,423 |
$15,103 |
$16,285 |
8/20 |
$14,669 |
$15,387 |
$15,414 |
$17,455 |
9/20 |
$14,439 |
$14,856 |
$15,201 |
$16,792 |
10/20 |
$13,781 |
$14,400 |
$14,460 |
$16,346 |
11/20 |
$14,789 |
$16,242 |
$15,754 |
$18,135 |
12/20 |
$15,341 |
$16,930 |
$16,240 |
$18,832 |
1/21 |
$15,282 |
$16,762 |
$16,413 |
$18,642 |
2/21 |
$15,070 |
$17,192 |
$15,967 |
$19,156 |
3/21 |
$15,400 |
$17,764 |
$16,358 |
$19,995 |
4/21 |
$16,037 |
$18,590 |
$16,982 |
$21,062 |
5/21 |
$16,367 |
$18,858 |
$17,332 |
$21,209 |
6/21 |
$16,814 |
$19,139 |
$17,851 |
$21,704 |
7/21 |
$17,392 |
$19,482 |
$18,515 |
$22,220 |
8/21 |
$17,981 |
$19,967 |
$19,029 |
$22,895 |
9/21 |
$16,932 |
$19,138 |
$18,032 |
$21,831 |
10/21 |
$18,063 |
$20,222 |
$18,793 |
$23,360 |
11/21 |
$17,274 |
$19,779 |
$18,122 |
$23,198 |
12/21 |
$18,725 |
$20,624 |
$19,457 |
$24,238 |
1/22 |
$17,060 |
$19,533 |
$18,019 |
$22,984 |
2/22 |
$17,124 |
$19,039 |
$17,939 |
$22,295 |
3/22 |
$18,059 |
$19,561 |
$18,803 |
$23,123 |
4/22 |
$17,124 |
$17,936 |
$17,932 |
$21,107 |
5/22 |
$17,009 |
$17,950 |
$18,020 |
$21,146 |
6/22 |
$16,714 |
$16,395 |
$17,448 |
$19,400 |
7/22 |
$17,278 |
$17,697 |
$18,018 |
$21,189 |
8/22 |
$15,946 |
$16,957 |
$16,933 |
$20,325 |
9/22 |
$15,241 |
$15,380 |
$16,266 |
$18,453 |
10/22 |
$16,368 |
$16,485 |
$17,633 |
$19,947 |
11/22 |
$17,239 |
$17,631 |
$18,624 |
$21,062 |
12/22 |
$16,959 |
$16,882 |
$18,403 |
$19,848 |
1/23 |
$16,866 |
$18,077 |
$18,284 |
$21,095 |
2/23 |
$16,238 |
$17,642 |
$17,538 |
$20,581 |
3/23 |
$16,893 |
$18,188 |
$18,109 |
$21,336 |
4/23 |
$17,494 |
$18,506 |
$18,742 |
$21,669 |
5/23 |
$16,959 |
$18,322 |
$17,974 |
$21,763 |
6/23 |
$17,467 |
$19,430 |
$18,547 |
$23,201 |
7/23 |
$17,681 |
$20,082 |
$18,787 |
$23,947 |
8/23 |
$17,574 |
$19,603 |
$18,642 |
$23,566 |
9/23 |
$16,906 |
$18,757 |
$18,036 |
$22,442 |
10/23 |
$16,171 |
$18,213 |
$17,294 |
$21,970 |
11/23 |
$17,173 |
$19,920 |
$18,286 |
$23,977 |
12/23 |
$17,920 |
$20,898 |
$19,095 |
$25,066 |
1/24 |
$18,386 |
$21,149 |
$19,608 |
$25,487 |
2/24 |
$18,990 |
$22,046 |
$20,049 |
$26,848 |
3/24 |
$19,346 |
$22,754 |
$20,521 |
$27,712 |
4/24 |
$18,565 |
$21,909 |
$19,710 |
$26,580 |
5/24 |
$19,223 |
$22,887 |
$20,236 |
$27,898 |
6/24 |
$19,730 |
$23,353 |
$20,619 |
$28,899 |
7/24 |
$20,361 |
$23,765 |
$21,294 |
$29,251 |
8/24 |
$21,471 |
$24,393 |
$22,463 |
$29,960 |
9/24 |
$20,868 |
$24,839 |
$21,794 |
$30,600 |
10/24 |
$19,894 |
$24,347 |
$20,743 |
$30,323 |
11/24 |
$19,771 |
$25,464 |
$20,562 |
$32,102 |
12/24 |
$18,552 |
$24,800 |
$19,310 |
$31,337 |
1/25 |
$19,770 |
$25,675 |
$20,545 |
$32,210 |
2/25 |
$20,000 |
$25,491 |
$20,776 |
$31,790 |
3/25 |
$19,197 |
$24,356 |
$20,295 |
$29,998 |
4/25 |
$18,853 |
$24,572 |
$19,911 |
$29,795 |
5/25 |
$18,179 |
$26,027 |
$19,187 |
$31,670 |
6/25 |
$18,365 |
$27,150 |
$19,465 |
$33,281 |
7/25 |
$17,634 |
$27,499 |
$18,886 |
$34,028 |
8/25 |
$18,494 |
$28,217 |
$19,858 |
$34,718 |
9/25 |
$18,437 |
$29,124 |
$20,050 |
$35,985 |
10/25 |
$19,082 |
$29,707 |
$20,672 |
$36,827 |
11/25 |
$20,544 |
$29,791 |
$22,351 |
$36,918 |
12/25 |
$20,460 |
$30,032 |
$22,174 |
$36,940 |
1/26 |
$20,522 |
$30,704 |
$22,417 |
$37,476 |
2/26 |
$20,830 |
$30,929 |
$23,065 |
$37,191 |
3/26 |
$19,243 |
$28,959 |
$21,154 |
$35,339 |
4/26 |
$19,074 |
$31,736 |
$21,103 |
$39,047 |
5/26 |
$19,212 |
$33,181 |
$21,507 |
$41,102 |
6/26 |
$20,337 |
$32,943 |
$22,582 |
$40,711 |
7/26 |
$20,460 |
$33,112 |
$22,909 |
$40,685 |
8/26 |
$21,164 |
$33,965 |
$23,759 |
$41,793 |
Average Annual Total Returns (%)
Table Summary
Fund |
1 Year |
5 Years |
10 Years |
Class A |
14.46% |
3.32% |
8.37% |
Class A with 5.25% Maximum Sales Charge |
8.49% |
2.20% |
7.78% |
MSCI World Index (net of foreign withholding taxes) |
20.37% |
11.20% |
13.00% |
MSCI World Health Care Index (net of foreign withholding taxes) |
19.65% |
4.54% |
9.03% |
S&P 500® Index |
20.38% |
12.78% |
15.37% |
Performance does not reflect the deduction of taxes that a shareholder would pay on Fund distributions or redemption of Fund shares. Performance assumes that all dividends and distributions, if any, were reinvested. For more recent performance information, visit www.eatonvance.com/performance.php.
THE FUND'S PAST PERFORMANCE IS NO GUARANTEE OF FUTURE RESULTS.
Table Summary
Total Net Assets |
$805,680,610 |
# of Portfolio Holdings |
41 |
Portfolio Turnover Rate |
30% |
Total Advisory Fees Paid |
$4,518,327 |
What did the Fund invest in?
The following tables reflect what the Fund invested in as of the report date.
Sector Allocation (% of total investments)
Table Summary
Value |
Value |
Short-Term Investments |
0.7% |
Health Care Technology |
1.4% |
Health Care Supplies |
1.9% |
Health Care Services |
3.6% |
Managed Health Care |
5.3% |
Life Sciences Tools & Services |
8.6% |
Health Care Equipment |
11.6% |
Biotechnology |
21.5% |
Pharmaceuticals |
45.4% |
Top Ten Holdings (% of total investments)Footnote Referencea
Table Summary
Eli Lilly & Co. |
12.0% |
Johnson & Johnson |
7.2% |
AbbVie, Inc |
7.2% |
Merck & Co., Inc. |
6.0% |
Roche Holding AG |
5.3% |
UnitedHealth Group, Inc. |
5.3% |
AstraZeneca PLC |
4.3% |
Bristol-Myers Squibb Co. |
4.3% |
Vertex Pharmaceuticals, Inc. |
3.7% |
Abbott Laboratories |
3.3% |
Total |
58.6% |
| Footnote |
Description |
Footnotea |
Excluding cash equivalents |
If you wish to view additional information about the Fund, including the prospectus, statement of additional information, financial statements and holdings, please scan the QR code or visit www.eatonvance.com/open-end-mutual-fund-documents.php. For proxy information, please visit www.eatonvance.com/proxyvoting.
The Funds may deliver a single copy of certain required shareholder documents (including prospectuses, shareholder reports, and proxy materials) to investors with the same last name and the same address. Your participation will continue indefinitely unless you instruct otherwise by calling 1-800-262-1122 or by contacting your financial intermediary. Your instruction will typically be effective within 30 days of receipt.
Not FDIC Insured | May Lose Value | No Bank Guarantee
Annual Shareholder Report August 31, 2026
Eaton Vance Worldwide Health Sciences Fund
Annual Shareholder Report August 31, 2026
This annual shareholder report contains important information about the Eaton Vance Worldwide Health Sciences Fund for the period of September 1, 2025 to August 31, 2026. You can find additional information about the Fund at www.eatonvance.com/open-end-mutual-fund-documents.php. You can also request this information by contacting us at 1-800-262-1122.
What were the Fund costs for the last year?
(based on a hypothetical $10,000 investment)
Table Summary
Class Name |
Costs of a $10,000 investment |
Costs paid as a percentage of a $10,000 investment |
Class C |
$201 |
1.88% |
How did the Fund perform last year and what affected its performance?
Key contributors to (↑) and detractors from (↓) performance, relative to the MSCI World Health Care Index (the Index):
↓ Overweight to Zoetis, Inc. detracted due to its lowered 2026 guidance on weaker US pet demand and competition in dermatology and parasiticide products. This was sold by period end
↓ Overweight to Boston Scientific Corp. detracted as its 2026 growth outlook was cut on weaker WATCHMAN demand and electrophysiology US market share losses. This was sold by period end
↓ Overweight to CSL Ltd. hurt due to weaker US flu vaccine demand, lower immunoglobulin and China albumin sales and a chief executive officer change. This was sold by period end
↓ On an industry basis, stock selection in biotechnology detracted the most, followed by health care equipment and supplies, and life science tools and services
↑ Overweight to Eli Lilly & Co. helped as strong Mounjaro and Zepbound GLP-1 drugs sales and US approval of obesity pill Foundayo supported shares
↑ Out-of-index allocation to Structure Therapeutics, Inc. added as shares rose on strong mid-stage trial results for its oral weight-loss drug. This was sold by period end
↑ Overweight to Bristol Myers Squibb Co. helped as growth from newer drugs in cardiomyopathy and blood cancers more than offset declines in older drugs
↑ Stock selection in pharmaceuticals and health care technology helped returns
Comparison of the change in value of a $10,000 investment for the period indicated.

Table Summary
|
Class C |
MSCI World Index |
MSCI World Health Care Index |
S&P 500® Index |
8/16 |
$10,000 |
$10,000 |
$10,000 |
$10,000 |
9/16 |
$9,991 |
$10,053 |
$9,987 |
$10,002 |
10/16 |
$9,093 |
$9,859 |
$9,297 |
$9,819 |
11/16 |
$9,075 |
$10,000 |
$9,306 |
$10,183 |
12/16 |
$9,199 |
$10,240 |
$9,452 |
$10,384 |
1/17 |
$9,447 |
$10,487 |
$9,659 |
$10,581 |
2/17 |
$9,973 |
$10,778 |
$10,217 |
$11,001 |
3/17 |
$10,033 |
$10,892 |
$10,250 |
$11,014 |
4/17 |
$10,271 |
$11,054 |
$10,443 |
$11,127 |
5/17 |
$10,212 |
$11,288 |
$10,671 |
$11,284 |
6/17 |
$10,559 |
$11,331 |
$10,961 |
$11,354 |
7/17 |
$10,628 |
$11,602 |
$10,969 |
$11,588 |
8/17 |
$10,767 |
$11,619 |
$11,077 |
$11,623 |
9/17 |
$10,817 |
$11,879 |
$11,226 |
$11,863 |
10/17 |
$10,450 |
$12,104 |
$11,080 |
$12,140 |
11/17 |
$10,698 |
$12,366 |
$11,331 |
$12,512 |
12/17 |
$10,618 |
$12,533 |
$11,324 |
$12,651 |
1/18 |
$11,189 |
$13,195 |
$11,958 |
$13,376 |
2/18 |
$10,648 |
$12,648 |
$11,422 |
$12,883 |
3/18 |
$10,485 |
$12,373 |
$11,184 |
$12,555 |
4/18 |
$10,597 |
$12,515 |
$11,291 |
$12,604 |
5/18 |
$10,771 |
$12,593 |
$11,345 |
$12,907 |
6/18 |
$10,965 |
$12,587 |
$11,495 |
$12,987 |
7/18 |
$11,648 |
$12,980 |
$12,202 |
$13,470 |
8/18 |
$12,005 |
$13,141 |
$12,562 |
$13,909 |
9/18 |
$12,219 |
$13,214 |
$12,817 |
$13,988 |
10/18 |
$11,444 |
$12,244 |
$11,974 |
$13,032 |
11/18 |
$12,127 |
$12,383 |
$12,627 |
$13,297 |
12/18 |
$11,175 |
$11,441 |
$11,608 |
$12,097 |
1/19 |
$11,909 |
$12,332 |
$12,206 |
$13,066 |
2/19 |
$12,164 |
$12,703 |
$12,447 |
$13,486 |
3/19 |
$12,398 |
$12,869 |
$12,553 |
$13,748 |
4/19 |
$12,015 |
$13,326 |
$12,229 |
$14,304 |
5/19 |
$11,771 |
$12,557 |
$11,936 |
$13,395 |
6/19 |
$12,611 |
$13,384 |
$12,741 |
$14,339 |
7/19 |
$12,440 |
$13,451 |
$12,600 |
$14,546 |
8/19 |
$12,430 |
$13,175 |
$12,596 |
$14,315 |
9/19 |
$12,324 |
$13,456 |
$12,583 |
$14,583 |
10/19 |
$12,855 |
$13,798 |
$13,211 |
$14,899 |
11/19 |
$13,429 |
$14,182 |
$13,835 |
$15,440 |
12/19 |
$13,958 |
$14,607 |
$14,306 |
$15,906 |
1/20 |
$13,725 |
$14,518 |
$14,103 |
$15,899 |
2/20 |
$12,825 |
$13,291 |
$13,139 |
$14,591 |
3/20 |
$12,380 |
$11,532 |
$12,664 |
$12,788 |
4/20 |
$13,769 |
$12,792 |
$14,134 |
$14,428 |
5/20 |
$14,281 |
$13,410 |
$14,705 |
$15,115 |
6/20 |
$14,114 |
$13,765 |
$14,508 |
$15,416 |
7/20 |
$14,625 |
$14,423 |
$15,103 |
$16,285 |
8/20 |
$15,003 |
$15,387 |
$15,414 |
$17,455 |
9/20 |
$14,758 |
$14,856 |
$15,201 |
$16,792 |
10/20 |
$14,081 |
$14,400 |
$14,460 |
$16,346 |
11/20 |
$15,103 |
$16,242 |
$15,754 |
$18,135 |
12/20 |
$15,655 |
$16,930 |
$16,240 |
$18,832 |
1/21 |
$15,584 |
$16,762 |
$16,413 |
$18,642 |
2/21 |
$15,359 |
$17,192 |
$15,967 |
$19,156 |
3/21 |
$15,690 |
$17,764 |
$16,358 |
$19,995 |
4/21 |
$16,329 |
$18,590 |
$16,982 |
$21,062 |
5/21 |
$16,660 |
$18,858 |
$17,332 |
$21,209 |
6/21 |
$17,097 |
$19,139 |
$17,851 |
$21,704 |
7/21 |
$17,677 |
$19,482 |
$18,515 |
$22,220 |
8/21 |
$18,256 |
$19,967 |
$19,029 |
$22,895 |
9/21 |
$17,180 |
$19,138 |
$18,032 |
$21,831 |
10/21 |
$18,315 |
$20,222 |
$18,793 |
$23,360 |
11/21 |
$17,511 |
$19,779 |
$18,122 |
$23,198 |
12/21 |
$18,972 |
$20,624 |
$19,457 |
$24,238 |
1/22 |
$17,265 |
$19,533 |
$18,019 |
$22,984 |
2/22 |
$17,329 |
$19,039 |
$17,939 |
$22,295 |
3/22 |
$18,259 |
$19,561 |
$18,803 |
$23,123 |
4/22 |
$17,304 |
$17,936 |
$17,932 |
$21,107 |
5/22 |
$17,176 |
$17,950 |
$18,020 |
$21,146 |
6/22 |
$16,871 |
$16,395 |
$17,448 |
$19,400 |
7/22 |
$17,418 |
$17,697 |
$18,018 |
$21,189 |
8/22 |
$16,081 |
$16,957 |
$16,933 |
$20,325 |
9/22 |
$15,356 |
$15,380 |
$16,266 |
$18,453 |
10/22 |
$16,476 |
$16,485 |
$17,633 |
$19,947 |
11/22 |
$17,342 |
$17,631 |
$18,624 |
$21,062 |
12/22 |
$17,041 |
$16,882 |
$18,403 |
$19,848 |
1/23 |
$16,949 |
$18,077 |
$18,284 |
$21,095 |
2/23 |
$16,313 |
$17,642 |
$17,538 |
$20,581 |
3/23 |
$16,949 |
$18,188 |
$18,109 |
$21,336 |
4/23 |
$17,545 |
$18,506 |
$18,742 |
$21,669 |
5/23 |
$17,002 |
$18,322 |
$17,974 |
$21,763 |
6/23 |
$17,492 |
$19,430 |
$18,547 |
$23,201 |
7/23 |
$17,704 |
$20,082 |
$18,787 |
$23,947 |
8/23 |
$17,585 |
$19,603 |
$18,642 |
$23,566 |
9/23 |
$16,896 |
$18,757 |
$18,036 |
$22,442 |
10/23 |
$16,167 |
$18,213 |
$17,294 |
$21,970 |
11/23 |
$17,147 |
$19,920 |
$18,286 |
$23,977 |
12/23 |
$17,878 |
$20,898 |
$19,095 |
$25,066 |
1/24 |
$18,326 |
$21,149 |
$19,608 |
$25,487 |
2/24 |
$18,923 |
$22,046 |
$20,049 |
$26,848 |
3/24 |
$19,276 |
$22,754 |
$20,521 |
$27,712 |
4/24 |
$18,475 |
$21,909 |
$19,710 |
$26,580 |
5/24 |
$19,127 |
$22,887 |
$20,236 |
$27,898 |
6/24 |
$19,615 |
$23,353 |
$20,619 |
$28,899 |
7/24 |
$20,240 |
$23,765 |
$21,294 |
$29,251 |
8/24 |
$21,312 |
$24,393 |
$22,463 |
$29,960 |
9/24 |
$20,715 |
$24,839 |
$21,794 |
$30,600 |
10/24 |
$19,724 |
$24,347 |
$20,743 |
$30,323 |
11/24 |
$19,602 |
$25,464 |
$20,562 |
$32,102 |
12/24 |
$18,363 |
$24,800 |
$19,310 |
$31,337 |
1/25 |
$19,567 |
$25,675 |
$20,545 |
$32,210 |
2/25 |
$19,794 |
$25,491 |
$20,776 |
$31,790 |
3/25 |
$18,972 |
$24,356 |
$20,295 |
$29,998 |
4/25 |
$18,632 |
$24,572 |
$19,911 |
$29,795 |
5/25 |
$17,952 |
$26,027 |
$19,187 |
$31,670 |
6/25 |
$18,122 |
$27,150 |
$19,465 |
$33,281 |
7/25 |
$17,385 |
$27,499 |
$18,886 |
$34,028 |
8/25 |
$18,235 |
$28,217 |
$19,858 |
$34,718 |
9/25 |
$18,150 |
$29,124 |
$20,050 |
$35,985 |
10/25 |
$18,774 |
$29,707 |
$20,672 |
$36,827 |
11/25 |
$20,205 |
$29,791 |
$22,351 |
$36,918 |
12/25 |
$20,100 |
$30,032 |
$22,174 |
$36,940 |
1/26 |
$20,161 |
$30,704 |
$22,417 |
$37,476 |
2/26 |
$20,448 |
$30,929 |
$23,065 |
$37,191 |
3/26 |
$18,875 |
$28,959 |
$21,154 |
$35,339 |
4/26 |
$18,694 |
$31,736 |
$21,103 |
$39,047 |
5/26 |
$18,830 |
$33,181 |
$21,507 |
$41,102 |
6/26 |
$19,919 |
$32,943 |
$22,582 |
$40,711 |
7/26 |
$20,025 |
$33,112 |
$22,909 |
$40,685 |
8/26 |
$20,705 |
$33,965 |
$23,759 |
$41,793 |
Average Annual Total Returns (%)
Table Summary
Fund |
1 Year |
5 Years |
10 Years |
Class C, with conversion to Class A after 8 years |
13.55% |
2.55% |
7.55% |
Class C, with 1% Maximum Contingent Deferred Sales Charge and conversion to Class A after 8 years |
12.55% |
2.55% |
7.55% |
MSCI World Index (net of foreign withholding taxes) |
20.37% |
11.20% |
13.00% |
MSCI World Health Care Index (net of foreign withholding taxes) |
19.65% |
4.54% |
9.03% |
S&P 500® Index |
20.38% |
12.78% |
15.37% |
Performance does not reflect the deduction of taxes that a shareholder would pay on Fund distributions or redemption of Fund shares. Performance assumes that all dividends and distributions, if any, were reinvested. For more recent performance information, visit www.eatonvance.com/performance.php.
THE FUND'S PAST PERFORMANCE IS NO GUARANTEE OF FUTURE RESULTS.
Table Summary
Total Net Assets |
$805,680,610 |
# of Portfolio Holdings |
41 |
Portfolio Turnover Rate |
30% |
Total Advisory Fees Paid |
$4,518,327 |
What did the Fund invest in?
The following tables reflect what the Fund invested in as of the report date.
Sector Allocation (% of total investments)
Table Summary
Value |
Value |
Short-Term Investments |
0.7% |
Health Care Technology |
1.4% |
Health Care Supplies |
1.9% |
Health Care Services |
3.6% |
Managed Health Care |
5.3% |
Life Sciences Tools & Services |
8.6% |
Health Care Equipment |
11.6% |
Biotechnology |
21.5% |
Pharmaceuticals |
45.4% |
Top Ten Holdings (% of total investments)Footnote Referencea
Table Summary
Eli Lilly & Co. |
12.0% |
Johnson & Johnson |
7.2% |
AbbVie, Inc |
7.2% |
Merck & Co., Inc. |
6.0% |
Roche Holding AG |
5.3% |
UnitedHealth Group, Inc. |
5.3% |
AstraZeneca PLC |
4.3% |
Bristol-Myers Squibb Co. |
4.3% |
Vertex Pharmaceuticals, Inc. |
3.7% |
Abbott Laboratories |
3.3% |
Total |
58.6% |
| Footnote |
Description |
Footnotea |
Excluding cash equivalents |
If you wish to view additional information about the Fund, including the prospectus, statement of additional information, financial statements and holdings, please scan the QR code or visit www.eatonvance.com/open-end-mutual-fund-documents.php. For proxy information, please visit www.eatonvance.com/proxyvoting.
The Funds may deliver a single copy of certain required shareholder documents (including prospectuses, shareholder reports, and proxy materials) to investors with the same last name and the same address. Your participation will continue indefinitely unless you instruct otherwise by calling 1-800-262-1122 or by contacting your financial intermediary. Your instruction will typically be effective within 30 days of receipt.
Not FDIC Insured | May Lose Value | No Bank Guarantee
Annual Shareholder Report August 31, 2026
Eaton Vance Worldwide Health Sciences Fund
Annual Shareholder Report August 31, 2026
This annual shareholder report contains important information about the Eaton Vance Worldwide Health Sciences Fund for the period of September 1, 2025 to August 31, 2026. You can find additional information about the Fund at www.eatonvance.com/open-end-mutual-fund-documents.php. You can also request this information by contacting us at 1-800-262-1122.
What were the Fund costs for the last year?
(based on a hypothetical $10,000 investment)
Table Summary
Class Name |
Costs of a $10,000 investment |
Costs paid as a percentage of a $10,000 investment |
Class I |
$94 |
0.88% |
How did the Fund perform last year and what affected its performance?
Key contributors to (↑) and detractors from (↓) performance, relative to the MSCI World Health Care Index (the Index):
↓ Overweight to Zoetis, Inc. detracted due to its lowered 2026 guidance on weaker US pet demand and competition in dermatology and parasiticide products. This was sold by period end
↓ Overweight to Boston Scientific Corp. detracted as its 2026 growth outlook was cut on weaker WATCHMAN demand and electrophysiology US market share losses. This was sold by period end
↓ Overweight to CSL Ltd. hurt due to weaker US flu vaccine demand, lower immunoglobulin and China albumin sales and a chief executive officer change. This was sold by period end
↓ On an industry basis, stock selection in biotechnology detracted the most, followed by health care equipment and supplies, and life science tools and services
↑ Overweight to Eli Lilly & Co. helped as strong Mounjaro and Zepbound GLP-1 drugs sales and US approval of obesity pill Foundayo supported shares
↑ Out-of-index allocation to Structure Therapeutics, Inc. added as shares rose on strong mid-stage trial results for its oral weight-loss drug. This was sold by period end
↑ Overweight to Bristol Myers Squibb Co. helped as growth from newer drugs in cardiomyopathy and blood cancers more than offset declines in older drugs
↑ Stock selection in pharmaceuticals and health care technology helped returns
Comparison of the change in value of a $1,000,000 investment for the period indicated.

Table Summary
|
Class I |
MSCI World Index |
MSCI World Health Care Index |
S&P 500® Index |
8/16 |
$1,000,000 |
$1,000,000 |
$1,000,000 |
$1,000,000 |
9/16 |
$1,000,882 |
$1,005,312 |
$998,682 |
$1,000,189 |
10/16 |
$910,935 |
$985,856 |
$929,748 |
$981,944 |
11/16 |
$910,053 |
$1,000,032 |
$930,578 |
$1,018,311 |
12/16 |
$923,384 |
$1,023,961 |
$945,203 |
$1,038,439 |
1/17 |
$949,199 |
$1,048,674 |
$965,864 |
$1,058,134 |
2/17 |
$1,002,815 |
$1,077,768 |
$1,021,719 |
$1,100,148 |
3/17 |
$1,009,765 |
$1,089,249 |
$1,024,978 |
$1,101,432 |
4/17 |
$1,034,587 |
$1,105,377 |
$1,044,335 |
$1,112,743 |
5/17 |
$1,028,630 |
$1,128,761 |
$1,067,108 |
$1,128,403 |
6/17 |
$1,065,367 |
$1,133,104 |
$1,096,060 |
$1,135,446 |
7/17 |
$1,072,317 |
$1,160,221 |
$1,096,879 |
$1,158,793 |
8/17 |
$1,088,203 |
$1,161,855 |
$1,107,685 |
$1,162,341 |
9/17 |
$1,094,160 |
$1,187,932 |
$1,122,575 |
$1,186,318 |
10/17 |
$1,057,424 |
$1,210,382 |
$1,108,042 |
$1,214,001 |
11/17 |
$1,083,239 |
$1,236,608 |
$1,133,096 |
$1,251,234 |
12/17 |
$1,076,222 |
$1,253,332 |
$1,132,355 |
$1,265,146 |
1/18 |
$1,135,389 |
$1,319,508 |
$1,195,817 |
$1,337,581 |
2/18 |
$1,081,322 |
$1,264,844 |
$1,142,206 |
$1,288,281 |
3/18 |
$1,065,001 |
$1,237,275 |
$1,118,444 |
$1,255,542 |
4/18 |
$1,078,262 |
$1,251,493 |
$1,129,123 |
$1,260,359 |
5/18 |
$1,096,624 |
$1,259,335 |
$1,134,461 |
$1,290,711 |
6/18 |
$1,117,026 |
$1,258,734 |
$1,149,547 |
$1,298,656 |
7/18 |
$1,188,435 |
$1,298,049 |
$1,220,164 |
$1,346,983 |
8/18 |
$1,225,159 |
$1,314,109 |
$1,256,240 |
$1,390,875 |
9/18 |
$1,248,621 |
$1,321,427 |
$1,281,698 |
$1,398,792 |
10/18 |
$1,170,072 |
$1,224,397 |
$1,197,421 |
$1,303,184 |
11/18 |
$1,240,460 |
$1,238,306 |
$1,262,679 |
$1,329,741 |
12/18 |
$1,143,967 |
$1,144,148 |
$1,160,819 |
$1,209,678 |
1/19 |
$1,220,232 |
$1,233,169 |
$1,220,580 |
$1,306,616 |
2/19 |
$1,248,159 |
$1,270,250 |
$1,244,670 |
$1,348,569 |
3/19 |
$1,272,865 |
$1,286,934 |
$1,255,274 |
$1,374,774 |
4/19 |
$1,234,195 |
$1,332,568 |
$1,222,914 |
$1,430,438 |
5/19 |
$1,210,564 |
$1,255,678 |
$1,193,620 |
$1,339,537 |
6/19 |
$1,297,570 |
$1,338,421 |
$1,274,142 |
$1,433,942 |
7/19 |
$1,281,458 |
$1,345,050 |
$1,259,971 |
$1,454,551 |
8/19 |
$1,281,458 |
$1,317,538 |
$1,259,593 |
$1,431,511 |
9/19 |
$1,272,865 |
$1,345,576 |
$1,258,271 |
$1,458,295 |
10/19 |
$1,328,720 |
$1,379,818 |
$1,321,088 |
$1,489,881 |
11/19 |
$1,388,873 |
$1,418,246 |
$1,383,514 |
$1,543,962 |
12/19 |
$1,444,651 |
$1,460,734 |
$1,430,637 |
$1,590,562 |
1/20 |
$1,421,936 |
$1,451,843 |
$1,410,306 |
$1,589,938 |
2/20 |
$1,329,942 |
$1,329,126 |
$1,313,907 |
$1,459,056 |
3/20 |
$1,285,649 |
$1,153,226 |
$1,266,442 |
$1,278,844 |
4/20 |
$1,429,886 |
$1,279,209 |
$1,413,443 |
$1,442,783 |
5/20 |
$1,484,402 |
$1,341,005 |
$1,470,475 |
$1,511,500 |
6/20 |
$1,468,501 |
$1,376,476 |
$1,450,803 |
$1,541,560 |
7/20 |
$1,523,016 |
$1,442,329 |
$1,510,310 |
$1,628,481 |
8/20 |
$1,563,903 |
$1,538,697 |
$1,541,354 |
$1,745,537 |
9/20 |
$1,540,052 |
$1,485,613 |
$1,520,141 |
$1,679,212 |
10/20 |
$1,469,637 |
$1,440,042 |
$1,445,978 |
$1,634,556 |
11/20 |
$1,577,532 |
$1,624,168 |
$1,575,398 |
$1,813,481 |
12/20 |
$1,637,445 |
$1,693,027 |
$1,624,043 |
$1,883,206 |
1/21 |
$1,631,340 |
$1,676,201 |
$1,641,339 |
$1,864,193 |
2/21 |
$1,609,361 |
$1,719,152 |
$1,596,701 |
$1,915,598 |
3/21 |
$1,644,772 |
$1,776,352 |
$1,635,794 |
$1,999,493 |
4/21 |
$1,713,151 |
$1,859,024 |
$1,698,242 |
$2,106,204 |
5/21 |
$1,748,562 |
$1,885,804 |
$1,733,170 |
$2,120,914 |
6/21 |
$1,796,184 |
$1,913,915 |
$1,785,103 |
$2,170,427 |
7/21 |
$1,858,458 |
$1,948,195 |
$1,851,526 |
$2,221,985 |
8/21 |
$1,921,953 |
$1,996,683 |
$1,902,892 |
$2,289,546 |
9/21 |
$1,809,615 |
$1,913,779 |
$1,803,151 |
$2,183,059 |
10/21 |
$1,931,722 |
$2,022,177 |
$1,879,271 |
$2,336,009 |
11/21 |
$1,848,689 |
$1,977,865 |
$1,812,183 |
$2,319,822 |
12/21 |
$2,003,808 |
$2,062,399 |
$1,945,660 |
$2,423,788 |
1/22 |
$1,825,986 |
$1,953,276 |
$1,801,902 |
$2,298,364 |
2/22 |
$1,832,621 |
$1,903,875 |
$1,793,858 |
$2,229,548 |
3/22 |
$1,933,475 |
$1,956,124 |
$1,880,252 |
$2,312,330 |
4/22 |
$1,832,621 |
$1,793,622 |
$1,793,158 |
$2,110,690 |
5/22 |
$1,822,005 |
$1,794,980 |
$1,801,999 |
$2,114,563 |
6/22 |
$1,791,484 |
$1,639,496 |
$1,744,836 |
$1,940,019 |
7/22 |
$1,851,200 |
$1,769,666 |
$1,801,797 |
$2,118,897 |
8/22 |
$1,709,208 |
$1,695,680 |
$1,693,263 |
$2,032,484 |
9/22 |
$1,634,895 |
$1,538,049 |
$1,626,587 |
$1,845,295 |
10/22 |
$1,754,327 |
$1,648,501 |
$1,763,274 |
$1,994,693 |
11/22 |
$1,848,546 |
$1,763,122 |
$1,862,377 |
$2,106,165 |
12/22 |
$1,818,650 |
$1,688,247 |
$1,840,318 |
$1,984,819 |
1/23 |
$1,810,333 |
$1,807,701 |
$1,828,409 |
$2,109,533 |
2/23 |
$1,742,410 |
$1,764,247 |
$1,753,803 |
$2,058,063 |
3/23 |
$1,813,105 |
$1,818,761 |
$1,810,868 |
$2,133,623 |
4/23 |
$1,878,255 |
$1,850,643 |
$1,874,184 |
$2,166,925 |
5/23 |
$1,820,036 |
$1,832,168 |
$1,797,438 |
$2,176,344 |
6/23 |
$1,875,482 |
$1,942,973 |
$1,854,727 |
$2,320,147 |
7/23 |
$1,899,047 |
$2,008,243 |
$1,878,665 |
$2,394,681 |
8/23 |
$1,887,958 |
$1,960,275 |
$1,864,194 |
$2,356,554 |
9/23 |
$1,817,263 |
$1,875,711 |
$1,803,564 |
$2,244,199 |
10/23 |
$1,738,252 |
$1,821,286 |
$1,729,396 |
$2,197,011 |
11/23 |
$1,844,987 |
$1,992,035 |
$1,828,560 |
$2,397,654 |
12/23 |
$1,927,315 |
$2,089,833 |
$1,909,460 |
$2,506,581 |
1/24 |
$1,977,172 |
$2,114,912 |
$1,960,751 |
$2,548,702 |
2/24 |
$2,042,698 |
$2,204,579 |
$2,004,918 |
$2,684,791 |
3/24 |
$2,081,159 |
$2,275,423 |
$2,052,115 |
$2,771,174 |
4/24 |
$1,997,114 |
$2,190,903 |
$1,971,005 |
$2,657,986 |
5/24 |
$2,069,763 |
$2,288,731 |
$2,023,648 |
$2,789,782 |
6/24 |
$2,123,893 |
$2,335,302 |
$2,061,944 |
$2,889,885 |
7/24 |
$2,193,692 |
$2,376,456 |
$2,129,370 |
$2,925,062 |
8/24 |
$2,311,924 |
$2,439,267 |
$2,246,342 |
$2,996,014 |
9/24 |
$2,249,247 |
$2,483,939 |
$2,179,380 |
$3,060,000 |
10/24 |
$2,143,835 |
$2,434,666 |
$2,074,300 |
$3,032,250 |
11/24 |
$2,131,015 |
$2,546,384 |
$2,056,189 |
$3,210,247 |
12/24 |
$1,999,397 |
$2,480,024 |
$1,931,039 |
$3,133,720 |
1/25 |
$2,130,602 |
$2,567,540 |
$2,054,537 |
$3,220,986 |
2/25 |
$2,157,440 |
$2,549,061 |
$2,077,635 |
$3,178,958 |
3/25 |
$2,070,963 |
$2,435,576 |
$2,029,457 |
$2,999,842 |
4/25 |
$2,035,180 |
$2,457,221 |
$1,991,067 |
$2,979,501 |
5/25 |
$1,962,122 |
$2,602,668 |
$1,918,694 |
$3,167,044 |
6/25 |
$1,981,505 |
$2,714,981 |
$1,946,455 |
$3,328,097 |
7/25 |
$1,903,974 |
$2,749,930 |
$1,888,646 |
$3,402,789 |
8/25 |
$1,997,906 |
$2,821,663 |
$1,985,798 |
$3,471,769 |
9/25 |
$1,990,451 |
$2,912,368 |
$2,004,972 |
$3,598,489 |
10/25 |
$2,060,527 |
$2,970,689 |
$2,067,162 |
$3,682,743 |
11/25 |
$2,218,570 |
$2,979,081 |
$2,235,131 |
$3,691,769 |
12/25 |
$2,210,607 |
$3,003,162 |
$2,217,402 |
$3,694,029 |
1/26 |
$2,218,616 |
$3,070,370 |
$2,241,688 |
$3,747,593 |
2/26 |
$2,252,256 |
$3,092,861 |
$2,306,469 |
$3,719,112 |
3/26 |
$2,080,854 |
$2,895,861 |
$2,115,381 |
$3,533,918 |
4/26 |
$2,061,631 |
$3,173,627 |
$2,110,320 |
$3,904,720 |
5/26 |
$2,079,252 |
$3,318,094 |
$2,150,733 |
$4,110,236 |
6/26 |
$2,200,995 |
$3,294,285 |
$2,258,203 |
$4,071,094 |
7/26 |
$2,213,810 |
$3,311,191 |
$2,290,852 |
$4,068,511 |
8/26 |
$2,290,701 |
$3,396,519 |
$2,375,934 |
$4,179,309 |
Average Annual Total Returns (%)
Table Summary
Fund |
1 Year |
5 Years |
10 Years |
Class I |
14.66% |
3.57% |
8.64% |
MSCI World Index (net of foreign withholding taxes) |
20.37% |
11.20% |
13.00% |
MSCI World Health Care Index (net of foreign withholding taxes) |
19.65% |
4.54% |
9.03% |
S&P 500® Index |
20.38% |
12.78% |
15.37% |
Performance does not reflect the deduction of taxes that a shareholder would pay on Fund distributions or redemption of Fund shares. Performance assumes that all dividends and distributions, if any, were reinvested. For more recent performance information, visit www.eatonvance.com/performance.php.
THE FUND'S PAST PERFORMANCE IS NO GUARANTEE OF FUTURE RESULTS.
Table Summary
Total Net Assets |
$805,680,610 |
# of Portfolio Holdings |
41 |
Portfolio Turnover Rate |
30% |
Total Advisory Fees Paid |
$4,518,327 |
What did the Fund invest in?
The following tables reflect what the Fund invested in as of the report date.
Sector Allocation (% of total investments)
Table Summary
Value |
Value |
Short-Term Investments |
0.7% |
Health Care Technology |
1.4% |
Health Care Supplies |
1.9% |
Health Care Services |
3.6% |
Managed Health Care |
5.3% |
Life Sciences Tools & Services |
8.6% |
Health Care Equipment |
11.6% |
Biotechnology |
21.5% |
Pharmaceuticals |
45.4% |
Top Ten Holdings (% of total investments)Footnote Referencea
Table Summary
Eli Lilly & Co. |
12.0% |
Johnson & Johnson |
7.2% |
AbbVie, Inc |
7.2% |
Merck & Co., Inc. |
6.0% |
Roche Holding AG |
5.3% |
UnitedHealth Group, Inc. |
5.3% |
AstraZeneca PLC |
4.3% |
Bristol-Myers Squibb Co. |
4.3% |
Vertex Pharmaceuticals, Inc. |
3.7% |
Abbott Laboratories |
3.3% |
Total |
58.6% |
| Footnote |
Description |
Footnotea |
Excluding cash equivalents |
If you wish to view additional information about the Fund, including the prospectus, statement of additional information, financial statements and holdings, please scan the QR code or visit www.eatonvance.com/open-end-mutual-fund-documents.php. For proxy information, please visit www.eatonvance.com/proxyvoting.
The Funds may deliver a single copy of certain required shareholder documents (including prospectuses, shareholder reports, and proxy materials) to investors with the same last name and the same address. Your participation will continue indefinitely unless you instruct otherwise by calling 1-800-262-1122 or by contacting your financial intermediary. Your instruction will typically be effective within 30 days of receipt.
Not FDIC Insured | May Lose Value | No Bank Guarantee
Annual Shareholder Report August 31, 2026
Eaton Vance Worldwide Health Sciences Fund
Annual Shareholder Report August 31, 2026
This annual shareholder report contains important information about the Eaton Vance Worldwide Health Sciences Fund for the period of September 1, 2025 to August 31, 2026. You can find additional information about the Fund at www.eatonvance.com/open-end-mutual-fund-documents.php. You can also request this information by contacting us at 1-800-262-1122.
What were the Fund costs for the last year?
(based on a hypothetical $10,000 investment)
Table Summary
Class Name |
Costs of a $10,000 investment |
Costs paid as a percentage of a $10,000 investment |
Class R |
$148 |
1.38% |
How did the Fund perform last year and what affected its performance?
Key contributors to (↑) and detractors from (↓) performance, relative to the MSCI World Health Care Index (the Index):
↓ Overweight to Zoetis, Inc. detracted due to its lowered 2026 guidance on weaker US pet demand and competition in dermatology and parasiticide products. This was sold by period end
↓ Overweight to Boston Scientific Corp. detracted as its 2026 growth outlook was cut on weaker WATCHMAN demand and electrophysiology US market share losses. This was sold by period end
↓ Overweight to CSL Ltd. hurt due to weaker US flu vaccine demand, lower immunoglobulin and China albumin sales and a chief executive officer change. This was sold by period end
↓ On an industry basis, stock selection in biotechnology detracted the most, followed by health care equipment and supplies, and life science tools and services
↑ Overweight to Eli Lilly & Co. helped as strong Mounjaro and Zepbound GLP-1 drugs sales and US approval of obesity pill Foundayo supported shares
↑ Out-of-index allocation to Structure Therapeutics, Inc. added as shares rose on strong mid-stage trial results for its oral weight-loss drug. This was sold by period end
↑ Overweight to Bristol Myers Squibb Co. helped as growth from newer drugs in cardiomyopathy and blood cancers more than offset declines in older drugs
↑ Stock selection in pharmaceuticals and health care technology helped returns
Comparison of the change in value of a $10,000 investment for the period indicated.

Table Summary
|
Class R |
MSCI World Index |
MSCI World Health Care Index |
S&P 500® Index |
8/16 |
$10,000 |
$10,000 |
$10,000 |
$10,000 |
9/16 |
$10,000 |
$10,053 |
$9,987 |
$10,002 |
10/16 |
$9,102 |
$9,859 |
$9,297 |
$9,819 |
11/16 |
$9,086 |
$10,000 |
$9,306 |
$10,183 |
12/16 |
$9,222 |
$10,240 |
$9,452 |
$10,384 |
1/17 |
$9,468 |
$10,487 |
$9,659 |
$10,581 |
2/17 |
$10,009 |
$10,778 |
$10,217 |
$11,001 |
3/17 |
$10,066 |
$10,892 |
$10,250 |
$11,014 |
4/17 |
$10,313 |
$11,054 |
$10,443 |
$11,127 |
5/17 |
$10,256 |
$11,288 |
$10,671 |
$11,284 |
6/17 |
$10,607 |
$11,331 |
$10,961 |
$11,354 |
7/17 |
$10,683 |
$11,602 |
$10,969 |
$11,588 |
8/17 |
$10,825 |
$11,619 |
$11,077 |
$11,623 |
9/17 |
$10,882 |
$11,879 |
$11,226 |
$11,863 |
10/17 |
$10,512 |
$12,104 |
$11,080 |
$12,140 |
11/17 |
$10,768 |
$12,366 |
$11,331 |
$12,512 |
12/17 |
$10,691 |
$12,533 |
$11,324 |
$12,651 |
1/18 |
$11,276 |
$13,195 |
$11,958 |
$13,376 |
2/18 |
$10,740 |
$12,648 |
$11,422 |
$12,883 |
3/18 |
$10,574 |
$12,373 |
$11,184 |
$12,555 |
4/18 |
$10,691 |
$12,515 |
$11,291 |
$12,604 |
5/18 |
$10,867 |
$12,593 |
$11,345 |
$12,907 |
6/18 |
$11,071 |
$12,587 |
$11,495 |
$12,987 |
7/18 |
$11,772 |
$12,980 |
$12,202 |
$13,470 |
8/18 |
$12,132 |
$13,141 |
$12,562 |
$13,909 |
9/18 |
$12,356 |
$13,214 |
$12,817 |
$13,988 |
10/18 |
$11,577 |
$12,244 |
$11,974 |
$13,032 |
11/18 |
$12,269 |
$12,383 |
$12,627 |
$13,297 |
12/18 |
$11,313 |
$11,441 |
$11,608 |
$12,097 |
1/19 |
$12,066 |
$12,332 |
$12,206 |
$13,066 |
2/19 |
$12,321 |
$12,703 |
$12,447 |
$13,486 |
3/19 |
$12,565 |
$12,869 |
$12,553 |
$13,748 |
4/19 |
$12,189 |
$13,326 |
$12,229 |
$14,304 |
5/19 |
$11,934 |
$12,557 |
$11,936 |
$13,395 |
6/19 |
$12,800 |
$13,384 |
$12,741 |
$14,339 |
7/19 |
$12,627 |
$13,451 |
$12,600 |
$14,546 |
8/19 |
$12,627 |
$13,175 |
$12,596 |
$14,315 |
9/19 |
$12,535 |
$13,456 |
$12,583 |
$14,583 |
10/19 |
$13,075 |
$13,798 |
$13,211 |
$14,899 |
11/19 |
$13,675 |
$14,182 |
$13,835 |
$15,440 |
12/19 |
$14,214 |
$14,607 |
$14,306 |
$15,906 |
1/20 |
$13,979 |
$14,518 |
$14,103 |
$15,899 |
2/20 |
$13,081 |
$13,291 |
$13,139 |
$14,591 |
3/20 |
$12,632 |
$11,532 |
$12,664 |
$12,788 |
4/20 |
$14,043 |
$12,792 |
$14,134 |
$14,428 |
5/20 |
$14,567 |
$13,410 |
$14,705 |
$15,115 |
6/20 |
$14,417 |
$13,765 |
$14,508 |
$15,416 |
7/20 |
$14,941 |
$14,423 |
$15,103 |
$16,285 |
8/20 |
$15,336 |
$15,387 |
$15,414 |
$17,455 |
9/20 |
$15,090 |
$14,856 |
$15,201 |
$16,792 |
10/20 |
$14,396 |
$14,400 |
$14,460 |
$16,346 |
11/20 |
$15,443 |
$16,242 |
$15,754 |
$18,135 |
12/20 |
$16,023 |
$16,930 |
$16,240 |
$18,832 |
1/21 |
$15,966 |
$16,762 |
$16,413 |
$18,642 |
2/21 |
$15,738 |
$17,192 |
$15,967 |
$19,156 |
3/21 |
$16,069 |
$17,764 |
$16,358 |
$19,995 |
4/21 |
$16,741 |
$18,590 |
$16,982 |
$21,062 |
5/21 |
$17,083 |
$18,858 |
$17,332 |
$21,209 |
6/21 |
$17,539 |
$19,139 |
$17,851 |
$21,704 |
7/21 |
$18,143 |
$19,482 |
$18,515 |
$22,220 |
8/21 |
$18,747 |
$19,967 |
$19,029 |
$22,895 |
9/21 |
$17,653 |
$19,138 |
$18,032 |
$21,831 |
10/21 |
$18,826 |
$20,222 |
$18,793 |
$23,360 |
11/21 |
$18,006 |
$19,779 |
$18,122 |
$23,198 |
12/21 |
$19,521 |
$20,624 |
$19,457 |
$24,238 |
1/22 |
$17,765 |
$19,533 |
$18,019 |
$22,984 |
2/22 |
$17,839 |
$19,039 |
$17,939 |
$22,295 |
3/22 |
$18,809 |
$19,561 |
$18,803 |
$23,123 |
4/22 |
$17,826 |
$17,936 |
$17,932 |
$21,107 |
5/22 |
$17,704 |
$17,950 |
$18,020 |
$21,146 |
6/22 |
$17,397 |
$16,395 |
$17,448 |
$19,400 |
7/22 |
$17,974 |
$17,697 |
$18,018 |
$21,189 |
8/22 |
$16,599 |
$16,957 |
$16,933 |
$20,325 |
9/22 |
$15,862 |
$15,380 |
$16,266 |
$18,453 |
10/22 |
$17,016 |
$16,485 |
$17,633 |
$19,947 |
11/22 |
$17,912 |
$17,631 |
$18,624 |
$21,062 |
12/22 |
$17,623 |
$16,882 |
$18,403 |
$19,848 |
1/23 |
$17,534 |
$18,077 |
$18,284 |
$21,095 |
2/23 |
$16,871 |
$17,642 |
$17,538 |
$20,581 |
3/23 |
$17,547 |
$18,188 |
$18,109 |
$21,336 |
4/23 |
$18,171 |
$18,506 |
$18,742 |
$21,669 |
5/23 |
$17,610 |
$18,322 |
$17,974 |
$21,763 |
6/23 |
$18,120 |
$19,430 |
$18,547 |
$23,201 |
7/23 |
$18,350 |
$20,082 |
$18,787 |
$23,947 |
8/23 |
$18,235 |
$19,603 |
$18,642 |
$23,566 |
9/23 |
$17,534 |
$18,757 |
$18,036 |
$22,442 |
10/23 |
$16,782 |
$18,213 |
$17,294 |
$21,970 |
11/23 |
$17,802 |
$19,920 |
$18,286 |
$23,977 |
12/23 |
$18,581 |
$20,898 |
$19,095 |
$25,066 |
1/24 |
$19,050 |
$21,149 |
$19,608 |
$25,487 |
2/24 |
$19,675 |
$22,046 |
$20,049 |
$26,848 |
3/24 |
$20,053 |
$22,754 |
$20,521 |
$27,712 |
4/24 |
$19,232 |
$21,909 |
$19,710 |
$26,580 |
5/24 |
$19,910 |
$22,887 |
$20,236 |
$27,898 |
6/24 |
$20,431 |
$23,353 |
$20,619 |
$28,899 |
7/24 |
$21,083 |
$23,765 |
$21,294 |
$29,251 |
8/24 |
$22,216 |
$24,393 |
$22,463 |
$29,960 |
9/24 |
$21,604 |
$24,839 |
$21,794 |
$30,600 |
10/24 |
$20,574 |
$24,347 |
$20,743 |
$30,323 |
11/24 |
$20,457 |
$25,464 |
$20,562 |
$32,102 |
12/24 |
$19,177 |
$24,800 |
$19,310 |
$31,337 |
1/25 |
$20,437 |
$25,675 |
$20,545 |
$32,210 |
2/25 |
$20,681 |
$25,491 |
$20,776 |
$31,790 |
3/25 |
$19,841 |
$24,356 |
$20,295 |
$29,998 |
4/25 |
$19,488 |
$24,572 |
$19,911 |
$29,795 |
5/25 |
$18,784 |
$26,027 |
$19,187 |
$31,670 |
6/25 |
$18,974 |
$27,150 |
$19,465 |
$33,281 |
7/25 |
$18,215 |
$27,499 |
$18,886 |
$34,028 |
8/25 |
$19,095 |
$28,217 |
$19,858 |
$34,718 |
9/25 |
$19,028 |
$29,124 |
$20,050 |
$35,985 |
10/25 |
$19,692 |
$29,707 |
$20,672 |
$36,827 |
11/25 |
$21,196 |
$29,791 |
$22,351 |
$36,918 |
12/25 |
$21,100 |
$30,032 |
$22,174 |
$36,940 |
1/26 |
$21,172 |
$30,704 |
$22,417 |
$37,476 |
2/26 |
$21,490 |
$30,929 |
$23,065 |
$37,191 |
3/26 |
$19,830 |
$28,959 |
$21,154 |
$35,339 |
4/26 |
$19,657 |
$31,736 |
$21,103 |
$39,047 |
5/26 |
$19,801 |
$33,181 |
$21,507 |
$41,102 |
6/26 |
$20,956 |
$32,943 |
$22,582 |
$40,711 |
7/26 |
$21,071 |
$33,112 |
$22,909 |
$40,685 |
8/26 |
$21,793 |
$33,965 |
$23,759 |
$41,793 |
Average Annual Total Returns (%)
Table Summary
Fund |
1 Year |
5 Years |
10 Years |
Class R |
14.13% |
3.06% |
8.10% |
MSCI World Index (net of foreign withholding taxes) |
20.37% |
11.20% |
13.00% |
MSCI World Health Care Index (net of foreign withholding taxes) |
19.65% |
4.54% |
9.03% |
S&P 500® Index |
20.38% |
12.78% |
15.37% |
Performance does not reflect the deduction of taxes that a shareholder would pay on Fund distributions or redemption of Fund shares. Performance assumes that all dividends and distributions, if any, were reinvested. For more recent performance information, visit www.eatonvance.com/performance.php.
THE FUND'S PAST PERFORMANCE IS NO GUARANTEE OF FUTURE RESULTS.
Table Summary
Total Net Assets |
$805,680,610 |
# of Portfolio Holdings |
41 |
Portfolio Turnover Rate |
30% |
Total Advisory Fees Paid |
$4,518,327 |
What did the Fund invest in?
The following tables reflect what the Fund invested in as of the report date.
Sector Allocation (% of total investments)
Table Summary
Value |
Value |
Short-Term Investments |
0.7% |
Health Care Technology |
1.4% |
Health Care Supplies |
1.9% |
Health Care Services |
3.6% |
Managed Health Care |
5.3% |
Life Sciences Tools & Services |
8.6% |
Health Care Equipment |
11.6% |
Biotechnology |
21.5% |
Pharmaceuticals |
45.4% |
Top Ten Holdings (% of total investments)Footnote Referencea
Table Summary
Eli Lilly & Co. |
12.0% |
Johnson & Johnson |
7.2% |
AbbVie, Inc |
7.2% |
Merck & Co., Inc. |
6.0% |
Roche Holding AG |
5.3% |
UnitedHealth Group, Inc. |
5.3% |
AstraZeneca PLC |
4.3% |
Bristol-Myers Squibb Co. |
4.3% |
Vertex Pharmaceuticals, Inc. |
3.7% |
Abbott Laboratories |
3.3% |
Total |
58.6% |
| Footnote |
Description |
Footnotea |
Excluding cash equivalents |
If you wish to view additional information about the Fund, including the prospectus, statement of additional information, financial statements and holdings, please scan the QR code or visit www.eatonvance.com/open-end-mutual-fund-documents.php. For proxy information, please visit www.eatonvance.com/proxyvoting.
The Funds may deliver a single copy of certain required shareholder documents (including prospectuses, shareholder reports, and proxy materials) to investors with the same last name and the same address. Your participation will continue indefinitely unless you instruct otherwise by calling 1-800-262-1122 or by contacting your financial intermediary. Your instruction will typically be effective within 30 days of receipt.
Not FDIC Insured | May Lose Value | No Bank Guarantee
Annual Shareholder Report August 31, 2026
(b) Not applicable.
Item 2. Code of Ethics
The registrant (sometimes referred to as the “Fund”) has adopted a code of ethics applicable to its Principal Executive Officer, Principal Financial Officer and Principal Accounting Officer. The registrant undertakes to provide a copy of such code of ethics to any person upon request, without charge, by calling 1-800-262-1122. The registrant has amended the code of ethics as described in Form N-CSR during the period covered by the report. The new Fund policy is substantially similar to the superseded Fund policy but now has an expanded scope that applies to 1940 Act Fund families. The registrant has not granted any waiver, including an implicit waiver, from a provision of the code of ethics as described in Form N-CSR during the period covered by this report.
Item 3. Audit Committee Financial Expert
The registrant’s Board of Trustees has determined that George J. Gorman, an “independent” Trustee, is an “audit committee financial expert” serving on its audit committee. Under applicable securities laws, a person who is determined to be an audit committee financial expert will not be deemed an “expert” for any purpose, including without limitation for the purposes of Section 11 of the Securities Act of 1933, as a result of being designated or identified as an audit committee financial expert. The designation or identification of a person as an audit committee financial expert does not impose on such person any duties, obligations, or the liabilities that are greater than the duties, obligations, and liabilities imposed on such person as a member of the audit committee and Board of Trustees in the absence of such designation or identification.
Item 4. Principal Accountant Fees and Services
Eaton Vance China Equity Fund, Eaton Vance All Asset Strategy Fund, Eaton Vance Equity Strategy Fund and Eaton Vance Worldwide Health Sciences Fund (the “Fund(s)”) are series of Eaton Vance Growth Trust (the “Trust”), a Massachusetts business trust, which, including the Funds, contains a total of 9 series (the “Series”). The Trust is registered under the Investment Company Act of 1940 as an open-end management investment company. This Form N-CSR relates to the Funds’ annual reports.
(a)-(d)
The following tables present the aggregate fees billed to each Fund for each Fund’s fiscal years ended August 31, 2025 and August 31, 2026 by the registrant’s principal accountant, Deloitte & Touche LLP (“D&T”), for professional services rendered for the audit of the Funds’ annual financial statements and fees billed for other services rendered by D&T during those periods.
Eaton Vance China Equity Fund
|
|
|
|
|
|
|
|
|
| Fiscal Years Ended |
|
8/31/25 |
|
|
8/31/26 |
|
| Audit Fees |
|
$ |
33,900 |
|
|
$ |
33,900 |
|
| Audit-Related Fees(1) |
|
$ |
0 |
|
|
$ |
0 |
|
| Tax Fees(2) |
|
$ |
0 |
|
|
$ |
0 |
|
| All Other Fees(3) |
|
$ |
0 |
|
|
$ |
0 |
|
|
|
|
|
|
|
|
|
|
| Total |
|
$ |
33,900 |
|
|
$ |
33,900 |
|
|
|
|
|
|
|
|
|
|
Eaton Vance All Asset Strategy Fund
|
|
|
|
|
|
|
|
|
| Fiscal Years Ended |
|
8/31/25 |
|
|
8/31/26 |
|
| Audit Fees |
|
$ |
35,100 |
|
|
$ |
35,100 |
|
| Audit-Related Fees(1) |
|
$ |
0 |
|
|
$ |
0 |
|
| Tax Fees(2) |
|
$ |
0 |
|
|
$ |
0 |
|
| All Other Fees(3) |
|
$ |
0 |
|
|
$ |
0 |
|
|
|
|
|
|
|
|
|
|
| Total |
|
$ |
35,100 |
|
|
$ |
35,100 |
|
|
|
|
|
|
|
|
|
|
Eaton Vance Equity Strategy Fund
|
|
|
|
|
|
|
|
|
| Fiscal Years Ended |
|
8/31/25 |
|
|
8/31/26 |
|
| Audit Fees |
|
$ |
35,100 |
|
|
$ |
35,100 |
|
| Audit-Related Fees(1) |
|
$ |
0 |
|
|
$ |
0 |
|
| Tax Fees(2) |
|
$ |
0 |
|
|
$ |
0 |
|
| All Other Fees(3) |
|
$ |
0 |
|
|
$ |
0 |
|
|
|
|
|
|
|
|
|
|
| Total |
|
$ |
35,100 |
|
|
$ |
35,100 |
|
|
|
|
|
|
|
|
|
|
Eaton Vance Worldwide Health Sciences Fund
|
|
|
|
|
|
|
|
|
| Fiscal Years Ended |
|
8/31/25 |
|
|
8/31/26 |
|
| Audit Fees |
|
$ |
68,200 |
|
|
$ |
68,200 |
|
| Audit-Related Fees(1) |
|
$ |
0 |
|
|
$ |
0 |
|
| Tax Fees(2) |
|
$ |
0 |
|
|
$ |
0 |
|
| All Other Fees(3) |
|
$ |
0 |
|
|
$ |
0 |
|
|
|
|
|
|
|
|
|
|
| Total |
|
$ |
68,200 |
|
|
$ |
68,200 |
|
|
|
|
|
|
|
|
|
|
| (1) |
Audit-related fees consist of the aggregate fees billed for assurance and related services that are reasonably related to the performance of the audit of the registrant’s financial statements and are not reported under the category of audit fees. |
| (2) |
Tax fees consist of the aggregate fees billed for professional services rendered by the principal accountant relating to tax compliance, tax advice, and tax planning and specifically include fees for tax return preparation and other related tax compliance/planning matters. |
| (3) |
All other fees consist of the aggregate fees billed for products and services provided by the principal accountant other than audit, audit-related, and tax services. |
The various Series comprising the Trust have varying fiscal year ends (February 28/29, August 31, September 30 or November 30). The following table presents the aggregate audit, audit-related, tax, and other fees billed to all of the Series in the Trust by D&T for the last two fiscal years of each Series.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Fiscal Years Ended |
|
9/30/24 |
|
|
11/30/24 |
|
|
2/28/25 |
|
|
8/31/25 |
|
|
9/30/25 |
|
|
11/30/25 |
|
|
2/28/26 |
|
|
8/31/26 |
|
| Audit Fees |
|
$ |
119,800 |
|
|
$ |
33,900 |
|
|
$ |
70,200 |
|
|
$ |
172,300 |
|
|
$ |
119,800 |
|
|
$ |
28,900 |
|
|
$ |
69,200 |
|
|
$ |
172,300 |
|
| Audit-Related Fees(1) |
|
$ |
0 |
|
|
$ |
0 |
|
|
$ |
0 |
|
|
$ |
0 |
|
|
$ |
0 |
|
|
$ |
0 |
|
|
$ |
0 |
|
|
$ |
0 |
|
| Tax Fees(2) |
|
$ |
0 |
|
|
$ |
0 |
|
|
$ |
0 |
|
|
$ |
0 |
|
|
$ |
0 |
|
|
$ |
0 |
|
|
$ |
0 |
|
|
$ |
0 |
|
| All Other Fees(3) |
|
$ |
0 |
|
|
$ |
0 |
|
|
$ |
0 |
|
|
$ |
0 |
|
|
$ |
0 |
|
|
$ |
0 |
|
|
$ |
0 |
|
|
$ |
0 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Total |
|
$ |
119,800 |
|
|
$ |
33,900 |
|
|
$ |
70,200 |
|
|
$ |
172,300 |
|
|
$ |
119,800 |
|
|
$ |
28,900 |
|
|
$ |
69,200 |
|
|
$ |
172,300 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| (1) |
Audit-related fees consist of the aggregate fees billed for assurance and related services that are reasonably related to the performance of the audit of the registrant’s financial statements and are not reported under the category of audit fees. |
| (2) |
Tax fees consist of the aggregate fees billed for professional services rendered by the principal accountant relating to tax compliance, tax advice, and tax planning and specifically include fees for tax return preparation and other related tax compliance/planning matters. |
| (3) |
All other fees consist of the aggregate fees billed for products and services provided by the principal accountant other than audit, audit-related, and tax services. |
(e)(1) The registrant’s audit committee has adopted policies and procedures relating to the pre-approval of services provided by the registrant’s principal accountant (the “Pre-Approval Policies”). The Pre-Approval Policies establish a framework intended to assist the audit committee in the proper discharge of its pre-approval responsibilities. As a general matter, the Pre-Approval Policies (i) specify certain types of audit, audit-related, tax, and other services determined to be pre-approved by the audit committee; and (ii) delineate specific procedures governing the mechanics of the pre-approval process, including the approval and monitoring of audit and non-audit service fees. Unless a service is specifically pre-approved under the Pre-Approval Policies, it must be separately pre-approved by the audit committee.
The Pre-Approval Policies and the types of audit and non-audit services pre-approved therein must be reviewed and ratified by the registrant’s audit committee at least annually. The registrant’s audit committee maintains full responsibility for the appointment, compensation, and oversight of the work of the registrant’s principal accountant.
(e)(2) No services described in paragraphs (b)-(d) above were approved by the registrant’s audit committee pursuant to the “de minimis exception” set forth in Rule 2-01(c)(7)(i)(C) of Regulation S-X.
(f) Not applicable.
(g) The following table presents (i) the aggregate non-audit fees (i.e., fees for audit-related, tax, and other services) billed for services rendered to all of the Series in the Trust by D&T for the last two fiscal years of each Series; and (ii) the aggregate non-audit fees (i.e., fees for audit-related, tax, and other services) billed for services rendered to the Eaton Vance organization by D&T for the last 2 fiscal years of each Series.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Fiscal Years Ended |
|
9/30/24 |
|
|
11/30/24 |
|
|
2/28/25 |
|
|
8/31/25 |
|
|
9/30/25 |
|
|
11/30/25 |
|
|
2/28/26 |
|
|
8/31/26 |
|
| Registrant(1) |
|
$ |
0 |
|
|
$ |
0 |
|
|
$ |
0 |
|
|
$ |
0 |
|
|
$ |
0 |
|
|
$ |
0 |
|
|
$ |
0 |
|
|
$ |
0 |
|
| Eaton Vance(2) |
|
$ |
18,490 |
|
|
$ |
18,490 |
|
|
$ |
18,490 |
|
|
$ |
18,490 |
|
|
$ |
18,490 |
|
|
$ |
18,490 |
|
|
$ |
18,490 |
|
|
$ |
19,414 |
|
| (1) |
Includes all of the Series of the Trust. During the fiscal years reported above, certain of the Funds were “feeder” funds in a “master-feeder” fund structure or funds of funds. |
| (2) |
Various subsidiaries of Morgan Stanley act in either an investment advisory and/or service provider capacity with respect to the Series and/or their respective “master” funds (if applicable). |
(h) The registrant’s audit committee has considered whether the provision by the registrant’s principal accountant of non-audit services to the registrant’s investment adviser and any entity controlling, controlled by, or under common control with the adviser that provides ongoing services to the registrant that were not pre-approved pursuant to Rule 2-01(c)(7)(ii) of Regulation S-X is compatible with maintaining the principal accountant’s independence.
(i) Not applicable.
(j) Not applicable.
Item 5. Audit Committee of Listed Registrants
Not applicable.
Item 6. Schedule of Investments
| (a) |
Please see schedule of investments contained in the Financial Statements and Financial Highlights included under Item 7 of this Form N-CSR. |
Item 7. Financial Statements and Financial Highlights for Open-End Management Investment Companies
Eaton Vance
Annual Financial Statements and
Additional Information
This report must be preceded or accompanied by a current summary prospectus or prospectus. Before investing, investors should consider carefully the investment objective, risks, and charges and expenses of a mutual fund. This and other important information is contained in the prospectus and/or statement of additional information, which can be obtained by calling 1-800-262-1122 or from a financial intermediary. Prospective investors should read the prospectus carefully before investing.
Annual Financial Statements and Additional Information August 31, 2026
Eaton Vance
China Equity Fund
Items 8 and 9 of Form N-CSR are Not Applicable. For Item 10 of Form N-CSR, see Item 7.
Eaton Vance
China Equity Fund
August 31, 2026
| |
|
|
| |
Automobile Components — 0.7% |
Fuyao Glass Industry Group Co. Ltd., Class H(1) |
|
|
|
| |
|
|
|
| |
| |
|
|
|
| |
|
|
|
| |
Bank of Jiangsu Co. Ltd., Class A |
|
|
|
Bank of Ningbo Co. Ltd., Class A |
|
|
|
China Construction Bank Corp., Class H |
|
|
|
Industrial & Commercial Bank of China Ltd., Class H |
|
|
|
| |
|
|
|
| |
Eastroc Beverage Group Co. Ltd., Class A |
|
|
|
Nongfu Spring Co. Ltd., Class H(1) |
|
|
|
| |
|
|
|
| |
Innovent Biologics, Inc.(1)(2) |
|
|
|
| |
|
|
|
| |
Alibaba Group Holding Ltd. |
|
|
|
PDD Holdings, Inc. ADR(2) |
|
|
|
| |
|
|
|
| |
China International Capital Corp. Ltd., Class H(1) |
|
|
|
Huatai Securities Co. Ltd., Class H(1) |
|
|
|
| |
|
|
|
| |
Wanhua Chemical Group Co. Ltd., Class A |
|
|
|
| |
|
|
|
Communications Equipment — 1.6% |
Suzhou TFC Optical Communication Co. Ltd., Class A |
|
|
|
| |
|
|
Communications Equipment (continued) |
Zhongji Innolight Co. Ltd., Class A |
|
|
|
| |
|
|
|
Consumer Staples Distribution & Retail — 0.3% |
JD Health International, Inc.(1)(2) |
|
|
|
| |
|
|
|
Electrical Equipment — 4.1% |
Contemporary Amperex Technology Co. Ltd., Class A |
|
|
|
Dongfang Electric Corp. Ltd., Class H |
|
|
|
Huaming Power Equipment Co. Ltd., Class A |
|
|
|
Shenzhen Megmeet Electrical Co. Ltd., Class A |
|
|
|
Sieyuan Electric Co. Ltd., Class A |
|
|
|
| |
|
|
|
Electronic Equipment, Instruments & Components — 1.0% |
Luxshare Precision Industry Co. Ltd., Class A |
|
|
|
Shanghai BOCHU Electronic Technology Corp. Ltd., Class A |
|
|
|
Victory Giant Technology Huizhou Co. Ltd., Class A |
|
|
|
| |
|
|
|
| |
Foshan Haitian Flavouring & Food Co. Ltd., Class H |
|
|
|
| |
|
|
|
| |
| |
|
|
|
| |
|
|
|
Hotels, Restaurants & Leisure — 2.8% |
Atour Lifestyle Holdings Ltd. ADR |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
Household Durables — 0.8% |
Midea Group Co. Ltd., Class H(3) |
|
|
|
| |
|
|
|
Independent Power and Renewable Electricity Producers — 0.6% |
China Yangtze Power Co. Ltd., Class A |
|
|
|
| |
|
|
|
See Notes to Financial Statements.
Eaton Vance
China Equity Fund
August 31, 2026
Portfolio of Investments — continued
| |
|
|
| |
PICC Property & Casualty Co. Ltd., Class H |
|
|
|
Ping An Insurance Group Co. of China Ltd., Class H |
|
|
|
| |
|
|
|
Interactive Media & Services — 17.5% |
| |
|
|
|
| |
|
|
|
| |
Vnet Group, Inc. ADR(2)(3) |
|
|
|
| |
|
|
|
Life Sciences Tools & Services — 4.7% |
WuXi AppTec Co. Ltd., Class H(1)(3) |
|
|
|
WuXi Biologics Cayman, Inc.(1)(2) |
|
|
|
| |
|
|
|
| |
Anhui Yingliu Electromechanical Co. Ltd., Class A |
|
|
|
Jiangsu Hengli Hydraulic Co. Ltd., Class A |
|
|
|
Sany Heavy Industry Co. Ltd., Class H |
|
|
|
Shenzhen Han's CNC Technology Co. Ltd., Class H(3) |
|
|
|
| |
|
|
|
| |
China Hongqiao Group Ltd. |
|
|
|
Zijin Mining Group Co. Ltd., Class H |
|
|
|
| |
|
|
|
Oil, Gas & Consumable Fuels — 4.0% |
China Shenhua Energy Co. Ltd., Class H(3) |
|
|
|
PetroChina Co. Ltd., Class H |
|
|
|
| |
|
|
|
Real Estate Management & Development — 1.3% |
China Resources Mixc Lifestyle Services Ltd.(1) |
|
|
|
| |
|
|
|
Semiconductors & Semiconductor Equipment — 9.9% |
Advanced Micro-Fabrication Equipment, Inc. China, Class A |
|
|
|
Cambricon Technologies Corp. Ltd., Class A |
|
|
|
Hangzhou Chang Chuan Technology Co. Ltd., Class A |
|
|
|
Hua Hong Grace Semiconductor Ltd., Class H(1)(2) |
|
|
|
Hygon Information Technology Co. Ltd., Class A |
|
|
|
Montage Technology Co. Ltd., Class A |
|
|
|
| |
|
|
Semiconductors & Semiconductor Equipment (continued) |
Montage Technology Co. Ltd., Class H(2)(3) |
|
|
|
NAURA Technology Group Co. Ltd., Class A |
|
|
|
Nexchip Semiconductor Corp., Class H(2) |
|
|
|
| |
|
|
|
| |
|
|
|
Technology Hardware, Storage & Peripherals — 1.2% |
| |
|
|
|
| |
|
|
|
Transportation Infrastructure — 1.3% |
China Merchants Port Holdings Co. Ltd. |
|
|
|
| |
|
|
|
Total China
(identified cost $21,559,613) |
|
|
|
| |
| |
Zijin Gold International Co. Ltd.(3) |
|
|
|
| |
|
|
|
Semiconductors & Semiconductor Equipment — 0.5% |
| |
|
|
|
| |
|
|
|
Total Hong Kong
(identified cost $103,411) |
|
|
|
Total Common Stocks
(identified cost $21,663,024) |
|
|
|
Short-Term Investments — 0.0%† |
| |
|
|
Morgan Stanley Institutional Liquidity Funds - Government Portfolio, Institutional Class, 3.58%(4) |
|
|
|
Total Short-Term Investments
(identified cost $3,539) |
|
|
|
Total Investments — 99.4%
(identified cost $21,666,563) |
|
|
|
Other Assets, Less Liabilities — 0.6% |
|
|
|
| |
|
|
|
See Notes to Financial Statements.
Eaton Vance
China Equity Fund
August 31, 2026
Portfolio of Investments — continued
The percentage shown for each investment category in the Portfolio of Investments is based on net assets. |
| |
Amount is less than 0.05% or (0.05)%, as applicable. |
| |
Security exempt from registration under Rule 144A of the Securities Act of 1933, as amended. These securities may be sold in certain transactions in reliance on an exemption from registration (normally to qualified institutional buyers). At August 31, 2026, the aggregate value of these securities is $3,746,468 or 11.1% of the Fund's net assets. |
| |
Non-income producing security. |
| |
All or a portion of this security was on loan at August 31, 2026. The aggregate market value of securities on loan at August 31, 2026 was $1,725,577. |
| |
May be deemed to be an affiliated investment company (see Note 11). The rate shown is the annualized seven-day yield as of August 31, 2026. |
| |
| |
– American Depositary Receipt |
See Notes to Financial Statements.
Eaton Vance
China Equity Fund
August 31, 2026
Statement of Assets and Liabilities
| |
|
| |
|
Unaffiliated investments, at value (identified cost $21,663,024) — including $1,725,577 of securities on loan |
|
Affiliated investments, at value (identified cost $3,539) |
|
| |
|
Foreign currency, at value (identified cost $903) |
|
| |
|
Dividends receivable from affiliated investments |
|
Receivable for investments sold |
|
Receivable for Fund shares sold |
|
Securities lending income receivable |
|
Trustees' deferred compensation plan |
|
| |
|
| |
|
| |
|
Payable for Fund shares redeemed |
|
| |
|
| |
|
| |
|
Distribution and service fees |
|
| |
|
Trustees' deferred compensation plan |
|
| |
|
Payable for custodian fee |
|
Payable for legal and accounting services |
|
Payable for printing and postage |
|
Payable for registration fees |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
Net Asset Value and Redemption Price Per Share
(net assets ÷ shares of beneficial interest outstanding) |
|
Maximum Offering Price Per Share
(100 ÷ 94.75 of net asset value per share) |
|
| |
|
| |
|
| |
|
Net Asset Value and Offering Price Per Share*
(net assets ÷ shares of beneficial interest outstanding) |
|
See Notes to Financial Statements.
Eaton Vance
China Equity Fund
August 31, 2026
Statement of Assets and Liabilities — continued
| |
|
| |
|
| |
|
| |
|
Net Asset Value, Offering Price and Redemption Price Per Share
(net assets ÷ shares of beneficial interest outstanding) |
|
On sales of $50,000 or more, the offering price of Class A shares is reduced. |
| |
Redemption price per share is equal to the net asset value less any applicable contingent deferred sales charge. |
See Notes to Financial Statements.
Eaton Vance
China Equity Fund
August 31, 2026
| |
|
| |
|
| |
|
Dividend income (net of foreign taxes withheld of $62,705) |
|
Dividend income from affiliated investments |
|
Securities lending income, net |
|
| |
|
| |
|
| |
|
| |
|
Distribution and service fees: |
|
| |
|
| |
|
Trustees’ fees and expenses |
|
| |
|
Transfer and dividend disbursing agent fees |
|
Legal and accounting services |
|
| |
|
| |
|
| |
|
| |
|
| |
|
Waiver and/or reimbursement of expenses by affiliates |
|
| |
|
| |
|
| |
|
Realized and Unrealized Gain (Loss) |
|
Net realized gain (loss): |
|
| |
|
| |
|
Foreign currency transactions |
|
| |
|
Change in unrealized appreciation (depreciation): |
|
| |
|
| |
|
| |
|
Net change in unrealized appreciation (depreciation) |
|
Net realized and unrealized loss |
|
Net decrease in net assets from operations |
|
See Notes to Financial Statements.
Eaton Vance
China Equity Fund
August 31, 2026
Statements of Changes in Net Assets
| |
|
| |
|
|
Increase (Decrease) in Net Assets |
|
|
| |
|
|
| |
|
|
| |
|
|
Net change in unrealized appreciation (depreciation) |
|
|
Net increase (decrease) in net assets from operations |
|
|
Distributions to shareholders: |
|
|
| |
|
|
| |
|
|
| |
|
|
Total distributions to shareholders |
|
|
Transactions in shares of beneficial interest: |
|
|
| |
|
|
| |
|
|
| |
|
|
Net decrease in net assets from Fund share transactions |
|
|
Net increase (decrease) in net assets |
|
|
| |
|
|
| |
|
|
| |
|
|
See Notes to Financial Statements.
Eaton Vance
China Equity Fund
August 31, 2026
| |
|
| |
|
| |
|
|
|
|
|
Net asset value — Beginning of year |
|
|
|
|
|
Income (Loss) From Operations |
|
|
|
|
|
| |
|
|
|
|
|
Net realized and unrealized gain (loss) |
|
|
|
|
|
Total income (loss) from operations |
|
|
|
|
|
| |
|
|
|
|
|
From net investment income |
|
|
|
|
|
| |
|
|
|
|
|
| |
|
|
|
|
|
Net asset value — End of year |
|
|
|
|
|
| |
|
|
|
|
|
| |
|
|
|
|
|
Net assets, end of year (000’s omitted) |
|
|
|
|
|
Ratios (as a percentage of average daily net assets):(4) |
|
|
|
|
|
| |
|
|
|
|
|
| |
|
|
|
|
|
| |
|
|
|
|
|
| |
|
|
|
|
|
| |
Computed using average shares outstanding. |
| |
Net investment income (loss) per share includes special dividends which amounted to $0.20 per share. Excluding special dividends, the ratio of net investment income (loss) to average daily net assets would have been 0.89%. |
| |
Returns are historical and are calculated by determining the percentage change in net asset value with all distributions reinvested and do not reflect
the effect of sales charges. |
| |
Total expenses do not reflect amounts reimbursed and/or waived by the adviser and administrator and certain of its affiliates, if applicable. Net expenses are net of all reductions and represent the net expenses paid by the Fund. |
| |
Includes interest expense of 0.01% for the year ended August 31, 2024. |
| |
Includes a reduction by the investment adviser of a portion of its adviser fee due to the Fund’s investment in the Liquidity Fund (equal to less than 0.005% of average daily net assets for the years ended August 31, 2026, 2025, 2024, 2023 and 2022). |
See Notes to Financial Statements.
Eaton Vance
China Equity Fund
August 31, 2026
Financial Highlights — continued
| |
|
| |
|
| |
|
|
|
|
|
Net asset value — Beginning of year |
|
|
|
|
|
Income (Loss) From Operations |
|
|
|
|
|
Net investment income (loss)(1) |
|
|
|
|
|
Net realized and unrealized gain (loss) |
|
|
|
|
|
Total income (loss) from operations |
|
|
|
|
|
| |
|
|
|
|
|
From net investment income |
|
|
|
|
|
| |
|
|
|
|
|
| |
|
|
|
|
|
Net asset value — End of year |
|
|
|
|
|
| |
|
|
|
|
|
| |
|
|
|
|
|
Net assets, end of year (000’s omitted) |
|
|
|
|
|
Ratios (as a percentage of average daily net assets):(4) |
|
|
|
|
|
| |
|
|
|
|
|
| |
|
|
|
|
|
Net investment income (loss) |
|
|
|
|
|
| |
|
|
|
|
|
| |
Computed using average shares outstanding. |
| |
Net investment income (loss) per share includes special dividends which amounted to $0.18 per share. Excluding special dividends, the ratio of net investment income (loss) to average daily net assets would have been (0.11)%. |
| |
Returns are historical and are calculated by determining the percentage change in net asset value with all distributions reinvested and do not reflect
the effect of sales charges. |
| |
Total expenses do not reflect amounts reimbursed and/or waived by the adviser and administrator and certain of its affiliates, if applicable. Net expenses are net of all reductions and represent the net expenses paid by the Fund. |
| |
Includes interest expense of 0.01% for the year ended August 31, 2024. |
| |
Includes a reduction by the investment adviser of a portion of its adviser fee due to the Fund’s investment in the Liquidity Fund (equal to less than 0.005% of average daily net assets for the years ended August 31, 2026, 2025, 2024, 2023 and 2022). |
See Notes to Financial Statements.
Eaton Vance
China Equity Fund
August 31, 2026
Financial Highlights — continued
| |
|
| |
|
| |
|
|
|
|
|
Net asset value — Beginning of year |
|
|
|
|
|
Income (Loss) From Operations |
|
|
|
|
|
| |
|
|
|
|
|
Net realized and unrealized gain (loss) |
|
|
|
|
|
Total income (loss) from operations |
|
|
|
|
|
| |
|
|
|
|
|
From net investment income |
|
|
|
|
|
| |
|
|
|
|
|
| |
|
|
|
|
|
Net asset value — End of year |
|
|
|
|
|
| |
|
|
|
|
|
| |
|
|
|
|
|
Net assets, end of year (000’s omitted) |
|
|
|
|
|
Ratios (as a percentage of average daily net assets):(4) |
|
|
|
|
|
| |
|
|
|
|
|
| |
|
|
|
|
|
| |
|
|
|
|
|
| |
|
|
|
|
|
| |
Computed using average shares outstanding. |
| |
Net investment income per share includes special dividends which amounted to $0.20 per share. Excluding special dividends, the ratio of net investment income to average daily net assets would have been 0.67%. |
| |
Returns are historical and are calculated by determining the percentage change in net asset value with all distributions reinvested. |
| |
Total expenses do not reflect amounts reimbursed and/or waived by the adviser and administrator and certain of its affiliates, if applicable. Net expenses are net of all reductions and represent the net expenses paid by the Fund. |
| |
Includes interest expense of 0.01% for the year ended August 31, 2024. |
| |
Includes a reduction by the investment adviser of a portion of its adviser fee due to the Fund’s investment in the Liquidity Fund (equal to less than 0.005% of average daily net assets for the years ended August 31, 2026, 2025, 2024, 2023 and 2022). |
See Notes to Financial Statements.
Eaton Vance
China Equity Fund
August 31, 2026
Notes to Financial Statements
1 Significant Accounting Policies
Eaton Vance China Equity Fund (the Fund) is a non-diversified series of Eaton Vance Growth Trust (the Trust). The Trust is a Massachusetts business trust registered under the Investment Company Act of 1940, as amended (the 1940 Act), as an open-end management investment company. The Fund’s investment objective is to seek long-term capital appreciation. The Fund offers three classes of shares. Class A shares are generally sold subject to a sales charge imposed at time of purchase. Class C shares are sold at net asset value and are generally subject to a contingent deferred sales charge (see Note 5). Effective November 5, 2020, Class C shares automatically convert to Class A shares eight years after their purchase as described in the Fund’s prospectus. Class I shares are sold at net asset value and are not subject to a sales charge. Each class represents a pro rata interest in the Fund, but votes separately on class-specific matters and (as noted below) is subject to different expenses. Realized and unrealized gains and losses and net investment income and losses, other than class-specific expenses, are allocated daily to each class of shares based on the relative net assets of each class to the total net assets of the Fund. Each class of shares differs in its distribution plan and certain other class-specific expenses.
The following is a summary of significant accounting policies of the Fund. The policies are in conformity with accounting principles generally accepted in the United States of America (U.S. GAAP). The Fund is an investment company and follows accounting and reporting guidance in the Financial Accounting Standards Board (FASB) Accounting Standards Codification Topic 946.
A Investment Valuation—The following methodologies are used to determine the market value or fair value of investments.
Equity Securities. Equity securities listed on a U.S. securities exchange generally are valued at the last sale or closing price on the day of valuation or, if no sales took place on such date, at the mean between the closing bid and ask prices on the exchange where such securities are principally traded. Equity securities listed on the NASDAQ National Market System are valued at the NASDAQ official closing price. Unlisted or listed securities for which closing sales prices or closing quotations are not available are valued at the mean between the latest available bid and ask prices.
Foreign Securities and Currencies. Foreign securities and currencies are valued in U.S. dollars, based on foreign currency exchange rate quotations supplied by a third party pricing service. The pricing service uses a proprietary model to determine the exchange rate. Inputs to the model include reported trades and implied bid/ask spreads. The daily valuation of exchange-traded foreign securities generally is determined as of the close of trading on the principal exchange on which such securities trade. Events occurring after the close of trading on foreign exchanges may result in adjustments to the valuation of foreign securities to more accurately reflect their fair value as of the close of regular trading on the New York Stock Exchange. When valuing foreign equity securities that meet certain criteria, the Fund's Trustees have approved the use of a fair value service that values such securities to reflect market trading that occurs after the close of the applicable foreign markets of comparable securities or other instruments that have a strong correlation to the fair-valued securities.
Other. Investments in management investment companies (including money market funds) that do not trade on an exchange are valued at the net asset value as of the close of each business day.
Fair Valuation. In connection with Rule 2a-5 of the 1940 Act, the Trustees have designated the Fund’s investment adviser as its valuation designee. Investments for which valuations or market quotations are not readily available or are deemed unreliable are valued by the investment adviser, as valuation designee, at fair value using methods that most fairly reflect the security’s “fair value”, which is the amount that the Fund might reasonably expect to receive for the security upon its current sale in the ordinary course. Each such determination is based on a consideration of relevant factors, which are likely to vary from one pricing context to another. These factors may include, but are not limited to, the type of security, the existence of any contractual restrictions on the security’s disposition, the price and extent of public trading in similar securities of the issuer or of comparable companies or entities, quotations or relevant information obtained from broker/dealers or other market participants, information obtained from the issuer, analysts, and/or the appropriate stock exchange (for exchange-traded securities), an analysis of the company’s or entity’s financial statements, and an evaluation of the forces that influence the issuer and the market(s) in which the security is purchased and sold.
B Investment Transactions—Investment transactions for financial statement purposes are accounted for on a trade date basis. Realized gains and losses on investments sold are determined on the basis of identified cost.
C Income—Dividend income is recorded on the ex-dividend date for dividends received in cash and/or securities. However, if the ex-dividend date has passed, certain dividends from foreign securities are recorded as the Fund is informed of the ex-dividend date. Withholding taxes on foreign dividends and capital gains have been provided for in accordance with the Fund's understanding of the applicable countries’ tax rules and rates.
D Federal and Other Taxes—The Fund’s policy is to comply with the provisions of the Internal Revenue Code applicable to regulated investment companies and to distribute to shareholders each year substantially all of its net investment income, and all or substantially all of its net realized capital
gains. Accordingly, no provision for federal income or excise tax is necessary. As of August 31, 2026, the Fund had no uncertain tax positions that would require financial statement recognition, de-recognition, or disclosure. The Fund files a U.S. federal income tax return annually after its fiscal year-end, which is subject to examination by the Internal Revenue Service for a period of three years from the date of filing.
During this reporting period, the Fund adopted FASB Accounting Standards Update No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures (ASU 2023-09), which requires annual disclosure of the amount of income taxes paid (net of refunds received) disaggregated by federal, state,
and foreign taxes, and further disaggregated by individual jurisdiction in which income taxes paid is equal to or greater than 5% of total income taxes paid.
Eaton Vance
China Equity Fund
August 31, 2026
Notes to Financial Statements — continued
The adoption of ASU 2023-09 did not result in any changes to the Fund's financial statement presentation or disclosure.
E Expenses—The majority of expenses of the Trust are directly identifiable to an individual fund. Expenses which are not readily identifiable to a specific fund are allocated taking into consideration, among other things, the nature and type of expense and the relative size of the funds.
F Foreign Currency Translation—Investment valuations, other assets, and liabilities initially expressed in foreign currencies are translated each business day into U.S. dollars based upon current exchange rates. Purchases and sales of foreign investment securities and income and expenses denominated in foreign currencies are translated into U.S. dollars based upon currency exchange rates in effect on the respective dates of such transactions. Recognized gains or losses on investment transactions attributable to changes in foreign currency exchange rates are recorded for financial statement purposes as net realized gains and losses on investments. That portion of unrealized gains and losses on investments that results from fluctuations in foreign currency exchange rates is not separately disclosed.
G Use of Estimates—The preparation of the financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of income and expense during the reporting period. Actual results could differ from those estimates.
H Indemnifications—Under the Trust’s organizational documents, its officers and Trustees may be indemnified against certain liabilities and expenses arising out of the performance of their duties to the Fund. Under Massachusetts law, if certain conditions prevail, shareholders of a Massachusetts business trust (such as the Trust) could be deemed to have personal liability for the obligations of the Trust. However, the Trust’s Declaration of Trust contains an express disclaimer of liability on the part of Fund shareholders and the By-laws provide that the Trust shall assume, upon request by the shareholder, the defense on behalf of any Fund shareholders. Moreover, the By-laws also provide for indemnification out of Fund property of any shareholder held personally liable solely by reason of being or having been a shareholder for all loss or expense arising from such liability. Additionally, in the normal course of business, the Fund enters into agreements with service providers that may contain indemnification clauses. The Fund’s maximum exposure under these arrangements is unknown as this would involve future claims that may be made against the Fund that have not yet occurred.
I Futures Contracts—Upon entering into a futures contract, the Fund is required to deposit with the broker, either in cash or securities, an amount equal to a certain percentage of the contract amount (initial margin). Subsequent payments, known as variation margin, are made or received by the Fund each business day, depending on the daily fluctuations in the value of the underlying security, index or currency, and are recorded as unrealized gains or losses by the Fund. Gains (losses) are realized upon the expiration or closing of the futures contracts. Should market conditions change unexpectedly, the Fund may not achieve the anticipated benefits of the futures contracts and may realize a loss. Futures contracts have minimal counterparty risk as they are exchange traded and the clearinghouse for the exchange is substituted as the counterparty, guaranteeing counterparty performance.
J Segment Reporting—The Fund operates as a single reportable segment, an investment company whose investment objective(s) is included in Note 1. The Fund’s President acts as the Fund's Chief Operating Decision Maker (CODM), who is responsible for assessing the performance of the Fund's single segment and deciding how to allocate the segment’s resources. To perform this function, the CODM reviews the information in the Fund’s financial statements.
K Recently Issued Accounting Pronouncements—In September 2026, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2026-03, Fair Value Measurement (Topic 820): Investment Companies with Equity Securities Subject to Contractual Sale Restrictions. ASU 2026-03 requires investment companies to consider the effects of certain contractual sale restrictions when measuring the fair value of equity securities and to provide related disclosures. ASU 2026-03 is effective for fiscal years beginning after December 15, 2027, and interim periods within those fiscal years, with early adoption permitted. Management is currently evaluating the impact of adopting ASU 2026-03; however, it does not currently expect the implementation of the standard to have a material effect on the Fund's financial statements.
2 Distributions to Shareholders and Income Tax Information
It is the present policy of the Fund to make at least one distribution annually (normally in December) of all or substantially all of its net investment income and to distribute annually all or substantially all of its net realized capital gains. Distributions to shareholders are recorded on the ex-dividend date. Distributions are declared separately for each class of shares. Shareholders may reinvest income and capital gain distributions in additional shares of the same class of the Fund at the net asset value as of the ex-dividend date or, at the election of the shareholder, receive distributions in cash. Distributions to shareholders are determined in accordance with income tax regulations, which may differ from U.S. GAAP. As required by U.S. GAAP, only distributions in excess of tax basis earnings and profits are reported in the financial statements as a return of capital. Permanent differences between book and tax accounting relating to distributions are reclassified to paid-in capital. For tax purposes, distributions from short-term capital gains are considered to be from ordinary income.
Eaton Vance
China Equity Fund
August 31, 2026
Notes to Financial Statements — continued
The tax character of distributions declared for the years ended August 31, 2026 and August 31, 2025 was as follows:
During the year ended August 31, 2026, distributable earnings was decreased by $12,096 and paid-in capital was increased by $12,096 due to the Fund’s use of equalization accounting. Tax equalization accounting allows the Fund to treat as a distribution that portion of redemption proceeds representing a redeeming shareholder’s portion of undistributed taxable income and net capital gains. These reclassifications had no effect on the net assets or net asset value per share of the Fund.
As of August 31, 2026, the components of distributable earnings (accumulated loss) on a tax basis were as follows:
Undistributed ordinary income |
|
| |
|
Net unrealized appreciation |
|
| |
|
At August 31, 2026, the Fund, for federal income tax purposes, had deferred capital losses of $6,449,394 which would reduce its taxable income arising from future net realized gains on investment transactions, if any, to the extent permitted by the Internal Revenue Code, and thus would reduce the amount of distributions to shareholders, which would otherwise be necessary to relieve the Fund of any liability for federal income or excise tax. The deferred capital losses are treated as arising on the first day of the Fund’s next taxable year and retain the same short-term or long-term character as when originally deferred. Of the deferred capital losses at August 31, 2026, $3,202,189 are short-term and $3,247,205 are long-term.
The cost and unrealized appreciation (depreciation) of investments of the Fund at August 31, 2026, as determined on a federal income tax basis, were as follows:
| |
|
Gross unrealized appreciation |
|
Gross unrealized depreciation |
|
Net unrealized appreciation |
|
3 Investment Adviser Fee and Other Transactions with Affiliates
The investment adviser fee is earned by Boston Management and Research (BMR), an indirect, wholly-owned subsidiary of Morgan Stanley, as compensation for investment advisory services rendered to the Fund. The fee is computed at an annual rate as a percentage of average daily net assets as follows and is payable monthly:
| |
|
| |
|
$500 million but less than $1 billion |
|
$1 billion but less than $1.5 billion |
|
$1.5 billion but less than $2 billion |
|
$2 billion but less than $3 billion |
|
| |
|
For the year ended August 31, 2026, the investment adviser fee amounted to $291,277 or 0.75% of the Fund's average daily net assets. Pursuant to an investment sub-advisory agreement, BMR has delegated the investment management of the Fund to Morgan Stanley Investment Management Company
Eaton Vance
China Equity Fund
August 31, 2026
Notes to Financial Statements — continued
(MSIM Company), a wholly-owned subsidiary of Morgan Stanley. MSIM Company uses the portfolio management, research and other resources of its affiliate, Morgan Stanley Asia Limited (MSAL), in rendering investment advisory services to the Fund. MSAL has entered into a Memorandum of Understanding with MSIM Company pursuant to which MSAL is considered a participating affiliate of the sub-adviser as that term is used in relief granted by the staff of the U.S. Securities and Exchange Commission allowing U.S. registered investment advisers to use portfolio management or research resources of unregistered advisory affiliates subject to the supervision of a U.S. registered adviser. BMR pays MSIM Company a portion of its investment adviser fee for sub-advisory services provided to the Fund. The Fund may invest in a money market fund, the Institutional Class of the Morgan Stanley Institutional Liquidity Funds - Government Portfolio (the “Liquidity Fund”), an open-end management investment company managed by Morgan Stanley Investment Management Inc., a wholly-owned subsidiary of Morgan Stanley. The investment adviser fee paid by the Fund is reduced by an amount equal to its pro rata share of the advisory and administration fees paid by the Fund due to its investment in the Liquidity Fund. For the year ended August 31, 2026, the investment adviser fee paid was reduced by $1,593 relating to the Fund’s investment in the Liquidity Fund.
The administration fee is earned by Eaton Vance Management (EVM), an affiliate of BMR and an indirect, wholly-owned subsidiary of Morgan Stanley, for administering the business affairs of the Fund and is computed at an annual rate of 0.15% of the Fund’s average daily net assets. For the year ended August 31, 2026, the administration fee amounted to $58,255.
EVM and MSIM Company have agreed to reimburse the Fund’s expenses to the extent that total annual operating expenses (relating to ordinary operating expenses only and excluding expenses such as brokerage commissions, acquired fund fees and expenses of unaffiliated funds, borrowing costs, taxes or litigation expenses) exceed 1.50%, 2.25% and 1.25% of the Fund’s average daily net assets for Class A, Class C and Class I, respectively. This agreement may be changed or terminated after January 1, 2027. Pursuant to this agreement, EVM and MSIM Company were allocated $188,336 in total of the Fund’s operating expenses for the year ended August 31, 2026.
EVM provides sub-transfer agency and related services to the Fund pursuant to a Sub-Transfer Agency Support Services Agreement. For the year ended August 31, 2026, EVM earned $34,092 from the Fund pursuant to such agreement, which is included in transfer and dividend disbursing agent fees on
the Statement of Operations. The Fund was informed that Eaton Vance Distributors, Inc. (EVD), an affiliate of EVM and the Fund’s principal underwriter,
received $151 as its portion of the sales charge on sales of Class A shares for the year ended August 31, 2026. EVD also received distribution and service fees from Class A and Class C shares (see Note 4).
Trustees and officers of the Fund who are members of EVM’s or BMR's organizations receive remuneration for their services to the Fund out of the investment adviser fee. Trustees of the Fund who are not affiliated with the investment adviser and administrator may elect to defer receipt of all or a percentage of their annual fees in accordance with the terms of the Trustees Deferred Compensation Plan. Certain officers and Trustees of the Fund are officers of the above organizations.
The Fund has in effect a distribution plan for Class A shares (Class A Plan) pursuant to Rule 12b-1 under the 1940 Act. Pursuant to the Class A Plan, the Fund pays EVD a distribution and service fee of 0.25% per annum of its average daily net assets attributable to Class A shares for distribution services and facilities provided to the Fund by EVD, as well as for personal services and/or the maintenance of shareholder accounts. Distribution and service fees paid or accrued to EVD for the year ended August 31, 2026 amounted to $86,352 for Class A shares.
The Fund also has in effect a distribution plan for Class C shares (Class C Plan) pursuant to Rule 12b-1 under the 1940 Act. Pursuant to the Class C Plan, the Fund pays EVD amounts equal to 0.75% per annum of its average daily net assets attributable to Class C shares for providing ongoing distribution services and facilities to the Fund. For the year ended August 31, 2026, the Fund paid or accrued to EVD $2,808 for Class C shares.
Pursuant to the Class C Plan, the Fund also makes payments of service fees to EVD, financial intermediaries and other persons in amounts equal to 0.25% per annum of its average daily net assets attributable to that class. Service fees paid or accrued are for personal services and/or the maintenance of shareholder accounts. They are separate and distinct from the sales commissions and distribution fees payable to EVD. Service fees paid or accrued for the year ended August 31, 2026 amounted to $936 for Class C shares.
Distribution and service fees are subject to the limitations contained in the Financial Industry Regulatory Authority Rule 2341(d).
5 Contingent Deferred Sales Charges
A contingent deferred sales charge (CDSC) of 1% generally is imposed on redemptions of Class C shares made within 12 months of purchase. Class A shares may be subject to a 1% CDSC if redeemed within 12 months of purchase (depending on the circumstances of purchase). Generally, the CDSC is based upon the lower of the net asset value at date of redemption or date of purchase. No charge is levied on shares acquired by reinvestment of dividends or capital gain distributions. For the year ended August 31, 2026, the Fund was informed that EVD received no CDSCs paid by Class A and Class C shareholders.
Eaton Vance
China Equity Fund
August 31, 2026
Notes to Financial Statements — continued
6 Purchases and Sales of Investments
Purchases and sales of investments, other than short-term obligations, aggregated $12,646,155 and $17,006,983, respectively, for the year ended August 31, 2026.
7 Shares of Beneficial Interest
The Fund’s Declaration of Trust permits the Trustees to issue an unlimited number of full and fractional shares of beneficial interest (without par value). Such shares may be issued in a number of different series (such as the Fund) and classes. Transactions in Fund shares, including direct exchanges pursuant to share class conversions, were as follows:
| |
Year Ended
August 31, 2026 |
Year Ended
August 31, 2025 |
| |
|
|
|
|
| |
|
|
|
|
| |
|
|
|
|
Issued to shareholders electing to receive payments of distributions in Fund shares |
|
|
|
|
| |
|
|
|
|
| |
|
|
|
|
| |
|
|
|
|
| |
|
|
|
|
Issued to shareholders electing to receive payments of distributions in Fund shares |
|
|
|
|
| |
|
|
|
|
| |
|
|
|
|
| |
|
|
|
|
| |
|
|
|
|
Issued to shareholders electing to receive payments of distributions in Fund shares |
|
|
|
|
| |
|
|
|
|
| |
|
|
|
|
The Fund may trade in financial instruments with off-balance sheet risk in the normal course of its investing activities. These financial instruments may include futures contracts and may involve, to a varying degree, elements of risk in excess of the amounts recognized for financial statement purposes. The notional or contractual amounts of these instruments represent the investment the Fund has in particular classes of financial instruments and do not necessarily represent the amounts potentially subject to risk. The measurement of the risks associated with these instruments is meaningful only when all related and offsetting transactions are considered. At August 31, 2026, there were no obligations outstanding under these financial instruments.
The Fund is subject to equity price risk in the normal course of pursuing its investment objective. During the year ended August 31, 2026, the Fund entered into equity index futures contracts to manage cash flows.
Eaton Vance
China Equity Fund
August 31, 2026
Notes to Financial Statements — continued
The effect of derivative instruments (not considered to be hedging instruments for accounting disclosure purposes) on the Statement of Operations and whose primary underlying risk exposure is equity price risk for the year ended August 31, 2026 was as follows:
| |
Realized Gain (Loss)
on Derivatives Recognized
in Income |
Change in Unrealized
Appreciation (Depreciation) on
Derivatives Recognized in Income |
| |
|
|
| |
Statement of Operations location: Net realized gain (loss): Futures contracts. |
| |
Statement of Operations location: Change in unrealized appreciation (depreciation): Futures contracts. |
The average notional cost of futures contracts (long) outstanding during the year ended August 31, 2026, which is indicative of the volume of this derivative type, was approximately $454,000.
The Fund participates with other portfolios and funds managed by EVM and its affiliates in a $650 million unsecured revolving line of credit agreement with a group of banks, which is in effect through October 20, 2026. Borrowings are made by the Fund solely for temporary purposes related to redemptions and other short-term cash needs. Interest is charged to the Fund based on its borrowings generally at an amount above either the Secured Overnight Financing Rate (SOFR) or Federal Funds rate. In addition, a fee computed at an annual rate of 0.15% on the daily unused portion of the line of credit is allocated among the participating portfolios and funds at the end of each quarter. In connection with the renewal of the agreement in October 2025, an arrangement fee of $150,000 was incurred that was allocated to the participating portfolios and funds. Because the line of credit is not available exclusively to the Fund, it may be unable to borrow some or all of its requested amounts at any particular time. At August 31, 2026, the Fund had a balance outstanding pursuant to this line of credit of $10,000 at an annual interest rate of 4.63%. Based on the short-term nature of the borrowings under the line of credit and variable interest rate, the carrying value of the borrowings approximated its fair value at August 31, 2026. If measured at fair value, borrowings under the line of credit would have been considered as Level 2 in the fair value hierarchy (see Note 12) at August 31, 2026. The Fund’s average borrowings and allocated fees for the year ended August 31, 2026 were not significant.
10 Securities Lending Agreement
The Fund has established a securities lending agreement with State Street Bank and Trust Company (SSBT) as securities lending agent in which the Fund lends portfolio securities to qualified borrowers in exchange for collateral consisting of either cash or securities issued or guaranteed by the U.S. government or its agencies or instrumentalities in an amount at least equal to the market value of the securities on loan. The market value of securities loaned is determined daily and any additional required collateral is delivered to the Fund on the next business day. Cash collateral is invested in the State Street Navigator Securities Lending Government Money Market Portfolio, a money market fund registered under the 1940 Act. The Fund earns interest on the amount invested but it must pay (and at times receive from) the broker a loan rebate fee computed as a varying percentage of the collateral received. For security loans secured by non-cash collateral, the Fund earns a negotiated lending fee from the borrower. A portion of the income earned by the Fund from its investment of cash collateral, net of rebate fees, and lending fees received is allocated to SSBT for its services as lending agent and the portion allocated to the Fund is presented as securities lending income, net on the Statement of Operations. Non-cash collateral is held by the lending agent on behalf of the Fund and cannot be sold or re-pledged by the Fund; accordingly, such collateral is not reflected in the Statement of Assets and Liabilities.
The Fund is subject to possible delay in the recovery of loaned securities. Pursuant to the securities lending agreement, SSBT has provided indemnification to the Fund in the event of default by a borrower with respect to a loan. The Fund bears the risk of loss with respect to the investment of cash collateral.
At August 31, 2026, the value of the securities loaned and the value of the collateral received, which exceeded the value of the securities loaned, amounted to $1,725,577 and $1,824,740, respectively. Collateral received was comprised of U.S. Government and/or agencies securities. The securities lending transactions have no contractual maturity date and each of the Fund and borrower has the option to terminate a loan at any time.
Eaton Vance
China Equity Fund
August 31, 2026
Notes to Financial Statements — continued
11 Affiliated Investments
At August 31, 2026, the value of the Fund's investment in funds that may be deemed to be affiliated was $3,539, which represents less than 0.05% of the Fund's net assets. Transactions in such investments by the Fund for the year ended August 31, 2026 were as follows:
| |
Value,
beginning
of period |
|
|
|
Change in
unrealized
appreciation
(depreciation) |
|
|
|
| |
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
12 Fair Value Measurements
Under generally accepted accounting principles for fair value measurements, a three-tier hierarchy to prioritize the assumptions, referred to as inputs, is used in valuation techniques to measure fair value. The three-tier hierarchy of inputs is summarized in the three broad levels listed below.
• Level 1 – quoted prices in active markets for identical investments
• Level 2 – other significant observable inputs (including quoted prices for similar investments, interest rates, prepayment speeds, credit risk, etc.)
• Level 3 – significant unobservable inputs (including a fund's own assumptions in determining the fair value of investments)
In cases where the inputs used to measure fair value fall in different levels of the fair value hierarchy, the level disclosed is determined based on the lowest level input that is significant to the fair value measurement in its entirety. The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.
At August 31, 2026, the hierarchy of inputs used in valuing the Fund's investments, which are carried at fair value, were as follows:
| |
Includes foreign equity securities whose values were adjusted to reflect market trading of comparable securities or other correlated instruments that occurred after the close of trading in their applicable foreign markets. |
Eaton Vance
China Equity Fund
August 31, 2026
Notes to Financial Statements — continued
13 Risks and Uncertainties
Risks Associated with Foreign Investments
Foreign investments can be adversely affected by political, economic and market developments abroad, including the imposition of economic and other sanctions by the United States or another country, and by acts of terrorism and war. There may be less publicly available information about foreign issuers because they may not be subject to reporting practices, requirements or regulations comparable to those to which United States companies are subject. Foreign markets may be smaller, less liquid and more volatile than the major markets in the United States. Trading in foreign markets typically involves higher expense than trading in the United States. The Fund may have difficulties enforcing its legal or contractual rights in a foreign country. Securities that trade or are denominated in currencies other than the U.S. dollar may be adversely affected by fluctuations in currency exchange rates.
The securities markets in the China region, which includes Hong Kong, are impacted by the economies of countries in the region, which differ from the U.S. economy in various ways, such as structure, general development, government involvement, wealth distribution, interest rates, rate of growth of gross national product, rate of inflation, capital reinvestment, resource self-sufficiency and balance of payments position. As export-driven economies, the economies of countries in the China region are affected by developments in the economies and governmental actions of their principal trading partners, such as the imposition of trading restrictions and tariffs. China’s governmental actions and the actions of other governments can also have a significant effect on the economic conditions in the China region or a particular issuer or industry, which could adversely affect the value and liquidity of investments. A government may restrict investment in companies or industries considered important to national interests, intervene in the financial markets, maintain strict currency controls, or impose repatriation restrictions. An increase in tariffs or trade restrictions, or even the threat of such developments, could lead to a significant reduction in international trade, which could have a negative impact on the Fund. Although larger and/or more established than many emerging markets, markets in the China region carry the high levels of risk associated with emerging markets.
Eaton Vance
China Equity Fund
August 31, 2026
Report of Independent Registered Public Accounting Firm
To the Trustees of Eaton Vance Growth Trust and Shareholders of Eaton Vance China Equity Fund:
Opinion on the Financial Statements and Financial Highlights
We have audited the accompanying statement of assets and liabilities of Eaton Vance China Equity Fund (the “Fund”) (one of the funds constituting Eaton Vance Growth Trust), including the portfolio of investments, as of August 31, 2026, the related statement of operations for the year then ended, the statements of changes in net assets for each of the two years in the period then ended, the financial highlights for each of the five years in the period then ended, and the related notes (collectively referred to as the “financial statements and financial highlights”). In our opinion, the financial statements and financial highlights present fairly, in all material respects, the financial position of the Fund as of August 31, 2026, and the results of its operations for the year then ended, the changes in its net assets for each of the two years in the period then ended, and the financial highlights for each of the five years in the period then ended, in conformity with accounting principles generally accepted in the United States of America.
These financial statements and financial highlights are the responsibility of the Fund's management. Our responsibility is to express an opinion on the Fund's financial statements and financial highlights based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Fund in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements and financial highlights are free of material misstatement, whether due to error or fraud. The Fund is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Fund’s internal control over financial reporting. Accordingly, we express no such opinion.
Our audits included performing procedures to assess the risks of material misstatement of the financial statements and financial highlights, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements and financial highlights. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements and financial highlights. Our procedures included confirmation of securities owned as of August 31, 2026, by correspondence with the custodian and brokers; when replies were not received from brokers, we performed other auditing procedures. We believe that our audits provide a reasonable basis for our opinion.
/s/ Deloitte & Touche LLP
Boston, Massachusetts
October 19, 2026
We have served as the auditor of one or more Eaton Vance investment companies since 1959.
Eaton Vance
China Equity Fund
August 31, 2026
Federal Tax Information (Unaudited)
The Form 1099-DIV you receive in February 2027 will show the tax status of all distributions paid to your account in calendar year 2026. Shareholders
are advised to consult their own tax adviser with respect to the tax consequences of their investment in the Fund. As required by the Internal Revenue Code and/or regulations, shareholders must be notified regarding the status of qualified dividend income for individuals and the foreign tax credit.
Qualified Dividend Income. For the fiscal year ended August 31, 2026, the Fund designates approximately $618,431, or up to the maximum amount of such dividends allowable pursuant to the Internal Revenue Code, as qualified dividend income eligible for the reduced tax rate of 15%.
Foreign Tax Credit. For the fiscal year ended August 31, 2026, the Fund paid foreign taxes of $61,805 and recognized foreign source income of $843,995.
Eaton Vance
China Equity Fund
August 31, 2026
Board of Trustees’ Contract Approval
Overview of the Contract Review Process
The Investment Company Act of 1940, as amended (the “1940 Act”), provides, in substance, that the investment advisory agreement between a fund and its investment adviser will continue in effect from year-to-year only if its continuation is approved on an annual basis by a vote of the fund’s board of trustees, including a majority of the trustees who are not “interested persons” of the fund (“independent trustees”), cast in person at a meeting called for the purpose of considering such approval.
At a meeting held on June 11, 2026, the Boards of Trustees/Directors (collectively, the “Board”) that oversee the registered investment companies advised by Eaton Vance Management or its affiliate, Boston Management and Research (the “Eaton Vance Funds”), including a majority of the independent trustees (the “Independent Trustees”), voted to approve the continuation of existing investment advisory agreements and sub-advisory agreements1 for each of the Eaton Vance Funds for an additional one-year period. The Board relied upon the affirmative recommendation of its Contract Review Committee, which is a committee comprised of all of the Independent Trustees. Prior to making its recommendation, the Contract Review Committee reviewed information furnished by the adviser and sub-adviser to each of the Eaton Vance Funds (including information specifically requested by the Board) for a series of meetings held between April and June 2026, as well as certain additional information provided in response to specific requests from the Independent Trustees as members of the Contract Review Committee. Members of the Contract Review Committee also considered information received at prior meetings of the Board and its committees, to the extent such information was relevant to the Contract Review Committee’s annual evaluation of the investment advisory agreements and sub-advisory agreements.
In connection with its evaluation of the investment advisory agreements and sub-advisory agreements, the Board (directly or through one or more of its committees) considered various information relating to the Eaton Vance Funds. This included information applicable to all or groups of the Eaton Vance Funds, which is referenced immediately below, and information applicable to the particular Eaton Vance Fund covered by this report (each Eaton Vance Fund is referred to below as a “fund”). (For funds that invest through one or more underlying portfolios, references to “each fund” in this section may include information that was considered at the portfolio-level.)
Information about Fees, Performance and Expenses
• A report from an independent data provider comparing advisory and other fees paid by each fund to such fees paid by comparable funds, as identified by the independent data provider (“comparable funds”);
• A report from an independent data provider comparing each fund’s total expense ratio (and its components) to those of comparable funds;
• A report from an independent data provider comparing the investment performance of each fund to the investment performance of comparable funds and, as applicable, benchmark indices, over various time periods;
• In certain instances, data regarding investment performance relative to customized groups of peer funds and blended indices identified by the adviser in consultation with the Portfolio Management Committee of the Board (a committee exclusively comprised of Independent Trustees);
• Comparative information concerning the fees charged and services provided by the adviser and sub-adviser to each fund in managing other accounts (which may include other funds, collective investment trusts and institutional accounts) with the same or substantially similar investment objective as the fund and with a significant overlap in holdings based on criteria set by the Board, if any;
• Profitability analyses on a fund-by-fund basis for the adviser and its affiliates and the cost allocation methodology used to determine such analyses;
Information about Portfolio Management and Trading
• Descriptions of the investment management services provided to each fund, as well as each of the funds’ investment strategies and policies;
• The procedures and processes used by the adviser to determine the value of fund assets, including, when necessary, the determination of “fair value” by the adviser in its role as each fund’s valuation designee and actions taken to monitor and test the effectiveness of such procedures and processes;
• Information about the policies and practices of each fund’s adviser and sub-adviser with respect to trading, including their processes for seeking best execution of portfolio transactions;
• Information about the allocation of brokerage transactions and the benefits, if any, received by the adviser and sub-adviser to each fund as a result of brokerage allocation, including, as applicable, information concerning the acquisition of research through client commission arrangements and policies with respect to “soft dollars”;
• Data relating to the portfolio turnover rate of each fund and related information regarding active management in the context of particular strategies;
Information about each Adviser and Sub-Adviser
• Information regarding the individual investment professionals whose responsibilities include portfolio management and investment research for the funds, and, for portfolio managers and certain other investment professionals, information relating to their responsibilities with respect to managing other funds and investment accounts, as applicable;
1 Not all Eaton Vance Funds have entered into a sub-advisory agreement with a sub-adviser. Accordingly, references to “sub-adviser” or “sub-advisory agreement” in this “Overview” section may not be applicable to the particular Eaton Vance Fund covered by this report. Eaton Vance Management and Boston Management and Research are referred to collectively as the “adviser.”
Eaton Vance
China Equity Fund
August 31, 2026
Board of Trustees’ Contract Approval — continued
• Information regarding the adviser’s and its parent company’s (Morgan Stanley’s) efforts to retain and attract talented investment professionals, including in the context of a competitive marketplace for talent;
• Information regarding the adviser’s compensation methodology for its investment professionals and the incentives and accountability it creates, along with investment professionals’ investments in the fund(s) they manage;
• The personal trading codes of ethics of the adviser and its affiliates and the sub-adviser of each fund, together with information relating to compliance with, and the administration of, such codes;
• Policies and procedures relating to proxy voting, including regular reporting with respect to fund proxy voting activities;
• Information regarding the handling of corporate actions and class actions, as well as information regarding litigation and other regulatory matters;
• Information concerning the resources devoted to compliance efforts undertaken by the adviser and its affiliates and the sub-adviser of each fund, including descriptions of their various compliance programs and their record of compliance and remediation;
• Information concerning the business continuity and disaster recovery plans of the adviser and its affiliates and the sub-adviser of each fund;
• A description of the adviser’s oversight of sub-advisers, including with respect to regulatory and compliance issues, investment management and other matters, if any;
Other Relevant Information
• Information regarding ongoing initiatives to further integrate and harmonize, where applicable, the investment management and other departments of the adviser and its affiliates with the overall investment management infrastructure of Morgan Stanley, in light of Morgan Stanley’s acquisition of Eaton Vance Corp. on March 1, 2021;
• Information concerning the nature, cost, and character of the administrative and other non-investment advisory services provided by the adviser and its affiliates;
• Information concerning oversight of the relationship with the custodian, subcustodians, fund accountants, and other third-party service providers by the adviser and/or administrator to each of the funds;
• Information concerning efforts to maintain policies and procedures with respect to various regulations applicable to the funds, including, without limitation, Rule 22e-4 (the Liquidity Risk Management Rule), Rule 12d1-4 (the Fund-of-Funds Rule), Rule 18f-4 (the Derivatives Rule), and Rule 2a-5 (the Fair Valuation Rule);
• For each Eaton Vance Fund structured as an exchange-listed closed-end fund, information concerning the benefits of the closed-end fund structure, as well as, where relevant, the closed-end fund’s market prices (including as compared to the closed-end fund’s net asset value (NAV)), trading volume data, continued use of auction preferred shares (where applicable), distribution rates, and other relevant matters;
• The risks that the adviser and/or its affiliates incur in connection with the management and operation of the funds, including, among others, litigation, regulatory, entrepreneurial, data privacy and cybersecurity, and other business risks (and the associated costs of such risks, if any); and
• The terms of each investment advisory agreement and sub-advisory agreement.
During the various meetings of the Board and its committees over the course of the year leading up to the June 11, 2026 meeting, the Board and its committees received information from portfolio managers and other investment professionals of the adviser and sub-advisers of the funds regarding investment and performance matters, and considered various investment and trading strategies used in pursuing the funds’ investment objectives. The Board and its committees also received information regarding risk management techniques employed in connection with the management of the funds. The Board and its committees evaluated issues pertaining to industry and regulatory developments, compliance procedures, fund governance, and other issues with respect to the funds, and received and participated in reports and presentations provided by the adviser, sub-advisers, and certain other service providers, with respect to such matters. In addition to the formal meetings of the Board and its committees, the Independent Trustees met in executive sessions and held regular video or telephone conferences to discuss, among other topics, matters relating to the continuation of investment advisory agreements and sub-advisory agreements.
Each of the Contract Review Committee and the Board was advised throughout the contract review process by Kirkland & Ellis LLP, independent legal counsel for the Independent Trustees. The members of the Contract Review Committee and the members of the Board, with the advice of such counsel, exercised their own business judgment in determining the material factors to be considered in evaluating each investment advisory agreement and sub-advisory agreement and the weight to be given to each such factor. The conclusions reached with respect to each investment advisory agreement and sub-advisory agreement were based on a comprehensive evaluation of all the information provided and not any single factor. Moreover, each member of the Contract Review Committee and Board may have placed varying emphasis on particular factors in reaching conclusions with respect to each investment advisory agreement and sub-advisory agreement. In evaluating each investment advisory agreement and sub-advisory agreement, including the fee structures and other terms contained in such agreements, the members of the Contract Review Committee and Board were also informed by multiple years of analysis and discussion with the adviser and sub-adviser to each of the Eaton Vance Funds.
Results of the Contract Review Process
Based on its consideration of the foregoing, and such other information it deemed relevant, including the factors and conclusions described below, the Contract Review Committee concluded that the continuation of the investment advisory agreement between Eaton Vance China Equity Fund (the “Fund”) and Boston Management and Research (the “Adviser”) and the sub-advisory agreement between the Adviser and Morgan Stanley Investment Management
Eaton Vance
China Equity Fund
August 31, 2026
Board of Trustees’ Contract Approval — continued
Company (the “Sub-adviser”), an affiliate of the Adviser, with respect to the Fund, including their respective fee structures, are in the interests of shareholders and, therefore, recommended to the Board approval of each agreement. Based on the recommendation of the Contract Review Committee, the Board, including a majority of the Independent Trustees, voted to approve continuation of the investment advisory agreement and the sub-advisory agreement for the Fund.
Nature, Extent and Quality of Services
In considering whether to approve the investment advisory agreement and the sub-advisory agreement for the Fund, the Board evaluated the nature, extent and quality of services provided to the Fund by the Adviser and the Sub-adviser.
The Board considered the Adviser’s and the Sub-adviser’s management capabilities and investment processes in light of the types of investments held by the Fund, including the education and experience of the investment professionals who provide services to the Fund, including recent changes to such personnel. Regarding the Adviser, the Board considered the Adviser’s responsibilities with respect to oversight of the Sub-adviser. With respect to the Sub-adviser, the Board took into account the resources available to the Sub-adviser in fulfilling its duties under the sub-advisory agreement and the Sub-adviser’s experience in managing equity portfolios. The Board also took into account the resources dedicated to portfolio management and other services, the compensation methods of the Adviser and other factors, including the reputation and resources of the Adviser to recruit and retain highly qualified research, advisory and supervisory investment professionals. In addition, the Board considered the time and attention devoted to the Eaton Vance Funds, including the Fund, by senior management, as well as the infrastructure, operational capabilities and support staff in place to assist in the portfolio management and operations of the Fund, including the provision of administrative services. The Board also considered the business-related and other risks to which the Adviser or its affiliates may be subject in managing the Fund.
The Board considered the compliance programs of the Adviser and relevant affiliates thereof, including the Sub-adviser. The Board considered compliance and reporting matters regarding, among other things, personal trading by investment professionals, disclosure of portfolio holdings, compliance with policies and procedures, portfolio valuation, business continuity and the allocation of investment opportunities. The Board also considered relevant examinations of the Adviser and its affiliates by regulatory authorities, such as the Securities and Exchange Commission and the Financial Industry Regulatory Authority.
The Board considered other administrative services provided or overseen by Eaton Vance Management and its affiliates, including transfer agency and accounting services. The Board evaluated the benefits to shareholders of investing in a fund that is a part of a large fund complex offering exposure to a variety of asset classes and investment disciplines, as well as the ability, in many cases, to exchange an investment among different funds without incurring additional sales charges.
After consideration of the foregoing factors, among others, the Board concluded that the nature, extent and quality of services provided by the Adviser and the Sub-adviser, taken as a whole, are appropriate and consistent with the terms of the investment advisory agreement and the sub-advisory agreement.
The Board compared the Fund’s investment performance to that of comparable funds identified by an independent data provider (the peer group), as well as an appropriate benchmark index. The Board’s review included comparative performance data with respect to the Fund for the one-, three-, five- and ten-year periods ended December 31, 2025. In this regard, the Board noted that the performance of the Fund was lower than the median performance of the Fund’s peer group for the three-year period. The Board also noted that the performance of the Fund was lower than its benchmark index for the three-year period. On the basis of the foregoing, the performance of the Fund over other periods, and other relevant information provided by the Adviser in response to requests from the Contract Review Committee, the Board concluded that the performance of the Fund was satisfactory.
Management Fees and Expenses
The Board considered contractual fee rates payable by the Fund for advisory and administrative services (referred to collectively as “management fees”). As part of its review, the Board considered the Fund’s management fees and total expense ratio for the one-year period ended December 31, 2025, as compared to those of comparable funds, before and after giving effect to any undertaking to waive fees or reimburse expenses. The Board also considered certain factors identified by management in response to requests from the Contract Review Committee regarding the Fund’s total expense ratio relative to comparable funds.
After considering the foregoing information, and in light of the nature, extent and quality of the services provided by the Adviser and the Sub-adviser, the Board concluded that the management fees charged for advisory and related services are reasonable.
Profitability and “Fall-Out” Benefits
The Board considered the level of profits realized by the Adviser and relevant affiliates thereof, including the Sub-adviser, in providing investment advisory and administrative services to the Fund and to all Eaton Vance Funds as a group. The Board considered the level of profits realized without regard to marketing support or other payments by the Adviser and its affiliates to third parties in respect of distribution or other services.
Eaton Vance
China Equity Fund
August 31, 2026
Board of Trustees’ Contract Approval — continued
The Board concluded that, in light of the foregoing factors and the nature, extent and quality of the services rendered, the profits realized by the Adviser and its affiliates, including the Sub-adviser, are not excessive.
The Board also considered direct and indirect fall-out benefits received by the Adviser and its affiliates, including the Sub-adviser, in connection with their respective relationships with the Fund and the other Eaton Vance Funds, including, among other things, fees for trading, distribution and/or shareholder servicing and for transaction processing and reporting platforms used by securities lending agent(s), and research received by the Adviser and/or the Sub-adviser generated from commission dollars spent on funds’ portfolio trading.
In reviewing management fees and profitability, the Board also considered the extent to which the Adviser and its affiliates, on the one hand, and the Fund, on the other hand, can expect to realize benefits from economies of scale as the assets of the Fund increase. The Board acknowledged the difficulty in accurately measuring the benefits resulting from economies of scale, if any, with respect to the management of any specific fund or group of funds. To assist in the evaluation of the sharing of any economies of scale, the Board received data for recent years showing asset levels, Adviser profitability and total expense ratios. Based upon the foregoing, the Board concluded that the Fund currently shares in the benefits from economies of scale, if any, when they are realized by the Adviser. The Board also concluded that the structure of the advisory fee, which includes breakpoints at several asset levels, will allow the Fund to continue to benefit from any economies of scale in the future.
Eaton Vance
Worldwide Health Sciences Fund
Annual Financial Statements and
Additional Information
This report must be preceded or accompanied by a current summary prospectus or prospectus. Before investing, investors should consider carefully the investment objective, risks, and charges and expenses of a mutual fund. This and other important information is contained in the prospectus and/or statement of additional information, which can be obtained by calling 1-800-262-1122 or from a financial intermediary. Prospective investors should read the prospectus carefully before investing.
Annual Financial Statements and Additional Information August 31, 2026
Eaton Vance
Worldwide Health Sciences Fund
Items 8 and 9 of Form N-CSR are Not Applicable. For Item 10 of Form N-CSR, see Item 7.
Eaton Vance
Worldwide Health Sciences Fund
August 31, 2026
| |
|
|
| |
| |
|
|
|
| |
|
|
|
Caris Life Sciences, Inc.(1) |
|
|
|
Generate Biomedicines, Inc.(1) |
|
|
|
| |
|
|
|
| |
|
|
|
Neurocrine Biosciences, Inc.(1) |
|
|
|
NewAmsterdam Pharma Co. NV(1) |
|
|
|
Vertex Pharmaceuticals, Inc.(1) |
|
|
|
Xenon Pharmaceuticals, Inc.(1) |
|
|
|
| |
|
|
|
Health Care Equipment — 11.5% |
| |
|
|
|
Fisher & Paykel Healthcare Corp. Ltd., Class C |
|
|
|
Intuitive Surgical, Inc.(1) |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
Health Care Services — 3.6% |
| |
|
|
|
| |
|
|
|
| |
|
|
|
Health Care Supplies — 2.0% |
| |
|
|
|
| |
|
|
|
Medline, Inc., Class A(1) |
|
|
|
| |
|
|
|
Health Care Technology — 1.4% |
| |
|
|
|
| |
|
|
|
Life Sciences Tools & Services — 8.6% |
| |
|
|
|
| |
|
|
|
| |
|
|
Life Sciences Tools & Services (continued) |
Mettler-Toledo International, Inc.(1) |
|
|
|
Thermo Fisher Scientific, Inc. |
|
|
|
| |
|
|
|
Managed Health Care — 5.3% |
| |
|
|
|
| |
|
|
|
| |
| |
|
|
|
| |
|
|
|
| |
|
|
|
Enliven Therapeutics, Inc.(1) |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
Royalty Pharma PLC, Class A |
|
|
|
| |
|
|
|
| |
|
|
|
Total Common Stocks
(identified cost $436,476,973) |
|
|
|
Short-Term Investments — 0.7% |
| |
|
|
Morgan Stanley Institutional Liquidity Funds - Government Portfolio, Institutional Class, 3.58%(2) |
|
|
|
Total Short-Term Investments
(identified cost $5,492,356) |
|
|
|
Total Investments — 99.8%
(identified cost $441,969,329) |
|
|
|
Other Assets, Less Liabilities — 0.2% |
|
|
|
| |
|
|
|
The percentage shown for each investment category in the Portfolio of Investments is based on net assets. |
| |
Non-income producing security. |
| |
May be deemed to be an affiliated investment company (see Note 9). The rate shown is the annualized seven-day yield as of August 31, 2026. |
See Notes to Financial Statements.
Eaton Vance
Worldwide Health Sciences Fund
August 31, 2026
Portfolio of Investments — continued
Country Concentration of Portfolio |
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| |
– American Depositary Receipt |
See Notes to Financial Statements.
Eaton Vance
Worldwide Health Sciences Fund
August 31, 2026
Statement of Assets and Liabilities
| |
|
| |
|
Unaffiliated investments, at value (identified cost $436,476,973) |
|
Affiliated investments, at value (identified cost $5,492,356) |
|
| |
|
Dividends receivable from affiliated investments |
|
Receivable for Fund shares sold |
|
| |
|
Trustees' deferred compensation plan |
|
| |
|
| |
|
Payable for Fund shares redeemed |
|
| |
|
| |
|
| |
|
Distribution and service fees |
|
| |
|
Trustees' deferred compensation plan |
|
| |
|
Payable for transfer and dividend disbursing agent fees |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
Net Asset Value and Redemption Price Per Share
(net assets ÷ shares of beneficial interest outstanding) |
|
Maximum Offering Price Per Share
(100 ÷ 94.75 of net asset value per share) |
|
| |
|
| |
|
| |
|
Net Asset Value and Offering Price Per Share*
(net assets ÷ shares of beneficial interest outstanding) |
|
| |
|
| |
|
| |
|
Net Asset Value, Offering Price and Redemption Price Per Share
(net assets ÷ shares of beneficial interest outstanding) |
|
See Notes to Financial Statements.
Eaton Vance
Worldwide Health Sciences Fund
August 31, 2026
Statement of Assets and Liabilities — continued
| |
|
| |
|
| |
|
| |
|
Net Asset Value, Offering Price and Redemption Price Per Share
(net assets ÷ shares of beneficial interest outstanding) |
|
On sales of $50,000 or more, the offering price of Class A shares is reduced. |
| |
Redemption price per share is equal to the net asset value less any applicable contingent deferred sales charge. |
See Notes to Financial Statements.
Eaton Vance
Worldwide Health Sciences Fund
August 31, 2026
| |
|
| |
|
| |
|
Dividend income (net of foreign taxes withheld of $539,917) |
|
Dividend income from affiliated investments |
|
| |
|
| |
|
| |
|
| |
|
| |
|
Distribution and service fees: |
|
| |
|
| |
|
| |
|
Trustees’ fees and expenses |
|
| |
|
Transfer and dividend disbursing agent fees |
|
Legal and accounting services |
|
| |
|
| |
|
ReFlow liquidity program fees |
|
| |
|
| |
|
| |
|
Waiver and/or reimbursement of expenses by affiliates |
|
| |
|
| |
|
| |
|
Realized and Unrealized Gain (Loss) |
|
Net realized gain (loss): |
|
| |
|
Foreign currency transactions |
|
| |
|
Change in unrealized appreciation (depreciation): |
|
| |
|
| |
|
Net change in unrealized appreciation (depreciation) |
|
Net realized and unrealized gain |
|
Net increase in net assets from operations |
|
| |
Includes $37,216,305 of net realized gains from redemptions in-kind. |
See Notes to Financial Statements.
Eaton Vance
Worldwide Health Sciences Fund
August 31, 2026
Statements of Changes in Net Assets
| |
|
| |
|
|
Increase (Decrease) in Net Assets |
|
|
| |
|
|
| |
|
|
| |
|
|
Net change in unrealized appreciation (depreciation) |
|
|
Net increase (decrease) in net assets from operations |
|
|
Distributions to shareholders: |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
Total distributions to shareholders |
|
|
Transactions in shares of beneficial interest: |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
Net decrease in net assets from Fund share transactions |
|
|
Net decrease in net assets |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
Includes $37,216,305 of net realized gains from redemptions in-kind. |
See Notes to Financial Statements.
Eaton Vance
Worldwide Health Sciences Fund
August 31, 2026
| |
|
| |
|
| |
|
|
|
|
|
Net asset value — Beginning of year |
|
|
|
|
|
Income (Loss) From Operations |
|
|
|
|
|
| |
|
|
|
|
|
Net realized and unrealized gain (loss) |
|
|
|
|
|
Total income (loss) from operations |
|
|
|
|
|
| |
|
|
|
|
|
From net investment income |
|
|
|
|
|
| |
|
|
|
|
|
| |
|
|
|
|
|
Net asset value — End of year |
|
|
|
|
|
| |
|
|
|
|
|
| |
|
|
|
|
|
Net assets, end of year (000’s omitted) |
|
|
|
|
|
Ratios (as a percentage of average daily net assets):(3) |
|
|
|
|
|
| |
|
|
|
|
|
| |
|
|
|
|
|
| |
|
|
|
|
|
| |
|
|
|
|
|
| |
Computed using average shares outstanding. |
| |
Returns are historical and are calculated by determining the percentage change in net asset value with all distributions reinvested and do not reflect
the effect of sales charges. |
| |
Total expenses do not reflect amounts reimbursed and/or waived by the adviser and administrator and certain of its affiliates, if applicable. Net expenses are net of all reductions and represent the net expenses paid by the Fund. |
| |
Includes a reduction by the investment adviser of a portion of its adviser fee due to the Fund's investment in the Liquidity Fund (equal to less than 0.005% of average daily net assets for the years ended August 31, 2026, 2025, 2024, 2023 and 2022). |
See Notes to Financial Statements.
Eaton Vance
Worldwide Health Sciences Fund
August 31, 2026
Financial Highlights — continued
| |
|
| |
|
| |
|
|
|
|
|
Net asset value — Beginning of year |
|
|
|
|
|
Income (Loss) From Operations |
|
|
|
|
|
| |
|
|
|
|
|
Net realized and unrealized gain (loss) |
|
|
|
|
|
Total income (loss) from operations |
|
|
|
|
|
| |
|
|
|
|
|
| |
|
|
|
|
|
| |
|
|
|
|
|
Net asset value — End of year |
|
|
|
|
|
| |
|
|
|
|
|
| |
|
|
|
|
|
Net assets, end of year (000’s omitted) |
|
|
|
|
|
Ratios (as a percentage of average daily net assets):(3) |
|
|
|
|
|
| |
|
|
|
|
|
| |
|
|
|
|
|
| |
|
|
|
|
|
| |
|
|
|
|
|
| |
Computed using average shares outstanding. |
| |
Returns are historical and are calculated by determining the percentage change in net asset value with all distributions reinvested and do not reflect
the effect of sales charges. |
| |
Total expenses do not reflect amounts reimbursed and/or waived by the adviser and administrator and certain of its affiliates, if applicable. Net expenses are net of all reductions and represent the net expenses paid by the Fund. |
| |
Includes a reduction by the investment adviser of a portion of its adviser fee due to the Fund's investment in the Liquidity Fund (equal to less than 0.005% of average daily net assets for the years ended August 31, 2026, 2025, 2024, 2023 and 2022). |
See Notes to Financial Statements.
Eaton Vance
Worldwide Health Sciences Fund
August 31, 2026
Financial Highlights — continued
| |
|
| |
|
| |
|
|
|
|
|
Net asset value — Beginning of year |
|
|
|
|
|
Income (Loss) From Operations |
|
|
|
|
|
| |
|
|
|
|
|
Net realized and unrealized gain (loss) |
|
|
|
|
|
Total income (loss) from operations |
|
|
|
|
|
| |
|
|
|
|
|
From net investment income |
|
|
|
|
|
| |
|
|
|
|
|
| |
|
|
|
|
|
Net asset value — End of year |
|
|
|
|
|
| |
|
|
|
|
|
| |
|
|
|
|
|
Net assets, end of year (000’s omitted) |
|
|
|
|
|
Ratios (as a percentage of average daily net assets):(3) |
|
|
|
|
|
| |
|
|
|
|
|
| |
|
|
|
|
|
| |
|
|
|
|
|
| |
|
|
|
|
|
| |
Computed using average shares outstanding. |
| |
Returns are historical and are calculated by determining the percentage change in net asset value with all distributions reinvested. |
| |
Total expenses do not reflect amounts reimbursed and/or waived by the adviser and administrator and certain of its affiliates, if applicable. Net expenses are net of all reductions and represent the net expenses paid by the Fund. |
| |
Includes a reduction by the investment adviser of a portion of its adviser fee due to the Fund's investment in the Liquidity Fund (equal to less than 0.005% of average daily net assets for the years ended August 31, 2026, 2025, 2024, 2023 and 2022). |
See Notes to Financial Statements.
Eaton Vance
Worldwide Health Sciences Fund
August 31, 2026
Financial Highlights — continued
| |
|
| |
|
| |
|
|
|
|
|
Net asset value — Beginning of year |
|
|
|
|
|
Income (Loss) From Operations |
|
|
|
|
|
Net investment income (loss)(1) |
|
|
|
|
|
Net realized and unrealized gain (loss) |
|
|
|
|
|
Total income (loss) from operations |
|
|
|
|
|
| |
|
|
|
|
|
From net investment income |
|
|
|
|
|
| |
|
|
|
|
|
| |
|
|
|
|
|
Net asset value — End of year |
|
|
|
|
|
| |
|
|
|
|
|
| |
|
|
|
|
|
Net assets, end of year (000’s omitted) |
|
|
|
|
|
Ratios (as a percentage of average daily net assets):(4) |
|
|
|
|
|
| |
|
|
|
|
|
| |
|
|
|
|
|
Net investment income (loss) |
|
|
|
|
|
| |
|
|
|
|
|
| |
Computed using average shares outstanding. |
| |
Amount is less than $0.005 or $(0.005), as applicable. |
| |
Returns are historical and are calculated by determining the percentage change in net asset value with all distributions reinvested. |
| |
Total expenses do not reflect amounts reimbursed and/or waived by the adviser and administrator and certain of its affiliates, if applicable. Net expenses are net of all reductions and represent the net expenses paid by the Fund. |
| |
Includes a reduction by the investment adviser of a portion of its adviser fee due to the Fund's investment in the Liquidity Fund (equal to less than 0.005% of average daily net assets for the years ended August 31, 2026, 2025, 2024, 2023 and 2022). |
See Notes to Financial Statements.
Eaton Vance
Worldwide Health Sciences Fund
August 31, 2026
Notes to Financial Statements
1 Significant Accounting Policies
Eaton Vance Worldwide Health Sciences Fund (the Fund) is a diversified series of Eaton Vance Growth Trust (the Trust). The Trust is a Massachusetts business trust registered under the Investment Company Act of 1940, as amended (the 1940 Act), as an open-end management investment company. The Fund’s investment objective is to seek long-term capital growth by investing in a worldwide and diversified portfolio of health sciences companies. The Fund offers four classes of shares. Class A shares are generally sold subject to a sales charge imposed at time of purchase. Class C shares are sold at net asset value and are generally subject to a contingent deferred sales charge (see Note 5). Effective November 5, 2020, Class C shares automatically convert to Class A shares eight years after their purchase as described in the Fund’s prospectus. Class I and Class R shares are sold at net asset value and are not subject to a sales charge. Each class represents a pro rata interest in the Fund, but votes separately on class-specific matters and (as noted below) is subject to different expenses. Realized and unrealized gains and losses and net investment income and losses, other than class-specific expenses, are allocated daily to each class of shares based on the relative net assets of each class to the total net assets of the Fund. Each class of shares differs in its distribution plan and certain other class-specific expenses.
The following is a summary of significant accounting policies of the Fund. The policies are in conformity with accounting principles generally accepted in the United States of America (U.S. GAAP). The Fund is an investment company and follows accounting and reporting guidance in the Financial Accounting Standards Board (FASB) Accounting Standards Codification Topic 946.
A Investment Valuation—The following methodologies are used to determine the market value or fair value of investments.
Equity Securities. Equity securities (common stocks and exchange-traded funds) listed on a U.S. securities exchange generally are valued at the last sale or closing price on the day of valuation or, if no sales took place on such date, at the mean between the closing bid and ask prices on the exchange where such securities are principally traded. Equity securities listed on the NASDAQ National Market System are valued at the NASDAQ official closing price. Unlisted or listed securities for which closing sales prices or closing quotations are not available are valued at the mean between the latest available bid and ask prices.
Foreign Securities and Currencies. Foreign securities and currencies are valued in U.S. dollars, based on foreign currency exchange rate quotations supplied by a third party pricing service. The pricing service uses a proprietary model to determine the exchange rate. Inputs to the model include reported trades and implied bid/ask spreads. The daily valuation of exchange-traded foreign securities generally is determined as of the close of trading on the principal exchange on which such securities trade. Events occurring after the close of trading on foreign exchanges may result in adjustments to the valuation of foreign securities to more accurately reflect their fair value as of the close of regular trading on the New York Stock Exchange. When valuing foreign equity securities that meet certain criteria, the Fund's Trustees have approved the use of a fair value service that values such securities to reflect market trading that occurs after the close of the applicable foreign markets of comparable securities or other instruments that have a strong correlation to the fair-valued securities.
Other. Investments in management investment companies (including money market funds) that do not trade on an exchange are valued at the net asset value as of the close of each business day.
Fair Valuation. In connection with Rule 2a-5 of the 1940 Act, the Trustees have designated the Fund’s investment adviser as its valuation designee. Investments for which valuations or market quotations are not readily available or are deemed unreliable are valued by the investment adviser, as valuation designee, at fair value using methods that most fairly reflect the security’s “fair value”, which is the amount that the Fund might reasonably expect to receive for the security upon its current sale in the ordinary course. Each such determination is based on a consideration of relevant factors, which are likely to vary from one pricing context to another. These factors may include, but are not limited to, the type of security, the existence of any contractual restrictions on the security’s disposition, the price and extent of public trading in similar securities of the issuer or of comparable companies or entities, quotations or relevant information obtained from broker/dealers or other market participants, information obtained from the issuer, analysts, and/or the appropriate stock exchange (for exchange-traded securities), an analysis of the company’s or entity’s financial statements, and an evaluation of the forces that influence the issuer and the market(s) in which the security is purchased and sold.
B Investment Transactions—Investment transactions for financial statement purposes are accounted for on a trade date basis. Realized gains and losses on investments sold are determined on the basis of identified cost.
C Income—Dividend income is recorded on the ex-dividend date for dividends received in cash and/or securities. However, if the ex-dividend date has passed, certain dividends from foreign securities are recorded as the Fund is informed of the ex-dividend date. Withholding taxes on foreign dividends and capital gains have been provided for in accordance with the Fund's understanding of the applicable countries’ tax rules and rates. As a result of several court cases in certain countries across the European Union (EU), the Fund filed additional tax reclaims for previously withheld taxes on dividends earned in those countries. Income recognized, if any, for EU reclaims and interest thereon is reflected as other income in the Statement of Operations, and any related receivable, if any, is reflected as European Union tax reclaims receivable in the Statement of Assets and Liabilities. Any fees associated with these filings are reflected in miscellaneous expenses in the Statement of Operations. When uncertainty exists as to the ultimate resolution of these proceedings, the likelihood of receipt of these EU reclaims, and the potential timing of payment, no amounts are reflected in the financial statements. For U.S. income tax purposes, EU reclaims received by the Fund, if any, may reduce the amount of foreign taxes Fund shareholders can use as tax deductions or credits on their income tax returns. In the event that EU reclaims received by the Fund during a fiscal year exceed foreign withholding taxes paid by the Fund, and the Fund previously passed through to its shareholders foreign taxes incurred by the Fund to be used as a credit or deduction on a shareholder’s income tax
Eaton Vance
Worldwide Health Sciences Fund
August 31, 2026
Notes to Financial Statements — continued
return, the Fund may be required to enter into a closing agreement with the Internal Revenue Service in order to pay the associated tax liability on behalf of the Fund’s shareholders. Interest income is recorded on the basis of interest accrued, adjusted for amortization of premium or accretion of discount. Distributions from investment companies are recorded as dividend income, capital gains or return of capital based on the nature of the distribution.
D Federal and Other Taxes—The Fund's policy is to comply with the provisions of the Internal Revenue Code applicable to regulated investment companies and to distribute to shareholders each year substantially all of its net investment income, and all or substantially all of its net realized capital gains. Accordingly, no provision for federal income or excise tax is necessary.
As of August 31, 2026, the Fund had no uncertain tax positions that would require financial statement recognition, de-recognition, or disclosure. The Fund files a U.S. federal income tax return annually after its fiscal year-end, which is subject to examination by the Internal Revenue Service for a period of three years from the date of filing.
During this reporting period, the Fund adopted FASB Accounting Standards Update No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures (ASU 2023-09), which requires annual disclosure of the amount of income taxes paid (net of refunds received) disaggregated by federal, state,
and foreign taxes, and further disaggregated by individual jurisdiction in which income taxes paid is equal to or greater than 5% of total income taxes paid. The adoption of ASU 2023-09 did not result in any changes to the Fund's financial statement presentation or disclosure.
E Expenses—The majority of expenses of the Trust are directly identifiable to an individual fund. Expenses which are not readily identifiable to a specific fund are allocated taking into consideration, among other things, the nature and type of expense and the relative size of the funds.
F Foreign Currency Translation—Investment valuations, other assets, and liabilities initially expressed in foreign currencies are translated each business day into U.S. dollars based upon current exchange rates. Purchases and sales of foreign investment securities and income and expenses denominated in foreign currencies are translated into U.S. dollars based upon currency exchange rates in effect on the respective dates of such transactions. Recognized gains or losses on investment transactions attributable to changes in foreign currency exchange rates are recorded for financial statement purposes as net realized gains and losses on investments. That portion of unrealized gains and losses on investments that results from fluctuations in foreign currency exchange rates is not separately disclosed.
G Use of Estimates—The preparation of the financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of income and expense during the reporting period. Actual results could differ from those estimates.
H Indemnifications—Under the Trust’s organizational documents, its officers and Trustees may be indemnified against certain liabilities and expenses arising out of the performance of their duties to the Fund. Under Massachusetts law, if certain conditions prevail, shareholders of a Massachusetts business trust (such as the Trust) could be deemed to have personal liability for the obligations of the Trust. However, the Trust’s Declaration of Trust contains an express disclaimer of liability on the part of Fund shareholders and the By-laws provide that the Trust shall assume, upon request by the shareholder, the defense on behalf of any Fund shareholders. Moreover, the By-laws also provide for indemnification out of Fund property of any shareholder held personally liable solely by reason of being or having been a shareholder for all loss or expense arising from such liability. Additionally, in the normal course of business, the Fund enters into agreements with service providers that may contain indemnification clauses. The maximum exposure under these arrangements is unknown as this would involve future claims that may be made against the Fund that have not yet occurred.
I Segment Reporting—The Fund operates as a single reportable segment, an investment company whose investment objective(s) is included in Note 1. The Fund’s President acts as the Fund's Chief Operating Decision Maker (CODM), who is responsible for assessing the performance of the Fund's single segment and deciding how to allocate the segment’s resources. To perform this function, the CODM reviews the information in the Fund’s financial statements.
J Recently Issued Accounting Pronouncements—In September 2026, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2026-03, Fair Value Measurement (Topic 820): Investment Companies with Equity Securities Subject to Contractual Sale Restrictions. ASU 2026-03 requires investment companies to consider the effects of certain contractual sale restrictions when measuring the fair value of equity securities and to provide related disclosures. ASU 2026-03 is effective for fiscal years beginning after December 15, 2027, and interim periods within those fiscal years, with early adoption permitted. Management is currently evaluating the impact of adopting ASU 2026-03; however, it does not currently expect the implementation of the standard to have a material effect on the Fund's financial statements.
Eaton Vance
Worldwide Health Sciences Fund
August 31, 2026
Notes to Financial Statements — continued
2 Distributions to Shareholders and Income Tax Information
It is the present policy of the Fund to make at least one distribution annually (normally in December) of all or substantially all of its net investment income and to distribute annually all or substantially all of its net realized capital gains. Distributions to shareholders are recorded on the ex-dividend date. Distributions are declared separately for each class of shares. Shareholders may reinvest income and capital gain distributions in additional shares of the same class of the Fund at the net asset value as of the ex-dividend date or, at the election of the shareholder, receive distributions in cash. Distributions to shareholders are determined in accordance with income tax regulations, which may differ from U.S. GAAP. As required by U.S. GAAP, only distributions in excess of tax basis earnings and profits are reported in the financial statements as a return of capital. Permanent differences between book and tax accounting relating to distributions are reclassified to paid-in capital. For tax purposes, distributions from short-term capital gains are considered to be from ordinary income.
The tax character of distributions declared for the years ended August 31, 2026 and August 31, 2025 was as follows:
During the year ended August 31, 2026, distributable earnings was decreased by $40,820,004 and paid-in capital was increased by $40,820,004 due to the Fund’s use of equalization accounting and differences between book and tax accounting, primarily for redemptions in-kind. Tax equalization accounting allows the Fund to treat as a distribution that portion of redemption proceeds representing a redeeming shareholder’s portion of undistributed taxable income and net capital gains. These reclassifications had no effect on the net assets or net asset value per share of the Fund.
As of August 31, 2026, the components of distributable earnings (accumulated loss) on a tax basis were as follows:
Undistributed ordinary income |
|
Undistributed long-term capital gains |
|
Net unrealized appreciation |
|
| |
|
The cost and unrealized appreciation (depreciation) of investments of the Fund at August 31, 2026, as determined on a federal income tax basis, were as follows:
| |
|
Gross unrealized appreciation |
|
Gross unrealized depreciation |
|
Net unrealized appreciation |
|
Eaton Vance
Worldwide Health Sciences Fund
August 31, 2026
Notes to Financial Statements — continued
3 Investment Adviser Fee and Other Transactions with Affiliates
The investment adviser fee is earned by Eaton Vance Management (EVM), an indirect, wholly-owned subsidiary of Morgan Stanley, as compensation for investment advisory services rendered to the Fund. The fee is computed at an annual rate as a percentage of the Fund’s average daily net assets as follows and is payable monthly:
| |
|
| |
|
$500 million but less than $1 billion |
|
$1 billion but less than $1.5 billion |
|
$1.5 billion but less than $2 billion |
|
$2 billion but less than $2.5 billion |
|
| |
|
In addition, EVM’s fee is subject to an upward or downward performance adjustment of up to 0.15% (annually) of the average daily net assets of the Fund depending on whether, and to what extent, the investment performance of the Fund differs by at least one percentage point from the record of the MSCI World Health Care Index over a 36-month performance period. For the year ended August 31, 2026, the investment adviser fee, including a downward performance adjustment of $265,644, amounted to $4,969,002 or 0.61% of the Fund’s average daily net assets. Pursuant to an investment sub-advisory agreement, EVM has delegated a portion of the investment management of the Fund to Eaton Vance Advisers International Ltd. (EVAIL), an affiliate of EVM and an indirect, wholly-owned subsidiary of Morgan Stanley. EVM pays EVAIL a portion of its investment adviser fee for sub-advisory services provided to the Fund. The Fund may invest in a money market fund, the Institutional Class of the Morgan Stanley Institutional Liquidity Funds - Government Portfolio (the “Liquidity Fund”), an open-end management investment company managed by Morgan Stanley Investment Management Inc., a wholly-owned subsidiary of Morgan Stanley. The investment adviser fee paid by the Fund is reduced by an amount equal to its pro rata share of the advisory and administration fees paid by the Fund due to its investment in the Liquidity Fund. For the year ended August 31, 2026, the investment adviser fee paid was reduced by $2,629 relating to the Fund’s investment in the Liquidity Fund.
The administration fee is earned by EVM for administering the business affairs of the Fund and is computed at an annual rate of 0.15% of the Fund’s average daily net assets. For the year ended August 31, 2026, the administration fee amounted to $1,222,791.
EVM and EVAIL have agreed to reimburse the Fund’s expenses to the extent that total annual operating expenses (relating to ordinary operating expenses only and excluding expenses such as brokerage commissions, acquired fund fees and expenses of unaffiliated funds, any performance-based adjustment to an asset-based investment advisory fee, borrowing costs, taxes or litigation expenses) exceed 1.15%, 1.90%, 0.90% and 1.40% of the Fund’s average daily net assets for Class A, Class C, Class I and Class R, respectively. This agreement may be changed or terminated after January 1, 2027. Pursuant to this agreement, EVM and EVAIL waived and/or reimbursed $448,046 in total of the Fund’s operating expenses for the year ended August 31, 2026.
EVM provides sub-transfer agency and related services to the Fund pursuant to a Sub-Transfer Agency Support Services Agreement. For the year ended August 31, 2026, EVM earned $156,220 from the Fund pursuant to such agreement, which is included in transfer and dividend disbursing agent fees on the Statement of Operations. The Fund was informed that Eaton Vance Distributors, Inc. (EVD), an affiliate of EVM and the Fund’s principal underwriter, received $2,203 as its portion of the sales charge on sales of Class A shares for the year ended August 31, 2026. EVD also received distribution and service fees from Class A, Class C and Class R shares (see Note 4) and contingent deferred sales charges (see Note 5).
Trustees and officers of the Fund who are members of EVM’s organization receive remuneration for their services to the Fund out of the investment adviser fee. Trustees of the Fund who are not affiliated with the investment adviser may elect to defer receipt of all or a percentage of their annual fees in accordance with the terms of the Trustees Deferred Compensation Plan. Certain officers and Trustees of the Fund are officers of EVM.
The Fund has in effect a distribution plan for Class A shares (Class A Plan) pursuant to Rule 12b-1 under the 1940 Act. Pursuant to the Class A Plan, the Fund pays EVD a distribution and service fee of 0.25% per annum of its average daily net assets attributable to Class A shares for distribution services and facilities provided to the Fund by EVD, as well as for personal services and/or the maintenance of shareholder accounts. Distribution and service fees paid or accrued to EVD for the year ended August 31, 2026 amounted to $1,437,041 for Class A shares.
The Fund also has in effect distribution plans for Class C shares (Class C Plan) and Class R shares (Class R Plan) pursuant to Rule 12b-1 under the 1940 Act. Pursuant to the Class C Plan, the Fund pays EVD amounts equal to 0.75% per annum of its average daily net assets attributable to Class C shares for providing ongoing distribution services and facilities to the Fund. For the year ended August 31, 2026, the Fund paid or accrued to EVD $117,834 for Class C shares.
Eaton Vance
Worldwide Health Sciences Fund
August 31, 2026
Notes to Financial Statements — continued
The Class R Plan requires the Fund to pay EVD an amount up to 0.50% per annum of its average daily net assets attributable to Class R shares for providing ongoing distribution services and facilities to the Fund. The Trustees of the Trust have currently limited Class R distribution payments to 0.25% per annum of the average daily net assets attributable to Class R shares. For the year ended August 31, 2026, the Fund paid or accrued to EVD $126,583 for Class R shares.
Pursuant to the Class C and Class R Plans, the Fund also makes payments of service fees to EVD, financial intermediaries and other persons in amounts equal to 0.25% per annum of its average daily net assets attributable to that class. Service fees paid or accrued are for personal services and/or the maintenance of shareholder accounts. They are separate and distinct from the sales commissions and distribution fees payable to EVD. Service fees paid or accrued for the year ended August 31, 2026 amounted to $39,278 and $126,583 for Class C and Class R shares, respectively.
Distribution and service fees are subject to the limitations contained in the Financial Industry Regulatory Authority Rule 2341(d).
5 Contingent Deferred Sales Charges
A contingent deferred sales charge (CDSC) of 1% generally is imposed on redemptions of Class C shares made within 12 months of purchase. Class A shares may be subject to a 1% CDSC if redeemed within 12 months of purchase (depending on the circumstances of purchase). Generally, the CDSC is based upon the lower of the net asset value at date of redemption or date of purchase. No charge is levied on shares acquired by reinvestment of dividends or capital gain distributions. For the year ended August 31, 2026, the Fund was informed that EVD received $247 and $760 of CDSCs paid by Class A and Class C shareholders, respectively.
6 Purchases and Sales of Investments
Purchases and sales of investments, other than short-term obligations and in-kind transactions, aggregated $240,185,514 and $324,829,373, respectively, for the year ended August 31, 2026. In-kind sales for the year ended August 31, 2026 aggregated $53,162,068.
7 Shares of Beneficial Interest
The Fund’s Declaration of Trust permits the Trustees to issue an unlimited number of full and fractional shares of beneficial interest (without par value). Such shares may be issued in a number of different series (such as the Fund) and classes. Sales and redemptions of Class I shares include shares purchased and redeemed in connection with the ReFlow liquidity program, a program designed to provide an alternative liquidity source for mutual funds experiencing net redemptions of their shares. Transactions in Fund shares, including direct exchanges pursuant to share class conversions, were as follows:
| |
Year Ended
August 31, 2026 |
Year Ended
August 31, 2025 |
| |
|
|
|
|
| |
|
|
|
|
| |
|
|
|
|
Issued to shareholders electing to receive payments of distributions in Fund shares |
|
|
|
|
| |
|
|
|
|
| |
|
|
|
|
| |
|
|
|
|
| |
|
|
|
|
Issued to shareholders electing to receive payments of distributions in Fund shares |
|
|
|
|
| |
|
|
|
|
| |
|
|
|
|
Eaton Vance
Worldwide Health Sciences Fund
August 31, 2026
Notes to Financial Statements — continued
| |
Year Ended August 31, 2026 |
Year Ended August 31, 2025 |
| |
|
|
|
|
| |
|
|
|
|
| |
|
|
|
|
Issued to shareholders electing to receive payments of distributions in Fund shares |
|
|
|
|
| |
|
|
|
|
| |
|
|
|
|
| |
|
|
|
|
| |
|
|
|
|
Issued to shareholders electing to receive payments of distributions in Fund shares |
|
|
|
|
| |
|
|
|
|
| |
|
|
|
|
The Fund participates with other portfolios and funds managed by EVM and its affiliates in a $650 million unsecured revolving line of credit agreement with a group of banks, which is in effect through October 20, 2026. Borrowings are made by the Fund solely for temporary purposes related to redemptions and other short-term cash needs. Interest is charged to the Fund based on its borrowings generally at an amount above either the Secured Overnight Financing Rate (SOFR) or Federal Funds rate. In addition, a fee computed at an annual rate of 0.15% on the daily unused portion of the line of credit is allocated among the participating portfolios and funds at the end of each quarter. In connection with the renewal of the agreement in October 2025, an arrangement fee of $150,000 was incurred that was allocated to the participating portfolios and funds. Because the line of credit is not available exclusively to the Fund, it may be unable to borrow some or all of its requested amounts at any particular time. The Fund did not have any significant borrowings or allocated fees during the year ended August 31, 2026.
At August 31, 2026, the value of the Fund's investment in funds that may be deemed to be affiliated was $5,492,356, which represents 0.7% of the Fund's net assets. Transactions in such investments by the Fund for the year ended August 31, 2026 were as follows:
| |
Value,
beginning
of period |
|
|
|
Change in
unrealized
appreciation
(depreciation) |
|
|
|
| |
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
10 Fair Value Measurements
Under generally accepted accounting principles for fair value measurements, a three-tier hierarchy to prioritize the assumptions, referred to as inputs, is used in valuation techniques to measure fair value. The three-tier hierarchy of inputs is summarized in the three broad levels listed below.
• Level 1 – quoted prices in active markets for identical investments
• Level 2 – other significant observable inputs (including quoted prices for similar investments, interest rates, prepayment speeds, credit risk, etc.)
• Level 3 – significant unobservable inputs (including a fund's own assumptions in determining the fair value of investments)
Eaton Vance
Worldwide Health Sciences Fund
August 31, 2026
Notes to Financial Statements — continued
In cases where the inputs used to measure fair value fall in different levels of the fair value hierarchy, the level disclosed is determined based on the lowest level input that is significant to the fair value measurement in its entirety. The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.
At August 31, 2026, the hierarchy of inputs used in valuing the Fund's investments, which are carried at fair value, were as follows:
| |
|
|
|
|
| |
|
|
|
|
| |
|
|
|
|
| |
|
|
|
|
| |
|
|
|
|
| |
|
|
|
|
| |
|
|
|
|
Life Sciences Tools & Services |
|
|
|
|
| |
|
|
|
|
| |
|
|
|
|
| |
|
|
|
|
| |
|
|
|
|
| |
|
|
|
|
| |
Includes foreign equity securities whose values were adjusted to reflect market trading of comparable securities or other correlated instruments that occurred after the close of trading in their applicable foreign markets. |
11 Risks and Uncertainties
Risks Associated with Foreign Investments
Foreign investments can be adversely affected by political, economic and market developments abroad, including the imposition of economic and other sanctions by the United States or another country, and by acts of terrorism and war. There may be less publicly available information about foreign issuers because they may not be subject to reporting practices, requirements or regulations comparable to those to which United States companies are subject. Foreign markets may be smaller, less liquid and more volatile than the major markets in the United States. Trading in foreign markets typically involves higher expense than trading in the United States. The Fund may have difficulties enforcing its legal or contractual rights in a foreign country. Securities that trade or are denominated in currencies other than the U.S. dollar may be adversely affected by fluctuations in currency exchange rates.
As the Fund invests a significant portion of its assets in pharmaceutical, biotechnology, life sciences, and health care equipment and services companies, it may be affected by developments that adversely affect such companies. These developments include product obsolescence, the failure of a company to develop new products and the expiration of patent rights. The value of the Fund’s shares can also be impacted by regulatory activities that affect health sciences companies. The Fund has historically held approximately 60 stocks or less at any one time; therefore, it is more sensitive to developments affecting particular stocks than would be a more broadly diversified fund.
Eaton Vance
Worldwide Health Sciences Fund
August 31, 2026
Report of Independent Registered Public Accounting Firm
To the Trustees of Eaton Vance Growth Trust and Shareholders of Eaton Vance Worldwide Health Sciences Fund:
Opinion on the Financial Statements and Financial Highlights
We have audited the accompanying statement of assets and liabilities of Eaton Vance Worldwide Health Sciences Fund (the "Fund") (one of the funds constituting Eaton Vance Growth Trust), including the portfolio of investments, as of August 31, 2026, the related statement of operations for the year then ended, the statements of changes in net assets for each of the two years in the period then ended, the financial highlights for each of the five years in the period then ended, and the related notes (collectively referred to as the “financial statements and financial highlights”). In our opinion, the financial statements and financial highlights present fairly, in all material respects, the financial position of the Fund as of August 31, 2026, and the results of its operations for the year then ended, the changes in its net assets for each of the two years in the period then ended, and the financial highlights for each of the five years in the period then ended, in conformity with accounting principles generally accepted in the United States of America.
These financial statements and financial highlights are the responsibility of the Fund's management. Our responsibility is to express an opinion on the Fund's financial statements and financial highlights based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Fund in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements and financial highlights are free of material misstatement, whether due to error or fraud. The Fund is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Fund’s internal control over financial reporting. Accordingly, we express no such opinion.
Our audits included performing procedures to assess the risks of material misstatement of the financial statements and financial highlights, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements and financial highlights. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements and financial highlights. Our procedures included confirmation of securities owned as of August 31, 2026, by correspondence with the custodian and brokers; when replies were not received from brokers, we performed other auditing procedures. We believe that our audits provide a reasonable basis for our opinion.
/s/ Deloitte & Touche LLP
Boston, Massachusetts
October 19, 2026
We have served as the auditor of one or more Eaton Vance investment companies since 1959.
Eaton Vance
Worldwide Health Sciences Fund
August 31, 2026
Federal Tax Information (Unaudited)
The Form 1099-DIV you receive in February 2027 will show the tax status of all distributions paid to your account in calendar year 2026. Shareholders
are advised to consult their own tax adviser with respect to the tax consequences of their investment in the Fund. As required by the Internal Revenue Code and/or regulations, shareholders must be notified regarding the status of qualified dividend income for individuals, the dividends received deduction for corporations and capital gains dividends.
Qualified Dividend Income. For the fiscal year ended August 31, 2026, the Fund designates approximately $13,907,618, or up to the maximum amount of such dividends allowable pursuant to the Internal Revenue Code, as qualified dividend income eligible for the reduced tax rate of 15%.
Dividends Received Deduction. Corporate shareholders are generally entitled to take the dividends received deduction on the portion of the Fund’s dividend distribution that qualifies under tax law. For the Fund’s fiscal 2026 ordinary income dividends, 82.22% qualifies for the corporate dividends received deduction.
Capital Gains Dividends. The Fund hereby designates as a capital gain dividend with respect to the taxable year ended August 31, 2026, $42,097,014
or, if subsequently determined to be different, the net capital gain of such year.
Eaton Vance
Worldwide Health Sciences Fund
August 31, 2026
Board of Trustees’ Contract Approval
Overview of the Contract Review Process
The Investment Company Act of 1940, as amended (the “1940 Act”), provides, in substance, that the investment advisory agreement between a fund and its investment adviser will continue in effect from year-to-year only if its continuation is approved on an annual basis by a vote of the fund’s board of trustees, including a majority of the trustees who are not “interested persons” of the fund (“independent trustees”), cast in person at a meeting called for the purpose of considering such approval.
At a meeting held on June 11, 2026, the Boards of Trustees/Directors (collectively, the “Board”) that oversee the registered investment companies advised by Eaton Vance Management or its affiliate, Boston Management and Research (the “Eaton Vance Funds”), including a majority of the independent trustees (the “Independent Trustees”), voted to approve the continuation of existing investment advisory agreements and sub-advisory agreements1 for each of the Eaton Vance Funds for an additional one-year period. The Board relied upon the affirmative recommendation of its Contract Review Committee, which is a committee comprised of all of the Independent Trustees. Prior to making its recommendation, the Contract Review Committee reviewed information furnished by the adviser and sub-adviser to each of the Eaton Vance Funds (including information specifically requested by the Board) for a series of meetings held between April and June 2026, as well as certain additional information provided in response to specific requests from the Independent Trustees as members of the Contract Review Committee. Members of the Contract Review Committee also considered information received at prior meetings of the Board and its committees, to the extent such information was relevant to the Contract Review Committee’s annual evaluation of the investment advisory agreements and sub-advisory agreements.
In connection with its evaluation of the investment advisory agreements and sub-advisory agreements, the Board (directly or through one or more of its committees) considered various information relating to the Eaton Vance Funds. This included information applicable to all or groups of the Eaton Vance Funds, which is referenced immediately below, and information applicable to the particular Eaton Vance Fund covered by this report (each Eaton Vance Fund is referred to below as a “fund”). (For funds that invest through one or more underlying portfolios, references to “each fund” in this section may include information that was considered at the portfolio-level.)
Information about Fees, Performance and Expenses
• A report from an independent data provider comparing advisory and other fees paid by each fund to such fees paid by comparable funds, as identified by the independent data provider (“comparable funds”);
• A report from an independent data provider comparing each fund’s total expense ratio (and its components) to those of comparable funds;
• A report from an independent data provider comparing the investment performance of each fund to the investment performance of comparable funds and, as applicable, benchmark indices, over various time periods;
• In certain instances, data regarding investment performance relative to customized groups of peer funds and blended indices identified by the adviser in consultation with the Portfolio Management Committee of the Board (a committee exclusively comprised of Independent Trustees);
• Comparative information concerning the fees charged and services provided by the adviser and sub-adviser to each fund in managing other accounts (which may include other funds, collective investment trusts and institutional accounts) with the same or substantially similar investment objective as the fund and with a significant overlap in holdings based on criteria set by the Board, if any;
• Profitability analyses on a fund-by-fund basis for the adviser and its affiliates and the cost allocation methodology used to determine such analyses;
Information about Portfolio Management and Trading
• Descriptions of the investment management services provided to each fund, as well as each of the funds’ investment strategies and policies;
• The procedures and processes used by the adviser to determine the value of fund assets, including, when necessary, the determination of “fair value” by the adviser in its role as each fund’s valuation designee and actions taken to monitor and test the effectiveness of such procedures and processes;
• Information about the policies and practices of each fund’s adviser and sub-adviser with respect to trading, including their processes for seeking best execution of portfolio transactions;
• Information about the allocation of brokerage transactions and the benefits, if any, received by the adviser and sub-adviser to each fund as a result of brokerage allocation, including, as applicable, information concerning the acquisition of research through client commission arrangements and policies with respect to “soft dollars”;
• Data relating to the portfolio turnover rate of each fund and related information regarding active management in the context of particular strategies;
Information about each Adviser and Sub-Adviser
• Information regarding the individual investment professionals whose responsibilities include portfolio management and investment research for the funds, and, for portfolio managers and certain other investment professionals, information relating to their responsibilities with respect to managing other funds and investment accounts, as applicable;
1 Not all Eaton Vance Funds have entered into a sub-advisory agreement with a sub-adviser. Accordingly, references to “sub-adviser” or “sub-advisory agreement” in this “Overview” section may not be applicable to the particular Eaton Vance Fund covered by this report. Eaton Vance Management and Boston Management and Research are referred to collectively as the “adviser.”
Eaton Vance
Worldwide Health Sciences Fund
August 31, 2026
Board of Trustees’ Contract Approval — continued
• Information regarding the adviser’s and its parent company’s (Morgan Stanley’s) efforts to retain and attract talented investment professionals, including in the context of a competitive marketplace for talent;
• Information regarding the adviser’s compensation methodology for its investment professionals and the incentives and accountability it creates, along with investment professionals’ investments in the fund(s) they manage;
• The personal trading codes of ethics of the adviser and its affiliates and the sub-adviser of each fund, together with information relating to compliance with, and the administration of, such codes;
• Policies and procedures relating to proxy voting, including regular reporting with respect to fund proxy voting activities;
• Information regarding the handling of corporate actions and class actions, as well as information regarding litigation and other regulatory matters;
• Information concerning the resources devoted to compliance efforts undertaken by the adviser and its affiliates and the sub-adviser of each fund, including descriptions of their various compliance programs and their record of compliance and remediation;
• Information concerning the business continuity and disaster recovery plans of the adviser and its affiliates and the sub-adviser of each fund;
• A description of the adviser’s oversight of sub-advisers, including with respect to regulatory and compliance issues, investment management and other matters, if any;
Other Relevant Information
• Information regarding ongoing initiatives to further integrate and harmonize, where applicable, the investment management and other departments of the adviser and its affiliates with the overall investment management infrastructure of Morgan Stanley, in light of Morgan Stanley’s acquisition of Eaton Vance Corp. on March 1, 2021;
• Information concerning the nature, cost, and character of the administrative and other non-investment advisory services provided by the adviser and its affiliates;
• Information concerning oversight of the relationship with the custodian, subcustodians, fund accountants, and other third-party service providers by the adviser and/or administrator to each of the funds;
• Information concerning efforts to maintain policies and procedures with respect to various regulations applicable to the funds, including, without limitation, Rule 22e-4 (the Liquidity Risk Management Rule), Rule 12d1-4 (the Fund-of-Funds Rule), Rule 18f-4 (the Derivatives Rule), and Rule 2a-5 (the Fair Valuation Rule);
• For each Eaton Vance Fund structured as an exchange-listed closed-end fund, information concerning the benefits of the closed-end fund structure, as well as, where relevant, the closed-end fund’s market prices (including as compared to the closed-end fund’s net asset value (NAV)), trading volume data, continued use of auction preferred shares (where applicable), distribution rates, and other relevant matters;
• The risks that the adviser and/or its affiliates incur in connection with the management and operation of the funds, including, among others, litigation, regulatory, entrepreneurial, data privacy and cybersecurity, and other business risks (and the associated costs of such risks, if any); and
• The terms of each investment advisory agreement and sub-advisory agreement.
During the various meetings of the Board and its committees over the course of the year leading up to the June 11, 2026 meeting, the Board and its committees received information from portfolio managers and other investment professionals of the adviser and sub-advisers of the funds regarding investment and performance matters, and considered various investment and trading strategies used in pursuing the funds’ investment objectives. The Board and its committees also received information regarding risk management techniques employed in connection with the management of the funds. The Board and its committees evaluated issues pertaining to industry and regulatory developments, compliance procedures, fund governance, and other issues with respect to the funds, and received and participated in reports and presentations provided by the adviser, sub-advisers, and certain other service providers, with respect to such matters. In addition to the formal meetings of the Board and its committees, the Independent Trustees met in executive sessions and held regular video or telephone conferences to discuss, among other topics, matters relating to the continuation of investment advisory agreements and sub-advisory agreements.
Each of the Contract Review Committee and the Board was advised throughout the contract review process by Kirkland & Ellis LLP, independent legal counsel for the Independent Trustees. The members of the Contract Review Committee and the members of the Board, with the advice of such counsel, exercised their own business judgment in determining the material factors to be considered in evaluating each investment advisory agreement and sub-advisory agreement and the weight to be given to each such factor. The conclusions reached with respect to each investment advisory agreement and sub-advisory agreement were based on a comprehensive evaluation of all the information provided and not any single factor. Moreover, each member of the Contract Review Committee and Board may have placed varying emphasis on particular factors in reaching conclusions with respect to each investment advisory agreement and sub-advisory agreement. In evaluating each investment advisory agreement and sub-advisory agreement, including the fee structures and other terms contained in such agreements, the members of the Contract Review Committee and Board were also informed by multiple years of analysis and discussion with the adviser and sub-adviser to each of the Eaton Vance Funds.
Results of the Contract Review Process
Based on its consideration of the foregoing, and such other information it deemed relevant, including the factors and conclusions described below, the Contract Review Committee concluded that the continuation of the investment advisory agreement between Eaton Vance Worldwide Health Sciences Fund (the “Fund”) and Eaton Vance Management (the “Adviser”) and the sub-advisory agreement between the Adviser and Eaton Vance Advisers International
Eaton Vance
Worldwide Health Sciences Fund
August 31, 2026
Board of Trustees’ Contract Approval — continued
Ltd. (the “Sub-adviser”), an affiliate of the Adviser, with respect to the Fund, including their respective fee structures, are in the interests of shareholders and, therefore, recommended to the Board approval of each agreement. Based on the recommendation of the Contract Review Committee, the Board, including a majority of the Independent Trustees, voted to approve continuation of the investment advisory agreement and the sub-advisory agreement for the Fund.
Nature, Extent and Quality of Services
In considering whether to approve the investment advisory agreement and the sub-advisory agreement for the Fund, the Board evaluated the nature, extent and quality of services provided to the Fund by the Adviser and the Sub-adviser.
The Board considered the Adviser’s and the Sub-adviser’s management capabilities and investment processes in light of the types of investments held by the Fund, including the education and experience of the investment professionals who provide services to the Fund. Regarding the Adviser, the Board considered the Adviser’s responsibilities with respect to oversight of the Sub-adviser. With respect to the Sub-adviser, the Board considered the resources available to the Sub-adviser in fulfilling its duties under the sub-advisory agreement. In particular, the Board considered the abilities and experience of the Adviser’s and the Sub-adviser’s investment professionals in investing in equity securities, particularly in managing health sciences portfolios and in the health care sector more broadly. The Board also considered the international investment capabilities of the Sub-adviser, which is based in London, and the benefits to the Fund of having portfolio management services involving investments in international equities provided by investment professionals located abroad. The Board also took into account the resources dedicated to portfolio management and other services, the compensation methods of the Adviser and other factors, including the reputation and resources of the Adviser to recruit and retain highly qualified research, advisory and supervisory investment professionals. In addition, the Board considered the time and attention devoted to the Eaton Vance Funds, including the Fund, by senior management, as well as the infrastructure, operational capabilities and support staff in place to assist in the portfolio management and operations of the Fund, including the provision of administrative services. The Board also considered the business-related and other risks to which the Adviser or its affiliates may be subject in managing the Fund.
The Board considered the compliance programs of the Adviser and relevant affiliates thereof, including the Sub-adviser. The Board considered compliance and reporting matters regarding, among other things, personal trading by investment professionals, disclosure of portfolio holdings, compliance with policies and procedures, portfolio valuation, business continuity and the allocation of investment opportunities. The Board also considered relevant examinations of the Adviser and its affiliates by regulatory authorities, such as the Securities and Exchange Commission and the Financial Industry Regulatory Authority.
The Board considered other administrative services provided or overseen by Eaton Vance Management and its affiliates, including transfer agency and accounting services. The Board evaluated the benefits to shareholders of investing in a fund that is a part of a large fund complex offering exposure to a variety of asset classes and investment disciplines, as well as the ability, in many cases, to exchange an investment among different funds without incurring additional sales charges.
After consideration of the foregoing factors, among others, the Board concluded that the nature, extent and quality of services provided by the Adviser and the Sub-adviser, taken as a whole, are appropriate and consistent with the terms of the investment advisory agreement and the sub-advisory agreement.
The Board compared the Fund’s investment performance to that of comparable funds identified by an independent data provider (the peer group), as well as an appropriate benchmark index. The Board’s review included comparative performance data with respect to the Fund for the one-, three-, five- and ten-year periods ended December 31, 2025. In this regard, the Board noted that the performance of the Fund was lower than the median performance of the Fund’s peer group for the three-year period. The Board also noted that the performance of the Fund was higher than its primary performance benchmark index for the three-year period. On the basis of the foregoing, the performance of the Fund over other periods, and other relevant information provided by the Adviser in response to requests from the Contract Review Committee, the Board concluded that the performance of the Fund was satisfactory.
Management Fees and Expenses
The Board considered contractual fee rates payable by the Fund for advisory and administrative services (referred to collectively as “management fees”). As part of its review, the Board considered the Fund’s management fees and total expense ratio for the one-year period ended December 31, 2025, as compared to those of comparable funds, before and after giving effect to any undertaking to waive fees or reimburse expenses. The Board also considered factors that had an impact on the Fund’s total expense ratio relative to comparable funds.
After considering the foregoing information, and in light of the nature, extent and quality of the services provided by the Adviser and the Sub-adviser, the Board concluded that the management fees charged for advisory and related services are reasonable.
Eaton Vance
Worldwide Health Sciences Fund
August 31, 2026
Board of Trustees’ Contract Approval — continued
Profitability and “Fall-Out” Benefits
The Board considered the level of profits realized by the Adviser and relevant affiliates thereof, including the Sub-adviser, in providing investment advisory and administrative services to the Fund and to all Eaton Vance Funds as a group. The Board considered the level of profits realized without regard to marketing support or other payments by the Adviser and its affiliates to third parties in respect of distribution or other services.
The Board concluded that, in light of the foregoing factors and the nature, extent and quality of the services rendered, the profits realized by the Adviser and its affiliates, including the Sub-adviser, are not excessive.
The Board also considered direct and indirect fall-out benefits received by the Adviser and its affiliates, including the Sub-adviser, in connection with their respective relationships with the Fund and the other Eaton Vance Funds, including, among other things, fees for trading, distribution and/or shareholder servicing and for transaction processing and reporting platforms used by securities lending agent(s), and research received by the Adviser and/or the Sub-adviser generated from commission dollars spent on funds’ portfolio trading.
In reviewing management fees and profitability, the Board also considered the extent to which the Adviser and its affiliates, on the one hand, and the Fund, on the other hand, can expect to realize benefits from economies of scale as the assets of the Fund increase. The Board acknowledged the difficulty in accurately measuring the benefits resulting from economies of scale, if any, with respect to the management of any specific fund or group of funds. To assist in the evaluation of the sharing of any economies of scale, the Board received data for recent years showing asset levels, Adviser profitability and total expense ratios. Based upon the foregoing, the Board concluded that the Fund currently shares in the benefits from economies of scale, if any, when they are realized by the Adviser. The Board also concluded that the structure of the advisory fee, which includes breakpoints at several asset levels, will allow the Fund to continue to benefit from any economies of scale in the future.
This Page Intentionally Left Blank
Eaton Vance
Annual Financial Statements and
Additional Information
This report must be preceded or accompanied by a current summary prospectus or prospectus. Before investing, investors should consider carefully the investment objective, risks, and charges and expenses of a mutual fund. This and other important information is contained in the prospectus and/or statement of additional information, which can be obtained by calling 1-800-262-1122 or from a financial intermediary. Prospective investors should read the prospectus carefully before investing.
Annual Financial Statements and Additional Information August 31, 2026
Eaton Vance
Equity Strategy Fund
Items 8 and 9 of Form N-CSR are Not Applicable. For Item 10 of Form N-CSR, see Item 7.
Eaton Vance
Equity Strategy Fund
August 31, 2026
| |
|
|
Aerospace & Defense — 3.5% |
AeroVironment, Inc.(1)(2) |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
Kratos Defense & Security Solutions, Inc.(1) |
|
|
|
L3Harris Technologies, Inc. |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
| |
|
|
|
| |
|
|
|
| |
| |
|
|
|
Banca Monte dei Paschi di Siena SpA |
|
|
|
Banco Bilbao Vizcaya Argentaria SA |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
Citizens Financial Group, Inc. |
|
|
|
| |
|
|
|
Fukuoka Financial Group, Inc. |
|
|
|
| |
|
|
|
| |
|
|
|
Huntington Bancshares, Inc. |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
Kyushu Financial Group, Inc. |
|
|
|
| |
|
|
|
| |
|
|
| |
Mizuho Financial Group, Inc. |
|
|
|
National Bank of Greece SA |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
Shizuoka Financial Group, Inc. |
|
|
|
| |
|
|
|
Sumitomo Mitsui Financial Group, Inc. |
|
|
|
Sumitomo Mitsui Trust Group, Inc. |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
Yokohama Financial Group, Inc. |
|
|
|
| |
|
|
|
| |
| |
|
|
|
| |
|
|
|
| |
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
| |
|
|
|
Johnson Controls International PLC |
|
|
|
| |
|
|
|
| |
| |
|
|
|
| |
|
|
|
Goldman Sachs Group, Inc. |
|
|
|
| |
|
|
|
| |
|
|
|
See Notes to Financial Statements.
Eaton Vance
Equity Strategy Fund
August 31, 2026
Portfolio of Investments — continued
| |
|
|
Capital Markets (continued) |
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
Air Products and Chemicals, Inc. |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
Commercial Services & Supplies — 0.4% |
| |
|
|
|
| |
|
|
|
| |
|
|
|
Communications Equipment — 0.8% |
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
Construction & Engineering — 0.2% |
| |
|
|
|
| |
|
|
|
| |
| |
|
|
|
| |
|
|
|
Consumer Staples Distribution & Retail — 0.4% |
| |
|
|
|
| |
|
|
|
Electric Utilities — 3.1% |
American Electric Power Co., Inc. |
|
|
|
Constellation Energy Corp. |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
Electric Utilities (continued) |
| |
|
|
|
| |
|
|
|
| |
|
|
|
Electrical Equipment — 3.0% |
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
Electronic Equipment, Instruments & Components — 0.6% |
| |
|
|
|
| |
|
|
|
Next Vision Stabilized Systems Ltd. |
|
|
|
| |
|
|
|
Energy Equipment & Services — 0.3% |
| |
|
|
|
| |
|
|
|
| |
| |
|
|
|
| |
|
|
|
Financial Services — 1.8% |
Berkshire Hathaway, Inc., Class B(1) |
|
|
|
| |
|
|
|
Mastercard, Inc., Class A |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
| |
|
|
|
| |
|
|
|
Ground Transportation — 0.6% |
| |
|
|
|
See Notes to Financial Statements.
Eaton Vance
Equity Strategy Fund
August 31, 2026
Portfolio of Investments — continued
| |
|
|
Ground Transportation (continued) |
Uber Technologies, Inc.(1) |
|
|
|
| |
|
|
|
| |
|
|
|
Health Care Equipment & Supplies — 0.8% |
| |
|
|
|
Boston Scientific Corp.(1) |
|
|
|
| |
|
|
|
Intuitive Surgical, Inc.(1) |
|
|
|
| |
|
|
|
Health Care Providers & Services — 4.0% |
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
Molina Healthcare, Inc.(1) |
|
|
|
| |
|
|
|
| |
|
|
|
Hotels, Restaurants & Leisure — 1.0% |
| |
|
|
|
| |
|
|
|
Marriott International, Inc., Class A |
|
|
|
Red Rock Resorts, Inc., Class A |
|
|
|
| |
|
|
|
| |
|
|
|
Household Durables — 0.4% |
Century Communities, Inc. |
|
|
|
| |
|
|
|
| |
|
|
|
Household Products — 0.2% |
| |
|
|
|
| |
|
|
|
Independent Power and Renewable Electricity Producers — 0.3% |
| |
|
|
|
| |
|
|
|
| |
|
|
Industrial Conglomerates — 0.2% |
| |
|
|
|
| |
|
|
|
| |
| |
|
|
|
| |
|
|
|
| |
| |
|
|
|
American International Group, Inc. |
|
|
|
Hartford Insurance Group, Inc. |
|
|
|
| |
|
|
|
Muenchener Rueckversicherungs-Gesellschaft AG in Muenchen |
|
|
|
| |
|
|
|
Interactive Media & Services — 4.5% |
| |
|
|
|
| |
|
|
|
Meta Platforms, Inc., Class A |
|
|
|
| |
|
|
|
| |
| |
|
|
|
Cloudflare, Inc., Class A(1) |
|
|
|
International Business Machines Corp. |
|
|
|
| |
|
|
|
| |
|
|
|
| |
YETI Holdings, Inc.(1)(2) |
|
|
|
| |
|
|
|
Life Sciences Tools & Services — 0.2% |
Thermo Fisher Scientific, Inc. |
|
|
|
| |
|
|
|
| |
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
See Notes to Financial Statements.
Eaton Vance
Equity Strategy Fund
August 31, 2026
Portfolio of Investments — continued
| |
|
|
| |
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
Oil, Gas & Consumable Fuels — 1.6% |
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
ExxonMobil Holdings Corp. |
|
|
|
| |
|
|
|
| |
|
|
|
Passenger Airlines — 0.2% |
| |
|
|
|
| |
|
|
|
| |
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
Professional Services — 1.3% |
Automatic Data Processing, Inc. |
|
|
|
CACI International, Inc., Class A(1) |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
Science Applications International Corp. |
|
|
|
| |
|
|
|
Semiconductors & Semiconductor Equipment — 13.4% |
Advanced Micro Devices, Inc.(1) |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
Taiwan Semiconductor Manufacturing Co. Ltd. ADR |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
| |
|
|
|
C3.ai, Inc., Class A(1)(2) |
|
|
|
Crowdstrike Holdings, Inc., Class A(1) |
|
|
|
Datadog, Inc., Class A(1) |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
Palantir Technologies, Inc., Class A(1) |
|
|
|
Palo Alto Networks, Inc.(1) |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
See Notes to Financial Statements.
Eaton Vance
Equity Strategy Fund
August 31, 2026
Portfolio of Investments — continued
| |
|
|
| |
| |
|
|
|
| |
|
|
|
| |
Abercrombie & Fitch Co., Class A(1) |
|
|
|
Boot Barn Holdings, Inc.(1)(2) |
|
|
|
| |
|
|
|
Sally Beauty Holdings, Inc.(1)(2) |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
Technology Hardware, Storage & Peripherals — 4.7% |
| |
|
|
|
Dell Technologies, Inc., Class C |
|
|
|
| |
|
|
|
Seagate Technology Holdings PLC |
|
|
|
| |
|
|
|
| |
|
|
|
Textiles, Apparel & Luxury Goods — 0.2% |
| |
|
|
|
| |
|
|
|
| |
Philip Morris International, Inc. |
|
|
|
| |
|
|
|
Trading Companies & Distributors — 0.3% |
| |
|
|
|
| |
|
|
|
| |
| |
|
|
|
United Utilities Group PLC |
|
|
|
| |
|
|
|
Wireless Telecommunication Services — 0.2% |
| |
|
|
|
| |
|
|
|
Total Common Stocks
(identified cost $307,014,822) |
|
|
|
Exchange-Traded Funds — 11.4% |
| |
|
|
| |
| |
|
|
|
Franklin FTSE Latin America ETF |
|
|
|
Franklin FTSE South Korea ETF(2) |
|
|
|
iShares Core MSCI Emerging Markets ETF |
|
|
|
iShares MSCI Brazil ETF(2) |
|
|
|
iShares MSCI South Korea ETF |
|
|
|
iShares MSCI Taiwan ETF(2) |
|
|
|
Total Exchange-Traded Funds
(identified cost $54,348,221) |
|
|
|
Short-Term Investments — 3.7% |
| |
|
|
Morgan Stanley Institutional Liquidity Funds - Government Portfolio, Institutional Class, 3.58%(4) |
|
|
|
Total Affiliated Fund
(identified cost $11,189,122) |
|
|
|
Securities Lending Collateral — 1.9% |
| |
|
|
State Street Navigator Securities Lending Government Money Market Portfolio, 3.70%(5) |
|
|
|
Total Securities Lending Collateral
(identified cost $11,402,356) |
|
|
|
Total Short-Term Investments
(identified cost $22,591,478) |
|
|
|
Total Investments — 101.0%
(identified cost $383,954,521) |
|
|
|
Other Assets, Less Liabilities — (1.0)% |
|
|
|
| |
|
|
|
The percentage shown for each investment category in the Portfolio of Investments is based on net assets. |
| |
Non-income producing security. |
| |
All or a portion of this security was on loan at August 31, 2026. The aggregate market value of securities on loan at August 31, 2026 was $22,936,127. |
See Notes to Financial Statements.
Eaton Vance
Equity Strategy Fund
August 31, 2026
Portfolio of Investments — continued
| |
Security exempt from registration under Rule 144A of the Securities Act of 1933, as amended. These securities may be sold in certain transactions in reliance on an exemption from registration (normally to qualified institutional buyers). At August 31, 2026, the aggregate value of these securities is $1,268,441 or 0.2% of the Fund's net assets. |
| |
May be deemed to be an affiliated investment company (see Note 11). The rate shown is the annualized seven-day yield as of August 31, 2026. |
| |
Represents investment of cash collateral received in connection with securities lending. |
Country Concentration of Portfolio |
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| |
|
|
|
|
Value/Unrealized
Appreciation
(Depreciation) |
| |
|
|
|
|
|
| |
|
|
|
|
|
| |
|
|
|
|
|
| |
| |
– American Depositary Receipt |
| |
– Global Depositary Receipt |
| |
– Real Estate Investment Trusts |
See Notes to Financial Statements.
Eaton Vance
Equity Strategy Fund
August 31, 2026
Statement of Assets and Liabilities
| |
|
| |
|
Unaffiliated investments, at value (identified cost $372,765,399) — including $22,936,127 of securities on loan |
|
Affiliated investments, at value (identified cost $11,189,122) |
|
Deposits for derivatives collateral - futures contracts |
|
Foreign currency, at value (identified cost $2,810,909) |
|
| |
|
Dividends receivable from affiliated investments |
|
Receivable for Fund shares sold |
|
Securities lending income receivable |
|
Receivable for variation margin on open futures contracts |
|
| |
|
Receivable from affiliates |
|
Trustees' deferred compensation plan |
|
| |
|
| |
|
Collateral for securities loaned |
|
Payable for Fund shares redeemed |
|
| |
|
Investment adviser and administration fee |
|
Distribution and service fees |
|
| |
|
Trustees' deferred compensation plan |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
Net Asset Value and Redemption Price Per Share
(net assets ÷ shares of beneficial interest outstanding) |
|
Maximum Offering Price Per Share
(100 ÷ 94.75 of net asset value per share) |
|
| |
|
| |
|
| |
|
Net Asset Value and Offering Price Per Share*
(net assets ÷ shares of beneficial interest outstanding) |
|
| |
|
| |
|
| |
|
Net Asset Value, Offering Price and Redemption Price Per Share
(net assets ÷ shares of beneficial interest outstanding) |
|
On sales of $50,000 or more, the offering price of Class A shares is reduced. |
| |
Redemption price per share is equal to the net asset value less any applicable contingent deferred sales charge. |
See Notes to Financial Statements.
Eaton Vance
Equity Strategy Fund
August 31, 2026
| |
|
| |
|
| |
|
Dividend income (net of foreign taxes withheld of $386,865) |
|
Dividend income from affiliated investments |
|
| |
|
Securities lending income, net |
|
| |
|
| |
|
Investment adviser and administration fee |
|
Distribution and service fees: |
|
| |
|
| |
|
Trustees’ fees and expenses |
|
| |
|
Transfer and dividend disbursing agent fees |
|
Legal and accounting services |
|
| |
|
| |
|
| |
|
| |
|
| |
|
Waiver and/or reimbursement of expenses by affiliates |
|
| |
|
| |
|
| |
|
Realized and Unrealized Gain (Loss) |
|
Net realized gain (loss): |
|
| |
|
Foreign currency transactions |
|
Capital gain distributions received |
|
| |
|
Change in unrealized appreciation (depreciation): |
|
| |
|
| |
|
| |
|
Net change in unrealized appreciation (depreciation) |
|
Net realized and unrealized gain |
|
Net increase in net assets from operations |
|
See Notes to Financial Statements.
Eaton Vance
Equity Strategy Fund
August 31, 2026
Statements of Changes in Net Assets
| |
|
| |
|
|
Increase (Decrease) in Net Assets |
|
|
| |
|
|
| |
|
|
| |
|
|
Net change in unrealized appreciation (depreciation) |
|
|
Net increase in net assets from operations |
|
|
Distributions to shareholders: |
|
|
| |
|
|
| |
|
|
| |
|
|
Total distributions to shareholders |
|
|
Transactions in shares of beneficial interest: |
|
|
| |
|
|
| |
|
|
| |
|
|
Net increase (decrease) in net assets from Fund share transactions |
|
|
Net increase (decrease) in net assets |
|
|
| |
|
|
| |
|
|
| |
|
|
See Notes to Financial Statements.
Eaton Vance
Equity Strategy Fund
August 31, 2026
| |
|
| |
|
| |
|
|
|
|
|
Net asset value — Beginning of year |
|
|
|
|
|
Income (Loss) From Operations |
|
|
|
|
|
| |
|
|
|
|
|
Net realized and unrealized gain (loss) |
|
|
|
|
|
Total income (loss) from operations |
|
|
|
|
|
| |
|
|
|
|
|
From net investment income |
|
|
|
|
|
| |
|
|
|
|
|
| |
|
|
|
|
|
Net asset value — End of year |
|
|
|
|
|
| |
|
|
|
|
|
| |
|
|
|
|
|
Net assets, end of year (000’s omitted) |
|
|
|
|
|
Ratios (as a percentage of average daily net assets):(3) |
|
|
|
|
|
| |
|
|
|
|
|
| |
|
|
|
|
|
| |
|
|
|
|
|
| |
|
|
|
|
|
| |
Computed using average shares outstanding. |
| |
Returns are historical and are calculated by determining the percentage change in net asset value with all distributions reinvested and do not reflect
the effect of sales charges. |
| |
Total expenses do not reflect amounts reimbursed and/or waived by the adviser and certain of its affiliates, if applicable. Net expenses are net of all reductions and represent the net expenses paid by the Fund. |
| |
Includes a reduction by the investment adviser of a portion of its adviser and administration fee due to the Fund’s investment in the Liquidity Fund (equal to less than 0.005% of average daily net assets for the years ended August 31, 2026, 2025 and 2024 and less than 0.01% of average daily net assets for the years ended August 31, 2023 and 2022). |
See Notes to Financial Statements.
Eaton Vance
Equity Strategy Fund
August 31, 2026
Financial Highlights — continued
| |
|
| |
|
| |
|
|
|
|
|
Net asset value — Beginning of year |
|
|
|
|
|
Income (Loss) From Operations |
|
|
|
|
|
Net investment income (loss)(1) |
|
|
|
|
|
Net realized and unrealized gain (loss) |
|
|
|
|
|
Total income (loss) from operations |
|
|
|
|
|
| |
|
|
|
|
|
From net investment income |
|
|
|
|
|
| |
|
|
|
|
|
| |
|
|
|
|
|
Net asset value — End of year |
|
|
|
|
|
| |
|
|
|
|
|
| |
|
|
|
|
|
Net assets, end of year (000’s omitted) |
|
|
|
|
|
Ratios (as a percentage of average daily net assets):(4) |
|
|
|
|
|
| |
|
|
|
|
|
| |
|
|
|
|
|
Net investment income (loss) |
|
|
|
|
|
| |
|
|
|
|
|
| |
Computed using average shares outstanding. |
| |
Amount is less than $0.005. |
| |
Returns are historical and are calculated by determining the percentage change in net asset value with all distributions reinvested and do not reflect
the effect of sales charges. |
| |
Total expenses do not reflect amounts reimbursed and/or waived by the adviser and certain of its affiliates, if applicable. Net expenses are net of all reductions and represent the net expenses paid by the Fund. |
| |
Includes a reduction by the investment adviser of a portion of its adviser and administration fee due to the Fund’s investment in the Liquidity Fund (equal to less than 0.005% of average daily net assets for the years ended August 31, 2026, 2025 and 2024 and less than 0.01% of average daily net assets for the years ended August 31, 2023 and 2022). |
| |
Amount is less than 0.005%. |
See Notes to Financial Statements.
Eaton Vance
Equity Strategy Fund
August 31, 2026
Financial Highlights — continued
| |
|
| |
|
| |
|
|
|
|
|
Net asset value — Beginning of year |
|
|
|
|
|
Income (Loss) From Operations |
|
|
|
|
|
| |
|
|
|
|
|
Net realized and unrealized gain (loss) |
|
|
|
|
|
Total income (loss) from operations |
|
|
|
|
|
| |
|
|
|
|
|
From net investment income |
|
|
|
|
|
| |
|
|
|
|
|
| |
|
|
|
|
|
Net asset value — End of year |
|
|
|
|
|
| |
|
|
|
|
|
| |
|
|
|
|
|
Net assets, end of year (000’s omitted) |
|
|
|
|
|
Ratios (as a percentage of average daily net assets):(3) |
|
|
|
|
|
| |
|
|
|
|
|
| |
|
|
|
|
|
| |
|
|
|
|
|
| |
|
|
|
|
|
| |
Computed using average shares outstanding. |
| |
Returns are historical and are calculated by determining the percentage change in net asset value with all distributions reinvested. |
| |
Total expenses do not reflect amounts reimbursed and/or waived by the adviser and certain of its affiliates, if applicable. Net expenses are net of all reductions and represent the net expenses paid by the Fund. |
| |
Includes a reduction by the investment adviser of a portion of its adviser and administration fee due to the Fund’s investment in the Liquidity Fund (equal to less than 0.005% of average daily net assets for the years ended August 31, 2026, 2025 and 2024 and less than 0.01% of average daily net assets for the years ended August 31, 2023 and 2022). |
See Notes to Financial Statements.
Eaton Vance
Equity Strategy Fund
August 31, 2026
Notes to Financial Statements
1 Significant Accounting Policies
Eaton Vance Equity Strategy Fund (the Fund) is a diversified series of Eaton Vance Growth Trust (the Trust). The Trust is a Massachusetts business trust registered under the Investment Company Act of 1940, as amended (the 1940 Act), as an open-end management investment company. The Fund’s investment objective is to seek total return. The Fund offers three classes of shares. Class A shares are generally sold subject to a sales charge imposed at time of purchase. Class C shares are sold at net asset value and are generally subject to a contingent deferred sales charge (see Note 5). Effective November 5, 2020, Class C shares automatically convert to Class A shares eight years after their purchase as described in the Fund’s prospectus. Class I shares are sold at net asset value and are not subject to a sales charge. Each class represents a pro rata interest in the Fund, but votes separately on class-specific matters and (as noted below) is subject to different expenses. Realized and unrealized gains and losses and net investment income and losses, other than class-specific expenses, are allocated daily to each class of shares based on the relative net assets of each class to the total net assets of the Fund. Each class of shares differs in its distribution plan and certain other class-specific expenses.
The following is a summary of significant accounting policies of the Fund. The policies are in conformity with accounting principles generally accepted in the United States of America (U.S. GAAP). The Fund is an investment company and follows accounting and reporting guidance in the Financial Accounting Standards Board (FASB) Accounting Standards Codification Topic 946.
A Investment Valuation—The following methodologies are used to determine the market value or fair value of investments.
Equity Securities. Equity securities listed on a U.S. securities exchange generally are valued at the last sale or closing price on the day of valuation or, if no sales took place on such date, at the mean between the closing bid and ask prices on the exchange where such securities are principally traded. Equity securities listed on the NASDAQ National Market System are valued at the NASDAQ official closing price. Unlisted or listed securities for which closing sales prices or closing quotations are not available are valued at the mean between the latest available bid and ask prices.
Derivatives. Futures contracts are valued at the closing settlement price established by the board of trade or exchange on which they are traded.
Foreign Securities and Currencies. Foreign securities and currencies are valued in U.S. dollars, based on foreign currency exchange rate quotations supplied by a third party pricing service. The pricing service uses a proprietary model to determine the exchange rate. Inputs to the model include reported trades and implied bid/ask spreads. The daily valuation of exchange-traded foreign securities generally is determined as of the close of trading on the principal exchange on which such securities trade. Events occurring after the close of trading on foreign exchanges may result in adjustments to the valuation of foreign securities to more accurately reflect their fair value as of the close of regular trading on the New York Stock Exchange. When valuing foreign equity securities that meet certain criteria, the Fund's Trustees have approved the use of a fair value service that values such securities to reflect market trading that occurs after the close of the applicable foreign markets of comparable securities or other instruments that have a strong correlation to the fair-valued securities.
Other. Investments in management investment companies (including money market funds) that do not trade on an exchange are valued at the net asset value as of the close of each business day. Exchange-traded funds are valued at the official closing price as reported by an independent pricing service on the primary market or exchange on which they are traded.
Fair Valuation. In connection with Rule 2a-5 of the 1940 Act, the Trustees have designated the Fund’s investment adviser as its valuation designee. Investments for which valuations or market quotations are not readily available or are deemed unreliable are valued by the investment adviser, as valuation designee, at fair value using methods that most fairly reflect the security’s “fair value”, which is the amount that the Fund might reasonably expect to receive for the security upon its current sale in the ordinary course. Each such determination is based on a consideration of relevant factors, which are likely to vary from one pricing context to another. These factors may include, but are not limited to, the type of security, the existence of any contractual restrictions on the security’s disposition, the price and extent of public trading in similar securities of the issuer or of comparable companies or entities, quotations or relevant information obtained from broker/dealers or other market participants, information obtained from the issuer, analysts, and/or the appropriate stock exchange (for exchange-traded securities), an analysis of the company’s or entity’s financial statements, and an evaluation of the forces that influence the issuer and the market(s) in which the security is purchased and sold.
B Investment Transactions—Investment transactions for financial statement purposes are accounted for on a trade date basis. Realized gains and losses on investments sold are determined on the basis of identified cost.
C Income—Dividend income is recorded on the ex-dividend date for dividends received in cash and/or securities. However, if the ex-dividend date has passed, certain dividends from foreign securities are recorded as the Fund is informed of the ex-dividend date. Distributions from investment companies are recorded as dividend income, capital gains or return of capital based on the nature of the distribution. Withholding taxes on foreign dividends and capital gains have been provided for in accordance with the Fund’s understanding of the applicable countries’ tax rules and rates. As a result of several court cases in certain countries across the European Union (EU), the Fund filed additional tax reclaims for previously withheld taxes on dividends earned in those countries. Income recognized, if any, for EU reclaims and interest thereon is reflected as other income in the Statement of Operations, and any related receivable, if any, is reflected as European Union tax reclaims receivable in the Statement of Assets and Liabilities. Any fees associated with these filings are reflected in miscellaneous expenses in the Statement of Operations. When uncertainty exists as to the ultimate resolution of these proceedings, the likelihood of receipt of these EU reclaims, and the potential timing of payment, no amounts are reflected in the financial statements. For U.S. income tax purposes, EU reclaims received by the Fund, if any, may reduce the amount of foreign taxes Fund shareholders can use as tax deductions or credits on their
Eaton Vance
Equity Strategy Fund
August 31, 2026
Notes to Financial Statements — continued
income tax returns. In the event that EU reclaims received by the Fund during a fiscal year exceed foreign withholding taxes paid by the Fund, and the Fund previously passed through to its shareholders foreign taxes incurred by the Fund to be used as a credit or deduction on a shareholder’s income tax return, the Fund may be required to enter into a closing agreement with the Internal Revenue Service in order to pay the associated tax liability on behalf of the Fund’s shareholders. Interest income is recorded on the basis of interest accrued.
D Federal and Other Taxes—The Fund's policy is to comply with the provisions of the Internal Revenue Code applicable to regulated investment companies and to distribute to shareholders each year substantially all of its net investment income, and all or substantially all of its net realized capital gains. Accordingly, no provision for federal income or excise tax is necessary.
As of August 31, 2026, the Fund had no uncertain tax positions that would require financial statement recognition, de-recognition, or disclosure. The Fund files a U.S. federal income tax return annually after its fiscal year-end, which is subject to examination by the Internal Revenue Service for a period of three years from the date of filing.
During this reporting period, the Fund adopted FASB Accounting Standards Update No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures (ASU 2023-09), which requires annual disclosure of the amount of income taxes paid (net of refunds received) disaggregated by federal, state,
and foreign taxes, and further disaggregated by individual jurisdiction in which income taxes paid is equal to or greater than 5% of total income taxes paid. The adoption of ASU 2023-09 did not result in any changes to the Fund's financial statement presentation or disclosure.
E Expenses—The majority of expenses of the Trust are directly identifiable to an individual fund. Expenses which are not readily identifiable to a specific fund are allocated taking into consideration, among other things, the nature and type of expense and the relative size of the funds. Expenses do not include the Fund’s pro rata share of the indirect expenses borne by the Fund from its investments in exchange-traded funds.
F Foreign Currency Translation—Investment valuations, other assets, and liabilities initially expressed in foreign currencies are translated each business day into U.S. dollars based upon current exchange rates. Purchases and sales of foreign investment securities and income and expenses denominated in foreign currencies are translated into U.S. dollars based upon currency exchange rates in effect on the respective dates of such transactions. Recognized gains or losses on investment transactions attributable to changes in foreign currency exchange rates are recorded for financial statement purposes as net realized gains and losses on investments. That portion of unrealized gains and losses on investments that results from fluctuations in foreign currency exchange rates is not separately disclosed.
G Use of Estimates—The preparation of the financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of income and expense during the reporting period. Actual results could differ from those estimates.
H Indemnifications—Under the Trust’s organizational documents, its officers and Trustees may be indemnified against certain liabilities and expenses arising out of the performance of their duties to the Fund. Under Massachusetts law, if certain conditions prevail, shareholders of a Massachusetts business trust (such as the Trust) could be deemed to have personal liability for the obligations of the Trust. However, the Trust’s Declaration of Trust contains an express disclaimer of liability on the part of Fund shareholders and the By-laws provide that the Trust shall assume, upon request by the shareholder, the defense on behalf of any Fund shareholders. Moreover, the By-laws also provide for indemnification out of Fund property of any shareholder held personally liable solely by reason of being or having been a shareholder for all loss or expense arising from such liability. Additionally, in the normal course of business, the Fund enters into agreements with service providers that may contain indemnification clauses. The Fund’s maximum exposure under these arrangements is unknown as this would involve future claims that may be made against the Fund that have not yet occurred.
I Futures Contracts—Upon entering into a futures contract, the Fund is required to deposit with the broker, either in cash or securities, an amount equal to a certain percentage of the contract amount (initial margin). Subsequent payments, known as variation margin, are made or received by the Fund each business day, depending on the daily fluctuations in the value of the underlying security or index, and are recorded as unrealized gains or losses by the Fund. Gains (losses) are realized upon the expiration or closing of the futures contracts. Should market conditions change unexpectedly, the Fund may not achieve the anticipated benefits of the futures contracts and may realize a loss. Futures contracts have minimal counterparty risk as they are exchange traded and the clearinghouse for the exchange is substituted as the counterparty, guaranteeing counterparty performance.
J Segment Reporting—The Fund operates as a single reportable segment, an investment company whose investment objective(s) is included in Note 1. The Fund’s President acts as the Fund's Chief Operating Decision Maker (CODM), who is responsible for assessing the performance of the Fund's single segment and deciding how to allocate the segment’s resources. To perform this function, the CODM reviews the information in the Fund’s financial statements.
K Recently Issued Accounting Pronouncements—In September 2026, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2026-03, Fair Value Measurement (Topic 820): Investment Companies with Equity Securities Subject to Contractual Sale Restrictions. ASU 2026-03 requires investment companies to consider the effects of certain contractual sale restrictions when measuring the fair value of equity securities and to provide related disclosures. ASU 2026-03 is effective for fiscal years beginning after December 15, 2027, and interim periods within those fiscal years, with early adoption permitted. Management is currently evaluating the impact of adopting ASU 2026-03; however, it does not currently expect the implementation of the standard to have a material effect on the Fund's financial statements.
Eaton Vance
Equity Strategy Fund
August 31, 2026
Notes to Financial Statements — continued
2 Distributions to Shareholders and Income Tax Information
It is the present policy of the Fund to make at least one distribution annually (normally in December) of all or substantially all of its net investment income and to distribute annually all or substantially all of its net realized capital gains. Distributions to shareholders are recorded on the ex-dividend date. Distributions are declared separately for each class of shares. Shareholders may reinvest income and capital gain distributions in additional shares of the same class of the Fund at the net asset value as of the ex-dividend date or, at the election of the shareholder, receive distributions in cash. Distributions to shareholders are determined in accordance with income tax regulations, which may differ from U.S. GAAP. As required by U.S. GAAP, only distributions in excess of tax basis earnings and profits are reported in the financial statements as a return of capital. Permanent differences between book and tax accounting relating to distributions are reclassified to paid-in capital. For tax purposes, distributions from short-term capital gains are considered to be from ordinary income.
The tax character of distributions declared for the years ended August 31, 2026 and August 31, 2025 was as follows:
During the year ended August 31, 2026, distributable earnings was decreased by $9,150,460 and paid-in capital was increased by $9,150,460 due to the Fund’s use of equalization accounting. Tax equalization accounting allows the Fund to treat as a distribution that portion of redemption proceeds representing a redeeming shareholder’s portion of undistributed taxable income and net capital gains. These reclassifications had no effect on the net assets or net asset value per share of the Fund.
As of August 31, 2026, the components of distributable earnings (accumulated loss) on a tax basis were as follows:
Undistributed ordinary income |
|
Undistributed long-term capital gains |
|
Net unrealized appreciation |
|
| |
|
The cost and unrealized appreciation (depreciation) of investments, including open derivative contracts, of the Fund at August 31, 2026, as determined on a federal income tax basis, were as follows:
| |
|
Gross unrealized appreciation |
|
Gross unrealized depreciation |
|
Net unrealized appreciation |
|
Eaton Vance
Equity Strategy Fund
August 31, 2026
Notes to Financial Statements — continued
3 Investment Adviser and Administration Fee and Other Transactions with Affiliates
The investment adviser and administration fee is earned by Eaton Vance Management (EVM), an indirect, wholly-owned subsidiary of Morgan Stanley, as compensation for investment advisory and administrative services rendered to the Fund. The investment adviser and administration fee is computed at an annual rate as a percentage of the Fund’s average daily net assets as follows and is payable monthly:
| |
|
| |
|
$500 million but less than $1 billion |
|
$1 billion but less than $2.5 billion |
|
$2.5 billion but less than $5 billion |
|
| |
|
For the year ended August 31, 2026, the investment adviser and administration fee amounted to $3,982,445 or 0.75% of the Fund’s average daily net assets.
The Fund may invest in a money market fund, the Institutional Class of the Morgan Stanley Institutional Liquidity Funds - Government Portfolio (the “Liquidity Fund”), an open-end management investment company managed by Morgan Stanley Investment Management Inc., a wholly-owned subsidiary of Morgan Stanley. The investment adviser and administration fee paid by the Fund is reduced by an amount equal to its pro rata share of the advisory and administration fees paid by the Fund due to its investment in the Liquidity Fund. For the year ended August 31, 2026, the investment adviser and administration fee paid was reduced by $16,889 relating to the Fund’s investment in the Liquidity Fund.
EVM has agreed to reimburse the Fund’s expenses to the extent that total annual operating expenses (relating to ordinary operating expenses only and excluding expenses such as brokerage commissions, acquired fund fees and expenses of unaffiliated funds, borrowing costs (including borrowing costs of any acquired funds), taxes or litigation expenses) exceed 1.10%, 1.85% and 0.85% of the Fund’s average daily net assets for Class A, Class C and Class I, respectively. This agreement may be changed or terminated after January 1, 2027. Pursuant to this agreement, EVM waived and/or reimbursed $141,334 of the Fund’s operating expenses for the year ended August 31, 2026.
EVM provides sub-transfer agency and related services to the Fund pursuant to a Sub-Transfer Agency Support Services Agreement. For the year ended August 31, 2026, EVM earned $12,021 from the Fund pursuant to such agreement, which is included in transfer and dividend disbursing agent fees on the Statement of Operations. The Fund was informed that Eaton Vance Distributors, Inc. (EVD), an affiliate of EVM and the Fund’s principal underwriter, received $1,648 as its portion of the sales charge on sales of Class A shares for the year ended August 31, 2026. The Fund was informed that Morgan Stanley affiliated broker-dealers, which may be deemed to be affiliates of EVM and EVD, also received a portion of the sales charge on sales of Class A shares for the year ended August 31, 2026 in the amount of less than $100. EVD also received distribution and service fees from Class A and Class C shares (see Note 4) and contingent deferred sales charges (see Note 5).
Trustees and officers of the Fund who are members of EVM’s organization receive remuneration for their services to the Fund out of the investment adviser and administration fee. Trustees of the Fund who are not affiliated with EVM may elect to defer receipt of all or a percentage of their annual fees in accordance with the terms of the Trustees Deferred Compensation Plan. Certain officers and Trustees of the Fund are officers of EVM.
The Fund has in effect a distribution plan for Class A shares (Class A Plan) pursuant to Rule 12b-1 under the 1940 Act. Pursuant to the Class A Plan, the Fund pays EVD a distribution and service fee of 0.25% per annum of its average daily net assets attributable to Class A shares for distribution services and facilities provided to the Fund by EVD, as well as for personal services and/or the maintenance of shareholder accounts. Distribution and service fees paid or accrued to EVD for the year ended August 31, 2026 amounted to $409,584 for Class A shares.
The Fund also has in effect a distribution plan for Class C shares (Class C Plan) pursuant to Rule 12b-1 under the 1940 Act. Pursuant to the Class C Plan, the Fund pays EVD amounts equal to 0.75% per annum of its average daily net assets attributable to Class C shares for providing ongoing distribution services and facilities to the Fund. For the year ended August 31, 2026, the Fund paid or accrued to EVD $103,556 for Class C shares.
Pursuant to the Class C Plan, the Fund also makes payments of service fees to EVD, financial intermediaries and other persons in amounts equal to 0.25% per annum of its average daily net assets attributable to that class. Service fees paid or accrued are for personal services and/or the maintenance of shareholder accounts. They are separate and distinct from the sales commissions and distribution fees payable to EVD. Service fees paid or accrued for the year ended August 31, 2026 amounted to $34,518 for Class C shares.
Distribution and service fees are subject to the limitations contained in the Financial Industry Regulatory Authority Rule 2341(d).
Eaton Vance
Equity Strategy Fund
August 31, 2026
Notes to Financial Statements — continued
5 Contingent Deferred Sales Charges
A contingent deferred sales charge (CDSC) of 1% generally is imposed on redemptions of Class C shares made within 12 months of purchase. Class A shares may be subject to a 1% CDSC if redeemed within 12 months of purchase (depending on the circumstances of purchase). Generally, the CDSC is based upon the lower of the net asset value at date of redemption or date of purchase. No charge is levied on shares acquired by reinvestment of dividends or capital gain distributions. For the year ended August 31, 2026, the Fund was informed that EVD received $1,631 of CDSCs paid by Class C shareholders and no CDSCs paid by Class A shareholders.
6 Purchases and Sales of Investments
Purchases and sales of investments, other than short-term obligations, aggregated $1,024,534,764 and $990,542,529, respectively, for the year ended August 31, 2026.
7 Shares of Beneficial Interest
The Fund’s Declaration of Trust permits the Trustees to issue an unlimited number of full and fractional shares of beneficial interest (without par value). Such shares may be issued in a number of different series (such as the Fund) and classes. Transactions in Fund shares, including direct exchanges pursuant to share class conversions, were as follows:
| |
Year Ended
August 31, 2026 |
Year Ended
August 31, 2025 |
| |
|
|
|
|
| |
|
|
|
|
| |
|
|
|
|
Issued to shareholders electing to receive payments of distributions in Fund shares |
|
|
|
|
| |
|
|
|
|
| |
|
|
|
|
| |
|
|
|
|
| |
|
|
|
|
Issued to shareholders electing to receive payments of distributions in Fund shares |
|
|
|
|
| |
|
|
|
|
| |
|
|
|
|
| |
|
|
|
|
| |
|
|
|
|
Issued to shareholders electing to receive payments of distributions in Fund shares |
|
|
|
|
| |
|
|
|
|
| |
|
|
|
|
The Fund may trade in financial instruments with off-balance sheet risk in the normal course of its investing activities. These financial instruments may include futures contracts and may involve, to a varying degree, elements of risk in excess of the amounts recognized for financial statement purposes. The notional or contractual amounts of these instruments represent the investment the Fund has in particular classes of financial instruments and do not necessarily represent the amounts potentially subject to risk. The measurement of the risks associated with these instruments is meaningful only when all related and offsetting transactions are considered. A summary of obligations under these financial instruments at August 31, 2026 is included in the Portfolio of Investments. At August 31, 2026, the Fund had sufficient cash and/or securities to cover commitments under these contracts.
Eaton Vance
Equity Strategy Fund
August 31, 2026
Notes to Financial Statements — continued
The Fund is subject to equity price risk in the normal course of pursuing its investment objective. The Fund enters into equity index futures contracts to enhance total return and/or to manage certain investment risks.
The fair value of open derivative instruments (not considered to be hedging instruments for accounting disclosure purposes) and whose primary underlying risk exposure is equity price risk at August 31, 2026 was as follows:
| |
Only the current day’s variation margin on open futures contracts is reported within the Statement of Assets and Liabilities as Receivable or Payable for variation margin on open futures contracts, as applicable. |
The effect of derivative instruments (not considered to be hedging instruments for accounting disclosure purposes) on the Statement of Operations and whose primary underlying risk exposure is equity price risk for the year ended August 31, 2026 was as follows:
| |
Realized Gain (Loss)
on Derivatives Recognized
in Income |
Change in Unrealized
Appreciation (Depreciation) on
Derivatives Recognized in Income(1) |
| |
|
|
| |
Statement of Operations location: Change in unrealized appreciation (depreciation): Futures contracts. |
The average notional cost of futures contracts (long) outstanding during the year ended August 31, 2026, which is indicative of the volume of this derivative type, was approximately $551,000.
The Fund participates with other portfolios and funds managed by EVM and its affiliates in a $650 million unsecured revolving line of credit agreement with a group of banks, which is in effect through October 20, 2026. Borrowings are made by the Fund solely for temporary purposes related to redemptions and other short-term cash needs. Interest is charged to the Fund based on its borrowings generally at an amount above either the Secured Overnight Financing Rate (SOFR) or Federal Funds rate. In addition, a fee computed at an annual rate of 0.15% on the daily unused portion of the line of credit is allocated among the participating portfolios and funds at the end of each quarter. In connection with the renewal of the agreement in October 2025, an arrangement fee of $150,000 was incurred that was allocated to the participating portfolios and funds. Because the line of credit is not available exclusively to the Fund, it may be unable to borrow some or all of its requested amounts at any particular time. The Fund did not have any significant borrowings or allocated fees during the year ended August 31, 2026.
10 Securities Lending Agreement
The Fund has established a securities lending agreement with State Street Bank and Trust Company (SSBT) as securities lending agent in which the Fund lends portfolio securities to qualified borrowers in exchange for collateral consisting of either cash or securities issued or guaranteed by the U.S. government or its agencies or instrumentalities in an amount at least equal to the market value of the securities on loan. The market value of securities loaned is determined daily and any additional required collateral is delivered to the Fund on the next business day. Cash collateral is invested in the State Street Navigator Securities Lending Government Money Market Portfolio, a money market fund registered under the 1940 Act. The Fund earns interest on the amount invested but it must pay (and at times receive from) the broker a loan rebate fee computed as a varying percentage of the collateral received. For security loans secured by non-cash collateral, the Fund earns a negotiated lending fee from the borrower. A portion of the income earned by the Fund from its investment of cash collateral, net of rebate fees, and lending fees received is allocated to SSBT for its services as lending agent and the portion allocated to the Fund is presented as securities lending income, net on the Statement of Operations. Non-cash collateral is held by the lending agent on behalf of the Fund and cannot be sold or re-pledged by the Fund; accordingly, such collateral is not reflected in the Statement of Assets and Liabilities.
The Fund is subject to possible delay in the recovery of loaned securities. Pursuant to the securities lending agreement, SSBT has provided indemnification to the Fund in the event of default by a borrower with respect to a loan. The Fund bears the risk of loss with respect to the investment of cash collateral.
Eaton Vance
Equity Strategy Fund
August 31, 2026
Notes to Financial Statements — continued
At August 31, 2026, the value of the securities loaned and the value of the collateral received, which exceeded the value of the securities loaned, amounted to $22,936,127 and $23,658,966, respectively. Collateral received was comprised of cash of $11,402,356 and U.S. government and/or agencies securities of $12,256,610. The securities lending transactions have no contractual maturity date and each of the Fund and borrower has the option to terminate a loan at any time.
The following table provides a breakdown of securities lending transactions accounted for as secured borrowings, the obligations by class of collateral pledged, and the remaining contractual maturity of those transactions as of August 31, 2026.
| |
Remaining Contractual Maturity of the Transactions |
| |
|
|
|
|
|
| |
|
|
|
|
|
| |
|
|
|
|
|
| |
|
|
|
|
|
The carrying amount of the liability for collateral for securities loaned at August 31, 2026 approximated its fair value. If measured at fair value, such liability would have been considered as Level 2 in the fair value hierarchy (see Note 12) at August 31, 2026.
11 Affiliated Investments
At August 31, 2026, the value of the Fund's investment in funds that may be deemed to be affiliated was $11,189,122, which represents 1.8% of the Fund's net assets. Transactions in such investments by the Fund for the year ended August 31, 2026 were as follows:
| |
Value,
beginning
of period |
|
|
|
Change in
unrealized
appreciation
(depreciation) |
|
|
|
| |
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
12 Fair Value Measurements
Under generally accepted accounting principles for fair value measurements, a three-tier hierarchy to prioritize the assumptions, referred to as inputs, is used in valuation techniques to measure fair value. The three-tier hierarchy of inputs is summarized in the three broad levels listed below.
• Level 1 – quoted prices in active markets for identical investments
• Level 2 – other significant observable inputs (including quoted prices for similar investments, interest rates, prepayment speeds, credit risk, etc.)
• Level 3 – significant unobservable inputs (including a fund's own assumptions in determining the fair value of investments)
In cases where the inputs used to measure fair value fall in different levels of the fair value hierarchy, the level disclosed is determined based on the lowest level input that is significant to the fair value measurement in its entirety. The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.
At August 31, 2026, the hierarchy of inputs used in valuing the Fund's investments and open derivative instruments, which are carried at fair value, were as follows:
Eaton Vance
Equity Strategy Fund
August 31, 2026
Notes to Financial Statements — continued
Asset Description (continued) |
|
|
|
|
| |
|
|
|
|
| |
|
|
|
|
| |
|
|
|
|
| |
|
|
|
|
| |
|
|
|
|
| |
|
|
|
|
| |
|
|
|
|
| |
|
|
|
|
| |
|
|
|
|
| |
|
|
|
|
| |
|
|
|
|
| |
|
|
|
|
Securities Lending Collateral |
|
|
|
|
| |
|
|
|
|
| |
|
|
|
|
| |
|
|
|
|
| |
|
|
|
|
| |
Includes foreign equity securities whose values were adjusted to reflect market trading of comparable securities or other correlated instruments that occurred after the close of trading in their applicable foreign markets. |
13 Risks and Uncertainties
Risks Associated with Foreign Investments
Foreign investments can be adversely affected by political, economic and market developments abroad, including the imposition of economic and other sanctions by the United States or another country, and by acts of terrorism and war. There may be less publicly available information about foreign issuers because they may not be subject to reporting practices, requirements or regulations comparable to those to which United States companies are subject. Foreign markets may be smaller, less liquid and more volatile than the major markets in the United States. Trading in foreign markets typically involves higher expense than trading in the United States. The Fund may have difficulties enforcing its legal or contractual rights in a foreign country. Securities that trade or are denominated in currencies other than the U.S. dollar may be adversely affected by fluctuations in currency exchange rates.
Eaton Vance
Equity Strategy Fund
August 31, 2026
Report of Independent Registered Public Accounting Firm
To the Trustees of Eaton Vance Growth Trust and Shareholders of Eaton Vance Equity Strategy Fund:
Opinion on the Financial Statements and Financial Highlights
We have audited the accompanying statement of assets and liabilities of Eaton Vance Equity Strategy Fund (the "Fund") (one of the funds constituting Eaton Vance Growth Trust), including the portfolio of investments, as of August 31, 2026, the related statement of operations for the year then ended, the statements of changes in net assets for each of the two years in the period then ended, the financial highlights for each of the five years in the period then ended, and the related notes (collectively referred to as the “financial statements and financial highlights”). In our opinion, the financial statements and financial highlights present fairly, in all material respects, the financial position of the Fund as of August 31, 2026, and the results of its operations for the year then ended, the changes in its net assets for each of the two years in the period then ended, and the financial highlights for each of the five years in the period then ended, in conformity with accounting principles generally accepted in the United States of America.
These financial statements and financial highlights are the responsibility of the Fund's management. Our responsibility is to express an opinion on the Fund's financial statements and financial highlights based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Fund in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements and financial highlights are free of material misstatement, whether due to error or fraud. The Fund is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Fund’s internal control over financial reporting. Accordingly, we express no such opinion.
Our audits included performing procedures to assess the risks of material misstatement of the financial statements and financial highlights, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements and financial highlights. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements and financial highlights. Our procedures included confirmation of securities owned as of August 31, 2026, by correspondence with the custodian and brokers; when replies were not received from brokers, we performed other auditing procedures. We believe that our audits provide a reasonable basis for our opinion.
/s/ Deloitte & Touche LLP
Boston, Massachusetts
October 19, 2026
We have served as the auditor of one or more Eaton Vance investment companies since 1959.
Eaton Vance
Equity Strategy Fund
August 31, 2026
Federal Tax Information (Unaudited)
The Form 1099-DIV you receive in February 2027 will show the tax status of all distributions paid to your account in calendar year 2026. Shareholders
are advised to consult their own tax adviser with respect to the tax consequences of their investment in the Fund. As required by the Internal Revenue Code and/or regulations, shareholders must be notified regarding the status of qualified dividend income for individuals, the dividends received deduction for corporations and capital gains dividends.
Qualified Dividend Income. For the fiscal year ended August 31, 2026, the Fund designates approximately $6,609,771, or up to the maximum amount of such dividends allowable pursuant to the Internal Revenue Code, as qualified dividend income eligible for the reduced tax rate of 15%.
Dividends Received Deduction. Corporate shareholders are generally entitled to take the dividends received deduction on the portion of the Fund’s dividend distribution that qualifies under tax law. For the Fund’s fiscal 2026 ordinary income dividends, 50.79% qualifies for the corporate dividends received deduction.
Capital Gains Dividends. The Fund hereby designates as a capital gain dividend with respect to the taxable year ended August 31, 2026, $48,234,999
or, if subsequently determined to be different, the net capital gain of such year.
Eaton Vance
Equity Strategy Fund
August 31, 2026
Board of Trustees’ Contract Approval
Overview of the Contract Review Process
The Investment Company Act of 1940, as amended (the “1940 Act”), provides, in substance, that the investment advisory agreement between a fund and its investment adviser will continue in effect from year-to-year only if its continuation is approved on an annual basis by a vote of the fund’s board of trustees, including a majority of the trustees who are not “interested persons” of the fund (“independent trustees”), cast in person at a meeting called for the purpose of considering such approval.
At a meeting held on June 11, 2026, the Boards of Trustees/Directors (collectively, the “Board”) that oversee the registered investment companies advised by Eaton Vance Management or its affiliate, Boston Management and Research (the “Eaton Vance Funds”), including a majority of the independent trustees (the “Independent Trustees”), voted to approve the continuation of existing investment advisory agreements and sub-advisory agreements1 for each of the Eaton Vance Funds for an additional one-year period. The Board relied upon the affirmative recommendation of its Contract Review Committee, which is a committee comprised of all of the Independent Trustees. Prior to making its recommendation, the Contract Review Committee reviewed information furnished by the adviser and sub-adviser to each of the Eaton Vance Funds (including information specifically requested by the Board) for a series of meetings held between April and June 2026, as well as certain additional information provided in response to specific requests from the Independent Trustees as members of the Contract Review Committee. Members of the Contract Review Committee also considered information received at prior meetings of the Board and its committees, to the extent such information was relevant to the Contract Review Committee’s annual evaluation of the investment advisory agreements and sub-advisory agreements.
In connection with its evaluation of the investment advisory agreements and sub-advisory agreements, the Board (directly or through one or more of its committees) considered various information relating to the Eaton Vance Funds. This included information applicable to all or groups of the Eaton Vance Funds, which is referenced immediately below, and information applicable to the particular Eaton Vance Fund covered by this report (each Eaton Vance Fund is referred to below as a “fund”). (For funds that invest through one or more underlying portfolios, references to “each fund” in this section may include information that was considered at the portfolio-level.)
Information about Fees, Performance and Expenses
• A report from an independent data provider comparing advisory and other fees paid by each fund to such fees paid by comparable funds, as identified by the independent data provider (“comparable funds”);
• A report from an independent data provider comparing each fund’s total expense ratio (and its components) to those of comparable funds;
• A report from an independent data provider comparing the investment performance of each fund to the investment performance of comparable funds and, as applicable, benchmark indices, over various time periods;
• In certain instances, data regarding investment performance relative to customized groups of peer funds and blended indices identified by the adviser in consultation with the Portfolio Management Committee of the Board (a committee exclusively comprised of Independent Trustees);
• Comparative information concerning the fees charged and services provided by the adviser and sub-adviser to each fund in managing other accounts (which may include other funds, collective investment trusts and institutional accounts) with the same or substantially similar investment objective as the fund and with a significant overlap in holdings based on criteria set by the Board, if any;
• Profitability analyses on a fund-by-fund basis for the adviser and its affiliates and the cost allocation methodology used to determine such analyses;
Information about Portfolio Management and Trading
• Descriptions of the investment management services provided to each fund, as well as each of the funds’ investment strategies and policies;
• The procedures and processes used by the adviser to determine the value of fund assets, including, when necessary, the determination of “fair value” by the adviser in its role as each fund’s valuation designee and actions taken to monitor and test the effectiveness of such procedures and processes;
• Information about the policies and practices of each fund’s adviser and sub-adviser with respect to trading, including their processes for seeking best execution of portfolio transactions;
• Information about the allocation of brokerage transactions and the benefits, if any, received by the adviser and sub-adviser to each fund as a result of brokerage allocation, including, as applicable, information concerning the acquisition of research through client commission arrangements and policies with respect to “soft dollars”;
• Data relating to the portfolio turnover rate of each fund and related information regarding active management in the context of particular strategies;
Information about each Adviser and Sub-Adviser
• Information regarding the individual investment professionals whose responsibilities include portfolio management and investment research for the funds, and, for portfolio managers and certain other investment professionals, information relating to their responsibilities with respect to managing other funds and investment accounts, as applicable;
1 Not all Eaton Vance Funds have entered into a sub-advisory agreement with a sub-adviser. Accordingly, references to “sub-adviser” or “sub-advisory agreement” in this “Overview” section may not be applicable to the particular Eaton Vance Fund covered by this report. Eaton Vance Management and Boston Management and Research are referred to collectively as the “adviser.”
Eaton Vance
Equity Strategy Fund
August 31, 2026
Board of Trustees’ Contract Approval — continued
• Information regarding the adviser’s and its parent company’s (Morgan Stanley’s) efforts to retain and attract talented investment professionals, including in the context of a competitive marketplace for talent;
• Information regarding the adviser’s compensation methodology for its investment professionals and the incentives and accountability it creates, along with investment professionals’ investments in the fund(s) they manage;
• The personal trading codes of ethics of the adviser and its affiliates and the sub-adviser of each fund, together with information relating to compliance with, and the administration of, such codes;
• Policies and procedures relating to proxy voting, including regular reporting with respect to fund proxy voting activities;
• Information regarding the handling of corporate actions and class actions, as well as information regarding litigation and other regulatory matters;
• Information concerning the resources devoted to compliance efforts undertaken by the adviser and its affiliates and the sub-adviser of each fund, including descriptions of their various compliance programs and their record of compliance and remediation;
• Information concerning the business continuity and disaster recovery plans of the adviser and its affiliates and the sub-adviser of each fund;
• A description of the adviser’s oversight of sub-advisers, including with respect to regulatory and compliance issues, investment management and other matters, if any;
Other Relevant Information
• Information regarding ongoing initiatives to further integrate and harmonize, where applicable, the investment management and other departments of the adviser and its affiliates with the overall investment management infrastructure of Morgan Stanley, in light of Morgan Stanley’s acquisition of Eaton Vance Corp. on March 1, 2021;
• Information concerning the nature, cost, and character of the administrative and other non-investment advisory services provided by the adviser and its affiliates;
• Information concerning oversight of the relationship with the custodian, subcustodians, fund accountants, and other third-party service providers by the adviser and/or administrator to each of the funds;
• Information concerning efforts to maintain policies and procedures with respect to various regulations applicable to the funds, including, without limitation, Rule 22e-4 (the Liquidity Risk Management Rule), Rule 12d1-4 (the Fund-of-Funds Rule), Rule 18f-4 (the Derivatives Rule), and Rule 2a-5 (the Fair Valuation Rule);
• For each Eaton Vance Fund structured as an exchange-listed closed-end fund, information concerning the benefits of the closed-end fund structure, as well as, where relevant, the closed-end fund’s market prices (including as compared to the closed-end fund’s net asset value (NAV)), trading volume data, continued use of auction preferred shares (where applicable), distribution rates, and other relevant matters;
• The risks that the adviser and/or its affiliates incur in connection with the management and operation of the funds, including, among others, litigation, regulatory, entrepreneurial, data privacy and cybersecurity, and other business risks (and the associated costs of such risks, if any); and
• The terms of each investment advisory agreement and sub-advisory agreement.
During the various meetings of the Board and its committees over the course of the year leading up to the June 11, 2026 meeting, the Board and its committees received information from portfolio managers and other investment professionals of the adviser and sub-advisers of the funds regarding investment and performance matters, and considered various investment and trading strategies used in pursuing the funds’ investment objectives. The Board and its committees also received information regarding risk management techniques employed in connection with the management of the funds. The Board and its committees evaluated issues pertaining to industry and regulatory developments, compliance procedures, fund governance, and other issues with respect to the funds, and received and participated in reports and presentations provided by the adviser, sub-advisers, and certain other service providers, with respect to such matters. In addition to the formal meetings of the Board and its committees, the Independent Trustees met in executive sessions and held regular video or telephone conferences to discuss, among other topics, matters relating to the continuation of investment advisory agreements and sub-advisory agreements.
Each of the Contract Review Committee and the Board was advised throughout the contract review process by Kirkland & Ellis LLP, independent legal counsel for the Independent Trustees. The members of the Contract Review Committee and the members of the Board, with the advice of such counsel, exercised their own business judgment in determining the material factors to be considered in evaluating each investment advisory agreement and sub-advisory agreement and the weight to be given to each such factor. The conclusions reached with respect to each investment advisory agreement and sub-advisory agreement were based on a comprehensive evaluation of all the information provided and not any single factor. Moreover, each member of the Contract Review Committee and Board may have placed varying emphasis on particular factors in reaching conclusions with respect to each investment advisory agreement and sub-advisory agreement. In evaluating each investment advisory agreement and sub-advisory agreement, including the fee structures and other terms contained in such agreements, the members of the Contract Review Committee and Board were also informed by multiple years of analysis and discussion with the adviser and sub-adviser to each of the Eaton Vance Funds.
Eaton Vance
Equity Strategy Fund
August 31, 2026
Board of Trustees’ Contract Approval — continued
Results of the Contract Review Process
Based on its consideration of the foregoing, and such other information it deemed relevant, including the factors and conclusions described below, the Contract Review Committee concluded that the continuation of the investment advisory and administrative agreement between Eaton Vance Equity Strategy Fund (formerly, Eaton Vance RBA Equity Strategy Fund) (the “Fund”) and Eaton Vance Management (the “Adviser”), including its fee structure, is in the interests of shareholders and, therefore, recommended to the Board approval of the agreement. Based on the recommendation of the Contract Review Committee, the Board, including a majority of the Independent Trustees, voted to approve continuation of the investment advisory and administrative agreement for the Fund.
Nature, Extent and Quality of Services
In considering whether to approve the investment advisory and administrative agreement for the Fund, the Board evaluated the nature, extent and quality of services provided to the Fund by the Adviser.
The Board considered the Adviser’s management capabilities and investment processes in light of the types of investments held by the Fund, including the education and experience of the investment professionals who provide services to the Fund, including recent changes to such personnel. The Board specifically noted that the Adviser has devoted extensive resources to in-house equity research and also draws upon independent research available from third-party sources. In particular, the Board considered the principal elements of the Adviser’s investment process and portfolio construction techniques. The Board also took into account the resources dedicated to portfolio management and other services, the compensation methods of the Adviser and other factors, including the reputation and resources of the Adviser to recruit and retain highly qualified research, advisory and supervisory investment professionals. In addition, the Board considered the time and attention devoted to the Eaton Vance Funds, including the Fund, by senior management, as well as the infrastructure, operational capabilities and support staff in place to assist in the portfolio management and operations of the Fund, including the provision of administrative services. The Board also considered the business-related and other risks to which the Adviser or its affiliates may be subject in managing the Fund.
The Board considered the compliance programs of the Adviser and relevant affiliates thereof. The Board considered compliance and reporting matters regarding, among other things, personal trading by investment professionals, disclosure of portfolio holdings, compliance with policies and procedures, portfolio valuation, business continuity and the allocation of investment opportunities. The Board also considered relevant examinations of the Adviser and its affiliates by regulatory authorities, such as the Securities and Exchange Commission and the Financial Industry Regulatory Authority.
The Board considered other administrative services provided or overseen by Eaton Vance Management and its affiliates, including transfer agency and accounting services. The Board evaluated the benefits to shareholders of investing in a fund that is a part of a large fund complex offering exposure to a variety of asset classes and investment disciplines, as well as the ability, in many cases, to exchange an investment among different funds without incurring additional sales charges.
After consideration of the foregoing factors, among others, the Board concluded that the nature, extent and quality of services provided by the Adviser, taken as a whole, are appropriate and consistent with the terms of the investment advisory and administrative agreement.
The Board noted that, effective August 18, 2025, the name and investment strategies of the Fund were changed to provide the Fund with the flexibility to achieve diversified, superior risk adjusted returns by dynamically allocating to multiple strategies, regions, sectors and factors in a changing and diverse growth cycle. Although the Board considered information comparing the Fund’s investment performance to that of comparable funds identified by an independent data provider (the peer group), the Board determined, in light of the recent changes, to continue to monitor and evaluate the effectiveness of such changes over time.
Management Fees and Expenses
The Board considered contractual fee rates payable by the Fund for advisory and administrative services (referred to collectively as “management fees”). As part of its review, the Board considered the Fund’s management fees and total expense ratio for the one-year period ended December 31, 2025, as compared to those of comparable funds, before and after giving effect to any undertaking to waive fees or reimburse expenses. The Board also considered certain factors identified by management in response to requests from the Contract Review Committee regarding the Fund’s total expense ratio relative to comparable funds. The Board also considered that the management fees paid by the Fund are for services provided in addition to, and are not duplicative of, services provided under the advisory contract(s) of the exchange traded funds in which the Fund may invest.
After considering the foregoing information, and in light of the nature, extent and quality of the services provided by the Adviser, the Board concluded that the management fees charged for advisory and related services are reasonable.
Eaton Vance
Equity Strategy Fund
August 31, 2026
Board of Trustees’ Contract Approval — continued
Profitability and “Fall-Out” Benefits
The Board considered the level of profits realized by the Adviser and relevant affiliates thereof in providing investment advisory and administrative services to the Fund and to all Eaton Vance Funds as a group. The Board considered the level of profits realized without regard to marketing support or other payments by the Adviser and its affiliates to third parties in respect of distribution or other services.
The Board concluded that, in light of the foregoing factors and the nature, extent and quality of the services rendered, the profits realized by the Adviser and its affiliates are not excessive.
The Board also considered direct and indirect fall-out benefits received by the Adviser and its affiliates in connection with their respective relationships with the Fund and the other Eaton Vance Funds, including, among other things, fees for trading, distribution and/or shareholder servicing and for transaction processing and reporting platforms used by securities lending agent(s), and research received by each Adviser generated from commission dollars spent on funds’ portfolio trading.
In reviewing management fees and profitability, the Board also considered the extent to which the Adviser and its affiliates, on the one hand, and the Fund, on the other hand, can expect to realize benefits from economies of scale as the assets of the Fund increase. The Board acknowledged the difficulty in accurately measuring the benefits resulting from economies of scale, if any, with respect to the management of any specific fund or group of funds. To assist in the evaluation of the sharing of any economies of scale, the Board received data for recent years showing asset levels, Adviser profitability and total expense ratios. Based upon the foregoing, the Board concluded that the Fund currently shares in the benefits from economies of scale, if any, when they are realized by the Adviser. The Board also concluded that the structure of the advisory fee, which includes breakpoints at several asset levels, will allow the Fund to continue to benefit from any economies of scale in the future.
Eaton Vance
Annual Financial Statements and
Additional Information
This report must be preceded or accompanied by a current summary prospectus or prospectus. Before investing, investors should consider carefully the investment objective, risks, and charges and expenses of a mutual fund. This and other important information is contained in the prospectus and/or statement of additional information, which can be obtained by calling 1-800-262-1122 or from a financial intermediary. Prospective investors should read the prospectus carefully before investing.
Annual Financial Statements and Additional Information August 31, 2026
Eaton Vance
All Asset Strategy Fund
Items 8 and 9 of Form N-CSR are Not Applicable. For Item 10 of Form N-CSR, see Item 7.
Eaton Vance
All Asset Strategy Fund
August 31, 2026
| |
|
|
Aerospace & Defense — 2.5% |
AeroVironment, Inc.(1)(2) |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
Red Cat Holdings, Inc.(1)(2) |
|
|
|
| |
|
|
|
| |
|
|
|
| |
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
| |
|
|
|
| |
|
|
|
Atlantic Union Bankshares Corp.(2) |
|
|
|
Banca Monte dei Paschi di Siena SpA |
|
|
|
Banco Bilbao Vizcaya Argentaria SA |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
Citizens Financial Group, Inc. |
|
|
|
Columbia Banking System, Inc. |
|
|
|
| |
|
|
|
Fukuoka Financial Group, Inc. |
|
|
|
Hachijuni Nagano Bank Ltd. |
|
|
|
| |
|
|
|
Huntington Bancshares, Inc. |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
Kyushu Financial Group, Inc. |
|
|
|
| |
|
|
| |
| |
|
|
|
Mizuho Financial Group, Inc. |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
Sumitomo Mitsui Financial Group, Inc. |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
Yokohama Financial Group, Inc. |
|
|
|
| |
|
|
|
| |
| |
|
|
|
| |
|
|
|
| |
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
| |
|
|
|
| |
|
|
|
| |
Johnson Controls International PLC |
|
|
|
| |
|
|
|
| |
Ares Management Corp., Class A(2) |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
Goldman Sachs Group, Inc. |
|
|
|
| |
|
|
|
| |
Air Products and Chemicals, Inc. |
|
|
|
See Notes to Financial Statements.
Eaton Vance
All Asset Strategy Fund
August 31, 2026
Portfolio of Investments — continued
| |
|
|
| |
| |
|
|
|
| |
|
|
|
Communications Equipment — 0.4% |
| |
|
|
|
| |
|
|
|
| |
|
|
|
Construction & Engineering — 0.2% |
| |
|
|
|
| |
|
|
|
Consumer Staples Distribution & Retail — 0.3% |
| |
|
|
|
| |
|
|
|
Diversified Telecommunication Services — 0.2% |
| |
|
|
|
| |
|
|
|
Electric Utilities — 1.9% |
Constellation Energy Corp. |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
Terna - Rete Elettrica Nazionale |
|
|
|
| |
|
|
|
Electrical Equipment — 1.9% |
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
Electronic Equipment, Instruments & Components — 0.5% |
| |
|
|
|
| |
|
|
|
Teledyne Technologies, Inc.(1) |
|
|
|
| |
|
|
|
Energy Equipment & Services — 0.2% |
| |
|
|
|
| |
|
|
|
| |
| |
|
|
|
| |
|
|
|
Financial Services — 1.6% |
Berkshire Hathaway, Inc., Class B(1) |
|
|
|
| |
|
|
|
| |
|
|
|
Mastercard, Inc., Class A |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
Chesapeake Utilities Corp.(2) |
|
|
|
| |
|
|
|
Ground Transportation — 0.1% |
| |
|
|
|
| |
|
|
|
Health Care Equipment & Supplies — 0.6% |
| |
|
|
|
Boston Scientific Corp.(1) |
|
|
|
| |
|
|
|
Intuitive Surgical, Inc.(1) |
|
|
|
| |
|
|
|
Health Care Providers & Services — 2.6% |
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
See Notes to Financial Statements.
Eaton Vance
All Asset Strategy Fund
August 31, 2026
Portfolio of Investments — continued
| |
|
|
Health Care Providers & Services (continued) |
| |
|
|
|
Molina Healthcare, Inc.(1) |
|
|
|
| |
|
|
|
| |
|
|
|
Hotels, Restaurants & Leisure — 0.7% |
| |
|
|
|
Chipotle Mexican Grill, Inc.(1) |
|
|
|
DoorDash, Inc., Class A(1) |
|
|
|
| |
|
|
|
United Parks & Resorts, Inc.(1)(2) |
|
|
|
| |
|
|
|
Household Durables — 0.3% |
Century Communities, Inc. |
|
|
|
Ethan Allen Interiors, Inc.(2) |
|
|
|
| |
|
|
|
Household Products — 0.2% |
| |
|
|
|
| |
|
|
|
Independent Power and Renewable Electricity Producers — 0.4% |
Clearway Energy, Inc., Class C(2) |
|
|
|
| |
|
|
|
| |
|
|
|
Industrial Conglomerates — 0.5% |
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
Rexford Industrial Realty, Inc. |
|
|
|
| |
|
|
|
| |
| |
|
|
|
American International Group, Inc. |
|
|
|
| |
|
|
|
Muenchener Rueckversicherungs-Gesellschaft AG in Muenchen |
|
|
|
| |
|
|
|
| |
|
|
Interactive Media & Services — 3.1% |
| |
|
|
|
| |
|
|
|
| |
|
|
|
Meta Platforms, Inc., Class A |
|
|
|
| |
|
|
|
| |
Cloudflare, Inc., Class A(1) |
|
|
|
International Business Machines Corp. |
|
|
|
| |
|
|
|
| |
|
|
|
| |
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
| |
|
|
|
| |
|
|
|
Oil, Gas & Consumable Fuels — 1.1% |
| |
|
|
|
| |
|
|
|
See Notes to Financial Statements.
Eaton Vance
All Asset Strategy Fund
August 31, 2026
Portfolio of Investments — continued
| |
|
|
Oil, Gas & Consumable Fuels (continued) |
| |
|
|
|
| |
|
|
|
ExxonMobil Holdings Corp. |
|
|
|
| |
|
|
|
| |
|
|
|
Passenger Airlines — 0.2% |
| |
|
|
|
| |
|
|
|
| |
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
Professional Services — 0.8% |
Automatic Data Processing, Inc. |
|
|
|
| |
|
|
|
| |
|
|
|
Paylocity Holding Corp.(1) |
|
|
|
Recruit Holdings Co. Ltd. |
|
|
|
| |
|
|
|
Semiconductors & Semiconductor Equipment — 8.6% |
Advanced Micro Devices, Inc.(1) |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
Taiwan Semiconductor Manufacturing Co. Ltd. ADR |
|
|
|
| |
|
|
Semiconductors & Semiconductor Equipment (continued) |
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
| |
|
|
|
Crowdstrike Holdings, Inc., Class A(1) |
|
|
|
Datadog, Inc., Class A(1) |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
Palantir Technologies, Inc., Class A(1) |
|
|
|
Palo Alto Networks, Inc.(1) |
|
|
|
| |
|
|
|
Workday, Inc., Class A(1) |
|
|
|
| |
|
|
|
| |
Digital Realty Trust, Inc. |
|
|
|
| |
|
|
|
| |
Abercrombie & Fitch Co., Class A(1) |
|
|
|
Boot Barn Holdings, Inc.(1)(2) |
|
|
|
Floor & Decor Holdings, Inc., Class A(1) |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
Technology Hardware, Storage & Peripherals — 3.1% |
| |
|
|
|
Seagate Technology Holdings PLC |
|
|
|
| |
|
|
|
| |
|
|
|
| |
Philip Morris International, Inc. |
|
|
|
| |
|
|
|
Trading Companies & Distributors — 0.3% |
| |
|
|
|
See Notes to Financial Statements.
Eaton Vance
All Asset Strategy Fund
August 31, 2026
Portfolio of Investments — continued
| |
|
|
Trading Companies & Distributors (continued) |
| |
|
|
|
| |
|
|
|
| |
American Water Works Co., Inc. |
|
|
|
| |
|
|
|
United Utilities Group PLC |
|
|
|
| |
|
|
|
Wireless Telecommunication Services — 0.1% |
| |
|
|
|
| |
|
|
|
Total Common Stocks
(identified cost $63,712,635) |
|
|
|
Exchange-Traded Funds — 37.9% |
| |
|
|
| |
Franklin FTSE China ETF(2) |
|
|
|
Franklin FTSE Latin America ETF |
|
|
|
iShares Core MSCI Emerging Markets ETF |
|
|
|
iShares MSCI South Korea ETF |
|
|
|
iShares MSCI Taiwan ETF(2) |
|
|
|
| |
|
|
|
Fixed-Income Funds — 30.0% |
Eaton Vance Mortgage Opportunities ETF(4) |
|
|
|
Eaton Vance Total Return Bond ETF(4) |
|
|
|
| |
|
|
|
Vanguard Emerging Markets Government Bond ETF |
|
|
|
Vanguard Long-Term Treasury ETF(2) |
|
|
|
| |
|
|
|
Total Exchange-Traded Funds
(identified cost $74,710,295) |
|
|
|
Sovereign Government Bonds — 3.1% |
|
|
|
| |
Principal
Amount
(000's omitted) |
|
| |
|
|
|
Brazil Letras do Tesouro Nacional, 0.00%, 1/1/29 |
|
|
|
Total Sovereign Government Bonds
(identified cost $6,682,258) |
|
|
|
Short-Term Investments — 4.5% |
| |
|
|
Morgan Stanley Institutional Liquidity Funds - Government Portfolio, Institutional Class, 3.58%(5) |
|
|
|
Total Affiliated Fund
(identified cost $3,576,658) |
|
|
|
Securities Lending Collateral — 2.8% |
| |
|
|
State Street Navigator Securities Lending Government Money Market Portfolio, 3.70%(6) |
|
|
|
Total Securities Lending Collateral
(identified cost $5,805,791) |
|
|
|
Total Short-Term Investments
(identified cost $9,382,449) |
|
|
|
Total Investments — 101.9%
(identified cost $154,487,637) |
|
|
|
Other Assets, Less Liabilities — (1.9)% |
|
|
|
| |
|
|
|
The percentage shown for each investment category in the Portfolio of Investments is based on net assets. |
| |
Non-income producing security. |
| |
All or a portion of this security was on loan at August 31, 2026. The aggregate market value of securities on loan at August 31, 2026 was $7,918,918. |
| |
Security exempt from registration under Rule 144A of the Securities Act of 1933, as amended. These securities may be sold in certain transactions in reliance on an exemption from registration (normally to qualified institutional buyers). At August 31, 2026, the aggregate value of these securities is $623,333 or 0.3% of the Fund's net assets. |
| |
Affiliated fund (see Note 11). |
| |
May be deemed to be an affiliated investment company (see Note 11). The rate shown is the annualized seven-day yield as of August 31, 2026. |
See Notes to Financial Statements.
Eaton Vance
All Asset Strategy Fund
August 31, 2026
Portfolio of Investments — continued
| |
Represents investment of cash collateral received in connection with securities lending. |
Country Concentration of Portfolio |
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| |
|
|
|
|
Value/Unrealized
Appreciation
(Depreciation) |
| |
|
|
|
|
|
| |
|
|
|
|
|
| |
|
|
|
|
|
| |
| |
– American Depositary Receipt |
| |
– Global Depositary Receipt |
| |
– Real Estate Investment Trusts |
See Notes to Financial Statements.
Eaton Vance
All Asset Strategy Fund
August 31, 2026
Statement of Assets and Liabilities
| |
|
| |
|
Unaffiliated investments, at value (identified cost $108,804,449) — including $7,918,918 of securities on loan |
|
Affiliated investments, at value (identified cost $45,683,188) |
|
Deposits for derivatives collateral - futures contracts |
|
Foreign currency, at value (identified cost $1,495,688) |
|
| |
|
Dividends receivable from affiliated investments |
|
Receivable for Fund shares sold |
|
Securities lending income receivable |
|
Receivable for variation margin on open futures contracts |
|
| |
|
Receivable from affiliates |
|
Trustees' deferred compensation plan |
|
| |
|
| |
|
Collateral for securities loaned |
|
Payable for Fund shares redeemed |
|
| |
|
Investment adviser and administration fee |
|
Distribution and service fees |
|
| |
|
Trustees' deferred compensation plan |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
Net Asset Value and Redemption Price Per Share
(net assets ÷ shares of beneficial interest outstanding) |
|
Maximum Offering Price Per Share
(100 ÷ 94.75 of net asset value per share) |
|
| |
|
| |
|
| |
|
Net Asset Value and Offering Price Per Share*
(net assets ÷ shares of beneficial interest outstanding) |
|
| |
|
| |
|
| |
|
Net Asset Value, Offering Price and Redemption Price Per Share
(net assets ÷ shares of beneficial interest outstanding) |
|
On sales of $50,000 or more, the offering price of Class A shares is reduced. |
| |
Redemption price per share is equal to the net asset value less any applicable contingent deferred sales charge. |
See Notes to Financial Statements.
Eaton Vance
All Asset Strategy Fund
August 31, 2026
| |
|
| |
|
| |
|
Dividend income (net of foreign taxes withheld of $95,323) |
|
Dividend income from affiliated investments |
|
| |
|
Securities lending income, net |
|
| |
|
| |
|
Investment adviser and administration fee |
|
Distribution and service fees: |
|
| |
|
| |
|
Trustees’ fees and expenses |
|
| |
|
Transfer and dividend disbursing agent fees |
|
Legal and accounting services |
|
| |
|
| |
|
| |
|
| |
|
| |
|
Waiver and/or reimbursement of expenses by affiliates |
|
| |
|
| |
|
| |
|
Realized and Unrealized Gain (Loss) |
|
Net realized gain (loss): |
|
| |
|
Investment transactions - affiliated investments |
|
Foreign currency transactions |
|
Capital gain distributions received |
|
| |
|
Change in unrealized appreciation (depreciation): |
|
| |
|
Investments - affiliated investments |
|
| |
|
| |
|
Net change in unrealized appreciation (depreciation) |
|
Net realized and unrealized gain |
|
Net increase in net assets from operations |
|
See Notes to Financial Statements.
Eaton Vance
All Asset Strategy Fund
August 31, 2026
Statements of Changes in Net Assets
| |
|
| |
|
|
Increase (Decrease) in Net Assets |
|
|
| |
|
|
| |
|
|
| |
|
|
Net change in unrealized appreciation (depreciation) |
|
|
Net increase in net assets from operations |
|
|
Distributions to shareholders: |
|
|
| |
|
|
| |
|
|
| |
|
|
Total distributions to shareholders |
|
|
Transactions in shares of beneficial interest: |
|
|
| |
|
|
| |
|
|
| |
|
|
Net decrease in net assets from Fund share transactions |
|
|
Net decrease in net assets |
|
|
| |
|
|
| |
|
|
| |
|
|
See Notes to Financial Statements.
Eaton Vance
All Asset Strategy Fund
August 31, 2026
| |
|
| |
|
| |
|
|
|
|
|
Net asset value — Beginning of year |
|
|
|
|
|
Income (Loss) From Operations |
|
|
|
|
|
| |
|
|
|
|
|
Net realized and unrealized gain (loss) |
|
|
|
|
|
Total income (loss) from operations |
|
|
|
|
|
| |
|
|
|
|
|
From net investment income |
|
|
|
|
|
| |
|
|
|
|
|
| |
|
|
|
|
|
Net asset value — End of year |
|
|
|
|
|
| |
|
|
|
|
|
| |
|
|
|
|
|
Net assets, end of year (000’s omitted) |
|
|
|
|
|
Ratios (as a percentage of average daily net assets):(4) |
|
|
|
|
|
| |
|
|
|
|
|
| |
|
|
|
|
|
| |
|
|
|
|
|
| |
|
|
|
|
|
| |
Computed using average shares outstanding. |
| |
Amount is less than $(0.005). |
| |
Returns are historical and are calculated by determining the percentage change in net asset value with all distributions reinvested and do not reflect
the effect of sales charges. |
| |
Total expenses do not reflect amounts reimbursed and/or waived by the adviser and certain of its affiliates, if applicable. Net expenses are net of all reductions and represent the net expenses paid by the Fund. |
| |
Includes a reduction by the investment adviser of a portion of its adviser and administration fee due to the Fund’s investment in the Liquidity Fund and in other affiliated funds (equal to 0.09% of average daily net assets for the year ended August 31, 2026 and less than 0.01% of average daily net assets for the years ended August 31, 2025, 2024, 2023 and 2022). |
See Notes to Financial Statements.
Eaton Vance
All Asset Strategy Fund
August 31, 2026
Financial Highlights — continued
| |
|
| |
|
| |
|
|
|
|
|
Net asset value — Beginning of year |
|
|
|
|
|
Income (Loss) From Operations |
|
|
|
|
|
| |
|
|
|
|
|
Net realized and unrealized gain (loss) |
|
|
|
|
|
Total income (loss) from operations |
|
|
|
|
|
| |
|
|
|
|
|
From net investment income |
|
|
|
|
|
| |
|
|
|
|
|
| |
|
|
|
|
|
Net asset value — End of year |
|
|
|
|
|
| |
|
|
|
|
|
| |
|
|
|
|
|
Net assets, end of year (000’s omitted) |
|
|
|
|
|
Ratios (as a percentage of average daily net assets):(4) |
|
|
|
|
|
| |
|
|
|
|
|
| |
|
|
|
|
|
| |
|
|
|
|
|
| |
|
|
|
|
|
| |
Computed using average shares outstanding. |
| |
Amount is less than $(0.005). |
| |
Returns are historical and are calculated by determining the percentage change in net asset value with all distributions reinvested and do not reflect
the effect of sales charges. |
| |
Total expenses do not reflect amounts reimbursed and/or waived by the adviser and certain of its affiliates, if applicable. Net expenses are net of all reductions and represent the net expenses paid by the Fund. |
| |
Includes a reduction by the investment adviser of a portion of its adviser and administration fee due to the Fund’s investment in the Liquidity Fund and in other affiliated funds (equal to 0.09% of average daily net assets for the year ended August 31, 2026 and less than 0.01% of average daily net assets for the years ended August 31, 2025, 2024, 2023 and 2022). |
See Notes to Financial Statements.
Eaton Vance
All Asset Strategy Fund
August 31, 2026
Financial Highlights — continued
| |
|
| |
|
| |
|
|
|
|
|
Net asset value — Beginning of year |
|
|
|
|
|
Income (Loss) From Operations |
|
|
|
|
|
| |
|
|
|
|
|
Net realized and unrealized gain (loss) |
|
|
|
|
|
Total income (loss) from operations |
|
|
|
|
|
| |
|
|
|
|
|
From net investment income |
|
|
|
|
|
| |
|
|
|
|
|
| |
|
|
|
|
|
Net asset value — End of year |
|
|
|
|
|
| |
|
|
|
|
|
| |
|
|
|
|
|
Net assets, end of year (000’s omitted) |
|
|
|
|
|
Ratios (as a percentage of average daily net assets):(4) |
|
|
|
|
|
| |
|
|
|
|
|
| |
|
|
|
|
|
| |
|
|
|
|
|
| |
|
|
|
|
|
| |
Computed using average shares outstanding. |
| |
Amount is less than $(0.005). |
| |
Returns are historical and are calculated by determining the percentage change in net asset value with all distributions reinvested. |
| |
Total expenses do not reflect amounts reimbursed and/or waived by the adviser and certain of its affiliates, if applicable. Net expenses are net of all reductions and represent the net expenses paid by the Fund. |
| |
Includes a reduction by the investment adviser of a portion of its adviser and administration fee due to the Fund’s investment in the Liquidity Fund and in other affiliated funds (equal to 0.09% of average daily net assets for the year ended August 31, 2026 and less than 0.01% of average daily net assets for the years ended August 31, 2025, 2024, 2023 and 2022). |
See Notes to Financial Statements.
Eaton Vance
All Asset Strategy Fund
August 31, 2026
Notes to Financial Statements
1 Significant Accounting Policies
Eaton Vance All Asset Strategy Fund (the Fund) is a diversified series of Eaton Vance Growth Trust (the Trust). The Trust is a Massachusetts business trust registered under the Investment Company Act of 1940, as amended (the 1940 Act), as an open-end management investment company. The Fund’s investment objective is to seek total return. The Fund offers three classes of shares. Class A shares are generally sold subject to a sales charge imposed at time of purchase. Class C shares are sold at net asset value and are generally subject to a contingent deferred sales charge (see Note 5). Effective November 5, 2020, Class C shares automatically convert to Class A shares eight years after their purchase as described in the Fund’s prospectus. Class I shares are sold at net asset value and are not subject to a sales charge. Each class represents a pro rata interest in the Fund, but votes separately on class-specific matters and (as noted below) is subject to different expenses. Realized and unrealized gains and losses and net investment income and losses, other than class-specific expenses, are allocated daily to each class of shares based on the relative net assets of each class to the total net assets of the Fund. Each class of shares differs in its distribution plan and certain other class-specific expenses.
The following is a summary of significant accounting policies of the Fund. The policies are in conformity with accounting principles generally accepted in the United States of America (U.S. GAAP). The Fund is an investment company and follows accounting and reporting guidance in the Financial Accounting Standards Board (FASB) Accounting Standards Codification Topic 946.
A Investment Valuation—The following methodologies are used to determine the market value or fair value of investments.
Equity Securities. Equity securities listed on a U.S. securities exchange generally are valued at the last sale or closing price on the day of valuation or, if no sales took place on such date, at the mean between the closing bid and ask prices on the exchange where such securities are principally traded. Equity securities listed on the NASDAQ National Market System are valued at the NASDAQ official closing price. Unlisted or listed securities for which closing sales prices or closing quotations are not available are valued at the mean between the latest available bid and ask prices.
Debt Obligations. Debt obligations are generally valued on the basis of valuations provided by third party pricing services, as derived from such services’ pricing models. Inputs to the models may include, but are not limited to, reported trades, executable bid and ask prices, broker/dealer quotations, prices or yields of securities with similar characteristics, interest rates, anticipated prepayments, benchmark curves or information pertaining to the issuer, as well as industry and economic events. The pricing services may use a matrix approach, which considers information regarding securities with similar characteristics to determine the valuation for a security. Short-term debt obligations purchased with a remaining maturity of sixty days or less for which a valuation from a third party pricing service is not readily available may be valued at amortized cost, which approximates fair value.
Derivatives. Futures contracts are valued at the closing settlement price established by the board of trade or exchange on which they are traded.
Foreign Securities and Currencies. Foreign securities and currencies are valued in U.S. dollars, based on foreign currency exchange rate quotations supplied by a third party pricing service. The pricing service uses a proprietary model to determine the exchange rate. Inputs to the model include reported trades and implied bid/ask spreads. The daily valuation of exchange-traded foreign securities generally is determined as of the close of trading on the principal exchange on which such securities trade. Events occurring after the close of trading on foreign exchanges may result in adjustments to the valuation of foreign securities to more accurately reflect their fair value as of the close of regular trading on the New York Stock Exchange. When valuing foreign equity securities that meet certain criteria, the Fund's Trustees have approved the use of a fair value service that values such securities to reflect market trading that occurs after the close of the applicable foreign markets of comparable securities or other instruments that have a strong correlation to the fair-valued securities.
Other. Investments in management investment companies (including money market funds) that do not trade on an exchange are valued at the net asset value as of the close of each business day. Exchange-traded funds are valued at the official closing price as reported by an independent pricing service on the primary market or exchange on which they are traded.
Fair Valuation. In connection with Rule 2a-5 of the 1940 Act, the Trustees have designated the Fund’s investment adviser as its valuation designee. Investments for which valuations or market quotations are not readily available or are deemed unreliable are valued by the investment adviser, as valuation designee, at fair value using methods that most fairly reflect the security’s “fair value”, which is the amount that the Fund might reasonably expect to receive for the security upon its current sale in the ordinary course. Each such determination is based on a consideration of relevant factors, which are likely to vary from one pricing context to another. These factors may include, but are not limited to, the type of security, the existence of any contractual restrictions on the security’s disposition, the price and extent of public trading in similar securities of the issuer or of comparable companies or entities, quotations or relevant information obtained from broker/dealers or other market participants, information obtained from the issuer, analysts, and/or the appropriate stock exchange (for exchange-traded securities), an analysis of the company’s or entity’s financial statements, and an evaluation of the forces that influence the issuer and the market(s) in which the security is purchased and sold.
B Investment Transactions—Investment transactions for financial statement purposes are accounted for on a trade date basis. Realized gains and losses on investments sold are determined on the basis of identified cost.
C Income—Dividend income is recorded on the ex-dividend date for dividends received in cash and/or securities. However, if the ex-dividend date has passed, certain dividends from foreign securities are recorded as the Fund is informed of the ex-dividend date. Distributions from investment companies are recorded as dividend income, capital gains or return of capital based on the nature of the distribution. Withholding taxes on foreign dividends and capital gains have been provided for in accordance with the Fund's understanding of the applicable countries’ tax rules and rates. As a result of several court cases
Eaton Vance
All Asset Strategy Fund
August 31, 2026
Notes to Financial Statements — continued
in certain countries across the European Union (EU), the Fund filed additional tax reclaims for previously withheld taxes on dividends earned in those countries. Income recognized, if any, for EU reclaims and interest thereon is reflected as other income in the Statement of Operations, and any related receivable, if any, is reflected as European Union tax reclaims receivable in the Statement of Assets and Liabilities. Any fees associated with these filings are reflected in miscellaneous expenses in the Statement of Operations. When uncertainty exists as to the ultimate resolution of these proceedings, the likelihood of receipt of these EU reclaims, and the potential timing of payment, no amounts are reflected in the financial statements. For U.S. income tax purposes, EU reclaims received by the Fund, if any, may reduce the amount of foreign taxes Fund shareholders can use as tax deductions or credits on their income tax returns. In the event that EU reclaims received by the Fund during a fiscal year exceed foreign withholding taxes paid by the Fund, and the Fund previously passed through to its shareholders foreign taxes incurred by the Fund to be used as a credit or deduction on a shareholder’s income tax return, the Fund may be required to enter into a closing agreement with the Internal Revenue Service in order to pay the associated tax liability on behalf of the Fund’s shareholders. Interest income is recorded on the basis of interest accrued, adjusted for amortization of premium or accretion of discount.
D Federal and Other Taxes—The Fund's policy is to comply with the provisions of the Internal Revenue Code applicable to regulated investment companies and to distribute to shareholders each year substantially all of its net investment income, and all or substantially all of its net realized capital gains. Accordingly, no provision for federal income or excise tax is necessary.
As of August 31, 2026, the Fund had no uncertain tax positions that would require financial statement recognition, de-recognition, or disclosure. The Fund files a U.S. federal income tax return annually after its fiscal year-end, which is subject to examination by the Internal Revenue Service for a period of three years from the date of filing.
During this reporting period, the Fund adopted FASB Accounting Standards Update No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures (ASU 2023-09), which requires annual disclosure of the amount of income taxes paid (net of refunds received) disaggregated by federal, state,
and foreign taxes, and further disaggregated by individual jurisdiction in which income taxes paid is equal to or greater than 5% of total income taxes paid. The adoption of ASU 2023-09 did not result in any changes to the Fund’s financial statement presentation or disclosure.
E Expenses—The majority of expenses of the Trust are directly identifiable to an individual fund. Expenses which are not readily identifiable to a specific fund are allocated taking into consideration, among other things, the nature and type of expense and the relative size of the funds. Expenses do not include the Fund’s pro rata share of the indirect expenses borne by the Fund from its investments in exchange-traded funds.
F Foreign Currency Translation—Investment valuations, other assets, and liabilities initially expressed in foreign currencies are translated each business day into U.S. dollars based upon current exchange rates. Purchases and sales of foreign investment securities and income and expenses denominated in foreign currencies are translated into U.S. dollars based upon currency exchange rates in effect on the respective dates of such transactions. Recognized gains or losses on investment transactions attributable to changes in foreign currency exchange rates are recorded for financial statement purposes as net realized gains and losses on investments. That portion of unrealized gains and losses on investments that results from fluctuations in foreign currency exchange rates is not separately disclosed.
G Use of Estimates—The preparation of the financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of income and expense during the reporting period. Actual results could differ from those estimates.
H Indemnifications—Under the Trust’s organizational documents, its officers and Trustees may be indemnified against certain liabilities and expenses arising out of the performance of their duties to the Fund. Under Massachusetts law, if certain conditions prevail, shareholders of a Massachusetts business trust (such as the Trust) could be deemed to have personal liability for the obligations of the Trust. However, the Trust’s Declaration of Trust contains an express disclaimer of liability on the part of Fund shareholders and the By-laws provide that the Trust shall assume, upon request by the shareholder, the defense on behalf of any Fund shareholders. Moreover, the By-laws also provide for indemnification out of Fund property of any shareholder held personally liable solely by reason of being or having been a shareholder for all loss or expense arising from such liability. Additionally, in the normal course of business, the Fund enters into agreements with service providers that may contain indemnification clauses. The Fund’s maximum exposure under these arrangements is unknown as this would involve future claims that may be made against the Fund that have not yet occurred.
I Futures Contracts—Upon entering into a futures contract, the Fund is required to deposit with the broker, either in cash or securities, an amount equal to a certain percentage of the contract amount (initial margin). Subsequent payments, known as variation margin, are made or received by the Fund each business day, depending on the daily fluctuations in the value of the underlying security or index, and are recorded as unrealized gains or losses by the Fund. Gains (losses) are realized upon the expiration or closing of the futures contracts. Should market conditions change unexpectedly, the Fund may not achieve the anticipated benefits of the futures contracts and may realize a loss. Futures contracts have minimal counterparty risk as they are exchange traded and the clearinghouse for the exchange is substituted as the counterparty, guaranteeing counterparty performance.
J Segment Reporting—The Fund operates as a single reportable segment, an investment company whose investment objective(s) is included in Note 1. The Fund’s President acts as the Fund's Chief Operating Decision Maker (CODM), who is responsible for assessing the performance of the Fund's single segment and deciding how to allocate the segment’s resources. To perform this function, the CODM reviews the information in the Fund’s financial statements.
Eaton Vance
All Asset Strategy Fund
August 31, 2026
Notes to Financial Statements — continued
K Recently Issued Accounting Pronouncements—In September 2026, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2026-03, Fair Value Measurement (Topic 820): Investment Companies with Equity Securities Subject to Contractual Sale Restrictions. ASU 2026-03 requires investment companies to consider the effects of certain contractual sale restrictions when measuring the fair value of equity securities and to provide related disclosures. ASU 2026-03 is effective for fiscal years beginning after December 15, 2027, and interim periods within those fiscal years, with early adoption permitted. Management is currently evaluating the impact of adopting ASU 2026-03; however, it does not currently expect the implementation of the standard to have a material effect on the Fund's financial statements.
2 Distributions to Shareholders and Income Tax Information
It is the present policy of the Fund to make at least one distribution annually (normally in December) of all or substantially all of its net investment income and to distribute annually all or substantially all of its net realized capital gains. Distributions to shareholders are recorded on the ex-dividend date. Distributions are declared separately for each class of shares. Shareholders may reinvest income and capital gain distributions in additional shares of the same class of the Fund at the net asset value as of the ex-dividend date or, at the election of the shareholder, receive distributions in cash. Distributions to shareholders are determined in accordance with income tax regulations, which may differ from U.S. GAAP. As required by U.S. GAAP, only distributions in excess of tax basis earnings and profits are reported in the financial statements as a return of capital. Permanent differences between book and tax accounting relating to distributions are reclassified to paid-in capital. For tax purposes, distributions from short-term capital gains are considered to be from ordinary income.
The tax character of distributions declared for the years ended August 31, 2026 and August 31, 2025 was as follows:
During the year ended August 31, 2026, distributable earnings was decreased by $1,671,353 and paid-in capital was increased by $1,671,353 due to the Fund’s use of equalization accounting. Tax equalization accounting allows the Fund to treat as a distribution that portion of redemption proceeds representing a redeeming shareholder’s portion of undistributed taxable income and net capital gains. These reclassifications had no effect on the net assets or net asset value per share of the Fund.
As of August 31, 2026, the components of distributable earnings (accumulated loss) on a tax basis were as follows:
Undistributed ordinary income |
|
Undistributed long-term capital gains |
|
Net unrealized appreciation |
|
| |
|
The cost and unrealized appreciation (depreciation) of investments, including open derivative contracts, of the Fund at August 31, 2026, as determined on a federal income tax basis, were as follows:
| |
|
Gross unrealized appreciation |
|
Gross unrealized depreciation |
|
Net unrealized appreciation |
|
Eaton Vance
All Asset Strategy Fund
August 31, 2026
Notes to Financial Statements — continued
3 Investment Adviser and Administration Fee and Other Transactions with Affiliates
The investment adviser and administration fee is earned by Eaton Vance Management (EVM), an indirect, wholly-owned subsidiary of Morgan Stanley, as compensation for investment advisory and administrative services rendered to the Fund. The investment adviser and administration fee is computed at an annual rate as a percentage of the Fund’s average daily net assets as follows and is payable monthly:
| |
|
| |
|
$500 million but less than $1 billion |
|
$1 billion but less than $2.5 billion |
|
$2.5 billion but less than $5 billion |
|
| |
|
For the year ended August 31, 2026, the investment adviser and administration fee amounted to $1,732,896 or 0.75% of the Fund’s average daily net assets.
The Fund may invest in a money market fund, the Institutional Class of the Morgan Stanley Institutional Liquidity Funds - Government Portfolio (the “Liquidity Fund”), an open-end management investment company managed by Morgan Stanley Investment Management Inc., a wholly-owned subsidiary of Morgan Stanley, and in other affiliated funds. The investment adviser and administration fee paid by the Fund is reduced by an amount equal to its pro rata share of the advisory and administration fees paid by the Fund due to its investment in the Liquidity Fund and in other affiliated funds. For the year ended August 31, 2026, the investment adviser and administration fee paid was reduced by $205,923 relating to the Fund’s investment in the Liquidity Fund and in other affiliated funds.
EVM has agreed to reimburse the Fund's expenses to the extent that total annual operating expenses (relating to ordinary operating expenses only and excluding expenses such as brokerage commissions, acquired fund fees and expenses of unaffiliated funds, borrowing costs (including borrowing costs of any acquired funds), taxes or litigation expenses) exceed 1.10%, 1.85% and 0.85% of the Fund's average daily net assets for Class A, Class C and Class I, respectively. This agreement may be changed or terminated after January 1, 2027. Pursuant to this agreement, EVM waived and/or reimbursed $216,282 of the Fund's operating expenses for the year ended August 31, 2026.
EVM provides sub-transfer agency and related services to the Fund pursuant to a Sub-Transfer Agency Support Services Agreement. For the year ended August 31, 2026, EVM earned $13,438 from the Fund pursuant to such agreement, which is included in transfer and dividend disbursing agent fees on the Statement of Operations. The Fund was informed that Eaton Vance Distributors, Inc. (EVD), an affiliate of EVM and the Fund’s principal underwriter, received $669 as its portion of the sales charge on sales of Class A shares for the year ended August 31, 2026. EVD also received distribution and service fees from Class A and Class C shares (see Note 4) and contingent deferred sales charges (see Note 5).
Trustees and officers of the Fund who are members of EVM’s organization receive remuneration for their services to the Fund out of the investment adviser and administration fee. Trustees of the Fund who are not affiliated with EVM may elect to defer receipt of all or a percentage of their annual fees in accordance with the terms of the Trustees Deferred Compensation Plan. Certain officers and Trustees of the Fund are officers of EVM.
The Fund has in effect a distribution plan for Class A shares (Class A Plan) pursuant to Rule 12b-1 under the 1940 Act. Pursuant to the Class A Plan, the Fund pays EVD a distribution and service fee of 0.25% per annum of its average daily net assets attributable to Class A shares for distribution services and facilities provided to the Fund by EVD, as well as for personal services and/or the maintenance of shareholder accounts. Distribution and service fees paid or accrued to EVD for the year ended August 31, 2026 amounted to $201,271 for Class A shares.
The Fund also has in effect a distribution plan for Class C shares (Class C Plan) pursuant to Rule 12b-1 under the 1940 Act. Pursuant to the Class C Plan, the Fund pays EVD amounts equal to 0.75% per annum of its average daily net assets attributable to Class C shares for providing ongoing distribution services and facilities to the Fund. For the year ended August 31, 2026, the Fund paid or accrued to EVD $154,507 for Class C shares.
Pursuant to the Class C Plan, the Fund also makes payments of service fees to EVD, financial intermediaries and other persons in amounts equal to 0.25% per annum of its average daily net assets attributable to that class. Service fees paid or accrued are for personal services and/or the maintenance of shareholder accounts. They are separate and distinct from the sales commissions and distribution fees payable to EVD. Service fees paid or accrued for the year ended August 31, 2026 amounted to $51,502 for Class C shares.
Distribution and service fees are subject to the limitations contained in the Financial Industry Regulatory Authority Rule 2341(d).
Eaton Vance
All Asset Strategy Fund
August 31, 2026
Notes to Financial Statements — continued
5 Contingent Deferred Sales Charges
A contingent deferred sales charge (CDSC) of 1% generally is imposed on redemptions of Class C shares made within 12 months of purchase. Class A shares may be subject to a 1% CDSC if redeemed within 12 months of purchase (depending on the circumstances of purchase). Generally, the CDSC is based upon the lower of the net asset value at date of redemption or date of purchase. No charge is levied on shares acquired by reinvestment of dividends or capital gain distributions. For the year ended August 31, 2026, the Fund was informed that EVD received $1,018 of CDSCs paid by Class C shareholders and no CDSCs paid by Class A shareholders.
6 Purchases and Sales of Investments
Purchases and sales of investments, other than short-term obligations, aggregated $241,246,539 and $317,493,945, respectively, for the year ended August 31, 2026.
7 Shares of Beneficial Interest
The Fund’s Declaration of Trust permits the Trustees to issue an unlimited number of full and fractional shares of beneficial interest (without par value). Such shares may be issued in a number of different series (such as the Fund) and classes. Transactions in Fund shares, including direct exchanges pursuant to share class conversions, were as follows:
| |
Year Ended
August 31, 2026 |
Year Ended
August 31, 2025 |
| |
|
|
|
|
| |
|
|
|
|
| |
|
|
|
|
Issued to shareholders electing to receive payments of distributions in Fund shares |
|
|
|
|
| |
|
|
|
|
| |
|
|
|
|
| |
|
|
|
|
| |
|
|
|
|
Issued to shareholders electing to receive payments of distributions in Fund shares |
|
|
|
|
| |
|
|
|
|
| |
|
|
|
|
| |
|
|
|
|
| |
|
|
|
|
Issued to shareholders electing to receive payments of distributions in Fund shares |
|
|
|
|
| |
|
|
|
|
| |
|
|
|
|
The Fund may trade in financial instruments with off-balance sheet risk in the normal course of its investing activities. These financial instruments may include futures contracts and may involve, to a varying degree, elements of risk in excess of the amounts recognized for financial statement purposes. The notional or contractual amounts of these instruments represent the investment the Fund has in particular classes of financial instruments and do not necessarily represent the amounts potentially subject to risk. The measurement of the risks associated with these instruments is meaningful only when all related and offsetting transactions are considered. A summary of obligations under these financial instruments at August 31, 2026 is included in the Portfolio of Investments. At August 31, 2026, the Fund had sufficient cash and/or securities to cover commitments under these contracts.
Eaton Vance
All Asset Strategy Fund
August 31, 2026
Notes to Financial Statements — continued
The Fund is subject to equity price risk in the normal course of pursuing its investment objective. The Fund enters into equity index futures contracts to enhance total return and/or to manage certain investment risks.
The fair value of open derivative instruments (not considered to be hedging instruments for accounting disclosure purposes) and whose primary underlying risk exposure is equity price risk at August 31, 2026 was as follows:
| |
Only the current day’s variation margin on open futures contracts is reported within the Statement of Assets and Liabilities as Receivable or Payable for variation margin on open futures contracts, as applicable. |
The effect of derivative instruments (not considered to be hedging instruments for accounting disclosure purposes) on the Statement of Operations and whose primary underlying risk exposure is equity price risk for the year ended August 31, 2026 was as follows:
| |
Realized Gain (Loss)
on Derivatives Recognized
in Income |
Change in Unrealized
Appreciation (Depreciation) on
Derivatives Recognized in Income(1) |
| |
|
|
| |
Statement of Operations location: Change in unrealized appreciation (depreciation): Futures contracts. |
The average notional cost of futures contracts (long) outstanding during the year ended August 31, 2026, which is indicative of the volume of this derivative type, was approximately $86,000.
The Fund participates with other portfolios and funds managed by EVM and its affiliates in a $650 million unsecured revolving line of credit agreement with a group of banks, which is in effect through October 20, 2026. Borrowings are made by the Fund solely for temporary purposes related to redemptions and other short-term cash needs. Interest is charged to the Fund based on its borrowings generally at an amount above either the Secured Overnight Financing Rate (SOFR) or Federal Funds rate. In addition, a fee computed at an annual rate of 0.15% on the daily unused portion of the line of credit is allocated among the participating portfolios and funds at the end of each quarter. In connection with the renewal of the agreement in October 2025, an arrangement fee of $150,000 was incurred that was allocated to the participating portfolios and funds. Because the line of credit is not available exclusively to the Fund, it may be unable to borrow some or all of its requested amounts at any particular time. The Fund did not have any significant borrowings or allocated fees during the year ended August 31, 2026.
10 Securities Lending Agreement
The Fund has established a securities lending agreement with State Street Bank and Trust Company (SSBT) as securities lending agent in which the Fund lends portfolio securities to qualified borrowers in exchange for collateral consisting of either cash or securities issued or guaranteed by the U.S. government or its agencies or instrumentalities in an amount at least equal to the market value of the securities on loan. The market value of securities loaned is determined daily and any additional required collateral is delivered to the Fund on the next business day. Cash collateral is invested in the State Street Navigator Securities Lending Government Money Market Portfolio, a money market fund registered under the 1940 Act. The Fund earns interest on the amount invested but it must pay (and at times receive from) the broker a loan rebate fee computed as a varying percentage of the collateral received. For security loans secured by non-cash collateral, the Fund earns a negotiated lending fee from the borrower. A portion of the income earned by the Fund from its investment of cash collateral, net of rebate fees, and lending fees received is allocated to SSBT for its services as lending agent and the portion allocated to the Fund is presented as securities lending income, net on the Statement of Operations. Non-cash collateral is held by the lending agent on behalf of the Fund and cannot be sold or re-pledged by the Fund; accordingly, such collateral is not reflected in the Statement of Assets and Liabilities.
The Fund is subject to possible delay in the recovery of loaned securities. Pursuant to the securities lending agreement, SSBT has provided indemnification to the Fund in the event of default by a borrower with respect to a loan. The Fund bears the risk of loss with respect to the investment of cash collateral.
Eaton Vance
All Asset Strategy Fund
August 31, 2026
Notes to Financial Statements — continued
At August 31, 2026, the value of the securities loaned and the value of the collateral received, which exceeded the value of the securities loaned, amounted to $7,918,918 and $8,137,313, respectively. Collateral received was comprised of cash of $5,805,791 and U.S. government and/or agencies securities of $2,331,522. The securities lending transactions have no contractual maturity date and each of the Fund and borrower has the option to terminate a loan at any time.
The following table provides a breakdown of securities lending transactions accounted for as secured borrowings, the obligations by class of collateral pledged, and the remaining contractual maturity of those transactions as of August 31, 2026.
| |
Remaining Contractual Maturity of the Transactions |
| |
|
|
|
|
|
| |
|
|
|
|
|
| |
|
|
|
|
|
| |
|
|
|
|
|
The carrying amount of the liability for collateral for securities loaned at August 31, 2026 approximated its fair value. If measured at fair value, such liability would have been considered as Level 2 in the fair value hierarchy (see Note 12) at August 31, 2026.
11 Affiliated Investments
At August 31, 2026, the value of the Fund's investment in affiliated funds and funds that may be deemed to be affiliated was $44,941,115, which represents 21.7% of the Fund's net assets. Transactions in such investments by the Fund for the year ended August 31, 2026 were as follows:
| |
Value,
beginning
of period |
|
|
|
Change in
unrealized
appreciation
(depreciation) |
|
|
|
| |
|
|
|
|
|
|
|
|
Eaton Vance Mortgage Opportunities ETF |
|
|
|
|
|
|
|
|
Eaton Vance Total Return Bond ETF |
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
12 Fair Value Measurements
Under generally accepted accounting principles for fair value measurements, a three-tier hierarchy to prioritize the assumptions, referred to as inputs, is used in valuation techniques to measure fair value. The three-tier hierarchy of inputs is summarized in the three broad levels listed below.
• Level 1 – quoted prices in active markets for identical investments
• Level 2 – other significant observable inputs (including quoted prices for similar investments, interest rates, prepayment speeds, credit risk, etc.)
• Level 3 – significant unobservable inputs (including a fund's own assumptions in determining the fair value of investments)
In cases where the inputs used to measure fair value fall in different levels of the fair value hierarchy, the level disclosed is determined based on the lowest level input that is significant to the fair value measurement in its entirety. The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.
Eaton Vance
All Asset Strategy Fund
August 31, 2026
Notes to Financial Statements — continued
At August 31, 2026, the hierarchy of inputs used in valuing the Fund's investments and open derivative instruments, which are carried at fair value, were as follows:
| |
|
|
|
|
| |
|
|
|
|
| |
|
|
|
|
| |
|
|
|
|
| |
|
|
|
|
| |
|
|
|
|
| |
|
|
|
|
| |
|
|
|
|
| |
|
|
|
|
| |
|
|
|
|
| |
|
|
|
|
| |
|
|
|
|
| |
|
|
|
|
| |
|
|
|
|
| |
|
|
|
|
Sovereign Government Bonds |
|
|
|
|
| |
|
|
|
|
| |
|
|
|
|
Securities Lending Collateral |
|
|
|
|
| |
|
|
|
|
| |
|
|
|
|
| |
|
|
|
|
| |
|
|
|
|
| |
Includes foreign equity securities whose values were adjusted to reflect market trading of comparable securities or other correlated instruments that occurred after the close of trading in their applicable foreign markets. |
Eaton Vance
All Asset Strategy Fund
August 31, 2026
Notes to Financial Statements — continued
13 Risks and Uncertainties
Risks Associated with Foreign Investments
Foreign investments can be adversely affected by political, economic and market developments abroad, including the imposition of economic and other sanctions by the United States or another country, and by acts of terrorism and war. There may be less publicly available information about foreign issuers because they may not be subject to reporting practices, requirements or regulations comparable to those to which United States companies are subject. Foreign markets may be smaller, less liquid and more volatile than the major markets in the United States. Trading in foreign markets typically involves higher expense than trading in the United States. The Fund may have difficulties enforcing its legal or contractual rights in a foreign country. Securities that trade or are denominated in currencies other than the U.S. dollar may be adversely affected by fluctuations in currency exchange rates.
Eaton Vance
All Asset Strategy Fund
August 31, 2026
Report of Independent Registered Public Accounting Firm
To the Trustees of Eaton Vance Growth Trust and Shareholders of Eaton Vance All Asset Strategy Fund:
Opinion on the Financial Statements and Financial Highlights
We have audited the accompanying statement of assets and liabilities of Eaton Vance All Asset Strategy Fund (the “Fund”) (one of the funds constituting Eaton Vance Growth Trust), including the portfolio of investments, as of August 31, 2026, the related statement of operations for the year then ended, the statements of changes in net assets for each of the two years in the period then ended, the financial highlights for each of the five years in the period then ended, and the related notes (collectively referred to as the “financial statements and financial highlights”). In our opinion, the financial statements and financial highlights present fairly, in all material respects, the financial position of the Fund as of August 31, 2026, and the results of its operations for the year then ended, the changes in its net assets for each of the two years in the period then ended, and the financial highlights for each of the five years in the period then ended, in conformity with accounting principles generally accepted in the United States of America.
These financial statements and financial highlights are the responsibility of the Fund's management. Our responsibility is to express an opinion on the Fund's financial statements and financial highlights based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Fund in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements and financial highlights are free of material misstatement, whether due to error or fraud. The Fund is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Fund’s internal control over financial reporting. Accordingly, we express no such opinion.
Our audits included performing procedures to assess the risks of material misstatement of the financial statements and financial highlights, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements and financial highlights. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements and financial highlights. Our procedures included confirmation of securities owned as of August 31, 2026, by correspondence with the custodian and brokers; when replies were not received from brokers, we performed other auditing procedures. We believe that our audits provide a reasonable basis for our opinion.
/s/ Deloitte & Touche LLP
Boston, Massachusetts
October 19, 2026
We have served as the auditor of one or more Eaton Vance investment companies since 1959.
Eaton Vance
All Asset Strategy Fund
August 31, 2026
Federal Tax Information (Unaudited)
The Form 1099-DIV you receive in February 2027 will show the tax status of all distributions paid to your account in calendar year 2026. Shareholders
are advised to consult their own tax adviser with respect to the tax consequences of their investment in the Fund. As required by the Internal Revenue Code and/or regulations, shareholders must be notified regarding the status of qualified business income, qualified dividend income for individuals, the dividends received deduction for corporations, capital gains dividends and 163(j) interest dividends.
Qualified Business Income. For the fiscal year ended August 31, 2026 the Fund designates approximately $31,071, or up to the maximum amount of such dividends allowable pursuant to the Internal Revenue Code, as qualified business income.
Qualified Dividend Income. For the fiscal year ended August 31, 2026, the Fund designates approximately $1,804,095, or up to the maximum amount of such dividends allowable pursuant to the Internal Revenue Code, as qualified dividend income eligible for the reduced tax rate of 15%.
Dividends Received Deduction. Corporate shareholders are generally entitled to take the dividends received deduction on the portion of the Fund’s dividend distribution that qualifies under tax law. For the Fund’s fiscal 2026 ordinary income dividends, 15.81% qualifies for the corporate dividends received deduction.
Capital Gains Dividends. The Fund hereby designates as a capital gain dividend with respect to the taxable year ended August 31, 2026, $8,678,075
or, if subsequently determined to be different, the net capital gain of such year.
163(j) Interest Dividends. For the fiscal year ended August 31, 2026, the Fund designates 24.68% of distributions from net investment income as a 163(j) interest dividend.
Eaton Vance
All Asset Strategy Fund
August 31, 2026
Board of Trustees’ Contract Approval
Overview of the Contract Review Process
The Investment Company Act of 1940, as amended (the “1940 Act”), provides, in substance, that the investment advisory agreement between a fund and its investment adviser will continue in effect from year-to-year only if its continuation is approved on an annual basis by a vote of the fund’s board of trustees, including a majority of the trustees who are not “interested persons” of the fund (“independent trustees”), cast in person at a meeting called for the purpose of considering such approval.
At a meeting held on June 11, 2026, the Boards of Trustees/Directors (collectively, the “Board”) that oversee the registered investment companies advised by Eaton Vance Management or its affiliate, Boston Management and Research (the “Eaton Vance Funds”), including a majority of the independent trustees (the “Independent Trustees”), voted to approve the continuation of existing investment advisory agreements and sub-advisory agreements1 for each of the Eaton Vance Funds for an additional one-year period. The Board relied upon the affirmative recommendation of its Contract Review Committee, which is a committee comprised of all of the Independent Trustees. Prior to making its recommendation, the Contract Review Committee reviewed information furnished by the adviser and sub-adviser to each of the Eaton Vance Funds (including information specifically requested by the Board) for a series of meetings held between April and June 2026, as well as certain additional information provided in response to specific requests from the Independent Trustees as members of the Contract Review Committee. Members of the Contract Review Committee also considered information received at prior meetings of the Board and its committees, to the extent such information was relevant to the Contract Review Committee’s annual evaluation of the investment advisory agreements and sub-advisory agreements.
In connection with its evaluation of the investment advisory agreements and sub-advisory agreements, the Board (directly or through one or more of its committees) considered various information relating to the Eaton Vance Funds. This included information applicable to all or groups of the Eaton Vance Funds, which is referenced immediately below, and information applicable to the particular Eaton Vance Fund covered by this report (each Eaton Vance Fund is referred to below as a “fund”). (For funds that invest through one or more underlying portfolios, references to “each fund” in this section may include information that was considered at the portfolio-level.)
Information about Fees, Performance and Expenses
• A report from an independent data provider comparing advisory and other fees paid by each fund to such fees paid by comparable funds, as identified by the independent data provider (“comparable funds”);
• A report from an independent data provider comparing each fund’s total expense ratio (and its components) to those of comparable funds;
• A report from an independent data provider comparing the investment performance of each fund to the investment performance of comparable funds and, as applicable, benchmark indices, over various time periods;
• In certain instances, data regarding investment performance relative to customized groups of peer funds and blended indices identified by the adviser in consultation with the Portfolio Management Committee of the Board (a committee exclusively comprised of Independent Trustees);
• Comparative information concerning the fees charged and services provided by the adviser and sub-adviser to each fund in managing other accounts (which may include other funds, collective investment trusts and institutional accounts) with the same or substantially similar investment objective as the fund and with a significant overlap in holdings based on criteria set by the Board, if any;
• Profitability analyses on a fund-by-fund basis for the adviser and its affiliates and the cost allocation methodology used to determine such analyses;
Information about Portfolio Management and Trading
• Descriptions of the investment management services provided to each fund, as well as each of the funds’ investment strategies and policies;
• The procedures and processes used by the adviser to determine the value of fund assets, including, when necessary, the determination of “fair value” by the adviser in its role as each fund’s valuation designee and actions taken to monitor and test the effectiveness of such procedures and processes;
• Information about the policies and practices of each fund’s adviser and sub-adviser with respect to trading, including their processes for seeking best execution of portfolio transactions;
• Information about the allocation of brokerage transactions and the benefits, if any, received by the adviser and sub-adviser to each fund as a result of brokerage allocation, including, as applicable, information concerning the acquisition of research through client commission arrangements and policies with respect to “soft dollars”;
• Data relating to the portfolio turnover rate of each fund and related information regarding active management in the context of particular strategies;
Information about each Adviser and Sub-Adviser
• Information regarding the individual investment professionals whose responsibilities include portfolio management and investment research for the funds, and, for portfolio managers and certain other investment professionals, information relating to their responsibilities with respect to managing other funds and investment accounts, as applicable;
1 Not all Eaton Vance Funds have entered into a sub-advisory agreement with a sub-adviser. Accordingly, references to “sub-adviser” or “sub-advisory agreement” in this “Overview” section may not be applicable to the particular Eaton Vance Fund covered by this report. Eaton Vance Management and Boston Management and Research are referred to collectively as the “adviser.”
Eaton Vance
All Asset Strategy Fund
August 31, 2026
Board of Trustees’ Contract Approval — continued
• Information regarding the adviser’s and its parent company’s (Morgan Stanley’s) efforts to retain and attract talented investment professionals, including in the context of a competitive marketplace for talent;
• Information regarding the adviser’s compensation methodology for its investment professionals and the incentives and accountability it creates, along with investment professionals’ investments in the fund(s) they manage;
• The personal trading codes of ethics of the adviser and its affiliates and the sub-adviser of each fund, together with information relating to compliance with, and the administration of, such codes;
• Policies and procedures relating to proxy voting, including regular reporting with respect to fund proxy voting activities;
• Information regarding the handling of corporate actions and class actions, as well as information regarding litigation and other regulatory matters;
• Information concerning the resources devoted to compliance efforts undertaken by the adviser and its affiliates and the sub-adviser of each fund, including descriptions of their various compliance programs and their record of compliance and remediation;
• Information concerning the business continuity and disaster recovery plans of the adviser and its affiliates and the sub-adviser of each fund;
• A description of the adviser’s oversight of sub-advisers, including with respect to regulatory and compliance issues, investment management and other matters, if any;
Other Relevant Information
• Information regarding ongoing initiatives to further integrate and harmonize, where applicable, the investment management and other departments of the adviser and its affiliates with the overall investment management infrastructure of Morgan Stanley, in light of Morgan Stanley’s acquisition of Eaton Vance Corp. on March 1, 2021;
• Information concerning the nature, cost, and character of the administrative and other non-investment advisory services provided by the adviser and its affiliates;
• Information concerning oversight of the relationship with the custodian, subcustodians, fund accountants, and other third-party service providers by the adviser and/or administrator to each of the funds;
• Information concerning efforts to maintain policies and procedures with respect to various regulations applicable to the funds, including, without limitation, Rule 22e-4 (the Liquidity Risk Management Rule), Rule 12d1-4 (the Fund-of-Funds Rule), Rule 18f-4 (the Derivatives Rule), and Rule 2a-5 (the Fair Valuation Rule);
• For each Eaton Vance Fund structured as an exchange-listed closed-end fund, information concerning the benefits of the closed-end fund structure, as well as, where relevant, the closed-end fund’s market prices (including as compared to the closed-end fund’s net asset value (NAV)), trading volume data, continued use of auction preferred shares (where applicable), distribution rates, and other relevant matters;
• The risks that the adviser and/or its affiliates incur in connection with the management and operation of the funds, including, among others, litigation, regulatory, entrepreneurial, data privacy and cybersecurity, and other business risks (and the associated costs of such risks, if any); and
• The terms of each investment advisory agreement and sub-advisory agreement.
During the various meetings of the Board and its committees over the course of the year leading up to the June 11, 2026 meeting, the Board and its committees received information from portfolio managers and other investment professionals of the adviser and sub-advisers of the funds regarding investment and performance matters, and considered various investment and trading strategies used in pursuing the funds’ investment objectives. The Board and its committees also received information regarding risk management techniques employed in connection with the management of the funds. The Board and its committees evaluated issues pertaining to industry and regulatory developments, compliance procedures, fund governance, and other issues with respect to the funds, and received and participated in reports and presentations provided by the adviser, sub-advisers, and certain other service providers, with respect to such matters. In addition to the formal meetings of the Board and its committees, the Independent Trustees met in executive sessions and held regular video or telephone conferences to discuss, among other topics, matters relating to the continuation of investment advisory agreements and sub-advisory agreements.
Each of the Contract Review Committee and the Board was advised throughout the contract review process by Kirkland & Ellis LLP, independent legal counsel for the Independent Trustees. The members of the Contract Review Committee and the members of the Board, with the advice of such counsel, exercised their own business judgment in determining the material factors to be considered in evaluating each investment advisory agreement and sub-advisory agreement and the weight to be given to each such factor. The conclusions reached with respect to each investment advisory agreement and sub-advisory agreement were based on a comprehensive evaluation of all the information provided and not any single factor. Moreover, each member of the Contract Review Committee and Board may have placed varying emphasis on particular factors in reaching conclusions with respect to each investment advisory agreement and sub-advisory agreement. In evaluating each investment advisory agreement and sub-advisory agreement, including the fee structures and other terms contained in such agreements, the members of the Contract Review Committee and Board were also informed by multiple years of analysis and discussion with the adviser and sub-adviser to each of the Eaton Vance Funds.
Eaton Vance
All Asset Strategy Fund
August 31, 2026
Board of Trustees’ Contract Approval — continued
Results of the Contract Review Process
Based on its consideration of the foregoing, and such other information it deemed relevant, including the factors and conclusions described below, the Contract Review Committee concluded that the continuation of the investment advisory and administrative agreement between Eaton Vance All Asset Strategy Fund (formerly, Eaton Vance RBA All Asset Strategy Fund) (the “Fund”) and Eaton Vance Management (the “Adviser”), including its fee structure, is in the interests of shareholders and, therefore, recommended to the Board approval of the agreement. Based on the recommendation of the Contract Review Committee, the Board, including a majority of the Independent Trustees, voted to approve continuation of the investment advisory and administrative agreement for the Fund.
Nature, Extent and Quality of Services
In considering whether to approve the investment advisory and administrative agreement for the Fund, the Board evaluated the nature, extent and quality of services provided to the Fund by the Adviser.
The Board considered the Adviser’s management capabilities and investment processes in light of the types of investments held by the Fund, including the education and experience of the investment professionals who provide services to the Fund, including recent changes to such personnel. The Board specifically noted that the Adviser has devoted extensive resources to in-house equity research and also draws upon independent research available from third-party sources. In particular, the Board evaluated the abilities and experience of the Adviser’s investment professionals in investing in assets around the world and among various asset classes, including equity, fixed-income, commodity, currency and cash investments. The Board also took into account the resources dedicated to portfolio management and other services, the compensation methods of the Adviser and other factors, including the reputation and resources of the Adviser to recruit and retain highly qualified research, advisory and supervisory investment professionals. In addition, the Board considered the time and attention devoted to the Eaton Vance Funds, including the Fund, by senior management, as well as the infrastructure, operational capabilities and support staff in place to assist in the portfolio management and operations of the Fund, including the provision of administrative services. The Board also considered the business-related and other risks to which the Adviser or its affiliates may be subject in managing the Fund.
The Board considered the compliance programs of the Adviser and relevant affiliates thereof. The Board considered compliance and reporting matters regarding, among other things, personal trading by investment professionals, disclosure of portfolio holdings, compliance with policies and procedures, portfolio valuation, business continuity and the allocation of investment opportunities. The Board also considered relevant examinations of the Adviser and its affiliates by regulatory authorities, such as the Securities and Exchange Commission and the Financial Industry Regulatory Authority.
The Board considered other administrative services provided or overseen by Eaton Vance Management and its affiliates, including transfer agency and accounting services. The Board evaluated the benefits to shareholders of investing in a fund that is a part of a large fund complex offering exposure to a variety of asset classes and investment disciplines, as well as the ability, in many cases, to exchange an investment among different funds without incurring additional sales charges.
After consideration of the foregoing factors, among others, the Board concluded that the nature, extent and quality of services provided by the Adviser, taken as a whole, are appropriate and consistent with the terms of the investment advisory and administrative agreement.
The Board noted that, effective August 18, 2025, the name and investment strategies of the Fund were changed to provide the Fund with the flexibility to allocate its assets in markets around the world and among various asset classes, including equity, fixed-income, commodity, currency and cash investments. Although the Board considered information comparing the Fund’s investment performance to that of comparable funds identified by an independent data provider (the peer group), the Board determined, in light of the recent changes, to continue to monitor and evaluate the effectiveness of such changes over time.
Management Fees and Expenses
The Board considered contractual fee rates payable by the Fund for advisory and administrative services (referred to collectively as “management fees”). As part of its review, the Board considered the Fund’s management fees and total expense ratio for the one-year period ended December 31, 2025, as compared to those of comparable funds, before and after giving effect to any undertaking to waive fees or reimburse expenses. The Board also considered certain factors identified by management in response to requests from the Contract Review Committee regarding the Fund’s total expense ratio relative to comparable funds. The Board also considered that the management fees paid by the Fund are for services provided in addition to, and are not duplicative of, services provided under the advisory contract(s) of the exchange traded funds in which the Fund may invest.
After considering the foregoing information, and in light of the nature, extent and quality of the services provided by the Adviser, the Board concluded that the management fees charged for advisory and related services are reasonable.
Eaton Vance
All Asset Strategy Fund
August 31, 2026
Board of Trustees’ Contract Approval — continued
Profitability and “Fall-Out” Benefits
The Board considered the level of profits realized by the Adviser and relevant affiliates thereof in providing investment advisory and administrative services to the Fund and to all Eaton Vance Funds as a group. The Board considered the level of profits realized without regard to marketing support or other payments by the Adviser and its affiliates to third parties in respect of distribution or other services.
The Board concluded that, in light of the foregoing factors and the nature, extent and quality of the services rendered, the profits realized by the Adviser and its affiliates are not excessive.
The Board also considered direct and indirect fall-out benefits received by the Adviser and its affiliates in connection with their respective relationships with the Fund and the other Eaton Vance Funds, including, among other things, fees for trading, distribution and/or shareholder servicing and for transaction processing and reporting platforms used by securities lending agent(s), and research received by each Adviser generated from commission dollars spent on funds’ portfolio trading.
In reviewing management fees and profitability, the Board also considered the extent to which the Adviser and its affiliates, on the one hand, and the Fund, on the other hand, can expect to realize benefits from economies of scale as the assets of the Fund increase. The Board acknowledged the difficulty in accurately measuring the benefits resulting from economies of scale, if any, with respect to the management of any specific fund or group of funds. To assist in the evaluation of the sharing of any economies of scale, the Board received data for recent years showing asset levels, Adviser profitability and total expense ratios. Based upon the foregoing, the Board concluded that the Fund currently shares in the benefits from economies of scale, if any, when they are realized by the Adviser. The Board also concluded that the structure of the advisory fee, which includes breakpoints at several asset levels, will allow the Fund to continue to benefit from any economies of scale in the future.
This Page Intentionally Left Blank
Item 8. Changes in and Disagreements with Accountants for Open-End Management Investment Companies
Not applicable.
Item 9. Proxy Disclosures for Open-End Management Investment Companies
Not applicable.
Item 10. Remuneration Paid to Directors, Officers, and Others of Open-End Management Investment Companies
The information is disclosed as part of the Financial Statements included in Item 7 of this Form N-CSR.
Item 11. Statement Regarding Basis for Approval of Investment Advisory Contract
The information is included in Item 7 of this Form N-CSR.
Item 12. Disclosure of Proxy Voting Policies and Procedures for Closed-End Management Investment Companies
Not applicable.
Item 13. Portfolio Managers of Closed-End Management Investment Companies
Not applicable.
Item 14. Purchases of Equity Securities by Closed-End Management Investment Company and Affiliated Purchasers
Not applicable.
Item 15. Submission of Matters to a Vote of Security Holders
There have been no material changes to the procedures by which shareholders may recommend nominee to the Fund’s Board of Trustees since the Fund last provided disclosure in response to this item.
Item 16. Controls and Procedures
| (a) |
It is the conclusion of the registrant’s principal executive officer and principal financial officer that the effectiveness of the registrant’s current disclosure controls and procedures (such disclosure controls and procedures having been evaluated within 90 days of the date of this filing) provide reasonable assurance that the information required to be disclosed by the registrant has been recorded, processed, summarized and reported within the time period specified in the Commission’s rules and forms and that the information required to be disclosed by the registrant has been accumulated and communicated to the registrant’s principal executive officer and principal financial officer in order to allow timely decisions regarding required disclosure. |
| (b) |
There have been no changes in the registrant’s internal control over financial reporting during the period covered by this report that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting. |
Item 17. Disclosure of Securities Lending Activities for Closed-End Management Investment Companies
Not applicable.
Item 18. Recovery of Erroneously Awarded Compensation
Not applicable.
Item 19. Exhibits
(a)(1) Registrant’s Code of Ethics – Not applicable (please see Item 2).
(a)(2)(i) Principal Financial Officer’s Section 302 certification.
(a)(2)(ii) Principal Executive Officer’s Section 302 certification.
(b) Combined Section 906 certification.
Signatures
Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
|
|
| Eaton Vance Growth Trust |
|
|
| By: |
|
/s/ Kenneth A. Topping |
|
|
Kenneth A. Topping |
|
|
Principal Executive Officer |
Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
|
|
|
| By: |
|
/s/ James F. Kirchner |
|
|
James F. Kirchner |
|
|
Principal Financial Officer |
|
|
|
| By: |
|
/s/ Kenneth A. Topping |
|
|
Kenneth A. Topping |
|
|
Principal Executive Officer |